Citrus Sinensis ID: 003350
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 828 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LX66 | 830 | Receptor-like protein kin | yes | no | 0.979 | 0.977 | 0.669 | 0.0 | |
| Q9FN92 | 829 | Probable receptor-like pr | no | no | 0.975 | 0.974 | 0.671 | 0.0 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.977 | 0.946 | 0.524 | 0.0 | |
| Q9T020 | 878 | Probable receptor-like pr | no | no | 0.956 | 0.902 | 0.503 | 0.0 | |
| Q9FLJ8 | 842 | Probable receptor-like pr | no | no | 0.935 | 0.920 | 0.506 | 0.0 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.957 | 0.962 | 0.495 | 0.0 | |
| Q9SJT0 | 871 | Probable receptor-like pr | no | no | 0.957 | 0.910 | 0.486 | 0.0 | |
| O80623 | 815 | Probable receptor-like pr | no | no | 0.927 | 0.942 | 0.485 | 0.0 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.919 | 0.896 | 0.449 | 0.0 | |
| Q9SCZ4 | 895 | Receptor-like protein kin | no | no | 0.958 | 0.887 | 0.428 | 0.0 |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1135 bits (2935), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 559/835 (66%), Positives = 666/835 (79%), Gaps = 24/835 (2%)
Query: 8 FHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNV 67
F I ++++ +C C F P DNYLI+CGS TN T+ R+F++D +SK L++ + +
Sbjct: 6 FETFILISTISILLCICH-GFTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKLLTSSKEI 64
Query: 68 VANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASF 127
+A SV ++ S +Y TAR+FT S Y FS++ RGRHW+RLYF PF YQ++ M A F
Sbjct: 65 LA----SVGGNSGSDIYHTARVFTEVSSYKFSVT-RGRHWVRLYFNPFDYQNFKMGSAKF 119
Query: 128 SVSTNDHVLLNNFSV-SSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLI 186
+VS+ HVLL++F+V SS V KE+S+NVT++ L + F+PS+ SFAF+NA+EV+S+PD LI
Sbjct: 120 AVSSQSHVLLSDFTVTSSKVVKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVISIPDTLI 179
Query: 187 TDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKS 246
T + P ++ + Q ET+HRVNMGGPLV NDTL RTWVPD FL+ +NLAKS
Sbjct: 180 TGSPRFVGNPAQFPDMSMQGLETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLEKNLAKS 239
Query: 247 VSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHF 306
+S V +V G AT++SAP TVYG+ T MNS D+PN+ FNVTWEFDVD GFQY RFHF
Sbjct: 240 MSKFSTVNFVPGYATEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHF 299
Query: 307 CDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVT-VQTASSKLRISIG 365
CDIVS LNQLYFN+Y+DS +A D+DLST NTLA AY +D VT S+K+R+SIG
Sbjct: 300 CDIVSLSLNQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNKVRVSIG 359
Query: 366 RSTLHDTYPDAILNGLEIMKMKNLQGSLGNSS--------SKKHVGVIVGVTIGVSVAAL 417
ST+H YP+AI+NGLEIMKM N +G L + SK ++G+IVG IG +A +
Sbjct: 360 PSTVHTDYPNAIVNGLEIMKMNNSKGQLSTGTFVPGSSSSSKSNLGLIVGSAIGSLLAVV 419
Query: 418 LAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTT-TSANSNSGYRFPF 476
G F+L +KR++ Q GHSK W+P SING +MGSKYS+GTT TS +N+ YR PF
Sbjct: 420 FLGSCFVLYKKRKR-GQDGHSKTWMPFSING---TSMGSKYSNGTTLTSITTNANYRIPF 475
Query: 477 VAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 536
AV++ATNNFDES IG+GGFGKVYKGELNDGTKVAVKRGNP+SQQGLAEF+TEIEMLSQ
Sbjct: 476 AAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQ 535
Query: 537 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 596
FRHRHLVSLIGYCDE NEMILIYEYMENGT+K HLYGSGLPSL+WKQRLEICIG+ARGLH
Sbjct: 536 FRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLH 595
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656
YLHTG +K VIHRDVKSANILLDENFMAKVADFGLSKTGPE+DQTHVSTAVKGSFGYLDP
Sbjct: 596 YLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDP 655
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716
EYFRRQQLT+KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ KGQLDQIID
Sbjct: 656 EYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIID 715
Query: 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENST 776
+L G IRPDSLRKF ET EKCLAD+GVDRPSMGDVLWNLEYALQLQEAV+ G+P++NST
Sbjct: 716 QSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNST 775
Query: 777 NLIGELSPQIHNFSQVDTSVN---AAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 828
N+IGEL PQI+NFSQ DTSVN A + + S++DD+SGVSMS+VFSQLVKSEGR
Sbjct: 776 NMIGELPPQINNFSQGDTSVNVPGTAGRFEESSIDDLSGVSMSKVFSQLVKSEGR 830
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1110 bits (2871), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 562/837 (67%), Positives = 665/837 (79%), Gaps = 29/837 (3%)
Query: 8 FHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNV 67
F FLIW+ S+ C + C + P DNYLI+CGS TN TV +RVF++DN AS FL++P +
Sbjct: 6 FGFLIWILSIPCLIFLC-YGYVPVDNYLINCGSSTNVTVTSRVFISDNLASNFLTSPNEI 64
Query: 68 VANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASF 127
+A + +++S +YQTARIFTG SKY FS++ RGRHWIRL+F PF YQ++ M A F
Sbjct: 65 LA----ASNRNSNSDIYQTARIFTGISKYRFSVA-RGRHWIRLHFNPFQYQNFQMVSAKF 119
Query: 128 SVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLIT 187
SVS+ HVLL++F+VSS V KE+S+NV +D L++ F+PS +SFAF+NALEVVSVPD L +
Sbjct: 120 SVSSETHVLLSDFTVSSRVMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFS 179
Query: 188 DDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSV 247
D S PGK+QGL +Q ETV+RVNMGGP VTP NDTL R W PD FLV +NL KSV
Sbjct: 180 GDPSFAGSPGKFQGLSWQALETVYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLVKSV 239
Query: 248 SNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFC 307
S I +V YV G AT+E+AP TVYGT T MNS D+P++NFNVTW+FDVD GFQY +RFHFC
Sbjct: 240 SKIASVDYVPGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFC 299
Query: 308 DIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSK-LRISIGR 366
DIVS LNQLYFN+Y+DS V +LDLS+Y +NTL+ AY +D VT +K +R+SIGR
Sbjct: 300 DIVSKALNQLYFNLYVDSMDVVENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGR 359
Query: 367 STLHDTYPDAILNGLEIMKMKNLQGSLG---------NSSSKKHVGVIVGVTIGVSVAAL 417
S++H YP AILNGLEIMKM N + L +S++KK+VG+I+G+TIG +A +
Sbjct: 360 SSVHTDYPTAILNGLEIMKMNNSKSQLSIGTFLPSGSSSTTKKNVGMIIGLTIGSLLALV 419
Query: 418 LAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFV 477
+ G F+L +KR + Q G+SK WIP+S NG S + G+ + S SNS YR P V
Sbjct: 420 VLGGFFVLYKKRGR-DQDGNSKTWIPLSSNGTTSSSNGTTLA-----SIASNSSYRIPLV 473
Query: 478 AVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF 537
AV+EATN+FDE+ IG+GGFGKVYKGEL+DGTKVAVKR NP+SQQGLAEF+TEIEMLSQF
Sbjct: 474 AVKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQF 533
Query: 538 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
RHRHLVSLIGYCDE NEMIL+YEYMENGTLK HLYGSGL SLSWKQRLEICIGSARGLHY
Sbjct: 534 RHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHY 593
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
LHTG AK VIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE
Sbjct: 594 LHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 653
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717
YFRRQQLTEKSDVYSFGVV+FEVLCARPVIDPTL REMVNLAEWAMKWQ KGQL+ IIDP
Sbjct: 654 YFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDP 713
Query: 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTN 777
+L GKIRPDSLRKFGET EKCLAD+GVDRPSMGDVLWNLEYALQLQEAVV GDP E+STN
Sbjct: 714 SLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGDP-EDSTN 772
Query: 778 LIGELSPQIHNFSQVDTSVNAAAQSDVSAVDD------ISGVSMSRVFSQLVKSEGR 828
+IGEL + ++++ DTSVN + + ++ SGVSMS+VFSQL+KSEGR
Sbjct: 773 MIGELPLRFNDYNHGDTSVNFSVAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 836 bits (2159), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/864 (52%), Positives = 579/864 (67%), Gaps = 55/864 (6%)
Query: 11 LIWVASVLCFVCFCSCQ--------FDPADNYLIDCGSRTNTTVGNRVFVADN-SASKFL 61
+++ S+L + F SC F+P DNYLI CGS N T NR+FV D+ +S L
Sbjct: 1 MVFTKSLLVLLWFLSCYTTTTSSALFNPPDNYLISCGSSQNITFQNRIFVPDSLHSSLVL 60
Query: 62 STPQNVVANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYN 121
+ VA + S S+ + +YQTAR+F+ + Y F I+ GRHWIRL+F P ++N
Sbjct: 61 KIGNSSVATSTTSNNST--NSIYQTARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWN 118
Query: 122 MSRASFSVSTNDHVLLNNFSVS----SNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALE 177
++ AS +V T D VLLNNFS + S +FKE++VNVTS+ L + F PSNNS F+NA+E
Sbjct: 119 LTSASITVVTEDFVLLNNFSFNNFNGSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIE 178
Query: 178 VVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSF 237
VVSVPD LI D A +++P + GL FETV+R+NMGGPL+T +NDTL R W D +
Sbjct: 179 VVSVPDNLIPDQALALNPSTPFSGLSLLAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEY 238
Query: 238 L-VNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDS 296
L VN ++ +N ++KY T+E+APN VY TA M + + +FNVTW VD
Sbjct: 239 LHVNSSVLVVTANPSSIKY-SPSVTQETAPNMVYATADTMGDANVASPSFNVTWVLPVDP 297
Query: 297 GFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTA 356
F+Y VR HFCDIVS LN L FN+Y++ +A+ LDLST TN L Y+ D ++ +
Sbjct: 298 DFRYFVRVHFCDIVSQALNTLVFNLYVNDDLALGSLDLSTL-TNGLKVPYFKDFISNGSV 356
Query: 357 SSK--LRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLGNSSSKKHV------------ 402
S L +S+G + D +A +NGLE++K+ N SL SS K +
Sbjct: 357 ESSGVLTVSVGPDSQADIT-NATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKK 415
Query: 403 GVIVGVTIGVSVAALLAGILFMLC----RKRRQL-PQLG-HSKAWIPVSINGGNSHTMGS 456
VI+G +G LL + C RK+R PQ G + W+P+ + G + S
Sbjct: 416 AVIIGSLVGAVTLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTKS 475
Query: 457 KYSHGTTTS-----ANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKV 511
SH + T+ A+++ G F F + +ATN FDES ++G+GGFG+VYKG L DGTKV
Sbjct: 476 TASHKSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKV 535
Query: 512 AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL 571
AVKRGNPRS+QG+AEF+TEIEMLS+ RHRHLVSLIGYCDE++EMIL+YEYM NG L+ HL
Sbjct: 536 AVKRGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHL 595
Query: 572 YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631
YG+ LP LSWKQRLEICIG+ARGLHYLHTG ++++IHRDVK+ NILLDEN +AKVADFGL
Sbjct: 596 YGADLPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGL 655
Query: 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL 691
SKTGP +DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL EVLC RP ++P L
Sbjct: 656 SKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVL 715
Query: 692 PREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGD 751
PRE VN+AEWAM WQ KG LDQI+D L GK+ P SL+KFGETAEKCLA++GVDRPSMGD
Sbjct: 716 PREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGD 775
Query: 752 VLWNLEYALQLQE-AVVHGDPDENSTNLI-----GELSPQIHNFSQVDT-SVNAAAQSDV 804
VLWNLEYALQL+E + +PD+NSTN I + P ++ S +D VN+ +D
Sbjct: 776 VLWNLEYALQLEETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTD- 834
Query: 805 SAVDDISGVSMSRVFSQLVKSEGR 828
DD + S VFSQLV GR
Sbjct: 835 ---DDAEDATTSAVFSQLVHPRGR 855
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/836 (50%), Positives = 540/836 (64%), Gaps = 44/836 (5%)
Query: 28 FDPADNYLIDCGSRTNT-TVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQT 86
F PAD+ LIDCGS++++ T RVF +D +++ +++ +S + S +Y T
Sbjct: 52 FKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDI--QVSAPPSDKVASPIYLT 109
Query: 87 ARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSN- 145
ARIF + Y F ++ G HW+RL+F F +++ +A+FSV T +VLL+NF +S+N
Sbjct: 110 ARIFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNN 169
Query: 146 ------VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKY 199
V KE+ VN+T + F P +S AFINA+EVVS PD+LI+D +++ P +
Sbjct: 170 NDSQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPVIGF 229
Query: 200 QGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIP-AVKYVQG 258
GL +++V+RVN+GGPL+ P+NDTL RTW+PD+ FL + NLAK V P A+KY
Sbjct: 230 SGLSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKY-PP 288
Query: 259 GATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLY 318
T AP TVY TA M + + NFNV+W F + F YL+R HFCDIVS LN LY
Sbjct: 289 EVTPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLY 348
Query: 319 FNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQT-ASSKLRISIGRSTLHDTYPDAI 377
FNVYI+ A+ LDLST + N LAA YY D+V T +L++ IG +AI
Sbjct: 349 FNVYINGKTAISGLDLSTVAGN-LAAPYYKDIVVNATLMGPELQVQIGPMGEDTGTKNAI 407
Query: 378 LNGLEIMKMKN----LQGSLG----NSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKR 429
LNG+E++KM N L G G + KH V + + A + G + +KR
Sbjct: 408 LNGVEVLKMSNSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIGLGAMVYKWKKR 467
Query: 430 RQLPQLGHS-KAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGY--RFPFVAVQEATNNF 486
Q Q +S +W+ + I+ G+S M SK + NS G F +QEAT NF
Sbjct: 468 PQDWQKRNSFSSWL-LPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKNF 526
Query: 487 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
+ S +IG+GGFG VY G L+DGTKVAVKRGNP+S+QG+ EFQTEI+MLS+ RHRHLVSLI
Sbjct: 527 EASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 586
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
GYCDE +EMIL+YE+M NG + HLYG L L+WKQRLEICIGSARGLHYLHTG A+ +
Sbjct: 587 GYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTAQGI 646
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
IHRDVKS NILLDE +AKVADFGLSK Q HVSTAVKGSFGYLDPEYFRRQQLT+
Sbjct: 647 IHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQLTD 705
Query: 667 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 726
KSDVYSFGVVL E LCARP I+P LPRE VNLAEWAM+W+ KG L++IIDP LAG I P+
Sbjct: 706 KSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPE 765
Query: 727 SLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSP-- 784
S++KF E AEKCL D+GVDRP+MGDVLWNLEYALQLQEA G +E ++P
Sbjct: 766 SMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEETENAKPDVVTPGS 825
Query: 785 -QIHNFSQVDTSV--NAAAQSDV---------SAVDDISGVSMSRVFSQLVKSEGR 828
+ + S + SV N AA V +AVD+ SG +M F+Q GR
Sbjct: 826 VPVSDPSPITPSVTTNEAATVPVPAKVEENSGTAVDEHSGTAM---FTQFANLNGR 878
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 764 bits (1972), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/833 (50%), Positives = 536/833 (64%), Gaps = 58/833 (6%)
Query: 1 MMGDCRGFHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGN-RVFVADNSASK 59
M GD R F + + + + S F PADNYLIDCGS T + + R F +D +
Sbjct: 1 MGGDFRHFSSHVSLLLLFLLIVKSSSSFTPADNYLIDCGSSDETKLSDGRNFKSDQQSVA 60
Query: 60 FLSTPQNVVANI-SESVTSSNDSQL--YQTARIFTGSSKYTFSISGRGRHWIRLYFYPFV 116
FL T +++ ++ S +T SN S L Y TARIF G S Y+F IS GRHWIRL+FYP
Sbjct: 61 FLQTDEDIKTSVDSIPITDSNASTLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLN 120
Query: 117 YQSYNMSRASFSVSTNDHVLLNNFSV---SSNVFKEFSVNVTSDSLDVIFSPSNNSFAFI 173
+ YN++ + FSV+T+ VLL++FS SS VFKE+ + ++ L + F P S AFI
Sbjct: 121 HPLYNLTNSVFSVTTDTTVLLHDFSAGDTSSIVFKEYLI-YAAEKLSLYFKPHKGSTAFI 179
Query: 174 NALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVP 233
NA+E+VSVPD+L+ D ASS+ ++GL + E +HR+N+GG L++P+ D L RTW+
Sbjct: 180 NAVEIVSVPDELVPDSASSVPQAPDFKGLSSFSLEILHRINIGGDLISPKIDPLSRTWLS 239
Query: 234 DQSFLVNRNLAKSVSNIPA-VKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEF 292
D+ + +++V+ P+ + Y GGAT APN VY TA M NFN++W
Sbjct: 240 DKPYNTFPEGSRNVTVDPSTITYPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRM 299
Query: 293 DVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMV- 351
VD G Y +R HFCDIVS LN L FNV+I+ A+ LDLS+ T+ L AYY D V
Sbjct: 300 SVDFGHDYFIRLHFCDIVSKSLNDLIFNVFINKLSAISALDLSSL-TSALGTAYYADFVL 358
Query: 352 -TVQTASSKLRISIGRS-TLHDTYPDAILNGLEIMKMKNLQGSL--------------GN 395
+ + + +G + L P+AILNGLEIMK+ N GSL G
Sbjct: 359 NASTITNGSILVQVGPTPNLQSGKPNAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGG 418
Query: 396 SSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQ--------------LPQLGHSKAW 441
SSKK I G+ +++ A L G++ +L R +R+ LP ++
Sbjct: 419 MSSKKLA--IAGIGFVMALTAFL-GVVVLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSY 475
Query: 442 IPVSINGGNSHTM---GSKYSHGTTTSA---NSNSGYRFPFVAVQEATNNFDESWVIGIG 495
I S G S M GSK S S+ N G FPF +Q AT NFDE+ V G+G
Sbjct: 476 IS-SKGGSTSRRMSIFGSKKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVG 534
Query: 496 GFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555
GFGKVY GE++ GT+VA+KRG+ S+QG+ EFQTEI+MLS+ RHRHLVSLIG+CDE EM
Sbjct: 535 GFGKVYIGEIDGGTQVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEM 594
Query: 556 ILIYEYMENGTLKGHLYGSG------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
IL+YEYM NG L+ HLYGS +P+LSWKQRLEICIGSARGLHYLHTG A+ +IHR
Sbjct: 595 ILVYEYMSNGPLRDHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHR 654
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
DVK+ NILLDEN +AKV+DFGLSK P +D+ HVSTAVKGSFGYLDPEYFRRQQLT+KSD
Sbjct: 655 DVKTTNILLDENLVAKVSDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSD 713
Query: 670 VYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLR 729
VYSFGVVLFEVLCARPVI+P LPRE VNLAE+AM KG L++IIDP + G I SLR
Sbjct: 714 VYSFGVVLFEVLCARPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLR 773
Query: 730 KFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGEL 782
KF E AEKCLA++GVDRP MGDVLWNLEYALQLQEA D E+ T + E+
Sbjct: 774 KFVEAAEKCLAEYGVDRPGMGDVLWNLEYALQLQEASAQVDLSEDKTTMNIEM 826
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 762 bits (1968), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/835 (49%), Positives = 549/835 (65%), Gaps = 42/835 (5%)
Query: 16 SVLCFVC----FCSCQFDPADNYLIDCGSRTNTTV-GNRVFVADNS--ASKFLSTPQNVV 68
++L F C F P DNYLI+ GS TNT+ R F++D+S S FLST +++
Sbjct: 10 TLLFFFCPLLHLSFAAFTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSI- 68
Query: 69 ANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFS 128
+IS++ S + LY TAR+F Y F ++ +G H+IRL+F PF +N+ A F
Sbjct: 69 -SISDTNPSPDSPVLYNTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFR 127
Query: 129 VSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNS-FAFINALEVVSVPDQLIT 187
V N ++N+FS SS V KEF + + L++ F P S F F+NA+EV S P I
Sbjct: 128 VLINGFSVINSFSTSSVVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIM 187
Query: 188 DDASSISPPGKYQ---GLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLA 244
D + + P Q L Q ETVHR+N+GG +TP NDTLWRTWV D ++L+ R A
Sbjct: 188 DQGTKLVIPNSAQIFSNLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAA 247
Query: 245 KSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDD-DPNANFNVTWEFDVDSG-FQYLV 302
+ + Y GGAT+E AP+ VY TA M+ D+ + A FN++W F VD +LV
Sbjct: 248 RRAWTTHSPNYQNGGATREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLV 307
Query: 303 RFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRI 362
R HFCDIVS LNQLYFNV+I+ ++A +D+DLST + + LA+ YID V S LRI
Sbjct: 308 RLHFCDIVSSSLNQLYFNVFINEYLAFKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRI 367
Query: 363 SIGRSTLHD-TYPDAILNGLEIMKMKNLQGSLGNSSSKKHVGVIVGVTIG--VSVAALLA 419
S+G S L + +A+LNG+EIM++ + S S + V ++VG +G V ++
Sbjct: 368 SVGPSDLSNPARVNALLNGVEIMRILSPVSSEVVSGKRNVVWIVVGSVLGGFVFLSLFFL 427
Query: 420 GILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGY---RFPF 476
+L LCR++ + S W P+ G+S++ TT S+SGY R F
Sbjct: 428 SVL-CLCRRKNNKTRSSESTGWTPLRRFRGSSNSR-------TTERTVSSSGYHTLRISF 479
Query: 477 VAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 536
+Q TNNFD S VIG+GGFG V++G L D TKVAVKRG+P S+QGL EF +EI +LS+
Sbjct: 480 AELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSK 539
Query: 537 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 596
RHRHLVSL+GYC+E++EMIL+YEYM+ G LK HLYGS P LSWKQRLE+CIG+ARGLH
Sbjct: 540 IRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLH 599
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656
YLHTG ++ +IHRD+KS NILLD N++AKVADFGLS++GP ID+THVST VKGSFGYLDP
Sbjct: 600 YLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDP 659
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716
EYFRRQQLT+KSDVYSFGVVLFEVLCARP +DP L RE VNLAEWA++WQ KG LDQI+D
Sbjct: 660 EYFRRQQLTDKSDVYSFGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVD 719
Query: 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENST 776
P +A +I+P SL+KF ETAEKC AD+GVDRP++GDVLWNLE+ LQLQE+ P+E+
Sbjct: 720 PNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEEDYG 779
Query: 777 NLIGELSPQ--IHNFSQVDTSVNAAAQSDVSAVDDISG-VSMSRVFSQLVKSEGR 828
++ + + + N S ++ D SG +S ++VFSQL+ + GR
Sbjct: 780 DVTDPRTARQGLSNGSNIERDYG----------DGTSGIISSTQVFSQLMTNAGR 824
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/829 (48%), Positives = 524/829 (63%), Gaps = 36/829 (4%)
Query: 28 FDPADNYLIDCGSRTNT-TVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQT 86
F PAD+ LIDCGS+++T T RVF +D+ +++ ++ +S + S +Y T
Sbjct: 51 FKPADDILIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDDI--QVSAPPSDKLPSPIYLT 108
Query: 87 ARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSN- 145
A+IF + Y F ++ G HW+RL+F+ F +++ +A+FSV T +VLL+NF +S++
Sbjct: 109 AKIFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFKLSNDN 168
Query: 146 ------VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKY 199
V KE+ +N+T + F P S AFIN +E+VS PD+LI+D +S+ P +
Sbjct: 169 NDSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTSLFPVNGF 228
Query: 200 QGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGG 259
GL +++V+RVN+GGPL+TP+NDTL RTW PD+ +L + NLAK V P G
Sbjct: 229 SGLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKTNPTAIIYPPG 288
Query: 260 ATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYF 319
T AP TVY T M + NFNVTW F + F Y +R HFCDI+S LN LYF
Sbjct: 289 VTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSLNDLYF 348
Query: 320 NVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQT-ASSKLRISIGRSTLHDTYPDAIL 378
NVYI+ A+ LDLST + + L+A YY D+V T +S+L++ IG +AIL
Sbjct: 349 NVYINGKTAISGLDLSTVAGD-LSAPYYKDIVVNSTLMTSELQVQIGPMGEDTGKKNAIL 407
Query: 379 NGLEIMKMKNLQGSL-------GNSSSKKHVGVIVGVTIGVSVAALLA-GILFMLCRKRR 430
NG+E++KM N SL G +S G++ + A + G + +KR
Sbjct: 408 NGVEVLKMSNSVNSLDGEFGVDGQRASMGKQGMVATAGFVMMFGAFVGLGAMVYKWKKRP 467
Query: 431 QLPQLGHS-KAWIPVSINGGNSHTMGSKYSHGTTTSANS--NSGYRFPFVAVQEATNNFD 487
Q Q +S +W+ + I+ G+S M SK + NS G F +QE T NFD
Sbjct: 468 QDWQKRNSFSSWL-LPIHAGDSTFMTSKTGSHKSNLYNSALGLGRYFSLSELQEVTKNFD 526
Query: 488 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
S +IG+GGFG VY G ++DGT+VA+KRGNP+S+QG+ EF TEI+MLS+ RHRHLVSLIG
Sbjct: 527 ASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRHLVSLIG 586
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
YCDE EMIL+YEYM NG + HLYG L L+WKQRLEICIG+ARGLHYLHTG A+ +I
Sbjct: 587 YCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTGTAQGII 646
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
HRDVKS NILLDE +AKVADFGLSK Q HVSTAVKGSFGYLDPEYFRRQQLT+K
Sbjct: 647 HRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDK 705
Query: 668 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727
SDVYSFGVVL E LCARP I+P LPRE VNLAEWAM W+ KG L++IIDP L G + P+S
Sbjct: 706 SDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVGAVNPES 765
Query: 728 LRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGD--------PDENSTNLI 779
++KF E AEKCLAD+GVDRP+MGDVLWNLEYALQLQEA G P +
Sbjct: 766 MKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQGKAEAEEVETPKPVAVPAA 825
Query: 780 GELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 828
SP + + V+ + D S VD SG +M F+Q GR
Sbjct: 826 APTSPAATTAAASERPVSQTEEKDDSTVDQHSGTTM---FTQFASLNGR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O80623|Y2393_ARATH Probable receptor-like protein kinase At2g39360 OS=Arabidopsis thaliana GN=At2g39360 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 748 bits (1930), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/847 (48%), Positives = 540/847 (63%), Gaps = 79/847 (9%)
Query: 18 LCFVC--FCSCQFDP-ADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISES 74
LCF+ CS +D + I+CGS TN TV NR FV+DN N+V S
Sbjct: 12 LCFLITLLCSSHISSVSDTFFINCGSPTNVTVNNRTFVSDN----------NLVQGFSVG 61
Query: 75 VTSSN---DSQLYQTARIFT--GSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSV 129
T SN +S L+QTAR+F+ SS Y F I G IR+YF P V S +++ A FSV
Sbjct: 62 TTDSNSGDESTLFQTARVFSDESSSTYRFPIEEHGWFLIRIYFLPLVSASQDLTTARFSV 121
Query: 130 STNDHVLLNNFSVSS-NVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITD 188
S + L+ + S+ +V +E+ +NVT+DSL + F P S +FINALEV+ +P+ LI +
Sbjct: 122 SAQNFTLIREYKPSTTSVVREYILNVTTDSLLLQFLPRTGSVSFINALEVLRLPETLIPE 181
Query: 189 DASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVS 248
DA I + L ETV RVNMG V+ + D LWR W D ++ + V
Sbjct: 182 DAKLIGTQKDLK-LSSHAMETVSRVNMGNLSVSRDQDKLWRQWDSDSAY--KAHFGTPVM 238
Query: 249 NIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCD 308
N+ AV + GG T + AP VYGTATR+NSD DPN N N+TW F V+ GF Y VRFHFC+
Sbjct: 239 NLKAVNFSAGGITDDIAPVYVYGTATRLNSDLDPNTNANLTWTFKVEPGFDYFVRFHFCN 298
Query: 309 IVSDGL---NQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSK--LRIS 363
I+ D Q+ F+++++S VR +D++ T A +++D V + S + L +S
Sbjct: 299 IIVDPFGFERQIRFDIFVNSE-KVRTIDMTEVLNGTFGAPFFVDAVMRKAKSREGFLNLS 357
Query: 364 IGRSTLHDTYPDAILNGLEIMKMKNLQGSLG------------NSSSKKHVGVIVGVTIG 411
IG +YP + +NG EI K+ N + SL N SS VG+I G++
Sbjct: 358 IGLVMDVSSYPVSFINGFEISKLSNDKRSLDAFDAILPDGSSSNKSSNTSVGLIAGLSAA 417
Query: 412 VSVAALLAGILFMLC-----RKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSA 466
+ VA + ++ C R+ RQ+ Q HS+ G+ H + + + +
Sbjct: 418 LCVALVFGVVVSWWCIRKRRRRNRQM-QTVHSR---------GDDHQIKKNETGESLIFS 467
Query: 467 NSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE 526
+S GYR+P ++EAT++FDES VIG+GGFGKVYKG L D T+VAVKRG P+S+QGLAE
Sbjct: 468 SSKIGYRYPLALIKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAE 527
Query: 527 FQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRL 585
F+TE+EML+QFRHRHLVSLIGYCDE +EMI++YEYME GTLK HLY P LSW+QRL
Sbjct: 528 FKTEVEMLTQFRHRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRL 587
Query: 586 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645
EIC+G+ARGLHYLHTG +A+IHRDVKSANILLD+NFMAKVADFGLSKTGP++DQTHVST
Sbjct: 588 EICVGAARGLHYLHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVST 647
Query: 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW 705
AVKGSFGYLDPEY RQQLTEKSDVYSFGVV+ EV+C RPVIDP+LPRE VNL EWAMK
Sbjct: 648 AVKGSFGYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKL 707
Query: 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ-- 763
KG+L+ IIDP L GK++ + ++K+ E EKCL+ G++RP+MGD+LWNLE+ LQ+Q
Sbjct: 708 VKKGKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNLEFMLQVQAK 767
Query: 764 --EAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQ 821
+A + D E S V + Q V+ V DI+GVSMS+VF+Q
Sbjct: 768 DEKAAMVDDKPEASV-------------------VGSTMQFSVNGVGDIAGVSMSKVFAQ 808
Query: 822 LVKSEGR 828
+V+ E R
Sbjct: 809 MVREETR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 668 bits (1724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/804 (44%), Positives = 494/804 (61%), Gaps = 43/804 (5%)
Query: 13 WVASVLCFVCFCSCQFD----PADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVV 68
++ +LC + F + + ++L+DCGS T V R +V D S +K ++
Sbjct: 8 YLEHLLCVLIFFTYVIGYGEAQSKSFLVDCGSNATTEVDGRTWVGDLSPNKSVTLQGFDA 67
Query: 69 ANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFS 128
S S SS +++Y+TAR+F YTF +G +++RL+F PF +++N++ +SFS
Sbjct: 68 ITASTSKGSSVYAEIYKTARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSFS 127
Query: 129 VSTNDHVLLNNFSVS-------------------SNVFKEFSVNVTSDSLDVIFSPSNNS 169
V + L+ + +++ S++ KEF + L + F P S
Sbjct: 128 VFADGLRLMLDINIAGEIAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKGS 187
Query: 170 FAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPEND-TLW 228
F F+NA+E+VSV D+L + + + GL + ET++R+N+GGP + P D L+
Sbjct: 188 FGFVNAIEIVSVDDKLFKESVTKVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLY 247
Query: 229 RTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNV 288
RTW D S++V N V N + Y + AP VY TA M++ + FN+
Sbjct: 248 RTWETDLSYMVIENAGVEVKNSSNITYALADDSP-VAPLLVYETARMMSNTEVLEKRFNI 306
Query: 289 TWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYI 348
+W+F+VD F YLVR HFC+++ D NQ F +YI++ A + D+ ++ Y
Sbjct: 307 SWKFEVDPNFDYLVRLHFCELLVDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQD 366
Query: 349 DMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMK---NLQ-----GSLGNSSSKK 400
+ V + + L I +G + DA+L+GLEI K+ NL S G+S S
Sbjct: 367 YLDPVSSKNDVLWIQLGPDSSVGASGDALLSGLEIFKLSKNGNLAHLIRFDSTGHSVSDS 426
Query: 401 HVGVI---VGVTIGVSVAALLAGILFM-LCRKRRQLPQLGHSK--AWIPVSINGGNSHTM 454
+ +I VG I + + + GIL + LC+KRR + W P+ ++ NS T
Sbjct: 427 KMRIIWISVGAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNS-TA 485
Query: 455 GSKYSHGT---TTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKV 511
+K + G+ T A S G +F ++ AT NFD+ IG+GGFGKVY+GEL DGT +
Sbjct: 486 NAKATGGSLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLI 545
Query: 512 AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL 571
A+KR P SQQGLAEF+TEI MLS+ RHRHLVSLIG+CDE NEMIL+YEYM NGTL+ HL
Sbjct: 546 AIKRATPHSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHL 605
Query: 572 YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631
+GS LP LSWKQRLE CIGSARGLHYLHTG + +IHRDVK+ NILLDENF+AK++DFGL
Sbjct: 606 FGSNLPPLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGL 665
Query: 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL 691
SK GP +D THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE +CAR VI+PTL
Sbjct: 666 SKAGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTL 725
Query: 692 PREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGD 751
P++ +NLAEWA+ WQ + L+ IID L G P+SL K+GE AEKCLAD G +RP MG+
Sbjct: 726 PKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGE 785
Query: 752 VLWNLEYALQLQEAVVHGDPDENS 775
VLW+LEY LQ+ EA + ENS
Sbjct: 786 VLWSLEYVLQIHEAWLRKQNGENS 809
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1 | Back alignment and function description |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/879 (42%), Positives = 517/879 (58%), Gaps = 85/879 (9%)
Query: 25 SCQFDPADNYLIDCGSRTN--TTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQ 82
+ + P + L++CG + T NR++++D SKFLS+ + +
Sbjct: 27 AADYSPTEKILLNCGGGASNLTDTDNRIWISD-VKSKFLSSSSEDSKTSPALTQDPSVPE 85
Query: 83 L-YQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFS 141
+ Y TAR+F YTF ++ GR ++RLYFYP Y N + + FSVS + LL NFS
Sbjct: 86 VPYMTARVFRSPFTYTFPVAS-GRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNFS 144
Query: 142 VSSN--------VFKEFSVNVTSDSLDVIFSPSN---NSFAFINALEVVSVPDQLITDDA 190
S + KEF VNV +L++ F+P + N++AF+N +EV S+PD + D
Sbjct: 145 ASQTAEALTYAFIIKEFVVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPDMYSSTDG 204
Query: 191 S--SISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDT-LWRTWVPDQSFLVNRNLAKSV 247
+ + G E V+R+N+GG ++P DT L+R+W DQ ++ L
Sbjct: 205 TLTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFGAGLGIPE 264
Query: 248 SNIP--AVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFH 305
+ P +KY G T AP VY TA M N N+N+TW F +DSGF YLVR H
Sbjct: 265 TADPNMTIKYPTGTPTY-VAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTYLVRLH 323
Query: 306 FCDIVSD--GLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQ---TASSKL 360
FC++ S+ +NQ F +Y+++ A + D+ + T++ ++ D V L
Sbjct: 324 FCEVSSNITKINQRVFTIYLNNQTAEPEADVIAW-TSSNGVPFHKDYVVNPPEGNGQQDL 382
Query: 361 RISIGRSTLHDT-YPDAILNGLEIMKMKNLQGSLGNSS---------------------S 398
+++ + ++ Y D++LNG+EI KM G+L ++ S
Sbjct: 383 WLALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVLRPTTRKS 442
Query: 399 KKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQL----PQLGHSKAWIPVSINGGNSHTM 454
K + +I G G V AL+ G +RR+ P + W+P+S+ G NSH+
Sbjct: 443 KSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYG-NSHSA 501
Query: 455 GSKYSHGTTTSANS---NSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGT-K 510
GS ++ T + A+S N F F ++ AT NFDES V+G+GGFGKVY+GE++ GT K
Sbjct: 502 GSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTK 561
Query: 511 VAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGH 570
VA+KRGNP S+QG+ EFQTEIEMLS+ RHRHLVSLIGYC+E EMIL+Y+YM +GT++ H
Sbjct: 562 VAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREH 621
Query: 571 LYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630
LY + PSL WKQRLEICIG+ARGLHYLHTG +IHRDVK+ NILLDE ++AKV+DFG
Sbjct: 622 LYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFG 681
Query: 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPT 690
LSKTGP +D THVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCARP ++PT
Sbjct: 682 LSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPT 741
Query: 691 LPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMG 750
L +E V+LAEWA KG LDQI+DP L GKI P+ +KF ETA KC+ D G++RPSMG
Sbjct: 742 LAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMG 801
Query: 751 DVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVS----- 805
DVLWNLE+ALQLQE+ +EN + G++ + + SDV
Sbjct: 802 DVLWNLEFALQLQESA-----EENGKGVCGDMDMDEIKYDDGNCKGKNDKSSDVYEGNVT 856
Query: 806 ----------------AVDDISGVSMSRVFSQLVKSEGR 828
A +D G++ S VFSQ++ +GR
Sbjct: 857 DSRSSGIDMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 895
|
Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 828 | ||||||
| 224054892 | 832 | predicted protein [Populus trichocarpa] | 0.995 | 0.990 | 0.770 | 0.0 | |
| 224104501 | 833 | predicted protein [Populus trichocarpa] | 0.996 | 0.990 | 0.755 | 0.0 | |
| 359478665 | 1006 | PREDICTED: receptor-like protein kinase | 0.958 | 0.789 | 0.756 | 0.0 | |
| 356542591 | 837 | PREDICTED: receptor-like protein kinase | 0.995 | 0.984 | 0.721 | 0.0 | |
| 147816692 | 802 | hypothetical protein VITISV_009237 [Viti | 0.921 | 0.951 | 0.759 | 0.0 | |
| 449461015 | 839 | PREDICTED: receptor-like protein kinase | 0.992 | 0.979 | 0.712 | 0.0 | |
| 351725301 | 811 | protein kinase precursor [Glycine max] g | 0.963 | 0.983 | 0.695 | 0.0 | |
| 357472565 | 840 | Kinase-like protein [Medicago truncatula | 0.992 | 0.978 | 0.693 | 0.0 | |
| 351726174 | 833 | protein kinase precursor [Glycine max] g | 0.991 | 0.985 | 0.715 | 0.0 | |
| 357454055 | 847 | Kinase-like protein [Medicago truncatula | 0.997 | 0.975 | 0.672 | 0.0 |
| >gi|224054892|ref|XP_002298383.1| predicted protein [Populus trichocarpa] gi|222845641|gb|EEE83188.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1313 bits (3398), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 643/835 (77%), Positives = 714/835 (85%), Gaps = 11/835 (1%)
Query: 2 MGDCRGFHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFL 61
MG F+ + S+L VC S F P DNYLIDCGS TNTTVGNRVFVADNSAS FL
Sbjct: 1 MGSVGSRRFICVLLSILSLVCLSS-GFTPVDNYLIDCGSLTNTTVGNRVFVADNSASNFL 59
Query: 62 STPQNVVANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYN 121
STP+N AN S SVTS +DS LYQTARIF G+SKYTF I+ GRHWIRLYFYPFV SYN
Sbjct: 60 STPKNTFANASISVTSGDDSPLYQTARIFDGTSKYTFLINQPGRHWIRLYFYPFVSGSYN 119
Query: 122 MSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSV 181
MS ASF VST ++ L+NFSV ++V KEFSVNVTS +L + +PS NSFAF+NALEVVSV
Sbjct: 120 MSNASFGVSTLNYAFLSNFSVKASVVKEFSVNVTSKNLVITITPSGNSFAFLNALEVVSV 179
Query: 182 PDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNR 241
PD+LITDDA + +P G+++GL +Q ETVHRVNMGGP V+ ENDTL RTWVPDQSFL+
Sbjct: 180 PDELITDDAETFNPVGRFKGLSWQALETVHRVNMGGPTVSFENDTLGRTWVPDQSFLIQN 239
Query: 242 NLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYL 301
NLA +VSNI AVKYV GGAT++SAPN VYGTA+RMNSD++P++NFNVTWEF+V GFQYL
Sbjct: 240 NLAINVSNIAAVKYVVGGATQDSAPNAVYGTASRMNSDNNPSSNFNVTWEFNVQPGFQYL 299
Query: 302 VRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLR 361
VRFHFCDIVS LN+LYF+VYIDSW+ ++D ST + NTLA A+Y+D VT T S+KLR
Sbjct: 300 VRFHFCDIVSRNLNELYFDVYIDSWLVAENVDPSTIA-NTLAVAFYMDFVTAATVSNKLR 358
Query: 362 ISIGRS-TLHDTYPDAILNGLEIMKMKNLQGSL-------GNSSSKKHVGVIVGVTIGVS 413
+SIG + T+ YP+AILNGLEIMKM N GSL NSSSKK+VGVIVG++IG
Sbjct: 359 VSIGPTNTISSAYPNAILNGLEIMKMNNSLGSLSGTAPAVANSSSKKNVGVIVGLSIGAL 418
Query: 414 VAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYR 473
+ A+LAGI FM CRKRR+L + GHSK WIP SINGGNSHTMGSKYS+GT TS N GYR
Sbjct: 419 ILAVLAGIFFMFCRKRRRLARQGHSKTWIPFSINGGNSHTMGSKYSNGTATSLGYNLGYR 478
Query: 474 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM 533
PFVAVQEATN+FDESWVIGIGGFGKVY+G LNDGTKVAVKRGNPRSQQGLAEFQTEIEM
Sbjct: 479 IPFVAVQEATNSFDESWVIGIGGFGKVYRGVLNDGTKVAVKRGNPRSQQGLAEFQTEIEM 538
Query: 534 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 593
LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK HLYGSG P+LSWK RLEICIG+AR
Sbjct: 539 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKSHLYGSGSPTLSWKDRLEICIGAAR 598
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
GLHYLHTGYAKAVIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY
Sbjct: 599 GLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 658
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713
LDPEYFRRQQLTEKSDVYSFGVVL EVLCARPVIDP+LPREMVNLAEWAMKWQ +GQL+Q
Sbjct: 659 LDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPVIDPSLPREMVNLAEWAMKWQKRGQLEQ 718
Query: 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDE 773
IID LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGD+LWNLEYALQLQEAV+ GDP+E
Sbjct: 719 IIDAALAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDILWNLEYALQLQEAVLPGDPEE 778
Query: 774 NSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 828
NSTN+IGELSPQI+NFS D SV +AAQ + S+VD +SGVSMSRVFSQLVKSEGR
Sbjct: 779 NSTNMIGELSPQINNFSHSDDSV-SAAQFEASSVDGLSGVSMSRVFSQLVKSEGR 832
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224104501|ref|XP_002313457.1| predicted protein [Populus trichocarpa] gi|222849865|gb|EEE87412.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1291 bits (3342), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/836 (75%), Positives = 712/836 (85%), Gaps = 11/836 (1%)
Query: 1 MMGDCRGFHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASKF 60
MMG G +I V + + F S F P DNYLIDCGS TNTTVG RVFVAD+SAS F
Sbjct: 1 MMGGG-GSRIVICVLLTVLILAFLSSGFTPVDNYLIDCGSPTNTTVGGRVFVADDSASIF 59
Query: 61 LSTPQNVVANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSY 120
LSTP++ +A+ S+SVTS +DS LYQTARIF G+SKY+FSI GRHWIRLYF PFV SY
Sbjct: 60 LSTPKSTLASSSKSVTSGDDSPLYQTARIFDGTSKYSFSIRQPGRHWIRLYFNPFVSGSY 119
Query: 121 NMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVS 180
+MS ASF VST +HV L+NFSV ++V KEFS NVTS L + F+PS NSFAF+NALEVVS
Sbjct: 120 DMSGASFDVSTPNHVFLSNFSVKTSVVKEFSANVTSKDLVITFTPSGNSFAFLNALEVVS 179
Query: 181 VPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVN 240
VPD+LITDDA + +P G+++GL +Q ETV+RVNMGGP V+ ENDTL RTWVPD+S+LV
Sbjct: 180 VPDELITDDAETFNPAGRFKGLSWQALETVYRVNMGGPTVSFENDTLGRTWVPDKSYLVG 239
Query: 241 RNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQY 300
NLA +VSNI AVKYV GGAT++SAPN VYGTA RMNS++DPN+NFNVTWEF+V+ GFQY
Sbjct: 240 NNLATNVSNIAAVKYVAGGATQDSAPNAVYGTAIRMNSENDPNSNFNVTWEFNVNPGFQY 299
Query: 301 LVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKL 360
LVRFHFCDIVS LN LYFNVYIDSW+ D D S+++ N LA A+Y D VT T S+KL
Sbjct: 300 LVRFHFCDIVSSSLNNLYFNVYIDSWLVAEDEDPSSFA-NALAVAFYKDFVTAATVSNKL 358
Query: 361 RISIGRS-TLHDTYPDAILNGLEIMKMKNLQGSLG-------NSSSKKHVGVIVGVTIGV 412
R+SIG + T+ YP+AILNGLEIMKM N GSL +SSSKK+VGVIVG++IG
Sbjct: 359 RVSIGPTNTIAVAYPNAILNGLEIMKMNNSLGSLSGPAPDVSDSSSKKNVGVIVGLSIGA 418
Query: 413 SVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGY 472
+ +LAGI F+ CRKRR+L + G+SK WIP+SINGGNSHTMG+KYS+GTT + +SN GY
Sbjct: 419 VILVVLAGIFFVFCRKRRRLARQGNSKMWIPLSINGGNSHTMGTKYSNGTTATLDSNLGY 478
Query: 473 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIE 532
PF AV EATNNFDESWVIGIGGFGKVYKG LNDGTKVAVKRGNPRSQQGLAEFQTEIE
Sbjct: 479 CIPFAAVHEATNNFDESWVIGIGGFGKVYKGVLNDGTKVAVKRGNPRSQQGLAEFQTEIE 538
Query: 533 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 592
MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK HLYGSG PSL WK RLEICIG+A
Sbjct: 539 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKSHLYGSGSPSLCWKDRLEICIGAA 598
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 652
RGLHYLHTGYAKAVIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFG
Sbjct: 599 RGLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 658
Query: 653 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712
YLDPEYFRRQQLTEKSD+YSFGVVLFEVLCARPVIDP+LPREMVNLAEWAMKWQ +GQL+
Sbjct: 659 YLDPEYFRRQQLTEKSDIYSFGVVLFEVLCARPVIDPSLPREMVNLAEWAMKWQKRGQLE 718
Query: 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPD 772
+IIDPTL GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVV GDP+
Sbjct: 719 EIIDPTLVGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVLGDPE 778
Query: 773 ENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 828
+NS N+IGELSPQI+NFS D+SV +AA+ + S+VDD+SGVSMSRVFSQLVKSEGR
Sbjct: 779 DNSINMIGELSPQINNFSHTDSSV-SAAKFEASSVDDLSGVSMSRVFSQLVKSEGR 833
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478665|ref|XP_002281617.2| PREDICTED: receptor-like protein kinase HERK 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1264 bits (3270), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 609/805 (75%), Positives = 696/805 (86%), Gaps = 11/805 (1%)
Query: 32 DNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANI-SESVTSSNDSQLYQTARIF 90
D+YLIDCGS TNT+V RVF+AD S+ +LSTP+ ++AN ++S +SS+D LYQTARIF
Sbjct: 205 DDYLIDCGSTTNTSVAGRVFLADTSS--YLSTPEKLLANTATKSDSSSDDLPLYQTARIF 262
Query: 91 TGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSS-NVFKE 149
TG+SKYTFS+ R+WIRLYF+PFVY +YNMS A+FSVST +HVL++NFS + + KE
Sbjct: 263 TGTSKYTFSVGSNRRYWIRLYFFPFVYDTYNMSTANFSVSTQNHVLISNFSPKAGSAMKE 322
Query: 150 FSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFET 209
FS NVTSD+L + F+PS+NSFAF+NALEVVSVP++LI+DDA +I+P GK++GLV Q ET
Sbjct: 323 FSENVTSDTLVITFAPSSNSFAFLNALEVVSVPNELISDDAITITPSGKFKGLVTQALET 382
Query: 210 VHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTV 269
V RVNMGGP VT ENDTLWRTW+PDQ+FLV NLA +VS I AV Y +GG TK AP +V
Sbjct: 383 VARVNMGGPTVTSENDTLWRTWLPDQNFLVENNLATNVSKIGAVIYAKGGPTKLIAPASV 442
Query: 270 YGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAV 329
YGTAT+MNSD +P NFNVTWEFDVD GFQYLVR+HFCDIVS LNQLYFNVY+DS++
Sbjct: 443 YGTATKMNSDANPQYNFNVTWEFDVDPGFQYLVRYHFCDIVSISLNQLYFNVYLDSYLVY 502
Query: 330 RDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNL 389
+LDLST + N L A YY+D+VT SKLR+SIG S++H YPDAILNGLEIMKM +
Sbjct: 503 EELDLSTLAFNILGAPYYLDVVTGTRVGSKLRVSIGPSSIHTEYPDAILNGLEIMKMNSS 562
Query: 390 QGSLG------NSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIP 443
GSL N SSKK+V V++G ++GV A +LAG+ F++ R+RR+L + GHSK W+
Sbjct: 563 MGSLSGSVIVSNPSSKKNVAVVIGASVGVFAALILAGVFFLVYRRRRKLARQGHSKTWMA 622
Query: 444 VSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG 503
S NGGNSHTMGSKYS+GT SA SN GYR PF+AVQEATNNFDESWVIGIGGFGKVYKG
Sbjct: 623 FSTNGGNSHTMGSKYSNGTIASAGSNFGYRIPFLAVQEATNNFDESWVIGIGGFGKVYKG 682
Query: 504 ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563
LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME
Sbjct: 683 TLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 742
Query: 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 623
NGT+K HLYGSGLPSL WK+RLEICIG+ARGLHYLHTGYAKAVIHRDVKSANILLDEN M
Sbjct: 743 NGTVKSHLYGSGLPSLDWKERLEICIGAARGLHYLHTGYAKAVIHRDVKSANILLDENLM 802
Query: 624 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 683
AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA
Sbjct: 803 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 862
Query: 684 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFG 743
RPVIDPTLPREMVNLAEWAMKWQ +GQL+QIIDP L GKIRPDSLRKFGETAEKCL+DFG
Sbjct: 863 RPVIDPTLPREMVNLAEWAMKWQKRGQLEQIIDPNLVGKIRPDSLRKFGETAEKCLSDFG 922
Query: 744 VDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSD 803
VDRPSMGD+LWNLEYALQLQEAV+ GDP+ENSTNLIGEL+PQ++NF+ DTSV +AAQ +
Sbjct: 923 VDRPSMGDILWNLEYALQLQEAVLVGDPEENSTNLIGELAPQVNNFNHADTSV-SAAQFE 981
Query: 804 VSAVDDISGVSMSRVFSQLVKSEGR 828
VS+VDD+SG+SMSRVFSQLVKSEGR
Sbjct: 982 VSSVDDLSGISMSRVFSQLVKSEGR 1006
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542591|ref|XP_003539750.1| PREDICTED: receptor-like protein kinase HERK 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1245 bits (3221), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/840 (72%), Positives = 703/840 (83%), Gaps = 16/840 (1%)
Query: 2 MGDCRGFHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFL 61
M DCR I V S+L VCF S F P DNYLIDCGS TNT + +R F AD+ FL
Sbjct: 1 MRDCREICLFICVLSILPLVCF-SANFVPTDNYLIDCGSPTNTPIDSRNFTADSFYKNFL 59
Query: 62 STPQNVVANIS-ESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSY 120
ST Q++VA+ S +S+TS++DS LY TARIFT SKYTF I+ +GRHWIRLYF+PF Y+ Y
Sbjct: 60 STQQDIVASTSLKSITSTSDSPLYSTARIFTAPSKYTFPINKKGRHWIRLYFFPFAYEKY 119
Query: 121 NMSRASFSVSTNDHVLLNNFSVSSN-VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVV 179
N+S A F+VST ++ LL++FSV N V KE+S+NVTSD+L + FSPS+NS AF+NA+EVV
Sbjct: 120 NLSAAKFAVSTQNYNLLSDFSVQKNPVMKEYSLNVTSDTLVITFSPSDNSIAFVNAIEVV 179
Query: 180 SVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLV 239
SVPD LI DDA++++P G Y GL Q ETV RVNMGGP ++ +DTL RTWVPD+ FL+
Sbjct: 180 SVPDDLIIDDANTLNPAGSYSGLFAQALETVFRVNMGGPTISSGSDTLQRTWVPDEKFLI 239
Query: 240 NRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQ 299
NLA++ +NI AVKYV GG T+ +AP +VYGT T+MNS DDP +NFNVTW+FDV+ FQ
Sbjct: 240 QPNLARNFTNIGAVKYVDGGPTENTAPPSVYGTLTQMNSADDPRSNFNVTWQFDVEPQFQ 299
Query: 300 YLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSK 359
YLVR HFCDI+S LN+LYFNVYI+SW +DLDLST + N LAA ++ DM+T +AS+K
Sbjct: 300 YLVRLHFCDIISKSLNELYFNVYINSWFVAKDLDLSTINNNILAAPFFKDMITAPSASTK 359
Query: 360 LRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLGNSSS----------KKHVGVIVGVT 409
+ ISIG ST++ YP+AILNGLEIMKM N SL +S++ K VG+IVGV+
Sbjct: 360 IFISIGPSTVNSNYPNAILNGLEIMKMNNSVSSLSSSTAVPLSSTSGSGSKKVGLIVGVS 419
Query: 410 IGVSVAALLAGILF-MLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANS 468
+G +A ++ G+ F +LCRKR++L + GHSK W+P+SIN G SHTMGSKYS+ TT SA S
Sbjct: 420 VGAFLAVVIVGVFFFLLCRKRKRLEKEGHSKTWVPLSINDGTSHTMGSKYSNATTGSAAS 479
Query: 469 NSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQ 528
N GYRFPFV VQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEF+
Sbjct: 480 NFGYRFPFVTVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFR 539
Query: 529 TEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 588
TEIEMLSQFRHRHLVSLIGYCDE+NEMILIYEYME GTLK HLYGSG PSLSWK+RLEIC
Sbjct: 540 TEIEMLSQFRHRHLVSLIGYCDERNEMILIYEYMEKGTLKSHLYGSGFPSLSWKERLEIC 599
Query: 589 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648
IG+ARGLHYLHTGYAKAVIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVK
Sbjct: 600 IGAARGLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVK 659
Query: 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708
GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW+MK Q +
Sbjct: 660 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWSMKLQKR 719
Query: 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH 768
GQL+QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVV
Sbjct: 720 GQLEQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVQ 779
Query: 769 GDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 828
GDP+ENSTN+IGELSPQ++NF+ + SV +AAQ + +++DD+SGVSMSRVFSQLVKSEGR
Sbjct: 780 GDPEENSTNMIGELSPQVNNFNH-EVSV-SAAQFEATSLDDLSGVSMSRVFSQLVKSEGR 837
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147816692|emb|CAN77769.1| hypothetical protein VITISV_009237 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1222 bits (3162), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 586/772 (75%), Positives = 669/772 (86%), Gaps = 9/772 (1%)
Query: 65 QNVVANI-SESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMS 123
+ ++AN ++S +SS+D LYQTARIFTG+SKYTFS+ R+WIRLYF+PFVY +YNMS
Sbjct: 32 KKLLANTATKSDSSSDDLPLYQTARIFTGTSKYTFSVGSNRRYWIRLYFFPFVYDTYNMS 91
Query: 124 RASFSVSTNDHVLLNNFSVSS-NVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVP 182
A+FSVST +HVL++NFS + + KEFS NVTSD+L + F+PS++SFAF+NALEVVSVP
Sbjct: 92 TANFSVSTQNHVLISNFSPKAGSAMKEFSENVTSDTLVITFAPSSDSFAFLNALEVVSVP 151
Query: 183 DQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRN 242
++LI+DDA +I+P GK++GLV Q ETV RVNMGGP VT ENDTLWRTW+PDQ+FLV N
Sbjct: 152 NELISDDAITITPSGKFKGLVTQALETVARVNMGGPTVTSENDTLWRTWLPDQNFLVENN 211
Query: 243 LAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLV 302
LA +VS I AV Y +GG TK AP +VYGTAT+MNSD +P NFNVTWEFDVD GFQYLV
Sbjct: 212 LATNVSKIGAVIYAKGGPTKLIAPASVYGTATKMNSDANPQYNFNVTWEFDVDPGFQYLV 271
Query: 303 RFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRI 362
R+HFCDIVS LNQLYFNVY+DS++ +LDLST + N L A YY+D+VT SKLR+
Sbjct: 272 RYHFCDIVSISLNQLYFNVYLDSYLVYEELDLSTLAFNILGAPYYLDVVTGTRVGSKLRV 331
Query: 363 SIGRSTLHDTYPDAILNGLEIMKMKNLQGSLG------NSSSKKHVGVIVGVTIGVSVAA 416
SIG S++H YPDAILNGLEIMKM + GSL N SSKK+V V++G ++GV A
Sbjct: 332 SIGPSSIHTEYPDAILNGLEIMKMNSSMGSLSGSVIVSNPSSKKNVAVVIGASVGVFAAL 391
Query: 417 LLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPF 476
+LAG+ F++ R+RR+L + GHSK W+ S NGGNSHTMGSKYS+GT SA SN GYR PF
Sbjct: 392 ILAGVFFLVYRRRRKLARQGHSKTWMAFSTNGGNSHTMGSKYSNGTXASAGSNFGYRIPF 451
Query: 477 VAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 536
+AVQEATNNFDESWVIGIGGFGKVYKG LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ
Sbjct: 452 LAVQEATNNFDESWVIGIGGFGKVYKGTLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 511
Query: 537 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 596
FRHRHLVSLIGYCDEKNEMILIYEYMENGT+K HLYGSGLPSL WK+RLEICIG+ARGLH
Sbjct: 512 FRHRHLVSLIGYCDEKNEMILIYEYMENGTVKSHLYGSGLPSLDWKERLEICIGAARGLH 571
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656
YLHTGYAKAVIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP
Sbjct: 572 YLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 631
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716
EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ +GQL+QIID
Sbjct: 632 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKRGQLEQIID 691
Query: 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENST 776
P L GKIRPDSLRKFGETAEKCL+DFGVDRPSMGD+LWNLEYALQLQEAV+ GDP+ENST
Sbjct: 692 PNLVGKIRPDSLRKFGETAEKCLSDFGVDRPSMGDILWNLEYALQLQEAVLVGDPEENST 751
Query: 777 NLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 828
NLIGEL+PQ++NF+ DTSV +AAQ +VS+VDD+SG+SMSRVFSQLVKSEGR
Sbjct: 752 NLIGELAPQVNNFNHADTSV-SAAQFEVSSVDDLSGISMSRVFSQLVKSEGR 802
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449461015|ref|XP_004148239.1| PREDICTED: receptor-like protein kinase HERK 1-like [Cucumis sativus] gi|449523606|ref|XP_004168814.1| PREDICTED: receptor-like protein kinase HERK 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1208 bits (3125), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/841 (71%), Positives = 676/841 (80%), Gaps = 19/841 (2%)
Query: 4 DC-RGFHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVAD-NSASKFL 61
DC R F L WV + + C F+P DNYLIDCGS N +VGNRVF+AD N ASKFL
Sbjct: 2 DCGRRFGLLSWVL-FISLLPSIFCLFNPVDNYLIDCGSAANVSVGNRVFMADDNLASKFL 60
Query: 62 STPQNVVANISES---VTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQ 118
STPQ ++A+ + S TSSNDS L++TAR+FTG+SKY F I GRHWIRLYF+PFV+
Sbjct: 61 STPQVIMADTNTSSLLATSSNDSLLFKTARVFTGTSKYKFPIKA-GRHWIRLYFFPFVFS 119
Query: 119 SYNMSRASFSVSTNDHVLLNNFSVSSN-VFKEFSVNVTSDSLDVIFSPSNNSFAFINALE 177
YNMS A+FSVST D VLL + + N + KEFSVN+ SD+L+VIF+P N S A++NA+E
Sbjct: 120 VYNMSAANFSVSTQDFVLLRDLAGGKNPIIKEFSVNLASDTLEVIFAPVNGSIAYVNAIE 179
Query: 178 VVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSF 237
V+SVPD LI D+A + P GK+QGL Q +ETV RVNMGGP V P+ND L R+WV D SF
Sbjct: 180 VISVPDILIGDEAILLEPSGKFQGLSNQAYETVARVNMGGPKVAPDNDPLTRSWVSDDSF 239
Query: 238 LVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSG 297
+VN+NLA S SNI AVKY GA E APN VYGT + MNS DDPN+NFNVTW+F VD
Sbjct: 240 IVNKNLATSFSNIAAVKYSAEGAAPEIAPNVVYGTLSEMNSKDDPNSNFNVTWKFKVDPE 299
Query: 298 FQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTAS 357
FQYLVRFHFCDIVS L++LYFNVYIDSW+ V LDLS N L+ AYYID V+ +
Sbjct: 300 FQYLVRFHFCDIVSKSLHELYFNVYIDSWLVVGGLDLSVPLNNALSTAYYIDSVSGVINN 359
Query: 358 SKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLG----------NSSSKKHVGVIVG 407
+L +SIG + + + YP+AILNGLEIMKM N GSL ++SS KH+GVIVG
Sbjct: 360 DELLVSIGPANIANVYPNAILNGLEIMKMNNSVGSLSGKDSVISFPDSNSSSKHIGVIVG 419
Query: 408 VTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSAN 467
V +G VAALL GILF+L ++RR+ SK WI +S G SHTMGSKYS+GT TSA
Sbjct: 420 VCVGAFVAALLVGILFILHKRRRKGMHQATSKTWISISTAGEMSHTMGSKYSNGTITSAA 479
Query: 468 SNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEF 527
SN GYR PF VQEATNNFDESWVIGIGGFGKVYKG LNDGTKVAVKRGNPRSQQGLAEF
Sbjct: 480 SNYGYRIPFATVQEATNNFDESWVIGIGGFGKVYKGVLNDGTKVAVKRGNPRSQQGLAEF 539
Query: 528 QTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEI 587
QTEIEMLSQFRHRHLVSLIGYCDE+NEMILIYEYME GTLK HLYGS PSLSWK+RLE+
Sbjct: 540 QTEIEMLSQFRHRHLVSLIGYCDERNEMILIYEYMEQGTLKSHLYGSDFPSLSWKERLEV 599
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
CIG+ARGLHYLHTGYAK VIHRDVKSANILLDE MAKVADFGLSKTGPEIDQTHVSTAV
Sbjct: 600 CIGAARGLHYLHTGYAKPVIHRDVKSANILLDETLMAKVADFGLSKTGPEIDQTHVSTAV 659
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 707
KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ
Sbjct: 660 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQK 719
Query: 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVV 767
KGQLDQIID TL GKIR SLRKFGETAEKCLAD+GVDRPSMGDVLWNLEYALQLQEAV+
Sbjct: 720 KGQLDQIIDSTLVGKIRSTSLRKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQEAVI 779
Query: 768 HGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEG 827
DP++NSTN+IGELSPQI+NF+ ++ V +A + D+ VDD+SGVSMSRVFSQLVKSEG
Sbjct: 780 ETDPEDNSTNMIGELSPQINNFNNIEAGV-SATRFDIPGVDDLSGVSMSRVFSQLVKSEG 838
Query: 828 R 828
R
Sbjct: 839 R 839
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725301|ref|NP_001235040.1| protein kinase precursor [Glycine max] gi|223452398|gb|ACM89526.1| protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1178 bits (3048), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 584/840 (69%), Positives = 672/840 (80%), Gaps = 42/840 (5%)
Query: 2 MGDCRGFHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFL 61
M DCR I S+L VCF S F P DNYLIDCGS TNT++ +R F AD+ FL
Sbjct: 1 MKDCREICSFICALSILPLVCF-SANFVPIDNYLIDCGSPTNTSIDSRNFSADSFYKNFL 59
Query: 62 STPQNVVANIS-ESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSY 120
ST Q+++A+ S +S+TS+ DS LY TARIFT SKYTF I+ +GRHWIRLYF+PF Y+ Y
Sbjct: 60 STQQDILASTSLKSITSTRDSPLYSTARIFTAPSKYTFPINKKGRHWIRLYFFPFAYEKY 119
Query: 121 NMSRASFSVSTNDHVLLNNFSVSSN-VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVV 179
++S A F+VST ++ LL++FSV N V KE+S+ +V
Sbjct: 120 DLSAAKFAVSTQNYNLLSDFSVLKNPVMKEYSL-------------------------IV 154
Query: 180 SVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLV 239
SVPD LI DDA +++P G Y GL Q ETV RVNMGGP V+ +DTL RTW+PD+ FL+
Sbjct: 155 SVPDDLIIDDAFTLNPAGSYSGLFAQALETVFRVNMGGPTVSSGSDTLQRTWLPDKKFLI 214
Query: 240 NRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQ 299
NLA++ +NI AVKYV GG T +AP VYGT T+MNS DDP +NFNVTW+FDV+ FQ
Sbjct: 215 QPNLARNFTNIGAVKYVDGGPTANTAPPIVYGTLTQMNSADDPRSNFNVTWQFDVEPQFQ 274
Query: 300 YLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSK 359
YLVR HFCDI+S LN+LYFNVYI+SW +DLDLST N L A ++ DM+T +AS+K
Sbjct: 275 YLVRLHFCDIISKSLNELYFNVYINSWFVAKDLDLST-RNNILGAPFFKDMITAPSASTK 333
Query: 360 LRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLGNSSS----------KKHVGVIVGVT 409
+ +SIG ST+ + YP+AILNGLEIMKM N SL +S++ K VG+IVGV+
Sbjct: 334 ILVSIGPSTVSNDYPNAILNGLEIMKMNNSVSSLSSSTAVPLSSTSGSGSKKVGLIVGVS 393
Query: 410 IGVSVAALLAGILF-MLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANS 468
+G +A + G+ F +LCRKR++ + GHSK WIP+SIN G SHTMGSKYS+ TT SA S
Sbjct: 394 VGAFLAVFIVGVFFFLLCRKRKRSGKEGHSKTWIPLSINDGTSHTMGSKYSNATTGSAAS 453
Query: 469 NSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQ 528
N GYRFPFV VQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEF+
Sbjct: 454 NLGYRFPFVTVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFR 513
Query: 529 TEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 588
TEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME GTLK HLYGSG PSLSWK+RLEIC
Sbjct: 514 TEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEKGTLKSHLYGSGFPSLSWKERLEIC 573
Query: 589 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648
IG+ARGLHYLHTGYAKAVIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVK
Sbjct: 574 IGAARGLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVK 633
Query: 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708
GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCARPVIDPTLPREMVNLAEW+MKWQ +
Sbjct: 634 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPVIDPTLPREMVNLAEWSMKWQKR 693
Query: 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH 768
GQL+QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVV
Sbjct: 694 GQLEQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVQ 753
Query: 769 GDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 828
GDP+ENSTN+IGELSPQ++NF + SV +AAQ + +++DD+SGVSMSRVFSQLVKSEGR
Sbjct: 754 GDPEENSTNMIGELSPQVNNFDH-EVSV-SAAQFEATSLDDLSGVSMSRVFSQLVKSEGR 811
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357472565|ref|XP_003606567.1| Kinase-like protein [Medicago truncatula] gi|355507622|gb|AES88764.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1176 bits (3042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 586/845 (69%), Positives = 682/845 (80%), Gaps = 23/845 (2%)
Query: 2 MGDCRG--FHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRV-FVADNSAS 58
M +CR I+V SV VCF S F P DNYLIDCGS TNT++G+ + F +D
Sbjct: 1 MWNCREDWLIIFIYVLSVFPLVCF-SANFVPIDNYLIDCGSHTNTSIGSNLNFTSDTFFK 59
Query: 59 KFLSTPQNVVANIS-ESVTSSND-SQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFV 116
FLST ++++AN + +S+ S+ D S LYQTARIF SSKYTF I+ +GRHWIRLYF+PF
Sbjct: 60 NFLSTQEDILANTTLKSINSTTDFSPLYQTARIFISSSKYTFPINKKGRHWIRLYFFPFS 119
Query: 117 YQSYNMSRASFSVSTNDHVLLNNFSVSSN--VFKEFSVNVTSDSLDVIFSPSNNSFAFIN 174
YQ+YN+S A+F+V+T ++LL++FSV V KE+ VNVT D+L + F+PSNNS AF+N
Sbjct: 120 YQNYNLSAANFAVTTEHNILLSSFSVPKKNPVMKEYLVNVTLDTLVITFTPSNNSTAFVN 179
Query: 175 ALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPD 234
A+EVVSVPD LI DDA +++P +Y GL+ FETV R+NMGGP V+ D L RTWVPD
Sbjct: 180 AIEVVSVPDDLIADDAIALNPRREYTGLLTDAFETVFRLNMGGPSVSSSVDPLHRTWVPD 239
Query: 235 QSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDV 294
SFL+ NLA + S+I AVKY +GGAT+ AP +VYGT T MNSD DP +NFNVTW+FDV
Sbjct: 240 TSFLIQPNLATNFSSIGAVKYAKGGATENIAPPSVYGTLTEMNSDGDPRSNFNVTWKFDV 299
Query: 295 DSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQ 354
+ GFQYLVR HFCDIVS GLN+LYFNVYI S +A +DLD+ + NTLA Y++D VT
Sbjct: 300 EPGFQYLVRLHFCDIVSKGLNELYFNVYITSLLAAKDLDIGEKTHNTLATPYFMDFVTTP 359
Query: 355 TASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSL----------GNSSSKKHVGV 404
+ +K+ +SIG S ++ YP+AILNGLEIMKM N SL + S K VGV
Sbjct: 360 SVDNKILVSIGPSDVNSDYPNAILNGLEIMKMNNSISSLSASAAVSLPSSHGSKSKKVGV 419
Query: 405 IVGVTIGVSVAAL-LAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTT 463
IVGV++G+ A + + G F+L ++RRQL Q G SK W+P+S G SHTMGSKYS+ TT
Sbjct: 420 IVGVSLGIFCALVAMVGGFFVLRKRRRQLAQQGDSKTWVPLS--DGTSHTMGSKYSNATT 477
Query: 464 TSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQG 523
SA SN GYRFPF VQEATNNFDESWVIG+GGFGKVYKGEL+DGTKVA KRGNPRS QG
Sbjct: 478 ASAASNFGYRFPFAVVQEATNNFDESWVIGVGGFGKVYKGELSDGTKVACKRGNPRSHQG 537
Query: 524 LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ 583
LAEF+TEIEMLSQFRHRHLVSLIGYCDE+NEMILIYEYMENGT+K HLYGSGLPSLSWK+
Sbjct: 538 LAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMILIYEYMENGTVKSHLYGSGLPSLSWKE 597
Query: 584 RLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643
RLEICIG+ARGLHYLHTGYAKAVIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHV
Sbjct: 598 RLEICIGAARGLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHV 657
Query: 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM 703
STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL EVLCARPVIDP+LPRE VNLAEWAM
Sbjct: 658 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPVIDPSLPRERVNLAEWAM 717
Query: 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763
KWQ KG+L +I+DPTLAGKIRPDSLRKF ETAEKCLADFGVDRPSMGDVLWNLEYALQLQ
Sbjct: 718 KWQKKGELARIVDPTLAGKIRPDSLRKFAETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 777
Query: 764 EAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLV 823
EAVV GDP+ENSTN+IGEL PQI+NF Q + SV + QS+ S++DD+SGVSMS+VFSQLV
Sbjct: 778 EAVVKGDPEENSTNMIGELCPQINNFEQ-EPSV-SVEQSEASSLDDLSGVSMSKVFSQLV 835
Query: 824 KSEGR 828
KSEGR
Sbjct: 836 KSEGR 840
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351726174|ref|NP_001235070.1| protein kinase precursor [Glycine max] gi|223452412|gb|ACM89533.1| protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1170 bits (3026), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 600/839 (71%), Positives = 671/839 (79%), Gaps = 18/839 (2%)
Query: 2 MGDCRGFHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFL 61
M D R F I V S+ VCFC+ F P DNYLIDCG+ T+T+VG R F+ADN L
Sbjct: 1 MTDWRNIGFFICVLSIFPLVCFCAT-FVPVDNYLIDCGATTSTSVGTRNFIADNK--DLL 57
Query: 62 STPQNVVANISESVTSSNDSQ--LYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQS 119
ST +++VA S +S+ LYQTAR+FT SSKYTF I+ +GRHWIRLYF PF Y+
Sbjct: 58 STQKDIVATTSSKSATSSSDDSSLYQTARVFTASSKYTFKINQKGRHWIRLYFLPFAYEK 117
Query: 120 YNMSRASFSVSTNDHVLLNNFSVSSN-VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEV 178
YN+ A F+VST +HVL + ++ + V KE+SVNVTSDSL + F+PS +S AF+NA+EV
Sbjct: 118 YNLRAADFTVSTQNHVLFRSLNMQKDPVMKEYSVNVTSDSLVLTFAPSGSSIAFVNAIEV 177
Query: 179 VSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFL 238
VSVPD LI DD ++ P GLV Q ETV RVNMGGP VTP NDTL RTWVPDQSFL
Sbjct: 178 VSVPDDLIVDDGFALDPSVTSSGLVTQALETVWRVNMGGPTVTPINDTLQRTWVPDQSFL 237
Query: 239 VNRNLAKSVSNIPAVKYV-QGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSG 297
+ NLA SNI VKY G AT+ +AP TVYGT T+MNS DP FNVTW+FDV G
Sbjct: 238 LQSNLASFSSNIKGVKYENHGQATENTAPPTVYGTLTQMNSTYDPRNIFNVTWQFDVSPG 297
Query: 298 FQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTAS 357
FQYLVR HFCD+VS LN+LYFN Y+DS +A D ST S N L YY D+VT S
Sbjct: 298 FQYLVRLHFCDVVSKALNELYFNAYVDSKLAASSADPSTTSNNALGVPYYRDLVTAVAVS 357
Query: 358 SKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSL-------GNSSSKKHVGVIVGVTI 410
LR+SIG S ++ YP+AILNGLEIMKM N GSL + SS K G+IVGV++
Sbjct: 358 KTLRVSIGPSEVNKEYPNAILNGLEIMKMNNSMGSLIPGAVAITSGSSSKKTGMIVGVSV 417
Query: 411 GVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNS-HTMGSKYSHGTTTSANSN 469
GV A +LAG+ F+LCRKRR+L Q SK W+P+SIN G + HTMGSKYS+GTT SA SN
Sbjct: 418 GVVGAVVLAGVFFVLCRKRRRLAQR-QSKTWVPLSINDGTTFHTMGSKYSNGTTLSAASN 476
Query: 470 SGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQT 529
YR PFVAVQEATNNFDESWVIGIGGFGKVYKGEL+DGTKVAVKRGNPRSQQGLAEFQT
Sbjct: 477 FEYRVPFVAVQEATNNFDESWVIGIGGFGKVYKGELSDGTKVAVKRGNPRSQQGLAEFQT 536
Query: 530 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 589
EIEMLSQFRHRHLVSLIGYCDE+NEMILIYEYME GTLKGHLYGSGLPSLSWK+RLEICI
Sbjct: 537 EIEMLSQFRHRHLVSLIGYCDERNEMILIYEYMEKGTLKGHLYGSGLPSLSWKERLEICI 596
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
G+ARGLHYLHTGYAKAVIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKG
Sbjct: 597 GAARGLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKG 656
Query: 650 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 709
SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ KG
Sbjct: 657 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKG 716
Query: 710 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 769
QL+QIID TLAGKIRPDSLRKFGETAEKCLAD+GVDR SMGDVLWNLEYALQLQEAVV G
Sbjct: 717 QLEQIIDQTLAGKIRPDSLRKFGETAEKCLADYGVDRSSMGDVLWNLEYALQLQEAVVQG 776
Query: 770 DPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 828
DP+ENSTN+IGELSPQ++NF+Q D S + Q S++DD+SGVSMSRVFSQLVKSEGR
Sbjct: 777 DPEENSTNMIGELSPQVNNFNQ-DASA-SVTQFAGSSLDDLSGVSMSRVFSQLVKSEGR 833
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357454055|ref|XP_003597308.1| Kinase-like protein [Medicago truncatula] gi|355486356|gb|AES67559.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1138 bits (2943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/849 (67%), Positives = 667/849 (78%), Gaps = 23/849 (2%)
Query: 1 MMGDCRGFHFLIWVASVLC-FVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASK 59
MM D + + V +L +CFC+ F P+DNYLIDCGS T T+VGNR F +D+ K
Sbjct: 1 MMLDWKKHGLFVCVLYMLLPLLCFCAT-FVPSDNYLIDCGSTTTTSVGNRNFSSDSFHKK 59
Query: 60 FLSTPQNVVANISESVTS--SNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVY 117
LST Q ++A+ S S ++S LYQTARIFTGSSKYTF I+ +GRHWIR YF+PF+Y
Sbjct: 60 LLSTQQEILASTSSKSVSDVGDESPLYQTARIFTGSSKYTFPINQKGRHWIRFYFFPFIY 119
Query: 118 QSYNMSRASFSVSTNDHVLLNNFSV-SSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINAL 176
YN++ A FSV+T VLL+ F+ S V KE+S+NV +D+L + F PS++S AF+NA+
Sbjct: 120 DRYNLNAAKFSVATQTFVLLSGFTAQKSPVMKEYSINVNTDTLVITFKPSDDSVAFVNAI 179
Query: 177 EVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQS 236
EVVSVPD+LI D+A ++SP + GL FQ ETV RVNMGGP+VT D L+RTW+ DQ
Sbjct: 180 EVVSVPDELIADEAPTLSPVSTFSGLGFQALETVWRVNMGGPVVTSGEDPLYRTWISDQK 239
Query: 237 FLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDD---DPNANFNVTWEFD 293
+L+ +LA VSN+ V + GG T+ AP +VYGT MN++ D N NFNVTW+FD
Sbjct: 240 YLLESSLANDVSNLVGVDFADGGPTENIAPRSVYGTVAEMNTNTSGGDANLNFNVTWQFD 299
Query: 294 VDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTV 353
+ GFQYLVR HFCDIVS GLN LYFNVYIDS V+DLDL++ S+N L+ YY D VT
Sbjct: 300 TEPGFQYLVRTHFCDIVSKGLNTLYFNVYIDSLTVVKDLDLASKSSNVLSVPYYQDSVTP 359
Query: 354 QTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLG-----------NSSSKKHV 402
+KLR+SIG S L P+AILNGLEI+KM N GSL + SS V
Sbjct: 360 LADGNKLRVSIGPSPLSKDSPNAILNGLEILKMNNSIGSLSADAASGAGGTTSGSSSSKV 419
Query: 403 GVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGT 462
GVI GV++GV +LAG+ +LCRK+++L + SK WIP+S+N SHTMGSKYS+GT
Sbjct: 420 GVIAGVSVGVVSVLVLAGVCCVLCRKKKRLARQRQSKTWIPLSVNDATSHTMGSKYSNGT 479
Query: 463 TTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ 522
T SA SN YR PF VQE TNNFDESWVIG+GGFGKVYKGEL DG KVAVKRGNPRSQQ
Sbjct: 480 TISAASNFEYRVPFAEVQEGTNNFDESWVIGVGGFGKVYKGELRDGRKVAVKRGNPRSQQ 539
Query: 523 GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK 582
G+AEF+TEIEMLSQFRHRHLVSLIGYCDE NEMILIYEYME GTLKGHLYG GLPSLSWK
Sbjct: 540 GIAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMEKGTLKGHLYGLGLPSLSWK 599
Query: 583 QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642
+RL+ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN MAKVADFGLSKTGPE+DQTH
Sbjct: 600 ERLDICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPELDQTH 659
Query: 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA 702
VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDP+LPREMVNLAEWA
Sbjct: 660 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPSLPREMVNLAEWA 719
Query: 703 MKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762
MK+Q KGQL+QIID L GKI+ DSLRKF ETAEKCLAD+GVDRPSMGDVLWNLEYALQL
Sbjct: 720 MKYQKKGQLEQIIDTALQGKIKADSLRKFAETAEKCLADYGVDRPSMGDVLWNLEYALQL 779
Query: 763 QEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQS---DVSAVDDISGVSMSRVF 819
QEAVV GDP+ENSTN+IGELSPQ++NF+Q D +V+++A + + S VDD+SGVSMSRVF
Sbjct: 780 QEAVVQGDPEENSTNMIGELSPQVNNFNQ-DANVSSSASAVPFEASTVDDLSGVSMSRVF 838
Query: 820 SQLVKSEGR 828
SQLVKSEGR
Sbjct: 839 SQLVKSEGR 847
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 828 | ||||||
| TAIR|locus:2075346 | 830 | HERK1 "hercules receptor kinas | 0.978 | 0.975 | 0.659 | 1.4e-291 | |
| TAIR|locus:2174249 | 829 | AT5G59700 [Arabidopsis thalian | 0.975 | 0.974 | 0.666 | 9.1e-290 | |
| TAIR|locus:2151349 | 855 | THE1 "THESEUS1" [Arabidopsis t | 0.541 | 0.523 | 0.587 | 8.5e-221 | |
| TAIR|locus:2163158 | 842 | AT5G61350 [Arabidopsis thalian | 0.403 | 0.396 | 0.669 | 3.2e-199 | |
| TAIR|locus:2178707 | 824 | AT5G24010 [Arabidopsis thalian | 0.943 | 0.947 | 0.496 | 3.6e-199 | |
| TAIR|locus:2039717 | 815 | AT2G39360 [Arabidopsis thalian | 0.933 | 0.948 | 0.484 | 1.3e-189 | |
| TAIR|locus:2136338 | 878 | AT4G39110 [Arabidopsis thalian | 0.896 | 0.845 | 0.500 | 5.2e-184 | |
| TAIR|locus:2050080 | 871 | AT2G21480 [Arabidopsis thalian | 0.887 | 0.843 | 0.485 | 7e-180 | |
| TAIR|locus:2204564 | 849 | HERK2 "hercules receptor kinas | 0.762 | 0.743 | 0.488 | 3.6e-174 | |
| TAIR|locus:2081895 | 895 | FER "FERONIA" [Arabidopsis tha | 0.457 | 0.423 | 0.595 | 1.8e-172 |
| TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2800 (990.7 bits), Expect = 1.4e-291, P = 1.4e-291
Identities = 551/836 (65%), Positives = 650/836 (77%)
Query: 8 FHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNV 67
F I ++++ +C C F P DNYLI+CGS TN T+ R+F++D +SK L++ + +
Sbjct: 6 FETFILISTISILLCICH-GFTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKLLTSSKEI 64
Query: 68 VANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASF 127
+A SV ++ S +Y TAR+FT S Y FS++ RGRHW+RLYF PF YQ++ M A F
Sbjct: 65 LA----SVGGNSGSDIYHTARVFTEVSSYKFSVT-RGRHWVRLYFNPFDYQNFKMGSAKF 119
Query: 128 SVSTNDHVLLNNFSV-SSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLI 186
+VS+ HVLL++F+V SS V KE+S+NVT++ L + F+PS+ SFAF+NA+EV+S+PD LI
Sbjct: 120 AVSSQSHVLLSDFTVTSSKVVKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVISIPDTLI 179
Query: 187 TDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKS 246
T + P ++ + Q ET+HRVNMGGPLV NDTL RTWVPD FL+ +NLAKS
Sbjct: 180 TGSPRFVGNPAQFPDMSMQGLETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLEKNLAKS 239
Query: 247 VSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHF 306
+S V +V G AT++SAP TVYG+ T MNS D+PN+ FNVTWEFDVD GFQY RFHF
Sbjct: 240 MSKFSTVNFVPGYATEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHF 299
Query: 307 CDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQT--ASSKLRISI 364
CDIVS LNQLYFN+Y+DS +A D+DLST NTLA AY +D VT QT S+K+R+SI
Sbjct: 300 CDIVSLSLNQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMDFVT-QTPKGSNKVRVSI 358
Query: 365 GRSTLHDTYPDAILNGLEIMKMKNLQGSLG--------NSSSKKHXXXXXXXXXXXXXAA 416
G ST+H YP+AI+NGLEIMKM N +G L +SSSK + A
Sbjct: 359 GPSTVHTDYPNAIVNGLEIMKMNNSKGQLSTGTFVPGSSSSSKSNLGLIVGSAIGSLLAV 418
Query: 417 LLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTT-TSANSNSGYRFP 475
+ G F+L +KR++ Q GHSK W+P SING + MGSKYS+GTT TS +N+ YR P
Sbjct: 419 VFLGSCFVLYKKRKR-GQDGHSKTWMPFSINGTS---MGSKYSNGTTLTSITTNANYRIP 474
Query: 476 FVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 535
F AV++ATNNFDES IG+GGFGKVYKGELNDGTKVAVKRGNP+SQQGLAEF+TEIEMLS
Sbjct: 475 FAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLS 534
Query: 536 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 595
QFRHRHLVSLIGYCDE NEMILIYEYMENGT+K HLYGSGLPSL+WKQRLEICIG+ARGL
Sbjct: 535 QFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGL 594
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
HYLHTG +K VIHRDVKSANILLDENFMAKVADFGLSKTGPE+DQTHVSTAVKGSFGYLD
Sbjct: 595 HYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLD 654
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715
PEYFRRQQLT+KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ KGQLDQII
Sbjct: 655 PEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQII 714
Query: 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENS 775
D +L G IRPDSLRKF ET EKCLAD+GVDRPSMGDVLWNLEYALQLQEAV+ G+P++NS
Sbjct: 715 DQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNS 774
Query: 776 TNLIGELSPQIHNFSQVDTXXXXXXXXXXXXXXXI---SGVSMSRVFSQLVKSEGR 828
TN+IGEL PQI+NFSQ DT I SGVSMS+VFSQLVKSEGR
Sbjct: 775 TNMIGELPPQINNFSQGDTSVNVPGTAGRFEESSIDDLSGVSMSKVFSQLVKSEGR 830
|
|
| TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2783 (984.7 bits), Expect = 9.1e-290, P = 9.1e-290
Identities = 558/837 (66%), Positives = 648/837 (77%)
Query: 8 FHFLIWVASVLCFVCFCSCQFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNV 67
F FLIW+ S+ C + C + P DNYLI+CGS TN TV +RVF++DN AS FL++P +
Sbjct: 6 FGFLIWILSIPCLIFLCY-GYVPVDNYLINCGSSTNVTVTSRVFISDNLASNFLTSPNEI 64
Query: 68 VANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASF 127
+A S +SN S +YQTARIFTG SKY FS++ RGRHWIRL+F PF YQ++ M A F
Sbjct: 65 LA---ASNRNSN-SDIYQTARIFTGISKYRFSVA-RGRHWIRLHFNPFQYQNFQMVSAKF 119
Query: 128 SVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLIT 187
SVS+ HVLL++F+VSS V KE+S+NV +D L++ F+PS +SFAF+NALEVVSVPD L +
Sbjct: 120 SVSSETHVLLSDFTVSSRVMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFS 179
Query: 188 DDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSV 247
D S PGK+QGL +Q ETV+RVNMGGP VTP NDTL R W PD FLV +NL KSV
Sbjct: 180 GDPSFAGSPGKFQGLSWQALETVYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLVKSV 239
Query: 248 SNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFC 307
S I +V YV G AT+E+AP TVYGT T MNS D+P++NFNVTW+FDVD GFQY +RFHFC
Sbjct: 240 SKIASVDYVPGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFC 299
Query: 308 DIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSK-LRISIGR 366
DIVS LNQLYFN+Y+DS V +LDLS+Y +NTL+ AY +D VT +K +R+SIGR
Sbjct: 300 DIVSKALNQLYFNLYVDSMDVVENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGR 359
Query: 367 STLHDTYPDAILNGLEIMKMKNLQGSL--------GNSSS-KKHXXXXXXXXXXXXXAAL 417
S++H YP AILNGLEIMKM N + L G+SS+ KK+ A +
Sbjct: 360 SSVHTDYPTAILNGLEIMKMNNSKSQLSIGTFLPSGSSSTTKKNVGMIIGLTIGSLLALV 419
Query: 418 LAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFV 477
+ G F+L +KR + Q G+SK WIP+S NG S + G+ T S SNS YR P V
Sbjct: 420 VLGGFFVLYKKRGR-DQDGNSKTWIPLSSNGTTSSSNGT-----TLASIASNSSYRIPLV 473
Query: 478 AVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF 537
AV+EATN+FDE+ IG+GGFGKVYKGEL+DGTKVAVKR NP+SQQGLAEF+TEIEMLSQF
Sbjct: 474 AVKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQF 533
Query: 538 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
RHRHLVSLIGYCDE NEMIL+YEYMENGTLK HLYGSGL SLSWKQRLEICIGSARGLHY
Sbjct: 534 RHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHY 593
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
LHTG AK VIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE
Sbjct: 594 LHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 653
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717
YFRRQQLTEKSDVYSFGVV+FEVLCARPVIDPTL REMVNLAEWAMKWQ KGQL+ IIDP
Sbjct: 654 YFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDP 713
Query: 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTN 777
+L GKIRPDSLRKFGET EKCLAD+GVDRPSMGDVLWNLEYALQLQEAVV GDP E+STN
Sbjct: 714 SLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGDP-EDSTN 772
Query: 778 LIGELSPQIHNFSQVDTXXXXXXXXXX------XXXXXISGVSMSRVFSQLVKSEGR 828
+IGEL + ++++ DT SGVSMS+VFSQL+KSEGR
Sbjct: 773 MIGELPLRFNDYNHGDTSVNFSVAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829
|
|
| TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1334 (474.7 bits), Expect = 8.5e-221, Sum P(2) = 8.5e-221
Identities = 273/465 (58%), Positives = 329/465 (70%)
Query: 378 LNGLEIMKMKNLQGSLGNSSSKKHXXXXXXXXXXXXXAALLAGILFMLC----RKRRQL- 432
L+G+ +K L G G+ S KK LL + C RK+R
Sbjct: 394 LSGVSSVKSL-LPGGSGSKSKKK--AVIIGSLVGAVTLILLIAVCCYCCLVASRKQRSTS 450
Query: 433 PQLG-HSKAWIPVSINGGNSHTMGSKYSHGTTTS-----ANSNSGYRFPFVAVQEATNNF 486
PQ G + W+P+ + G + S SH + T+ A+++ G F F + +ATN F
Sbjct: 451 PQEGGNGHPWLPLPLYGLSQTLTKSTASHKSATASCISLASTHLGRCFMFQEIMDATNKF 510
Query: 487 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
DES ++G+GGFG+VYKG L DGTKVAVKRGNPRS+QG+AEF+TEIEMLS+ RHRHLVSLI
Sbjct: 511 DESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLI 570
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
GYCDE++EMIL+YEYM NG L+ HLYG+ LP LSWKQRLEICIG+ARGLHYLHTG ++++
Sbjct: 571 GYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGAARGLHYLHTGASQSI 630
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
IHRDVK+ NILLDEN +AKVADFGLSKTGP +DQTHVSTAVKGSFGYLDPEYFRRQQLTE
Sbjct: 631 IHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTE 690
Query: 667 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 726
KSDVYSFGVVL EVLC RP ++P LPRE VN+AEWAM WQ KG LDQI+D L GK+ P
Sbjct: 691 KSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPA 750
Query: 727 SLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE-AVVHGDPDENSTNLI-G-ELS 783
SL+KFGETAEKCLA++GVDRPSMGDVLWNLEYALQL+E + +PD+NSTN I G ++
Sbjct: 751 SLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETSSALMEPDDNSTNHIPGIPMA 810
Query: 784 PQIHNFSQVDTXXXXXXXXXXXXXXXISGVSMSRVFSQLVKSEGR 828
P + + + S VFSQLV GR
Sbjct: 811 PMEPFDNSMSIIDRGGVNSGTGTDDDAEDATTSAVFSQLVHPRGR 855
|
|
| TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1166 (415.5 bits), Expect = 3.2e-199, Sum P(2) = 3.2e-199
Identities = 233/348 (66%), Positives = 270/348 (77%)
Query: 444 VSINGGN-SHTM---GSKYSHGTTTSA---NSNSGYRFPFVAVQEATNNFDESWVIGIGG 496
+S GG+ S M GSK S S+ N G FPF +Q AT NFDE+ V G+GG
Sbjct: 476 ISSKGGSTSRRMSIFGSKKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGG 535
Query: 497 FGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556
FGKVY GE++ GT+VA+KRG+ S+QG+ EFQTEI+MLS+ RHRHLVSLIG+CDE EMI
Sbjct: 536 FGKVYIGEIDGGTQVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMI 595
Query: 557 LIYEYMENGTLKGHLYGSG------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
L+YEYM NG L+ HLYGS +P+LSWKQRLEICIGSARGLHYLHTG A+ +IHRD
Sbjct: 596 LVYEYMSNGPLRDHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 655
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 670
VK+ NILLDEN +AKV+DFGLSK P +D+ HVSTAVKGSFGYLDPEYFRRQQLT+KSDV
Sbjct: 656 VKTTNILLDENLVAKVSDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDV 714
Query: 671 YSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRK 730
YSFGVVLFEVLCARPVI+P LPRE VNLAE+AM KG L++IIDP + G I SLRK
Sbjct: 715 YSFGVVLFEVLCARPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRK 774
Query: 731 FGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNL 778
F E AEKCLA++GVDRP MGDVLWNLEYALQLQEA D E+ T +
Sbjct: 775 FVEAAEKCLAEYGVDRPGMGDVLWNLEYALQLQEASAQVDLSEDKTTM 822
|
|
| TAIR|locus:2178707 AT5G24010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1928 (683.7 bits), Expect = 3.6e-199, P = 3.6e-199
Identities = 407/819 (49%), Positives = 535/819 (65%)
Query: 28 FDPADNYLIDCGSRTNTTV-GNRVFVADNS--ASKFLSTPQNVVANISESVTSSNDSQLY 84
F P DNYLI+ GS TNT+ R F++D+S S FLST +++ +IS++ S + LY
Sbjct: 26 FTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSI--SISDTNPSPDSPVLY 83
Query: 85 QTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSS 144
TAR+F Y F ++ +G H+IRL+F PF +N+ A F V N ++N+FS SS
Sbjct: 84 NTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSFSTSS 143
Query: 145 NVFKEFSVNVTSDSLDVIFSPSNNS-FAFINALEVVSVPDQLITDDASSISPPGKYQ--- 200
V KEF + + L++ F P S F F+NA+EV S P I D + + P Q
Sbjct: 144 VVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPNSAQIFS 203
Query: 201 GLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGA 260
L Q ETVHR+N+GG +TP NDTLWRTWV D ++L+ R A+ + Y GGA
Sbjct: 204 NLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQNGGA 263
Query: 261 TKESAPNTVYGTATRMNSDDDP-NANFNVTWEFDVDSG-FQYLVRFHFCDIVSDGLNQLY 318
T+E AP+ VY TA M+ D+ A FN++W F VD +LVR HFCDIVS LNQLY
Sbjct: 264 TREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLNQLY 323
Query: 319 FNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHD-TYPDAI 377
FNV+I+ ++A +D+DLST + + LA+ YID V S LRIS+G S L + +A+
Sbjct: 324 FNVFINEYLAFKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRISVGPSDLSNPARVNAL 383
Query: 378 LNGLEIMKMKNLQGSLGNSSSKKHXXXXXXXXXXXXXAALLAGILFMLC--RKRRQLPQL 435
LNG+EIM++ + S S K++ L L +LC R++ +
Sbjct: 384 LNGVEIMRILSPVSS-EVVSGKRNVVWIVVGSVLGGFVFLSLFFLSVLCLCRRKNNKTRS 442
Query: 436 GHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGY---RFPFVAVQEATNNFDESWVI 492
S W P+ G+S++ TT S+SGY R F +Q TNNFD S VI
Sbjct: 443 SESTGWTPLRRFRGSSNSR-------TTERTVSSSGYHTLRISFAELQSGTNNFDRSLVI 495
Query: 493 GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 552
G+GGFG V++G L D TKVAVKRG+P S+QGL EF +EI +LS+ RHRHLVSL+GYC+E+
Sbjct: 496 GVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCEEQ 555
Query: 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 612
+EMIL+YEYM+ G LK HLYGS P LSWKQRLE+CIG+ARGLHYLHTG ++ +IHRD+K
Sbjct: 556 SEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDIK 615
Query: 613 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 672
S NILLD N++AKVADFGLS++GP ID+THVST VKGSFGYLDPEYFRRQQLT+KSDVYS
Sbjct: 616 STNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYS 675
Query: 673 FGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFG 732
FGVVLFEVLCARP +DP L RE VNLAEWA++WQ KG LDQI+DP +A +I+P SL+KF
Sbjct: 676 FGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKKFA 735
Query: 733 ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQ--IHNFS 790
ETAEKC AD+GVDRP++GDVLWNLE+ LQLQE+ P+E+ ++ + + + N S
Sbjct: 736 ETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEEDYGDVTDPRTARQGLSNGS 795
Query: 791 QVDTXXXXXXXXXXXXXXXISGV-SMSRVFSQLVKSEGR 828
++ SG+ S ++VFSQL+ + GR
Sbjct: 796 NIERDYGDGT----------SGIISSTQVFSQLMTNAGR 824
|
|
| TAIR|locus:2039717 AT2G39360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1838 (652.1 bits), Expect = 1.3e-189, P = 1.3e-189
Identities = 408/842 (48%), Positives = 535/842 (63%)
Query: 18 LCFVC--FCSCQFDP-ADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISES 74
LCF+ CS +D + I+CGS TN TV NR FV+DN N+V S
Sbjct: 12 LCFLITLLCSSHISSVSDTFFINCGSPTNVTVNNRTFVSDN----------NLVQGFSVG 61
Query: 75 VTSSN---DSQLYQTARIFT--GSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSV 129
T SN +S L+QTAR+F+ SS Y F I G IR+YF P V S +++ A FSV
Sbjct: 62 TTDSNSGDESTLFQTARVFSDESSSTYRFPIEEHGWFLIRIYFLPLVSASQDLTTARFSV 121
Query: 130 STNDHVLLNNFSVSS-NVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITD 188
S + L+ + S+ +V +E+ +NVT+DSL + F P S +FINALEV+ +P+ LI +
Sbjct: 122 SAQNFTLIREYKPSTTSVVREYILNVTTDSLLLQFLPRTGSVSFINALEVLRLPETLIPE 181
Query: 189 DASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVS 248
DA I K L ETV RVNMG V+ + D LWR W D ++ + V
Sbjct: 182 DAKLIGTQ-KDLKLSSHAMETVSRVNMGNLSVSRDQDKLWRQWDSDSAY--KAHFGTPVM 238
Query: 249 NIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCD 308
N+ AV + GG T + AP VYGTATR+NSD DPN N N+TW F V+ GF Y VRFHFC+
Sbjct: 239 NLKAVNFSAGGITDDIAPVYVYGTATRLNSDLDPNTNANLTWTFKVEPGFDYFVRFHFCN 298
Query: 309 IVSD--GLN-QLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSK--LRIS 363
I+ D G Q+ F+++++S VR +D++ T A +++D V + S + L +S
Sbjct: 299 IIVDPFGFERQIRFDIFVNSE-KVRTIDMTEVLNGTFGAPFFVDAVMRKAKSREGFLNLS 357
Query: 364 IGRSTLHDTYPDAILNGLEIMKMKNLQGSL---------GNSSSKKHXXXXXXXXXXXXX 414
IG +YP + +NG EI K+ N + SL G+SS+K
Sbjct: 358 IGLVMDVSSYPVSFINGFEISKLSNDKRSLDAFDAILPDGSSSNKSSNTSVGLIAGLSAA 417
Query: 415 --AALLAGILFML-C-RKRRQLP---QLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSAN 467
AL+ G++ C RKRR+ Q HS+ G+ H + + + ++
Sbjct: 418 LCVALVFGVVVSWWCIRKRRRRNRQMQTVHSR---------GDDHQIKKNETGESLIFSS 468
Query: 468 SNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEF 527
S GYR+P ++EAT++FDES VIG+GGFGKVYKG L D T+VAVKRG P+S+QGLAEF
Sbjct: 469 SKIGYRYPLALIKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEF 528
Query: 528 QTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLE 586
+TE+EML+QFRHRHLVSLIGYCDE +EMI++YEYME GTLK HLY P LSW+QRLE
Sbjct: 529 KTEVEMLTQFRHRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLE 588
Query: 587 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 646
IC+G+ARGLHYLHTG +A+IHRDVKSANILLD+NFMAKVADFGLSKTGP++DQTHVSTA
Sbjct: 589 ICVGAARGLHYLHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVSTA 648
Query: 647 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706
VKGSFGYLDPEY RQQLTEKSDVYSFGVV+ EV+C RPVIDP+LPRE VNL EWAMK
Sbjct: 649 VKGSFGYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLV 708
Query: 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766
KG+L+ IIDP L GK++ + ++K+ E EKCL+ G++RP+MGD+LWNLE+ LQ+Q
Sbjct: 709 KKGKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNLEFMLQVQAK- 767
Query: 767 VHGDPDENSTNLIGELSPQIHNFSQVDTXXXXXXXXXXXXXXXISGVSMSRVFSQLVKSE 826
DE + ++ + P+ S V + I+GVSMS+VF+Q+V+ E
Sbjct: 768 -----DEKAA-MVDD-KPEA---SVVGSTMQFSVNGVGD----IAGVSMSKVFAQMVREE 813
Query: 827 GR 828
R
Sbjct: 814 TR 815
|
|
| TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1785 (633.4 bits), Expect = 5.2e-184, P = 5.2e-184
Identities = 383/765 (50%), Positives = 490/765 (64%)
Query: 28 FDPADNYLIDCGSRTNT-TVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQT 86
F PAD+ LIDCGS++++ T RVF +D +++ +++ + S ++ L
Sbjct: 52 FKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDIQVSAPPSDKVASPIYLTAR 111
Query: 87 ARIFTGSSKYTFSISGRGRHWIRLYFYP---FVYQ--SYNMSRASFSVSTNDHVLLNNFS 141
+ K+ + G + +P F Q ++++ + + N + NN
Sbjct: 112 IFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNNND 171
Query: 142 VSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQG 201
+ V KE+ VN+T + F P +S AFINA+EVVS PD+LI+D +++ P + G
Sbjct: 172 SQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPVIGFSG 231
Query: 202 LVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIP-AVKYVQGGA 260
L +++V+RVN+GGPL+ P+NDTL RTW+PD+ FL + NLAK V P A+KY
Sbjct: 232 LSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKYPPE-V 290
Query: 261 TKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFN 320
T AP TVY TA M + + NFNV+W F + F YL+R HFCDIVS LN LYFN
Sbjct: 291 TPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLYFN 350
Query: 321 VYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASS-KLRISIGRSTLHDTYPDAILN 379
VYI+ A+ LDLST + N LAA YY D+V T +L++ IG +AILN
Sbjct: 351 VYINGKTAISGLDLSTVAGN-LAAPYYKDIVVNATLMGPELQVQIGPMGEDTGTKNAILN 409
Query: 380 GLEIMKMKN----LQGSLG----NSSSKKHXXXXXXXXXXXXXAALLAGILFMLCRKRRQ 431
G+E++KM N L G G + KH A + G + +KR Q
Sbjct: 410 GVEVLKMSNSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIGLGAMVYKWKKRPQ 469
Query: 432 LPQLGHS-KAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYR--FPFVAVQEATNNFDE 488
Q +S +W+ + I+ G+S M SK + NS G F +QEAT NF+
Sbjct: 470 DWQKRNSFSSWL-LPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKNFEA 528
Query: 489 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
S +IG+GGFG VY G L+DGTKVAVKRGNP+S+QG+ EFQTEI+MLS+ RHRHLVSLIGY
Sbjct: 529 SQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 588
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
CDE +EMIL+YE+M NG + HLYG L L+WKQRLEICIGSARGLHYLHTG A+ +IH
Sbjct: 589 CDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTAQGIIH 648
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 668
RDVKS NILLDE +AKVADFGLSK Q HVSTAVKGSFGYLDPEYFRRQQLT+KS
Sbjct: 649 RDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKS 707
Query: 669 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 728
DVYSFGVVL E LCARP I+P LPRE VNLAEWAM+W+ KG L++IIDP LAG I P+S+
Sbjct: 708 DVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPESM 767
Query: 729 RKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDE 773
+KF E AEKCL D+GVDRP+MGDVLWNLEYALQLQEA G +E
Sbjct: 768 KKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEE 812
|
|
| TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1746 (619.7 bits), Expect = 7.0e-180, P = 7.0e-180
Identities = 371/764 (48%), Positives = 485/764 (63%)
Query: 28 FDPADNYLIDCGSRTNT-TVGNRVFVADNSASKFLSTPQNVVANI--SESVTSSN--DSQ 82
F PAD+ LIDCGS+++T T RVF +D+ +++ ++ + S+ + S ++
Sbjct: 51 FKPADDILIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDDIQVSAPPSDKLPSPIYLTAK 110
Query: 83 LYQTARIFTGSSKYTFSISGRGRHWIRLYFYP---FVYQ--SYNMSRASFSVSTNDHVLL 137
+++ I+ K+ + G + + +P F Q ++++ + + N +
Sbjct: 111 IFREEAIY----KFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFKLSN 166
Query: 138 NNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPG 197
+N + V KE+ +N+T + F P S AFIN +E+VS PD+LI+D +S+ P
Sbjct: 167 DNNDSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTSLFPVN 226
Query: 198 KYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQ 257
+ GL +++V+RVN+GGPL+TP+NDTL RTW PD+ +L + NLAK V P
Sbjct: 227 GFSGLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKTNPTAIIYP 286
Query: 258 GGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQL 317
G T AP TVY T M + NFNVTW F + F Y +R HFCDI+S LN L
Sbjct: 287 PGVTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSLNDL 346
Query: 318 YFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTA-SSKLRISIGRSTLHDTYPDA 376
YFNVYI+ A+ LDLST + + L+A YY D+V T +S+L++ IG +A
Sbjct: 347 YFNVYINGKTAISGLDLSTVAGD-LSAPYYKDIVVNSTLMTSELQVQIGPMGEDTGKKNA 405
Query: 377 ILNGLEIMKMKN----LQGSLG----NSSSKKHXXXXXXXXXXXXXAALLAGILFMLCRK 428
ILNG+E++KM N L G G +S K A + G + +K
Sbjct: 406 ILNGVEVLKMSNSVNSLDGEFGVDGQRASMGKQGMVATAGFVMMFGAFVGLGAMVYKWKK 465
Query: 429 RRQLPQLGHS-KAWIPVSINGGNSHTMGSKYSHGTTTSANS--NSGYRFPFVAVQEATNN 485
R Q Q +S +W+ + I+ G+S M SK + NS G F +QE T N
Sbjct: 466 RPQDWQKRNSFSSWL-LPIHAGDSTFMTSKTGSHKSNLYNSALGLGRYFSLSELQEVTKN 524
Query: 486 FDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
FD S +IG+GGFG VY G ++DGT+VA+KRGNP+S+QG+ EF TEI+MLS+ RHRHLVSL
Sbjct: 525 FDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRHLVSL 584
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
IGYCDE EMIL+YEYM NG + HLYG L L+WKQRLEICIG+ARGLHYLHTG A+
Sbjct: 585 IGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTGTAQG 644
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
+IHRDVKS NILLDE +AKVADFGLSK Q HVSTAVKGSFGYLDPEYFRRQQLT
Sbjct: 645 IIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQLT 703
Query: 666 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725
+KSDVYSFGVVL E LCARP I+P LPRE VNLAEWAM W+ KG L++IIDP L G + P
Sbjct: 704 DKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVGAVNP 763
Query: 726 DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 769
+S++KF E AEKCLAD+GVDRP+MGDVLWNLEYALQLQEA G
Sbjct: 764 ESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQG 807
|
|
| TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1539 (546.8 bits), Expect = 3.6e-174, Sum P(2) = 3.6e-174
Identities = 320/655 (48%), Positives = 417/655 (63%)
Query: 141 SVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQ 200
+ +S++ KEF + L + F P SF F+NA+E+VSV D+L + + +
Sbjct: 159 ATASSLVKEFLLPTGPGKLVLSFIPEKGSFGFVNAIEIVSVDDKLFKESVTKVGGSEVEL 218
Query: 201 GLVFQTFETVHRVNMGGPLVTPENDT-LWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGG 259
GL + ET++R+N+GGP + P D L+RTW D S++V N V N + Y
Sbjct: 219 GLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIENAGVEVKNSSNITYALAD 278
Query: 260 ATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYF 319
+ AP VY TA M++ + FN++W+F+VD F YLVR HFC+++ D NQ F
Sbjct: 279 DSPV-APLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCELLVDKQNQRIF 337
Query: 320 NVYIDSWIAVRDLDLSTYSTNTLAAAY--YIDMVTVQTASSKLRISIGRSTLHDTYPDAI 377
+YI++ A + D+ ++ Y Y+D V+ + + L I +G + DA+
Sbjct: 338 RIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVS--SKNDVLWIQLGPDSSVGASGDAL 395
Query: 378 LNGLEIMKMK---NLQ-----GSLGNSSSKKHXXXXXXXXXXXXXAALL---AGILFM-L 425
L+GLEI K+ NL S G+S S + GIL + L
Sbjct: 396 LSGLEIFKLSKNGNLAHLIRFDSTGHSVSDSKMRIIWISVGAGIAIIIFFVFLGILVVCL 455
Query: 426 CRKRRQLPQLGHSK--AWIPVSINGGNSHTMGSKYSHGT---TTSANSNSGYRFPFVAVQ 480
C+KRR + W P+ ++ NS T +K + G+ T A S G +F ++
Sbjct: 456 CKKRRSKSDESKNNPPGWRPLFLHVNNS-TANAKATGGSLRLNTLAASTMGRKFTLAEIR 514
Query: 481 EATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR 540
AT NFD+ IG+GGFGKVY+GEL DGT +A+KR P SQQGLAEF+TEI MLS+ RHR
Sbjct: 515 AATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEIVMLSRLRHR 574
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 600
HLVSLIG+CDE NEMIL+YEYM NGTL+ HL+GS LP LSWKQRLE CIGSARGLHYLHT
Sbjct: 575 HLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGSARGLHYLHT 634
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
G + +IHRDVK+ NILLDENF+AK++DFGLSK GP +D THVSTAVKGSFGYLDPEYFR
Sbjct: 635 GSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTAVKGSFGYLDPEYFR 694
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720
RQQLTEKSDVYSFGVVLFE +CAR VI+PTLP++ +NLAEWA+ WQ + L+ IID L
Sbjct: 695 RQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLESIIDSNLR 754
Query: 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENS 775
G P+SL K+GE AEKCLAD G +RP MG+VLW+LEY LQ+ EA + ENS
Sbjct: 755 GNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIHEAWLRKQNGENS 809
|
|
| TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1189 (423.6 bits), Expect = 1.8e-172, Sum P(2) = 1.8e-172
Identities = 234/393 (59%), Positives = 290/393 (73%)
Query: 398 SKKHXXXXXXXXXXXXXAALLAGI-LFMLCRKRRQ---LPQLGHSKAWIPVSINGGNSHT 453
SK + AL+ G +F R+R++ P + W+P+S+ G NSH+
Sbjct: 442 SKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYG-NSHS 500
Query: 454 MGSKYSHGTTTSANS---NSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGT- 509
GS ++ T + A+S N F F ++ AT NFDES V+G+GGFGKVY+GE++ GT
Sbjct: 501 AGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTT 560
Query: 510 KVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG 569
KVA+KRGNP S+QG+ EFQTEIEMLS+ RHRHLVSLIGYC+E EMIL+Y+YM +GT++
Sbjct: 561 KVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMRE 620
Query: 570 HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629
HLY + PSL WKQRLEICIG+ARGLHYLHTG +IHRDVK+ NILLDE ++AKV+DF
Sbjct: 621 HLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF 680
Query: 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDP 689
GLSKTGP +D THVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCARP ++P
Sbjct: 681 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNP 740
Query: 690 TLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM 749
TL +E V+LAEWA KG LDQI+DP L GKI P+ +KF ETA KC+ D G++RPSM
Sbjct: 741 TLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSM 800
Query: 750 GDVLWNLEYALQLQEAVVHGDPDENSTNLIGEL 782
GDVLWNLE+ALQLQE+ +EN + G++
Sbjct: 801 GDVLWNLEFALQLQESA-----EENGKGVCGDM 828
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LX66 | HERK_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6694 | 0.9794 | 0.9771 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.I.1449.1 | hypothetical protein (818 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 828 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 3e-64 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-27 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-22 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-10 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 4e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 9e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-04 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 3e-64
Identities = 96/375 (25%), Positives = 146/375 (38%), Gaps = 64/375 (17%)
Query: 36 IDCGSRTNTTV----GNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFT 91
IDCG +N + +V+D F+ T ++ NIS+ +SS S+ Y+T R F
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAG---FIDTGKS--GNISKENSSSFLSKPYKTLRSFP 55
Query: 92 GSSK--YTFSI--SGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNV- 146
+ YT + ++ IR F Y N S S + L ++ + V
Sbjct: 56 DGKRNCYTLPVTPGKGTKYLIRATFLYGNYDGLNSV--SSPPSFD---LYLGVNLWTTVN 110
Query: 147 ---------FKEFSVNVT-SDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPP 196
KE+ ++VT SD+L V + FI+ALE+ +PD L S
Sbjct: 111 LSNDSGDSVVKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGS---- 166
Query: 197 GKYQGLVFQTFETVHRVNMG--GPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVK 254
Q + V R+N G + +D R W P S ++ S+S
Sbjct: 167 --------QALKLVARLNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVD---- 214
Query: 255 YVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGL 314
+ P+ V TA + +A N TW+ D F+Y V HF +I S L
Sbjct: 215 -ISSNNAPYIPPSAVLQTAVTPTNA---SAPLNFTWDLV-DPNFEYYVYLHFAEIQS--L 267
Query: 315 NQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGR---STLHD 371
F++YI+ D+ T A Y+D + L IS+ STL
Sbjct: 268 ETREFDIYINGKTVYGDVSP--KYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTL-- 323
Query: 372 TYPDAILNGLEIMKM 386
+LN LEI K+
Sbjct: 324 ---PPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 6e-55
Identities = 71/210 (33%), Positives = 111/210 (52%), Gaps = 19/210 (9%)
Query: 491 VIGIGGFGKVYKGELNDG----TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FG+VYKG+L T+VAVK + + ++ +F E ++ + H ++V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVVR 60
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHL-------YGSGLPSLSWKQRLEICIGSARGLHY 597
L+G C E+ + L+ EYME G L +L +LS K L I A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
L +K +HRD+ + N L+ E+ + K++DFGLS+ + D T K ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 658 YFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
+ T KSDV+SFGV+L+E+ L A P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 4e-53
Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 18/206 (8%)
Query: 491 VIGIGGFGKVYKGELNDG-----TKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FG+VYKG L +VAVK S+Q + EF E ++ + H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
L+G C E+ ++++ EYM G L +L + LS L + ARG+ YL +K
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA---VKGSFGYLDPEYFRR 661
IHRD+ + N L+ EN + K++DFGLS+ + D V ++ ++ PE +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKE 178
Query: 662 QQLTEKSDVYSFGVVLFEV--LCARP 685
+ T KSDV+SFGV+L+E+ L P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 19/206 (9%)
Query: 491 VIGIGGFGKVYKGELND-----GTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FG+VYKG+L +VAVK S+Q + EF E ++ + H ++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
L+G C E+ + ++ EYME G L +L + P LS L + ARG+ YL +K
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLE---SK 121
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA---VKGSFGYLDPEYFRR 661
IHRD+ + N L+ EN + K++DFGLS+ + D ++ ++ PE +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESLKE 177
Query: 662 QQLTEKSDVYSFGVVLFEV--LCARP 685
+ T KSDV+SFGV+L+E+ L +P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-51
Identities = 68/198 (34%), Positives = 105/198 (53%), Gaps = 10/198 (5%)
Query: 491 VIGIGGFGKVYKGELND-----GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FG+VYKG L TKVAVK S++ EF E ++ + H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
L+G C + + ++ EYM G L L G L+ K L++ + A+G+ YL +K
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
+HRD+ + N L+ EN + K++DFGLS+ E D K ++ PE + +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 665 TEKSDVYSFGVVLFEVLC 682
T KSDV+SFGV+L+E+
Sbjct: 182 TSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 72/192 (37%), Positives = 99/192 (51%), Gaps = 10/192 (5%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGYC 549
+G GGFG VY G KVA+K L E EIE+L + H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+++N + L+ EY E G+LK L LS + L I + GL YLH + +IHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 610 DVKSANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ-LTEK 667
D+K NILLD N K+ADFGLSK + G+ Y+ PE + +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 668 SDVYSFGVVLFE 679
SD++S GV+L+E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 88/275 (32%), Positives = 129/275 (46%), Gaps = 37/275 (13%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G G FG VYK G VAVK RS+ + + EI +L + H ++V LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
++K+ + L+ EY E G L +L G LS + +I + RGL YLH + +I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLH---SNGII 120
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-YFRRQQLTE 666
HRD+K NILLDEN + K+ADFGL+K + ++T V G+ Y+ PE
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGP 178
Query: 667 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ--IIDPTLAGKIR 724
K DV+S GV+L+E+L +P + + LDQ +I L +
Sbjct: 179 KVDVWSLGVILYELLTGKPP------------------FSGENILDQLQLIRRILGPPLE 220
Query: 725 PDS--LRKFGETA----EKCLADFGVDRPSMGDVL 753
D E A +KCL RP+ ++L
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 73/275 (26%), Positives = 118/275 (42%), Gaps = 43/275 (15%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGY 548
+G G FGKVY + G VA+K + + E EI++L + +H ++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL--EICIGSARGLHYLHTGYAKAV 606
++++++ L+ EY E G L L G S + +I L YLH +K +
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLH---SKGI 118
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
+HRD+K NILLDE+ K+ADFGL++ ++D T G+ Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 667 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 726
D++S GV+L+E+L +P P + QL ++ K
Sbjct: 176 AVDIWSLGVILYELLTGKP---P---------------FPGDDQLLELFKKIGKPKPPFP 217
Query: 727 S-LRKFGETA----EKCLADFGVD---RPSMGDVL 753
A K L D R + + L
Sbjct: 218 PPEWDISPEAKDLIRKLLV---KDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 491 VIGIGGFGKVYKGELND-GTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
++G G FG VY D G +AVK + S++ L + EI +LS +H ++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 548 -YCDEKNEMILIY-EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
DE+ + I+ EY+ G+L L G ++ I GL YLH +
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--LEGLAYLH---SNG 121
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
++HRD+K ANIL+D + + K+ADFG +K +I+ + +V+G+ ++ PE R ++
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 666 EKSDVYSFGVVLFEVLCARPV 686
+D++S G + E+ +P
Sbjct: 182 RAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
IG GGFG+VYK G +VA+K S++ + EI++L + +H ++V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+K+E+ ++ E+ G+LK L + L+ Q +C +GL YLH + +IHR
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLH---SNGIIHR 122
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
D+K+ANILL + K+ DFGLS + + G+ ++ PE + K+D
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDYKAD 179
Query: 670 VYSFGVVLFE 679
++S G+ E
Sbjct: 180 IWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 66/190 (34%), Positives = 103/190 (54%), Gaps = 12/190 (6%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGYCD 550
IG G FG V G+ G KVAVK + A+ F E +++ RH +LV L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
+ N + ++ EYM G+L +L G ++ Q+L + G+ YL K +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 670
+ + N+L+ E+ +AKV+DFGL+K E Q S K + PE R ++ + KSDV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK---EASQGQDSG--KLPVKWTAPEALREKKFSTKSDV 182
Query: 671 YSFGVVLFEV 680
+SFG++L+E+
Sbjct: 183 WSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+IG G FG VYKG L G VA+K+ L EI++L +H ++V
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA--LKSIMQEIDLLKNLKHPNIVKY 64
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP-SLS---WKQRLEICIGSARGLHYLH 599
IG + + + +I EY ENG+L+ + +G P SL Q L+ GL YLH
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQ-------GLAYLH 116
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ VIHRD+K+ANIL ++ + K+ADFG++ D + +V G+ ++ PE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVI 171
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARP 685
+ SD++S G + E+L P
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 2e-31
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 10/200 (5%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
IG G FGKVY +DG +K + S++ + E+++L + H +++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 548 YCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
+EK ++ ++ EY + G L + +Q L+ + L YLH+ +
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RK 123
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
++HRD+K NI L N + K+ DFG+SK T V G+ YL PE + +
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181
Query: 666 EKSDVYSFGVVLFEVLCARP 685
KSD++S G VL+E+ +
Sbjct: 182 YKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 67/192 (34%), Positives = 105/192 (54%), Gaps = 9/192 (4%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGYCD 550
IG G FG VYKG L T+VAVK L +F E E+L Q+ H ++V LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
+K + ++ E + G+L L L+ K+ L++ + +A G+ YL +K IHRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKG-SFGYLDPEYFRRQQLTEKS 668
+ + N L+ EN + K++DFG+S+ E + VS +K + PE + T +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 669 DVYSFGVVLFEV 680
DV+S+G++L+E
Sbjct: 177 DVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 490 WVIGIGGFGKVYKGEL------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+G G FGKV+ GE ND VAVK S +F+ E E+L+ F+H ++
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHL------------YGSGLPSLSWKQRLEICIG 590
V G C E + I+++EYME+G L L S + L+ Q L+I +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
A G+ YL ++ +HRD+ + N L+ + + K+ DFG+S+ D V
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
++ PE ++ T +SDV+SFGVVL+E+
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 60/189 (31%), Positives = 100/189 (52%), Gaps = 5/189 (2%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
+G G FG+V++G + +VA+K +FQ E++ L + RH+HL+SL C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
+ +I E ME G+L L L +++ A G+ YL + IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 671
+ NIL+ E+ + KVADFGL++ + ++S+ K + + PE + KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 672 SFGVVLFEV 680
SFG++L+E+
Sbjct: 189 SFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 67/191 (35%), Positives = 107/191 (56%), Gaps = 10/191 (5%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
IG G FG V+ G + KVA+K R S++ +F E +++ + H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
E++ + L++E+ME+G L +L + S + L +C+ G+ YL + VIHR
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
D+ + N L+ EN + KV+DFG+++ + DQ ST K + PE F + + KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 670 VYSFGVVLFEV 680
V+SFGV+++EV
Sbjct: 184 VWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 17/224 (7%)
Query: 492 IGIGGFGKVYKGE---LNDGT--KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FGKV L D T +VAVK N +Q ++F+ EIE+L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 546 IGYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
G C++ + LI EY+ +G+L+ +L ++ K+ L +G+ YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS--- 127
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS--FGYLDPEYFRR 661
+ IHRD+ + NIL++ + K++DFGL+K PE + S F Y PE R
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186
Query: 662 QQLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREMVNLAEWAM 703
+ + SDV+SFGV L+E+ P M+ +A+ M
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 67/199 (33%), Positives = 108/199 (54%), Gaps = 15/199 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTK----VAVKR---GNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
VIG G FG+V +G L K VA+K G+ Q+ +F TE ++ QF H +++
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR--LDFLTEASIMGQFDHPNII 68
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGY 602
L G + +++I EYMENG+L L + + Q + + G A G+ YL Y
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 662
+HRD+ + NIL++ N + KV+DFGLS+ + + T+ + K + PE +
Sbjct: 128 ----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 663 QLTEKSDVYSFGVVLFEVL 681
+ T SDV+SFG+V++EV+
Sbjct: 184 KFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 65/189 (34%), Positives = 98/189 (51%), Gaps = 5/189 (2%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
+G G FG+V+ G N TKVAVK P + F E +++ + RH LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
+ + ++ EYM G+L L L Q +++ A G+ YL ++ IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 671
+ NIL+ EN + K+ADFGL++ E D+ K + PE + T KSDV+
Sbjct: 130 AARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 672 SFGVVLFEV 680
SFG++L E+
Sbjct: 189 SFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 62/190 (32%), Positives = 102/190 (53%), Gaps = 5/190 (2%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
+G G FG+V++G N+ T VAVK P + +F E +++ + RH L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
+ + ++ E M+ G+L +L G +L Q +++ A G+ YL A+ IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 671
+ N+L+ EN + KVADFGL++ E D K + PE + + KSDV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 672 SFGVVLFEVL 681
SFG++L E++
Sbjct: 189 SFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 474 FPFVAVQEATNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAE 526
FP +QE T +G G FG+V+ + T V VK + +E
Sbjct: 2 FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54
Query: 527 FQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-------GLPSL 579
F+ E++M + H+++V L+G C E +I EY + G LK L + P L
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 580 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639
S KQ++ +C A G+ +L +HRD+ + N L+ KV+ LSK
Sbjct: 115 STKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNS 170
Query: 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
+ + +L PE + + KSDV+SFGV+++EV
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 490 WVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
W +G G FGKV+ E D VAVK S+ +FQ E E+L+ +H+H+V
Sbjct: 11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-------------LPSLSWKQRLEICIG 590
G C E +++++EYM +G L L G L+ Q L I
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
A G+ YL + + +HRD+ + N L+ + + K+ DFG+S+ D V
Sbjct: 131 IASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
++ PE ++ T +SD++SFGVVL+E+
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 24/277 (8%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRH-RHLVSLI 546
+G G FG+VY VA+K + + + + F EI++L+ H ++V L
Sbjct: 7 KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 547 GYCDEKNEMILIYEYMENGTLKGHL-YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
+ ++ + L+ EY++ G+L+ L LS + L I L YLH+ K
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 606 VIHRDVKSANILLDEN-FMAKVADFGLSKTGPEIDQT----HVSTAVKGSFGYLDPEYFR 660
+IHRD+K NILLD + + K+ DFGL+K P+ T + + G+ GY+ PE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 661 RQQL---TEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716
L + SD++S G+ L+E+L P + +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT--LKIILELPTPSLASPL 239
Query: 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
++ + +K LA +R S L
Sbjct: 240 SPSNPELISKAASDL---LKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 71/218 (32%), Positives = 111/218 (50%), Gaps = 17/218 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
IG G FG V G+ G KVAVK + + +Q F E +++Q RH +LV L+G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGV 67
Query: 549 -CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
+EK + ++ EYM G+L +L G L L+ + + YL A +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
HRD+ + N+L+ E+ +AKV+DFGL+K T K + PE R ++ + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTK 179
Query: 668 SDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMK 704
SDV+SFG++L+E+ V P +P +++V E K
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 217
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 492 IGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FGKV+ E D VAVK S +F E E+L+ +H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 546 IGYCDEKNEMILIYEYMENGTL----KGH-----LYGSGLP--SLSWKQRLEICIGSARG 594
G C E + +I+++EYM++G L + H L G L+ Q L I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ YL + + +HRD+ + N L+ EN + K+ DFG+S+ D V ++
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVL 681
PE ++ T +SDV+S GVVL+E+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 20/213 (9%)
Query: 484 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQF 537
N+ ++G G FG+VY +++ G ++AVK+ +P +++ + + EI++L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 538 RHRHLVSLIGYCDEKNEMILIY-EYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARG 594
+H +V G C +E + I+ EYM G++K L YG+ +++ K +I G
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EG 116
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI--DQTHVSTAVKGSFG 652
+ YLH+ ++HRD+K ANIL D K+ DFG SK I T + + V G+
Sbjct: 117 VEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPY 172
Query: 653 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
++ PE + K+DV+S G + E+L +P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 68/212 (32%), Positives = 112/212 (52%), Gaps = 12/212 (5%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA-EFQTEIEMLSQFRHRHLVSLIGYC 549
++G G FG+V+KG L D T VAVK Q L +F +E +L Q+ H ++V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
++ + ++ E + G L L KQ ++ + +A G+ YL + K IHR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHR 117
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG-SFGYLDPEYFRRQQLTEKS 668
D+ + N L+ EN + K++DFG+S+ E D + S+ +K + PE + + +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 669 DVYSFGVVLFEV----LCARPVIDPTLPREMV 696
DV+S+G++L+E +C P + RE V
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 12/192 (6%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE--FQTEIEMLSQFRHRHLVSLIGYC 549
+G G FG V+ G+ VA+K + ++E F E +++ + H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 550 DEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
++ + ++ EYM NG L +L G W L++C + YL + IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLES---NGFIH 123
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 668
RD+ + N L+ E+ + KV+DFGL++ + DQ S K + PE F + + KS
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 669 DVYSFGVVLFEV 680
DV+SFGV+++EV
Sbjct: 183 DVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 67/192 (34%), Positives = 107/192 (55%), Gaps = 14/192 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
+IG G FG V +GE G KVAVK N + F E ++++ H++LV L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI- 68
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
N + ++ E M G L L G +S Q L+ + A G+ YL + K ++HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRD 125
Query: 611 VKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
+ + NIL+ E+ +AKV+DFGL++ G +D + + VK + PE + ++ + KSD
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVK----WTAPEALKHKKFSSKSD 179
Query: 670 VYSFGVVLFEVL 681
V+S+GV+L+EV
Sbjct: 180 VWSYGVLLWEVF 191
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 8e-25
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 8/206 (3%)
Query: 475 PFVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEM 533
V+ + + IG G G+VYK + G +VA+K+ R Q EI +
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILI 68
Query: 534 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 593
+ +H ++V +E+ ++ EYM+ G+L + + + ++ Q +C +
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQ 127
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
GL YLH ++ VIHRD+KS NILL ++ K+ADFG + + S V G+ +
Sbjct: 128 GLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYW 182
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFE 679
+ PE +R+ K D++S G++ E
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 492 IGIGGFGKVYKG----ELNDGT---KVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRH 541
+G G FG+VY+G L G+ +VAVK +G ++ EF E ++S F H +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-----GLPSLSWKQRLEICIGSARGLH 596
+V L+G C +I E ME G L +L + G P L+ K+ L+IC+ A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 597 YLHTGYAKAVIHRDVKSANILLDE-----NFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
YL + IHRD+ + N L+ E + + K+ DFGL++ + D
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 652 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
++ PE + T +SDV+SFGV+++E+L
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 492 IGIGGFGKVYKGE------LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FGKV+ E D VAVK + +FQ E E+L+ +H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLEICIGS 591
G C + + +I+++EYM++G L L G + L Q L I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
A G+ YL + + +HRD+ + N L+ N + K+ DFG+S+ D V
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 652 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
++ PE ++ T +SDV+SFGV+L+E+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 30/213 (14%)
Query: 492 IGIGGFGKVYKGEL---NDG---TKVAVK----RGNPRSQQGLAEFQTEIEMLSQFRHRH 541
+G G FGKVYKGEL N+ T VA+K P+ QQ EF+ E E++S +H +
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQHPN 69
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEI 587
+V L+G C ++ +++EY+ +G L L + SL L I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
I A G+ YL + +HRD+ + N L+ E K++DFGLS+ D V +
Sbjct: 130 AIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
++ PE + T +SD++SFGVVL+E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTK----VAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSL 545
VIG G FG+V++G L + VA+K P +++ +F +E ++ QF H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
G + ++I EYMENG L +L S Q + + G A G+ YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MN 127
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGYLDPEYFRRQ 662
+HRD+ + NIL++ N KV+DFGLS+ PE T+ ++ K + PE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE--GTYTTSGGKIPIRWTAPEAIAYR 185
Query: 663 QLTEKSDVYSFGVVLFEVL 681
+ T SDV+SFG+V++EV+
Sbjct: 186 KFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 60/190 (31%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
+G G FG+V+ G N+ TKVAVK P + + F E ++ +H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
+ + +I EYM G+L L + + ++ A G+ Y+ K IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 129
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 671
++AN+L+ E+ M K+ADFGL++ E ++ K + PE T KSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 672 SFGVVLFEVL 681
SFG++L+E++
Sbjct: 189 SFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
IG G FGKVY L+ G +AVK +P++ + +A+ E+++L +H +LV
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD---EMKVLELLKHPNLVKY 64
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHL-YGSGLPSLSWKQRLEICIGS-----ARGLHYLH 599
G + ++ + EY GTL+ L +G L E I GL YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILD--------EHVIRVYTLQLLEGLAYLH 116
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-------TGPEIDQTHVSTAVKGSFG 652
+ ++HRD+K ANI LD N + K+ DFG + T E Q+ T
Sbjct: 117 S---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA----- 168
Query: 653 YLDPEYFRRQQLTEK---SDVYSFGVVLFEVLCARP 685
Y+ PE + +D++S G V+ E+ +
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 69/200 (34%), Positives = 113/200 (56%), Gaps = 14/200 (7%)
Query: 491 VIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSL 545
VIG G FG VY G L +DG K+ AVK N + + + +F E ++ F H +++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 546 IGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
+G C E + ++++ YM++G L+ + S + + K + + A+G+ YL +
Sbjct: 62 LGICLPSEGSPLVVL-PYMKHGDLR-NFIRSETHNPTVKDLIGFGLQVAKGMEYLAS--- 116
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLDPEYFRR 661
K +HRD+ + N +LDE+F KVADFGL++ E H T K ++ E +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 662 QQLTEKSDVYSFGVVLFEVL 681
Q+ T KSDV+SFGV+L+E++
Sbjct: 177 QKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FG VY+G L+DG AVK Q+ + + + EI +LS+ +H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHL--YGS---GLPSLSWKQRLEICIGSARGLHYLHT 600
+G E++ + + E + G+L L YGS + L +Q L GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH- 119
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ +HRD+K ANIL+D N + K+ADFG++K E + KGS ++ PE
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWMAPEVIA 174
Query: 661 RQQL-TEKSDVYSFGVVLFEVLCARP 685
+Q +D++S G + E+ +P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 492 IGIGGFGKVYKGELND------GTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVS 544
+G G FG VY+G T+VA+K N + EF E ++ +F H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHL--------YGSGLPSLSWKQRLEICIGSARGLH 596
L+G +++ E M G LK +L GL + ++ +++ A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-- 654
YL AK +HRD+ + N ++ E+ K+ DFG+++ E D KG G L
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 185
Query: 655 ---DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
PE + T KSDV+SFGVVL+E+ L +P
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 76/230 (33%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 491 VIGIGGFGKV--YKGE-LNDGTK--VAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
V+G G FGKV Y + NDGT VAVK R QQ + ++ EI +L H ++
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENI 68
Query: 543 VSLIGYCDEKNEMI--LIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGLH 596
V G C E+ LI EY+ G+L+ +L L+ Q L +IC G+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQIC----EGMA 121
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKGSFGYLD 655
YLH ++ IHRD+ + N+LLD + + K+ DFGL+K PE + + V +
Sbjct: 122 YLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREMVNLAEWAM 703
E + + + SDV+SFGV L+E+L C P EM+ + M
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 46/218 (21%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEF-QT---EIEMLSQFRHRHLVSLI 546
IG G +G+VYK G VA+K+ R + F T EI++L + RH ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 547 GYC--DEKNEMILIYEYME---NGTLKGHLYGSGLPSL-SW-KQRLEICIGSARGLHYLH 599
K + +++EYM+ G L + + KQ LE GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQYLH 117
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVSTAVKGSFGYLD 655
+ ++HRD+K +NIL++ + + K+ADFGL +K V T Y
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT-----LWYRP 169
Query: 656 PE-------YFRRQQLTEKSDVYSFGVVLFEVLCARPV 686
PE Y + D++S G +L E+ +P+
Sbjct: 170 PELLLGATRY------GPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 63/190 (33%), Positives = 97/190 (51%), Gaps = 6/190 (3%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
+G G FG+V+ G N TKVA+K S A F E ++ Q +H LV L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
+ + +I EYMENG+L L L+ + +++ A G+ ++ K IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 671
++ANIL+ E K+ADFGL++ E ++ K + PE T KSDV+
Sbjct: 129 RAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 672 SFGVVLFEVL 681
SFG++L E++
Sbjct: 188 SFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 68/201 (33%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 491 VIGIGGFGKVYKGELNDGTKV-AVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSL- 545
VIG G FGKV + D K+ A+K N + + + E +L + H LV+L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ-RLEIC-IGSARGLHYLHTGYA 603
+ DE+N M L+ + + G L+ HL S S +Q + IC I A L YLH+
Sbjct: 67 YSFQDEEN-MYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLA--LEYLHS--- 118
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
K +IHRD+K NILLDE + DF ++ T T+ G+ GY+ PE RQ
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQG 175
Query: 664 LTEKSDVYSFGVVLFEVLCAR 684
+ D +S GV +E L +
Sbjct: 176 YSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 491 VIGIGGFGKVYK-GELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
IG G FG V K +DG + K + +Q L +E+ +L + +H ++V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV- 62
Query: 545 LIGYCDE----KNEMILIY-EYMENGTL--------KGHLYGSGLP-SLSWKQRLEICIG 590
Y D N+ + I EY E G L K Y + W+ ++ +
Sbjct: 63 --RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY---IEEEFIWRILTQLLLA 117
Query: 591 SARGLHYLHTGYAK--AVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVST 645
L+ H V+HRD+K ANI LD N K+ DFGL+K +T+V T
Sbjct: 118 ----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173
Query: 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 683
Y+ PE EKSD++S G +++E LCA
Sbjct: 174 PY-----YMSPEQLNHMSYDEKSDIWSLGCLIYE-LCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 485 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGL--AEFQTEIEMLSQFRHRH 541
+F+ IG G FG V+K D A+K+ + E E +L++ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLY---GSGLP-SLSWKQRLEICIGSARGLHY 597
++ +K ++ ++ EY ENG L L G LP W+ ++I +G L +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
LH+ K ++HRD+KS N+ LD K+ D G++K D T+ + + G+ YL PE
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPE 171
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVLC 682
+ EKSDV++ GVVL+E C
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYE-CC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 67/196 (34%), Positives = 104/196 (53%), Gaps = 18/196 (9%)
Query: 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGYC 549
IG G FG+V+ G L D T VAVK L A+F E +L Q+ H ++V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+K + ++ E ++ G L G P L K+ +++ +A G+ YL + K IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHR 118
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA------VKGSFGYLDPEYFRRQQ 663
D+ + N L+ E + K++DFG+S+ E D + ST VK + PE +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVK----WTAPEALNYGR 172
Query: 664 LTEKSDVYSFGVVLFE 679
+ +SDV+SFG++L+E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 64/226 (28%), Positives = 117/226 (51%), Gaps = 27/226 (11%)
Query: 492 IGIGGFGKVYKGEL------NDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQF-RHRHL 542
+G G FG+V K E N+ + VAVK + + +++ L++ +E+EM+ +H+++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 543 VSLIGYCDEKNEMILIYEYMENGTL---------KGHLYGSGLP-----SLSWKQRLEIC 588
++L+G C ++ + ++ EY +G L G P +L+ K +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 589 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648
ARG+ +L + K IHRD+ + N+L+ E+ + K+ADFGL++ ID +T +
Sbjct: 139 YQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694
++ PE + T +SDV+SFGV+L+E+ P +P E
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 491 VIGIGGFGKVYKGELN--DGT--KVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
++G G FG V +G+L+ DG+ KVAVK + + + + EF +E + F H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 545 LIGYCDEKNEM------ILIYEYMENGTLKGHLYGSGLPSLSWK---QRL-EICIGSARG 594
LIG C E + + ++I +M++G L L S L L K Q L + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSF 651
+ YL + IHRD+ + N +L E+ VADFGLSK G Q ++ K
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMPV 179
Query: 652 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
++ E + T KSDV++FGV ++E+
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 68/227 (29%), Positives = 115/227 (50%), Gaps = 27/227 (11%)
Query: 492 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 541
+G G FG+V E N TKVAVK + +++ L++ +E+EM+ +H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLEI 587
+++L+G C + + +I EY G L+ +L P LS+K +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
ARG+ YL + K IHRD+ + N+L+ E+ + K+ADFGL++ ID +T
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694
+ ++ PE + T +SDV+SFGV+L+E+ P +P E
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 491 VIGIGGFGKVYKGEL----NDGTK--VAVK-RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G FG+VY+G D + VAVK S+Q ++F E ++S+F H+++V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGS----GLPS-LSWKQRLEICIGSARGLHYL 598
LIG E+ ++ E M G LK L + PS L+ K L A+G YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 599 HTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGS----- 650
IHRD+ + N LL +AK+ADFG+++ D S KG
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLP 184
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
++ PE F T K+DV+SFGV+L+E+
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 3e-22
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 492 IGIGGFGKVYK-GELNDGT----KVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
+G G FGKV + + G KV K+ + ++ + TE +LS+ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE-VEHTLTERNILSRINHPFIVKLH 59
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
+ ++ L+ EY G L HL G S + I A L YLH + +
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA--LEYLH---SLGI 114
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
I+RD+K NILLD + K+ DFGL+K + + +T G+ YL PE + +
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 667 KSDVYSFGVVLFEVLCARP 685
D +S GV+L+E+L +P
Sbjct: 173 AVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 7/210 (3%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
+G G FG+V+ G N T+VA+K P + A F E +++ + RH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
+ + ++ EYM G+L L G L Q +++ A G+ Y+ +HRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 128
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 671
++ANIL+ EN + KVADFGL++ E ++ K + PE + T KSDV+
Sbjct: 129 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 672 SFGVVLFEVLCARPVIDPTL-PREMVNLAE 700
SFG++L E+ V P + RE+++ E
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVE 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 10/195 (5%)
Query: 492 IGIGGFGKVYKGE----LNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLI 546
+G G FG V +GE VAVK + +F E ++ H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
G ++++ E G+L L L + + A G+ YL + K
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGSFGYLDPEYFRRQQLT 665
IHRD+ + NILL + K+ DFGL + P+ + +V +K F + PE R + +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 666 EKSDVYSFGVVLFEV 680
SDV+ FGV L+E+
Sbjct: 179 HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 30/205 (14%)
Query: 491 VIGIGGFGKVYKGELNDGTK--VAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
V+G G G VYK + T A+K+ G+ ++ L E++ L ++V
Sbjct: 8 VLGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVK 63
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGL---PSLSWKQRLEICIGSARGLHYLHTG 601
G ++ E+ ++ EYM+ G+L L G P L+ I +GL YLHT
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHT- 117
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFGYLDPEY 658
+ +IHRD+K +N+L++ K+ADFG+SK + T V T Y+ PE
Sbjct: 118 -KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT-----YMSPER 171
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCA 683
+ + + +D++S G+ L E CA
Sbjct: 172 IQGESYSYAADIWSLGLTLLE--CA 194
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 62/191 (32%), Positives = 96/191 (50%), Gaps = 10/191 (5%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
+G G FG V G+ VA+K + S+ EF E +++ + H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
++ + ++ EYM NG L +L Q LE+C G+ YL + K IHR
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
D+ + N L+D+ KV+DFGLS+ + D+ S K + PE + + KSD
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 670 VYSFGVVLFEV 680
V++FGV+++EV
Sbjct: 184 VWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 48/297 (16%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 548
IG G +G VYK + G VA+K+ R + EI++L + H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
K ++ L++E+M+ L + L +GL + H + ++H
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 609 RDVKSANILLDENFMAKVADFGLSKT--GPEIDQTH-VSTAVKGSFGYLDPE-YFRRQQL 664
RD+K N+L++ + K+ADFGL+++ P TH V T Y PE +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY 176
Query: 665 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI--IDPTLAGK 722
+ D++S G + E+L RP+ + K ++DQ+ I TL G
Sbjct: 177 STPVDIWSVGCIFAELLSRRPL------------------FPGKSEIDQLFKIFRTL-GT 217
Query: 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL------EYALQLQEAVVHGDPDE 773
P+ KF A ++ P + AL L ++H DP +
Sbjct: 218 PDPEVWPKFTSLAR----NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 34/208 (16%)
Query: 492 IGIGGFGKVYKGEL--------NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G FG V EL N G VAVK+ + + L +F+ EIE+L +H ++V
Sbjct: 12 LGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 544 SLIGYCDE--KNEMILIYEYMENGTLKGHL-------YGSGLPSLSWKQRLEICIGSARG 594
G C + + L+ EY+ G+L+ +L L + +IC +G
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS----QIC----KG 120
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS--FG 652
+ YL +K +HRD+ + NIL++ K+ DFGL+K P+ + + S F
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 653 YLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
Y PE + + SDV+SFGVVL+E+
Sbjct: 178 YA-PESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 9e-22
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 492 IGIGGFGKVYKGEL------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
IG G FG+V++ T VAVK S A+FQ E ++++F H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHL--------------------YGSGLPSLSWKQR 584
L+G C M L++EYM G L L G LS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 585 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644
L I A G+ YL + +HRD+ + N L+ EN + K+ADFGLS+ D S
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
++ PE + T +SDV+++GVVL+E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
+G G FGKVYK + G A K S++ L +F EI++LS+ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
+N++ ++ E+ + G L + L+ Q +C L++LH + VIHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-----FRRQQLT 665
+K+ NILL + K+ADFG+S Q T + G+ ++ PE F+
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPYD 186
Query: 666 EKSDVYSFGVVLFEVLCARP 685
K+D++S G+ L E+ P
Sbjct: 187 YKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 72/215 (33%), Positives = 112/215 (52%), Gaps = 35/215 (16%)
Query: 491 VIGIGGFGKVYKGEL-NDGTKV--AVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRHLVSL 545
VIG G FG+V K + DG ++ A+KR S+ +F E+E+L + H ++++L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGS 591
+G C+ + + L EY +G L L S + +LS +Q L
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
ARG+ YL K IHRD+ + NIL+ EN++AK+ADFGLS+ G E+ VK +
Sbjct: 134 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 182
Query: 652 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 681
G L + + L T SDV+S+GV+L+E++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 491 VIGIGGFGKVYKG---ELNDGTK--VAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
V+G G FG VYKG + K VA+K S + E E +++ H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHL------YGSGLPSLSWKQRLEICIGSARGLHYL 598
L+G C ++ LI + M G L ++ GS L+W C+ A+G+ YL
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQY-LLNW------CVQIAKGMSYL 125
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
K ++HRD+ + N+L+ K+ DFGL+K ++ + + K ++ E
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLC--ARP 685
+ T KSDV+S+GV ++E++ A+P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 492 IGIGGFGKVY---KGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSL 545
I G +G+V+ K D A+K + TE ++LSQ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 546 I-GYCDEKNEMILIYEYMENGTLKG--HLYGSGLPSLSWKQRL-EICIGSARGLHYLHTG 601
+ +KN + L+ EY+ G L GS L + + EI + L YLH
Sbjct: 59 YYSFQGKKN-LYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLA----LEYLH-- 110
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK------GSFGYLD 655
+ +IHRD+K NIL+D N K+ DFGLSK G Q +++ K G+ Y+
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE Q ++ D +S G +L+E L P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 60/196 (30%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 492 IGIGGFGKVYKGEL----NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
+G G FG V KG +VAVK G EF E +++Q H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
G C + ++L+ E G L Y + E+ A G+ YL + K
Sbjct: 63 GVCKGE-PLMLVMELAPLGPL--LKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHF 116
Query: 607 IHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
+HRD+ + N+LL AK++DFG+S+ G D +TA + + PE + +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 666 EKSDVYSFGVVLFEVL 681
KSDV+S+GV L+E
Sbjct: 177 SKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 59/289 (20%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR---------GNPRSQQGLAEFQTEIEMLSQFRHR 540
+IG G FG VY G + G +AVK+ R + L EI +L + +H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSW---KQRLEICIGSARGL 595
++V +G + + + + EY+ G++ L YG+ +L +Q L +GL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------KGL 119
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-------VK 648
+YLH + +IHRD+K ANIL+D K++DFG+SK +++ +ST ++
Sbjct: 120 NYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQ 173
Query: 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708
GS ++ PE ++ T K+D++S G ++ E+L P + +
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG------KHP------------FPDC 215
Query: 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLAD-FGVD---RPSMGDVL 753
QL I + P+ A L F +D RP+ ++L
Sbjct: 216 TQLQAIF--KIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK-----RGNPRSQQGLAE-FQTEIEMLSQFRHRHLV 543
+G G F Y+ ++ GT +AVK R Q+ + E + EI ++++ H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
++G E + L E+M G++ L YG+ ++ ++ RGL YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE- 121
Query: 602 YAKAVIHRDVKSANILLDEN-FMAKVADFG----LSKTGPEIDQTHVSTAVKGSFGYLDP 656
+IHRDVK AN+L+D ++ADFG L+ G + + G+ ++ P
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMAP 177
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
E R +Q DV+S G V+ E+ A+P
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 486 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
FD +G G +G VYK G VA+K ++ L E EI +L Q ++V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
G + ++ ++ EY G++ + +L+ ++ I + +GL YLH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVS-DIMKITNKTLTEEEIAAILYQTLKGLEYLH---SN 118
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
IHRD+K+ NILL+E AK+ADFG+S G D V G+ ++ PE +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 665 TEKSDVYSFGVVLFEVLCARP 685
K+D++S G+ E+ +P
Sbjct: 177 NNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 492 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 541
+G G FG+V E + VAVK + +++ L++ +E+EM+ +H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLEI 587
+++L+G C + + +I EY G L+ +L P +++K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
ARG+ YL + + IHRD+ + N+L+ EN + K+ADFGL++ ID +T
Sbjct: 143 TYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694
+ ++ PE + T +SDV+SFGV+++E+ P +P E
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 30/226 (13%)
Query: 484 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-R 538
++F +IG G F V E + A+K + R ++ + + E E+L++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 539 HRHLVSLIG-YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
H ++ L + DE+N + + EY NG L ++ G SL K L Y
Sbjct: 61 HPGIIKLYYTFQDEEN-LYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEY 117
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID--------------QTHV 643
LH +K +IHRD+K NILLD++ K+ DFG +K Q
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 644 STAVKGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ SF G Y+ PE + + SD+++ G +++++L +P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 30/213 (14%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK----------RGNPRSQQGLAEFQTEIEMLSQFRH 539
+IG G +G+VY + G +AVK R + R + + ++EIE L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 540 RHLVSLIGYCDEKNEMILIY-EYMENGTLKGHL--YGSGLPSLS---WKQRLEICIGSAR 593
++V +G + E + I+ EY+ G++ L YG L +Q LE
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE------- 119
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
GL YLH+ K ++HRD+K+ N+L+D + + K++DFG+SK +I + +++GS +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 654 LDPE--YFRRQQLTEKSDVYSFGVVLFEVLCAR 684
+ PE + Q + K D++S G V+ E+ R
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 27/227 (11%)
Query: 492 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 541
+G G FG+V E N VAVK + + + L++ +E+EM+ +H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 587
+++L+G C + + ++ EY G L+ +L P L++K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
ARG+ YL + + IHRD+ + N+L+ E+ + K+ADFGL++ ID +T
Sbjct: 140 AYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694
+ ++ PE + T +SDV+SFGV+L+E+ P +P E
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 7/210 (3%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
+G G FG+V+ G N TKVAVK P + + F E +++ + RH LV L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
+ + ++ EYM G+L L +L +++ A G+ Y+ IHRD+
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 128
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 671
+SANIL+ + + K+ADFGL++ E ++ K + PE + T KSDV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 672 SFGVVLFEVLCARPVIDPTL-PREMVNLAE 700
SFG++L E++ V P + RE++ E
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 20/202 (9%)
Query: 491 VIGIGGFGKVYKGELNDGTK----VAVKR---GNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
VIG G FG+V G L K VA+K G Q+ +F +E ++ QF H +++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNII 68
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-TGY 602
L G + ++++ EYMENG+L L + Q + + G A G+ YL GY
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGYLDPEYF 659
+HRD+ + NIL++ N + KV+DFGLS+ PE T + K + PE
Sbjct: 128 ----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT--TRGGKIPIRWTAPEAI 181
Query: 660 RRQQLTEKSDVYSFGVVLFEVL 681
++ T SDV+S+G+V++EV+
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 32/211 (15%)
Query: 492 IGIGGFGKVY----KGELNDG--TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FG VY KG + D T+VA+K N S + EF E ++ +F H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLY----------GSGLPSLSWKQRLEICIGSARG 594
L+G + ++I E M G LK +L PSL K+ +++ A G
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL--KKMIQMAGEIADG 131
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG-- 652
+ YL+ A +HRD+ + N ++ E+F K+ DFG+++ E D KG G
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLL 183
Query: 653 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
++ PE + T SDV+SFGVVL+E+
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 486 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
++ IG G +G VYK ++ G VA+K Q EI ML + RH ++V+
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
G ++++ ++ EY G+L+ +Y LS Q +C + +GL YLH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETLKGLAYLHE---T 120
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G---YLDPEYF- 659
IHRD+K ANILL E+ K+ADFG+S ++ T A + SF G ++ PE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSA---QLTAT---IAKRKSFIGTPYWMAPEVAA 174
Query: 660 --RRQQLTEKSDVYSFGVVLFE 679
R+ K D+++ G+ E
Sbjct: 175 VERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 16/194 (8%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE--FQTEIEMLSQFRHRHLVSLIGYC 549
+G G FG V+ G+ KVA+K N + ++E F E +++ + H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 550 DEKNEMILIYEYMENGTLKGHL---YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
++ + ++ E+MENG L +L G LS L +C G+ YL +
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLER---NSF 121
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
IHRD+ + N L+ + KV+DFG+++ + D+ S+ K + PE F + +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 667 KSDVYSFGVVLFEV 680
KSDV+SFGV+++EV
Sbjct: 181 KSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 35/215 (16%)
Query: 491 VIGIGGFGKVYKGELN-DGTKV--AVKRGNP-RSQQGLAEFQTEIEMLSQF-RHRHLVSL 545
VIG G FG+V + + DG K+ A+K S+ +F E+E+L + H ++++L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGS 591
+G C+ + + + EY G L L S + +L+ +Q L+
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
A G+ YL K IHRD+ + N+L+ EN +K+ADFGLS+ G E+ VK +
Sbjct: 129 ATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR-GEEV-------YVKKTM 177
Query: 652 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 681
G L + + L T KSDV+SFGV+L+E++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 61/190 (32%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
+G G FG+V+ G N TKVA+K P + A F E +++ + RH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
+ + ++ E+M G+L L L Q +++ A G+ Y+ IHRD+
Sbjct: 73 E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDL 128
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 671
++ANIL+ +N + K+ADFGL++ E ++ K + PE + T KSDV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 672 SFGVVLFEVL 681
SFG++L E++
Sbjct: 188 SFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 46/276 (16%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVS---- 544
+G G +G VYK + L+D A+K + SQ+ + EI +L+ H +++S
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 545 -LIGYCDEKNEMILIYEYMENGTL-----KGHLYGSGLPS-LSWKQRLEICIGSARGLHY 597
L G N++ ++ EY G L K +P W+ +++ RGL
Sbjct: 68 FLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQA 118
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
LH + ++HRD+KSANILL N + K+ D G+SK + + T + G+ Y+ PE
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQI-GTPHYMAPE 171
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717
++ + + KSD++S G +L+E+ P P E ++ + K Q +G+ I
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAP------PFEARSMQDLRYKVQ-RGKYPPI--- 221
Query: 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
I L+ F L RP+ +L
Sbjct: 222 ---PPIYSQDLQNF---IRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 16/209 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTK----VAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
VIG G FG+V +G L K VA+K + +Q +F +E ++ QF H +++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIH 69
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
L G + +++I E+MENG L L + + Q + + G A G+ YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---M 125
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE--IDQTHVST-AVKGSFGYLDPEYFRR 661
+HRD+ + NIL++ N + KV+DFGLS+ + D T+ S+ K + PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 662 QQLTEKSDVYSFGVVLFEVLC--ARPVID 688
++ T SDV+S+G+V++EV+ RP D
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 15/187 (8%)
Query: 511 VAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG 569
VAVK P S +F E+++LS+ ++ L+G C + +I EYMENG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 570 HLYGS---------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 620
L SLS+ L + A G+ YL + +HRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGK 165
Query: 621 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
N+ K+ADFG+S+ D V ++ E + T KSDV++FGV L+E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 681 --LCARP 685
LC
Sbjct: 226 LTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 59/191 (30%), Positives = 96/191 (50%), Gaps = 8/191 (4%)
Query: 492 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
+G G +G+VY+G VAVK + + + EF E ++ + +H +LV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
+ +I E+M G L +L ++ L + + + YL K IHRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGSFGYLDPEYFRRQQLTEKSD 669
+ + N L+ EN + KVADFGLS+ T+ + A K + PE + + KSD
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 670 VYSFGVVLFEV 680
V++FGV+L+E+
Sbjct: 188 VWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 492 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FG VY+G D T+VAVK N S + EF E ++ F H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 596
L+G + +++ E M +G LK +L G P + ++ +++ A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 652
YL+ AK +HRD+ + N ++ +F K+ DFG+++ E D KG G
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 185
Query: 653 -YLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
++ PE + T SD++SFGVVL+E+
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA------EFQTEIEMLSQFRHRHLVS 544
V+G G +G VY G N G +AVK+ + LA + Q E+++L +H ++V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSW----KQRLEICIGSARGLHYLH 599
+G C + N + + E++ G++ L G LP + KQ L+ G+ YLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------GVAYLH 119
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----TGPEIDQTHVSTAVKGSFGYLD 655
V+HRD+K N++L N + K+ DFG ++ G +++ ++ G+ ++
Sbjct: 120 N---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE KSD++S G +FE+ +P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 61/227 (26%), Positives = 114/227 (50%), Gaps = 27/227 (11%)
Query: 492 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 541
+G G FG+V + E + VAVK + + + LA+ +E+E++ +H++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLEI 587
+++L+G C ++ + +I EY G L+ L P LS+K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
ARG+ YL + + IHRD+ + N+L+ E+ + K+ADFGL++ +ID ++
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694
+ ++ PE + T +SDV+SFG++++E+ P +P E
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 491 VIGIGGFGKVYKG----ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSL 545
IG G FG VY+G N+ VAVK + + E F E ++ QF H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSW-KQRLEICIGSARGLHYLHTGY 602
IG E N + ++ E G L+ +L L S ++ L YL +
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLS----TALAYLES-- 125
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFR 660
K +HRD+ + N+L+ K+ DFGLS+ ++ A KG ++ PE
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESIN 181
Query: 661 RQQLTEKSDVYSFGVVLFEVL 681
++ T SDV+ FGV ++E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
++G G FG+VY +++ G ++A K+ +P + + ++ + EI++L +H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 545 LIGYCDEKNE--MILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHT 600
G ++ E + + EYM G++K L YG+ S++ K +I G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH- 123
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST-AVKGSFGYLDPEYF 659
+ ++HRD+K ANIL D K+ DFG SK I + +V G+ ++ PE
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARP 685
+ K+DV+S G + E+L +P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 492 IGIGGFGKVYKGELNDGTKV-AVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G GGFG+V ++ K+ A K+ + + ++G E ++L + R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGLHYLHTGYA 603
+ K+++ L+ M G LK H+Y G P + + +I G L +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ--- 113
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
+ +++RD+K N+LLD++ +++D GL+ + G+ GY+ PE + +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEV 170
Query: 664 LTEKSDVYSFGVVLFEVLCAR 684
D ++ G L+E++ R
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-19
Identities = 84/299 (28%), Positives = 136/299 (45%), Gaps = 26/299 (8%)
Query: 477 VAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 535
+ + + ++ E VI G G YKG+ + +G + VK N + +EI +
Sbjct: 683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN--DVNSIPS--SEIADMG 738
Query: 536 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 595
+ +H ++V LIG C + LI+EY+E L L LSW++R +I IG A+ L
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKAL 793
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYL 654
+LH + AV+ ++ I++D + LS G D ++ Y+
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISS-----AYV 845
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN--LAEWAMKWQNKGQLD 712
PE + +TEKSD+Y FG++L E+L + P V+ + EWA + LD
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGK---SPADAEFGVHGSIVEWARYCYSDCHLD 902
Query: 713 QIIDPTLAGK--IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 769
IDP++ G + + + + A C A RP DVL LE A + + V G
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 12/212 (5%)
Query: 491 VIGIGGFGK--VYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLI 546
V+G G FG+ +Y+ D + V K N S++ + EI +LS +H ++++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
+ + N +++ EY GTL + + L + Y+H +
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGI 122
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
+HRD+K+ NI L + + K+ DFG+SK G E + T V G+ Y+ PE + +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SMAETVV-GTPYYMSPELCQGVKYN 179
Query: 666 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 697
KSD+++ G VL+E+L + D T P +V
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 491 VIGIGGFGKVYKGELND-GTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
IG G FG+VYK VA+K + ++ + + Q EI+ LSQ R ++ G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLP--SLSWKQRLEICIGSARGLHYLHTGYAKAV 606
+ +++ +I EY G+ L L +++ R E+ GL YLH +
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-EVL----LGLEYLH---EEGK 119
Query: 607 IHRDVKSANILLDENFMAKVADFG----LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 662
IHRD+K+ANILL E K+ADFG L+ T + +T V F ++ PE ++
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTST-----MSKRNTFVGTPF-WMAPEVIKQS 173
Query: 663 QLTEKSDVYSFGVVLFEVLCARP 685
EK+D++S G+ E+ P
Sbjct: 174 GYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 5e-19
Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 38/161 (23%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQT--EIEMLSQFRHR 540
+G G +G VYK + G VA+K+ G P + EI +L + +H
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST--------ALREISLLKELKHP 58
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP-----SLSWKQRLEICIGSAR 593
++V L+ + ++ L++EY + LK +L L S+ + Q L R
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMY-QLL-------R 109
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634
GL Y H + ++HRD+K NIL++ + + K+ADFGL++
Sbjct: 110 GLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARA 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
+G G FG+V+ N TKVAVK P S + F E ++ +H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV-T 71
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
K + +I E+M G+L L + ++ A G+ ++ + IHRD+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 128
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 671
++ANIL+ + + K+ADFGL++ E ++ K + PE T KSDV+
Sbjct: 129 RAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 672 SFGVVLFEVL 681
SFG++L E++
Sbjct: 188 SFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 492 IGIGGFGKVYKGEL-----NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G FGK+YKG L + VA+K + + Q EFQ E ++++ H ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLY---------------GSGLPSLSWKQRLEICIG 590
+G ++ + +++EY+ G L L G+ SL L I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
A G+ YL + + +H+D+ + NIL+ E K++D GLS+ D V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
++ PE + + SD++SFGVVL+E+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 15/200 (7%)
Query: 492 IGIGGFGKV----YKGE-LNDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FGKV Y E N G +VAVK P S +A+ + EIE+L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 546 IGYCDEK--NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
G C E N + LI E++ +G+LK +L ++ KQ+L+ + +G+ YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGS--- 127
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH--VSTAVKGSFGYLDPEYFRR 661
+ +HRD+ + N+L++ K+ DFGL+K E D+ + V + + PE +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 662 QQLTEKSDVYSFGVVLFEVL 681
+ SDV+SFGV L+E+L
Sbjct: 187 SKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 72/215 (33%), Positives = 112/215 (52%), Gaps = 35/215 (16%)
Query: 491 VIGIGGFGKVYKGELN-DGTKV--AVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRHLVSL 545
VIG G FG+V K + DG ++ A+KR S+ +F E+E+L + H ++++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGS 591
+G C+ + + L EY +G L L S + +LS +Q L
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
ARG+ YL K IHRD+ + NIL+ EN++AK+ADFGLS+ G E+ VK +
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 170
Query: 652 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 681
G L + + L T SDV+S+GV+L+E++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 78/282 (27%), Positives = 121/282 (42%), Gaps = 30/282 (10%)
Query: 484 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFR 538
E +G G G V K L N G A+K NP Q+ + E+E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---ELEINKSCK 57
Query: 539 HRHLVSLIG-YCDEKNEMILI-YEYMENGTLKGHLYGSGLPS---LSWKQRLEICIGSAR 593
++V G + DE + I I EY E G+L +Y + K +I +
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
GL YLH+ + +IHRD+K +NILL K+ DFG+S E+ + T SF Y
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSF-Y 169
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVI-DPTLPREMVNLAEWAMKWQNKGQL 711
+ PE + + + SDV+S G+ L EV R P + P + L + + N
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP--- 226
Query: 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
++ D G + + F ++CL RP+ D+L
Sbjct: 227 -ELKDEPGNGIKWSEEFKDF---IKQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
++G G FG+VY + + G ++AVK+ +P + + + + EI++L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 545 LIGYCDEKNEMIL--IYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHT 600
G + E L E+M G++K L YG+ +++ K +I G+ YLH+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS-TAVKGSFGYLDPEYF 659
++HRD+K ANIL D K+ DFG SK I + +V G+ ++ PE
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARP 685
+ K+D++S G + E+L +P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE---FQTEIEMLSQFRHRH 541
+++ V+G G FG V+ K+ + + P Q E Q E ++L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP- 59
Query: 542 LVSLIGYCD---EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598
++I Y + E ++++ EY GTL ++ L L + LH++
Sbjct: 60 --NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 599 HTGYAKAVIHRDVKSANILLDENFM-AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
HT K ++HRD+K+ NILLD++ M K+ DFG+SK + + V G+ Y+ PE
Sbjct: 118 HT---KLILHRDLKTQNILLDKHKMVVKIGDFGISK---ILSSKSKAYTVVGTPCYISPE 171
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVL 681
+ +KSD+++ G VL+E+
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 483 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLS 535
NF IG G F VYK L DG VA+K+ + +++Q + EI++L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57
Query: 536 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK---GHLYGSG--LPSLS-WKQRLEICI 589
Q H +++ + E NE+ ++ E + G L H +P + WK +++C
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC- 116
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
L ++H+ K ++HRD+K AN+ + + K+ D GL + +T + ++ G
Sbjct: 117 ---SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVG 168
Query: 650 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 684
+ Y+ PE KSD++S G +L+E+ +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 492 IGIGGFGKVYKGELNDGT---KVAVKRGN----PRSQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FG V +G+LN KVAVK RS+ + +F +E + +F H +++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDHPNVMR 64
Query: 545 LIGYCDEKNEM------ILIYEYMENGTLKGHLYGSGL---PSLSWKQRL-EICIGSARG 594
LIG C + E ++I +M++G L L S L P Q L + A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ YL + K+ IHRD+ + N +L+EN VADFGLSK D K ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEV 680
E + T KSDV+SFGV ++E+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 486 FDESWVIGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH 539
F + V+G GGFG+V G++ K+ KR R + +A E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGL 595
R +VSL + K+ + L+ M G LK H+Y G + + EIC G L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----L 115
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
LH + +++RD+K NILLD++ +++D GL+ PE QT + V G+ GY+
Sbjct: 116 EDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-GTVGYMA 169
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVL 681
PE + ++ T D ++ G +L+E++
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 486 FDESWVIGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH 539
F + V+G GGFG+V G++ ++ KR R + +A E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGL 595
+ +V+L + K+ + L+ M G LK H+Y G P ++ L EI G L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----L 115
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
LH + ++RD+K NILLD+ +++D GL+ PE + G+ GY+
Sbjct: 116 EDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMA 169
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVL 681
PE Q+ T D + G +++E++
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 485 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR--GNPRSQQGLAE---FQTEIEMLSQFR 538
N+ ++G G FG+VY + + G ++AVK+ +P SQ+ E + EI++L R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 539 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSAR 593
H +V G C E+ ++ + EYM G++K L YG+ +++ + +I +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----Q 117
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS-TAVKGSFG 652
G+ YLH + ++HRD+K ANIL D K+ DFG SK I + +V G+
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 653 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
++ PE + K+DV+S + E+L +P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 42/225 (18%)
Query: 491 VIGIGGFGKVYKGE------LNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLV 543
+G G FGKV K T VAVK + L + +E +L Q H H++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGS----------------------GLPSLSW 581
L G C + ++LI EY + G+L+ L S +L+
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 582 KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641
+ +RG+ YL ++HRD+ + N+L+ E K++DFGLS+ E D
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED-- 181
Query: 642 HVSTAVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
+ VK S G ++ E T +SDV+SFGV+L+E++
Sbjct: 182 ---SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
VIG+G VY L + KVA+KR + + Q + E + E++ +SQ H ++V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 549 CDEKNEMILIYEYMENGTL----KGHLYGSGLPSLSWKQRLEICI-----GSARGLHYLH 599
+E+ L+ Y+ G+L K GL E I +GL YLH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD--------EAIIATVLKEVLKGLEYLH 119
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLDPE 657
+ IHRD+K+ NILL E+ K+ADFG+S + V G+ ++ PE
Sbjct: 120 S---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 658 YFRRQQ-LTEKSDVYSFGVVLFE 679
+ K+D++SFG+ E
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 10/203 (4%)
Query: 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE---FQTEIEMLSQFRHRH 541
++ IG G FGK+Y + ++ V + ++ + E + E+ +L++ +H +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+V+ E + ++ EY + G L + S Q L + + GL ++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD- 119
Query: 602 YAKAVIHRDVKSANILLDENFM-AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ ++HRD+KS NI L +N M AK+ DFG+++ D ++ G+ YL PE +
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQ 175
Query: 661 RQQLTEKSDVYSFGVVLFEVLCA 683
+ K+D++S G VL+E LC
Sbjct: 176 NRPYNNKTDIWSLGCVLYE-LCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 21/189 (11%)
Query: 511 VAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG 569
VAVK P ++ +F E+++LS+ + +++ L+G C +++ + +I EYMENG L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 570 HLY--------GSG---------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 612
L +G LP++S+ L + + A G+ YL + +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLA 165
Query: 613 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 672
+ N L+ EN K+ADFG+S+ D + ++ E + T SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 673 FGVVLFEVL 681
FGV L+E+L
Sbjct: 226 FGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 491 VIGIGGFGKV----YKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
++G G FG V K E KVAVK + + S + EF E + +F H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 545 LIGYCDEKNEM------ILIYEYMENGTLKGHLYGSGLP----SLSWKQRLEICIGSARG 594
LIG ++I +M++G L L S + +L + + I A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ YL + K IHRD+ + N +L+EN VADFGLSK D A K +L
Sbjct: 126 MEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVL 681
E T SDV++FGV ++E++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 491 VIGIGGFGKVYKG---ELNDGTK--VAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVS 544
++G G FG V+KG D K VA+K RS +Q E + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
L+G C + L+ + G+L H+ SL ++ L C+ A+G++YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEE---H 128
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
++HR++ + NILL + + ++ADFG++ D+ + + K ++ E +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 665 TEKSDVYSFGVVLFEVL 681
T +SDV+S+GV ++E++
Sbjct: 189 THQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 491 VIGIGGFGKVYKGELNDGTK----VAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
++G G FG++ +G L +K VA+ R +Q F E L QF H ++V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVR 70
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGYA 603
L G N M+++ EYM NG L L L Q + + G A G+ YL GY
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGY- 128
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL--DPEYFRR 661
+H+ + + +L++ + + K++ F E + T + G L PE +
Sbjct: 129 ---VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 662 QQLTEKSDVYSFGVVLFEVLC--ARPVID 688
+ SDV+SFG+V++EV+ RP D
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 52/185 (28%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 511 VAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG 569
VAVK ++ +F EI+++S+ ++ +++ L+G C + + +I EYMENG L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 570 HL----------YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619
L + + +PS+S L + + A G+ YL + +HRD+ + N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVG 163
Query: 620 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 679
++ K+ADFG+S+ D + ++ E + T SDV++FGV L+E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 680 V--LC 682
+ LC
Sbjct: 224 MFTLC 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 487 DESWVI----GIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 541
+E W I G G FGKVYK + + G A K +S++ L ++ EIE+L+ H +
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+V L+G ++ ++ E+ G + + L+ Q IC L YLH+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS- 128
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
+IHRD+K+ N+LL + K+ADFG+S + Q S G+ ++ PE
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMC 184
Query: 662 QQLTE-----KSDVYSFGVVLFEVLCARP 685
+ + + K+D++S G+ L E+ P
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-16
Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 19/193 (9%)
Query: 508 GTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI--GYCDEKNEMILIYEYM 562
G +VA+K P + A F+ E + ++ H ++V+L+ G + ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---D 619
TL+ L G RL + L L + + ++HRD+K NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRL-----MLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 620 ENFMAKVADFGLSKTGP---EIDQTHVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 674
AKV DFG+ P + D ++ T V G+ Y PE R + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 675 VVLFEVLCARPVI 687
++ E L + V+
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 29/167 (17%)
Query: 486 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEFQT-EIEMLSQ---FRH 539
++E IG G +G VYK +LN G VA+K+ P S++G+ EI +L Q F H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 540 RHLVSLIGYC-----DEKNEMILIYEYMEN--GTLKGHLYGSGLPS-----LSWKQRLEI 587
++V L+ C D + ++ L++E+++ T GLP L Q L
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-QLL-- 117
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634
RG+ +LH+ ++HRD+K NIL+ + K+ADFGL++
Sbjct: 118 -----RGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 34/267 (12%)
Query: 500 VYKGELNDGTKVAV---KRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY----CDEK 552
+YKG N+ +V + K+ + + + + EI+ L + +++ + G+ D+
Sbjct: 36 IYKGIFNN-KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 612
+ LI EY G L+ L LS+K +L++ I +GL+ L+ K ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 613 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDV 670
S + L+ EN+ K+ GL K +V+ V Y + + T K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDI 205
Query: 671 YSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRK 730
YS GVVL+E+ + +P E NL K D II+ + K+ D +
Sbjct: 206 YSLGVVLWEIFTGK------IPFE--NLT-------TKEIYDLIINKNNSLKLPLDCPLE 250
Query: 731 FGETAEKCLADFGVDRPSMGDVLWNLE 757
E C + + RP++ ++L+NL
Sbjct: 251 IKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI- 546
IG G +G V G KVA+K+ +P Q + +T EI++L +F+H +++ ++
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ-RTLREIKILRRFKHENIIGILD 70
Query: 547 ----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EIC-----IGSARG 594
+ N++ ++ E ME + L L Q L I I RG
Sbjct: 71 IIRPPSFESFNDVYIVQELME----------TDLYKLIKTQHLSNDHIQYFLYQI--LRG 118
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGY 653
L Y+H + V+HRD+K +N+LL+ N K+ DFGL++ PE D T T + Y
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 654 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARPV 686
PE + K+ D++S G +L E+L RP+
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 41/228 (17%)
Query: 476 FVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EI 531
F V E TN + + +G+G FG V + G VA+K+ P S LA+ +T E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK-RTYREL 60
Query: 532 EMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE----- 586
++L RH +++SL D I I +E+ L G+ L L + LE
Sbjct: 61 KLLKHLRHENIISL---SD-----IFISP-LEDIYFVTELLGTDLHRLLTSRPLEKQFIQ 111
Query: 587 -ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645
RGL Y+H+ V+HRD+K +NIL++EN K+ DFGL++ Q T
Sbjct: 112 YFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMT 163
Query: 646 AVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARPV 686
GY+ Y+R Q+ + D++S G + E+L +P+
Sbjct: 164 ------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
IG G +G VYK +N G A+K + A Q EI M+ +H ++V+ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
++++ + E+ G+L+ + +G LS Q + + +GL+YLH+ K +HRD
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS---KGKMHRD 131
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF----GYLDPEYF---RRQQ 663
+K ANILL +N K+ADFG+S Q + A + SF ++ PE R+
Sbjct: 132 IKGANILLTDNGHVKLADFGVSA------QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 664 LTEKSDVYSFGVVLFEVLCARP 685
+ D+++ G+ E+ +P
Sbjct: 186 YNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 30/170 (17%)
Query: 481 EATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-R 538
+ T F+ VIG G +GKVYK G VA+K + + E + E +L ++
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 539 HRHLVSLIGYCDEKN------EMILIYEYMENGT----LKGHLYGSGLPSLSWKQRLE-- 586
H ++ + G +KN ++ L+ E G+ +KG +RL+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG--------LRKKGKRLKEE 113
Query: 587 ----ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632
I + RGL YLH VIHRD+K NILL +N K+ DFG+S
Sbjct: 114 WIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 491 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FRHRHLVSL 545
V+G G FGKV EL ++ +K+ + TE +L+ +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
K+ + + EY+ G L H+ SG + I GL +LH +
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLHE---RG 116
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
+I+RD+K N+LLD K+ADFG+ K G T ++ G+ Y+ PE Q
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYG 174
Query: 666 EKSDVYSFGVVLFEVLCARP 685
D ++ GV+L+E+L +
Sbjct: 175 PAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 492 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 547
+G GG+G+V+ + D G VA+KR L E + TE ++L+ + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
+ + L EY+ G + L G L + + + LH L GY
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL--GY---- 122
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
IHRD+K N L+D + K+ DFGLSK + +V GS Y+ PE R +
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKGYDF 177
Query: 667 KSDVYSFGVVLFEVLCARPVIDPTLPRE-MVNLAEW 701
D +S G +L+E LC P + P E NL W
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 34/230 (14%)
Query: 530 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC- 588
E++++ + R ++VS G +N + + E+M+ G+L +Y G P +EI
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPI-----PVEILG 106
Query: 589 ---IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVS 644
+ GL YL+ ++HRD+K +NIL++ K+ DFG+S + I T V
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVG 164
Query: 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 704
T+ Y+ PE + + T KSDV+S G+ + E+ + P N+ +
Sbjct: 165 TST-----YMSPERIQGGKYTVKSDVWSLGISIIELALGK------FPFAFSNIDDDGQD 213
Query: 705 WQNKGQLD---QIID---PTLAGKIRPDSLRKFGETAEKCLADFGVDRPS 748
G LD QI+ P L P+ LR F + CL +RP+
Sbjct: 214 DP-MGILDLLQQIVQEPPPRLPSSDFPEDLRDF---VDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-16
Identities = 69/265 (26%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 492 IGIGGFGKVYKGELNDGTK--VAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
IG G FG+V+KG +++ T+ VA+K + ++ + + Q EI +LSQ ++ G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
+ ++ +I EY+ G+ L L+ + +GL YLH+ + IH
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHS---EKKIH 124
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 668
RD+K+AN+LL E K+ADFG++ G D G+ ++ PE ++ K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 669 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 728
D++S G+ E+ P P ++ L + + PTL G +
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVLFL------------IPKNNPPTLTG----EFS 226
Query: 729 RKFGETAEKCLADFGVDRPSMGDVL 753
+ F E + CL RP+ ++L
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 485 NFDESWVI----GIGGFGKVYKGELNDGTKV--AVKRGNPRSQQGLAEFQTEIEMLSQFR 538
N +E W I G G FGKVYK + N T V A K + +S++ L ++ EI++L+
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD 60
Query: 539 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598
H ++V L+ +N + ++ E+ G + + P L+ Q +C + L+YL
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYL 119
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
H +IHRD+K+ NIL + K+ADFG+S Q S G+ ++ PE
Sbjct: 120 HE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEV 174
Query: 659 F-----RRQQLTEKSDVYSFGVVLFEVLCARP 685
+ + K+DV+S G+ L E+ P
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 66/239 (27%), Positives = 112/239 (46%), Gaps = 28/239 (11%)
Query: 455 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 508
G++Y + T + + FP NN +G G FGKV + + +
Sbjct: 13 GNEYVYIDPTQLPYDLKWEFP-------RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAV 65
Query: 509 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 566
KVAVK P + E +E++++S H ++V+L+G C +++I EY G
Sbjct: 66 MKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 567 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV 626
L L L+ + L A+G+ +L + K IHRD+ + N+LL + K+
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKI 182
Query: 627 ADFGLSKTGPEIDQTHVST-AVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
DFGL++ D + S VKG+ ++ PE T +SDV+S+G++L+E+
Sbjct: 183 CDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 491 VIGIGGFGKVYKGELNDGT--------KVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
V+G GG+GKV++ G KV K R+Q+ A + E +L +H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHT 600
V LI ++ LI EY+ G L HL G + + EI + L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHLHQ 118
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ +I+RD+K NILLD K+ DFGL K I + V+ G+ Y+ PE
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE--SIHEGTVTHTFCGTIEYMAPEILM 173
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
R + D +S G +++++L P
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 37/172 (21%)
Query: 486 FDESWVIGIGGFGKVYKG---ELNDGTKVAVK--RGNPRSQQGLAEFQT---EIEMLSQF 537
++ IG G +G+VYK DG + A+K +G+ G++ Q+ EI +L +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS--QSACREIALLREL 59
Query: 538 RHRHLVSLIGYCDEKNEMI--LIYEYMEN---GTLKGH-------LYGSGLPSLSWKQRL 585
+H ++VSL+ E + L+++Y E+ +K H + S + SL W Q L
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QIL 118
Query: 586 EICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSK 633
G+HYLH+ + V+HRD+K ANIL+ E + K+ D GL++
Sbjct: 119 N-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 484 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 540
N ++ V+G G +G V K G VA+K + + + E+++L Q RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKG-HLYGSGLP-----SLSWKQRLEICIGSARG 594
++V+L K + L++EY+E L+ GLP S W Q L +
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW-QLL-------QA 112
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ Y H + +IHRD+K NIL+ E+ + K+ DFG ++ + ++ Y+
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-------YV 162
Query: 655 DPEYFRRQQLTEKS-------DVYSFGVVLFEVLCARP 685
++R +L DV++ G ++ E+L P
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 492 IGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 548
IG G G V+K + G VA+K+ R +G Q EI+ L +H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLHT 600
+ +L+ EYM S L + + + + G+ Y+H
Sbjct: 68 FPHGSGFVLVMEYM----------PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH- 116
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDPE-Y 658
A ++HRD+K AN+L+ + + K+ADFGL++ E + + S V + Y PE
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQV-ATRWYRAPELL 172
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ ++ D+++ G + E+L P
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 492 IGIGGFGKVYKG-------ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FG V KG +++ KV +K N +S + E E E++ Q + ++V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKV-LKNENEKSVRD--EMMREAEIMHQLDNPYIVR 59
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
+IG C+ + M L+ E G L L ++ +E+ + G+ YL K
Sbjct: 60 MIGVCEAEALM-LVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLE---GK 114
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
+HRD+ + N+LL AK++DFGLSK G + +A K + PE ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 664 LTEKSDVYSFGVVLFEVL 681
+ +SDV+S+G+ ++E
Sbjct: 175 FSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 32/227 (14%)
Query: 491 VIGIGGFGKVYKG---------ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 541
V+G G FG VYKG ++ K+ + P++ EF E +++ H H
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN---VEFMDEALIMASMDHPH 70
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLY------GSGLPSLSWKQRLEICIGSARGL 595
LV L+G C + L+ + M +G L +++ GS L L+W C+ A+G+
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQL-LLNW------CVQIAKGM 122
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
YL + ++HRD+ + N+L+ K+ DFGL++ ++ + + K ++
Sbjct: 123 MYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPREMVNLAE 700
E ++ T +SDV+S+GV ++E++ +P D RE+ +L E
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY-DGIPTREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 491 VIGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
V+G GGFG+V G++ K+ KR R + +A E +L + R +VS
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVS 64
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGLHYLHT 600
L + K+ + L+ M G LK H+Y G P ++ + E+C G L L
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG----LEDLQR 120
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ +++RD+K NILLD+ +++D GL+ PE + G+ GY+ PE
Sbjct: 121 ---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEVIN 174
Query: 661 RQQLTEKSDVYSFGVVLFEVL 681
++ T D + G +++E++
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 492 IGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
IG G G V E + G +VAVK+ + R QQ E+ ++ + H ++V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
+E+ ++ E++E G L + + ++ +Q +C+ R L YLH + VIHRD
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRD 143
Query: 611 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
+KS +ILL + K++DFG ++ E+ + ++ G+ ++ PE R + D
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 670 VYSFGVVLFEVLCARP 685
++S G+++ E++ P
Sbjct: 201 IWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 48/248 (19%)
Query: 492 IGIGGFGKVYKGELND-GTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
IG G +G V+K + G VA+K+ +P ++ +A EI ML Q +H +LV+L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-IA--LREIRMLKQLKHPNLVNL 65
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
I K ++ L++EY ++ T+ L G+P K+ I + + +++ H
Sbjct: 66 IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCH---K 118
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQT-HVSTAVKGSFGYLDPEYF- 659
IHRDVK NIL+ + K+ DFG ++ TGP D T +V+T Y PE
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLV 173
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI--IDP 717
Q DV++ G V E+L +P+ W K +DQ+ I
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPL------------------WPGKSDVDQLYLIRK 215
Query: 718 TLAGKIRP 725
TL G + P
Sbjct: 216 TL-GDLIP 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 492 IGIGGFGKVY-----KGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+G G FG VY K + KV V NP + E ++LS+ H +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNET---VQANQEAQLLSKLDHPAI 64
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHT 600
V E++ +I EY E L L +LS Q E I G+HY+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ ++HRD+K+ NI L N + K+ DFG+S+ + ++T G+ Y+ PE +
Sbjct: 125 ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALK 178
Query: 661 RQQLTEKSDVYSFGVVLFEVLC 682
Q KSD++S G +L+E+ C
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 22/201 (10%)
Query: 491 VIGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
V+G GGFG+V G++ K+ KR R + +A E ++L + R +VS
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVS 64
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGLHYLHT 600
L + K+ + L+ M G LK H+Y G P ++ + EI G L LH
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LEDLHR 120
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ +++RD+K NILLD+ +++D GL+ PE + + V G+ GY+ PE +
Sbjct: 121 ---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVK 174
Query: 661 RQQLTEKSDVYSFGVVLFEVL 681
++ T D + G +++E++
Sbjct: 175 NERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 492 IGIGGFGKVYKGELNDGTKV-AVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
IG G FG+V+KG N KV A+K + ++ + + Q EI +LSQ ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+ ++ +I EY+ G+ L L Q I +GL YLH+ + IHR
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLDE---TQIATILREILKGLDYLHS---EKKIHR 125
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
D+K+AN+LL E+ K+ADFG++ G D G+ ++ PE ++ K+D
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 670 VYSFGVVLFEVLCARP 685
++S G+ E+ P
Sbjct: 184 IWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-15
Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
IG G G VY ++ G +VA+K+ N + Q EI ++ + +H ++V+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
+E+ ++ EY+ G+L + + + Q +C + L +LH + VIHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLH---SNQVIHRD 140
Query: 611 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
+KS NILL + K+ DFG ++ PE Q+ ST V G+ ++ PE R+ K D
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 670 VYSFGVVLFEVLCARP 685
++S G++ E++ P
Sbjct: 198 IWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 8e-15
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 66/230 (28%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKR-GNPRSQQGLAEFQT---------EIEMLSQFRH 539
IG G +G V G KVA+K+ N F EI++L RH
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNV--------FDDLIDAKRILREIKLLRHLRH 58
Query: 540 RHLVSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPS-LSWKQRLE------- 586
+++ L+ ++ N++ ++ E ME + L + Q L
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELME----------TDLHKVIKSPQPLTDDHIQYF 108
Query: 587 ---ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTH 642
I RGL YLH+ VIHRD+K +NIL++ N K+ DFGL++ P+ D+
Sbjct: 109 LYQIL----RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
Query: 643 VSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARP 685
T Y+ ++R + T+ D++S G + E+L +P
Sbjct: 162 FLT------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 66/263 (25%), Positives = 108/263 (41%), Gaps = 43/263 (16%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G G V K G +AVK N Q+ + E+++L + ++V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCNSPYIVGF 64
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
G ++ + EYM+ G+L L +P + I + +GL YLH +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK---IAVAVLKGLTYLHEKHK 121
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID---QTHVSTAVKGSFGYLDPEYFR 660
+IHRDVK +NIL++ K+ DFG+S G ++ +T V T+ Y+ PE +
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVS--GQLVNSLAKTFVGTSS-----YMAPERIQ 172
Query: 661 RQQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQLDQIID--- 716
+ KSD++S G+ L E+ R P P + + L I++
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-----------FELLQYIVNEPP 221
Query: 717 PTLAGKIRPDSLRKFGETAEKCL 739
P L + F CL
Sbjct: 222 PRLPSGKFSPDFQDF---VNLCL 241
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 52/203 (25%), Positives = 103/203 (50%), Gaps = 11/203 (5%)
Query: 485 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
D IG G G V + + G +VAVK+ + R QQ E+ ++ ++H ++V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
+ +E+ ++ E++E G L + + ++ +Q +C+ + L +LH A
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLH---A 133
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 662
+ VIHRD+KS +ILL + K++DFG ++ E+ + ++ G+ ++ PE R
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAPEVISRL 190
Query: 663 QLTEKSDVYSFGVVLFEVLCARP 685
+ D++S G+++ E++ P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVK--RGNPRS--QQGLAEFQT---EIEMLSQFRHRHLV 543
+G G + VYK G VA+K + R + G+ T EI++L + +H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN--FTALREIKLLQELKHPNII 65
Query: 544 SLIG-YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
L+ + + N + L++E+ME L+ + L+ + + RGL YLH+ +
Sbjct: 66 GLLDVFGHKSN-INLVFEFME-TDLE-KVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTH-VSTAVKGSFGYLDPE-Y 658
++HRD+K N+L+ + + K+ADFGL+++ P TH V T Y PE
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAPELL 174
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARP 685
F + D++S G + E+L P
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNP----RSQQGLAEFQTEIEMLSQFR 538
++F+ +G G FG+V K A+K + + +Q + E +L R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 539 HRHLVSLIG-YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSARGL 595
H LV+L G + D+ N + L+ EY+ G L HL SG + ++ + L
Sbjct: 60 HPFLVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----L 114
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
YLH+ +++RD+K N+LLD + K+ DFG +K T T YL
Sbjct: 115 EYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTP-----EYLA 166
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE + + D ++ G++++E+L P
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 492 IGIGGFGKVYKGELNDGTK--VAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
IG G FG+VYKG +++ TK VA+K + ++ + + Q EI +LSQ ++ G
Sbjct: 12 IGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
+ ++ +I EY+ G+ L L L + +GL YLH+ + IH
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHS---ERKIH 124
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 668
RD+K+AN+LL E K+ADFG++ G D G+ ++ PE ++ K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 669 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 728
D++S G+ E+ P P ++ L + + PTL G+
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFL------------IPKNSPPTLEGQYS---- 226
Query: 729 RKFGETAEKCLADFGVDRPSMGDVL 753
+ F E E CL RP+ ++L
Sbjct: 227 KPFKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 34/206 (16%)
Query: 492 IGIGGFGK-VYKGELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
IG G FGK + DG + +K + +P+ ++ E + E+ +LS +H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64
Query: 546 IGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598
+E + ++ +Y E G L +G L+ L W ++IC+ L ++
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF-PEDQILDW--FVQICLA----LKHV 117
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFGYLD 655
H + ++HRD+KS NI L ++ K+ DFG+++ + E+ +T + T YL
Sbjct: 118 HD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY-----YLS 169
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVL 681
PE + KSD+++ G VL+E+
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 82/278 (29%), Positives = 114/278 (41%), Gaps = 51/278 (18%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 547
IG G FG VY ++ VA+K+ + +Q ++Q E+ L Q RH + + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK----QRLEI---CIGSARGLHYLHT 600
++ L+ EY GS L Q +EI C G+ +GL YLH+
Sbjct: 83 CYLREHTAWLVMEY---------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY- 658
IHRD+K+ NILL E K+ADFG S P + V T ++ PE
Sbjct: 134 ---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFVGTPY-----WMAPEVI 183
Query: 659 --FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQNKGQLDQII 715
Q K DV+S G+ E+ +P P M L A QN
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIA---QND------- 230
Query: 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
PTL+ D R F + CL DRPS ++L
Sbjct: 231 SPTLSSNDWSDYFRNF---VDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 43/165 (26%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 526 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL---------KGHLYGSGL 576
+F EI+++S+ + +++ L+ C + + +I EYMENG L + + +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 577 PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636
++S+ + + A G+ YL + +HRD+ + N L+ +N+ K+ADFG+S+
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
D + ++ E + T SDV++FGV L+E+L
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 25/206 (12%)
Query: 491 VIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAE--FQTEIEMLSQFRHRHLVSLIG 547
++G G +G V K + + G VA+K+ + + EI ML Q RH +LV+LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 548 YCDEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
K + L++E++++ L Y +GL ++ L + RG+ + H+ +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL---RGIEFCHS---HNI 121
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKT--GP-EIDQTHVST----AVKGSFGYLDPEYF 659
IHRD+K NIL+ ++ + K+ DFG ++T P E+ +V+T A + G D +Y
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG--DTKYG 179
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARP 685
R D+++ G ++ E+L P
Sbjct: 180 R------AVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 491 VIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAEFQTEIEMLSQ------FRHRHLV 543
V+G G FGKV EL + A+K + L + E M+ + + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIK--ALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 544 SLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSARGLHYL 598
L +C K + + EY+ G L H+ SG + + R EI G L +L
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARFYAAEIICG----LQFL 112
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
H K +I+RD+K N+LLD++ K+ADFG+ K ++ ++ G+ Y+ PE
Sbjct: 113 HK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAPEI 167
Query: 659 FRRQQLTEKSDVYSFGVVLFEVL 681
+ Q+ E D +SFGV+L+E+L
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 67/248 (27%), Positives = 104/248 (41%), Gaps = 39/248 (15%)
Query: 492 IGIGGFGKVYKGELNDGTKVA---VKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
IG G FGKV GE + G A VK P Q F E++ + H +++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL---LFLQEVQPYRELNHPNVLQ 59
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARGLHYLH 599
+G C E +L+ E+ G LK +L + + QR+ + A GL +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV--ASGLLWLH 117
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG--YLDPE 657
IH D+ N L + K+ D+GL+ + + + T + +L PE
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALE--QYPEDYYITKDCHAVPLRWLAPE 172
Query: 658 YF--RRQQL-----TEKSDVYSFGVVLFEV--LCARPVIDPTLPREMVNLAEWAMKWQ-- 706
R Q L T+KS+++S GV ++E+ +P P L E V L + +
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQV-LKQVVREQDIK 229
Query: 707 -NKGQLDQ 713
K QLD
Sbjct: 230 LPKPQLDL 237
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 11/211 (5%)
Query: 477 VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 535
V++ + + IG G G V+ ++ G +VA+K+ N + Q EI ++
Sbjct: 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71
Query: 536 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 595
+ ++ ++V+ + +E+ ++ EY+ G+L + + + Q +C + L
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQAL 128
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYL 654
+LH A VIHRD+KS N+LL + K+ DFG ++ PE Q+ ST V G+ ++
Sbjct: 129 EFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWM 182
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE R+ K D++S G++ E++ P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 36/223 (16%)
Query: 486 FDESWVIGIGGFGKVYKGELND-GTKVAVKR---GNPRSQQGLAEFQTEIEMLSQFRHRH 541
FD IG G +G+VYK D G VA+K+ N + + + EI++L Q HR+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 542 LVSL----------IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQR 584
+V+L + + +K L++EYM++ L G L SGL S KQ
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMG-LLESGLVHFSEDHIKSFMKQL 125
Query: 585 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644
LE GL+Y H K +HRD+K +NILL+ K+ADFGL++ + +
Sbjct: 126 LE-------GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 645 TAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPV 686
V + Y PE ++ DV+S G +L E+ +P+
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-14
Identities = 38/103 (36%), Positives = 62/103 (60%), Gaps = 3/103 (2%)
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+H++H+ K +IHRD+KSANILL N + K+ DFG SK V G+ Y+
Sbjct: 156 VHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 697
PE +RR+ ++K+D++S GV+L+E+L + D E+++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
|
Length = 496 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 36/221 (16%)
Query: 483 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 541
+ E V+G G +G VY +L+ ++A+K R + + EI + S +HR+
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 587
+V +G E + E + G+L S L W KQ LE
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSL------SALLRSKWGPLKDNEQTIIFYTKQILE- 119
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTA 646
GL YLH ++HRD+K N+L++ + + K++DFG SK I+ +
Sbjct: 120 ------GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTET 168
Query: 647 VKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARP 685
G+ Y+ PE + +D++S G + E+ +P
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGL----AEFQTEIEMLSQFRHRHLVSL 545
IG+G +G VYK + + G VA+K ++ GL ++ L F H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 546 IGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 600
+ C D + ++ L++E+++ L+ +L P L + ++ RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS-TAVKGSFGYLDPEYF 659
++HRD+K NIL+ K+ADFGL++ I ++ T V + Y PE
Sbjct: 127 ---NCIVHRDLKPENILVTSGGQVKLADFGLAR----IYSCQMALTPVVVTLWYRAPEVL 179
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPV 686
+ D++S G + E+ +P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 38/232 (16%)
Query: 482 ATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEF--QTEIEMLSQFR 538
+++ +G G FG+VYK ++ G VA+K+ +++ EI++L + +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 539 HRHLVSLI--------GYCDEKNEMILIYEYME---NGTLKG---HLYGSGLPSLSWKQR 584
H ++V LI ++ + ++ YM+ +G L+ L S + Q
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI-KCYMLQL 124
Query: 585 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---------TG 635
LE G++YLH ++HRD+K+ANIL+D + K+ADFGL++ G
Sbjct: 125 LE-------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 636 PEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARPV 686
T T + + Y PE ++ T D++ G V E+ RP+
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 62/243 (25%), Positives = 119/243 (48%), Gaps = 27/243 (11%)
Query: 492 IGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
IG G G V + + G VAVK+ + R QQ E+ ++ ++H ++V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
+E+ ++ E++E G L + + ++ +Q +C+ + L LH A+ VIHRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRD 141
Query: 611 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
+KS +ILL + K++DFG ++ E+ + ++ G+ ++ PE R + D
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 670 VYSFGVVLFEVLCARP------------VIDPTLPREMVNLAEWAMKWQNKGQLDQII-- 715
++S G+++ E++ P +I LP ++ NL + + KG LD+++
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL--KGFLDRLLVR 256
Query: 716 DPT 718
DP
Sbjct: 257 DPA 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 11/211 (5%)
Query: 477 VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 535
V+V + + IG G G VY ++ G +VA+K+ N + Q EI ++
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 536 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 595
+ ++ ++V+ + +E+ ++ EY+ G+L + + + Q +C + L
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQAL 128
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYL 654
+LH+ VIHRD+KS NILL + K+ DFG ++ PE Q+ ST V G+ ++
Sbjct: 129 DFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWM 182
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE R+ K D++S G++ E++ P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 48/142 (33%), Positives = 76/142 (53%), Gaps = 6/142 (4%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
+G G +G VYK L+ G AVK + Q EI M+ + +H ++V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
+ ++ + EY G+L+ + +G LS Q +C + +GL YLH+ K +HRD
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHS---KGKMHRD 131
Query: 611 VKSANILLDENFMAKVADFGLS 632
+K ANILL +N K+ADFG++
Sbjct: 132 IKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 492 IGIGGFGKVY------KGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G GGFG+V G+L K+ KR R +G E +L++ R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
K ++ L+ M G L+ H+Y P + GL +LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ +I+RD+K N+LLD + +++D GL+ K G + + T G++ PE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP-----GFMAPELLQ 170
Query: 661 RQQLTEKSDVYSFGVVLFEVLCAR 684
++ D ++ GV L+E++ AR
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 55/204 (26%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 488 ESWV-IGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
E+++ IG G G V E + G +VAVK + R QQ E+ ++ ++H+++V +
Sbjct: 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
E+ ++ E+++ G L + + L+ +Q +C + L YLH ++
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLH---SQG 137
Query: 606 VIHRDVKSANILLDENFMAKVADFG----LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
VIHRD+KS +ILL + K++DFG +SK P+ ++ G+ ++ PE R
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISR 191
Query: 662 QQLTEKSDVYSFGVVLFEVLCARP 685
+ D++S G+++ E++ P
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 48/232 (20%)
Query: 491 VIGIGGFGKVYKGELNDGTKV-AVKRGNP-----RSQQGLAEFQTEIEMLSQFRHRHLVS 544
VIG G FG+V+ D +V A+K R+Q +A + E ++L+ +V
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADADSPWIVK 65
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL--EICIGSARGLHYLHT-G 601
L ++ + L+ EYM G L L + + E+ + L +H G
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA----LDSVHKLG 121
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-------------------- 641
+ IHRD+K NIL+D + K+ADFGL K +
Sbjct: 122 F----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 642 --------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
++ V G+ Y+ PE R + D +S GV+L+E+L P
Sbjct: 178 RDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 492 IGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G GGFG+V G++ K+ KR +S + +A + EI L + +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
+ K + L+ M G LK H+Y G L ++ + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
+++RD+K N+LLD+ +++D GL+ E+ T G+ GY+ PE + + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 666 EKSDVYSFGVVLFEVLCAR 684
D ++ G ++E++ R
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 67/247 (27%), Positives = 116/247 (46%), Gaps = 32/247 (12%)
Query: 486 FDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLV 543
F+ ++G G +G+VYKG + G A+K + + E + EI ML ++ HR++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 544 SLIGYCDEKN------EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
+ G +KN ++ L+ E+ G++ + + +L + IC RGL +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-HVSTAVKGSFGYLDP 656
LH VIHRD+K N+LL EN K+ DFG+S ++D+T G+ ++ P
Sbjct: 127 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWMAP 180
Query: 657 EYFRRQQLTE-----KSDVYSFGVVLFEVL-CARPVID----------PTLPREMVNLAE 700
E + + KSD++S G+ E+ A P+ D P P + +
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240
Query: 701 WAMKWQN 707
W+ K+Q+
Sbjct: 241 WSKKFQS 247
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR---GNPRSQQGLAEFQTEIEMLSQFRHR 540
NF IG G F +VY+ L DG VA+K+ + + A+ EI++L Q H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLK---GHLYGSG--LPSLS-WKQRLEICIGSARG 594
+++ E NE+ ++ E + G L H +P + WK +++C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
L ++H+ + V+HRD+K AN+ + + K+ D GL + +T + ++ G+ Y+
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYM 173
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEV 680
PE KSD++S G +L+E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 63/203 (31%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 491 VIGIGGFGKVYKGELN-DGTKVAVK-------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
VIG G FGKV + DG AVK + +AE +L +H L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV---LLKNVKHPFL 58
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
V L +++ + +Y+ G L HL + I SA G YLH+
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS-- 114
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 662
+I+RD+K NILLD + DFGL K G E +T ++ G+ YL PE R+Q
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQ 171
Query: 663 QLTEKSDVYSFGVVLFEVLCARP 685
D + G VL+E+L P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 491 VIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLI 546
++G G FGKV E G A+K ++ +A TE +L RH L SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
K+ + + EY+ G L HL + S + I SA L YLH+G +
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLHSG---KI 116
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
++RD+K N++LD++ K+ DFGL K G I G+ YL PE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEG--ITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 667 KSDVYSFGVVLFEVLCAR 684
D + GVV++E++C R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 492 IGIGGFGKVYKG--ELNDGTK-VAVK-RGNPRSQQGLA-EFQTEIEMLSQFRHRHLVSLI 546
+G G FG V KG ++ K VAVK N + L E E ++ Q + ++V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
G C+ ++ M L+ E E G L L + ++ K E+ + G+ YL
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEID-----QTHVSTAVKGSFGYLDPEYFRR 661
+HRD+ + N+LL AK++DFGLSK + +TH VK + PE
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYAPECMNY 172
Query: 662 QQLTEKSDVYSFGVVLFE 679
+ + KSDV+SFGV+++E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAE-FQTEIEMLSQFRHRHLVSLIG 547
+G+GGFG+V ++ A+K R + G E +E E+L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
+K + ++ EY G L L GL + C+ A YLH + +I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLA--FEYLH---NRGII 115
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
+RD+K N+LLD N K+ DFG +K +T T G+ Y+ PE +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYDFS 172
Query: 668 SDVYSFGVVLFEVLCARP 685
D +S G++L+E+L RP
Sbjct: 173 VDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 75/280 (26%), Positives = 112/280 (40%), Gaps = 39/280 (13%)
Query: 492 IGIGGFGKVYKGELND---------GTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRH 541
+G G F +YKG L G +V+V S + F ++SQ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHT 600
LV L G C ++E I++ EY++ G L L+ SL WK L++ A LHYL
Sbjct: 63 LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 601 GYAKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
K ++H +V NIL+ V LS G I V+ ++ PE
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-PWIAPEC 175
Query: 659 FRRQQ--LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716
R Q LT +D +SFG L E+ P ++ +E +Q++ +L
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGE-----EPLSTLSSSEKERFYQDQHRLPMPDC 230
Query: 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756
LA I +C RPS +L +L
Sbjct: 231 AELANLIN------------QCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 23/211 (10%)
Query: 485 NFDESWVIGIGGFGKVY----KGELNDGT----KVAVKRGNPRSQQGLAEFQTEIEMLSQ 536
NF+ V+G G +GKV+ G + G KV K + + +TE ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 537 FRHR-HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARG 594
R LV+L ++ LI +Y+ G L HLY + S + + I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLA 117
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFG 652
L +LH +I+RD+K NILLD + DFGLSK E ++ + + G+
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIE 171
Query: 653 YLDPEYFRRQQLTEKS--DVYSFGVVLFEVL 681
Y+ PE R D +S GV+ FE+L
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 65/270 (24%), Positives = 120/270 (44%), Gaps = 31/270 (11%)
Query: 491 VIGIGGFGKV-YKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLI- 546
V+G G +G+V DG + +K+ N R S++ + E ++LSQ +H ++V+
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
+ E + ++ + E G L L L Q +E + A L YLH K +
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHI 123
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
+HRD+K+ N+ L + KV D G+++ +Q +++ + G+ Y+ PE F +
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 667 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP- 725
KSDV++ G ++E+ + N ++ ++ + GK+ P
Sbjct: 182 KSDVWALGCCVYEMATLKHAF-------------------NAKDMNSLVYRIIEGKLPPM 222
Query: 726 --DSLRKFGETAEKCLADFGVDRPSMGDVL 753
D + GE L+ RPS+ +L
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 43/233 (18%)
Query: 492 IGIGGFGKVYKGELNDG--TKVAVKR---GNPRSQQGLAEFQTEIEML--------SQFR 538
+G G FG VYK + +A+K NP + E I + Q R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 539 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-----------WKQRLEI 587
H ++V E + + ++ + +E L H SL W +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF-----NSLKEKKQRFTEERIWNIFVQM 122
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTA 646
+ L YLH K ++HRD+ NI+L E+ + DFGL+K PE T+
Sbjct: 123 VLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL----TS 172
Query: 647 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA 699
V G+ Y PE + + EK+DV++FG +L+++ +P T M++LA
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST---NMLSLA 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 492 IGIGGFGKVYKG---ELNDG-----TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G F K++KG E+ D T+V +K + + F M+SQ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGY 602
G C +E I++ EY++ G+L +L + L ++SWK LE+ A LH+L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLED-- 118
Query: 603 AKAVIHRDVKSANILLDEN---------FMAKVADFGLSKT--GPEIDQTHVSTAVKGSF 651
K + H +V + N+LL F+ K++D G+S T EI +
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKEILLERIP------- 169
Query: 652 GYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLC 682
++ PE Q L+ +D +SFG L+E+
Sbjct: 170 -WVPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 8e-13
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 45/215 (20%)
Query: 492 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQT--------EIEMLSQF-RHRH 541
+G G FG VY + G VA+K+ +F + E++ L + H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS----GLPSLSWKQRLEICIGSARGLHY 597
+V L E +E+ ++EYME G+LY S I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-----GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 598 LHT-GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ-----THVSTAVKGSF 651
+H G+ HRD+K N+L+ + K+ADFGL++ EI +VST
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTR----- 162
Query: 652 GYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARP 685
Y PE R + D+++ G ++ E+ RP
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 495 GGFGKVYKGELNDGT-----KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
G FG+++ G L D +V VK + S+ + E +L H++++ ++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 549 CDEKNE--MILIYEYMENGTLKGHLY------GSGLPSLSWKQRLEICIGSARGLHYLHT 600
C E E +L Y YM G LK L + +LS +Q + + I A G+ YLH
Sbjct: 77 CIEDGEPPFVL-YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ VIH+D+ + N ++DE K+ D LS+ +D + ++ E
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
Query: 661 RQQLTEKSDVYSFGVVLFEV--LCARPV--IDP 689
++ + SDV+SFGV+L+E+ L P IDP
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 9e-13
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 11/211 (5%)
Query: 477 VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 535
V+V + + IG G G VY ++ G +VA+++ N + Q EI ++
Sbjct: 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 536 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 595
+ ++ ++V+ + +E+ ++ EY+ G+L + + + Q +C + L
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQAL 129
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYL 654
+LH+ VIHRD+KS NILL + K+ DFG ++ PE Q+ ST V G+ ++
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWM 183
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE R+ K D++S G++ E++ P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 478 AVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 536
A+++ F+ V+G G +G+VYKG + G A+K + + E + EI ML +
Sbjct: 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKK 68
Query: 537 F-RHRHLVSLIGYCDEK------NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 589
+ HR++ + G +K +++ L+ E+ G++ + + +L IC
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--HVSTAV 647
RGL +LH A VIHRD+K N+LL EN K+ DFG+S ++D+T +T +
Sbjct: 129 EILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFI 182
Query: 648 KGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEVLCARP 685
G+ ++ PE + + +SD++S G+ E+ P
Sbjct: 183 -GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 26/203 (12%)
Query: 491 VIGIGGFGK--VYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
V+G G FG+ + + +D + P+S + + + E +L++ +H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 549 CDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+ + ++ EY + G L +G L+ L W +++C+G + ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDT-ILQW--FVQMCLG----VQHIHE- 118
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYF 659
K V+HRD+KS NI L +N K+ DFG ++ T P + T V G+ Y+ PE +
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYV-GTPYYVPPEIW 172
Query: 660 RRQQLTEKSDVYSFGVVLFEVLC 682
KSD++S G +L+E LC
Sbjct: 173 ENMPYNNKSDIWSLGCILYE-LC 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 492 IGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQ---FRHRHLVS 544
IG G +GKV+K N G VA+KR ++ + T E+ +L F H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 545 LIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
L C D + ++ L++E+++ L +L P + + ++ RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ V+HRD+K NIL+ + K+ADFGL++ T+V + Y PE
Sbjct: 128 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 181
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPV 686
+ D++S G + E+ +P+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 29/228 (12%)
Query: 485 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLS 535
F++ IG G +G VY+ + G VA+K+ G P S L EI +L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPIS--SL----REITLLL 61
Query: 536 QFRHRHLVSL----IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS 591
RH ++V L +G + + L+ EY E L L P S Q + +
Sbjct: 62 NLRHPNIVELKEVVVG--KHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKCLMLQL 117
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
RGL YLH + +IHRD+K +N+LL + K+ADFGL++T + V +
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TL 172
Query: 652 GYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 698
Y PE T D+++ G +L E+L +P++ E ++L
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 37/90 (41%), Positives = 54/90 (60%), Gaps = 5/90 (5%)
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
A L +LH+ +I+RD+K NILLDE K+ DFGLSK ID + + G+
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTV 162
Query: 652 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
Y+ PE R+ T+ +D +SFGV++FE+L
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 491 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLS-QFRHRHLVSL 545
++G G FGKV+ EL + A+K+ + E +LS + H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHL---YGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
K + + EY+ G L H+ + LP ++ IC GL +LH+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC-----GLQFLHS-- 114
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 662
K +++RD+K NILLD + K+ADFG+ K + T G+ Y+ PE Q
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN-MLGDAKTCTFC-GTPDYIAPEILLGQ 171
Query: 663 QLTEKSDVYSFGVVLFEVL 681
+ D +SFGV+L+E+L
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 31/212 (14%)
Query: 486 FDESWVIGIGGFGKVYKGELN-DGTK----VAVKR----GNPRSQQGLAEFQTEIEMLSQ 536
F + V+G G FG VYKG +G K VA+K +P++ + E E +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK---EILDEAYVMAS 65
Query: 537 FRHRHLVSLIGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICI 589
+ H+ L+G C + + LI + M G L K ++ L L+W C+
Sbjct: 66 VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNW------CV 116
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
A+G++YL + ++HRD+ + N+L+ K+ DFGL+K ++ + + K
Sbjct: 117 QIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
Query: 650 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
++ E + T +SDV+S+GV ++E++
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 78/276 (28%), Positives = 121/276 (43%), Gaps = 47/276 (17%)
Query: 492 IGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLI 546
IG G FG VY N T VAVK+ + +Q ++Q E++ L Q +H + +
Sbjct: 29 IGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK--QRLEICI---GSARGLHYLHTG 601
G +++ L+ EY S L + K Q +EI G+ +GL YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCLGS-------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS- 139
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY-- 658
+IHRD+K+ NILL E K+ADFG SK+ P + + G+ ++ PE
Sbjct: 140 --HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVIL 190
Query: 659 -FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717
Q K DV+S G+ E+ +P + N+ + + + Q P
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKP--------PLFNMNAMSALY----HIAQNDSP 238
Query: 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
TL DS R F + CL +RP+ ++L
Sbjct: 239 TLQSNEWTDSFRGF---VDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTE---IEMLSQFRHRHLV 543
V+G G FGKV E ++ A+K+G+ ++ + E E + RH LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
+L ++ + + EY G L H++ + + S C+ GL YLH
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACV--VLGLQYLHE--- 119
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
+++RD+K N+LLD K+ADFGL K G ST G+ +L PE
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTFC-GTPEFLAPEVLTETS 177
Query: 664 LTEKSDVYSFGVVLFEVL 681
T D + GV+++E+L
Sbjct: 178 YTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 485 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHR 540
+ + +G G FG+V+ + A+K L + Q E +L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 600
++ L ++ + ++ EY+ G L +L SG S S I A L YLH+
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA--LEYLHS 119
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
K +++RD+K NILLD+ K+ DFG +K D+T + G+ YL PE +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTW---TLCGTPEYLAPEVIQ 171
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
+ + D ++ G++++E+L P
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 25/201 (12%)
Query: 472 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR---GNPRSQQGLAEF 527
Y FPF + + +++ IG G FG+V+K VA+K+ N + +
Sbjct: 3 YEFPFC---DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL 59
Query: 528 QTEIEMLSQFRHRHLVSLIGYCDEKNEM--------ILIYEYMENGTLKGHLYGSGLP-S 578
+ EI++L +H ++V+LI C K L++E+ E+ L G L + +
Sbjct: 60 R-EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFT 117
Query: 579 LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GP 636
LS +++ + + GL+Y+H ++HRD+K+ANIL+ ++ + K+ADFGL++
Sbjct: 118 LSEIKKVMKMLLN--GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 637 EIDQTHVSTAVKGSFGYLDPE 657
+ + + T + Y PE
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-12
Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 24/194 (12%)
Query: 515 RGNPRSQQGLAEF------------QTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562
RG+ ++ +A+F ++E+ L+ H +V ++++LI EY
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147
Query: 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY-----LHTGYAKAVIHRDVKSANIL 617
G L + K+ L L Y L +++ ++HRD+KSANI
Sbjct: 148 SGGDLNKQI------KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 618 LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 677
L + K+ DFG SK + V+++ G+ YL PE + R++ ++K+D++S GV+L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 678 FEVLCA-RPVIDPT 690
+E+L RP P+
Sbjct: 262 YELLTLHRPFKGPS 275
|
Length = 478 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 41/292 (14%)
Query: 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQF 537
NF IG G F +VY+ L D VA+K+ + +++Q + EI++L Q
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59
Query: 538 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLY-----GSGLPSLS-WKQRLEICIGS 591
H +++ + E NE+ ++ E + G L + +P + WK +++C
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC--- 116
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
+ ++H+ + V+HRD+K AN+ + + K+ D GL + +T + ++ G+
Sbjct: 117 -SAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTP 170
Query: 652 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711
Y+ PE KSD++S G +L+E+ + + +NL K +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQK------I 220
Query: 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763
+Q P L + + LR E C+ RP +G V + A Q+
Sbjct: 221 EQCDYPPLPTEHYSEKLR---ELVSMCIYPDPDQRPDIGYV---HQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 533 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW-KQRL-EICIG 590
M+ Q ++ L K+ + L+ EY+ G + G W KQ + E+ +G
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG 109
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
+ LH + +IHRD+K N+L+D+ K+ DFGLS+ G + G+
Sbjct: 110 ----VEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGT 156
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 695
YL PE + SD +S G V+FE L P P +
Sbjct: 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 491 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ------FRHRHLV 543
V+G G FGKV EL G AVK + L + E M+ + + + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHT 600
L K + + E++ G L H+ G L ++ +C GL +LH+
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHS 114
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
K +I+RD+K N++LD + K+ADFG+ K + + ++ G+ Y+ PE +
Sbjct: 115 ---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDYIAPEILQ 169
Query: 661 RQQLTEKSDVYSFGVVLFEVL 681
+ T D +SFGV+L+E+L
Sbjct: 170 GLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 497 FGKVYKGEL------NDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGYC 549
FGKVYKG L VA+K +++ L EF+ E M S+ +H ++V L+G
Sbjct: 18 FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77
Query: 550 DEKNEMILIYEYMENGTLKGHL--------YGSGLPSLSWKQRLE------ICIGSARGL 595
++ + +I+ Y + L L GS + K LE I A G+
Sbjct: 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
+L + + V+H+D+ + N+L+ + K++D GL + D + ++
Sbjct: 138 EFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMS 194
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVL 681
PE + + SD++S+GVVL+EV
Sbjct: 195 PEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 64/211 (30%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 491 VIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIE-----MLSQFRHRHLVS 544
VIG G FGKV + +DG+ AVK ++ E Q I +L +H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG---------- 594
L ++ + +Y+ G L HL QR E C R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL-----------QR-ERCFLEPRARFYAAEVASA 108
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ YLH+ +I+RD+K NILLD + DFGL K G E ++T ++ G+ YL
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYL 163
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE R++ D + G VL+E+L P
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 45/213 (21%)
Query: 491 VIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
+IG GGFG+VY D K+ A+K + + +QG E MLS LVS
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVS-T 53
Query: 547 GYC----------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSAR 593
G C +++ I + M G L HL G+ S + + R EI +G
Sbjct: 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-EMRFYAAEIILG--- 109
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVSTAVKG 649
L ++H + V++RD+K ANILLDE+ +++D GL SK P H S G
Sbjct: 110 -LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---G 157
Query: 650 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 681
+ GY+ PE ++ + S D +S G +LF++L
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSL 545
VIG G + KV L ++ VK+ + + QTE + Q + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWK-QRLEICIGSARGLHYLHTGYA 603
+ + L+ EY+ G L H+ LP + EICI L++LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLHE--- 114
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
+ +I+RD+K N+LLD + K+ D+G+ K G + ++ G+ Y+ PE R ++
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 664 LTEKSDVYSFGVVLFEVLCARPVID 688
D ++ GV++FE++ R D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 59/198 (29%), Positives = 88/198 (44%), Gaps = 11/198 (5%)
Query: 491 VIGIGGFGKV-YKGELNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
++G G FGKV E G A+K + ++ +A TE +L RH L +L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
+ + + EY G L HL + S + I SA L YLH+ V
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHS---CDV 116
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
++RD+K N++LD++ K+ DFGL K G I G+ YL PE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 667 KSDVYSFGVVLFEVLCAR 684
D + GVV++E++C R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 8/169 (4%)
Query: 530 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 589
E+++L + ++V G E+ + E+M+ G+L L +G + ++ I +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
RGL YL + ++HRDVK +NIL++ K+ DFG+S G ID ++ + G
Sbjct: 109 --LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 160
Query: 650 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 698
+ Y+ PE + T +SD++S G+ L E+ R I P +E+ +
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 64/205 (31%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 491 VIGIGGFGKVYKGELN-DGTKVAVKRG------NPRSQQG-LAEFQTEIEMLSQFRHRHL 542
VIG G FGKV + DG AVK N + Q+ +AE +L +H L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV---LLKNVKHPFL 58
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGS-ARGLHYLHT 600
V L ++ + +++ G L HL P + R A L YLH+
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHS 114
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+++RD+K NILLD + DFGL K G I Q+ +T G+ YL PE R
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEG--IAQSDTTTTFCGTPEYLAPEVIR 169
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
+Q D + G VL+E+L P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 491 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGY 548
+IG G +G VY+G+ G VA+K N + +++ Q E+ +LSQ R ++ Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 549 --CDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIG-----SARGLHYLH 599
K + +I EY E G+++ +L + E I L Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVR---------TLMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYLDP 656
VIHRD+K+ANIL+ K+ DFG++ T V T ++ P
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY-----WMAP 170
Query: 657 EYFRR-QQLTEKSDVYSFGVVLFEVLCARP 685
E + K+D++S G+ ++E+ P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 39/210 (18%)
Query: 491 VIGIGGFGKVYKGELND-GTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
+IG GGFG+VY D G A+K + + +QG E MLS LVS
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVS-T 53
Query: 547 GYC----------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 596
G C +++ I + M G L HL G+ S K+ GL
Sbjct: 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLE 111
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVSTAVKGSFG 652
++H + V++RD+K ANILLDE+ +++D GL SK P H S G+ G
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTHG 160
Query: 653 YLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 681
Y+ PE ++ + S D +S G +LF++L
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 40/162 (24%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQ-QGLAEFQT-EIEMLSQFRHRHLVSLIGY 548
IG G +G VYKG G VA+K+ S+ +G+ EI +L + +H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 549 CDEKNEMILIYE-----------------YMENGTLKGHLYGSGLPSLSWKQRLEICIGS 591
+++ + LI+E YM+ +K +LY Q L+
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY----------QILQ----- 112
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
G+ + H ++ V+HRD+K N+L+D + K+ADFGL++
Sbjct: 113 --GILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 491 VIGIGGFGKVYKGEL-NDGTKVAVK--RGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLI 546
V+G G FGKV L G AVK + + Q E TE +LS R+ ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 547 GYCDEKNE-MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
C + + + + E++ G L H+ S + + I SA L +LH K
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHD---KG 116
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
+I+RD+K N+LLD K+ADFG+ K G I ++ G+ Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 666 EKSDVYSFGVVLFEVLC 682
D ++ GV+L+E+LC
Sbjct: 175 PSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 49/300 (16%)
Query: 492 IGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLI- 546
IG G FG V+ + DG +VA+K+ P Q L + E++ML F+H +++S +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKK-MPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 547 ----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK----QRLEICIGSARGLHYL 598
+ D E+ ++ E M++ K + L S K Q L RGL YL
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL-------RGLKYL 119
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
H+ ++HRD+K N+L++ N + K+ DFGL++ + H++ V + Y PE
Sbjct: 120 HSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI 175
Query: 659 FR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717
+ T D++S G + E+L R + P + QLD I D
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---------------QLDLITD- 219
Query: 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL-----EYALQLQEAVVHGDPD 772
L G +++R E A + G +P VL+ L A+ L ++ DPD
Sbjct: 220 -LLGTPSLEAMRSACEGARAHILR-GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 492 IGIGGFGKVYKGELNDG---TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
IG G FGKV GE+N G +V VK R + Q+ + +F E + +H +L+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM-KFLEEAQPYRSLQHSNLLQCL 61
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARGLHYLHTG 601
G C E +L+ E+ G LKG+L P + QR+ I A GL +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHK- 118
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
IH D+ N LL + K+ D+GLS + D + ++ PE
Sbjct: 119 --NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 662 QQ-------LTEKSDVYSFGVVLFEVL 681
T++S+V+S GV ++E+
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-11
Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 40/223 (17%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
IG GG G+VY + +VA+K+ NP ++ F E ++ + H +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLREAKIAADLIHPGIVP 66
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGS-----GLPS-----LSWKQRLEICIGSARG 594
+ C + + + Y+E TLK L S L S L I
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG--LSKTGPEIDQTHVSTAVKGSF- 651
+ Y+H+ K V+HRD+K NILL + D+G + K E D + +
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 652 -------------GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
Y+ PE +E +D+Y+ GV+L+++L
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 49/168 (29%), Positives = 88/168 (52%), Gaps = 12/168 (7%)
Query: 530 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRL-EI 587
E+++L + ++V G E+ + E+M+ G+L L +G +P +Q L ++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP----EQILGKV 108
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
I +GL YL + ++HRDVK +NIL++ K+ DFG+S G ID ++ +
Sbjct: 109 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 695
G+ Y+ PE + + +SD++S G+ L E+ R I P +E+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 10/198 (5%)
Query: 491 VIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLI 546
++G G FGKV E G A+K ++ +A TE +L RH L +L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
+ + + EY G L HL + S + I SA L YLH+ K V
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHS--EKNV 117
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
++RD+K N++LD++ K+ DFGL K G I G+ YL PE
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 667 KSDVYSFGVVLFEVLCAR 684
D + GVV++E++C R
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 11/198 (5%)
Query: 491 VIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLI 546
++G G FGKV E G A+K ++ +A TE +L RH L +L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
+ + + EY G L HL + + + I SA L YLH+ + V
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLHS---RDV 116
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
++RD+K N++LD++ K+ DFGL K G I G+ YL PE
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 667 KSDVYSFGVVLFEVLCAR 684
D + GVV++E++C R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 31/157 (19%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRHL 542
IG G +G VYK + G VA+K+ G P + EI +L + H ++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI------REISLLKELNHPNI 60
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL------EICIGSARGLH 596
V L+ +N++ L++E++ + LK ++ P L ++ +G+
Sbjct: 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYM--DSSPLTGLDPPLIKSYLYQLL----QGIA 113
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
Y H+ V+HRD+K N+L+D K+ADFGL++
Sbjct: 114 YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 20/172 (11%)
Query: 530 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---- 585
E+++L + ++V G E+ + E+M+ G+L L +R+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--------QVLKEAKRIPEEI 104
Query: 586 --EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643
++ I RGL YL + ++HRDVK +NIL++ K+ DFG+S G ID +
Sbjct: 105 LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 158
Query: 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 695
+ + G+ Y+ PE + + +SD++S G+ L E+ R I P +E+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRH 541
NF + IG G +G VYK G VA+K R + ++ + EI +L + H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+V L+ +N++ L++E++ + LK + S L + +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
+ V+HRD+K N+L++ K+ADFGL++
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 530 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEIC 588
EIE+L H ++V D E+ ++ E+M+ G+L+G H+ + +Q L
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-- 179
Query: 589 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH--VSTA 646
G+ YLH + ++HRD+K +N+L++ K+ADFG+S+ + QT +++
Sbjct: 180 -----GIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRI---LAQTMDPCNSS 228
Query: 647 VKGSFGYLDPEYFRRQQLTE------KSDVYSFGVVLFEVLCAR 684
V G+ Y+ PE L D++S GV + E R
Sbjct: 229 V-GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 56/197 (28%), Positives = 81/197 (41%), Gaps = 22/197 (11%)
Query: 495 GGFGKVY---KGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
G G+V+ K KV VK G EI++L HR +++LI
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRW 157
Query: 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
K+ + ++ M Y L +Q + I L YLH + +IHRDV
Sbjct: 158 KSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDV 211
Query: 612 KSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVKGSFGYLD---PEYFRRQQLTEK 667
K+ NI LDE A + DFG + K D + G G L+ PE K
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPD----TPQCYGWSGTLETNSPELLALDPYCAK 267
Query: 668 SDVYSFGVVLFEVLCAR 684
+D++S G+VLFE+
Sbjct: 268 TDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 73/277 (26%), Positives = 115/277 (41%), Gaps = 46/277 (16%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 547
IG G FG VY ++ + VA+K+ + +Q ++Q E+ L + RH + + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK--QRLEICI---GSARGLHYLHTGY 602
++ L+ EY S L + K Q +EI G+ +GL YLH+
Sbjct: 83 CYLREHTAWLVMEYCLGS-------ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-- 133
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY--- 658
+IHRDVK+ NILL E + K+ DFG S P + G+ ++ PE
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILA 185
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718
Q K DV+S G+ E+ +P + N+ + + + Q P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP--------PLFNMNAMSALY----HIAQNESPA 233
Query: 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755
L + R F + CL DRP+ +VL
Sbjct: 234 LQSGHWSEYFRNF---VDSCLQKIPQDRPT-SEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 18/220 (8%)
Query: 491 VIGIGGFGKVYKG-ELNDGTK----VAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
V+G G FG VYKG + DG VA+K R N S + E E +++ ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
L+G C + + L+ + M G L ++ + + L C+ A+G+ YL
Sbjct: 73 RLLGIC-LTSTVQLVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDPEYFRRQ 662
++HRD+ + N+L+ K+ DFGL++ +ID+T + K ++ E +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARL-LDIDETEYHADGGKVPIKWMALESILHR 186
Query: 663 QLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPREMVNLAE 700
+ T +SDV+S+GV ++E++ A+P D RE+ +L E
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPY-DGIPAREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 586 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645
+I + + L YLH+ + VIHRDVK +N+L++ N K+ DFG+S G +D T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161
Query: 646 AVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEV 680
G Y+ PE ++ KSDV+S G+ + E+
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/225 (25%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 497 FGK----VYKGELNDGTKVAVKRGNPRSQQGLAEFQT---------------EIEMLSQF 537
FGK V +L +GT V +G + + L + E+ +L
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60
Query: 538 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA-RGLH 596
+H ++V+L + + L++EY+++ LK +L G +L ++I + RGL
Sbjct: 61 KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLS 117
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656
Y H + ++HRD+K N+L++E K+ADFGL++ +T+ + V + Y P
Sbjct: 118 YCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPP 172
Query: 657 EYFRRQQLTEKS---DVYSFGVVLFEVLCARPVIDPTLPREMVNL 698
+ TE S D++ G +L+E+ RP+ + +E ++L
Sbjct: 173 DVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 59/226 (26%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQT--EIEMLSQFR-HRHL 542
+G G +G V+K + VA+K+ N Q +T EI L + H ++
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ-----RTFREIMFLQELGDHPNI 69
Query: 543 VSLIGYCDEKN--EMILIYEYMEN--------GTLKG-H----LYGSGLPSLSWKQRLEI 587
V L+ +N ++ L++EYME L+ H +Y Q L
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY----------QLL-- 117
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
+ L Y+H+G VIHRD+K +NILL+ + K+ADFGL+++ E+++ + +
Sbjct: 118 -----KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGV-------VLFEVLCARPV 686
Y+ ++R ++ S Y+ GV +L E+L +P+
Sbjct: 170 T---DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 492 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAE-FQT---------EIEMLSQFRHR 540
+G G +G+V G KVA+K+ L+ FQ+ E+ +L H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKK--------LSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 541 HLVSLIG-YC-DEKNEMIL-IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GS 591
+++ L+ + E +Y HL G+ L ++ Q+L I
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVT-------HLMGADLNNIVKCQKLSDDHIQFLVYQI 127
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
RGL Y+H+ +IHRD+K +NI ++E+ K+ DFGL++ + +V+T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR----- 179
Query: 652 GYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
Y PE + D++S G ++ E+L +
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 45/275 (16%)
Query: 492 IGIGGFGKVY-KGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 547
IG G FG VY ++ VA+K+ + +Q ++Q E++ L + +H + + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK--QRLEICI---GSARGLHYLHTGY 602
++ L+ EY S L + K Q +EI G+ +GL YLH+
Sbjct: 93 CYLREHTAWLVMEYCLGS-------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-- 143
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY--- 658
+IHRD+K+ NILL E K+ADFG S P + + G+ ++ PE
Sbjct: 144 -HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFVGTPYWMAPEVILA 195
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718
Q K DV+S G+ E+ +P + N+ + + + Q PT
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKP--------PLFNMNAMSALY----HIAQNESPT 243
Query: 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
L D R F + CL DRP+ ++L
Sbjct: 244 LQSNEWSDYFRNF---VDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 40/161 (24%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRHL 542
IG G +G V+K VA+KR G P S EI +L + +H+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNI 61
Query: 543 VSLIGYCDEKNEMILIYEYME----------NGTLKGHLYGSGLPSLSWKQRLEICIGSA 592
V L ++ L++EY + NG + + S + L
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------------L 109
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
+GL + H + V+HRD+K N+L+++N K+ADFGL++
Sbjct: 110 KGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 50/213 (23%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ------GLAEFQTEIEMLSQFRHRHLVS 544
IG G +GKVYK + N G VA+K+ + L E ++MLS+ ++V
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISL-LQMLSE--SIYIVR 65
Query: 545 LIG--YCDEKNEMILIY---EYMENGTLK-----GHLYGSGLPSLSWKQRL-EICIGSAR 593
L+ + +EKN +Y EY+++ K G G LP+ + K + ++ G A
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA- 124
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMA-KVADFGLSKT------------------ 634
+ H V+HRD+K N+L+D+ K+AD GL +
Sbjct: 125 ---HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR 178
Query: 635 GPEI--DQTHVSTAVK-GSFGYLDPEYFRRQQL 664
PE+ TH ST V S G + E R+Q L
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 52/225 (23%), Positives = 97/225 (43%), Gaps = 40/225 (17%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKR--------GNPRSQQGLAE----FQT--EIEMLSQ 536
+G G +GKV K G VA+K+ + +Q + F T E++++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 537 FRHRHLVSLIG-YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA--R 593
+H +++ L+ Y E + + L+ + M LK + + S + CI
Sbjct: 77 IKHENIMGLVDVYV-EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVK----CILLQILN 130
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-------TGPEIDQTHVS-- 644
GL+ LH Y +HRD+ ANI ++ + K+ADFGL++ + +
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 645 ---TAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
T+ + Y PE ++ D++S G + E+L +P
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSL 545
VIG G + KV L ++ VK+ + + QTE + Q H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWK-QRLEICIGSARGLHYLHTGYA 603
++ + + EY+ G L H+ LP + EI + L+YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHE--- 114
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
+ +I+RD+K N+LLD K+ D+G+ K G T ++ G+ Y+ PE R +
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGED 172
Query: 664 LTEKSDVYSFGVVLFEVLCARPVID 688
D ++ GV++FE++ R D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 68/247 (27%), Positives = 110/247 (44%), Gaps = 38/247 (15%)
Query: 485 NFDESWVIGIGGFGKVY---KGELNDGTKV----AVKRGNPRSQQGLAEF-QTEIEMLSQ 536
NF+ V+G G +GKV+ K +D K+ +K+ + E +TE ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 537 FRHR-HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARG 594
R LV+L ++ LI +Y+ G L HL +Q ++I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
L +LH +I+RD+K NILLD N + DFGLSK E D+ + + G+ Y+
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYM 173
Query: 655 DPEYFRRQQLTEKS--DVYSFGVVLFEVLC-----------------ARPVI--DPTLPR 693
P+ R D +S GV+++E+L +R ++ +P P+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233
Query: 694 EMVNLAE 700
EM LA+
Sbjct: 234 EMSALAK 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 492 IGIGGFGKVYKG--ELNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGY 548
+G G + VYKG +L D VA+K ++G E+ +L +H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
+ + L++EY++ LK +L G S++ RGL+Y H + V+H
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLH 127
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-YFRRQQLTEK 667
RD+K N+L++E K+ADFGL++ +T+ + V + Y P+ + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQ 185
Query: 668 SDVYSFGVVLFEVLCARPV 686
D++ G + +E+ RP+
Sbjct: 186 IDMWGVGCIFYEMSTGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 491 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSL 545
VIG G + KV EL ++ +K+ + + QTE + H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR-----------LEICIGSARG 594
++ + + E++ G L H+ +QR EI +
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQ---------RQRKLPEEHARFYSAEISLA---- 108
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
L++LH + +I+RD+K N+LLD K+ D+G+ K G I ++ G+ Y+
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYI 163
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 688
PE R + D ++ GV++FE++ R D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 27/197 (13%)
Query: 495 GGFGKVYKGELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 552
+ K + T VAVK+ N S++ L Q EI Q +H +++ +
Sbjct: 13 LMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 553 NEMILIYEYMENGT----LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
+E+ ++ M G+ LK H + GLP L+ I L Y+H+ K IH
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAF---ILKDVLNALDYIHS---KGFIH 124
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS-------FGYLDPEYFRR 661
R VK+++ILL + ++ GL + I V +L PE +
Sbjct: 125 RSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ- 181
Query: 662 QQL---TEKSDVYSFGV 675
Q L EKSD+YS G+
Sbjct: 182 QNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 30/152 (19%), Positives = 55/152 (36%), Gaps = 24/152 (15%)
Query: 33 NYLIDCGSRTNTTVGNRVFVADNS----ASKFLSTPQNVVANISESVTSSNDSQLYQTAR 88
I+CG +T + AD ++ + + N ++I + D +LYQT R
Sbjct: 2 VLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSI----AGTTDPELYQTER 57
Query: 89 IFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFK 148
S Y G + + L+F + + R F V ++L +F ++
Sbjct: 58 YSPSSFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQGKLVLKDF----DIVA 113
Query: 149 E------------FSVNVTSDSLDVIFSPSNN 168
E V VT +L++ F +
Sbjct: 114 EAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGK 145
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 51/200 (25%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 492 IGIGGFGKVYKG--ELNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGY 548
+G G + V+KG +L + VA+K ++G E+ +L +H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA-RGLHYLHTGYAKAVI 607
+ L++EY++ LK ++ G ++ ++I + RGL Y H + V+
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHR---RKVL 126
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTE 666
HRD+K N+L++E K+ADFGL++ +T+ + V + Y P+ + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 667 KSDVYSFGVVLFEVLCARPV 686
+ D++ G + FE+ RP+
Sbjct: 185 QIDMWGVGCIFFEMASGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 492 IGIGGFGKVYKGELNDGTKV-AVKRGNPR---SQQGLAEFQTEIEML---SQFRHRHLVS 544
IG G FG+VY+ D ++ A+K + + +++ +A E +L +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARGLHYLHTGYA 603
L +++ L+ +YM G L HL G S + R + I L +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHK--- 114
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
+++RD+K NILLD + DFGLSK + + G+ YL PE ++
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 664 -LTEKSDVYSFGVVLFEVLC 682
T+ D +S GV++FE+ C
Sbjct: 173 GYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
A GL +LH+ K +I+RD+K N++LD K+ADFG+ K +T + G+
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165
Query: 652 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 688
Y+ PE Q + D ++FGV+L+E+L +P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 25/201 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
++G G G VYK L +AVK Q+ + +E+E+L + +++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK---QIMSELEILYKCDSPYIIGF 64
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSARGLHYLHTGYAK 604
G +N + + E+M+ G+L +Y +P + L I + +GL YL ++
Sbjct: 65 YGAFFVENRISICTEFMDGGSLD--VYRK-IP----EHVLGRIAVAVVKGLTYL---WSL 114
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
++HRDVK +N+L++ K+ DFG+S + I +T+V G+ Y+ PE +Q
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQ 169
Query: 664 LTEKSDVYSFGVVLFEVLCAR 684
SDV+S G+ E+ R
Sbjct: 170 YGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 479 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKV----------AVKRGNPRSQQGLAEFQ 528
+Q ++D VIG G FG+V KV +KR + A F
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS------AFFW 91
Query: 529 TEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 588
E ++++ +V L + + ++ EYM G L + +P W +
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAK----- 145
Query: 589 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648
+A + L ++ +IHRDVK N+LLD++ K+ADFG E TAV
Sbjct: 146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204
Query: 649 GSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVL 681
G+ Y+ PE + Q + D +S GV LFE+L
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 491 VIGIGGFGKVYKGELNDGTKV-AVK--RGNPRSQQGLAE-FQTEIEMLSQFR-HRHLVSL 545
V+G G FGKV EL +V A+K + + Q + TE +L+ H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
K+ + + EY+ G L + S + + A L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFLHR---HG 116
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
VI+RD+K NILLD K+ADFG+ K G I +T G+ Y+ PE + +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 666 EKSDVYSFGVVLFEVLCARP 685
D ++ GV+++E++ +P
Sbjct: 175 PSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 70/273 (25%), Positives = 108/273 (39%), Gaps = 89/273 (32%)
Query: 491 VIGIGGFGKVYK------GELNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQF-RHR 540
+G G FGKV + + VAVK G S+ TE+++L H
Sbjct: 14 PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEY--KALMTELKILIHIGHHL 71
Query: 541 HLVSLIGYCDEKN-EMILIYEYMENGTLKGHL----------------YGSGLPSLSWKQ 583
++V+L+G C + +++I EY + G L +L KQ
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 584 RLE-----------------------------------------IC--IGSARGLHYLHT 600
RL+ I ARG+ +L +
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS 191
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI--DQTHVSTAVKGS----FGYL 654
+ IHRD+ + NILL EN + K+ DFGL++ +I D +V KG ++
Sbjct: 192 ---RKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVR---KGDARLPLKWM 242
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
PE + T +SDV+SFGV+L+E+ L A P
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 35/90 (38%), Positives = 47/90 (52%), Gaps = 11/90 (12%)
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID-QTHVSTAVKGSFGY 653
LHYL + VIHRDVK +NILLD + K+ DFG+S G +D + +A G Y
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVDSKAKTRSA--GCAAY 180
Query: 654 LDPEYFRRQQLTEK----SDVYSFGVVLFE 679
+ PE K +DV+S G+ L E
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 26/204 (12%)
Query: 492 IGIGGFGKV----YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVS 544
+G G FG+V +KG G A+K R + + Q E +L + H +V+
Sbjct: 26 LGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 545 LI-GYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWK-QRLEICIGSARGLHYLHTG 601
++ + DE L+ E++ G L HL +G P+ K E+ + YLH+
Sbjct: 83 MMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEYLHS- 136
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
K +I+RD+K N+LLD KV DFG +K P+ T + G+ YL PE +
Sbjct: 137 --KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQS 189
Query: 662 QQLTEKSDVYSFGVVLFEVLCARP 685
+ + D ++ GV+L+E + P
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 37/100 (37%), Positives = 53/100 (53%), Gaps = 14/100 (14%)
Query: 587 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID---QTHV 643
I + + + L+YL +IHRDVK +NILLD N K+ DFG+S G +D +T
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSIAKTRD 167
Query: 644 STAVKGSFGYLDPEY---FRRQQLTEKSDVYSFGVVLFEV 680
+ G Y+ PE R +SDV+S G+ L+EV
Sbjct: 168 A----GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 546
IG G +G V + G KVA+K+ + LA+ +T E+++L F+H +++++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK-RTLRELKILRHFKHDNIIAIR 70
Query: 547 G-YCDEKNEMILIY---EYMENGTLKGHLYGSGLPSLSWK-------QRLEICIGSARGL 595
+ +Y + ME+ H+ S P L+ + Q L RGL
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDL--HHIIHSDQP-LTEEHIRYFLYQLL-------RGL 120
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFG 652
Y+H + VIHRD+K +N+L++E+ ++ DFG+++ + P + ++ V +
Sbjct: 121 KYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-ATRW 176
Query: 653 YLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPV 686
Y PE + T D++S G + E+L R +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 481 EATNNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-R 538
+ T+ ++ IG G +GKVYK DG+ AVK +P S E + E +L
Sbjct: 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPN 77
Query: 539 HRHLVSLIG--YCDEK---NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------I 587
H ++V G Y +K ++ L+ E G++ + G L QRL+ I
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL----LICGQRLDEAMISYI 133
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--ST 645
G+ GL +LH +IHRDVK NILL K+ DFG+S ++ T + +T
Sbjct: 134 LYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNT 187
Query: 646 AVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEV 680
+V F ++ PE +Q + S DV+S G+ E+
Sbjct: 188 SVGTPF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 30/210 (14%)
Query: 492 IGIGGFGKVYKGELNDGTKVA---VKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
IG G FGKV E+ T VA VK + + Q EF + + +H +++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN---EFLQQGDPYRILQHPNILQ 59
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHL------YGSGLPSLSWKQRLEICIGSARGLHYL 598
+G C E +L++EY E G LK +L + L + EI G +H
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH-MHKH 118
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
+ +H D+ N L + KV D+G+ + + D +L PE
Sbjct: 119 N------FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172
Query: 659 FRRQQ-------LTEKSDVYSFGVVLFEVL 681
T+ S+V++ GV L+E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 59/201 (29%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 491 VIGIGGFGKVY-----KGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
VIG G FGKV E KV K+ + ++ +L +H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC-IGSARGLHYLHTGYAK 604
+++ + +Y+ G L HL L + R I SA G YLH+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALG--YLHS---L 115
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
+++RD+K NILLD + DFGL K E + T ++ G+ YL PE +Q
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPY 173
Query: 665 TEKSDVYSFGVVLFEVLCARP 685
D + G VL+E+L P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 41/279 (14%)
Query: 485 NFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNP-----RSQQGLAEFQTEIEMLSQFR 538
+FD VIG G FG+V +V A+K + RS A F E ++++
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS--AFFWEERDIMAHAN 101
Query: 539 HRHLVSL-IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSARGL 595
+V L + D+K + ++ EYM G L + +P W + E+ + L
Sbjct: 102 SEWIVQLHYAFQDDKY-LYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLA----L 155
Query: 596 HYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFG----LSKTGPEIDQTHVSTAVKGS 650
+H+ G+ IHRDVK N+LLD++ K+ADFG + G TAV G+
Sbjct: 156 DAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG----MVRCDTAV-GT 206
Query: 651 FGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706
Y+ PE + Q + D +S GV L+E+L P +V M +
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT---PFYADSLVGTYSKIMDHK 263
Query: 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVD 745
N I+ + K D + F E L GVD
Sbjct: 264 NSLTFPDDIEISKQAK---DLICAFLTDREVRLGRNGVD 299
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 492 IGIGGFGKVYKG---ELNDGTKVAVKR-GNPRSQQGLAEFQT-EIEMLSQFR-HRHLVSL 545
+G G +G V E ++ VA+K+ N S++ LA+ E+++L FR H+++ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 546 ----IGYCDEKNEMILIYEYME---NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598
I + NE+ L E ME + ++ SG P L+ GL Y+
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIR-----SGQP-LTDAHFQSFIYQILCGLKYI 121
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFGYLD 655
H+ V+HRD+K N+L++ + K+ DFGL++ P + ++ V + Y
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYRA 177
Query: 656 PEYFRRQQLTEKS-DVYSFGVVLFEVLCARPV 686
PE Q K+ DV+S G +L E+L +PV
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 485 NFDESWVIGIGGFGKVY---------KGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 535
NF+ V+G G +GKV+ G+L KV K + + + +TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLY-AMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 536 QFRHR-HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR- 593
R LV+L + ++ LI +Y+ G + HLY QR R
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRF 109
Query: 594 -------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 646
L +LH +++RD+K NILLD + DFGLSK ++ + +
Sbjct: 110 YSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYS 165
Query: 647 VKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 681
G+ Y+ PE R + K+ D +S G+++FE+L
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 40/102 (39%), Positives = 60/102 (58%), Gaps = 17/102 (16%)
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI--DQTHVSTAVKG 649
ARG+ +L + + IHRD+ + NILL EN + K+ DFGL++ +I D +V KG
Sbjct: 184 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVR---KG 234
Query: 650 S----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
S ++ PE + T +SDV+SFGV+L+E+ L A P
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 55/226 (24%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 479 VQEATNNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLS 535
+ E + + + +G G +G V + G KVA+K+ Q L + E+ +L
Sbjct: 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 69
Query: 536 QFRHRHLVSLIGY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 589
+H +++ L+ D ++ L+ +M GT G L LS + R++ +
Sbjct: 70 HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMK--HEKLS-EDRIQFLV 124
Query: 590 GSA-RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAV 647
+GL Y+H A +IHRD+K N+ ++E+ K+ DFGL++ T E+
Sbjct: 125 YQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT-------- 173
Query: 648 KGSFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 686
GY+ ++R ++ T+ D++S G ++ E+L +P+
Sbjct: 174 ----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 46/148 (31%), Positives = 72/148 (48%), Gaps = 13/148 (8%)
Query: 492 IGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
I G FGKVY G + +K+ VK+ + ++ + + Q E + L+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 548 YCDEKNEMILIYEYMENGTLKG--HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
N + L+ EY+ G +K H+YG ++ K E+ A L YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEV----ALALDYLHR---HG 124
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSK 633
+IHRD+K N+L+ K+ DFGLSK
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-09
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 485 NFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEMLSQFRHR 540
+F+ VIG G FG+V +L + KV A+K N AE F+ E ++L ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP---SLSWKQRLEICIGSARGL 595
+ +L ++N + L+ +Y G L L + LP + + + I I S L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
HY +HRD+K NIL+D N ++ADFG E D T S+ G+ Y+
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYIS 171
Query: 656 PEYFR-----RQQLTEKSDVYSFGVVLFEVL 681
PE + + + + D +S GV ++E+L
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 42/226 (18%)
Query: 488 ESWVIGIGGFGKVYKGELNDGTK---VAVKR--GNPRSQQGLAEFQTEIEMLSQFRHRHL 542
E +G G +G VYK + DG A+K+ G S EI +L + +H ++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNV 60
Query: 543 VSL----IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR----- 593
+SL + + D K + L+++Y E+ H+ S + K+ +++ G +
Sbjct: 61 ISLQKVFLSHADRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 594 ---GLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSK-----TGPEIDQT 641
G+HYLH + V+HRD+K ANIL+ E K+AD G ++ P D
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 642 HVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPV 686
V +F Y PE + T+ D+++ G + E+L + P+
Sbjct: 174 PVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHL 542
NF + +G G + VYKG G VA+K + +++G EI ++ + +H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSL-------SWKQRLEICIGSARGL 595
V L +N+++L++EYM+ LK ++ G+ S+ +L +G+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL------LKGI 113
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYL 654
+ H V+HRD+K N+L+++ K+ADFGL++ G ++ T + V + Y
Sbjct: 114 AFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVV--TLWYR 167
Query: 655 DPEYFRRQQLTEKS-DVYSFGVVLFEVLCARPV 686
P+ + S D++S G ++ E++ RP+
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 6/89 (6%)
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 652
GL YLH A+ +IHRDVK+ NI +++ + D G ++ P + + A G+
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLA--GTVE 221
Query: 653 YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
PE R + K+D++S G+VLFE+L
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 39/212 (18%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ-----GLAEFQTEIEMLSQFRHRHLVSL 545
IG G F +V K G A+K + L E Q + LS H +++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA-LRRLSP--HPNILRL 63
Query: 546 IGYC-DEK-NEMILIYEYMENGT---LKGHLYGSGLPSLSWKQRL-EICIGSARGLHYLH 599
I D K + L++E M+ +KG LP K + ++ + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRP--LPEKRVKSYMYQLL----KSLDHMH 117
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-- 657
+ HRD+K NIL+ ++ + K+ADFG + I T + Y PE
Sbjct: 118 ---RNGIFHRDIKPENILIKDDIL-KLADFGSCRG---IYSKPPYTEYISTRWYRAPECL 170
Query: 658 ----YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
Y+ K D+++ G V FE+L P
Sbjct: 171 LTDGYY-----GPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 484 NNFDESWVIGIGGFGKVY---KGELND--GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR 538
+FD ++G G FG+V + D KV +K+ +Q+ ++ F+ E ++LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59
Query: 539 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGL-PSLSWKQRLEICIGSARGL 595
+ L +K+ + L+ EY G L L Y ++ E+ + +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA----I 115
Query: 596 HYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
H +H GY +HRD+K N+L+D K+ADFG S ++ S G+ Y+
Sbjct: 116 HSVHQMGY----VHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYI 170
Query: 655 DPEYFRRQQLTEKS------DVYSFGVVLFEVLCAR 684
PE K D +S GV+ +E++ R
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 36/146 (24%), Positives = 76/146 (52%), Gaps = 14/146 (9%)
Query: 495 GGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT---EIEMLSQFRHRHLVSL--IG 547
G +G VY+ + G VA+K+ + ++G T EI +L + +H ++V++ +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFP--ITSLREINILLKLQHPNIVTVKEVV 73
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
+++ ++ EY+E+ LK L + + + + G+ +LH ++
Sbjct: 74 VGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWIL 128
Query: 608 HRDVKSANILLDENFMAKVADFGLSK 633
HRD+K++N+LL+ + K+ DFGL++
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS--ARGLHYLHTGYAKAVIHRD 610
+ + + EY+ G L + G +K+ + + A GL +LH+ K +I+RD
Sbjct: 74 DRLYFVMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRD 126
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 670
+K N++LD K+ADFG+ K + + G+ Y+ PE Q + D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 671 YSFGVVLFEVLCARPVID 688
++FGV+L+E+L + +
Sbjct: 185 WAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 612
+ + + EY+ G L H+ G Q + + GL +LH + +I+RD+K
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLK 128
Query: 613 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 672
N++LD K+ADFG+ K + + G+ Y+ PE Q + D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 673 FGVVLFEVLCARPVID 688
+GV+L+E+L +P D
Sbjct: 187 YGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTK-VAVKRGNPRSQQGLAEFQT--EIEMLSQFRHR 540
N F+ V+G G +G V K + + VA+K+ + + T E++ML +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
++V L + ++ L++EY+E L+ +G+P + + I + +H+ H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLI---KAIHWCH 117
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
++HRD+K N+L+ N + K+ DFG ++ E + + V + Y PE
Sbjct: 118 K---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELL 173
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPV 686
+ D++S G +L E+ +P+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 11/198 (5%)
Query: 492 IGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
IG G FGKV + D ++ +++ + S+ + E +L+Q +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
++ L+ ++ G L HL G LS + R +A L L + VI
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFY----TAELLCALENLHKFNVI 115
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
+RD+K NILLD + DFGL K + + G+ YL PE T+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 668 SDVYSFGVVLFEVLCARP 685
D ++ GV+L+E+L P
Sbjct: 174 VDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 548
+G G +G V + G +VAVK+ + Q + +T E+ +L +H +++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 602
+ E + L HL G+ L ++ Q+L + RGL Y+H+
Sbjct: 85 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 139
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-YFRR 661
+IHRD+K +N+ ++E+ K+ DFGL++ + +V+T Y PE
Sbjct: 140 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192
Query: 662 QQLTEKSDVYSFGVVLFEVLCARPVIDPT 690
+ D++S G ++ E+L R + T
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ---GLAEFQT-EIEMLSQFRHRHLVSL- 545
IG G +G VYK + +A+K+ R +Q G+ EI +L + +H ++V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKK--IRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 546 -IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-----ARGLHYLH 599
+ + +++ + L++EY++ LK H+ S P + RL I + RG+ Y H
Sbjct: 68 DVVHSEKR--LYLVFEYLDL-DLKKHMDSS--PDFAKNPRL---IKTYLYQILRGIAYCH 119
Query: 600 TGYAKAVIHRDVKSANILLDENFMA-KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE- 657
+ V+HRD+K N+L+D A K+ADFGL++ +T V + Y PE
Sbjct: 120 S---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEI 174
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVLCARPV 686
+ + D++S G + E++ +P+
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPL 203
|
Length = 294 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 7/97 (7%)
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGS 650
A+G+ +L + + IHRD+ + NILL EN + K+ DFGL++ + D +V +
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARLP 244
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
++ PE + T +SDV+SFGV+L+E+ L A P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 84/321 (26%), Positives = 129/321 (40%), Gaps = 79/321 (24%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRHLVS--- 544
VIG G +G V + + G KVA+K+ N + EI++L RH +V
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 545 --LIGYCDEKNEMILIYEYME---------NGTLKGHLYGSGLPSLSWKQRLEICIGSAR 593
L E ++ +++E ME N L + L L R
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQL------------LR 114
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-----TGPEIDQT-HVSTAV 647
L Y+HT V HRD+K NIL + + K+ DFGL++ T I T +V+T
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR- 170
Query: 648 KGSFGYLDPE----YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWA 702
Y PE +F + T D++S G + EVL +P+ P + +V+
Sbjct: 171 ----WYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPL----FPGKNVVH----- 215
Query: 703 MKWQNKGQLDQIID------PTLAGKIRPDSLRKFGETAEKCLA-DFGVDRPSMGDVLWN 755
QLD I D P ++R + R++ + K F P+ D L
Sbjct: 216 -------QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPN-ADPL-- 265
Query: 756 LEYALQLQEAVVHGDPDENST 776
AL+L E ++ DP + T
Sbjct: 266 ---ALRLLERLLAFDPKDRPT 283
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 61/226 (26%)
Query: 492 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 548
IG G +G V + ++ KVA+K+ + +T EI++L H +++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 549 C-----DEKNEMILIYEYME---------NGTLKG-H----LYGSGLPSLSWKQRLEICI 589
+ N++ ++YE M+ + TL H LY Q L
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY----------QLL---- 118
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
RGL Y+H+ V+HRD+K +N+LL+ N K+ DFGL++T T+ KG
Sbjct: 119 ---RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART----------TSEKG 162
Query: 650 SF--GYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 686
F Y+ ++R +L T DV+S G + E+L +P+
Sbjct: 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 42/226 (18%)
Query: 488 ESWVIGIGGFGKVYKGELNDGT---KVAVKR--GNPRSQQGLAEFQTEIEMLSQFRHRHL 542
E +G G +G VYK + DG + A+K+ G S EI +L + +H ++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNV 60
Query: 543 VSL----IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR----- 593
++L + + D K + L+++Y E+ H+ S + K+ +++ +
Sbjct: 61 IALQKVFLSHSDRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 594 ---GLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSK-----TGPEIDQT 641
G+HYLH + V+HRD+K ANIL+ E K+AD G ++ P D
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 642 HVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPV 686
V +F Y PE + T+ D+++ G + E+L + P+
Sbjct: 174 PVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 37/121 (30%), Positives = 60/121 (49%), Gaps = 13/121 (10%)
Query: 577 PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636
P+LS+ + A G+ +L + K +HRD+ + N+L+ E + K+ DFGL++
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLAR--- 287
Query: 637 EIDQTHVSTAV-KGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL 691
D S + KGS ++ PE T SDV+SFG++L+E+ P L
Sbjct: 288 --DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
Query: 692 P 692
P
Sbjct: 346 P 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 39/128 (30%), Positives = 63/128 (49%), Gaps = 13/128 (10%)
Query: 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618
Y+ + +K L G L+ L ARG+ +L + K +HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270
Query: 619 DENFMAKVADFGLSKTGPEIDQTHVSTAV-KGS----FGYLDPEYFRRQQLTEKSDVYSF 673
+ + K+ DFGL++ D H S V KGS ++ PE T SDV+S+
Sbjct: 271 AQGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 674 GVVLFEVL 681
G++L+E+
Sbjct: 326 GILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 492 IGIGGFGKVYKG--ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIG 547
+G G + VYKG +N G VA+K + ++++G+ F E +L +H ++V L
Sbjct: 13 LGEGSYATVYKGISRIN-GQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPS--LSWKQRLEICIGSARGLHYLHTGYAKA 605
K + ++EYM + Y P + RL RGL Y+H +
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQH 123
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQL 664
++HRD+K N+L+ K+ADFGL++ QT+ S V + Y P+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDY 181
Query: 665 TEKSDVYSFGVVLFEVLCARPV 686
+ D++ G + E+L +P
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 23/153 (15%)
Query: 491 VIGIGGFGKVYKG--ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 546
+G G + VYKG +L VA+K ++G A F E +L +H ++V+L
Sbjct: 12 KLGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLH 69
Query: 547 GYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSARGLHYLHT 600
K + L++EY++ LK ++ G GL + + Q L RGL Y H
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAYCHQ 121
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
+ V+HRD+K N+L+ E K+ADFGL++
Sbjct: 122 ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 51/238 (21%)
Query: 492 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV------- 543
+G G G V+ +D +VAVK+ Q + EI+++ + H ++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 544 -------SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS----LSWKQRLEICIGSA 592
+G E N + ++ EYME L L L L Q L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLL------- 124
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
RGL Y+H+ V+HRD+K AN+ ++ E+ + K+ DFGL++ I H S
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLAR----IVDPHYSHK----- 172
Query: 652 GYLD----PEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 698
GYL +++R +L T+ D+++ G + E+L +P+ E + L
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 548
+G G + VYKG+ +G VA+K + ++G F E +L +H ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA-RGLHYLHTGYAKAVI 607
K + L++EY+ + Y P + +++ + RGL Y+H Y ++
Sbjct: 72 IHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---IL 125
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
HRD+K N+L+ + K+ADFGL++ T+ + V + Y P+ TE
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS--TEY 181
Query: 668 S---DVYSFGVVLFEVL 681
S D++ G + E++
Sbjct: 182 STCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLIGY 548
+G G +G VYK L+ T V + R + ++F E+++L + ++V G
Sbjct: 9 LGKGNYGSVYKV-LHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPS--LSWKQRLEICIGSARGLHYLHTGYAKAV 606
+ + + EYM+ G+L LY G+ + + I +GL +L + +
Sbjct: 68 FFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 607 IHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVKGSFGYLDPEYFR----- 660
IHRDVK N+L++ N K+ DFG+S + +T++ G Y+ PE +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPN 179
Query: 661 -RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID--- 716
T +SDV+S G+ + E+ R P P N+ QL I+D
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRY---PYPPETYANIF---------AQLSAIVDGDP 227
Query: 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH 768
PTL D+ + F KCL RP+ +L + ++ + A V
Sbjct: 228 PTLPSGYSDDA-QDF---VAKCLNKIPNRRPTYAQLL-EHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 48/228 (21%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDG-TKVAVKRGNPRS-------QQGLAEFQTEIEMLS 535
+F+ +I G +G VY + + A+K+ N ++ QQ E ++L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER----DILT 56
Query: 536 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSAR- 593
+ +VS+ + K + ++ EY+E G L G LP + AR
Sbjct: 57 FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALP-----------VDMARM 105
Query: 594 -------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG----------- 635
L YLH ++HRD+K N+L+ K+ DFGLSK G
Sbjct: 106 YFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 636 -PEID-QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
E D + + V G+ Y+ PE RQ + D ++ G++L+E L
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 11/93 (11%)
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS- 650
A+G+ +L +K IHRDV + N+LL + +AK+ DFGL++ D +V VKG+
Sbjct: 222 AQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARD-IMNDSNYV---VKGNA 274
Query: 651 ---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
++ PE T +SDV+S+G++L+E+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 41/235 (17%)
Query: 474 FPFVAVQEATNNF---DESW----VIGIGGFGKVYKGELN--DGTKVAVKRGNPRSQQGL 524
FP ++F ++W IG G +GKV+K LN +G+K AVK +P
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID- 58
Query: 525 AEFQTEIEMLSQFR-HRHLVSLIGYC---DEKN--EMILIYEYMENGTLKGHLYGSGLPS 578
E + E +L H ++V G D KN ++ L+ E G++ + G
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF---- 114
Query: 579 LSWKQRLE------ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632
L +R+E I + GL +LH IHRDVK NILL K+ DFG+S
Sbjct: 115 LKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
Query: 633 KTGPEIDQTHV--STAVKGSFGYLDPEYFR-RQQL----TEKSDVYSFGVVLFEV 680
++ T + +T+V F ++ PE QQL + DV+S G+ E+
Sbjct: 172 A---QLTSTRLRRNTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 58/253 (22%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ----QGLAEFQTEIEMLSQFRH 539
+F VIG G FG+V + D K+ + +S+ LA + E ++L++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEI--CIGSARGLHY 597
+VSL + + LI E++ G L L S R + C+ + +H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-VTRFYMAECVLAIEAVHK 119
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS------------------------- 632
L G+ IHRD+K NIL+D K++DFGLS
Sbjct: 120 L--GF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 633 --KTGPEIDQTHVSTAVK------------------GSFGYLDPEYFRRQQLTEKSDVYS 672
+ +D +++ + K G+ Y+ PE F +Q ++ D +S
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 673 FGVVLFEVLCARP 685
G ++FE L P
Sbjct: 234 LGAIMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 84/395 (21%), Positives = 152/395 (38%), Gaps = 55/395 (13%)
Query: 12 IWVASVLCFVCFCSCQFDPADNYL-IDCGSRTN--TTVGNRVFVADNSASKFLSTPQNVV 68
+W+ + + + P + I CG+R N T N ++ D + + +
Sbjct: 3 LWLLAASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRP 62
Query: 69 ANISESVTSSNDSQLYQTARIFTGSSK----YTFSISGRGRHWIRLYFYPFVYQSYNMSR 124
+ I+ + +T R F S Y + +G + +R+ F+ V + S
Sbjct: 63 SFIAPPL---------KTLRYFPLSDGPENCYNINRVPKGHYSVRV-FFGLVAEPNFDSE 112
Query: 125 ASFSVS---TNDHVLLNNFS-VSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVS 180
F VS T L + +S VF E V +T S + F + + I ++E++
Sbjct: 113 PLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQ 172
Query: 181 VPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPEND---TLW---RTWVPD 234
V D A + P QG++ + T R++ G + D W R W
Sbjct: 173 V-----DDKAYNFGPSWG-QGVILR---TAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRM 223
Query: 235 QSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDV 294
Q+F + A S N+ + P ++Y +A +++D P ++++ DV
Sbjct: 224 QTFGSGSDQAISTENVIK----KASNAPNFYPESLYQSAL-VSTDTQP----DLSYTMDV 274
Query: 295 DSGFQYLVRFHFCDIVS--DGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVT 352
D Y V HF +I + + F+V I+ A +D+D+ S A V
Sbjct: 275 DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVA 334
Query: 353 VQTASSKLRISIGRSTLHDTY-PDAILNGLEIMKM 386
V + L I L AI+N +E+ ++
Sbjct: 335 V--SGRTLTI-----VLQPKKGTHAIINAIEVFEI 362
|
Length = 623 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 11/94 (11%)
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS- 650
A+G+ +L + K IHRD+ + NILL + K+ DFGL++ D +V VKG+
Sbjct: 224 AKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARD-IRNDSNYV---VKGNA 276
Query: 651 ---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
++ PE T +SDV+S+G++L+E+
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 54/249 (21%), Positives = 101/249 (40%), Gaps = 44/249 (17%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRH 539
++F+ VIG G FG+V + D + +++ + ++ +A + E ++L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ-RLEICIGSARGLHYL 598
+V + +K + LI E++ G + L S Q + + + +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGL--------------------------- 631
IHRD+K N+LLD K++DFGL
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 632 ---SKTGPEI---DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
SK E ++ ++ + G+ Y+ PE F + + D +S GV+++E+L P
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 686 VIDPTLPRE 694
P+E
Sbjct: 235 PFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 38/208 (18%)
Query: 492 IGIGGFGKV---YKGELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 546
+G G +G V Y L KVAVK+ + Q + +T E+ +L +H +++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 547 GY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARG 594
+ NE+ L+ M G+ L ++ Q+L + RG
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM----------GADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
L Y+H+ +IHRD+K +N+ ++E+ ++ DFGL++ + +V+T Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYR 182
Query: 655 DPE-YFRRQQLTEKSDVYSFGVVLFEVL 681
PE + D++S G ++ E+L
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEMLSQFRH 539
++F+ VIG G FG+V ++ ++ A+K N AE F+ E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP---SLSWKQRLEICIGSARG 594
+ + +L ++N + L+ +Y G L L + LP + + + + I S
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
LHY +HRD+K N+LLD N ++ADFG S D T S+ G+ Y+
Sbjct: 121 LHY---------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYI 170
Query: 655 DPEYFRRQQ-----LTEKSDVYSFGVVLFEVL 681
PE + + + D +S GV ++E+L
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 491 VIGIGGFGKVYKGELNDGTKV----------AVKRGNPRSQQGLAEFQTEIEMLSQFRHR 540
VIG G FG+V KV +KR + A F E ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS------AFFWEERDIMAFANSP 103
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 600
+V L + + ++ EYM G L + +P W + +A + L
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWAR-----FYTAEVVLALDA 157
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
++ IHRDVK N+LLD++ K+ADFG + TAV G+ Y+ PE +
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLK 216
Query: 661 RQ----QLTEKSDVYSFGVVLFEVL 681
Q + D +S GV L+E+L
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 54/232 (23%), Positives = 85/232 (36%), Gaps = 48/232 (20%)
Query: 491 VIGIGGFGKVYKGELNDGT------KVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLV 543
++G G G+V+ L GT KV K+ R++ TE E+L+ H L
Sbjct: 8 LLGKGDVGRVFLVRL-KGTGKLFALKVLDKKEMIKRNKVKRVL--TEQEILATLDHPFLP 64
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLY---GSGLPSLSWKQRL-EICIGSARGLHYLH 599
+L + + L+ +Y G L L G L + E+ + L YLH
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLH 120
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG------- 652
+++RD+K NILL E+ ++DF LSK KGS
Sbjct: 121 ---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 653 --------------------YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 684
Y+ PE D ++ G++L+E+L
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEMLSQFRH 539
++F+ VIG G FG+V ++ + +V A+K N AE F+ E ++L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 540 RHLVSL-IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK---QRLEICIGSAR 593
R + +L + DE N + L+ +Y G L L + LP + + + I S
Sbjct: 61 RWITNLHYAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
L Y +HRD+K N+LLD+N ++ADFG S D T S G+ Y
Sbjct: 120 QLGY---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDY 169
Query: 654 LDPEYFR-----RQQLTEKSDVYSFGVVLFEVL 681
+ PE + + + + D +S GV ++E+L
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 492 IGIGGFGKVYKGELNDGT-------------KVAVKRGNPRSQQ-GLAEFQTEIEMLSQF 537
+G G ++Y G LN KV +K +P + LA F+T M+ Q
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETA-SMMRQV 61
Query: 538 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLY-GSGLPSLSWKQRLEICIGSARGLH 596
H+H+V L G C E I++ E++E G L ++ S + + WK ++ + SA L
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASA--LS 119
Query: 597 YLHTGYAKAVIHRDVKSANILL-DENFMAKVADF-GLSKTGPEIDQTHVSTAVKGSFGYL 654
YL K ++H +V + NILL E + F LS G I V+ ++
Sbjct: 120 YLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-RIPWI 175
Query: 655 DPEYFR-RQQLTEKSDVYSFGVVLFEVLCAR---PVIDPTL 691
PE + L+ +D +SFG L+E+ C P+ D TL
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEI-CYNGEIPLKDKTL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 10/108 (9%)
Query: 579 LSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632
L+ K+ + IC A R + YLH +IHRD+K+ NI ++ + DFG +
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
+I+ G+ PE R D++S G+VLFE+
Sbjct: 230 CFPVDINANKY-YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 485 NFDESWVIGIGGFGKV----YKGELNDGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF 537
+F+ +G G FG+V YK E D VA+KR Q+ + +E ++L+
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 538 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEI---CIGSARG 594
H V+L G +++ + L+ E++ G L +R C +A+
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEF--------FTFLRRNKRFPNDVGCFYAAQI 140
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ + +++RD+K N+LLD++ K+ DFG +K + T T + G+ Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK----VVDTRTYT-LCGTPEYI 195
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE + +D ++ G+ ++E+L P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 29/199 (14%)
Query: 508 GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 565
GT V V+ + +++ L Q E+ + FRH ++++ + + +I +M G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 566 TLKGHLYGSGLPS-LSWKQRLEICIGSARGLHYLH-TGYAKAVIHRDVKSANILLDENFM 623
+ L + P +S I G+ RGL+YLH GY IHR++K+++IL+ + +
Sbjct: 85 SAN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGDGL 139
Query: 624 AKVADFGLS----------KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL---TEKSDV 670
++ GLS K D ST+V +L PE RQ L KSD+
Sbjct: 140 VSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELL-RQDLYGYNVKSDI 193
Query: 671 YSFGVVLFEVLCAR-PVID 688
YS G+ E+ R P D
Sbjct: 194 YSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 25/191 (13%)
Query: 503 GELNDGT---KVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558
E N+ +V +K +P + LA F+T ++SQ H HL + G C +E I++
Sbjct: 36 VEGNNNGRELRVVLKVLDPSHRDIALAFFETA-SLMSQVSHIHLAFVHGVCVRGSENIMV 94
Query: 559 YEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611
E++E+G L KG + ++WK + + SA L YL K ++H +V
Sbjct: 95 EEFVEHGPLDVCLRKEKGRV------PVAWKITVAQQLASA--LSYLED---KNLVHGNV 143
Query: 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK-GSFGYLDPEYFRR-QQLTEKSD 669
+ NILL +A+ + + P + T +S + ++ PE L+ +D
Sbjct: 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAAD 203
Query: 670 VYSFGVVLFEV 680
+SFG L E+
Sbjct: 204 KWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 33/126 (26%), Positives = 51/126 (40%), Gaps = 20/126 (15%)
Query: 579 LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638
L+ ++ +C+ L LH R KS NILL + + K D ++ PE
Sbjct: 14 LNEEEIWAVCLQCLGALRELH---------RQAKSGNILLTWDGLLK-LDGSVAFKTPEQ 63
Query: 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 698
+ F PE + Q TEK+D+YS G+ L+E L RE+ +
Sbjct: 64 SR------PDPYFM--APEVIQGQSYTEKADIYSLGITLYEALDYEL--PYNEERELSAI 113
Query: 699 AEWAMK 704
E +
Sbjct: 114 LEILLN 119
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 46/220 (20%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKR--GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+IG G FG VY+ ++ KVA+K+ +P+ + E+ ++ H +++ L
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINIIFLKD 126
Query: 548 Y----CDEKNE----MILIYEYMENGTLKGHLYGS----GLPSLSWK-QRLEICIGSARG 594
Y C +KNE + ++ E++ K + + LP K ++C R
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC----RA 182
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
L Y+H+ K + HRD+K N+L+D N K+ DFG +K A + S Y
Sbjct: 183 LAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN---------LLAGQRSVSY 230
Query: 654 LDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 686
+ ++R +L T D++S G ++ E++ P+
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270
|
Length = 440 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 53/271 (19%), Positives = 105/271 (38%), Gaps = 59/271 (21%)
Query: 486 FDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 541
F + +GIG FG+V D + +++ + + +A + E ++L++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ-RLEICIGSARGLHYLHT 600
+V L +K+ + + +Y+ G + L G+ + + + +H +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM-- 120
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLS------------KTGPEIDQTH------ 642
IHRD+K NIL+D + K+ DFGL ++G + Q
Sbjct: 121 ----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 643 ---------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 675
++ ++ G+ Y+ PE R T+ D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 676 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706
+L+E+L +P P L + + + WQ
Sbjct: 237 ILYEMLVGQP---PFLAQTPLETQMKVINWQ 264
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 53/248 (21%), Positives = 99/248 (39%), Gaps = 44/248 (17%)
Query: 485 NFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHR 540
+F+ VIG G FG+V + D V +++ + ++ + + E ++L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ-RLEICIGSARGLHYLH 599
+V + +K + LI E++ G + L + Q + + + +H L
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL- 120
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGL---------------------------- 631
IHRD+K N+LLD K++DFGL
Sbjct: 121 -----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 632 --SKTGPEI---DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 686
SK E ++ ++ + G+ Y+ PE F + + D +S GV+++E+L P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 687 IDPTLPRE 694
P+E
Sbjct: 236 FCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 56/264 (21%), Positives = 107/264 (40%), Gaps = 63/264 (23%)
Query: 492 IGIGGFGKV-YKGELNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+GIG FG+V +++ A+K + + ++ +A + E ++L++ + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGL-P---SLSWKQRLEICIGSARGLHYLHTGYA 603
+K+ + + +Y+ G + L + P + + L + I S + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLS------------KTGPEIDQTH--------- 642
IHRD+K NIL+D + K+ DFGL + G I Q
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 643 ------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 678
++ ++ G+ Y+ PE R+ T+ D +S GV+LF
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 679 EVLCAR-PVIDPTLPREMVNLAEW 701
E+L + P + PT + + W
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 55/247 (22%)
Query: 484 NNFDESWVIGIGGFGKV---YKGELND--GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR 538
++F+ VIG G FG+V K + K K +Q +A + E ++L++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 539 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 595
+ +V L Y DE + LI EY+ G + L + + ++ + +
Sbjct: 60 NPWVVKL--YYSFQDENY-LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAI 114
Query: 596 HYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFGLSK--------------------T 634
+H GY IHRD+K N+LLD K++DFGL
Sbjct: 115 DSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 635 GPEIDQTHVSTAVK----------------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 678
+ +S+ K G+ Y+ PE F + ++ D +S GV+++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 679 EVLCARP 685
E+L P
Sbjct: 231 EMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 55/216 (25%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQTEI---------EMLSQFRHR 540
+G G +G V + G KVA+K+ P FQ+EI +L +H
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP--------FQSEIFAKRAYRELTLLKHMQHE 74
Query: 541 HLVSLIGY------CDEKNEMILIYEYMENGTLK--GHLYGSGLPSLSWKQRLEICIGSA 592
+++ L+ DE + L+ YM+ K GH LS + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-------PLSEDKVQYLVYQML 127
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 652
GL Y+H + +IHRD+K N+ ++E+ K+ DFGL++ + + T G
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMT----------G 173
Query: 653 YLDPEYFRRQQL-------TEKSDVYSFGVVLFEVL 681
Y+ ++R ++ + D++S G ++ E+L
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 33/150 (22%), Positives = 58/150 (38%), Gaps = 22/150 (14%)
Query: 539 HRHLVSLIGYCDEKNEMILIYEYMENG----TLKGHLYGSGLPSLSWKQRLEICIGSARG 594
+ + + L +LI +Y+++G LK LS + +I
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE------GKLSEAEVKKIIRQLVEA 121
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKV--ADFGLSKTGPEIDQTHVSTAVKGSFG 652
L+ LH +IH D+K N+L D ++ D+GL K + G+
Sbjct: 122 LNDLH---KHNIIHNDIKLENVLYDR-AKDRIYLCDYGLCKI------IGTPSCYDGTLD 171
Query: 653 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 682
Y PE + D ++ GV+ +E+L
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 25/89 (28%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
G+ +LH+ +IHRD+K +NI++ + K+ DFGL++T + + T + Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC 682
PE E D++S G ++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 58/254 (22%), Positives = 103/254 (40%), Gaps = 69/254 (27%)
Query: 492 IGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
IGIG FG+V D + A+K + + + A + E ++L++ + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLH 599
+K+ + + +Y+ G + L G+ +++ L AR + +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGI----FEEDL------ARFYIAELTCAIESVH 118
Query: 600 -TGYAKAVIHRDVKSANILLDENFMAKVADFGL--------------------------S 632
G+ IHRD+K NIL+D + K+ DFGL S
Sbjct: 119 KMGF----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 633 KTGPEIDQTHVST---------------AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 677
+ EID+ + ++ G+ Y+ PE R T+ D +S GV+L
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234
Query: 678 FEVLCAR-PVIDPT 690
+E+L + P + T
Sbjct: 235 YEMLVGQPPFLADT 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 508 GTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLIGY------CDEKNEMILIY 559
G VAVK+ P Q A+ E+ +L H++++SL+ +E ++ L+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619
E M+ + +S+ +C G+ +LH+ +IHRD+K +NI++
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVK 157
Query: 620 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 679
+ K+ DFGL++T + T + Y PE E D++S G ++ E
Sbjct: 158 SDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 680 VL 681
++
Sbjct: 215 LV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 35/144 (24%), Positives = 61/144 (42%), Gaps = 16/144 (11%)
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIG--SARGLHYL 598
++V L Y ++ + L+ ++ E G L H+ + E C+ +A + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-------SKFLNIPEECVKRWAAEMVVAL 98
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPE 657
+ + ++ RD+ NILLD+ ++ F S+ D V Y PE
Sbjct: 99 DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPE 152
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVL 681
+ TE D +S G +LFE+L
Sbjct: 153 VGGISEETEACDWWSLGAILFELL 176
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 31/154 (20%), Positives = 59/154 (38%), Gaps = 15/154 (9%)
Query: 486 FDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS- 544
+ G G +VY D +K R + A+ + E+ +L + L
Sbjct: 1 SSIKLLKG-GLTNRVYLLGTKDE-DYVLKINPSREKG--ADREREVAILQLLARKGLPVP 56
Query: 545 -LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
++ + L+ E++E G L +S +++ +I A L LH
Sbjct: 57 KVLASGESDGWSYLLMEWIE---------GETLDEVSEEEKEDIAEQLAELLAKLHQLPL 107
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637
+ H D+ NIL+D+ + + D+ + GP
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 25/88 (28%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
G+ +LH+ +IHRD+K +NI++ + K+ DFGL++T + + T + Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
PE E D++S G ++ E++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 32/121 (26%), Positives = 56/121 (46%), Gaps = 15/121 (12%)
Query: 455 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 508
G+ Y+ T N + FP +N +G G FGKV + G+ ++
Sbjct: 16 GNNYTFIDPTQLPYNEKWEFP-------RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNV 68
Query: 509 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 566
+VAVK + E +E+++LS +H+++V+L+G C +++I EY G
Sbjct: 69 LRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 567 L 567
L
Sbjct: 129 L 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 6e-04
Identities = 62/265 (23%), Positives = 98/265 (36%), Gaps = 40/265 (15%)
Query: 448 GGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQ-EATNNFDESW-VIGI---GGFGKVYK 502
G S S SH A ++ P + + + F + VI G FGK++
Sbjct: 107 DGPSGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFI 166
Query: 503 GELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN- 553
L T+ A R G P+ ++ +A+ + +++L G + +N
Sbjct: 167 CALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL-GRLNHENI 225
Query: 554 ---EMILIYE---YMENGTLKGHLYGSGLP-SLSWK------QRLEICIGSARGLHYLHT 600
E IL E YM LY + WK Q I + Y+H
Sbjct: 226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEI--DQTHVSTAVKGSFGYLDP 656
K +IHRD+K NI L+ + + DFG + D V T S P
Sbjct: 286 ---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNS-----P 337
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVL 681
E E +D++S G++L ++L
Sbjct: 338 EILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQT-HVSTAVKGSF 651
G+ +LH + +IHRD+K +NI++ + K+ DFGL++T G T +V T
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 652 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 684
Y PE E D++S G ++ E++
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 828 | |||
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.92 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.43 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 98.42 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.32 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.1 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.04 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.95 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.9 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.81 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.77 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.62 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.56 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.53 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.5 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.37 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.29 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.15 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.15 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.95 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.94 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.92 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.91 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.73 | |
| PLN02236 | 344 | choline kinase | 96.35 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.19 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.13 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.95 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.47 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.47 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.38 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.36 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.02 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.92 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.84 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.47 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.25 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.09 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.02 |
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-64 Score=546.26 Aligned_cols=323 Identities=37% Similarity=0.555 Sum_probs=266.8
Q ss_pred EecCCCccee-c----CCceeeeCCCCceeeecCCcccccccc--CcCCCCCccccceeeeeecCceeEEee--c--CCc
Q 003350 36 IDCGSRTNTT-V----GNRVFVADNSASKFLSTPQNVVANISE--SVTSSNDSQLYQTARIFTGSSKYTFSI--S--GRG 104 (828)
Q Consensus 36 idCG~~~~~~-~----~~~~~~~D~~~s~~~~~~~~~~~~~~~--~~~~~~~~~~~~t~R~f~~~~~~~~~~--~--~~~ 104 (828)
||||++.+++ + +||+|++|.+ |+++|. +++++. ........++|+|||+||.|.|+||++ . +++
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~---~~~~g~--~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~ 75 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDD---FIDTGK--SGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGG 75 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCC---cccCCC--ccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCc
Confidence 8999997765 3 6999999998 999885 456532 223456789999999999999999998 3 356
Q ss_pred eEEEEEEeeccCCCCcC----CccceEEE--EeCcEEEEeecCCC-CcEEEEEEEecC-CCcEEEEEecCCCCc-ceeee
Q 003350 105 RHWIRLYFYPFVYQSYN----MSRASFSV--STNDHVLLNNFSVS-SNVFKEFSVNVT-SDSLDVIFSPSNNSF-AFINA 175 (828)
Q Consensus 105 ~ylvR~~f~~~~~~~~~----~~~~~f~~--~~~~~~~~~~~~~~-~~~~~E~~~~~~-~~~~~vc~~~~~~~~-pfi~~ 175 (828)
|||||+||+|||||+++ .+.+.||| ++|.|.+|+..+.. .++++|+++.+. +++++|||+|+++|+ ||||+
T Consensus 76 ~yliRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsa 155 (347)
T PF12819_consen 76 KYLIRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISA 155 (347)
T ss_pred eEEEEEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeE
Confidence 99999999999999884 23478998 88889999988721 579999888887 799999999999887 99999
Q ss_pred eeeEEeCCcccccCCCccCCCCccCCccceeEEEEEEeecCCCC--cCCCCCccccccCCCCcceecccCCcccccCCcc
Q 003350 176 LEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPL--VTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAV 253 (828)
Q Consensus 176 iE~~~~~~~~y~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~--~~~~~D~~~R~W~~~~~~~~~~~~~~~~~~~~~i 253 (828)
|||||||+++|++.. ...+.+|++++|+||||.. +|||+|+|||+|.|+.. ...|.++++..++
T Consensus 156 iEl~~lp~~ly~~~~----------~~~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~~~~----~~~~~~ist~~~i 221 (347)
T PF12819_consen 156 IELRPLPDSLYPDTD----------ANSSQALETVYRLNVGGSSSFIRYPDDTYDRIWQPYSS----SPGWSNISTTSNI 221 (347)
T ss_pred EEEEECCccceeccc----------cCCCceeEEEEeecCCCcccccCCCCCcceeecccccc----Cccccccccceee
Confidence 999999999996421 1256899999999999988 99999999999997632 4667777776655
Q ss_pred eeccCCCCccCCchhhHhhccccccCCCCCCcceEEEEeecCCCCceEEEEEeceeeec--CCCceEEEEEEcccccccc
Q 003350 254 KYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSD--GLNQLYFNVYIDSWIAVRD 331 (828)
Q Consensus 254 ~~~~~~~~~~~~P~~V~~tA~~~~~~~~~~~~l~ltw~~~~~~~~~ylv~LhFaei~~~--~~~~R~F~I~in~~~~~~~ 331 (828)
+ ....++.+.+|.+||+||+++.... .+++++|.+ ++++..|+|+||||||+.. ..++|+|||||||+.+.++
T Consensus 222 ~-~~~~~~~~~~P~~V~~TA~~~~~~s---~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~ 296 (347)
T PF12819_consen 222 N-INSSNNPYDAPSAVYQTARTPSNSS---DPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSD 296 (347)
T ss_pred e-cccCCccCcChHHHHHhhhcccccc---cceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCc
Confidence 5 2345678999999999999998543 359999999 8889999999999999863 4557999999999999875
Q ss_pred cCccccccCcccceEEEeeeEeecCCCcEEEEeccCCCCCCCCCcccccceeeec
Q 003350 332 LDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKM 386 (828)
Q Consensus 332 ~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~i~l~~~~~s~~~p~~ilng~ei~~~ 386 (828)
+++..+ +....+++.++++.++..+.++|+|+++..+.++| ||||+|||++
T Consensus 297 ~~~~~~--~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~lpp--iLNalEIy~v 347 (347)
T PF12819_consen 297 VSPPYL--GADTVPYYSDYVVNVPDSGFLNISLGPTPDSTLPP--ILNALEIYKV 347 (347)
T ss_pred cCcccc--cCcceEeecceEEEecCCCEEEEEEEeCCCCCcCc--eeEeeeeEeC
Confidence 555443 33467889999988887778899999999998877 9999999985
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-58 Score=500.81 Aligned_cols=290 Identities=51% Similarity=0.842 Sum_probs=260.5
Q ss_pred CCcccCHHHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEE
Q 003350 470 SGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549 (828)
Q Consensus 470 ~~~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (828)
....|++.+++.||++|...++||+|+||.||+|.+++|+.||||++.....+..++|.+|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34679999999999999999999999999999999999999999988876543246699999999999999999999999
Q ss_pred ccCC-cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEe
Q 003350 550 DEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 628 (828)
Q Consensus 550 ~~~~-~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~D 628 (828)
.+.+ +++||||||++|+|.++|+.....+|+|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999886543899999999999999999999999988999999999999999999999999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
||+|+..+.. ..+..+...||.+|+|||++..+..++|+|||||||+|+||+||+++.+...+....+++.|++....+
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999876531 222222228999999999999999999999999999999999999999877666777799999999999
Q ss_pred CCcccccCcccc-CCCCh-hHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 709 GQLDQIIDPTLA-GKIRP-DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 709 ~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
+.+.+++|+++. +.+.. +++.++.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999987 56654 68899999999999999999999999999996544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-57 Score=528.36 Aligned_cols=328 Identities=20% Similarity=0.270 Sum_probs=261.4
Q ss_pred CcCCCccEEEecCCCcce-e-cCCceeeeCCCCceeeecCCccccccccCcCCCCCccccceeeeeec--CceeEEee--
Q 003350 27 QFDPADNYLIDCGSRTNT-T-VGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTG--SSKYTFSI-- 100 (828)
Q Consensus 27 ~~~~~~~~~idCG~~~~~-~-~~~~~~~~D~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~--~~~~~~~~-- 100 (828)
+..+.++|+||||++.+. + .+||+|++|.. |. ++...... .+ ....++|+|||+||. |.+|||++
T Consensus 19 ~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~---~~--~~~~~~~~---~~-~~~~~~~~t~R~F~~~~g~~~cY~~~~ 89 (623)
T PLN03150 19 ASPEPFTMRISCGARVNVRTAPTNTLWYKDFA---YT--GGIPANAT---RP-SFIAPPLKTLRYFPLSDGPENCYNINR 89 (623)
T ss_pred ccCCCccEEEeCCCCCCcccCCCCCEEcCCcc---cc--cCcccccc---Cc-ccccchhhccccCCcccccccceEeee
Confidence 334779999999999876 4 48999999955 53 22222111 11 245678999999995 56889988
Q ss_pred cCCceEEEEEEeeccCCCCcCCccceEEEEeCc--EEEEee-c-CCCCcEEEEEEEecCCCcEEEEEecCCCCcceeeee
Q 003350 101 SGRGRHWIRLYFYPFVYQSYNMSRASFSVSTND--HVLLNN-F-SVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINAL 176 (828)
Q Consensus 101 ~~~~~ylvR~~f~~~~~~~~~~~~~~f~~~~~~--~~~~~~-~-~~~~~~~~E~~~~~~~~~~~vc~~~~~~~~pfi~~i 176 (828)
+++||||||+||+|||||+++.+ |.|||.+++ |.+|.. + .+...+++|+|+++++++++|||+|+++|+||||+|
T Consensus 90 ~~~g~ylVRl~F~~~~y~~~~~~-~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~i 168 (623)
T PLN03150 90 VPKGHYSVRVFFGLVAEPNFDSE-PLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSI 168 (623)
T ss_pred cCCCcEEEEEEeecCCcCCCCCC-CceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEE
Confidence 67899999999999999999955 999996655 888874 2 234678999999999999999999999999999999
Q ss_pred eeEEeCCcccccCCCccCCCCccCCccceeEEEEEEeecCCCC----cCCCCCcc--ccccCCCCcceecccCCcccccC
Q 003350 177 EVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPL----VTPENDTL--WRTWVPDQSFLVNRNLAKSVSNI 250 (828)
Q Consensus 177 E~~~~~~~~y~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~----~~~~~D~~--~R~W~~~~~~~~~~~~~~~~~~~ 250 (828)
|||+||+++|.... ..+ .+.+|+++||+||||++ +|||||+| ||+|.+|+.|+ ...+.++++.
T Consensus 169 Ev~~l~~~~y~~~~-~~~--------~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~--~~~~~~~st~ 237 (623)
T PLN03150 169 EILQVDDKAYNFGP-SWG--------QGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFG--SGSDQAISTE 237 (623)
T ss_pred EEEEcCcccccccc-ccc--------CceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccC--CCcccccccc
Confidence 99999999995321 000 25689999999999864 69999999 99999999876 3335566666
Q ss_pred CcceeccCCCCccCCchhhHhhccccccCCCCCCcceEEEEeecCCCCceEEEEEeceeee--cCCCceEEEEEEccccc
Q 003350 251 PAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVS--DGLNQLYFNVYIDSWIA 328 (828)
Q Consensus 251 ~~i~~~~~~~~~~~~P~~V~~tA~~~~~~~~~~~~l~ltw~~~~~~~~~ylv~LhFaei~~--~~~~~R~F~I~in~~~~ 328 (828)
..+++. +++.+.+|+.|||||+++... ..+++|.++++++..|+|+|||||++. ...++|+||||+||+.+
T Consensus 238 ~~I~~~--~~~~~~~P~~VyqTA~~~~~~-----~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~ 310 (623)
T PLN03150 238 NVIKKA--SNAPNFYPESLYQSALVSTDT-----QPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTA 310 (623)
T ss_pred cccccc--cCCCccChHHHhhhhccccCC-----CCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEe
Confidence 555543 346788999999999987642 257899999998999999999999973 35578999999999999
Q ss_pred ccccCccccccCcccceEEEeeeEeecCCCcEEEEeccCCCCCCCCCcccccceeeeccc
Q 003350 329 VRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKN 388 (828)
Q Consensus 329 ~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~i~l~~~~~s~~~p~~ilng~ei~~~~~ 388 (828)
.+++|+..+ .+....+++.++.+.... +.++|+++|...+ + |||||+|||++..
T Consensus 311 ~~~~di~~~-~g~~~~~~~~~~~v~~~~-g~l~isl~p~~~s--~--pilNaiEI~~~~~ 364 (623)
T PLN03150 311 FKDVDIVKM-SGERYTALVLNKTVAVSG-RTLTIVLQPKKGT--H--AIINAIEVFEIIT 364 (623)
T ss_pred ecccChhhh-cCCcccceEEEeEEeecC-CeEEEEEeeCCCC--c--ceeeeeeeeeccc
Confidence 999999887 455567889888876654 7899999987533 3 4999999999976
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=400.00 Aligned_cols=255 Identities=34% Similarity=0.515 Sum_probs=214.0
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCccc--HHHHHHHHHHHHcCCCCceEEEEEEEccCC-cEEEEEEeccCCc
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-EMILIYEYMENGT 566 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~ey~~~gs 566 (828)
+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 5699999999999999854459999988754322 569999999999999999999999998887 8999999999999
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC-EEeeeeecCcEEeCCCC-cEEEEeeCCCCCCCCCCcccee
Q 003350 567 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA-VIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 567 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDIkp~NILld~~~-~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|.++++......+++..+++|+.+||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus 127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~ 201 (362)
T KOG0192|consen 127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSM 201 (362)
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccc
Confidence 9999988545689999999999999999999999 66 99999999999999997 99999999998754311 233
Q ss_pred ccccccccccChhhhc--cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 645 TAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~--~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
+...||+.|||||++. ...++.|+||||||++||||+||+.||....+.+. +..+ .. ...+..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---~~~v---~~---------~~~Rp~ 266 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---ASAV---VV---------GGLRPP 266 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---HHHH---Hh---------cCCCCC
Confidence 4478999999999999 66999999999999999999999999987655221 1111 11 112223
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
++..+...+..++.+||+.+|..||++.+++..|+.+.....
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 334467788999999999999999999999999998876554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=381.40 Aligned_cols=263 Identities=30% Similarity=0.452 Sum_probs=222.2
Q ss_pred CcccCHHHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEc
Q 003350 471 GYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550 (828)
Q Consensus 471 ~~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 550 (828)
...++.+++... +.||+|.||.||.|.++....||+|.++.... ..++|.+|+++|++|+|+|||+++|+|.
T Consensus 200 ~wei~r~~l~l~-------~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 200 PWEIPREELKLI-------RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred CeeecHHHHHHH-------HHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 356666666654 56999999999999999878999999887643 3578999999999999999999999999
Q ss_pred cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 551 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
.++.++||||||++|+|.++|.......+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccc
Confidence 98899999999999999999987666789999999999999999999999 999999999999999999999999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKG 709 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (828)
|||...+ +.........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+....++ +|
T Consensus 349 LAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-------~G 420 (468)
T KOG0197|consen 349 LARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-------RG 420 (468)
T ss_pred cccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-------cc
Confidence 9995443 33334445556788999999999999999999999999999998 788887665544333222 11
Q ss_pred CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 710 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.+-..+..|+..+.+++..|++.+|++|||.+.+.+.|+.+..
T Consensus 421 ---------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 ---------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1112345678889999999999999999999988888877543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=366.42 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=210.9
Q ss_pred ccCHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEc
Q 003350 473 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550 (828)
Q Consensus 473 ~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 550 (828)
..++.+++.. +.||+|..|+|||+.++ +++.+|+|.+... .....+++.+|++++++.+||+||.++|.|.
T Consensus 75 ~i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 4555566553 57999999999999887 5788999988544 3455788999999999999999999999999
Q ss_pred cCC-cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 551 EKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 551 ~~~-~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
... +..++||||++|+|++++... +.+++...-+|+.++++||.|||+. ++||||||||+|||++..|++|||||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence 888 599999999999999999665 3689999999999999999999963 89999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 709 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (828)
|.++.+-.. ......||..|||||.+++..|+.++||||||+.++|+.+|+-|+....+. ..+..+..
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll------- 291 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELL------- 291 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHH-------
Confidence 999875432 456789999999999999999999999999999999999999999764111 11111111
Q ss_pred CcccccCccccCCCCh-hHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 710 QLDQIIDPTLAGKIRP-DSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 710 ~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+++..- ...+. .+..++..++..||+++|.+||++.|++++
T Consensus 292 --~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 292 --CAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --HHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222110 11222 367789999999999999999999999853
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=397.59 Aligned_cols=259 Identities=29% Similarity=0.457 Sum_probs=221.0
Q ss_pred CCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
+....+.||+|.||+||+|+.. +.+.||||.++..... ..++|++|+++|..++|||||+|+|+|.+++.++|
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3344467999999999999753 3467999999987655 78999999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCC------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEE
Q 003350 558 IYEYMENGTLKGHLYGSG------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAK 625 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~k 625 (828)
|+|||..|+|.+||.... ..+|+..+.+.||.|||.||+||-+ +.+|||||..+|+|+.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEE
Confidence 999999999999996311 2349999999999999999999999 9999999999999999999999
Q ss_pred EEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHH
Q 003350 626 VADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 704 (828)
|+||||+|..-..+..+......-+.+||+||.++.+++|.+||||||||+|||+++ |+.|+.+....+.+..
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~------ 717 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC------ 717 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH------
Confidence 999999998665555554444456789999999999999999999999999999997 8899887666554332
Q ss_pred HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 705 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
.+.+++. ..++.++.++.+++..||+.+|.+||+++||-..|+...+.
T Consensus 718 -i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 718 -IRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -HHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 3333331 34577889999999999999999999999999999876644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=364.81 Aligned_cols=206 Identities=30% Similarity=0.527 Sum_probs=184.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.+|...+.||+|.||+||+|+++ ++..||||.+... ..+..+.+..|+++|+.++|||||.|++++..++.++||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 45667778999999999999876 5789999988766 45566778899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC------CcEEEEeeCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN------FMAKVADFGLSKT 634 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~------~~~kl~DFGla~~ 634 (828)
||.+|+|.+|++..+ .+++.....++.|+|.||++||+ ++||||||||.||||+.. -.+||+|||+||.
T Consensus 90 yC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999997765 69999999999999999999999 999999999999999765 5689999999998
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 697 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~ 697 (828)
+.. .......+|++-|||||+++.++|+.|+|+||.|++|||+++|++||+...+.+...
T Consensus 165 L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 165 LQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred CCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 753 445567899999999999999999999999999999999999999999777666543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=377.73 Aligned_cols=248 Identities=24% Similarity=0.417 Sum_probs=212.3
Q ss_pred cCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..|...++||+|||+.||.++. ..|+.||+|++... .....+...+||++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999987 78999999987663 3344677889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
|+|++++|..++. ..+++++.+++.+..||+.||.|||+ .+|+|||||..|+||++++++||+|||||..+...+
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999886 44689999999999999999999999 999999999999999999999999999998865422
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
....+.+||+.|+|||++.....+..+||||+||+||-||+|+|||+...-.+..+-++. .+.
T Consensus 173 --Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~----------~~Y----- 235 (592)
T KOG0575|consen 173 --ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL----------NEY----- 235 (592)
T ss_pred --cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh----------cCc-----
Confidence 234578999999999999999999999999999999999999999987654443322220 111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+........+++.++|+.+|.+||++++|+..
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222345567889999999999999999999853
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=377.04 Aligned_cols=275 Identities=26% Similarity=0.393 Sum_probs=228.5
Q ss_pred cCHHHHHHHhcCC-----CccceEeeeCcEEEEEEEecC----CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceE
Q 003350 474 FPFVAVQEATNNF-----DESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLV 543 (828)
Q Consensus 474 ~~~~~l~~at~~f-----~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv 543 (828)
-|...+++.+... .++++||.|.||.||+|+++- ...||||.++... ++...+|+.|+.+|.++.||||+
T Consensus 614 DPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNII 693 (996)
T KOG0196|consen 614 DPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 693 (996)
T ss_pred CccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEE
Confidence 3444444444433 466899999999999998862 3579999998864 45578899999999999999999
Q ss_pred EEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc
Q 003350 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 623 (828)
Q Consensus 544 ~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 623 (828)
+|.|+.......++|.|||+||+|+.||+.+. ..+++.+..-++++||.||.||.+ .++|||||.++|||++.+..
T Consensus 694 rLEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLv 769 (996)
T KOG0196|consen 694 RLEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLV 769 (996)
T ss_pred EEEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceE
Confidence 99999999999999999999999999998876 459999999999999999999999 99999999999999999999
Q ss_pred EEEEeeCCCCCCCCCCccceecc--ccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHH
Q 003350 624 AKVADFGLSKTGPEIDQTHVSTA--VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAE 700 (828)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~--~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~ 700 (828)
+|++||||+|.+.+ +.....+. ..=+.+|.|||.+..+++|.++||||||+||||.++ |.+|+-.....+.++-+
T Consensus 770 CKVsDFGLSRvled-d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI- 847 (996)
T KOG0196|consen 770 CKVSDFGLSRVLED-DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI- 847 (996)
T ss_pred EEeccccceeeccc-CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-
Confidence 99999999997644 22222222 233578999999999999999999999999999986 88888655544433222
Q ss_pred HHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhhhcC
Q 003350 701 WAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 769 (828)
Q Consensus 701 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~~~~ 769 (828)
+...+-..+.+++..|.++++.||+++-.+||.+.+|+..|.++++....++..
T Consensus 848 ---------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~ 901 (996)
T KOG0196|consen 848 ---------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTI 901 (996)
T ss_pred ---------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhccc
Confidence 222333456789999999999999999999999999999999999887777543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.55 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=202.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcc-------cHHHHHHHHHHHHcCCCCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQ-------GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (828)
.+.|...+.||+|+||.|-+|.. ++|+.||||+++..... .....++|+++|++|+|||||++.++++..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34566778999999999999965 47999999987754211 12234699999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC---CcEEEEeeCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN---FMAKVADFGL 631 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kl~DFGl 631 (828)
.|||+|||++|.|.+++..++ .+.+..-..++.|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999997665 57777788999999999999999 999999999999999765 8899999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCC---CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
|+... ......+.+||+.|.|||++.+.. +..|.|+||+||+||-++||.+||....... .+.+ ....
T Consensus 326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----QI~~ 396 (475)
T KOG0615|consen 326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----QILK 396 (475)
T ss_pred hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----HHhc
Confidence 99864 344567889999999999998653 3348899999999999999999997543221 1111 0111
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+... +-| ..-.+..++..+++.++|..+|++||++.|+++.
T Consensus 397 G~y~--f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYA--FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Cccc--ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1110 001 1113456678899999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=341.35 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=207.3
Q ss_pred CCCccceEeeeCcEEEEEEE-ecCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEE-EEccCCc-EEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG-YCDEKNE-MILIY 559 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~ 559 (828)
+|.+.++||+|.||.|||+. +.+|..+|.|.+.-. +.+..+.+..|+.+|++|+|||||+.++ -+.+.++ +.+||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45556789999999999995 568999999987633 4455778899999999999999999998 4555556 89999
Q ss_pred EeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCC-CEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 560 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 560 ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
|||..|+|...+.. ...+.++++.++++..|+++||..+|..... -|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999998853 4456799999999999999999999985433 48999999999999999999999999999875
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
. ........+||+.||+||.++...|+.||||||+||++|||+.-++||.+. ++.+....+ ..+...
T Consensus 180 s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI-~qgd~~---- 246 (375)
T KOG0591|consen 180 S--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKI-EQGDYP---- 246 (375)
T ss_pred c--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHH-HcCCCC----
Confidence 4 333456789999999999999999999999999999999999999999865 222222221 111111
Q ss_pred ccccCCCC-hhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 717 PTLAGKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 717 ~~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.++ .-.+.++.+++..|+..+|..||+...+++.+..
T Consensus 247 -----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 -----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 122 3456788999999999999999997666555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.10 Aligned_cols=242 Identities=27% Similarity=0.368 Sum_probs=202.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|+..++||+|+||+||.++.+ .++.+|+|.++... ....+...+|..+|.+++||.||+++..|.+...++||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457888899999999999999765 58899999877653 34467788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
+||+.||.|..+|.+++ .+++....-++.+|+.||.|||+ ++||||||||+|||||++|+++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 99999999999997665 68888899999999999999999 9999999999999999999999999999996432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
....+...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||......+. ........
T Consensus 178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I~~~k--------- 241 (357)
T KOG0598|consen 178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKILKGK--------- 241 (357)
T ss_pred -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHHhcCc---------
Confidence 22345568999999999999999999999999999999999999999986543322 22211111
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCC
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRP 747 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 747 (828)
+ ...+.-...+..+++.+.|+.+|++|-
T Consensus 242 ~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 L-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred C-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0 011122455678889999999999995
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=361.18 Aligned_cols=259 Identities=29% Similarity=0.485 Sum_probs=210.9
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+.+...+.||+|.||+||+|++.. .||||+++.. ..+..+.|++|+.++++-+|.||+-++|||..... .+|..+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 334445789999999999999973 6999988765 44568899999999999999999999999988777 999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
|++.+|..+||..+ .+++..+.+.||+|||+||.|||. ++|||||||+.||+|.++++|||+||||+..-......
T Consensus 469 CeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred ccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999999998766 569999999999999999999999 99999999999999999999999999999653332233
Q ss_pred ceeccccccccccChhhhcc---CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 642 HVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.......|...|||||+++. ..+++.+||||||+|+|||+||..||.....+... | ++..|. +-++
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi----f---mVGrG~----l~pd 613 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII----F---MVGRGY----LMPD 613 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE----E---Eecccc----cCcc
Confidence 33344568889999999974 37899999999999999999999999733222211 0 011111 1111
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
+. ....++.+++.+++..|+..++++||...+|+..|+.++.
T Consensus 614 ~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 614 LS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 2345678889999999999999999999999998888765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.99 Aligned_cols=261 Identities=24% Similarity=0.384 Sum_probs=205.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEe------cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccC-C
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK-N 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 553 (828)
.++|...++||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++..+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45678889999999999999964 234679999987543 23356789999999999 899999999988654 4
Q ss_pred cEEEEEEeccCCcccccccCCC----------------------------------------------------------
Q 003350 554 EMILIYEYMENGTLKGHLYGSG---------------------------------------------------------- 575 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~---------------------------------------------------------- 575 (828)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6889999999999998886421
Q ss_pred --CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccc
Q 003350 576 --LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653 (828)
Q Consensus 576 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y 653 (828)
..++++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1358889999999999999999999 99999999999999999999999999999864332221122334567889
Q ss_pred cChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHH
Q 003350 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFG 732 (828)
Q Consensus 654 ~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 732 (828)
+|||++.+..++.++|||||||+||||++ |+.||......+. . ... ...+.. . ..+......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~---~~~-~~~~~~-----~----~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F---CQR-LKDGTR-----M----RAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H---HHH-HhcCCC-----C----CCCCCCCHHHH
Confidence 99999999999999999999999999997 9999975432211 0 111 111110 1 11223355688
Q ss_pred HHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 733 ETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 733 ~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
+++.+|++.+|.+||++.|+++.|+.+++
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=346.19 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=204.9
Q ss_pred CCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC--cEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN--EMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ey 561 (828)
++...+.||+|.||.||++...+ |...|||..........+.+.+|+.+|.+++|||||+.+|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 45556899999999999998764 8899999876654333677899999999999999999999854444 69999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-CCcEEEEeeCCCCCCCC-CC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPE-ID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kl~DFGla~~~~~-~~ 639 (828)
+++|+|.+++.+.+. .|++..+..++.||++||+|||+ +++|||||||+||||+. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999988766 79999999999999999999999 99999999999999999 79999999999987543 11
Q ss_pred ccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.........||+.|||||++..+ ....++|||||||++.||+||++||... . ....+........
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~---~~~~~~~~ig~~~--------- 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--F---EEAEALLLIGRED--------- 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--c---chHHHHHHHhccC---------
Confidence 22223457899999999999854 3345999999999999999999999753 1 1111111111111
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
....++...+.+..+++.+|++.+|.+|||+.+++....
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111344556677889999999999999999999986543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=397.70 Aligned_cols=262 Identities=31% Similarity=0.471 Sum_probs=218.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
...+...++||+|+||.||+|+. .++..||||++...... ...|++.+++++||||++++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 44577788999999999999987 46899999998754332 23568899999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|+|.++++ .++|.++.+|+.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||.......
T Consensus 765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999984 38999999999999999999997666899999999999999999988876 766543221
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.....+|..|+|||++.+..++.|+|||||||++|||+||+.|++.... ....+.+|+...........++|+.+..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 1223678999999999999999999999999999999999999964332 2345677877665555566677777644
Q ss_pred C--CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 722 K--IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 722 ~--~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
. ...++..++.+++.+|++.+|++||+|.||++.|+++.+
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3 345667788999999999999999999999999988654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=328.83 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=207.4
Q ss_pred CCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.|+...++|+|+||.|||++.++ |+.||||++..... .-.+-.++|+++|++++|+|+|.|+.+|..+..++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 45555689999999999998874 89999999876543 3345568999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
|+.--|.+ |.... ..++...+.+++.|+++|+.|+|+ +++|||||||+|||++.++.+||||||.||.+.. ..
T Consensus 83 ~dhTvL~e-Le~~p-~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pg 155 (396)
T KOG0593|consen 83 CDHTVLHE-LERYP-NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PG 155 (396)
T ss_pred cchHHHHH-HHhcc-CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC--Cc
Confidence 98744443 33322 358899999999999999999999 9999999999999999999999999999998764 33
Q ss_pred ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH--------HHhhcC-Cc
Q 003350 642 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------KWQNKG-QL 711 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~-~~ 711 (828)
...+..+.|..|.|||.+-+ .+|....||||.||++.||++|.+.|.+..+-+...++.... .+.... ..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 34567889999999999987 689999999999999999999999998877655544433221 111111 11
Q ss_pred ccccCccc-----cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTL-----AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+.=|.. .+.--+....-+.+++..||+.||++|++-+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111 11111234456789999999999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.22 Aligned_cols=261 Identities=29% Similarity=0.429 Sum_probs=217.8
Q ss_pred CCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCccc-HHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 486 FDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
....++||+|.||.|..+....+.+||||.++...... .++|.+|+++|.+++||||+.|+|+|..++.+++|+|||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 34557899999999999999888999999999876554 58999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+|+..+..+.+.-....+||.|||.||+||.+ ..+|||||.++|+|+|.++++||+|||++|.+-..+..+..
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 999999988766666778888999999999999999 99999999999999999999999999999976555555555
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHH--hcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ell--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
...+-+.+|||+|.+.-+++|.++|||+||++|||++ |...|+.....++...-. ..+.+.+.. ...-.
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~---~~~~~~~~~------~~~l~ 767 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA---GEFFRDQGR------QVVLS 767 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh---hhhcCCCCc------ceecc
Confidence 5666788999999999999999999999999999985 677888765544432211 111111111 11112
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
-+.-++..+.+++++|+..+-.+||+.+++...|.+
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 234567888999999999999999999999877764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=377.74 Aligned_cols=262 Identities=31% Similarity=0.465 Sum_probs=218.2
Q ss_pred CCCccceEeeeCcEEEEEEEecC--Cc----EEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELND--GT----KVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
+....+.||+|.||.||+|...+ +. .||||.+... +.+...+|.+|..+|+.++|||||+++|+|......++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34455789999999999997653 32 5899988765 55678899999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCC-----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 558 IYEYMENGTLKGHLYGSG-----LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
++|||++|+|..||++.+ ...|+....+.++.|||+|+.||++ +++|||||.++|+||++...+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998752 3569999999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
+.....+.........-...|||||.++.+.++.|+|||||||+|||++| |..||......+... .+.+.++
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~ggR- 922 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGGR- 922 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCCc-
Confidence 96544344333333345678999999999999999999999999999998 678887665444322 1222222
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhh
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 765 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~ 765 (828)
| +.+..++.++.+++..||+.+|++||++..+++.+..+.+....
T Consensus 923 -------L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 923 -------L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred -------c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 1 23467788899999999999999999999999988887766543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=356.03 Aligned_cols=257 Identities=29% Similarity=0.456 Sum_probs=211.0
Q ss_pred CccceEeeeCcEEEEEEEecC--C---cEEEEEEcCC---CCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 487 DESWVIGIGGFGKVYKGELND--G---TKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
...++||+|.||.||+|++.. + ..||||..+. .......+|.+|+++|++++|||||+++|++.....+++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 334799999999999997753 2 2389998775 3456688999999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
||+|.||+|.++|...+. .++..+++.++.++|+||+|||+ +++|||||.++|+|++.+..+||+||||++....
T Consensus 240 mEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~- 314 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ- 314 (474)
T ss_pred EEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc-
Confidence 999999999999987653 69999999999999999999999 9999999999999999999999999999987541
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.........-+..|+|||.+..+.++.++|||||||++||+++ |..|+.+....+... ++ ...+
T Consensus 315 -~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~---kI---~~~~-------- 379 (474)
T KOG0194|consen 315 -YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA---KI---VKNG-------- 379 (474)
T ss_pred -eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH---HH---HhcC--------
Confidence 1111112245678999999999999999999999999999998 788998765543221 11 0111
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
..-..+...+..+..+..+|+..+|++||+|.++.+.|+.+.+..+
T Consensus 380 -~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 -YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1112233456677888889999999999999999999998776654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.00 Aligned_cols=250 Identities=28% Similarity=0.464 Sum_probs=212.1
Q ss_pred cccCHHHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc
Q 003350 472 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551 (828)
Q Consensus 472 ~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (828)
+.++++++.+. +-||.|+.|.||+|+++ ++.||||+.+... ..+|+-|++|+|+||+.+.|+|..
T Consensus 119 WeiPFe~IsEL-------eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEISEL-------EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhhhh-------hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence 66777777654 57999999999999998 6889999875432 367888999999999999999999
Q ss_pred CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
..-+|+|||||..|.|...|...+ +++......+..+||.||+|||. +.|||||||+-||||..+..+||+|||.
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred CceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccc
Confidence 999999999999999999996654 78889999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
++..... .....+.||..|||||+++....++|.|||||||||||||||..|+......- .+
T Consensus 259 S~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------II 320 (904)
T KOG4721|consen 259 SKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------II 320 (904)
T ss_pred hHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eE
Confidence 9876542 22346789999999999999999999999999999999999999996432111 11
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
..+-...|.-..+..++.-+.-+++.||+..|.+||++++++..|+-+
T Consensus 321 wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 321 WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 111223344456678888899999999999999999999999888654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.41 Aligned_cols=247 Identities=22% Similarity=0.341 Sum_probs=201.8
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCccc---HHHHHHHHHHHHcCCCCceEEEEEEEcc----CCcEEEEEEec
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQG---LAEFQTEIEMLSQFRHRHLVSLIGYCDE----KNEMILIYEYM 562 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ey~ 562 (828)
..||+|++|.||+|.+ +|+.||||++....... .+.|.+|+++|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999988 48899999987654333 5678899999999999999999999866 45789999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.+++... ..++|...++++.+++.||+|||+. .+++||||||+|||+++++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---- 176 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---- 176 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence 999999999654 3689999999999999999999972 37889999999999999999999999999864321
Q ss_pred eeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 643 VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+... .....+. .+
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~------~i~~~~~-----~~--- 241 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD------LIINKNN-----SL--- 241 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhcCC-----CC---
Confidence 123457899999999976 689999999999999999999999998654332211 1111110 01
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
..+...+..+.+++.+||+.+|.+||++.|+++.|+...+
T Consensus 242 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 242 -KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1222446678899999999999999999999999987653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=341.17 Aligned_cols=264 Identities=26% Similarity=0.344 Sum_probs=206.9
Q ss_pred cCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 558 (828)
+.|+..++||+|.||.||||+. .+|+.||+|++.... .....-..+||.+|++|.||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3455567899999999999965 579999999876554 44456667999999999999999999998766 789999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
+|||+. +|..++.... -.++..++..++.|++.||+|||. .+|+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~- 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP- 270 (560)
T ss_pred Eecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC-
Confidence 999987 8888876543 469999999999999999999999 9999999999999999999999999999997655
Q ss_pred CccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC-----Ccc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG-----QLD 712 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----~~~ 712 (828)
......+..+-|..|.|||.+.+. .|+.+.|+||.||||.||+.|++.+.+..+.+....+-....-..+. .+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 233335667789999999999874 89999999999999999999999998877655443332111101111 110
Q ss_pred --cccCc------cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 --QIIDP------TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 --~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+.+ .+.+. -.......++++..+|..+|.+|.|+.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 11111 1123455778899999999999999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=348.30 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=211.8
Q ss_pred CCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 485 NFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
.|..-.+||+|..|.||.+.. ..++.||||++....+...+-+.+|+.+|+..+|+|||.++..+..+++++.|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 556667899999999999954 4688999999988877777778999999999999999999999988899999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+.+.... +++.++..|++++++||+|||. ++|+|||||.+||||+.++.+||+|||++..+..... .
T Consensus 354 ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K 425 (550)
T KOG0578|consen 354 GGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K 425 (550)
T ss_pred CCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence 999999986554 9999999999999999999999 9999999999999999999999999999987654222 3
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
.....||+.|||||++....|.+|.||||||++++||+-|.+||-...+-....++. . .-.|.+. .
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~-----ng~P~lk--~ 491 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------T-----NGTPKLK--N 491 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------h-----cCCCCcC--C
Confidence 457789999999999999999999999999999999999999996544433222211 1 1112222 2
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
++.....+.++..+||+.|+.+||++.|+++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 3455677999999999999999999999986
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=341.86 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=204.2
Q ss_pred cCCCccceEeeeCcEEEEEEEecC-----------------CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND-----------------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSL 545 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 545 (828)
++|...++||+|+||.||++.+++ +..||+|.+.... .....+|.+|+++|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 457777899999999999997532 3469999887643 3345679999999999999999999
Q ss_pred EEEEccCCcEEEEEEeccCCcccccccCCC-----------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEe
Q 003350 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSG-----------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608 (828)
Q Consensus 546 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 608 (828)
++++...+..++||||+++|+|.+++.... ...++|.++++++.|++.||+|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999999885321 1357899999999999999999999 89999
Q ss_pred eeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh--cCCC
Q 003350 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPV 686 (828)
Q Consensus 609 rDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt--G~~p 686 (828)
|||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543222222334456789999999998899999999999999999987 4567
Q ss_pred CCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 687 IDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 687 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
+......+. ..+.......... .. ....++.++..+.+++.+|++.+|.+||++.||.+.|+
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQV---IENAGEFFRDQGR-QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHH---HHHHHHHhhhccc-cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 765433222 2222221111100 00 00112344567899999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.49 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=210.8
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
....++|...+.||+|+|++|++|+.. .++.+|||++... .+...+-...|-+.|.+| .||.|++|+..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344567888899999999999999765 5889999987654 223345567899999999 89999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+|+|+||+++|+|.++|...+ .++......++.+|+.||+|||+ .|||||||||+|||||+|+++||+|||-|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999997765 79999999999999999999999 9999999999999999999999999999997
Q ss_pred CCCCCcc---------ce--eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH
Q 003350 635 GPEIDQT---------HV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 635 ~~~~~~~---------~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (828)
+...... .. ....+||..|.+||++.....+..+|+|+|||+||+|+.|++||....+.-...
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq------ 297 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ------ 297 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH------
Confidence 6542222 11 145789999999999999999999999999999999999999998765432211
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
++++ +.-.+++..+..+.+|+.+.|..+|.+|++..++.+.
T Consensus 298 ---------kI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 ---------KIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------HHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 0111 1123445556778899999999999999999888763
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=353.63 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=203.7
Q ss_pred cCCCccceEeeeCcEEEEEEEe------cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (828)
++|...+.||+|+||.||+|+. ..+..||||+++... ....+.+.+|+++|..+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4577779999999999999963 235689999987543 33456788999999999 899999999999999999
Q ss_pred EEEEEeccCCcccccccCCC------------------------------------------------------------
Q 003350 556 ILIYEYMENGTLKGHLYGSG------------------------------------------------------------ 575 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~------------------------------------------------------------ 575 (828)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999998885421
Q ss_pred -------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 576 -------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 576 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
...++|..+++++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1258899999999999999999999 899999999999999999999999999998654322211
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....+ ...+.. .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~---------~ 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYR---------M 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCcc---------C
Confidence 2223445678999999999999999999999999999998 888886543221 11111 111110 0
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
..+...+.++.+++.+|++.+|.+||++.||++.|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01112245688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=352.86 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=205.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
.++|+..+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 346778899999999999998642 24579999987543 33356788999999999 89999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003350 555 MILIYEYMENGTLKGHLYGSG----------------------------------------------------------- 575 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------- 575 (828)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998875321
Q ss_pred ---------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceecc
Q 003350 576 ---------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 646 (828)
Q Consensus 576 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 646 (828)
..++++.++++++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1247889999999999999999999 9999999999999999999999999999976533221112223
Q ss_pred ccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003350 647 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725 (828)
Q Consensus 647 ~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (828)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. .....+ ..+ ..+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~~~~~-----~~~----~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KMVKRG-----YQM----SRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HHHHcc-----cCc----cCCC
Confidence 345678999999998999999999999999999997 9999975432211 00 111111 001 1111
Q ss_pred hHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 726 DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 726 ~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
..+..+.+++.+|++.+|.+||++.+|++.|++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 22456889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=334.53 Aligned_cols=249 Identities=35% Similarity=0.544 Sum_probs=198.6
Q ss_pred cceEeeeCcEEEEEEEec-----CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 489 SWVIGIGGFGKVYKGELN-----DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999877 25689999996643 344788999999999999999999999999888899999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.++|.......+++.++++|+.|+|+||+|||+ .+++|+||+++|||+++++.+||+|||+++.........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999988755679999999999999999999999 899999999999999999999999999998763322333
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
..........|+|||.+....++.++||||||+++|||++ |+.|+......+. ...+ .++.. .
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~------~~~~-~~~~~---------~ 224 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI------IEKL-KQGQR---------L 224 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH------HHHH-HTTEE---------T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccc-ccccc---------c
Confidence 3344567789999999999999999999999999999999 6788865533221 1111 11110 1
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
..+..++..+.+++.+||+.+|.+||++.++++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12233466788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=329.82 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=208.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.+.|...++||.|..+.||+|+. ..++.||||++..... ...+.+++|+..|+.++||||++.+..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35677789999999999999964 4679999999887644 336889999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC-
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID- 639 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~- 639 (828)
||.+||+.+.+...-...+++..+..|.+++++||.|||+ +|.||||||+.||||+.+|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999976555569999999999999999999999 999999999999999999999999999876443322
Q ss_pred cccee-ccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc--ccc
Q 003350 640 QTHVS-TAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL--DQI 714 (828)
Q Consensus 640 ~~~~~-~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--~~~ 714 (828)
..... ....||++|||||+++. ..|+.|+||||||++.+||.+|..||....+-+.. .+.+...... ...
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPPTLLTSG 256 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCCCccccc
Confidence 11112 56789999999999654 47999999999999999999999999866543321 1111111100 001
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.|... .......+.+++..||+.||.+|||++++++
T Consensus 257 ~~~d~----~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDE----DKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHH----hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111 1223346889999999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=310.74 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=209.6
Q ss_pred CCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcc--cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...++||+|.||.||+|+. ..|+.||||+++..... ......+|++.|+.++|+||+.|++++.+.+.+-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 456668999999999999975 46899999998776432 245678999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
|+. +|...+.... ..++..++..++.++++||+|||. +.|+||||||.|+|++++|.+||+|||+|+.....+..
T Consensus 83 m~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 986 8988886654 468999999999999999999999 99999999999999999999999999999987654433
Q ss_pred ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc---cccC-
Q 003350 642 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD---QIID- 716 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d- 716 (828)
. +..+-|..|.|||.+.+ ++|+...|+||.||++.||+-|.+-|.+..+-+....+-.+.....+++.. ++.|
T Consensus 158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 2 33377899999999876 579999999999999999999998887766555433332222111221111 1111
Q ss_pred -------ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 717 -------PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 717 -------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+.....+-+.+.....++...++..+|.+|.+++|++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111223456667899999999999999999999743
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=333.50 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=201.6
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
|...+.||+|+||.||++... +++.||+|.+.... ......+.+|++++.+++|+||+++.+++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 666789999999999999764 68999999876432 22345678999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--- 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---
Confidence 999999988865544579999999999999999999999 99999999999999999999999999999764321
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.......||..|+|||++.+..++.++|||||||++|||++|+.||........... .... .... ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~-~~~~----------~~ 222 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE--VDRR-VKED----------QE 222 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH--HHHH-hhcc----------cc
Confidence 122345789999999999999999999999999999999999999975433211110 0000 0000 01
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCC-----hHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW 754 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eVl~ 754 (828)
.++......+.+++.+||+.+|.+||+ +.++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 122334567889999999999999997 677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.97 Aligned_cols=255 Identities=21% Similarity=0.343 Sum_probs=205.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...+.||+|+||.||+|.++ .+..||+|.+.... ......|.+|+.++.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45777889999999999999753 35689999887653 33356789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++.... ..++|.+++.++.|++.||+|||+ .+++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~- 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS- 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc-
Confidence 99999999999986543 468999999999999999999999 9999999999999999999999999998765322
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||......+. .+. ...+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~----~~~~~------- 225 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA----VEDGF------- 225 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH----HHCCC-------
Confidence 11111122345678999999999999999999999999999775 9999976543322 111 11110
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
....+..++..+.+++.+|++.+|.+||++.|+.+.|+++
T Consensus 226 --~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 --RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112234566788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.03 Aligned_cols=264 Identities=21% Similarity=0.316 Sum_probs=209.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHH--HHHHHHHHcCC-CCceEEEEEEEccCC-cEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEF--QTEIEMLSQFR-HRHLVSLIGYCDEKN-EMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 557 (828)
.++|...++||.|.||.||+|+-. .+..||||+++..-.. ++++ .+|++.|++|+ ||||++|..++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 456777789999999999999754 6889999998876443 3444 58999999998 999999999998877 9999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|||||+. +|.+.+... ...+++..+..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+||||||....
T Consensus 88 VfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 9999975 999988766 5789999999999999999999999 9999999999999999999999999999997533
Q ss_pred CCccceeccccccccccChhhhc-cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC------
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ------ 710 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------ 710 (828)
....+..+.|..|.|||++. .+-|+.+.|+|++|||++|+.+-++.|.+..+.+...-+.-+..-..+..
T Consensus 163 ---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 ---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred ---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 22346778899999999875 67899999999999999999999999987766554332222211111111
Q ss_pred cccccC---ccc----cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 711 LDQIID---PTL----AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 711 ~~~~~d---~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+...+. |.. ....-+.+..+..+++.+|++.||.+|||+.|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111 110 011123367788999999999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.92 Aligned_cols=254 Identities=25% Similarity=0.416 Sum_probs=208.6
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46777899999999999999988888999998765433 35788999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...... ...
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc-eec
Confidence 9999999976555678999999999999999999999 899999999999999999999999999998754311 111
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||++....++.++|||||||++|||++ |+.||......+. ..+. ..+. .. .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~-----~~----~ 224 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSAL----QRGY-----RM----P 224 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHH----HcCC-----CC----C
Confidence 223446778999999998899999999999999999998 9999975433221 1111 1110 00 0
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.....+..+.+++.+|++.+|++||++.++.+.|++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112234568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.50 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=207.7
Q ss_pred CCCccceEeeeCcEEEEEEEecC------CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
+|...+.||+|+||.||+|.... ...|++|.+.... .....+|.+|++++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 56677899999999999997643 2579999887543 3345678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCC--------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc
Q 003350 558 IYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 623 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 623 (828)
+|||+++|+|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999864321 458899999999999999999999 89999999999999999999
Q ss_pred EEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHH
Q 003350 624 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWA 702 (828)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 702 (828)
+||+|||+++.....+.........++..|+|||++.+..++.++|||||||++|||++ |+.||......+... +
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~---~- 238 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE---M- 238 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---H-
Confidence 99999999986543232223344556889999999998899999999999999999998 999987654433211 1
Q ss_pred HHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 703 MKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 703 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
...+.. ...+...+..+.+++.+|++.+|.+||++.||++.|+.
T Consensus 239 ---i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ---IRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 11234556789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=336.03 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=206.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCc----EEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.+|+..+.||+|+||.||+|++. +++ .||+|.+.... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999764 333 48999987543 34467899999999999999999999999764 5779
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999987643 358899999999999999999999 9999999999999999999999999999987543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
...........++..|+|||++.+..++.++|||||||++|||++ |+.|++.....+... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~------ 228 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGE------ 228 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHhCCC------
Confidence 222222223345678999999999999999999999999999997 999997554332211 111110
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
....+..+...+.+++.+|++.+|.+||++.+++..|..+.+..
T Consensus 229 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00111233456889999999999999999999999888765443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=331.25 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=210.8
Q ss_pred CCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4667789999999999999742 3456899998777666667899999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 559 YEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
|||+++++|.+++.... ...++|.++++++.|++.||+|||+ .+++||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 99999999999986432 2358999999999999999999999 999999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||+| |+.||......+...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~------ 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE------ 236 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------
Confidence 9999999976543222222334556788999999999999999999999999999999 999987554433211
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
....+...+ .....+..+.+++.+|++.+|.+||++.+|+++|+.+..
T Consensus 237 -~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 -CITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111 112235668899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.04 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=207.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
+|...+.||+|++|.||+|... .++.||+|..... ....+++.+|++++++++|+||+++++++...+..+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4667789999999999999865 4788999987654 3345788999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.......+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++....... ..
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~ 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TA 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee-ec
Confidence 9999999976555679999999999999999999999 8999999999999999999999999999987543211 11
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||++.+..++.++|||||||++|||++ |..|+......+.. ... ..+ ....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~------~~~-~~~---------~~~~ 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ELL-EKG---------YRME 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HHH-HCC---------CCCC
Confidence 122334668999999999999999999999999999998 89998754332211 111 111 1111
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
.+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2233456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.30 Aligned_cols=246 Identities=27% Similarity=0.431 Sum_probs=210.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|.||.||||+.+ +.+.||+|.+.+.. .+..+.+.+|++++++++||||+.++.+|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999766 57889999876653 3456778999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+.+ +|..+|...+ .|+++++..|+.++..||.|||+ .+|+|||+||.||||+..+.+|++|||+|+.... .
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 9986 9999996554 69999999999999999999999 9999999999999999999999999999998654 5
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
+.+.+.+.||+-|||||.+.++.|+..+|.||+||++|||.+|++||.... ...+++ .+.. |+.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~---~I~~--------d~v-- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVK---SILK--------DPV-- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHH---HHhc--------CCC--
Confidence 667788999999999999999999999999999999999999999996432 222222 2111 111
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+..++...|.+||.+|-+-.+++.
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 123456778899999999999999999888875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=338.39 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=205.2
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC----Cc-ccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCc
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR----SQ-QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNE 554 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 554 (828)
...+|...+.||+|.||+|+.|... +++.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3557888899999999999999664 6899999976553 12 23456678999999998 9999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC-CcEEEEeeCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSK 633 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kl~DFGla~ 633 (828)
.++||||+.+|+|.+++... .++.+.+...++.|++.|++|||+ ++|+||||||+|||+|.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999773 468889999999999999999999 999999999999999999 999999999999
Q ss_pred CCCCCCccceeccccccccccChhhhccCC-CC-cccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ-LT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... +.. . ...+.
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~~---k-i~~~~- 239 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LYR---K-IRKGE- 239 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HHH---H-HhcCC-
Confidence 763 1223456789999999999999877 75 89999999999999999999998633221 111 1 11111
Q ss_pred ccccCccccCCCChhH-HHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 712 DQIIDPTLAGKIRPDS-LRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
. .++... ..++..++.+|+..+|.+|+++.|++
T Consensus 240 -------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 -------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 122222 56788999999999999999999998
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=325.46 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=208.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.++|...+.||+|++|.||+|..++++.||+|.+.... ...+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35677889999999999999998778889999987543 33577899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++....... .
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence 99999999976554579999999999999999999999 8999999999999999999999999999986542111 1
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.......+..|+|||++.+..++.++||||||+++|||++ |+.||......+... ....... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------~~~~~~~----------~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ------QVDQGYR----------M 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH------HHHcCCC----------C
Confidence 1112223457999999998999999999999999999999 999987544322111 1111100 0
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
......+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1122345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=323.84 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=203.5
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||++.++++..+|+|.+.... ...++|.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3466778999999999999998888899999876443 335678999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+++.... ..++|..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...... ...
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eec
Confidence 999999986543 358999999999999999999999 999999999999999999999999999998643211 111
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ..+ ... +. ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~---i~~-~~--~~~~~----- 223 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEM---ISR-GF--RLYRP----- 223 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH---HHC-CC--CCCCC-----
Confidence 223345678999999988899999999999999999999 8999875543222 111 111 11 01111
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
......+.+++.+|++.+|.+||++.|+++.|
T Consensus 224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 12245688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=338.38 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=205.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36788899999999999999876 48899999876432 233567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999996543 68999999999999999999999 9999999999999999999999999999986432
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh-HHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~ 718 (828)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +..|.. .+. .+.
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------~~~---~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE------TLQ---RPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc------ccc---CCC
Confidence 2345679999999999999999999999999999999999999998665443221 111110 000 011
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.. .........+.+++.+|++.+|.+||++.|+++.
T Consensus 222 ~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 0012335568889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=345.93 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=205.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 554 (828)
.++|...++||+|+||.||+|+.. .+..||||++..... ...+.|.+|+++|+++. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 456777789999999999999753 134799999875433 33567899999999996 9999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003350 555 MILIYEYMENGTLKGHLYGSG----------------------------------------------------------- 575 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------- 575 (828)
.++||||+++|+|.++|+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998875421
Q ss_pred -----------------------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC
Q 003350 576 -----------------------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 620 (828)
Q Consensus 576 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~ 620 (828)
...+++.+++.++.|+++||+|||+ .+|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 1248889999999999999999999 89999999999999999
Q ss_pred CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHH
Q 003350 621 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 699 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~ 699 (828)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.. .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--Y 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--H
Confidence 99999999999986533222112223456788999999998899999999999999999997 88998654322111 0
Q ss_pred HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 700 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
. ....+. ....+...+..+.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus 351 ~----~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 N----KIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H----HHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 011110 00112344567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=324.89 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=208.1
Q ss_pred cCCCccceEeeeCcEEEEEEEecC----CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...+.||+|+||.||+|.+.. ...||||.+.... .....+|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998742 3579999887543 33456789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++++|.+++.... ..+++.++++++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999986643 368999999999999999999999 99999999999999999999999999999876422
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .... ..+.. .
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~----~- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAV----EDGYR----L- 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHH----HcCCC----C-
Confidence 22222223445678999999998999999999999999999998 9999865433221 1111 11100 0
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
......+..+.+++.+|++.+|++||++.||++.|+++
T Consensus 228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.37 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=212.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
..+|...++||.|+||.||+|...+++.+++|.+.........++..|+++++.++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45677778999999999999998888999999988776656778999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.......+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++...... ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--VY 159 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc--cc
Confidence 99999999987655679999999999999999999999 89999999999999999999999999999765331 11
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......++..|+|||.+....++.++||||||+++|||++ |+.||......+... ... .+ ...
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~---~~~----~~---------~~~ 223 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD---QIT----AG---------YRM 223 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH---HHH----hC---------CcC
Confidence 1223456778999999998899999999999999999998 899997554322211 111 10 011
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
..+..++..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1223445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=329.22 Aligned_cols=260 Identities=28% Similarity=0.430 Sum_probs=210.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46778899999999999999742 345689999877666667789999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCC-----------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEE
Q 003350 558 IYEYMENGTLKGHLYGSG-----------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV 626 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl 626 (828)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999886432 2358999999999999999999999 99999999999999999999999
Q ss_pred EeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHH
Q 003350 627 ADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKW 705 (828)
Q Consensus 627 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 705 (828)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |++||......+... .
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~------~- 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE------C- 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------H-
Confidence 99999986543222222233446788999999998999999999999999999998 899987554332111 1
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
...+.... .....+..+.+++.+|++.+|.+||++.||.+.|+.+.+.
T Consensus 235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111100 1112345689999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.76 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=208.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC------CcEEEEEEcCCC-CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
.++|+..+.||+|+||.||++...+ ...+|+|..... ......++.+|++++.++ +|+||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 4567778899999999999997642 367999987754 233456788999999999 89999999999999999
Q ss_pred EEEEEEeccCCcccccccCC--------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC
Q 003350 555 MILIYEYMENGTLKGHLYGS--------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 620 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~ 620 (828)
.+++|||+++|+|.+++... ....+++..+++++.|++.||+|||+ .+|+||||||+|||+++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcC
Confidence 99999999999999998532 23568999999999999999999999 99999999999999999
Q ss_pred CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHH
Q 003350 621 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 699 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~ 699 (828)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+......+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~- 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL- 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH-
Confidence 99999999999987544322222233445678999999998999999999999999999998 8888865433222111
Q ss_pred HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 700 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
...+. ....+......+.+++.+|++.+|.+|||+.|+++.|+.++
T Consensus 247 ------~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 ------LKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11110 01122334567889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.68 Aligned_cols=236 Identities=25% Similarity=0.371 Sum_probs=199.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
.+|+..+.||.|+||.|.+++.+ +|..+|+|++..... +..+...+|..+|+.+.||.++++++.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35667789999999999999876 578899999876543 33556779999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|.|..+|+..+ +++.....-+|.||+.||+|||+ .+|++|||||+|||||.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 9999999999997765 69999999999999999999999 9999999999999999999999999999997543
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.+-+.+||+.|+|||.++...+..++|+|||||++|||+.|.+||....+...-. +++...+
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~---------------KI~~~~v 258 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE---------------KILEGKV 258 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH---------------HHHhCcc
Confidence 2557899999999999999999999999999999999999999998766532211 1111111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCC
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDR 746 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~R 746 (828)
.++.-....+.+++...|+.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2333445567788888888888888
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=339.68 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=204.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEc-cCCc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD-EKNE 554 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~-~~~~ 554 (828)
++|...++||+|+||.||+|... .++.||+|++.... ....+.+..|++++.++ +|+||++++++|. .+..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 35777899999999999999642 24689999887543 23346678899999999 8999999999885 4467
Q ss_pred EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003350 555 MILIYEYMENGTLKGHLYGSG----------------------------------------------------------- 575 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------- 575 (828)
.++++||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999998875321
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccC
Q 003350 576 LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655 (828)
Q Consensus 576 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 655 (828)
...++|..+.+++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1268999999999999999999999 8999999999999999999999999999987543222222233456778999
Q ss_pred hhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHH
Q 003350 656 PEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGET 734 (828)
Q Consensus 656 PE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 734 (828)
||++.+..++.++|||||||++|||++ |+.||......+. +. .....+.. ...+.....++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~---------~~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEGTR---------MRAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhccCC---------CCCCccCCHHHHHH
Confidence 999999999999999999999999998 9999875433221 11 11111110 01112334568899
Q ss_pred HHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 735 AEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 735 ~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
+.+|++.+|++||++.|++++|+++++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=336.24 Aligned_cols=241 Identities=24% Similarity=0.301 Sum_probs=197.3
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 565 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~g 565 (828)
++||+|+||.||+++.. +|+.||+|.+... .......+.+|++++++++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999765 6889999987643 2233466789999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceec
Q 003350 566 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645 (828)
Q Consensus 566 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (828)
+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~ 153 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK 153 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCccc
Confidence 999988654 368999999999999999999999 9999999999999999999999999999875322 111233
Q ss_pred cccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003350 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725 (828)
Q Consensus 646 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (828)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .+. . .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~------~~-~~~------~----~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------IL-MEE------I----RFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH------HH-cCC------C----CCCC
Confidence 45799999999999999999999999999999999999999975433221111 00 110 1 1223
Q ss_pred hHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 726 DSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 726 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
.....+.+++.+||+.+|.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3455688999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=327.20 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=205.1
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (828)
++++|+..+.||+|+||.||+|... .+..||+|++.... .....+|.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888899999999999998753 24679999876432 2345678999999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC--------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEE
Q 003350 555 MILIYEYMENGTLKGHLYGSG--------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV 626 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl 626 (828)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986422 1346889999999999999999999 89999999999999999999999
Q ss_pred EeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHH
Q 003350 627 ADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKW 705 (828)
Q Consensus 627 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 705 (828)
+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||......+.. .+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~~---- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---RF---- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH----
Confidence 99999976543222222223345788999999998899999999999999999999 68888655432211 11
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
....... ..+...+..+.+++.+|++.+|.+||++.|+++.|+
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111110 112234567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=331.16 Aligned_cols=247 Identities=22% Similarity=0.331 Sum_probs=206.3
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
..++|+...+||+|+||.||+++.+ .|..+|+|+++... ....+..+.|-.+|....+|.||+|+..|.+...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4568888899999999999999765 58999999988764 3446678899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||++||++..+|...+ .|+......++.+++.|++-||+ .|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999997665 79999999999999999999999 9999999999999999999999999999842100
Q ss_pred ----------------------CCccc----e-------------------eccccccccccChhhhccCCCCcccceee
Q 003350 638 ----------------------IDQTH----V-------------------STAVKGSFGYLDPEYFRRQQLTEKSDVYS 672 (828)
Q Consensus 638 ----------------------~~~~~----~-------------------~~~~~gt~~Y~aPE~~~~~~~s~ksDVyS 672 (828)
.+... . ....+|||.|+|||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00000 0 12357999999999999999999999999
Q ss_pred hhhHHHHHHhcCCCCCCCChhhh-hhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCC
Q 003350 673 FGVVLFEVLCARPVIDPTLPREM-VNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS 748 (828)
Q Consensus 673 fGvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 748 (828)
+|||+||||.|.+||....+.+. ..+..|...+..... .....+..++|.+|+. +|.+|-.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999998887664 466666654433221 1223567888999998 9999965
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=327.79 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=206.3
Q ss_pred cCCCccceEeeeCcEEEEEEEecC------CcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
.+|...+.||+|+||.||+|...+ ++.||+|.+...... ..+.|.+|+++|++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 346677899999999999997643 478999998765443 4578999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCC------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 557 LIYEYMENGTLKGHLYGSG------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
+||||+++++|.+++...+ ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999986432 2458999999999999999999999 899999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~---~~~- 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---ECI- 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH-
Confidence 9999999976433222222233456788999999999999999999999999999998 99998654433221 111
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
..+... ..+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus 238 ---~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111 111234567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=326.23 Aligned_cols=258 Identities=27% Similarity=0.404 Sum_probs=206.3
Q ss_pred CCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
+|...+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667789999999999999753 23568888876543 3345678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCC----------------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCc
Q 003350 558 IYEYMENGTLKGHLYGS----------------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSAN 615 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~N 615 (828)
|+||+++|+|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 99999999999987532 12358899999999999999999999 999999999999
Q ss_pred EEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhh
Q 003350 616 ILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPRE 694 (828)
Q Consensus 616 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~ 694 (828)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||....+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986433222111233456778999999988899999999999999999999 999997654433
Q ss_pred hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 695 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.... ..+. .....+......+.+++.+|++.+|.+||++.|+++.|++++.
T Consensus 238 ~~~~-------~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNL-------LKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHH-------HhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2211 1111 0111122345678899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=335.54 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=200.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46777899999999999999876 5789999987643 2233567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999986543 68899999999999999999999 99999999999999999999999999999865331
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+.. .. ...+.+
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~-i~~~~~-------- 232 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY------EK-ILAGRL-------- 232 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH------HH-HhcCCc--------
Confidence 12356899999999999999999999999999999999999999755432211 11 111110
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCC-----hHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eVl~ 754 (828)
.++.....++.+++.+||+.+|.+||+ +.+++.
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111223456788999999999999997 566654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.84 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=204.6
Q ss_pred cCCCccceEeeeCcEEEEEEEe-----cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.+|+..+.||+|+||.||+|.. .++..+++|.+.... .....+|.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3466678999999999999974 245789999987543 3445678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCC---------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC
Q 003350 558 IYEYMENGTLKGHLYGSG---------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF 622 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 622 (828)
||||+++++|.+++.... ...+++.+.+.++.|++.||+|||+ .+++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999885321 2358899999999999999999999 8999999999999999999
Q ss_pred cEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHH
Q 003350 623 MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEW 701 (828)
Q Consensus 623 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~ 701 (828)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....+.+....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~--- 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM--- 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999986533222222334456778999999988889999999999999999998 9989865443222111
Q ss_pred HHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 702 AMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 702 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
....... ..+.....++.+++.+|++.+|.+||++.++.+.|+.
T Consensus 239 ----~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 ----VRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111100 1122345668889999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=328.57 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=197.5
Q ss_pred CCCccceEeeeCcEEEEEEEec--CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcC---CCCceEEEEEEEc-----cC
Q 003350 485 NFDESWVIGIGGFGKVYKGELN--DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQF---RHRHLVSLIGYCD-----EK 552 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~~ 552 (828)
+|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+++++.+ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6778889999999999999763 46789999876432 22234566777777765 6999999999984 34
Q ss_pred CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
...++|+||++ ++|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999997 689999876555679999999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc-
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL- 711 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~- 711 (828)
+..... .......||..|+|||.+.+..++.++|||||||++|||++|++||......+.................
T Consensus 158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 764321 2234556899999999999889999999999999999999999999866543322111100000000000
Q ss_pred ------ccccCcccc---CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 ------DQIIDPTLA---GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+.+... ....++....+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000111000 0011233456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.76 Aligned_cols=265 Identities=19% Similarity=0.235 Sum_probs=202.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|+||.||+++.+ +++.+|+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888899999999999999876 57889999876542 2335678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|++++.|..+... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 9998777654432 2468999999999999999999999 999999999999999999999999999998754311
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHH---------HHHhhcCCc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA---------MKWQNKGQL 711 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~ 711 (828)
........||..|+|||++.+..++.++|||||||++|||++|++||......+........ ..+......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 11223456899999999999889999999999999999999999999765433221111110 000011000
Q ss_pred ccccCccccC------CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAG------KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.....+.... .........+.+++.+||+.+|.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0110011100 011123456899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=350.02 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=204.7
Q ss_pred CCccceEeeeCcEEEEEEEec-C-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 486 FDESWVIGIGGFGKVYKGELN-D-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
|...+.||+|++|.||+|... + ++.||+|............+.+|+++|+.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777889999999999999654 3 57889998766655556678899999999999999999999999999999999999
Q ss_pred CCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 564 NGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 564 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+|+|.+++... ...++++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988542 23468899999999999999999999 99999999999999999999999999999865432222
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .... +.. +
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~------~~~~-~~~----~----- 289 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ------QVLY-GKY----D----- 289 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh-CCC----C-----
Confidence 23345679999999999999999999999999999999999999997543322111 1111 110 0
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+||+.+|.+||++.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112233456889999999999999999999975
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.77 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=205.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|+++|++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357888899999999999999876 57889999877542 3345679999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++|+|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999986543 58899999999999999999997 136999999999999999999999999998764321
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh--cCCcc------
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN--KGQLD------ 712 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~------ 712 (828)
......||..|+|||++.+..++.++|||||||++|||++|+.||......+....... .... .+...
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRP 233 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCccc
Confidence 12345689999999999999999999999999999999999999975543332111100 0000 00000
Q ss_pred ---------------------cccC----ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 713 ---------------------QIID----PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 713 ---------------------~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
+..+ .............++.+++.+||+.+|++||++.|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000 0000000112345789999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.60 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=203.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCc----EEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.+|...+.||+|+||.||+|.+. +++ .+++|...... .....++..|+.+++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35666789999999999999864 343 47888876443 2335678889999999999999999999864 45788
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
++||+++|+|.+++.... ..++|..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 468999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
...........++..|+|||++.++.++.++|||||||++|||++ |+.|+....+.+...+ ...+.. ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~--~~~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGER--LAQ 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCCc--CCC
Confidence 222222334567789999999998999999999999999999998 9999976544332211 111110 011
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
+ ..+...+.+++.+|+..+|.+||++.|+++.|..+.+
T Consensus 233 ~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 P-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 1223457788999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=331.25 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=200.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36778899999999999999876 58899999876432 233566889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++...+ .+++.....++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999986543 68999999999999999999999 99999999999999999999999999999864321
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ... .+. .
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~------~i~-~~~------~-- 215 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE------KIL-AGK------L-- 215 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-hCC------c--
Confidence 223568999999999999899999999999999999999999997654332211 111 111 0
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCC-----hHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eVl~ 754 (828)
.++......+.+++.+||+.+|.+||+ +.|+++
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 112223456788999999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.74 Aligned_cols=235 Identities=25% Similarity=0.281 Sum_probs=192.5
Q ss_pred EeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
||+|+||.||+++.. +++.||+|.+... .......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 5789999987643 233456788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccc
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (828)
.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ........
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~ 153 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTF 153 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccc
Confidence 99986543 68999999999999999999999 9999999999999999999999999999986322 11223456
Q ss_pred cccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003350 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727 (828)
Q Consensus 648 ~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (828)
.||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ....... . . .++...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~~-~------~----~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQE-P------L----RFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHcC-C------C----CCCCcC
Confidence 799999999999999999999999999999999999999975433221 1111111 0 0 122233
Q ss_pred HHHHHHHHHhhhhhCCCCCCChH
Q 003350 728 LRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 728 ~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
...+.+++.+||+.+|.+||+..
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCC
Confidence 45678899999999999998643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.24 Aligned_cols=251 Identities=29% Similarity=0.408 Sum_probs=202.9
Q ss_pred CCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
+|...+.||+|+||.||+|+..++..+|+|.+..... ...+|.+|+.++.+++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 4566688999999999999887777899998775432 356789999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++.... ..+++.++++++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++...... ....
T Consensus 84 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05113 84 GCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS 158 (256)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence 99999986543 268999999999999999999999 999999999999999999999999999988653311 1112
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. . ....... + ..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~---~~~~~~~------~----~~ 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV---E---KVSQGLR------L----YR 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---H---HHhcCCC------C----CC
Confidence 23345678999999998889999999999999999998 99998754432211 1 1111100 0 01
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.......+.+++.+||+.+|.+||++.++++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1123467889999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.48 Aligned_cols=253 Identities=28% Similarity=0.397 Sum_probs=204.9
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||+|..+++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 35677789999999999999888888899998876443 3467999999999999999999999885 456889999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.......+++.+++.++.+++.||+|||+ .+++||||||+||++++++.+||+|||++....... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTA 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-ccc
Confidence 9999999976555578999999999999999999999 899999999999999999999999999997653311 111
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. .+ +... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~~---~~~~----------~~~~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---EQ---VERG----------YRMP 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH---HHcC----------CCCC
Confidence 223345678999999988899999999999999999999 88998654332211 11 1110 0011
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.+...+..+.+++.+|++.+|.+|||+.++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223345678999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=320.66 Aligned_cols=284 Identities=24% Similarity=0.369 Sum_probs=215.9
Q ss_pred CCCCCcccCHHHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHH--cCCCCceEE
Q 003350 467 NSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS--QFRHRHLVS 544 (828)
Q Consensus 467 ~~~~~~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~ 544 (828)
.+.+|...|+.-.+....+....+.||+|.||.||+|.++ |+.||||++...++ +.+.+|.++.+ .|+|+||+.
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhh
Confidence 3455677888888888899999999999999999999998 88999999987655 34566777666 469999999
Q ss_pred EEEEEccC----CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhc-----CCCCEEeeeeecCc
Q 003350 545 LIGYCDEK----NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG-----YAKAVIHRDVKSAN 615 (828)
Q Consensus 545 l~g~~~~~----~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDIkp~N 615 (828)
+++.-..+ .+++||.+|.++|||.|||.. ..++....++++..+|.||++||.+ .++.|.|||||+.|
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 99876433 378999999999999999965 3699999999999999999999963 46789999999999
Q ss_pred EEeCCCCcEEEEeeCCCCCCCCCC--ccceeccccccccccChhhhccC------CCCcccceeehhhHHHHHHhc----
Q 003350 616 ILLDENFMAKVADFGLSKTGPEID--QTHVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCA---- 683 (828)
Q Consensus 616 ILld~~~~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGvvl~elltG---- 683 (828)
||+..++.+.|+|+|||-...... -....+..+||.+|||||++... +--..+||||||.|+||+...
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 999999999999999997654321 11223557899999999999643 223579999999999999763
Q ss_pred ------CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC-CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 684 ------RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK-IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 684 ------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
++||....+.+.. ..+ .....- .+-+.|.+... ...+.+..+.+++..||..+|.-|-|+-.+-+.|
T Consensus 427 gi~eey~~Pyyd~Vp~DPs-~ee-MrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSDPS-FEE-MRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CEehhhcCCcccCCCCCCC-HHH-Hhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 2555443332211 000 000111 11112222222 2246788899999999999999999999998888
Q ss_pred HHHHHhh
Q 003350 757 EYALQLQ 763 (828)
Q Consensus 757 ~~~~~~~ 763 (828)
.++.+..
T Consensus 501 ~~l~~~~ 507 (513)
T KOG2052|consen 501 AKLSNSD 507 (513)
T ss_pred HHHhcCh
Confidence 8766543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.59 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=197.8
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 565 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~g 565 (828)
++||+|+||.||++... +++.||+|.+... .......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999765 5889999987653 2334567889999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceec
Q 003350 566 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645 (828)
Q Consensus 566 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (828)
+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 999888654 368999999999999999999999 99999999999999999999999999998753221 11223
Q ss_pred cccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003350 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725 (828)
Q Consensus 646 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (828)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .... + +. .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~------~~~~-~------~~----~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------LILM-E------DI----KFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH------Hhcc-C------Cc----cCCC
Confidence 4579999999999999999999999999999999999999997543322211 1100 0 01 1222
Q ss_pred hHHHHHHHHHHhhhhhCCCCCC-----ChHHHHHH
Q 003350 726 DSLRKFGETAEKCLADFGVDRP-----SMGDVLWN 755 (828)
Q Consensus 726 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~~ 755 (828)
....++.+++.+||+.+|.+|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3445678899999999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.34 Aligned_cols=261 Identities=28% Similarity=0.454 Sum_probs=208.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec--------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCC
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN 553 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 553 (828)
++|...+.||+|+||.||+++.. +...+|+|.+.... .....++..|++++.++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46788899999999999999752 23469999887542 34456788999999999 7999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC
Q 003350 554 EMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld 619 (828)
..++||||+++|+|.+++.... ...++|.++++++.|++.||+|||+ .+++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 9999999999999999996532 1358999999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhH
Q 003350 620 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 698 (828)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l 698 (828)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.|+......+....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999976543222111222335578999999998899999999999999999998 8888865433222111
Q ss_pred HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 699 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
. .... ....+......+.+++.+|++.+|.+||+|.||++.|+++++..
T Consensus 255 ------~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 255 ------L-KEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ------H-HcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1111 01112334567888999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=304.30 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=210.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|+..+.||+|.||.||.|+.+ ++-.||+|.+.... .+..+++.+|+++-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 457888999999999999999776 46789999876542 23357789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
+||.++|.|...|.+.....++......+..|+|.||.|+|. ++||||||||+|+|++.++..||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999987777789999999999999999999999 999999999999999999999999999987643
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.......+||..|++||...+..++.+.|+|++|++.||++.|.+||+.....+...-+. -.++.+|
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~----------k~~~~~p- 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR----------KVDLKFP- 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH----------HccccCC-
Confidence 223456789999999999999999999999999999999999999998665333211111 0112222
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
........+++.+|+..+|.+|.+..||+..
T Consensus 243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 3345567889999999999999999999754
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.50 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=198.6
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
+.||+|+||.||+|+.. +++.+|+|..... .......|.+|++++++++||||++++++|......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 6889999987643 234456799999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccc
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (828)
.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++..............
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986543 468999999999999999999999 89999999999999999999999999998764321111111112
Q ss_pred cccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChh
Q 003350 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 726 (828)
Q Consensus 648 ~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 726 (828)
..+..|+|||.+.++.++.++|||||||++|||++ |..|+......+..... ... .....+..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-------~~~---------~~~~~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------EQG---------VRLPCPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-------HcC---------CCCCCccc
Confidence 23467999999999999999999999999999998 88888654332211111 110 01112223
Q ss_pred HHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 727 SLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 727 ~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.+..+.+++.+|++.+|++||++.|+.++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=325.71 Aligned_cols=265 Identities=29% Similarity=0.401 Sum_probs=199.4
Q ss_pred ccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHc--CCCCceEEEEEEEccCC----cEEEEEEe
Q 003350 488 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ--FRHRHLVSLIGYCDEKN----EMILIYEY 561 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~ey 561 (828)
..++||+|.||.||||.++ ++.||||++... ..+.|++|-++.+. ++|+||+++++.-.... +++||++|
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3468999999999999997 589999998754 34678888777765 58999999999876555 89999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhc------CCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG------YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
.++|+|.++|..+ .++|....+|+..+++||+|||++ ++++|+|||||++||||..|+++.|+|||||..+
T Consensus 290 h~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred ccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999999765 499999999999999999999974 4678999999999999999999999999999876
Q ss_pred CCCCccceeccccccccccChhhhccC-CC-----CcccceeehhhHHHHHHhcCCCCCC-C-----Chhh--hh---hH
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQ-QL-----TEKSDVYSFGVVLFEVLCARPVIDP-T-----LPRE--MV---NL 698 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~-----s~ksDVySfGvvl~elltG~~p~~~-~-----~~~~--~~---~l 698 (828)
............+||.+|||||++.+. .+ -.+.||||+|.|||||++.-..+++ . .+.+ .. .+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 543333333457899999999999763 12 2478999999999999997654421 1 1111 00 11
Q ss_pred HHHHHHHhhcCCcccccCccccCCCC-hhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 699 AEWAMKWQNKGQLDQIIDPTLAGKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
.+.-....++. ..|.+..... ...+..+.+.+..|+..|++-|-|+.=|.+.+.++....+
T Consensus 447 e~mq~~VV~kK-----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 447 EEMQELVVRKK-----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHhhc-----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 11000111111 1122221111 2346778999999999999999999999888777655443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=334.26 Aligned_cols=245 Identities=26% Similarity=0.347 Sum_probs=207.7
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
....++|...++||+|.||+|+++.++ +++.+|||.+++.. ....+....|.+++... +||.|++|+.++..+++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344568888999999999999999876 57899999988763 35567788899988877 59999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+++||||+.||++..+.+. ..+++....-++..++.||+|||+ ++||+||||.+|||||.+|++||+||||++.
T Consensus 444 l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999996555432 358999999999999999999999 9999999999999999999999999999997
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.-. ....+.+.+||+.|||||++.++.|+.+.|+|||||+|||||.|..||.+..+++..+-+. .
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------~------- 582 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------N------- 582 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------c-------
Confidence 532 2335678999999999999999999999999999999999999999999877665432111 1
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
|. ..++...+.+...++.+.|..+|.+|-.+
T Consensus 583 -d~---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 -DE---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CC---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 12445667788999999999999999877
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.59 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=202.1
Q ss_pred CCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
+|...+.||+|+||.||+|..+++..+|+|.+..... ...+|.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4666789999999999999887777899998764432 346788999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..... .....
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~-~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSS 158 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccc-ccccc
Confidence 99999986543 368999999999999999999999 89999999999999999999999999999764321 11111
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||....+.+.. . .. ..+ ... ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~---~~-~~~-----~~~----~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E---SV-SAG-----YRL----YR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H---HH-HcC-----CcC----CC
Confidence 22234567999999999999999999999999999999 79998754433221 1 11 111 011 11
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
+...+..+.+++.+|++.+|++||+|.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 123456788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.57 Aligned_cols=259 Identities=23% Similarity=0.357 Sum_probs=207.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
.++|...+.||+|+||.||++... .+..||+|++.... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356888899999999999999642 34579999877543 33356789999999999 79999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999999976544458999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
..............++..|+|||.+....++.++|||||||++|||++ |+.||......+.. ... ...+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~----~~~~~--- 261 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKL----IKEGY--- 261 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHH----HHcCC---
Confidence 543222112223446778999999999999999999999999999998 99998654332211 111 11110
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
....+.....++.+++.+|++.+|++||++.|+++.|+++
T Consensus 262 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0011112345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.50 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=205.9
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...++||+|+||.||+|+.++...||+|++..... ..++|.+|++++++++|+||+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 45777889999999999999887777899999875332 34678999999999999999999998754 56799999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+++.......+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence 9999999976544568999999999999999999999 9999999999999999999999999999976543221 11
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||+..+..++.++|||||||++|||++ |+.||......+.... ...+. ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~-------~~~~~---------~~~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VERGY---------RMP 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH-------HhcCC---------CCC
Confidence 223446778999999988899999999999999999999 8888875543322111 00100 001
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
...+.+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1234566788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.08 Aligned_cols=262 Identities=25% Similarity=0.440 Sum_probs=209.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec--------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccC
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK 552 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 552 (828)
..+|...+.||+|+||.||+++.. ++..||+|...... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 445677789999999999999641 24579999876542 34467789999999999 899999999999999
Q ss_pred CcEEEEEEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe
Q 003350 553 NEMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 618 (828)
...++||||+++|+|.+++.... ...++|.+++.++.|+++||+|||+ .+++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 99999999999999999986532 2358899999999999999999999 899999999999999
Q ss_pred CCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhh
Q 003350 619 DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVN 697 (828)
Q Consensus 619 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~ 697 (828)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~- 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-
Confidence 9999999999999987644332222333456778999999998889999999999999999998 78888654332221
Q ss_pred HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
... ..+.. ...+...+..+.+++.+|++.+|.+||+|.|+++.|++++.+.
T Consensus 250 -----~~~-~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 250 -----KLL-KEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred -----HHH-HcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 111 11110 0112234567888999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=320.16 Aligned_cols=254 Identities=30% Similarity=0.420 Sum_probs=199.0
Q ss_pred CccceEeeeCcEEEEEEEecC-Cc--EEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------CcE
Q 003350 487 DESWVIGIGGFGKVYKGELND-GT--KVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------NEM 555 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 555 (828)
...++||+|+||.||+|...+ +. .+|+|.+... +....+.|..|++++++++|+||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999998764 32 6899987654 344467889999999999999999999987432 256
Q ss_pred EEEEEeccCCcccccccCC----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 556 ILIYEYMENGTLKGHLYGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
++++||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887421 22458999999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQ 710 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (828)
++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. + . ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~---~-~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY---D---Y-LRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---H-HHcCC
Confidence 986543221111223346678999999999999999999999999999999 78888654332211 1 1 11111
Q ss_pred cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 711 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
.. ......+..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 11223455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.11 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=203.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC------CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
+++|...+.||+|++|.||+|...+ +..|++|...... ......|..|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678888999999999999997753 5678999876543 33346789999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC---cEEEE
Q 003350 556 ILIYEYMENGTLKGHLYGSGL-----PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---MAKVA 627 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kl~ 627 (828)
++||||+++++|.+++..... ..++|.++++++.||+.||+|||+ .+++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999865431 358999999999999999999999 8999999999999998654 69999
Q ss_pred eeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHh
Q 003350 628 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+.... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~------~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF------VT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------HH
Confidence 9999986532111111122234568999999999999999999999999999997 9999975543322111 11
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.... ...+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 236 ~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110 1122334567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=321.99 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=209.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC-----CcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc-CCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND-----GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 555 (828)
.++|...++||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4577888999999999999998765 678999987754 33446778899999999999999999998865 5778
Q ss_pred EEEEEeccCCcccccccCCCC------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 556 ILIYEYMENGTLKGHLYGSGL------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
++++||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865321 469999999999999999999999 89999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
|+++.....+.........++..|+|||++.+..++.++|||||||++||+++ |+.||....+.+ +..+.. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK---DG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH---cC
Confidence 99986543222222233456778999999998899999999999999999999 999997554332 222111 11
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.. . .....++..+.+++.+|++.+|++||++.|+++.|+.+.+
T Consensus 236 ~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YR------L----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC------C----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 0 0112234568899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=319.56 Aligned_cols=255 Identities=28% Similarity=0.405 Sum_probs=202.0
Q ss_pred CCccceEeeeCcEEEEEEEecC----CcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc-----
Q 003350 486 FDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE----- 554 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 554 (828)
|...+.||+|+||.||+|.... +..||+|++.... .....++.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4566889999999999997642 3679999877542 3345678999999999999999999999866554
Q ss_pred -EEEEEEeccCCcccccccCC----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 555 -MILIYEYMENGTLKGHLYGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 555 -~~lV~ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
.++++||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999988542 23468999999999999999999999 89999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+. .++. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----Hc
Confidence 99986543222211222345678999999988899999999999999999999 8888865433221 1111 11
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
+.. ...+......+.+++.+|++.+|.+||++.|+++.|+++
T Consensus 231 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 012234456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.30 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=203.6
Q ss_pred CCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 486 FDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
|...+.||+|+||.||+|... ++..||+|++...... ..+.|..|+.++.+++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 455578999999999999763 2478999998755432 346688999999999999999999999999999999
Q ss_pred EEeccCCcccccccCC--------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 559 YEYMENGTLKGHLYGS--------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
+||+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence 9999999999988421 12358899999999999999999999 899999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..|+......+.. .
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~------~ 237 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI------E 237 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------H
Confidence 9999999886543232222334456789999999988899999999999999999998 88888654332221 1
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
... .... ...+.+.+..+.+++.+|++.+|.+||++.+|+..|+.
T Consensus 238 ~i~-~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIR-NRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH-cCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 1111 11233456678899999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=335.41 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=206.0
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
|..++.||+|+.|.|-.|++. +|+.+|||.+.... ......+.+|+-+|+-+.|||+++|+++++++.++|||.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 556678999999999999775 69999999887652 23345678999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|-|.+++...+ ++++.+..+.+.||+.|+.|+|. .+|+|||+||+|+|||.+.++||+|||+|.+-. ..
T Consensus 94 v~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~g 165 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV---PG 165 (786)
T ss_pred cCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc---CC
Confidence 99999999997665 79999999999999999999999 999999999999999999999999999998732 23
Q ss_pred ceeccccccccccChhhhccCCCC-cccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
..-.+-+|.++|.|||++++..|. .++||||.|||||.||||+.||+... ...+...+ +.|. .
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV----~~G~-f-------- 229 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKV----QRGV-F-------- 229 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHH----HcCc-c--------
Confidence 344567899999999999998875 89999999999999999999998432 22222211 1111 1
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+.+...+.+..+++.+++..||.+|.|++||++.
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1234456678889999999999999999999764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=344.39 Aligned_cols=264 Identities=22% Similarity=0.296 Sum_probs=215.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCC-cEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEE-Ec-----c-CC
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDG-TKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGY-CD-----E-KN 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~-----~-~~ 553 (828)
..+..+.+.|.+|||+.||.+....+ ..+|+|++...++...+.+.+|+++|++|. |+|||.+++. .. . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 44566778999999999999988765 999999998888888999999999999996 9999999993 21 1 24
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
+.+|.||||++|+|-+++.......|++.++++|+.++++|+++||. ++++|||||||-+||||+.+++.||||||-|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 78999999999999999975444559999999999999999999997 56789999999999999999999999999986
Q ss_pred CCCCCC-cccee------ccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH
Q 003350 634 TGPEID-QTHVS------TAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 634 ~~~~~~-~~~~~------~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (828)
-..... ..... -...-|+-|+|||++. +..+++|+|||+|||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 422211 11000 1123688999999874 67899999999999999999999999985422
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
..|++-...-.-.+....+|..||..||+.+|.+||++-+|++.+.++....-.+
T Consensus 264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 2233333332233567889999999999999999999999999998887665433
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=334.34 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=196.7
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4777889999999999999765 57899999886532 2345678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999986543 58899999999999999999999 9999999999999999999999999999764211000
Q ss_pred ---------------------------------------------cceeccccccccccChhhhccCCCCcccceeehhh
Q 003350 641 ---------------------------------------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 675 (828)
Q Consensus 641 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGv 675 (828)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00112357999999999999889999999999999
Q ss_pred HHHHHHhcCCCCCCCChhhhh-hHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHh--hhhhCCCCCCChHHH
Q 003350 676 VLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEK--CLADFGVDRPSMGDV 752 (828)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPsm~eV 752 (828)
++|||++|+.||....+.+.. ....| ...+ .. ........++.+++.+ |+..++..||++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~------~~~~------~~--~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINW------ENTL------HI--PPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcc------cccc------CC--CCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999765443221 11111 0000 00 0001123445666765 666777779999999
Q ss_pred HHH
Q 003350 753 LWN 755 (828)
Q Consensus 753 l~~ 755 (828)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=317.14 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=206.3
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...++||+|+||.||+|..++++.+|+|.+..... ...+|.+|++++++++|+||+++++++. .+..++++||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 46777889999999999999988889999998875543 3568899999999999999999999874 467899999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||++....... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 159 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTA 159 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-ccc
Confidence 9999999876555679999999999999999999999 899999999999999999999999999997654211 111
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||++....++.++||||||+++|||++ |+.||......+.. . .+ ..+. .. .
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~---~~-~~~~-----~~----~ 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI---Q---NL-ERGY-----RM----P 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH---H---HH-HcCC-----CC----C
Confidence 223456778999999998899999999999999999999 99999755432221 1 11 1100 00 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.+...+..+.+++.+|++.+|++||++++++..|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112234568899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.09 Aligned_cols=241 Identities=24% Similarity=0.307 Sum_probs=196.6
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 565 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~g 565 (828)
+.||+|+||.||+++.. +|+.||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999765 5889999987643 2234566788999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceec
Q 003350 566 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645 (828)
Q Consensus 566 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (828)
+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 153 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence 9998886543 68999999999999999999999 89999999999999999999999999998753221 11123
Q ss_pred cccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003350 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725 (828)
Q Consensus 646 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (828)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ... . . .++.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~-~------~----~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LME-E------I----RFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcC-C------C----CCCC
Confidence 457999999999999999999999999999999999999999755433221110 000 0 0 1222
Q ss_pred hHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 726 DSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 726 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
.....+.+++.+||+.+|.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3355678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=316.51 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=204.3
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|++|.||++..+++..+|+|...... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3467778999999999999988777789999876543 23467889999999999999999999885 456889999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.......++|..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 9999999976555568999999999999999999999 8999999999999999999999999999976533211 11
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....+.+.. .+. ..+. .+ .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~-----~~----~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQV----ERGY-----RM----P 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCC-----CC----C
Confidence 223346778999999998899999999999999999999 89998755432211 111 1110 00 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.+...+..+.+++.+|++.+|.+||++.+|++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122345678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.83 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=217.1
Q ss_pred CCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 485 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++...++||-|.||.||.|.++. ...||||.++.... ..++|+.|..+|+.++|||+|+|+|+|.....+|+|.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 34455789999999999999875 56899999887654 47899999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
.|+|.++|....+..++-...+.+|.||+.||+||.. +.+|||||.++|+|+.++..+||+||||++++.. +....
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DTYTA 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DTYTA 422 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC-Cceec
Confidence 9999999998887889999999999999999999999 9999999999999999999999999999998765 32222
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....-...|.|||-+....++.|+|||+|||+||||.| |..|+.+..-.+...| ++...+-+
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L----------------LEkgyRM~ 486 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL----------------LEKGYRMD 486 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH----------------Hhcccccc
Confidence 333445678999999999999999999999999999987 6777765433222222 22222223
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
-++.|+.++.++++.||+.+|.+||++.|+-+.++.+.+
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 456788899999999999999999999999999988764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.21 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=199.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC--CcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND--GTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...+.||+|+||.||+|..+. +..||+|++... .....+.+.+|++++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468888999999999999997643 368999987543 22345678899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999986543 68999999999999999999999 9999999999999999999999999999986432
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+..... .. ..+..
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------~i-~~~~~------ 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------KI-LEGII------ 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------HH-hcCCC------
Confidence 1 234579999999999999889999999999999999999999997654322111 11 11110
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
.++......+.+++.+|++.+|.+|+ ++.|+++
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11222344577899999999999995 7777764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.40 Aligned_cols=264 Identities=21% Similarity=0.312 Sum_probs=200.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...++||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45777899999999999999765 57899999876543 22345678999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++ +|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 985 8988886443 357899999999999999999999 999999999999999999999999999997643211
Q ss_pred ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH---------HhhcCCc
Q 003350 642 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK---------WQNKGQL 711 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~~ 711 (828)
.......++..|+|||++.+ ..++.++||||+||++|||++|++||......+.......... .......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 11234568899999999865 5689999999999999999999999976554433221111000 0000001
Q ss_pred ccccCccccC----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.....+.... ...+....++.+++.+||+.+|.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111100 001123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=323.17 Aligned_cols=267 Identities=26% Similarity=0.368 Sum_probs=203.3
Q ss_pred CccceEeeeCcEEEEEEEe-----cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcEEEE
Q 003350 487 DESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILI 558 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 558 (828)
...+.||+|+||.||++.. .+++.||+|...... ......|.+|+++|++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6678999999999988643 357789999887543 23456788999999999999999999988653 458899
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++++|.+++... .+++.+++.++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999998653 48999999999999999999999 89999999999999999999999999999865432
Q ss_pred Ccc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 639 DQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
... .......++..|+|||.+....++.++||||||+++|||++|+.|+...... ......+.........+.+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhhc
Confidence 111 1112234566799999999889999999999999999999999998643211 11111110000000111111222
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
......+...+..+.+++.+|++.+|.+||++.++++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2222233445678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.95 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=202.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-----CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc--CCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-----DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 556 (828)
+.|...+.||+|+||.||++..+ ++..||+|++........+.|.+|++++++++||||+++.+++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 35667789999999999999742 478999999887766667889999999999999999999998743 45689
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+|+||+++++|.+++.... ..++|..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986543 358999999999999999999999 899999999999999999999999999998754
Q ss_pred CCCccc-eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC-----
Q 003350 637 EIDQTH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ----- 710 (828)
Q Consensus 637 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 710 (828)
...... ......++..|+|||++.+..++.++|||||||++|||++|..++...... +.........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 232 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQMIV 232 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccccch
Confidence 322111 111223445699999999889999999999999999999987665322110 0000000000
Q ss_pred --cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 711 --LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 711 --~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
+.+.+............+..+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000110001111233456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=324.77 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=206.6
Q ss_pred cCCCccceEeeeCcEEEEEEEecC-C--cEEEEEEcCCC-CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND-G--TKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...++||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467788999999999999998753 3 34788887743 334456789999999999 799999999999999999999
Q ss_pred EEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 559 YEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
+||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999986432 1358899999999999999999999 999999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |+.||......+.. .
T Consensus 159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~------~ 229 (297)
T cd05089 159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------E 229 (297)
T ss_pred EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------H
Confidence 9999999874321 111111233567999999998899999999999999999997 99999765443221 1
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhh
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 765 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~ 765 (828)
.... + .....+......+.+++.+|++.+|.+||++.++++.|+.+++..+.
T Consensus 230 ~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 KLPQ-G---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHhc-C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111 0 11111223456688999999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=314.44 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=200.5
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCccc
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 568 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~ 568 (828)
++||+|+||.||+|...+++.+|+|.+..... .....|.+|++++++++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999998876543 33456889999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceecccc
Q 003350 569 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648 (828)
Q Consensus 569 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (828)
+++.... ..+++.+++.++.|++.+|.|||+ .+++||||||+||++++++.+||+|||++....... ........
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQ 155 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCC
Confidence 9886543 458999999999999999999999 899999999999999999999999999987533211 11112234
Q ss_pred ccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003350 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727 (828)
Q Consensus 649 gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (828)
++..|+|||++.+..++.++||||||+++|||++ |..||.......... . ...+. ........
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~------~-~~~~~---------~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE------Q-VEKGY---------RMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH------H-HHcCC---------CCCCCCCC
Confidence 4678999999998999999999999999999998 999987553322111 1 11110 01122334
Q ss_pred HHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 728 LRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 728 ~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
+..+.+++.+|++.+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=322.27 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=205.3
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
+++...++||+|+||.||++... ++..+++|.+........+.|.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35666789999999999999642 356899998887766667889999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCC-------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 558 IYEYMENGTLKGHLYGSGL-------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
++||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999865321 358999999999999999999999 999999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |++||......+....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC----- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-----
Confidence 9999999875433222112223345678999999999999999999999999999998 8999865443322111
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
. ..+. .. ..+...+..+.+++.+|++.+|.+||++.||.+.|+
T Consensus 237 -~-~~~~-----~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 -I-TQGR-----EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -H-HcCc-----cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 1110 00 111233456889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=317.82 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=205.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CC---cEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DG---TKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.++|+..+.||+|+||.||+|+.. ++ ..+++|...... ....+++..|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346777899999999999999875 23 379999887552 3445678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999986543 468999999999999999999999 8999999999999999999999999999976543
Q ss_pred CCccce-eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 638 IDQTHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 638 ~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
...... ......+..|+|||++....++.++|||||||++|||++ |+.||......+. ..... .+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~------~~~i~-~~~----- 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV------MKAIN-DGF----- 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHh-cCC-----
Confidence 221111 112223567999999998899999999999999999997 9999865433221 11111 110
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
......+.+..+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=347.73 Aligned_cols=259 Identities=27% Similarity=0.356 Sum_probs=207.1
Q ss_pred HHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC-
Q 003350 478 AVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN- 553 (828)
Q Consensus 478 ~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~- 553 (828)
+.+...++|...++||+|+||.||+++.. +++.||||.+... +......+.+|+.++..++|+|++++...+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34444578999999999999999999754 6899999987654 3344567889999999999999999887764332
Q ss_pred -------cEEEEEEeccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 554 -------EMILIYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 554 -------~~~lV~ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence 368999999999999998642 23468999999999999999999999 999999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (828)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHH
Confidence 99999999865432222233456799999999999999999999999999999999999999975533221 111
Q ss_pred HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 705 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.. .+.. + ..+......+.+++.+||+.+|.+||++.+++..
T Consensus 257 ~~-~~~~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TL-AGRY----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hh-cCCC----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 1110 1 1223445678899999999999999999999864
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=324.97 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=202.6
Q ss_pred cCCCccceEeeeCcEEEEEEEecC---------------CcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND---------------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIG 547 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 547 (828)
++|...+.||+|+||.||++...+ ...||+|..... .......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467788899999999999986532 235899988754 3334567899999999999999999999
Q ss_pred EEccCCcEEEEEEeccCCcccccccCCC----------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEE
Q 003350 548 YCDEKNEMILIYEYMENGTLKGHLYGSG----------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANIL 617 (828)
Q Consensus 548 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NIL 617 (828)
++...+..++||||+++++|.+++.... ...++|.+++.++.|+++||+|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999885421 1347899999999999999999999 89999999999999
Q ss_pred eCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh--cCCCCCCCChhhh
Q 003350 618 LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPREM 695 (828)
Q Consensus 618 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt--G~~p~~~~~~~~~ 695 (828)
+++++.+||+|||+++...............++..|+|||++..+.++.++|||||||+++||++ |..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976543222222233445778999999998899999999999999999998 5567765433222
Q ss_pred hhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 696 VNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 696 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.... .......+.. .....++..+..+.+++.+|++.+|.+||+|.+|++.|+
T Consensus 242 ~~~~--~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENT--GEFFRNQGRQ-------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH--HHhhhhcccc-------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111 1111111110 000111223467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.48 Aligned_cols=247 Identities=29% Similarity=0.401 Sum_probs=207.9
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.|...++||+|.||.||||... .++.||+|.+.... ....++.++|+.+|.+++++||.+.+|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 3444578999999999999765 57899999987653 455788899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
.+|++.+.|.... .+++....-|.+++..||.|||. .+.+|||||+.|||+..+|.+||+|||++-...... .
T Consensus 94 ~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--K 166 (467)
T ss_pred cCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh--h
Confidence 9999999996544 45788888899999999999999 999999999999999999999999999998765422 2
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....+||+.|||||+++...|+.|+||||||++.+||++|.+|+....|....-+ +.+-.-|.+.+
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~- 233 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG- 233 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc-
Confidence 23678999999999999988999999999999999999999999976655221111 11222334433
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.....+.+++..||..+|+.||++.++++
T Consensus 234 ---~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 ---DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 45667899999999999999999999985
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.69 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=196.6
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC-----CcEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NEMI 556 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 556 (828)
+|...++||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677889999999999999865 6899999987643 223345788999999999999999999987433 3479
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||++ ++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999996 6898888544 368999999999999999999999 899999999999999999999999999998643
Q ss_pred CCCc-cceeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHH---------HHH
Q 003350 637 EIDQ-THVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW---------AMK 704 (828)
Q Consensus 637 ~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~ 704 (828)
.... ........||..|+|||++.+ ..++.++|||||||++|||++|++||.............. ...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2111 112234578999999999876 6789999999999999999999999975443221111000 000
Q ss_pred HhhcCCccccc---Cc----cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 705 WQNKGQLDQII---DP----TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 705 ~~~~~~~~~~~---d~----~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+ ......+.+ .+ .+...+ +.....+.+++.+||+.+|.+||++.|+++.
T Consensus 235 i-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 V-RNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred h-hhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 000000000 00 000000 1224557899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=334.16 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=204.3
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +++.||+|++.... ......+..|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36788899999999999999876 68899999876432 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999665 468999999999999999999999 999999999999999999999999999998654322
Q ss_pred ---------------------------ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCCh
Q 003350 640 ---------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP 692 (828)
Q Consensus 640 ---------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~ 692 (828)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 01122345699999999999999999999999999999999999999976543
Q ss_pred hhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCC-hHHHHHH
Q 003350 693 REMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-MGDVLWN 755 (828)
Q Consensus 693 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~eVl~~ 755 (828)
.+... ...... ..+.-.........+.+++.+|++ +|.+||+ +.|+++.
T Consensus 236 ~~~~~------~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYN------KIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHH------HHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 22111 111100 000000111135668889999997 9999999 9999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=337.31 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=204.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 555 (828)
++|...++||+|+||.||+|++. .++.||+|++..... ...+.+.+|+++|.++. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 34566789999999999999854 246899999876432 33457889999999997 99999999999999999
Q ss_pred EEEEEeccCCcccccccCCC------------------------------------------------------------
Q 003350 556 ILIYEYMENGTLKGHLYGSG------------------------------------------------------------ 575 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~------------------------------------------------------------ 575 (828)
++|+||+++|+|.++++...
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999886431
Q ss_pred ------------------------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC
Q 003350 576 ------------------------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619 (828)
Q Consensus 576 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld 619 (828)
...++|..+++++.|++.||+|||+ .+++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 1247888899999999999999999 8999999999999999
Q ss_pred CCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhH
Q 003350 620 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 698 (828)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l 698 (828)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~-- 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF-- 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--
Confidence 999999999999986432111111223356788999999998889999999999999999998 88888644322210
Q ss_pred HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 699 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
......+. ....+......+.+++.+|++.+|.+||++.||++.|+.++
T Consensus 352 ----~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 ----YNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----HHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 01111110 00112234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=328.19 Aligned_cols=241 Identities=27% Similarity=0.372 Sum_probs=195.4
Q ss_pred ceEeeeCcEEEEEEEe----cCCcEEEEEEcCCC----CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 490 WVIGIGGFGKVYKGEL----NDGTKVAVKRGNPR----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++||+|+||.||+++. ..++.||+|.+... .......+.+|+++|++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 35788999987643 223345678999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|+|.+++.... .+.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EG 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CC
Confidence 99999999986543 57888999999999999999999 9999999999999999999999999999875322 11
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .+. .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~~-~~~----------~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKIL-KGK----------L 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHHH-cCC----------C
Confidence 2233457999999999999888999999999999999999999999765432211 1111 111 0
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
.++......+.+++.+|++.+|.+|| ++.+++.
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 12233355688999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=321.95 Aligned_cols=262 Identities=27% Similarity=0.387 Sum_probs=206.0
Q ss_pred cCCCccceEeeeCcEEEEEEEecC-----------------CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND-----------------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSL 545 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 545 (828)
.+|...+.||+|+||.||++...+ +..||+|.+.... ....+++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467788999999999999987642 2458999877553 3446788999999999999999999
Q ss_pred EEEEccCCcEEEEEEeccCCcccccccCCC---------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcE
Q 003350 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSG---------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANI 616 (828)
Q Consensus 546 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 616 (828)
++++..++..++|+||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 999999999999999999999999986533 2368999999999999999999999 8999999999999
Q ss_pred EeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh--cCCCCCCCChhh
Q 003350 617 LLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPRE 694 (828)
Q Consensus 617 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt--G~~p~~~~~~~~ 694 (828)
+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999986543332233344567789999999998899999999999999999998 667775433222
Q ss_pred hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 695 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
............... .....+...+.++.+++.+|++.+|.+||++.||++.|+
T Consensus 242 ---~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 ---VIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 112121111111110 001112233467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=314.31 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=205.6
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|++|.||+|..+ +++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999875 5889999987643 344567889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++.......+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 999999999976545679999999999999999999999 899999999999999999999999999988654321
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.......|+..|+|||++.+..++.++|+|||||+++||++|+.||......+. .. .. ..+.. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~~-~~~~~---------~ 219 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---IL---KI-IRGVF---------P 219 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HH-HcCCC---------C
Confidence 122345688999999999999999999999999999999999999975543221 11 11 11110 1
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+.......+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122345668999999999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=327.08 Aligned_cols=240 Identities=25% Similarity=0.358 Sum_probs=192.1
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHH---HcCCCCceEEEEEEEccCCcEEEE
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEML---SQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
|...++||+|+||.||+|... +++.||||.+.... ....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 455689999999999999765 58899999876432 22345566676655 567899999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|..++.. ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988754 358999999999999999999999 99999999999999999999999999998753221
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+... ..... . .
T Consensus 155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------~i~~~-~------~- 218 (324)
T cd05589 155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVND-E------V- 218 (324)
T ss_pred --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC-C------C-
Confidence 122345679999999999999999999999999999999999999997654332211 11111 0 0
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
..+......+.+++.+||+.+|.+||++.
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 11223355678899999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.00 Aligned_cols=260 Identities=30% Similarity=0.464 Sum_probs=205.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCc--EEEEEEcCCC-CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGT--KVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...+.||+|+||.||+|..+ ++. .+++|++... .....+++.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777899999999999999865 343 4688876643 334456788999999999 899999999999999999999
Q ss_pred EEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 559 YEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
+||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999986432 2358999999999999999999999 999999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||+++.... ........++..|+|||++.+..++.++|||||||++|||+| |..||......+.. .
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~ 234 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E 234 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH------H
Confidence 9999999864221 111112234667999999988889999999999999999998 99998654332211 1
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhh
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 765 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~ 765 (828)
.... + .....+......+.+++.+|++.+|++||++.++++.|+.+++....
T Consensus 235 ~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 235 KLPQ-G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred HHhc-C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 1110 0 00011122345678999999999999999999999999987766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=321.22 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=205.5
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (828)
..++|...++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888899999999999999653 24579999876443 2334568899999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC--------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEE
Q 003350 555 MILIYEYMENGTLKGHLYGSG--------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV 626 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl 626 (828)
.++||||+++|+|.+++.... ...+++..+++++.|++.||+|||+ ++++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996421 2456788899999999999999999 99999999999999999999999
Q ss_pred EeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHH
Q 003350 627 ADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKW 705 (828)
Q Consensus 627 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 705 (828)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |+.||......+... ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~------~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK------FV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HH
Confidence 99999986543222222222345678999999999999999999999999999998 788886544332111 11
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
. .+... ..+......+.+++.+|++.+|++||++.++++.|++.+
T Consensus 235 ~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 M-DGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1 11100 111233467899999999999999999999998887753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.72 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=192.2
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
|...++||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+++++.++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 344578999999999999865 58899999886543 2335678999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+.. .+.+..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 224 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DP 224 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cc
Confidence 99987542 35677888999999999999999 899999999999999999999999999998653211 11
Q ss_pred eccccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 644 STAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+... .... .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~-~-------- 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA---ICMS-Q-------- 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hhcc-C--------
Confidence 234578999999998743 2345689999999999999999999973322221111110 0000 0
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..........++.+++.+||+.+|++||++.|+++
T Consensus 293 -~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 -PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112234567889999999999999999999975
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=329.12 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=201.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+++++.++|+||+++.+++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36788899999999999999765 58899999877532 234566889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~- 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN- 155 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCC-
Confidence 9999999999986542 368999999999999999999999 99999999999999999999999999999865432
Q ss_pred ccceeccccccccccChhhhc------cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||......+. ............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRFLK 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCccC
Confidence 222233457899999999986 45678999999999999999999999975543221 111111111000
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. .........+.+++.+|++ +|.+||++.+++.
T Consensus 230 ~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0111234567888999997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=318.99 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=206.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC------CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
.++|...+.||+|+||.||+|...+ +..||+|...... .....++.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3467778899999999999997642 3689999976553 23456788999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCC--------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEE
Q 003350 556 ILIYEYMENGTLKGHLYGSG--------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA 627 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~ 627 (828)
++||||+++|+|.+++.... ...++|..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 99999999999999986422 2347899999999999999999999 999999999999999999999999
Q ss_pred eeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHh
Q 003350 628 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+... +.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK---FV---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH---HH----
Confidence 9999976543222222234456789999999998899999999999999999998 899987554333221 11
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
..+... ..+...+..+.+++.+|++.+|.+||++.++++.|+
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111110 112233567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=320.38 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=201.6
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
+|+..++||+|+||.||++... +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3667789999999999999865 588999998765322 223457789999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++|+|.+++.......+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--
Confidence 9999999998876554579999999999999999999999 89999999999999999999999999998764321
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||........... ........ .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~---~~~~~~~~----------~ 221 (285)
T cd05605 156 -ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE---VERRVKED----------Q 221 (285)
T ss_pred -CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH---HHHHhhhc----------c
Confidence 112345689999999999988999999999999999999999999975433221111 11101110 0
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
..++......+.+++.+|++.+|.+|| ++.+++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 112233455688999999999999999 6777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.88 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=203.8
Q ss_pred CCCccceEeeeCcEEEEEEEecC-C---cEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELND-G---TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
.|...+.||+|+||.||+|.... + ..||||.+... .....++|..|+.++++++||||+++.+++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46677899999999999998653 3 36999998754 3445678999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999986543 468999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccceec-ccc--ccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 640 QTHVST-AVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 640 ~~~~~~-~~~--gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
...... ... .+..|+|||++.+..++.++|||||||++|||++ |..||......+ ...+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~----~~~----- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE----QDY----- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH----cCC-----
Confidence 111111 111 2457999999999999999999999999999886 999987544322 222211 100
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
......+.+..+.+++.+|++.+|.+||+|.+|+..|+.+
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011233456688999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=327.68 Aligned_cols=251 Identities=24% Similarity=0.297 Sum_probs=197.3
Q ss_pred CCCccceEeeeCcEEEEEEEe----cCCcEEEEEEcCCC----CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcE
Q 003350 485 NFDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNPR----SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (828)
+|...+.||+|+||.||+++. .+++.||+|.+... .....+.+..|++++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467788999999999999865 25789999987542 223345678899999999 599999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999998654 368999999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.... ........||..|+|||++.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 156 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~------- 225 (332)
T cd05614 156 LSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK------- 225 (332)
T ss_pred cccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-------
Confidence 3311 1123345799999999999865 47899999999999999999999996433221111 11111111
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
.++. ++......+.+++.+||+.+|.+|| ++.++++
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 2223345678899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=326.91 Aligned_cols=243 Identities=24% Similarity=0.339 Sum_probs=192.9
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+++.. +++.+|+|.+... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 5789999987653 223455678899988877 899999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence 9999888554 368999999999999999999999 89999999999999999999999999998753221 1122
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhh--hhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE--MVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
....||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+.......... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 34679999999999999999999999999999999999999996321111 11112222222111111 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
++......+.+++.+||+.+|.+||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 223345667899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.36 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=208.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.++|...++||+|+||.||+|..++++.+|||.+..... ..+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 456788899999999999999988788899998875433 3578999999999999999999999999989999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.......+++.+++.++.+++.||+|||+ .+++|+||||+||++++++.+||+|||+++..... ...
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYT 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch-hhh
Confidence 99999999977655679999999999999999999999 89999999999999999999999999998765431 111
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......++..|+|||.+.+..++.++||||||++++||++ |+.||......+.. .. .... ...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~---~~~~----------~~~ 223 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL---EQ---VERG----------YRM 223 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH---HHcC----------CCC
Confidence 1122334568999999998899999999999999999999 99999654332211 11 1000 000
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
..+.+.+..+.+++.+|++.+|.+||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1112235678899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.65 Aligned_cols=249 Identities=29% Similarity=0.469 Sum_probs=206.8
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45777789999999999999876 78899999876654 56789999999999999999999999998999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 9999999976554579999999999999999999999 999999999999999999999999999998753211
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
....++..|+|||++..+.++.++||||||++++||++ |+.||......+.. .. ...+. ...
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~----~~~~~---------~~~ 219 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PH----VEKGY---------RME 219 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH----HhcCC---------CCC
Confidence 12345678999999998899999999999999999997 99998755433221 11 11110 011
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.+...+..+.+++.+|++.+|.+||++.|++++|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 122335678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.64 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=205.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec--------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCC
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN 553 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 553 (828)
++|...+.||+|+||.||+++.. ....+|+|.+.... .....++..|+++++++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45677789999999999999642 24578999877543 34456788999999999 6999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC
Q 003350 554 EMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld 619 (828)
..++|+||+++|+|.+++.... ...++|.++++++.|++.||+|||+ .+++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 9999999999999999985422 2458999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhH
Q 003350 620 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 698 (828)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l 698 (828)
+++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986543222111222334567999999999999999999999999999999 8888865543332211
Q ss_pred HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 699 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
...+.. ...+.....++.+++.+|++.+|.+||++.|+++.|+++..
T Consensus 249 -------~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 249 -------LREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -------HHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111110 01123345568899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.13 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=197.1
Q ss_pred eEeeeCcEEEEEEEec---CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCC
Q 003350 491 VIGIGGFGKVYKGELN---DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 565 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~g 565 (828)
.||+|+||.||+|.++ ++..+|+|++.... ....+++.+|+.+++.+.|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 56889999876543 234577899999999999999999999985 45678999999999
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc-ee
Q 003350 566 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VS 644 (828)
Q Consensus 566 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~ 644 (828)
+|.+++... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999998654 368999999999999999999999 899999999999999999999999999998654322111 11
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
....++..|+|||.+....++.++|||||||++|||++ |+.||......+... . .+++. ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------~-i~~~~---------~~~~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ------M-IESGE---------RMEC 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------H-HHCCC---------CCCC
Confidence 22334678999999988889999999999999999998 999997654332211 1 11111 1112
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23345678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.53 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=196.5
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+++.. +++.||+|.+... .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 5789999988653 223356688999999998 799999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTT 153 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCcc
Confidence 9999888544 369999999999999999999999 9999999999999999999999999999875321 11123
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhh--hhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE--MVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
....||..|+|||++.+..++.++|||||||++|||++|+.||+.....+ ......+.......... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 34679999999999999999999999999999999999999996432111 11122222222222111 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCC------hHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPS------MGDVL 753 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPs------m~eVl 753 (828)
++......+.+++.+||+.+|.+||+ +.+++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 22233456889999999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.57 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=202.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|+..++||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|+||++++++|...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888899999999999999876 5788999987654 23345678999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ ..+++||||||+|||+++++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 999999999986543 58899999999999999999997 13699999999999999999999999999875432
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc--------
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD-------- 712 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------- 712 (828)
.......||..|+|||++.+..++.++|||||||++|||++|+.||......+...... ....+...
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG----CPVEGDPAESETSPRP 231 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhc----CcccCCccccccCccc
Confidence 11234568999999999998899999999999999999999999997543322111000 00000000
Q ss_pred ---------------------cccCccccC---CCC-hhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 713 ---------------------QIIDPTLAG---KIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 713 ---------------------~~~d~~l~~---~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
...+..... ... .....++.+++.+||+.+|.+||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000000 000 0123568899999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.30 Aligned_cols=238 Identities=26% Similarity=0.376 Sum_probs=191.1
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|+.. +++.||+|.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4788999987643 223345566677777654 899999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99999886543 68999999999999999999999 999999999999999999999999999997543211 223
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... .+ .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~-------~~----~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD------SILND-------RP----HFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHcC-------CC----CCC
Confidence 45679999999999999899999999999999999999999997654332211 11110 01 112
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGD 751 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~e 751 (828)
......+.+++.+||+.+|.+||++.+
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 223456788999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=328.69 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=196.4
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 565 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~g 565 (828)
+.||+|+||.||++... +++.||+|.+... .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 6889999987643 2233566788999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceec
Q 003350 566 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645 (828)
Q Consensus 566 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (828)
+|.+++.... .+++.++..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccccc
Confidence 9998885543 68999999999999999999995 258999999999999999999999999998753221 11223
Q ss_pred cccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003350 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725 (828)
Q Consensus 646 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (828)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ..+. . .++.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~~------~----~~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEE------I----RFPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcCC------C----CCCC
Confidence 456999999999999999999999999999999999999999755433221111 0000 0 1122
Q ss_pred hHHHHHHHHHHhhhhhCCCCCC-----ChHHHHHH
Q 003350 726 DSLRKFGETAEKCLADFGVDRP-----SMGDVLWN 755 (828)
Q Consensus 726 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~~ 755 (828)
.....+.+++.+||+.+|.+|+ ++.++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3345678899999999999996 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.38 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=203.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCc----EEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...++||+|+||.||+|++. +++ .||+|.+.... ....+++.+|+.++..++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46777789999999999999753 444 48999876543 3346678899999999999999999999975 45779
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
++||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999986543 468999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
...........++..|+|||.+.+..++.++|||||||++|||++ |..|+......+. ..+.. .+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~----~~~~~---- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLLE----KGERL---- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH----CCCcC----
Confidence 222111222345678999999998999999999999999999998 8999875443222 11111 11100
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.........+.+++.+|++.+|++||++.|++..|+.+.+
T Consensus 231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1112335568899999999999999999999988876643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=328.12 Aligned_cols=238 Identities=25% Similarity=0.312 Sum_probs=193.9
Q ss_pred ceEeeeCcEEEEEEEe----cCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 490 WVIGIGGFGKVYKGEL----NDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
+.||+|+||.||+++. .+|+.+|+|++.... ......+..|+++|++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 357899999876532 2234567789999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~ 154 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK 154 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence 99999998554 368999999999999999999999 99999999999999999999999999999764321 112
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||......+... ... ... ..+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~------~i~-~~~----------~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT------MIL-KAK----------LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH------HHH-cCC----------CCC
Confidence 334679999999999998889999999999999999999999997654322211 111 110 012
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGD 751 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~e 751 (828)
+......+.+++.+||+.+|.+||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2233456788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=332.39 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=198.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...++||+|+||.||+++.. +++.||||++.... ......+.+|+++|..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888899999999999999875 58899999876431 233456789999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999986543 68999999999999999999999 999999999999999999999999999987532211
Q ss_pred cc------------------------------------ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhc
Q 003350 640 QT------------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 683 (828)
Q Consensus 640 ~~------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG 683 (828)
.. .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 001124699999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCC---hHHHHH
Q 003350 684 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS---MGDVLW 754 (828)
Q Consensus 684 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---m~eVl~ 754 (828)
+.||....+.+.. . ...... ..+...........+.+++.+|+. +|.+|++ +.|++.
T Consensus 236 ~~Pf~~~~~~~~~---~---~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQETY---R---KIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHHHH---H---HHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999765443221 1 111000 000000001223456778888886 8999997 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=330.40 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=197.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||++... +++.||||.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36778899999999999999765 6889999987543 2234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998654 368899999999999999999999 999999999999999999999999999996321100
Q ss_pred cc---------------------------------------------ceeccccccccccChhhhccCCCCcccceeehh
Q 003350 640 QT---------------------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 674 (828)
Q Consensus 640 ~~---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfG 674 (828)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124699999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCCChhhhhh-HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCC---CChH
Q 003350 675 VVLFEVLCARPVIDPTLPREMVN-LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDR---PSMG 750 (828)
Q Consensus 675 vvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Psm~ 750 (828)
|++|||++|+.||....+.+... ...| ...+ .. + . .......+.+++.+|+. +|.+| +++.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~------~~~~-~~--p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINW------RETL-YF--P---D--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHcc------CCcc-CC--C---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999997654433211 1111 0000 00 0 0 01224557788999997 66665 6999
Q ss_pred HHHHH
Q 003350 751 DVLWN 755 (828)
Q Consensus 751 eVl~~ 755 (828)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.77 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=197.4
Q ss_pred eEeeeCcEEEEEEEec---CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 491 VIGIGGFGKVYKGELN---DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
.||+|+||.||+|.+. .+..||+|.+..... ...++|.+|++++++++|+||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 355799998876533 33567899999999999999999999985 457899999999999
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc-eec
Q 003350 567 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VST 645 (828)
Q Consensus 567 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~ 645 (828)
|.+++.... ..+++.++++++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++......... ...
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999986533 468999999999999999999999 899999999999999999999999999997643322111 112
Q ss_pred cccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 646 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
...++..|+|||++....++.++|||||||++|||++ |+.||......+... ....+. ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~---------~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-------FIEQGK---------RLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-------HHHCCC---------CCCCC
Confidence 2334678999999988889999999999999999996 999997654332211 111111 01122
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
..+..++.+++.+|++.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34456788999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.87 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=201.9
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEE-ccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC-DEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ey~ 562 (828)
++|...+.||+|+||.||++... +..+++|...... ..+.|.+|+.++++++|+|++++++++ ...+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35777789999999999999775 7789999876543 346789999999999999999999976 4556789999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.......+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---- 155 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence 99999999976655568999999999999999999999 89999999999999999999999999998754321
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.....++..|+|||++....++.++|||||||++|||++ |+.|+......+ +.. .. ..+. ..
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~---~~-~~~~---------~~ 218 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP---RV-EKGY---------KM 218 (256)
T ss_pred -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HH-hcCC---------CC
Confidence 123345678999999998899999999999999999998 999886443222 111 11 1110 01
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1122345678899999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.56 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=204.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
.++|...+.||+|+||.||++... ++..+|+|.+.... ....++|.+|+.++++++||||++++++|......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999763 46789999887543 34456799999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCC--------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCc
Q 003350 556 ILIYEYMENGTLKGHLYGSG--------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSAN 615 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~N 615 (828)
++|+||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999986321 2358899999999999999999999 899999999999
Q ss_pred EEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhh
Q 003350 616 ILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPRE 694 (828)
Q Consensus 616 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~ 694 (828)
||+++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432221111223345678999999998999999999999999999997 888886543332
Q ss_pred hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 695 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.. .. ...+... ..+...+.++.+++.+|++.+|.+||++.|+++.|+
T Consensus 241 ~~------~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VI------YY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HH------HH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11 11 1111111 112234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.44 Aligned_cols=205 Identities=24% Similarity=0.397 Sum_probs=176.3
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|+..+.||+|+||.||++... +++.||+|++.... ......+..|++++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46788899999999999999765 58899999886432 233456788999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999999654 368999999999999999999999 999999999999999999999999999987543211
Q ss_pred cc---------------------------------ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCC
Q 003350 640 QT---------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 686 (828)
Q Consensus 640 ~~---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p 686 (828)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 011235799999999999999999999999999999999999999
Q ss_pred CCCCChh
Q 003350 687 IDPTLPR 693 (828)
Q Consensus 687 ~~~~~~~ 693 (828)
|....+.
T Consensus 236 f~~~~~~ 242 (363)
T cd05628 236 FCSETPQ 242 (363)
T ss_pred CCCCCHH
Confidence 9765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.31 Aligned_cols=241 Identities=22% Similarity=0.307 Sum_probs=194.8
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|+.. +++.||+|.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 4789999987653 233455677899999866 899999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTT 153 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccC--Cccc
Confidence 99998886543 68999999999999999999999 89999999999999999999999999998753221 1123
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+... ...... . ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~------~i~~~~----~-------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE------SILHDD----V-------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH------HHHcCC----C-------CCC
Confidence 34579999999999999999999999999999999999999998654433211 111110 0 011
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCC-------ChHHHHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRP-------SMGDVLW 754 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RP-------sm~eVl~ 754 (828)
......+.+++.+||+.+|.+|| ++.++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 22345678899999999999999 6666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=333.39 Aligned_cols=254 Identities=22% Similarity=0.249 Sum_probs=200.8
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
..++|...++||+|+||.||+++.. +++.||+|.+... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888899999999999999875 5789999987542 22334557899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++... .++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999988543 47888899999999999999999 9999999999999999999999999999976432
Q ss_pred CCccceeccccccccccChhhhccC----CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
. .........||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ........
T Consensus 195 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~--- 264 (370)
T cd05596 195 N-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKN--- 264 (370)
T ss_pred C-CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCC---
Confidence 1 11122345799999999998653 4789999999999999999999999765432211 11111000
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCC--CCChHHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVD--RPSMGDVLWN 755 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eVl~~ 755 (828)
.+.-.........+.+++.+||+.+|.+ ||++.|++..
T Consensus 265 ----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000011123566788999999998987 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.51 Aligned_cols=238 Identities=24% Similarity=0.330 Sum_probs=193.4
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|+.+ +++.||+|.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 5789999987643 223456677888988876 699999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTT 153 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCcc
Confidence 99999886543 68999999999999999999999 9999999999999999999999999999875322 11223
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .... +.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~-~~~----------~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE------AILN-DEV----------VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH------HHhc-CCC----------CCC
Confidence 44679999999999999999999999999999999999999997654332211 1111 110 111
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGD 751 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~e 751 (828)
......+.+++.+||+.+|.+||++.+
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 223456788999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.04 Aligned_cols=255 Identities=23% Similarity=0.254 Sum_probs=198.4
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
...++|...++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34568888999999999999999876 5788999987542 2233456789999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||+++|+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999998543 47889999999999999999999 999999999999999999999999999998653
Q ss_pred CCCccceeccccccccccChhhhccC----CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. ........
T Consensus 194 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~-- 264 (370)
T cd05621 194 ETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKN-- 264 (370)
T ss_pred cCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCc--
Confidence 311 1122356799999999999754 3789999999999999999999999755432211 11111100
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCC--CCCChHHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGV--DRPSMGDVLWN 755 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~--~RPsm~eVl~~ 755 (828)
.+.-.........+.+++.+|++..+. .||++.|+++.
T Consensus 265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000000112345577788889875554 38899888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=330.46 Aligned_cols=260 Identities=23% Similarity=0.371 Sum_probs=202.0
Q ss_pred cCCCccceEeeeCcEEEEEEEe------cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEcc-CCc
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE-KNE 554 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~~ 554 (828)
++|...++||+|+||.||+|.. .+++.||||++.... ......+.+|+.+|.++ +|+||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4678889999999999999963 346789999987543 23356788999999999 78999999998854 456
Q ss_pred EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003350 555 MILIYEYMENGTLKGHLYGSG----------------------------------------------------------- 575 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------- 575 (828)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999998885421
Q ss_pred ------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccc
Q 003350 576 ------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649 (828)
Q Consensus 576 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 649 (828)
...++|.++..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1247889999999999999999999 9999999999999999999999999999976432211111223345
Q ss_pred cccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHH
Q 003350 650 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 728 (828)
Q Consensus 650 t~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (828)
+..|+|||++.+..++.++||||||+++|||++ |..|+......+. . ......+... ..+....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~~~~---------~~~~~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTRM---------RAPDYTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H----HHHHhccCCC---------CCCCCCC
Confidence 678999999998899999999999999999997 8888865322111 0 1111111100 0111123
Q ss_pred HHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 729 RKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 729 ~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.++.+++.+|++.+|.+||++.||++.|+.+++
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 467899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.91 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=206.7
Q ss_pred CCCccceEeeeCcEEEEEEEec--------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 485 NFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
+|...+.||+|+||.||++... .+..||+|...... ....+++.+|++++.++ +||||++++++|...+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 5777889999999999999642 12368999877542 34467899999999999 89999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC
Q 003350 555 MILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 620 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~ 620 (828)
.++++||+++|+|.+++.... ...++|.+++.++.|++.||+|||+ .+++||||||+|||+++
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcC
Confidence 999999999999999986421 2358999999999999999999999 99999999999999999
Q ss_pred CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHH
Q 003350 621 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 699 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~ 699 (828)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 246 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--- 246 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---
Confidence 99999999999986543222222223345678999999999999999999999999999998 88888654332221
Q ss_pred HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 700 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
...... .. ...+......+.+++.+|++.+|.+||++.|+++.|+.+....
T Consensus 247 ---~~~~~~-~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 247 ---KLLKEG-HR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ---HHHHcC-CC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111111 10 0112234567889999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.43 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=205.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.+|...+.||+|+||.||+|... .+..+|+|.+.... ....+.|.+|+.++.+++||||+++.+++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45777899999999999999763 23479999886543 33456889999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997543 468999999999999999999999 99999999999999999999999999999875432
Q ss_pred Cccce-eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 639 DQTHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 639 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
..... .....++..|+|||++.+..++.++|||||||++||+++ |+.||......+. ..+. .++. .
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~-----~ 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----EEGY-----R 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----hCCC-----c
Confidence 21111 112234568999999998899999999999999999886 9999865443321 1111 1110 0
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
. ......+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 11123456688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.64 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=213.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc-EEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE-MILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 559 (828)
++|...+++|+|+||.++..+.+ +++.+++|.+.... ....+....|+.++++++|||||.+.+.+.+++. +++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 45667789999999999998765 57789999876543 3345567899999999999999999999999998 99999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
+|++||+|.+.+...+...++++++..++.|++.|+.|||+ ..|+|||||+.||+++.+..+||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999987776779999999999999999999998 999999999999999999999999999999876532
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.......||+.|+.||.+.+.+|..|+|||||||++|||++-+++|........ +. +..+ ..
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i~---ki~~----------~~ 222 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---IL---KINR----------GL 222 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---HH---HHhh----------cc
Confidence 245678899999999999999999999999999999999999999986643332 22 1111 11
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
....+.....++..++..|++.+|..||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 223445567788999999999999999999999975
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.56 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=205.6
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||++...++..+++|.+.... ...+.|.+|++++++++|+||+++.+++.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 4677889999999999999988777889999877543 335678999999999999999999999877 78899999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.......+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++....... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTA 159 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC-ccc
Confidence 9999999976555678999999999999999999999 899999999999999999999999999997653311 111
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||++....++.++|+|||||++|||++ |+.||......+.. .+. ..+.. ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~----~~~~~---------~~ 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RAL----ERGYR---------MP 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----hCCCC---------CC
Confidence 223345678999999998889999999999999999999 89998754332211 111 11100 01
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112334568899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.67 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=194.8
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCC-ceEEEEEEEccCCcEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHR-HLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 559 (828)
+|...+.||+|+||.||+|+.. +++.||+|.+... .....+.+..|.+++..+.|+ +|+++.+++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677789999999999999876 4678999987643 233456788899999999765 5888999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 9999999999886543 58999999999999999999999 99999999999999999999999999998753221
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........||..|+|||++.+..++.++|||||||++|||+||+.||......+... ... ... .
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~------~i~-~~~------~-- 218 (324)
T cd05587 155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ------SIM-EHN------V-- 218 (324)
T ss_pred -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHH-cCC------C--
Confidence 112334579999999999999999999999999999999999999997654332211 111 110 1
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
.++......+.+++.+||+.+|.+|++.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122334567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.39 Aligned_cols=263 Identities=20% Similarity=0.279 Sum_probs=198.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357888899999999999999876 688999998765432 223467889999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-- 156 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--
Confidence 996 57877775433 458899999999999999999999 99999999999999999999999999998754321
Q ss_pred cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc---CCcc----
Q 003350 641 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK---GQLD---- 712 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~---- 712 (828)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+.. ............ ....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhh
Confidence 112234568999999999865 458899999999999999999999997543211 111111110000 0000
Q ss_pred -cccCccccCCCC----------hhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 -QIIDPTLAGKIR----------PDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 -~~~d~~l~~~~~----------~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...++....... ......+.+++.+||+.+|.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000010000000 011245778999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.06 Aligned_cols=241 Identities=22% Similarity=0.308 Sum_probs=194.9
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 559 (828)
+|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..+ +|++|+++.+++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999776 47899999876532 22345567788888877 5899999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~-- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-- 153 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC--
Confidence 9999999999886543 58999999999999999999999 8999999999999999999999999999875322
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .... ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~---~i~~-~~--------- 217 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---Q---SIME-HN--------- 217 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---H---HHHh-CC---------
Confidence 111233567999999999999999999999999999999999999999765443221 1 1111 10
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
..++.....++.+++.+|++.+|.+|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01222345567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.99 Aligned_cols=249 Identities=32% Similarity=0.485 Sum_probs=205.2
Q ss_pred ceEeeeCcEEEEEEEecC----CcEEEEEEcCCCCccc-HHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELND----GTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|.... +..+++|.+....... .+++.+|+++++.++|+|++++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 7789999987654433 67889999999999999999999999999999999999999
Q ss_pred CcccccccCCC-------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 565 GTLKGHLYGSG-------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 565 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 2579999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
...........++..|+|||.+....++.++|||||||++|||++ |+.||......+.. . .... +.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~---~~~~-~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---E---YLRK-GY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---H---HHHc-CC------
Confidence 332223344567889999999998899999999999999999999 59999765432221 1 1111 10
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
....+...+.++.+++.+|++.+|.+||++.|++..|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01122333567889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.23 Aligned_cols=249 Identities=30% Similarity=0.458 Sum_probs=197.4
Q ss_pred ceEeeeCcEEEEEEEecC-Cc--EEEEEEcCCC-CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELND-GT--KVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|...+ +. .+++|..... .....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 5788887753 334456789999999999 899999999999999999999999999
Q ss_pred CcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 565 GTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 565 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
|+|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1358899999999999999999999 999999999999999999999999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKG 709 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (828)
+++.... .........+..|+|||++....++.++|||||||++|||++ |+.||......+.. .......
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~ 228 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQGY 228 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH------HHHhCCC
Confidence 9864221 111112234567999999988899999999999999999997 99998654322211 1111110
Q ss_pred CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 710 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
. ...+......+.+++.+|++.+|.+||++.|+++.|++++
T Consensus 229 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 0111223456889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.70 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=193.4
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.|...++||+|+||.||+|+.. +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4777899999999999999765 57899999876532 2335678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC-
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID- 639 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~- 639 (828)
|+++|+|.+++...+ .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999986543 58889999999999999999999 899999999999999999999999999975321000
Q ss_pred --------------------------------------------ccceeccccccccccChhhhccCCCCcccceeehhh
Q 003350 640 --------------------------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 675 (828)
Q Consensus 640 --------------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGv 675 (828)
.........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000112346999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCC---hHHH
Q 003350 676 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS---MGDV 752 (828)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---m~eV 752 (828)
+||||++|++||....+.+... ..... ...+...........+.+++.+|+ .+|.+|++ +.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~------~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQM------KVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHH------HHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999997654433211 10000 000000001122334556666655 48999987 6666
Q ss_pred HH
Q 003350 753 LW 754 (828)
Q Consensus 753 l~ 754 (828)
+.
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.00 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=202.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-----------------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-----------------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSL 545 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 545 (828)
++|...+.||+|+||.||++... ++..+|+|++.... ....++|.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788899999999999998532 23468999887543 3445789999999999999999999
Q ss_pred EEEEccCCcEEEEEEeccCCcccccccCCCC---------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcE
Q 003350 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL---------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANI 616 (828)
Q Consensus 546 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 616 (828)
++++...+..++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 9999999999999999999999999865321 247889999999999999999999 8999999999999
Q ss_pred EeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh--cCCCCCCCChhh
Q 003350 617 LLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPRE 694 (828)
Q Consensus 617 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt--G~~p~~~~~~~~ 694 (828)
|++.++.+||+|||+++...............++..|+|||+...+.++.++|||||||++|||++ |..|+......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986433221111222344678999999988899999999999999999998 667876543332
Q ss_pred hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 695 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.... .......... .... ..+..++..+.+++.+|++.+|.+||+|.||++.|+
T Consensus 242 ~~~~---~~~~~~~~~~-~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIEN---TGEFFRDQGR-QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHH---HHHHHhhccc-cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2111 1111111100 0000 111234567889999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.67 Aligned_cols=240 Identities=28% Similarity=0.366 Sum_probs=191.4
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHH-HHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIE-MLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+++.. +|+.+|+|.+... ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999765 6889999987643 2223345556655 56779999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|..++... ..+++.++..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTT 153 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCc
Confidence 9999888544 368999999999999999999999 9999999999999999999999999999875322 11123
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+.. ...... . + ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~~~-~--------~--~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNILHK-P--------L--VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHHcC-C--------c--cCC
Confidence 4567999999999999999999999999999999999999999765433221 111111 0 0 111
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
+.....+.+++.+|++.+|.+||++.+.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 23345678899999999999999986443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.11 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=194.2
Q ss_pred eEeeeCcEEEEEEEecC---CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 491 VIGIGGFGKVYKGELND---GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
.||+|+||.||+|...+ +..+|+|++.... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999997653 3578999876543 2334578899999999999999999999999999999999999999
Q ss_pred ccccccCCC---CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 567 LKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 567 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
|.+++.... ....++..++.++.|+++||+|||+ .+++||||||+||+++.++++||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986532 2356788889999999999999999 8999999999999999999999999999975433222222
Q ss_pred eccccccccccChhhhccC-------CCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 644 STAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~-------~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||....+.+... . ...+......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~----~~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y----TVREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H----HhhcccCCCC
Confidence 2345578889999998642 35789999999999999996 999997554332211 1 0111111222
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
++.+. ......+.+++.+|+ .+|++||++.||++.|+
T Consensus 232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 23222 122345777889998 58999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.98 Aligned_cols=249 Identities=26% Similarity=0.416 Sum_probs=201.8
Q ss_pred ceEeeeCcEEEEEEEecC--C--cEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELND--G--TKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999887665 567789999999999999999999999988 889999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc-ce
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-HV 643 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~-~~ 643 (828)
++|.+++.......++|..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999976543568999999999999999999999 99999999999999999999999999999875432211 11
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||++.+..++.++|||||||++|||++ |+.|+......+... ....... . . .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------~~~~~~~--~-----~--~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK------KIDKEGE--R-----L--E 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHhcCC--c-----C--C
Confidence 223457889999999999999999999999999999999 999997544332211 1111100 0 0 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.+...+..+.+++.+|++.+|.+||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11233567889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.05 Aligned_cols=247 Identities=21% Similarity=0.318 Sum_probs=195.8
Q ss_pred EeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
||+|+||.||+++.+ +|+.+|+|.+.... ......+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999765 58999999876432 12234556799999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccc
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (828)
.+++.......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 998876655679999999999999999999999 99999999999999999999999999998765331 122345
Q ss_pred cccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003350 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727 (828)
Q Consensus 648 ~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (828)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........ ........... .... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~---------~~~~-~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED---------EVKF-EHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc---------cccc-ccccC
Confidence 689999999999988899999999999999999999999965432111 11111111110 0000 00123
Q ss_pred HHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 728 LRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 728 ~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
..++.+++.+||+.+|.+||++.|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 45678999999999999999998876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.79 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=196.6
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
+|...+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|+++|.+++|+||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999999765 58899999876432 2234668899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC-
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID- 639 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~- 639 (828)
|+++|+|.+++...+ .++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999996543 58889999999999999999999 999999999999999999999999999975321000
Q ss_pred ----------------------------------------ccceeccccccccccChhhhccCCCCcccceeehhhHHHH
Q 003350 640 ----------------------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 679 (828)
Q Consensus 640 ----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~e 679 (828)
.........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0001123569999999999999999999999999999999
Q ss_pred HHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCC---ChHHHHHH
Q 003350 680 VLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP---SMGDVLWN 755 (828)
Q Consensus 680 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---sm~eVl~~ 755 (828)
|++|+.||....+.+... ...... ..+...........+.+++.+|+ .+|.+|+ ++.|++..
T Consensus 237 ll~G~~Pf~~~~~~~~~~------~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQL------KVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHH------HHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999998665433211 100000 00000011123445667777766 4999999 88888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.19 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=206.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +++.||||.+... .......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46788899999999999999865 6889999976542 2333567889999999999999999999999999999999
Q ss_pred EeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 560 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 560 ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||+++|+|.+++.. .....+++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 223458899999999999999999999 9999999999999999999999999999886543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.. .......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+..... +...+.......+ .+
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~------~~ 226 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCD------YP 226 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCC------CC
Confidence 11 112235688899999999988899999999999999999999999854321 1111111111100 11
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
. .........+.+++.+|++.+|.+||++.+|++.|+++
T Consensus 227 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 P---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 11123446688999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.52 Aligned_cols=257 Identities=24% Similarity=0.352 Sum_probs=202.7
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--------------ccHHHHHHHHHHHHcCCCCceEE
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--------------QGLAEFQTEIEMLSQFRHRHLVS 544 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~ 544 (828)
....++|...+.||+|.||.|-+|+.. +++.||||++..... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344678888899999999999999765 689999998654311 11357889999999999999999
Q ss_pred EEEEEcc--CCcEEEEEEeccCCcccccccCCCCCC-CChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC
Q 003350 545 LIGYCDE--KNEMILIYEYMENGTLKGHLYGSGLPS-LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN 621 (828)
Q Consensus 545 l~g~~~~--~~~~~lV~ey~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~ 621 (828)
|+.+..+ .+.+|||+|||..|.+...- ...+ |+..+.+++++++..||+|||. ++||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 9999854 56899999999988876442 2233 9999999999999999999999 999999999999999999
Q ss_pred CcEEEEeeCCCCCCCCC---CccceeccccccccccChhhhccCC----CCcccceeehhhHHHHHHhcCCCCCCCChhh
Q 003350 622 FMAKVADFGLSKTGPEI---DQTHVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694 (828)
Q Consensus 622 ~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVySfGvvl~elltG~~p~~~~~~~~ 694 (828)
+++||+|||.+...... +.........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-.....+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999998765221 1111123468999999999987632 4578999999999999999999997543322
Q ss_pred hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 695 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.. ++++...+.-...+++..++.++++++|.+||.+|.+..+|.....
T Consensus 327 l~---------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 LF---------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HH---------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 21 1233333333333456778899999999999999999999875543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=322.70 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=194.6
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+++.. +++.+|+|.+.... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 57899999887542 23456688999999888 699999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|..++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 99998885443 69999999999999999999999 99999999999999999999999999998753221 1123
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+.......... .++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 4567999999999999999999999999999999999999999654332222222222222111110 122
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
......+.+++.+||+.+|.+|+++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 23345678899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=320.96 Aligned_cols=237 Identities=29% Similarity=0.384 Sum_probs=190.3
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHH-HHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIE-MLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|+.. +++.||+|.+.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 68899999876432 222344555554 56789999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT 153 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence 9999988654 368899999999999999999999 9999999999999999999999999999875322 11223
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ...... . . ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~-~------~----~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY------DNILNK-P------L----RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH------HHHHcC-C------C----CCC
Confidence 4457999999999999999999999999999999999999999755432211 111111 0 0 112
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
+.....+.+++.+|++.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 23356688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=319.44 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=204.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCc----EEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...+.||+|+||.||+|... ++. .+|+|.+..... ....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45667789999999999999764 343 578998765433 3345788999999999999999999998654 4679
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999986543 358999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
...........++..|+|||++.+..++.++|||||||++|||++ |+.|+......+.. .+. ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~~----- 229 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLL----EKGER----- 229 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HCCCC-----
Confidence 222111223445778999999998999999999999999999997 88998654332221 111 11110
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
. .....+...+.+++.+|+..+|++||++.++++.|+.+.+..+..
T Consensus 230 --~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (303)
T cd05110 230 --L--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRY 275 (303)
T ss_pred --C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhh
Confidence 0 011223456889999999999999999999999999876554433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.75 Aligned_cols=248 Identities=28% Similarity=0.415 Sum_probs=200.5
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCccc
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 568 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~ 568 (828)
++||+|+||.||++...+++.|++|........ ....+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998877899999987765433 5678999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceecccc
Q 003350 569 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648 (828)
Q Consensus 569 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (828)
+++.... ..+++..++.++.+++.+|+|||+ .+++||||||+|||++.++.+||+|||+++...............
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9986543 368899999999999999999999 899999999999999999999999999998643211111111223
Q ss_pred ccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003350 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727 (828)
Q Consensus 649 gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (828)
++..|+|||.+.++.++.++|||||||++|||+| |..||....+...... . ... .....+...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~------~-~~~---------~~~~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER------I-ESG---------YRMPAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH------H-hcC---------CCCCCCccC
Confidence 4667999999998899999999999999999999 7888865443221111 0 000 000112234
Q ss_pred HHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 728 LRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 728 ~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
+..+.+++.+|++.+|.+||++.|+++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.49 Aligned_cols=248 Identities=26% Similarity=0.361 Sum_probs=198.6
Q ss_pred ceEeeeCcEEEEEEEecC----CcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELND----GTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 26899998876543 34567899999999999999999999876 4568999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc-e
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-V 643 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~-~ 643 (828)
|+|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997554 68999999999999999999999 899999999999999999999999999998653322111 1
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||.+.+..++.++|||||||++|||++ |++||......+ +..+.. .... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~~---------~~ 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGER---------LP 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCCc---------CC
Confidence 112234568999999999999999999999999999998 999997654322 222211 1110 01
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
.+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.96 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=201.0
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccC------
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK------ 552 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------ 552 (828)
.+++.|...+.||+|+||.||+|... +++.+|+|...... ....++..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45667888889999999999999775 57889999876543 3456788999999998 799999999998642
Q ss_pred CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
...++||||+++++|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 458999999999999999976555579999999999999999999999 89999999999999999999999999998
Q ss_pred CCCCCCCccceeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
+...... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+....+...... ..
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-------~~ 229 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------IP 229 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-------Hh
Confidence 7643211 1223456899999999986 34688899999999999999999999965433221110 00
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... .+.+ .....+..+.+++.+|++.+|.+||++.|+++
T Consensus 230 ~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 110 1111 11223456889999999999999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.72 Aligned_cols=239 Identities=24% Similarity=0.359 Sum_probs=191.0
Q ss_pred ceEeeeCcEEEEEEEecC-------------CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 490 WVIGIGGFGKVYKGELND-------------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
+.||+|+||.||+|++.. ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997532 2358999877665555678899999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc-------EEEEee
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM-------AKVADF 629 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~-------~kl~DF 629 (828)
+||||+++|+|..++.... ..+++..+++++.|+++||+|||+ .+|+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999998886543 458999999999999999999999 99999999999999987664 899999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhc-cCCCCcccceeehhhHHHHHH-hcCCCCCCCChhhhhhHHHHHHHHhh
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVL-CARPVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
|++..... .....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......+... ...
T Consensus 157 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~~ 223 (262)
T cd05077 157 GIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FYE 223 (262)
T ss_pred CCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HHh
Confidence 99875432 12345788899999986 467899999999999999998 5888876443222111 000
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
+.. . ........+.+++.+|++.+|.+||++.++++.+
T Consensus 224 -~~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 -GQC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -cCc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0 0111245678999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=321.90 Aligned_cols=240 Identities=25% Similarity=0.349 Sum_probs=192.6
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 47899999876531 23345567788888764 999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence 9999998653 368999999999999999999999 999999999999999999999999999987532211 123
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+..... ... .+. ++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i-------~~~------~~~----~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-------RMD------NPC----YP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhC------CCC----CC
Confidence 3457899999999999999999999999999999999999999765433221111 100 111 11
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChH-HHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMG-DVL 753 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~-eVl 753 (828)
......+.+++.+|++.+|.+||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 22345678899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=311.59 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=198.1
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC-----cEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-----EMILI 558 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 558 (828)
.|...+++|.|.||.||+|.+. .++.||||+......- -.+|+++|+++.|||||+|+-++.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3555689999999999999876 4689999987665432 247999999999999999998884322 34689
Q ss_pred EEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC-CcEEEEeeCCCCCC
Q 003350 559 YEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTG 635 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kl~DFGla~~~ 635 (828)
||||+. +|.+.++. .....++...+.-+..||.+||+|||+ .+|+||||||.|+|+|.+ |.+||||||-|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 99988864 223568888899999999999999999 999999999999999966 99999999999986
Q ss_pred CCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc--
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD-- 712 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 712 (828)
.... .......|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+...++--+.....++.+.
T Consensus 177 ~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 4422 2345567889999999876 589999999999999999999999998765544333222222111111111
Q ss_pred -----cccCccccC-----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 -----QIIDPTLAG-----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 -----~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.-.|.+.. -+......+..+++.++++.+|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111122211 123445677899999999999999999999985
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.42 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=206.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|++|.||++... +++.++||.+... ......++.+|+++++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35777789999999999999864 6889999976543 2233567889999999999999999999999999999999
Q ss_pred EeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 560 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 560 ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||+++++|.+++.. .....+++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998853 223468999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.. .......|+..|+|||++.+..++.++||||||+++|||++|..||...... .. .+..... ....+
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~---~~~~~~~------~~~~~ 226 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LY---SLCKKIE------QCDYP 226 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HH---HHhhhhh------cCCCC
Confidence 11 1123456889999999999889999999999999999999999998643221 11 1111110 11111
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
.. ........+.+++.+|++.+|.+||+|.+|++.++++
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 1123456788999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=297.28 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=208.9
Q ss_pred hcCCCccceEeeeCcEEEEEEE-ecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc-----CCcEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-----KNEMI 556 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~ 556 (828)
.++|.+.+.||+|||+.||.++ ..++..+|+|++...+.+..+..++|++.-++++|||++++++++.. ..+.+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4567888999999999999996 45688999999988888888999999999999999999999988743 34589
Q ss_pred EEEEeccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
++++|...|+|.+.+... +...+++.+.+.|+.++++||++||+. .++++||||||.|||+.+.+.++|.|||-+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999998653 234699999999999999999999982 23599999999999999999999999999875
Q ss_pred CCCCCccc-------eeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH
Q 003350 635 GPEIDQTH-------VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 635 ~~~~~~~~-------~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (828)
..-.-... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+..... ..++
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSl------ 251 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSL------ 251 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeE------
Confidence 43211110 112345788999999985 457889999999999999999999999754321 1110
Q ss_pred HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 705 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
...+..+.+.-.-....++.+.+++.+|++.+|.+||++.+++..++.++
T Consensus 252 ------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01111222221112235678999999999999999999999998887653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=328.75 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC-----cEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-----EMI 556 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 556 (828)
+|+..++||+|+||.||++... +++.||+|++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677889999999999999864 6899999987653 2234567889999999999999999999997766 789
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+|+||+. ++|.+.+... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999997 5787777543 368999999999999999999999 899999999999999999999999999998643
Q ss_pred CCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHH--------------
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW-------------- 701 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~-------------- 701 (828)
.. .........+|..|+|||++.+. .++.++|||||||++|||++|+.||....+.+.......
T Consensus 155 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 31 11222345678999999998764 579999999999999999999999986654433221111
Q ss_pred --HHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 702 --AMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 702 --~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
........... ............+....+.+++.+||+.+|.+||++.|++..
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 000000001112335568899999999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=310.41 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=202.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-----cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-----QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...++||+|++|.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888899999999999999764 58899999865432 1234578899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999886543 58899999999999999999999 8999999999999999999999999999976433
Q ss_pred CCccc-eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
..... ......|+..|+|||++.+..++.++||||||+++|||++|+.||......+.. . .....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~---~~~~~-------- 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---F---KIATQ-------- 222 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---H---HHhcc--------
Confidence 21111 113356788999999999988999999999999999999999998654322111 1 00000
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.....++......+.+++.+|++.+|.+||++.|+++.
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01112223345568899999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=346.58 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=205.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...++||+|+||.||+|... .++.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999865 58899999886532 223567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCC---------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 560 EYMENGTLKGHLYGS---------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 560 ey~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
||+++|+|.+++... ....+++..+++++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988531 12346788899999999999999999 899999999999999999999999999
Q ss_pred CCCCCCCCCcc----------------ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhh
Q 003350 631 LSKTGPEIDQT----------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694 (828)
Q Consensus 631 la~~~~~~~~~----------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~ 694 (828)
+++........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99865211100 01123469999999999999999999999999999999999999997533221
Q ss_pred hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCC-ChHHHHHHHHHHHHh
Q 003350 695 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-SMGDVLWNLEYALQL 762 (828)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~eVl~~L~~~~~~ 762 (828)
... .. .+.++.-... ..+.+..+.+++.+|++.+|++|| +++++.+.|+..++.
T Consensus 239 i~~----------~~---~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISY----------RD---VILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhh----------hh---hccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 110 00 0111110000 123345678899999999999995 677787888877654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.02 Aligned_cols=240 Identities=24% Similarity=0.337 Sum_probs=192.7
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 57899999876531 23345567788888754 899999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++... ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRA 153 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCce
Confidence 9999988654 368899999999999999999999 9999999999999999999999999999875321 11123
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+... .. ..+ .+. ++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~------~~-~~~------~~~----~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE------SI-RVD------TPH----YP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HH-HhC------CCC----CC
Confidence 45679999999999999999999999999999999999999997554332211 11 000 111 11
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChH-HHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMG-DVL 753 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~-eVl 753 (828)
.....++.+++.+||+.+|.+||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22345678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.45 Aligned_cols=241 Identities=25% Similarity=0.334 Sum_probs=195.3
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||++... +++.||+|.+... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 4789999987643 223456677899999888 799999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++.... .+++.++..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT 153 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence 99998886543 69999999999999999999999 99999999999999999999999999998753221 1122
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||..|+|||++.+..++.++|||||||++|||++|+.||......+... ..... . . .++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~------~i~~~-~------~----~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ------SILED-E------V----RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH------HHHcC-C------C----CCC
Confidence 34568999999999999999999999999999999999999997554322111 11111 0 0 112
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCCh-----HHHHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSM-----GDVLW 754 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm-----~eVl~ 754 (828)
......+.+++.+||+.+|.+||++ .+++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2334568899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=314.96 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=194.5
Q ss_pred EeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
||+|+||.||++... +++.+|+|.+.... ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999765 68899999876432 22345678899999999999999999999999999999999999999
Q ss_pred cccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceec
Q 003350 568 KGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645 (828)
Q Consensus 568 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (828)
.+++... ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9887542 33569999999999999999999999 999999999999999999999999999997643311 1223
Q ss_pred cccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003350 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725 (828)
Q Consensus 646 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (828)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... ..... .++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~---------~~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRI---------LNDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhh---------cccCC--CCcc
Confidence 457899999999999999999999999999999999999999754321110 0100110 01100 1223
Q ss_pred hHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 726 DSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 726 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
..+..+.+++.+||+.+|.+|| ++++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 3456688999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=322.19 Aligned_cols=237 Identities=26% Similarity=0.330 Sum_probs=189.1
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHH-HHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIE-MLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|+.. +++.||+|.+.... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 57899999876432 222344555554 67889999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|..++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 9998888543 368889999999999999999999 99999999999999999999999999998753221 1223
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. . ...... . ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~---~~i~~~---------~--~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---Y---DNILHK---------P--LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---H---HHHhcC---------C--CCCC
Confidence 445789999999999998999999999999999999999999975532221 1 111110 0 0122
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
......+.+++.+||+.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 33455688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=309.76 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=207.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999876 7899999977532 2333567899999999999999999999999999999999
Q ss_pred EeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 560 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 560 ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||+++++|.+++.. .....+++.+++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998854 223468999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.|+.... .++.+...... .+.
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~------- 224 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIE-KCD------- 224 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhh-cCC-------
Confidence 11 11233468889999999998899999999999999999999999985432 11111111111 110
Q ss_pred cccCCCC-hhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 718 TLAGKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 718 ~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
....+ ......+.+++.+|++.+|++||++.+|+++|+.+
T Consensus 225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 01111 13455788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=311.58 Aligned_cols=257 Identities=22% Similarity=0.341 Sum_probs=204.9
Q ss_pred HHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 478 AVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 478 ~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
+++.+++++....+||+|+||.||+|... ++..|++|..........+.+.+|++++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45567788888889999999999999865 57789999887766666778999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCCCCC--ChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-CCcEEEEeeCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSL--SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSK 633 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kl~DFGla~ 633 (828)
+|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999987542 234 788999999999999999999 99999999999999986 6799999999987
Q ss_pred CCCCCCccceeccccccccccChhhhccC--CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
...... .......|+..|+|||++... .++.++||||||+++|||++|++|+........ ..|......
T Consensus 158 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~---- 228 (268)
T cd06624 158 RLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK---- 228 (268)
T ss_pred ecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc----
Confidence 643211 112234578999999998654 378999999999999999999999864322111 111111000
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
....++.....++.+++.+|++.+|.+||++.|++.
T Consensus 229 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011122334566888999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=310.26 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=208.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
..+|+..+.||+|.||+|-++.. ..|+.||||.++.. +++..-.+.+|+++|+.|+||||+.++.+|+.++...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34677778999999999999965 56999999977655 445566688999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||..+|.|.+++... ..|++.+..++++||..|+.|+|. ++++|||||.+|||||+++++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 9999999999999654 479999999999999999999999 9999999999999999999999999999987543
Q ss_pred CccceeccccccccccChhhhccCCCC-cccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
....++.+|++-|.+||.+.+..|. +..|-||+||+||-|+.|..||++..... ++. ++ ..|. ..
T Consensus 206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvr---QI-s~Ga---Yr-- 271 (668)
T KOG0611|consen 206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVR---QI-SRGA---YR-- 271 (668)
T ss_pred --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHH---Hh-hccc---cc--
Confidence 3345778999999999999988874 88999999999999999999998764322 221 11 1111 11
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
.++.+....-+|.|+|..+|++|.|+.+|....
T Consensus 272 ------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 ------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 133455667789999999999999999997544
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=307.92 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=203.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+|...+.||+|+||.||++... +++.+|+|.+... .....+.+..|+.++++++|+||+++.+.+..++..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4667789999999999999765 5789999987543 3344677889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.......+++...+.++.|++.||+|||+ .+++|+||||+||++++++.++|+|||+++..... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GA 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc--cc
Confidence 99999998865544568999999999999999999999 99999999999999999999999999998765331 11
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||......... ... ..+... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~-~~~~~~---------~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI------LKV-CQGSYK---------P 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH------HHH-hcCCCC---------C
Confidence 223456889999999999889999999999999999999999999754332211 111 111111 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+......+.+++.+||+.+|.+||++.|++.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 12233456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.79 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=216.1
Q ss_pred cCCCccceEeeeCcEEEEEEEecC---C--cEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND---G--TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
+.....++||+|.||.||+|.+.+ | -.||||..+.. ..+..+.|..|..+|+.++||||++|+|+|.+. ..++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 344556799999999999997643 3 36899988874 455678899999999999999999999999764 7899
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|||.++.|.|+.+|..++ ..|+......++.||+.+|+|||+ ..+|||||..+|||+...-.+||+||||+|....
T Consensus 468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999997665 469999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
....+. +...-+..|||||-+.-++++.++|||.|||.+||++. |.+||.+....+... .++
T Consensus 544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------------~iE 606 (974)
T KOG4257|consen 544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------------HIE 606 (974)
T ss_pred cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------------Eec
Confidence 444333 34455778999999999999999999999999999985 899997654333221 111
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
..-+-..++.|+..+..+..+||+.+|.+||...|+...|.++++..
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 11223456788999999999999999999999999999999998854
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.00 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=205.2
Q ss_pred cCCCccceEeeeCcEEEEEEEecC----CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...++||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 346777899999999999997643 2468999877654 4456789999999999999999999999875 457899
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++.... ..+++.+++.++.+++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999996543 358999999999999999999999 89999999999999999999999999999865432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
. ....+...++..|+|||.+....++.++||||||+++|||++ |+.||......+.. .+ .......
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~---~~~~~~~------ 227 (270)
T cd05056 161 S-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GR---IENGERL------ 227 (270)
T ss_pred c-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH---HHcCCcC------
Confidence 1 111223345568999999988889999999999999999996 99999755433221 11 1111110
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
..+...+..+.+++.+|+..+|.+||++.+++..|+++...
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11233456788999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.10 Aligned_cols=265 Identities=24% Similarity=0.319 Sum_probs=204.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCC--CCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc-----CCcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNP--RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-----KNEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~ 555 (828)
..|...+.||+|.||.|.++... +|+.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 34444578999999999999765 689999999873 344556778899999999999999999998844 4578
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+|+|+ -+|...++.+. .|+.....-+..|+++||.|+|+ .+|+||||||+|+|++.+...||+||||||..
T Consensus 102 YiV~elMe-tDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred EEehhHHh-hHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeec
Confidence 99999995 48888886543 59999999999999999999999 99999999999999999999999999999986
Q ss_pred CCCCccceeccccccccccChhhhc-cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.........+..+.|..|.|||.+. ...|+.+.||||.||++.||++|++.|.+....+...++--......++.+..+
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 5432333446778899999999875 568999999999999999999999999876544443332221111111111111
Q ss_pred c--------C-------ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 715 I--------D-------PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 715 ~--------d-------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
- . ..+...+ +.......+++.++|..||.+|+|++|.++.
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 0 0001111 2334557899999999999999999998753
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.64 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=197.6
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
|...++||+|+||+||+|... +++.+|+|.+.... ......+.+|+++|++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556688999999999999775 58899999876542 22234578899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--- 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence 999999998876555579999999999999999999999 99999999999999999999999999998764321
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.......|+..|+|||++.+..++.++|+|||||++|||++|+.||....+..... .+........ .
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~~~~~~~~~~-----------~ 222 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--EVDRRVLETE-----------E 222 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhhhccc-----------c
Confidence 11234568999999999998899999999999999999999999997554322211 1111111000 0
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
.+.......+.+++.+|++.+|.+||++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11223345678899999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.62 Aligned_cols=254 Identities=22% Similarity=0.240 Sum_probs=195.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++..++|+||+++.+++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46788899999999999999876 5788999987642 2233455788999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD- 155 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-
Confidence 9999999999997533 368899999999999999999999 99999999999999999999999999999765331
Q ss_pred ccceeccccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.........||+.|+|||++.+ +.++.++|||||||+||||++|+.||......+.. ...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~~- 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHEERFQ- 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHcCCCccc-
Confidence 1112234569999999999875 56789999999999999999999999754432211 11111110000
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCC--CCChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVD--RPSMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eVl~ 754 (828)
+.+. ..+.+..+.+++.+|+...+++ |+++.++++
T Consensus 229 ~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0010 1123456778888888765543 467777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.40 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=203.4
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcc--cHHHHHHHHHHHHcCCCCceEEEEEEE--ccCCcEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRHLVSLIGYC--DEKNEMILIY 559 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~lV~ 559 (828)
+|...+.|++|.||.||+|+.+ +++.||+|+++..... ..-.-.+||.+|.+++|||||.+-.+. .+-+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4555578999999999999875 5889999998765432 123457999999999999999998776 4556799999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
|||+. +|...+..-+ +++...++..+..|+++|++|||. .-|+|||||++|+|+...|.+||+||||||.+...
T Consensus 157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 99987 8888887655 579999999999999999999999 99999999999999999999999999999987653
Q ss_pred ccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC--
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID-- 716 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-- 716 (828)
....+..+-|..|.|||.+.+ ..|+...|+||+|||+.||+++++.|.+..+-+..+.+-.......+.....+.+
T Consensus 231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 223466778999999999886 5799999999999999999999999987765544433322222122211111111
Q ss_pred ------------ccccCCCChh-HHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 ------------PTLAGKIRPD-SLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ------------~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+...+... ....-.++....|..||.+|-|++|.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1112222211 2345667888999999999999999874
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=311.84 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=205.8
Q ss_pred cCCCccceEeeeCcEEEEEEEecC-Cc----EEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND-GT----KVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.+|...+.||+|+||.||+|..++ ++ .+|+|....... ....++.+|+.++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 356677899999999999997642 32 589998776543 345778999999999999999999999987 78999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999997643 358999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
...........++..|+|||.+....++.++||||||+++|||++ |+.||+.....+... .. ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~-~~~~~----- 229 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD------LL-EKGER----- 229 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH------HH-hCCCC-----
Confidence 222111122334678999999988899999999999999999998 999997654333211 11 11110
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
...+..+...+.+++.+|+..+|.+||++.++++.|+.+.+.
T Consensus 230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 011122345678899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=317.04 Aligned_cols=255 Identities=23% Similarity=0.276 Sum_probs=195.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...++||+|+||.||+++.+ .++.+|+|.+... .......+..|+.++..++|+||+++.+++...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999999999999876 4678999987542 2223455888999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~-~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-D 155 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc-C
Confidence 9999999999996533 358999999999999999999999 9999999999999999999999999999875432 1
Q ss_pred ccceeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. ...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~~- 228 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKERFQ- 228 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCCcccc-
Confidence 222233457999999999986 346889999999999999999999999755332211 11111110000
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhh--CCCCCCChHHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLAD--FGVDRPSMGDVLWN 755 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~--~p~~RPsm~eVl~~ 755 (828)
+ +. ........+.+++.+|+.. ++..|+++.|+++.
T Consensus 229 ~-p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 F-PA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C-CC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00 0112345567778887754 34446889888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=328.76 Aligned_cols=259 Identities=22% Similarity=0.221 Sum_probs=195.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||++... .++.||+|... ...+.+|+++|++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999765 57899999743 23567899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+. ++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 95 6888887544 368999999999999999999999 899999999999999999999999999997533211 1
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhh-----hhhHHHHHHHHh---hc-----
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-----MVNLAEWAMKWQ---NK----- 708 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~~~---~~----- 708 (828)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+-.....+ ...+........ .+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 12234679999999999999999999999999999999999997764321100 000000000000 00
Q ss_pred -CCccccc---------CccccCCC--ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 -GQLDQII---------DPTLAGKI--RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 -~~~~~~~---------d~~l~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+.+.. .+...... ..+.+..+.+++.+||+.+|.+|||+.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000000 0123557889999999999999999999974
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.09 Aligned_cols=249 Identities=30% Similarity=0.460 Sum_probs=198.3
Q ss_pred ceEeeeCcEEEEEEEecC-------CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 490 WVIGIGGFGKVYKGELND-------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+.||+|+||.||+|+..+ ++.+++|.+.... .....++.+|+++++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999997642 2578999876543 23467889999999999999999999999999999999999
Q ss_pred ccCCcccccccCC-----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-----cEEEEeeCC
Q 003350 562 MENGTLKGHLYGS-----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-----MAKVADFGL 631 (828)
Q Consensus 562 ~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-----~~kl~DFGl 631 (828)
+++++|.+++... ....++|.+++.++.|++.||+|||+ .+++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 22348899999999999999999998 8999999999999999877 899999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQ 710 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (828)
++...............++..|+|||++.++.++.++|||||||++|||++ |+.||......+. ... . ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~---~-~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH---V-TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH---H-hcCC
Confidence 976533222222223345778999999999999999999999999999998 9999865433221 111 1 1110
Q ss_pred cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 711 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
........+..+.+++.+|++.+|.+||++.+|++.|+
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00112334567889999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=307.92 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=202.2
Q ss_pred CCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
+|...+.||+|+||.||++...++..+|+|.+..... ...+|.+|++++++++|||++++++++......++|+||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 5666789999999999999887788999998765433 346789999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
++|.+++.... ..+++..++.++.+++.+|+|||+ .+++||||||+||+++.++.+||+|||+++...... ....
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS 158 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence 99999986543 358899999999999999999999 899999999999999999999999999987643211 1111
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
....++.+|+|||++.++.++.++||||||+++|||++ |+.||......+.. ... .++ .....+.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~------~~~-~~~--~~~~~~~----- 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV------ETI-NAG--FRLYKPR----- 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH------HHH-hCC--CCCCCCC-----
Confidence 22335678999999998899999999999999999998 99998754332211 111 111 0111111
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
..+..+.+++.+|++.+|++||++.|+++.|
T Consensus 225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1246688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.82 Aligned_cols=238 Identities=25% Similarity=0.366 Sum_probs=189.5
Q ss_pred eEeeeCcEEEEEEEecC-------------------------CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEE
Q 003350 491 VIGIGGFGKVYKGELND-------------------------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 545 (828)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998876555555678899999999999999999
Q ss_pred EEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC---
Q 003350 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF--- 622 (828)
Q Consensus 546 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~--- 622 (828)
+++|......++||||+++|+|..++.... ..+++..++.++.|+++||+|||+ .+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999886533 468999999999999999999999 8999999999999997644
Q ss_pred ----cEEEEeeCCCCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHH-hcCCCCCCCChhhhh
Q 003350 623 ----MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVL-CARPVIDPTLPREMV 696 (828)
Q Consensus 623 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~ell-tG~~p~~~~~~~~~~ 696 (828)
.+|++|||++..... .....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+....+.+..
T Consensus 158 ~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred CccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 489999999864322 112356788999998875 56899999999999999995 789998755443321
Q ss_pred hHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 697 NLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 697 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
... ... .. .+......+.+++.+|++.+|.+||++.+|++.|
T Consensus 232 ~~~-------~~~-------~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RFY-------EKK-------HR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH-------Hhc-------cC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 000 00 1111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.80 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=195.6
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcC---CCCceEEEEEEEcc-----CC
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQF---RHRHLVSLIGYCDE-----KN 553 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 553 (828)
+|...+.||+|+||.||+|... +++.||+|.+..... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677789999999999999775 588999998765322 2234556777777665 79999999998754 34
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++|+||+++ +|.+++.......+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 58999999984 88888876555569999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh-hHHHHHHHHhhcCCc-
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQL- 711 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~- 711 (828)
..... .......||..|+|||++.+..++.++|||||||++|||++|++||......+.. ....+..........
T Consensus 157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 65321 1223456889999999999889999999999999999999999999755433221 111110000000000
Q ss_pred -----ccccCccc---cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 -----DQIIDPTL---AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 -----~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.....+.. .....++....+.+++.+||+.+|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00111234566789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=326.63 Aligned_cols=261 Identities=22% Similarity=0.236 Sum_probs=202.0
Q ss_pred HHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc
Q 003350 476 FVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551 (828)
Q Consensus 476 ~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (828)
+.++....++|...+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344555688999999999999999999876 5788999987532 22334567899999999999999999999999
Q ss_pred CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
.+..++||||+++|+|.+++... .++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998543 47888999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccC----CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
++..... .........||+.|+|||++... .++.++|||||||++|||++|+.||......... ..+..
T Consensus 189 a~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~ 261 (371)
T cd05622 189 CMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMN 261 (371)
T ss_pred eeEcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHHHc
Confidence 9865431 11122356799999999999754 3789999999999999999999999765432211 11111
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCC--CCChHHHHHHH
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVD--RPSMGDVLWNL 756 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eVl~~L 756 (828)
....... .........+.+++.+|+...+.+ ||++.|+++..
T Consensus 262 ~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1110011 111234556788899999844433 77888887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.89 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=203.0
Q ss_pred CCCccceEeeeCcEEEEEEEe-----cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcEE
Q 003350 485 NFDESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMI 556 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 556 (828)
.|...+.||+|+||.||+++. .++..||+|.+.... ......+.+|++++++++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356778999999999999974 247789999987553 34456789999999999999999999998764 5689
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||+++++|.+++.... ..++|.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999986543 368999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChh---------hhhhHHHHHHHHh
Q 003350 637 EIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR---------EMVNLAEWAMKWQ 706 (828)
Q Consensus 637 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~~ 706 (828)
..... .......++..|+|||++.+..++.++|||||||++|||++++.|....... .......+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HH
Confidence 32211 1122345677899999998889999999999999999999987664321110 0001111111 11
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
..+. ........+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111 0111223456799999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.83 Aligned_cols=254 Identities=25% Similarity=0.352 Sum_probs=202.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
++|...+.||+|+||.||+|+.. +++.||+|+...........+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46778899999999999999864 67899999887655555667889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A 161 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence 999999988644 368999999999999999999999 899999999999999999999999999998643211 1
Q ss_pred eeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 643 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+....+.+... . .... ....+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-----~~~~---~~~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-----MSKS---NFQPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-----eecC---CCCCCCC
Confidence 123346888999999984 3457889999999999999999999986433221110 0 0000 0011111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
.. .......+.+++.+|++.+|++||+++++++.|
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 122346788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=308.59 Aligned_cols=251 Identities=28% Similarity=0.446 Sum_probs=195.3
Q ss_pred ceEeeeCcEEEEEEEec----CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEc-cCCcEEEEEEecc
Q 003350 490 WVIGIGGFGKVYKGELN----DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD-EKNEMILIYEYME 563 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~ey~~ 563 (828)
+.||+|+||.||+|... +...+|+|+.... .....+.+..|+.+++.++||||++++++|. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2357999987643 3344678889999999999999999999875 4556899999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc--
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-- 641 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~-- 641 (828)
+|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999986543 347888899999999999999999 89999999999999999999999999999754321111
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhc-CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.......++..|+|||++.+..++.++|||||||++|||++| .+|+......+ +.... .. +. .+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~---~~-~~-----~~--- 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL---LQ-GR-----RL--- 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---hc-CC-----CC---
Confidence 111234467789999999988999999999999999999995 56665433222 11111 11 10 00
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
..+...+..+.+++.+|++.+|++||++.||+..|+.+.
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011123456889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=315.37 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=203.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.+|...+.||+|++|.||+|... +++.+++|.+........+.+.+|++++++++|+||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46777789999999999999764 58899999887766555678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++... .+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++...... .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~ 171 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence 999999998543 48899999999999999999999 899999999999999999999999999987643211 1
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....+.+. +.. . ...+. +.+ .
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~---~-~~~~~------~~~--~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL---I-ATNGT------PEL--Q 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH---H-hcCCC------CCC--C
Confidence 12334688999999999988899999999999999999999999975443221 111 0 00000 000 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+......+.+++.+|+..+|.+||++.|++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 12233456888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=322.02 Aligned_cols=240 Identities=26% Similarity=0.349 Sum_probs=190.5
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHH-HHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEI-EMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
+.||+|+||.||+++.. +++.+|+|.+.... .....++..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999876 56789999876432 12233444444 457889999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++.... .+.+.....++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~ 153 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTT 153 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCc
Confidence 99999986543 57888899999999999999999 9999999999999999999999999999975322 11223
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||+.|+|||++.+..++.++|||||||++|||++|++||......+.. . ..... . ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~---~i~~~-~----------~~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---D---NILNK-P----------LQLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---H---HHHhC-C----------cCCC
Confidence 4567999999999999999999999999999999999999999755433211 1 11111 0 0112
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
+.....+.+++.+|++.+|.+||++.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 23455688899999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=313.60 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=200.3
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
|+..++||+|+||.||++... +++.+|+|.+.... ....+.+..|+.++++++|+|++++.+.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566789999999999999765 58899999876532 22234577899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++.......+++.+++.++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 999999999866555579999999999999999999999 999999999999999999999999999987643211
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............. ..... ...
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~------~~~---- 222 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE------VQE---- 222 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh------hhh----
Confidence 1223468999999999999999999999999999999999999997543211110000 00000 000
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCC-----hHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLWN 755 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eVl~~ 755 (828)
.........+.+++.+|++.+|.+||+ +.|+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 112233456789999999999999999 7788753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.06 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=204.7
Q ss_pred CCCccceEeeeCcEEEEEEEec-----CCcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEcc--CCcEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-----DGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMI 556 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 556 (828)
.|...+.||+|+||.||++++. .++.+|||.+...... ..++|.+|+++++.++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3555678999999999999854 3678999998765443 46789999999999999999999999877 66789
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999997644 359999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh---------hHHHHHHHHh
Q 003350 637 EIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV---------NLAEWAMKWQ 706 (828)
Q Consensus 637 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~---------~l~~~~~~~~ 706 (828)
..... .......++..|+|||.+....++.++||||||++++||++|+.|+......... ....+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL-L 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH-H
Confidence 32111 1112234566799999999889999999999999999999999887543221110 01111111 1
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
..+ .....+..++..+.+++.+|++.+|.+||+|.||+++|+.+
T Consensus 240 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111 11111223346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=311.38 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=198.0
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+|+..++||+|+||.||+|... +++.||+|..... .....+++.+|++++++++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5667789999999999999764 6789999987654 3334567899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|..+. .+++..+..++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 999987542 47888999999999999999999 99999999999999999999999999999764321
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh-hHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......||..|+|||++.+..++.++|||||||++|||++|+.||......+.. ....+........ .+.+.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~- 221 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLP- 221 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCC-
Confidence 123457899999999999889999999999999999999999999653322111 1111111111110 11111
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
......++.+++.+|++.+|.+||++.|++..
T Consensus 222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11234567899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=319.27 Aligned_cols=242 Identities=23% Similarity=0.328 Sum_probs=194.6
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 559 (828)
+|+..++||+|+||.||++... +++.||+|.+... .....+.+..|.+++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999765 5889999987643 2233456788999998885 577888999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD- 154 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence 9999999999886543 68999999999999999999999 99999999999999999999999999998753221
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.... . .... .. .
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~---~i~~-~~------~-- 218 (323)
T cd05615 155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF---Q---SIME-HN------V-- 218 (323)
T ss_pred -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H---HHHh-CC------C--
Confidence 11233456999999999999999999999999999999999999999765433221 1 1111 10 0
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
.++......+.+++.+|++.+|.+|++..
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11223345678899999999999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.54 Aligned_cols=259 Identities=19% Similarity=0.200 Sum_probs=195.1
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.+|...+.||+|+||.||++... .++.||||.... ..+.+|+++|++++|+||+++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 36888899999999999999876 478899996432 34578999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
. ++|.+++.... ..++|.+++.|+.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 243 ~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 243 R-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 5 68888875433 369999999999999999999999 899999999999999999999999999998654322222
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCC-h-------hhhhhHHHHHHHHhhcCCcccc
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL-P-------REMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~-~-------~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
......||..|+|||++.+..++.++|||||||+||||++|..++-... . .+....+.+..... ......
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~--~~~~~~ 395 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV--DEFPQH 395 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc--ccCCCC
Confidence 2334679999999999999999999999999999999999876542211 1 11111111111000 000000
Q ss_pred cCccc------------cCCCC-------hhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 715 IDPTL------------AGKIR-------PDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 715 ~d~~l------------~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
...++ ..... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00000 0112357789999999999999999999853
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.86 Aligned_cols=245 Identities=24% Similarity=0.383 Sum_probs=204.2
Q ss_pred ceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCccc
Q 003350 490 WVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 568 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~ 568 (828)
-+||+|.||+||.|+..+ ...+|||.+........+.+..|+.+-++|+|+|||+.+|.|.+++.+-+.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999998764 5678999988877777788899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCC--ChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC-CCCcEEEEeeCCCCCCCCCCccceec
Q 003350 569 GHLYGSGLPSL--SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVST 645 (828)
Q Consensus 569 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~ 645 (828)
+.|... ..+| .+.++--+..||++||.|||+ ..|||||||-+|||++ -.|.+||+|||.++.+.. -+..+.
T Consensus 661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 999643 2345 777888899999999999999 9999999999999996 678999999999987643 223355
Q ss_pred cccccccccChhhhccC--CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 646 AVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 646 ~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
+..||..|||||++..+ .|..++|||||||.+.||.|||+||......... +.+.|. -.....+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGm------yKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGM------YKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhcc------eecCCCC
Confidence 67899999999999865 6889999999999999999999999644322110 011110 0112356
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.+...+...++++|+.++|.+||++.++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6778888999999999999999999999975
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=315.50 Aligned_cols=255 Identities=23% Similarity=0.271 Sum_probs=194.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999999999999875 5889999987642 2233566889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD- 155 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-
Confidence 9999999999986532 458999999999999999999999 99999999999999999999999999998754331
Q ss_pred ccceeccccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.. ...........+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCcccC
Confidence 1112233569999999999863 45788999999999999999999999754332211 111111110010
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhh--CCCCCCChHHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLAD--FGVDRPSMGDVLWN 755 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~--~p~~RPsm~eVl~~ 755 (828)
.+. .......+.+++.+|+.. ++..||++.+++..
T Consensus 230 -~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 -PPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 010 012344566677776643 44447899888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=304.52 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=202.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcc--cHHHHHHHHHHHHcCCCCc-eEEEEEEEccCC------c
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRH-LVSLIGYCDEKN------E 554 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~ 554 (828)
.|...++||+|.||+||+|+.. +|+.||+|++.....+ ......+|+.+|++++|+| |+.|.+++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3444567999999999999765 6899999988766442 3445689999999999999 999999997766 7
Q ss_pred EEEEEEeccCCcccccccCCCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
+++|+||++. +|..++..... ..++...+..++.||++||+|||+ ++|+||||||.|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999975 99999866443 357778999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
+...... ...+...+|..|.|||++.+. .|+...||||+||++.||+++++.|.+..+.+....+-.......+...
T Consensus 168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9654322 224566789999999999876 7999999999999999999999999877654332222111111111111
Q ss_pred ccc---cCcc--ccC-----CCC---hhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 712 DQI---IDPT--LAG-----KIR---PDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 712 ~~~---~d~~--l~~-----~~~---~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+ .+-. ... ... +.......+++.+||+.+|.+|.++..++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111 1100 000 001 1112467899999999999999999998754
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.18 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=190.9
Q ss_pred eEeeeCcEEEEEEEecC---CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 491 VIGIGGFGKVYKGELND---GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
.||+|+||.||+|...+ ...+++|.+.... ......|.+|++.++.++|+||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3578889776543 3335678899999999999999999999999999999999999999
Q ss_pred ccccccCCC---CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 567 LKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 567 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
|.+++.... ....++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999986543 2335688899999999999999999 8999999999999999999999999999875332111111
Q ss_pred eccccccccccChhhhcc-------CCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 644 STAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||....+.+.. . ..... ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--~----~~~~~-~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL--K----QVVRE-QDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH--H----HHhhc-cCccCC
Confidence 223446778999999753 356889999999999999999 78888654332211 1 11111 111222
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
++.+ .......+.+++..|+ .+|++||++.||++.|
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 2222 2233455677788888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.19 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=192.0
Q ss_pred ceEeeeCcEEEEEEEecC--------CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 490 WVIGIGGFGKVYKGELND--------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+.||+|+||.||+|.... ...+++|..........+++.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997642 234888887665555567889999999999999999999999998999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc--------EEEEeeCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM--------AKVADFGLSK 633 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--------~kl~DFGla~ 633 (828)
+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997654 368999999999999999999999 99999999999999987765 6999999886
Q ss_pred CCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcC-CCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+....+...... ...
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~--- 220 (258)
T cd05078 157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YED--- 220 (258)
T ss_pred ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHc---
Confidence 5322 223467889999999986 45899999999999999999995 56554332221111 000
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
...++.....++.+++.+|++.+|++||+++++++.|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00112223356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=324.09 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=195.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|+..+.||+|+||.||++... +++.||+|.+... .......+..|++++.+++|+||+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36778899999999999999775 5889999987643 2334567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999986543 68999999999999999999999 999999999999999999999999999987542211
Q ss_pred c---------------------------------cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCC
Q 003350 640 Q---------------------------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 686 (828)
Q Consensus 640 ~---------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p 686 (828)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 0011235699999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCC---hHHHH
Q 003350 687 IDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS---MGDVL 753 (828)
Q Consensus 687 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---m~eVl 753 (828)
|....+.+... ....... ...+.+. .....++.+++.+|+. +|.+|++ +.|++
T Consensus 236 f~~~~~~~~~~------~i~~~~~-~~~~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 236 FCSETPQETYR------KVMNWKE-TLVFPPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCCHHHHHH------HHHcCCC-ceecCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 97665433211 1111000 0001110 1123456667777664 9999986 45554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=318.88 Aligned_cols=264 Identities=21% Similarity=0.315 Sum_probs=199.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 45777889999999999999875 578899998765432 2345678899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++ +|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 985 8888775543 358899999999999999999999 999999999999999999999999999987543211
Q ss_pred ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH---------HhhcCCc
Q 003350 642 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK---------WQNKGQL 711 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~~ 711 (828)
.......+|..|+|||++.+ ..++.++|||||||++|||+||++||......+.......... +......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 11233467899999999865 4689999999999999999999999976654433222211110 0000000
Q ss_pred ccccCccccC----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...-.+.... ...+.....+.+++.+||+.+|.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.20 Aligned_cols=249 Identities=28% Similarity=0.403 Sum_probs=204.3
Q ss_pred cCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
++|...+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 567888899999999999998865 78999998865533 678999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~ 154 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A 154 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence 9999999986543 468999999999999999999999 899999999999999999999999999998654322 1
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....+.+.... ... ...+.+ .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~-----~~~~~~--~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPN-----KPPPTL--S 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hcc-----CCCCCC--C
Confidence 22345578899999999988999999999999999999999999975433221100 000 000111 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+......+.+++.+|++.+|.+||++.||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11233456889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.31 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=203.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
++|...+.||+|+||.||+|+.+ +.+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46777889999999999999854 2467999987765443 4678999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCC-------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 557 LIYEYMENGTLKGHLYGSG-------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
+||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999986543 1268999999999999999999999 89999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
|+++...... ........++..|+|||.+.+...+.++||||||+++|||++ |..||........ .. . ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~---~-~~~ 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LN---R-LQA 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HH---H-HHc
Confidence 9987532211 111223356778999999988889999999999999999999 7888864332221 11 1 111
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
+... .......+..+.+++.+|++.+|.+||++.|++..|+
T Consensus 234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111 0111234567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.05 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=199.7
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 445578999999999999876 4778899988776666677899999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
++|..++.... .++++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++..... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 160 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 160 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence 99998876533 469999999999999999999999 89999999999999999999999999998764321 1122
Q ss_pred ccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 645 TAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
....++..|+|||++. +..++.++|||||||++|||++|++||....+.+.. .. ..... .+.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~----~~~~~------~~~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LK----IAKSE------PPTL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HH----HhhcC------CCCC
Confidence 3456889999999984 345788999999999999999999998754332211 11 11100 0111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+|++.+|.+||++.++++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011223456889999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.78 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=201.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...+.||+|+||.||++... ++..+|+|.+... ......++.+|++++.+++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999765 5788899987654 233456788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++... ..+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999654 468999999999999999999997 248999999999999999999999999998754321
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc----------
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL---------- 711 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------- 711 (828)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... .+..........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE---AMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH---HhhcCccccccccCCcccccCC
Confidence 123456889999999998888999999999999999999999998644322211 111000000000
Q ss_pred ----------ccccCccc---cCCCC-hhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 712 ----------DQIIDPTL---AGKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 712 ----------~~~~d~~l---~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
.+..+... ....+ ......+.+++.+|++.+|++||++.|++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000 00000 11344688999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.44 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=200.9
Q ss_pred CCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC------cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
+|...+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++.++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366778999999999999988888999999876432 12245688999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
+||+++++|.+++.... ++++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999996543 58899999999999999999999 89999999999999999999999999998754221
Q ss_pred C----ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 639 D----QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 639 ~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
. .........|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. .. ..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~----~~~~~----~ 225 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--FY----IGAHR----G 225 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--HH----hhhcc----C
Confidence 1 111223456889999999999888999999999999999999999999754322111 00 00000 0
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+. .+......+.+++.+|++.+|.+||++.|++.
T Consensus 226 ~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111 12233456788999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.23 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=205.1
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|+..++||.|+||.||.++.. +++.+++|.+... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4677789999999999998754 5788999986643 344567789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++.......+++.++..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999976544578999999999999999999999 8999999999999999999999999999986543221
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......++..|+|||++.+...+.++||||||+++|||++|+.||......+.. .... .+... +
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~-~~~~~----~---- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKIV-QGNYT----P---- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-cCCCC----C----
Confidence 233456899999999998888999999999999999999999999754433221 1111 11110 0
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.......++.+++.+|++.+|.+||++.|+++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112335668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=331.78 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=193.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccC--------C
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--------N 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~ 553 (828)
..+|...++||+|+||.||+|... .++.||||++.... ....+|+.+|+.++||||+++.+++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457889999999999999999875 57899999875432 2345799999999999999998876321 2
Q ss_pred cEEEEEEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-cEEEEeeC
Q 003350 554 EMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFG 630 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kl~DFG 630 (828)
.+++||||+++ +|.+++.. .....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999985 67666642 233568999999999999999999999 9999999999999999664 79999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh--
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN-- 707 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-- 707 (828)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+.............
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 998653311 1234568999999999875 4689999999999999999999999976544322111110000000
Q ss_pred -----cC-----CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 708 -----KG-----QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 708 -----~~-----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.. ....+....+...++...+.++.+++.+||+.+|.+||++.|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 0000001111111222345678899999999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.77 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=209.0
Q ss_pred ceEeeeCcEEEEEEEec--CC--cEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN--DG--TKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|.||.|++|.|. .| ..||||.+...... ...+|.+|+.+|.+|+|+|+++|+|+..+ ..+.||+|.++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 68999999999999876 34 36899999887654 67899999999999999999999999877 678899999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+.|++.....|-......++.|||.||+||.. +++|||||..+|+||-....+||+||||.|.+...+.....
T Consensus 195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 999999988555678889999999999999999999 99999999999999999999999999999987664333222
Q ss_pred -ccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 645 -TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 645 -~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
....-...|+|||.+....++.++|||+|||+||||+| |..||.+....++. +.+|..-.-.
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD~~erLp 335 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNIDAGERLP 335 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------HhccccccCC
Confidence 23445678999999999999999999999999999998 57888766544432 2233222223
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
-++.|++++.+++..||..+|.+||++.++.+.+-
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 35678999999999999999999999999986543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.88 Aligned_cols=247 Identities=30% Similarity=0.439 Sum_probs=199.9
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||++.. .++.+|+|...... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3467778999999999999975 47789999876543 346789999999999999999999998654 4799999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.......+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 9999999976655578999999999999999999999 99999999999999999999999999998754321
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
......+..|+|||++.+..++.++|+|||||++|||++ |+.||......+... . ...+. ...
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~------~-~~~~~---------~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE------C-VEKGY---------RME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH------H-HhCCC---------CCC
Confidence 112234567999999998899999999999999999998 999987554332211 1 11111 001
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.....+..+.+++.+|++.+|.+||++.++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112335668899999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=307.94 Aligned_cols=238 Identities=26% Similarity=0.395 Sum_probs=190.4
Q ss_pred ceEeeeCcEEEEEEEecCCc-----------EEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 490 WVIGIGGFGKVYKGELNDGT-----------KVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
+.||+|+||.||+|...+.. .+++|........ ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999876432 5778876654433 6788999999999999999999999988 788999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-------cEEEEeeCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-------MAKVADFGL 631 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-------~~kl~DFGl 631 (828)
+||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999876442 68999999999999999999999 9999999999999999888 799999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccC--CCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+......+.. ..+...
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~------~~~~~~ 222 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE------RFYQDQ 222 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH------HHHhcC
Confidence 886432 1233466789999999876 78999999999999999999 57777544322111 111100
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.. .+......+.+++.+|++.+|.+||++.||++.|+
T Consensus 223 ~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 01111267889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.98 Aligned_cols=255 Identities=30% Similarity=0.412 Sum_probs=199.4
Q ss_pred CCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC------
Q 003350 486 FDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN------ 553 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (828)
|...++||+|+||.||+|.+. .++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999753 3678999987654 3344677899999999999999999999885432
Q ss_pred cEEEEEEeccCCcccccccCC----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 554 EMILIYEYMENGTLKGHLYGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
..++++||+++|+|.+++... ....+++...++++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247889999999998887432 22358899999999999999999999 89999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
|+++...............++..|++||.+....++.++|||||||++|||++ |++|+......+ +..+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---cC
Confidence 99986543221112223345678999999998889999999999999999999 888886543322 122111 11
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
... .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 01123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.83 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=204.1
Q ss_pred cCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.+|...+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4577888999999999999975 468899999887665555678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 999999988543 58999999999999999999999 9999999999999999999999999999876433211
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
......++..|+|||.+.+..++.++|||||||++|||++|+.||....+.+... . ... ... +.+ .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~--~----~~~-~~~-----~~~--~ 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IAT-NGT-----PEL--Q 236 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----HHh-cCC-----ccc--C
Confidence 1234568889999999998889999999999999999999999997654432211 0 000 000 000 0
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+......+.+++.+|++.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11233456788999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.15 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=203.7
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|+||.||++... +++.+++|++... .....+++.+|++++++++||||+++.+++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4677789999999999999765 5789999987643 233456889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++.......+++.++++++.|++.||+|||+ .+++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 999999999876544568999999999999999999999 8999999999999999999999999999976533111
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......|+..|+|||++.+...+.++|+|||||+++||++|+.|+......+. ...... +.. +
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~-~~~-----~---- 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIR-GSY-----P---- 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhc-CCC-----C----
Confidence 12234578899999999988999999999999999999999999875433221 111111 110 0
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+|++.+|.+||+|.||++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 112334566889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.92 Aligned_cols=244 Identities=27% Similarity=0.379 Sum_probs=201.5
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.|...+-||+|+||.||.++.. +.+.||||++.-... ..++++..|++.|.+++|||++.+-||+......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3455567999999999999764 578999999876544 346788999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
||- |+-.|.+.-.+ ++|-..++..|+.+.+.||+|||+ .+.||||||+.||||++.|.|||+|||.|.....
T Consensus 107 YCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 995 57777764333 578899999999999999999999 9999999999999999999999999999877533
Q ss_pred cceeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 641 THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
...++||+.|||||++. .++|+-|.||||+|++..||.-.++|+-.+..-.. ..+.. +.-.|
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYHIA---------QNesP 243 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIA---------QNESP 243 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHHHH---------hcCCC
Confidence 45789999999999985 57999999999999999999999999864432111 11110 11123
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+. .+++...+..++..||+.-|.+|||..+++.
T Consensus 244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 332 3678889999999999999999999988764
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.86 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=199.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45777889999999999999775 57899999876443 23345678899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
++ ++|.+++.... ..+++..+..++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 97 58988886543 358899999999999999999999 999999999999999999999999999997643211
Q ss_pred ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC----
Q 003350 642 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID---- 716 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---- 716 (828)
.......++..|+|||.+.+ ..++.++|||||||++|||++|++||......+......-............+++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 11233457889999999865 4578999999999999999999999976544322111110000000000000000
Q ss_pred -----ccccC----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 -----PTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 -----~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.... ...+.....+.+++.+|++.+|.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11100 111233456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.88 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=191.7
Q ss_pred eEeeeCcEEEEEEEecCC---cEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 491 VIGIGGFGKVYKGELNDG---TKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 346677665443 3446789999999999999999999999999999999999999999
Q ss_pred ccccccCCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 567 LKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 567 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|.+++.... ...+++..++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997542 2456777889999999999999999 89999999999999999999999999998643221111122
Q ss_pred ccccccccccChhhhcc-------CCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 645 TAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~-------~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
....++..|+|||++.. ..++.++|||||||++|||++ |..|+....+.+.. ..... +......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL------NHVIK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHh-hcccccCC
Confidence 34567889999999753 245789999999999999997 46777654332211 11111 12223344
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
+.+... ....+.+++..|+ .+|++||++.||++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 444322 3345777888999 57999999999988774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.02 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=199.1
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcc---------cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ---------GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
|.....||+|++|.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556689999999999999764 5789999987654321 235688999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999999654 368899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcc----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 636 PEIDQT----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 636 ~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~----- 225 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IF----KIG----- 225 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--HH----HHh-----
Confidence 421110 111234588899999999988899999999999999999999999975432111 00 000
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
....+. .+......+.+++.+|++.+|.+||++.|+++
T Consensus 226 -~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 -ENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -ccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011111 22234566888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.86 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=201.1
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHH--HHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
|+..+.||+|+||.||+++.. +++.+|+|.+......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 345689999999999999876 4678999998877554322 3456999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.. ...+++.+++.++.|+++||++||+ .+++|+||||+||++++++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE 153 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred ccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccc
Confidence 99999999972 2468999999999999999999999 899999999999999999999999999987531 2222
Q ss_pred eeccccccccccChhhhc-cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......++..|+|||++. +...+.++||||+|+++++|++|+.|+......+............ . ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~----~~~~-- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP----L----PSSS-- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH----H----HHHT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc----c----cccc--
Confidence 345567899999999998 8899999999999999999999999998653222222211111000 0 0000
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.........+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111367899999999999999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.37 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=201.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEcc-CCcEEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNEMILIYE 560 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e 560 (828)
+|...+.||+|++|.||++... +++.+++|++.... ....+.+.+|++++++++|+|++++.+.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4677789999999999999765 47889999876432 3345678899999999999999999988764 446789999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.+++.......+++.+++.++.+++.||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-- 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-- 155 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc--
Confidence 9999999999976555569999999999999999999999 89999999999999999999999999999765321
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
........+++.|+|||++.+..++.++||||||++++||++|+.||........ ..... .+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~-~~~~--------- 219 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII-EGKL--------- 219 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hcCC---------
Confidence 1123345688999999999999999999999999999999999999875432221 11111 1111
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+......+.+++.+|++.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112334567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.54 Aligned_cols=247 Identities=29% Similarity=0.392 Sum_probs=202.5
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+|...+.||.|++|.||+|+.. +++.+++|...... ......+.+|+++++.++|+||+++.+++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5667788999999999999875 58899999876543 344567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++... .+++.++..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++...... .
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 999999998654 68999999999999999999999 899999999999999999999999999998754321 1
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
......++..|+|||++.+..++.++|||||||++|||+||+.||....+.+.. .. .... ..+.+...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~~-~~~~-----~~~~~~~~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------FL-IPKN-----NPPSLEGN 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------HH-hhhc-----CCCCCccc
Confidence 223456888999999999888999999999999999999999999754432211 11 0111 11111111
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.....+.+++.+|+..+|++||++++++.
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 13456888999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.50 Aligned_cols=250 Identities=31% Similarity=0.502 Sum_probs=202.1
Q ss_pred CccceEeeeCcEEEEEEEecC-----CcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 487 DESWVIGIGGFGKVYKGELND-----GTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
...+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|++++.+++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 455789999999999998764 378999998765443 56789999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.+++.......+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999976543338999999999999999999999 8999999999999999999999999999987544211
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.. .....++..|+|||.+.+..++.++||||+|++++||++ |++|+......+. .... . .+..
T Consensus 159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~---~-~~~~-------- 222 (258)
T smart00219 159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYL---K-KGYR-------- 222 (258)
T ss_pred cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---h-cCCC--------
Confidence 11 112347789999999988889999999999999999998 7888865332221 1111 1 1110
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
.......+..+.+++.+|+..+|.+||++.|+++.|
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011122456788999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=325.22 Aligned_cols=261 Identities=23% Similarity=0.236 Sum_probs=198.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEec---CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN---DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..+|...+.||+|+||.||++... .+..|++|.+... +.+.+|+++|++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 356888899999999999999653 3578999987643 23568999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
|++. ++|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9996 688888833 3479999999999999999999999 899999999999999999999999999997654322
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh-hhHHHHHHHHhhcCCc-------
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM-VNLAEWAMKWQNKGQL------- 711 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~------- 711 (828)
.........||..|+|||++....++.++|||||||++|||++|+.||........ ..+...... ......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCccc
Confidence 22223356799999999999999999999999999999999999999865432211 111111110 000000
Q ss_pred ----------ccccCcccc--CCC-ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 712 ----------DQIIDPTLA--GKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 712 ----------~~~~d~~l~--~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.....+... ..+ .......+.+++.+||..+|++||++.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000 01123457788999999999999999999854
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=311.39 Aligned_cols=246 Identities=28% Similarity=0.384 Sum_probs=200.4
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
|...+.||+|+||.||+|... +++.||+|...... ....+.+.+|++++++++||||+++++++...+..++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445567999999999999765 57889999876443 3445678999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.. ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++....... ..
T Consensus 86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06642 86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence 9999998854 358999999999999999999999 899999999999999999999999999997654311 11
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+....+..... . .... ..+. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-~~~~-----~~~~----~ 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------L-IPKN-----SPPT----L 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------h-hhcC-----CCCC----C
Confidence 233468889999999998899999999999999999999999986543322110 0 0110 1111 2
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
....+..+.+++.+|++.+|.+||+|.|++..
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 22345668899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.71 Aligned_cols=261 Identities=27% Similarity=0.394 Sum_probs=206.8
Q ss_pred ccCHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEc
Q 003350 473 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD 550 (828)
Q Consensus 473 ~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 550 (828)
+.++.++......|...+.||+|+||.||+|... +++.+|+|...... ....++..|+.++.++ +|+||+++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 4566777778889999999999999999999875 57899999876543 3346788999999998 7999999999984
Q ss_pred ------cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 551 ------EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 551 ------~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
.....+++|||+++|+|.+++.......+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCE
Confidence 34678999999999999999876555568899999999999999999999 899999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA 699 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~ 699 (828)
+|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.+.....
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 999999987543211 1123456889999999985 346788999999999999999999999654332211100
Q ss_pred HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 700 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. ....+.. ........+.+++.+||+.+|.+||++.|+++
T Consensus 239 ------~------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 ------P------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------h------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0001111 11234567889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=303.95 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=194.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-----cccHHHHHHHHHHHHcCCCCceEEEEEEEcc--CCcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-----QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 555 (828)
.+|...++||+|+||.||+|... .+..|++|++.... .+....+.+|++++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999765 58899999875432 2234568899999999999999999998864 4578
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999986543 58999999999999999999998 89999999999999999999999999998764
Q ss_pred CCCCc-cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 636 PEIDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 636 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||......+.. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~----- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQP----- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCC-----
Confidence 32111 11112345889999999999889999999999999999999999999754322111 1111100
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+. ++......+.+++ +|+..+|++||++.||+.
T Consensus 226 ~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111 1222233455555 688899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.76 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=203.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
..+|...+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 356778899999999999999864 6899999998766555567788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-- 169 (297)
T cd06656 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (297)
T ss_pred cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--
Confidence 9999999998543 48899999999999999999999 899999999999999999999999999987643311
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...... ..... .+.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------~~~~~-----~~~~-- 235 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNG-----TPEL-- 235 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------eccCC-----CCCC--
Confidence 112345688899999999998899999999999999999999999965433221100 00000 0000
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+|++.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111233455788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.15 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=201.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-----cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-----QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
+|...+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666789999999999999876 68899999865433 23457789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
+||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999986543 68999999999999999999999 89999999999999999999999999998764332
Q ss_pred CccceeccccccccccChhhhccCC-CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
. ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||....+.+.. .........
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~------ 220 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKEL------ 220 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcccC------
Confidence 2 223456889999999997766 899999999999999999999999754422111 111110111
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..++......+.+++.+|++.+|.+||++.+++.
T Consensus 221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122233466788999999999999999999974
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.12 Aligned_cols=261 Identities=23% Similarity=0.266 Sum_probs=197.8
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4667789999999999999875 58899999876432 23356788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 562 MENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 562 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
++ ++|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68888875433 2568999999999999999999999 999999999999999999999999999987543211
Q ss_pred cceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh------------
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN------------ 707 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~------------ 707 (828)
.......++..|+|||++.+. .++.++|||||||+++||+||++||....+.+.. ......+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhh
Confidence 112334578899999998654 5789999999999999999999999754432211 000000000
Q ss_pred ---cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 708 ---KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 708 ---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
............. ........++.+++.+||+.+|.+||++.+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 001123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.43 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=200.3
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
++|...+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35666678999999999999765 58899999887665555667889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++...+ .+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...... ..
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA 161 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence 9999999886543 68999999999999999999999 89999999999999999999999999998754321 11
Q ss_pred eeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 643 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......|+..|+|||++. ...++.++|||||||++|||++|+.|+....+..... ... ... ...+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~~-~~~---~~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMT-KSN---FQPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hhh-ccC---CCCCcc
Confidence 123456899999999984 4568899999999999999999999986443322110 000 000 001111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... ......+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 110 123346788999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=304.00 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=199.6
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc----------ccHHHHHHHHHHHHcCCCCceEEEEEEEccCC
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ----------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN 553 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (828)
+|...+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566789999999999999764 588999997653211 11346788999999999999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999998665 368999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhccCC--CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
...............|+..|+|||.+.... ++.++|+||||+++|||++|+.|+......+ .. ...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~-~~~~~~-~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AM-FKLGNK-RS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HH-HHhhcc-cc
Confidence 654322222234456889999999987654 8899999999999999999999986432211 11 010000 11
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+.+ ....+....+.+++.+|++.+|.+||++.+|++
T Consensus 230 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 122234567888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=308.07 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=201.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
++|...+.||+|+||.||+|+.. +++.+++|.+........+.+.+|+++++.++|+|++++++++...+..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45667789999999999999876 47899999988777666788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|..++.... ..+++.+++.++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||++...... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 9999988875443 468999999999999999999999 89999999999999999999999999998753221 11
Q ss_pred eeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 643 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
......++..|+|||++. ...++.++|||||||++|||++|++|+....+.+. ........ .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~------~~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE------PP 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhcCC------Cc
Confidence 123456888999999984 34578899999999999999999999865432211 11111110 11
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. ..+.....++.+++.+|++.+|++||++.|+++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11 112233456889999999999999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=307.85 Aligned_cols=261 Identities=26% Similarity=0.348 Sum_probs=205.2
Q ss_pred cCHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEcc
Q 003350 474 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE 551 (828)
Q Consensus 474 ~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (828)
+++.++..++++|...+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455666777899999999999999999999875 58899999876542 2346678899999999 89999999999864
Q ss_pred C-----CcEEEEEEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 552 K-----NEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 552 ~-----~~~~lV~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
. +..++|+||+++++|.+++.. .....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 358999999999999998853 223468999999999999999999999 899999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccC-----CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA 699 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~ 699 (828)
||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.|+....+.+. +.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 9999999886543111 12345688999999998643 368999999999999999999999975433221 11
Q ss_pred HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 700 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+ . ......+.+ +.+....+.+++.+|++.+|++||++.|+++
T Consensus 244 ~~----~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KI----P-RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH----h-cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 1 111111111 1233456889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.74 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=200.7
Q ss_pred CCCccceEeeeCcEEEEEEEecC--CcEEEEEEcCCC----------CcccHHHHHHHHHHHHc-CCCCceEEEEEEEcc
Q 003350 485 NFDESWVIGIGGFGKVYKGELND--GTKVAVKRGNPR----------SQQGLAEFQTEIEMLSQ-FRHRHLVSLIGYCDE 551 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 551 (828)
+|...+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36677899999999999998765 678999976532 22334567789988875 799999999999999
Q ss_pred CCcEEEEEEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 552 KNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
.+..++||||+++++|.+++.. .....+++..+++++.|++.||.|||+ ..+++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 223468999999999999999999995 257999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 709 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (828)
|++....... ......|+..|+|||++.+..++.++||||||+++|||++|++||........ ...... .
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~~~~-~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATKIVE-A 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHHHhh-c
Confidence 9998654322 23455688999999999988899999999999999999999999865432221 111111 1
Q ss_pred CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 710 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.. .+.. .......+.+++.+|++.+|++||++.||.++++
T Consensus 229 ~~----~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VY----EPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC----CcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 10 1110 1123456888999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=317.75 Aligned_cols=263 Identities=19% Similarity=0.240 Sum_probs=198.2
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------ 552 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 552 (828)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568888899999999999999765 5789999988754 233356778999999999999999999988543
Q ss_pred CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999975 6666653 248899999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHH-------------
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA------------- 699 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~------------- 699 (828)
+.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 86432 12233457899999999999999999999999999999999999999765432211100
Q ss_pred ---HHHHHHhhc-CCcccccCccc--------cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 700 ---EWAMKWQNK-GQLDQIIDPTL--------AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 700 ---~~~~~~~~~-~~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.....+... ........+.. ...........+.+++.+||+.+|.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000111100 00000000000 001112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.64 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=203.6
Q ss_pred cCHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEc-
Q 003350 474 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD- 550 (828)
Q Consensus 474 ~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~- 550 (828)
+.+..+..+.++|...+.||+|+||.||++... +++.+|+|...... ....++.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 444556677889999999999999999999775 57899999876532 2246788999999999 6999999999883
Q ss_pred ----cCCcEEEEEEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 551 ----EKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 551 ----~~~~~~lV~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
.++..++||||+++++|.+++.. .....+++..+..++.|+++||.|||+ .+++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 44568999999999999988753 223468899999999999999999999 899999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA 699 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~ 699 (828)
||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+....+.... .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F 239 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence 999999987653211 12234568999999999853 45789999999999999999999998754332111 0
Q ss_pred HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 700 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
. . .........++ ......+.+++.+|++.+|++||++.|+++.
T Consensus 240 ~----~-~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 K----I-PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred h----c-cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 0 00000011111 1123468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=289.75 Aligned_cols=263 Identities=24% Similarity=0.297 Sum_probs=219.1
Q ss_pred HHHHHhcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEc
Q 003350 478 AVQEATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550 (828)
Q Consensus 478 ~l~~at~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 550 (828)
++.....++....++-+|.||.||+|.+. +.+.|.||.++.. ++-....+..|.-+|..+.|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34444556777788999999999999554 3456778866543 4555677889999999999999999999985
Q ss_pred c-CCcEEEEEEeccCCcccccccC------CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc
Q 003350 551 E-KNEMILIYEYMENGTLKGHLYG------SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 623 (828)
Q Consensus 551 ~-~~~~~lV~ey~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 623 (828)
+ ....+.+|.++.-|+|..||.. +..+.++..+...++.|++.|++|||+ .++||.||.++|+++|+..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhee
Confidence 4 5567889999999999999972 234568889999999999999999999 99999999999999999999
Q ss_pred EEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHH
Q 003350 624 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWA 702 (828)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 702 (828)
+||+|=.|+|.+-..+..+.......+..||+||.+....++.++|||||||+||||+| |+.|+...+|.|....
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y---- 510 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY---- 510 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH----
Confidence 99999999998777677777777778889999999999999999999999999999997 8899988877765332
Q ss_pred HHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 703 MKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 703 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
..+|. ++. -+.+++.++..+...||+..|++||+.++++.-|.+.
T Consensus 511 ---lkdGy-------Rla--QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 ---LKDGY-------RLA--QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ---Hhccc-------eec--CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 22221 122 2346788899999999999999999999999988764
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=316.37 Aligned_cols=192 Identities=23% Similarity=0.318 Sum_probs=164.8
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
...+|...+.||+|+||.||+|+.. .++.||+|..... ....|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999876 4678999975432 23569999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
++. ++|.+++.... ..+++.+++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 995 68888886533 469999999999999999999999 8999999999999999999999999999975322
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCC
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI 687 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~ 687 (828)
........||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 11223456899999999999999999999999999999999865544
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=319.00 Aligned_cols=203 Identities=26% Similarity=0.357 Sum_probs=177.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-C-----CceEEEEEEEccCCcEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-H-----RHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 557 (828)
+|.+.++||+|.||.|-+|... +++.||||+++... ....+...|+.+|..|+ | -|+|++++|+..++++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7888899999999999999654 68999999988653 33566788999999997 4 489999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC--CcEEEEeeCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN--FMAKVADFGLSKTG 635 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~--~~~kl~DFGla~~~ 635 (828)
|+|.++. +|.++|..+....++...+..|+.||+.||.+||+ .+|||+||||+||||.+. ..+||+|||.+...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999965 99999999888889999999999999999999999 999999999999999643 47999999999874
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 697 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~ 697 (828)
.. ... ...-+..|.|||++.+.+|+.+.|+||||||+.||++|.+.|.+..+.+...
T Consensus 342 ~q----~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~ 398 (586)
T KOG0667|consen 342 SQ----RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA 398 (586)
T ss_pred CC----cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence 32 112 4456778999999999999999999999999999999999888777665543
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=304.70 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=203.5
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4556678999999999999875 57899999876442 344677899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.. .++++.+...++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06640 85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence 99999998854 358899999999999999999999 899999999999999999999999999997653321 1
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
......++..|+|||++.+...+.++|||||||++|||++|+.|+....+....... .......
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----------------~~~~~~~ 220 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI----------------PKNNPPT 220 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh----------------hcCCCCC
Confidence 223346788999999999888999999999999999999999998755433221100 0001112
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.....+..+.+++.+|++.+|.+||++.+++..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 334556778999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.65 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=203.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
++|...+.||+|++|.||++... ++..+|+|..........+.|..|++++++++|+||+++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45777788999999999999875 57899999987776666778999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...... ..
T Consensus 85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 9999999886543 469999999999999999999999 89999999999999999999999999998764321 11
Q ss_pred eeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 643 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
......++..|+|||++. ...++.++||||||+++|||++|+.||......+.. . ..... . .+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~~-~-----~~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--L----KILKS-E-----PP 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--H----HHhcC-C-----CC
Confidence 223456889999999985 345678999999999999999999999755332211 1 11111 0 01
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+ ..+......+.+++.+|++.+|.+||++.++++.
T Consensus 227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11 0112334567889999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=331.24 Aligned_cols=266 Identities=20% Similarity=0.251 Sum_probs=195.6
Q ss_pred HHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC------CceEEEEEEEc
Q 003350 478 AVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH------RHLVSLIGYCD 550 (828)
Q Consensus 478 ~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~ 550 (828)
++...+++|...++||+|+||.||+|... .++.||||++.... ...+++..|++++.+++| .+++.+++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445678999999999999999999765 57889999986432 223456678888777754 45889998886
Q ss_pred cC-CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-------
Q 003350 551 EK-NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF------- 622 (828)
Q Consensus 551 ~~-~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~------- 622 (828)
.. ...++|||++ +++|.+++... ..+++.++..|+.||+.||+|||+ ..+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence 54 5788999988 66888888654 369999999999999999999996 14899999999999998765
Q ss_pred ---------cEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChh
Q 003350 623 ---------MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR 693 (828)
Q Consensus 623 ---------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~ 693 (828)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|++||+.....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886422 1234567999999999999999999999999999999999999999866544
Q ss_pred hhhhHHHHH---------HHH--------hh-cCCcccccCcccc----CC--C-ChhHHHHHHHHHHhhhhhCCCCCCC
Q 003350 694 EMVNLAEWA---------MKW--------QN-KGQLDQIIDPTLA----GK--I-RPDSLRKFGETAEKCLADFGVDRPS 748 (828)
Q Consensus 694 ~~~~l~~~~---------~~~--------~~-~~~~~~~~d~~l~----~~--~-~~~~~~~l~~l~~~Cl~~~p~~RPs 748 (828)
+...+.... ... .. .+.+....++... .. . .......+.+++.+||+.||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 333222111 100 00 0000000111000 00 0 0011345779999999999999999
Q ss_pred hHHHHH
Q 003350 749 MGDVLW 754 (828)
Q Consensus 749 m~eVl~ 754 (828)
+.|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999985
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.38 Aligned_cols=257 Identities=21% Similarity=0.312 Sum_probs=204.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|+..+.||+|+||.||++... +++.+|+|...... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45666789999999999999765 57889999866543 34467889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++... ..+++..+..++.+++.+|.|||+ ..+++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 9999999988654 368999999999999999999996 247999999999999999999999999998754221
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhh-----hhhHHHHHHHHhhcCCcccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-----MVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~d 716 (828)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+ ...+..+........ .
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 230 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P 230 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence 1224568999999999988899999999999999999999999997544321 112222222221111 0
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
+.+. ..+.+..+.+++.+|++.+|.+||++.|++++..
T Consensus 231 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 231 PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1110 1124556889999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=301.63 Aligned_cols=253 Identities=27% Similarity=0.389 Sum_probs=205.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
++|...+.||+|+||.||+|... +++.+++|..........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 46778899999999999999875 57889999887665556788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++...... ..
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 9999999886542 468999999999999999999999 89999999999999999999999999998764331 11
Q ss_pred eeccccccccccChhhhccC---CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 643 VSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......++..|+|||.+... .++.++|||||||++|||++|++|+....+.+... . ..... ...+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~-----~~~~~---~~~~~~ 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--L-----ISKSN---FPPPKL 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-----HHhcc---CCCccc
Confidence 22345688899999999776 88999999999999999999999997554332211 0 00000 001111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. ........+.+++.+|++.+|.+||++.+|+.
T Consensus 227 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 K--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 12234567889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=314.02 Aligned_cols=257 Identities=22% Similarity=0.277 Sum_probs=194.7
Q ss_pred cceEeee--CcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 489 SWVIGIG--GFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 489 ~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
.++||+| +|++||++... +|+.||+|++.... ....+.+.+|+++++.++||||++++++|..++..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3689999 78999999765 68999999987542 2334567789999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc--
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-- 641 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~-- 641 (828)
+|+|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999865544569999999999999999999999 89999999999999999999999999865432111110
Q ss_pred ---ceeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 642 ---HVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 642 ---~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .... .+.+....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-----~~~~~~~~~ 232 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKL-----NGTVPCLLD 232 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHh-----cCCcccccc
Confidence 01122346778999999976 46899999999999999999999999754322110 0000 000000000
Q ss_pred -------------------cc-----------------ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 717 -------------------PT-----------------LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 717 -------------------~~-----------------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.. ............+.+++.+||+.+|.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 0001112234578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=315.42 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=197.1
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC-----
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----- 553 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 553 (828)
..++|...+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3568888899999999999999765 5889999988643 2334567889999999999999999999985443
Q ss_pred -cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 554 -EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 554 -~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999975 5665553 247889999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh---------------
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN--------------- 697 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~--------------- 697 (828)
+.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus 171 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 76422 122334578999999999999999999999999999999999999997553322110
Q ss_pred -HHHHHHHHhhc-CCc-----ccccCcccc---CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 698 -LAEWAMKWQNK-GQL-----DQIIDPTLA---GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 698 -l~~~~~~~~~~-~~~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+......+... ... .+....... ..........+.+++.+||+.+|.+|||+.|++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000011000 000 000000000 00111124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.10 Aligned_cols=264 Identities=23% Similarity=0.272 Sum_probs=200.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35777889999999999999876 58899999875432 2234568899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|++++.|..++... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888776443 358999999999999999999999 9999999999999999999999999999987543221
Q ss_pred cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHH-HHHHH-------Hhh-cCC
Q 003350 641 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA-EWAMK-------WQN-KGQ 710 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~-~~~~~-------~~~-~~~ 710 (828)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ..... ... ...
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1223457889999999876 56789999999999999999999999765443221111 00000 000 000
Q ss_pred cccccCccccCCC-----ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 711 LDQIIDPTLAGKI-----RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 711 ~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......+...... .......+.+++.+|++.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000011110000 0122456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=300.02 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=201.9
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|++|.||++... +++.+|+|.+... .....+.+.+|++++++++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677789999999999999764 5788999987654 234467889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC-CcEEEEeeCCCCCCCCCCc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kl~DFGla~~~~~~~~ 640 (828)
+++++|.+++.......+++..+++++.+++++|+|||+ .+++|+||||+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 999999999976555568999999999999999999999 899999999999999855 468999999998654321
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ....... ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~~~-~~--------- 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIMSG-TF--------- 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHHhc-CC---------
Confidence 12235688899999999988899999999999999999999999875433221 1111111 00
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..........+.+++.+|++.+|.+||++.|+++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0112234556889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=310.05 Aligned_cols=196 Identities=26% Similarity=0.374 Sum_probs=159.9
Q ss_pred cceEeeeCcEEEEEEEec---CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc--CCcEEEEEEecc
Q 003350 489 SWVIGIGGFGKVYKGELN---DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMILIYEYME 563 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ey~~ 563 (828)
.++||+|+||.||+|+.. +++.+|+|.+..... ...+.+|+++|++++||||+++++++.. ....++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 457899998865432 3457889999999999999999998843 456889999986
Q ss_pred CCcccccccCC-------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe----CCCCcEEEEeeCCC
Q 003350 564 NGTLKGHLYGS-------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLS 632 (828)
Q Consensus 564 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kl~DFGla 632 (828)
+ +|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 777766421 12358899999999999999999999 899999999999999 46679999999999
Q ss_pred CCCCCCCcc-ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCC
Q 003350 633 KTGPEIDQT-HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPT 690 (828)
Q Consensus 633 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~ 690 (828)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 865432111 12234678999999999976 46899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.52 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=195.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-----cccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-----QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 555 (828)
++|...++||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999875 58899999865321 22346788999999999999999999988653 467
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+||+++++|.+++.... .+++...++++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999986443 58899999999999999999999 89999999999999999999999999998764
Q ss_pred CCCCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 636 PEIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 636 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .. .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~------ 224 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IF----KIATQ------ 224 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HH----HHhcC------
Confidence 321111 112334688999999999888899999999999999999999999864322211 10 00000
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+ .....+......+.+++.+|+. +|.+||+++|+++
T Consensus 225 --~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 --P-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --C-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 0111233445567788888985 8999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=315.55 Aligned_cols=235 Identities=24% Similarity=0.289 Sum_probs=184.5
Q ss_pred EeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcC---CCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF---RHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
||+|+||.||+|+.. +++.||+|++.... ......+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 58899999875432 12234455677777665 699999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~ 153 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTT 153 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCc
Confidence 9999888654 368999999999999999999999 99999999999999999999999999998753221 1223
Q ss_pred ccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
....||..|+|||++.+. .++.++|||||||++|||++|+.||......+... .. ..+. ..+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~------~i-~~~~------~~~~~-- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR------NI-AFGK------VRFPK-- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH------HH-HcCC------CCCCC--
Confidence 456799999999998764 48999999999999999999999997554322211 11 1111 01110
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
......+.+++.+||+.+|.+||++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCC
Confidence 1224557789999999999999854
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=325.45 Aligned_cols=254 Identities=25% Similarity=0.364 Sum_probs=213.3
Q ss_pred ccceEeeeCcEEEEEEEe-cCC----cEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 488 ESWVIGIGGFGKVYKGEL-NDG----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
..++||.|.||+||||.+ ..| -+||+|.+... +.+...++.+|+-.|.++.||||++|+|+|.... +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 347899999999999965 333 47899976654 4566789999999999999999999999998765 8899999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
|+.|+|.+|++.++ ..+--+..+.|+.|||+||.|||. +.++||||.++|||+.+-.++||.|||+++.+...+..
T Consensus 779 mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred cccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999998765 568889999999999999999998 99999999999999999999999999999987654433
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.......-.+.|||-|.+....++.++|||||||.+||++| |..|++....++..++.+... +|
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--------------RL- 919 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--------------RL- 919 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc--------------cC-
Confidence 33334445678999999999999999999999999999997 889998877666655443111 11
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
..++-+..++..++.+||..++..||+++++...+.+..+.
T Consensus 920 -sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 920 -SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 23466788899999999999999999999999888766554
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.48 Aligned_cols=264 Identities=24% Similarity=0.348 Sum_probs=200.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...++||+|+||.||+|..+ +++.+|+|++..... ...+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777899999999999999876 488999998764322 235678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.++.... ..++|.+++.++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999988876443 358999999999999999999999 899999999999999999999999999987653322
Q ss_pred cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh-hHHHHHHHHh-------hcCC-
Q 003350 641 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQ-------NKGQ- 710 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~-------~~~~- 710 (828)
.......++..|+|||++.+ ..++.++|||||||++|||++|++||......+.. .+..+...+. ....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22234567889999999875 45788999999999999999999998654332211 1111100000 0000
Q ss_pred cccccCccccC-----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 711 LDQIIDPTLAG-----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 711 ~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......+.... ...+.....+.+++.+|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000010000 011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=337.48 Aligned_cols=255 Identities=21% Similarity=0.340 Sum_probs=197.9
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc--CCcE
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEM 555 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 555 (828)
...++|...+.||+|+||.||++... .+..+|+|.+... .......|..|+.+|++++||||+++++++.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34567888899999999999999875 4678899987643 23345678999999999999999999998743 4568
Q ss_pred EEEEEeccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcC----CCCEEeeeeecCcEEeCC---------
Q 003350 556 ILIYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGY----AKAVIHRDVKSANILLDE--------- 620 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDIkp~NILld~--------- 620 (828)
++||||+++|+|.++|... ....+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999998642 2246999999999999999999999832 145999999999999964
Q ss_pred --------CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCCCCC
Q 003350 621 --------NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPT 690 (828)
Q Consensus 621 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~~~~ 690 (828)
...+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||+||||+||+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 34589999999986532 112334579999999999864 45889999999999999999999999643
Q ss_pred ChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 691 LPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 691 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.... .....+ ... +.+. .......+.+++..||+.+|.+||++.|++.
T Consensus 247 ~~~~-----qli~~l-k~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFS-----QLISEL-KRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHH-----HHHHHH-hcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3211 111111 111 1110 0122456889999999999999999999984
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.05 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=205.8
Q ss_pred CCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 486 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
|...+.||+|.-|+||++++.+ +...|+|++.... .+...+.+.|-+||+.+.||.++.|++.++.....||||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 3444689999999999999875 5889999987653 34456678899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC----
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE---- 637 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~---- 637 (828)
|+||+|...++.+..+.++...+.-++.+++-||+|||- .|||.|||||+||||.++|++.|+||.|+..+..
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999999988888889999999999999999999999 9999999999999999999999999999753211
Q ss_pred -----------------------------CCc---------------------cceeccccccccccChhhhccCCCCcc
Q 003350 638 -----------------------------IDQ---------------------THVSTAVKGSFGYLDPEYFRRQQLTEK 667 (828)
Q Consensus 638 -----------------------------~~~---------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~k 667 (828)
... ...+...+||-.|+|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 000 011234579999999999999999999
Q ss_pred cceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCC
Q 003350 668 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP 747 (828)
Q Consensus 668 sDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 747 (828)
.|+|+|||+||||+.|+.||.+....+.. . .++-..+.-.-.++.+..+.++|.+.|.+||.+|-
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl--~-------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETL--R-------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhH--H-------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 99999999999999999999876544331 1 11212121111234567789999999999999997
Q ss_pred C----hHHHHH
Q 003350 748 S----MGDVLW 754 (828)
Q Consensus 748 s----m~eVl~ 754 (828)
. +.||-+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 7 677653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=316.42 Aligned_cols=263 Identities=19% Similarity=0.250 Sum_probs=197.4
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------ 552 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 552 (828)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3567888899999999999999765 5788999988653 233456788999999999999999999987543
Q ss_pred CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999975 6766663 247899999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHH---------HH-
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE---------WA- 702 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~---------~~- 702 (828)
+.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+.....- +.
T Consensus 174 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 86432 112234578999999999999999999999999999999999999997654322211100 00
Q ss_pred ------HHHhh-cCCc-----ccccCccc---cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 703 ------MKWQN-KGQL-----DQIIDPTL---AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 703 ------~~~~~-~~~~-----~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+.. .... .+...... ...........+.+++.+||+.+|.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 0000 00000000 000111123467899999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.51 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=201.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36778899999999999999876 47899999876543 233567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++...+ .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999996543 68999999999999999999999 899999999999999999999999999987421100
Q ss_pred c-------------cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh
Q 003350 640 Q-------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 640 ~-------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
. ........++..|+|||++....++.++|+|||||++|||++|+.||......+.. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~------~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH
Confidence 0 00112345788999999998888999999999999999999999999754432211 1111
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.. . ...+... ...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 230 ~~-~---~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SD-D---IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hc-c---cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11 0 0111111 1234567899999999999999997766655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=305.67 Aligned_cols=264 Identities=21% Similarity=0.299 Sum_probs=202.5
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|+..+.||+|++|.||+|..+ +++.|++|++... .....+.+.+|++++++++|+||+++++++..++..++|+||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999876 5789999987653 233457789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
++++.+..++... ..+++.++..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 82 VERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9987776655332 358999999999999999999999 8999999999999999999999999999987554222
Q ss_pred ceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH---------HHhhcCCc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM---------KWQNKGQL 711 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~ 711 (828)
.......++..|+|||++.+. .++.++||||||+++|||++|++||......+......... .+......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 122345678899999999887 88999999999999999999999997543322111111000 00000000
Q ss_pred -----ccccCcc-ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 -----DQIIDPT-LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 -----~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
....++. ....++.....++.+++.+|++.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 001122233677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.58 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=205.1
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|+..+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46788899999999999999864 57889999886543 23567899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 562 MENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
+++++|.+++..... ..+++.....++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999965432 568999999999999999999999 9999999999999999999999999999876543222
Q ss_pred c--ceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 641 T--HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 641 ~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
. .......|+..|+|||++... ..+.++|+|||||++|||++|+.||....+.+. ..+ ..... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----HhcCC------CC
Confidence 2 122345688999999999877 789999999999999999999999975433221 111 11110 11
Q ss_pred cccCCC-ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 TLAGKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+.... ....+..+.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 1234567889999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.83 Aligned_cols=195 Identities=25% Similarity=0.374 Sum_probs=159.6
Q ss_pred ceEeeeCcEEEEEEEec---CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEc--cCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN---DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD--EKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~ey~~~ 564 (828)
.+||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++. .....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 68999999999999865 346899998765432 346789999999999999999999884 45678999999875
Q ss_pred CcccccccCC-------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe----CCCCcEEEEeeCCCC
Q 003350 565 GTLKGHLYGS-------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSK 633 (828)
Q Consensus 565 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kl~DFGla~ 633 (828)
+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 776665321 12358899999999999999999999 899999999999999 567799999999998
Q ss_pred CCCCCCcc-ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCC
Q 003350 634 TGPEIDQT-HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPT 690 (828)
Q Consensus 634 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~ 690 (828)
........ .......||..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 65432211 11234568999999999876 45899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=300.22 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=208.0
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
|++.++||+|+||.|||+.++ .|+.+|||.....+ ..+++..|+.+++++..|++|+++|.+.....+++|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556678999999999999776 58999999877654 468999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+..+.++..+ ++|++.++..|++..++||+|||. ..-||||||+.||||+.+|.+||+|||.|..+.. .-...
T Consensus 113 GSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR 186 (502)
T KOG0574|consen 113 GSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR 186 (502)
T ss_pred CcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence 99999986544 689999999999999999999999 8889999999999999999999999999976532 22234
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
+.+.||+.|||||++..-.|..++||||+|+...||..|++|+....|-...- .+..--.|.+ ..+
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------MIPT~PPPTF--~KP 252 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------MIPTKPPPTF--KKP 252 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------eccCCCCCCC--CCh
Confidence 56789999999999999999999999999999999999999997544321100 0000011122 234
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+++..++-+++..||-.+|++|.|+.++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 677889999999999999999999988875
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.22 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=200.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|++|.||++... +++.+|+|.+..... ...+.+..|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36778889999999999999876 488999998875432 24567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+.+++|.+++.......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999999876555679999999999999999999999 899999999999999999999999999987543211
Q ss_pred cc---------------------------ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCCh
Q 003350 640 QT---------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP 692 (828)
Q Consensus 640 ~~---------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~ 692 (828)
.. .......||..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 011234688899999999988999999999999999999999999975543
Q ss_pred hhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHH
Q 003350 693 REMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV 752 (828)
Q Consensus 693 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV 752 (828)
.... . ... +....-.........+.+++.+|++.+|.+||++...
T Consensus 238 ~~~~--~----~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 238 DETF--S----NIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred HHHH--H----HHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence 2211 0 000 1111000111245678999999999999999994333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.67 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=201.8
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEc--cCCcEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD--EKNEMILIY 559 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~ 559 (828)
+|+..+.||.|+||.||++... +++.+|+|.+... .....+++..|++++++++|+||+++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3667789999999999999764 5788999987643 3344567889999999999999999999874 345679999
Q ss_pred EeccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcC--CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 560 EYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGY--AKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 560 ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
||+++++|.+++... ...++++.+++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998642 2357999999999999999999999322 289999999999999999999999999999875
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.... .......++..|+|||.+.+..++.++||||||+++++|++|+.|+......+ +.+. ...+.
T Consensus 161 ~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~----- 226 (265)
T cd08217 161 GHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK----IKEGK----- 226 (265)
T ss_pred cCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH----HhcCC-----
Confidence 4322 11234568999999999998889999999999999999999999997654222 1111 11111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
....+......+.+++.+|++.+|.+||++.+|+++
T Consensus 227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112233445678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=308.14 Aligned_cols=245 Identities=23% Similarity=0.350 Sum_probs=198.8
Q ss_pred cceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 489 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
...||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 357999999999999765 6889999998765555567788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccc
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (828)
.+++.. ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....... ......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 177 (297)
T cd06659 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSL 177 (297)
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccce
Confidence 987744 358999999999999999999999 899999999999999999999999999987543211 112345
Q ss_pred cccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003350 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727 (828)
Q Consensus 648 ~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (828)
.|+..|+|||++.+..++.++|||||||++|||++|+.||....+.+... .. .... .+... .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~------~~-~~~~-----~~~~~--~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK------RL-RDSP-----PPKLK--NAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-hccC-----CCCcc--ccCCC
Confidence 68899999999998899999999999999999999999997544322211 11 1100 00000 11123
Q ss_pred HHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 728 LRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 728 ~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
...+.+++.+|++.+|.+||++.++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 4567889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.11 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=210.4
Q ss_pred HhcCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcc---cHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQ---GLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 556 (828)
....|...+.||+|.||.||+++.+. |+.+|+|.+...... ....+.+|+++|+++. ||||+.+.+.++.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34567777899999999999998775 999999987765432 3468899999999998 999999999999999999
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC----CCcEEEEeeCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE----NFMAKVADFGLS 632 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~----~~~~kl~DFGla 632 (828)
+|||++.+|.|.+.+... .+++.....++.|++.+++|||+ .+|+||||||+|+|+.. ++.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999665 39999999999999999999999 99999999999999953 357999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
..... .......+||+.|+|||++....|+.+.||||+||++|.|++|.+||......+... ....+..
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~- 255 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF- 255 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence 98654 344667899999999999999999999999999999999999999998765433321 1111111
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......-......+.+++..|+..+|.+|+++.++++
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1222222345677889999999999999999999987
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.46 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=199.4
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+|+..+.||+|+||.||++... .+..+|+|.+... ......++.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4666789999999999999876 6889999987653 3334567899999999999999999999999999999999999
Q ss_pred cCCcccccccCCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 563 ENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 563 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
++++|..++.... ...+++..+..++.+++.||.|||+ ..+++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 9999998886532 2468999999999999999999996 258999999999999999999999999998764321
Q ss_pred ceeccccccccccChhhhccC------CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||........... .... ..+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~-~~~~----- 226 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---LSAI-VDGD----- 226 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---HHHH-hhcC-----
Confidence 12334578899999998544 358899999999999999999999965432221110 0000 0000
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
....+.+....+.+++.+|++.+|.+||++.+++.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 ----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 01122345567889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=304.85 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=198.8
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|+..+.||.|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4777889999999999999775 58899999876542 22346788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+. ++|.+++.......+++.+++.++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 689888876555679999999999999999999999 8999999999999999999999999999876432111
Q ss_pred ceeccccccccccChhhhccCC-CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc------------
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK------------ 708 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------ 708 (828)
......++..|+|||++.+.. ++.++|||||||++|||+||+.||....+.+. +.+........
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHH
Confidence 122345688999999886644 68899999999999999999999975443221 11111100000
Q ss_pred ---CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 ---GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 ---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..........+. ...+.....+.+++.+|++.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 001122345778999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.30 Aligned_cols=244 Identities=23% Similarity=0.362 Sum_probs=198.3
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCccc
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 568 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~ 568 (828)
..||+|+||.||++... ++..||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 57999999999999765 57899999987665556677899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceecccc
Q 003350 569 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648 (828)
Q Consensus 569 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (828)
+++... .+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++....... .......
T Consensus 108 ~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 179 (292)
T cd06658 108 DIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV 179 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence 987432 58999999999999999999999 899999999999999999999999999987543211 1123356
Q ss_pred ccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHH
Q 003350 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 728 (828)
Q Consensus 649 gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (828)
|+..|+|||.+.+..++.++|||||||++|||++|+.||....+.+..... . ..+.+.+.. .....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-------~-----~~~~~~~~~--~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------R-----DNLPPRVKD--SHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------H-----hcCCCcccc--ccccC
Confidence 889999999998888999999999999999999999999754432221110 0 011111111 11224
Q ss_pred HHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 729 RKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 729 ~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+.+++.+|++.+|.+||++.|+++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 457788999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.81 Aligned_cols=264 Identities=22% Similarity=0.327 Sum_probs=196.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56778899999999999999876 578999998765432 2234577899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++ +|.+++.... ..+++.....++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 985 8998886544 368999999999999999999999 8999999999999999999999999999875432111
Q ss_pred ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCCh-hhhhhHHHHHHHHhhcCCc------cc
Q 003350 642 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQNKGQL------DQ 713 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~------~~ 713 (828)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+..............+.. .+
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1223346788999999875 4588999999999999999999999965431 1111111000000000000 00
Q ss_pred -------cc-CccccCCCC-hhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 714 -------II-DPTLAGKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 714 -------~~-d~~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. ...+..... ......+.+++.+|++.+|.+||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 000000000 111256788999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.09 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=200.7
Q ss_pred CCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCC------cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
+|+..+.||+|++|.||+|.. .+++.+|+|.+.... ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467778999999999999976 468899999876433 1235678899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-cEEEEeeCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGP 636 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kl~DFGla~~~~ 636 (828)
|+||+++++|.+++.... ++++..++.++.|++.||+|||+ .+++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999986543 68999999999999999999999 8999999999999998776 59999999987654
Q ss_pred CCCc--cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 637 EIDQ--THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 637 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.... ........++..|+|||.+.+..++.++||||+|++++||++|+.||.......... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~------ 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIASA------ 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhcc------
Confidence 3211 111223468889999999988889999999999999999999999986433211111 11110000
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......+......+.+++.+|++.+|.+||++.|++.
T Consensus 227 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011223344567889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=315.67 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=195.2
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccC-----
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK----- 552 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 552 (828)
...++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++|++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34577888899999999999999764 57899999886532 22345678999999999999999999887432
Q ss_pred -CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 553 -NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 553 -~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
...++++|++ +++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 4578999988 6788887743 358999999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh----
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ---- 706 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~---- 706 (828)
++.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ..+.....
T Consensus 165 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~ 237 (343)
T cd07878 165 ARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIMEVVGTPSP 237 (343)
T ss_pred ceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCCH
Confidence 986432 1234568999999999876 57899999999999999999999999754322211 11100000
Q ss_pred ------hcC-------CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 707 ------NKG-------QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 707 ------~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+ .+.......+...+ ......+.+++.+|++.+|.+|||+.|++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000000000 1122346789999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.30 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=199.5
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcc-----cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ-----GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
+|+..+.||+|++|.||+|... +++.|++|++...... ....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999865 5889999988755322 245577899999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+ +|+|.+++.... ..+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999986544 469999999999999999999999 89999999999999999999999999999865432
Q ss_pred CccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHH--------hhcC
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW--------QNKG 709 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~ 709 (828)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|.++|....+.+.. ....... ....
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HHHHHHcCCCchhhhhhcc
Confidence 11 1223456788999999865 46789999999999999999998888654432211 1111000 0000
Q ss_pred CcccccCccccC-----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 710 QLDQIIDPTLAG-----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 710 ~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
............ .........+.+++.+|++.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000 011233567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.79 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=201.2
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|+||.||+|... +++.+++|.+..... ...+++.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677789999999999999865 688999998776544 3577899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++.... .+++..+..++.++++||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999986543 58899999999999999999999 89999999999999999999999999998875432221
Q ss_pred ce--eccccccccccChhhhccCC---CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 642 HV--STAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 642 ~~--~~~~~gt~~Y~aPE~~~~~~---~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.. .....++..|+|||++.... .+.++||||||++++||++|+.||........ .. ..... + ..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~---~~~~~-~-----~~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IM---FHVGA-G-----HK 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HH---HHHhc-C-----CC
Confidence 11 12356788999999998766 89999999999999999999999975432111 11 11000 1 01
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.+.. .......+.+++.+|++.+|.+||++.|++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11110 1122456788999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.21 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=202.5
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|++|.||+|+.. +++.|++|++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4667789999999999999875 68899999876543 33356789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999986544 569999999999999999999999 8999999999999999999999999999987543221
Q ss_pred ceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC-----------
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG----------- 709 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 709 (828)
.......|+..|+|||++.+. .++.++||||+||+++||++|+++|....+.+. ..+........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence 122345688999999998654 468999999999999999999888865443221 11111111000
Q ss_pred -CcccccCccc----cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 710 -QLDQIIDPTL----AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 710 -~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
....+..+.. .....++....+.+++.+|++.+|.+||++++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 001112335778999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=298.51 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=200.5
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
|...+.||+|+||.||+|... +++.+|+|...... ....+.+.+|++++.+++||||+++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 556678999999999999764 57899999876443 3345678899999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++... .+++..+..++.|++.+|+|||+ .+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 86 ~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06641 86 GGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence 99999988543 58999999999999999999999 999999999999999999999999999987653311 11
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
.....++..|+|||.+.+...+.++|||||||++|||++|+.|+....+.... .... ... .+ ..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~-~~~-----~~----~~ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL------FLIP-KNN-----PP----TL 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH------HHHh-cCC-----CC----CC
Confidence 23356888999999998888999999999999999999999998654322111 1111 110 01 11
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.......+.+++.+|++.+|.+||++.+++..
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 22345668889999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=299.80 Aligned_cols=257 Identities=24% Similarity=0.296 Sum_probs=201.1
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEcc--CCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 559 (828)
++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||++++++|.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999875 578899998775432 345778999999999999999999998854 44689999
Q ss_pred EeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 560 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 560 ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||+++++|.+++.. .....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 223468999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCCh--hhhhhHHHHHHHHhhcCCccccc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP--REMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.|+..... .....+..|.... ....+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~- 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPEL- 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhh-
Confidence 11 1234578899999999999999999999999999999999999975422 1112222222210 00011
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.... .........+.+++.+|++.+|.+||++.|+++
T Consensus 229 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000 001224567889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=291.52 Aligned_cols=249 Identities=28% Similarity=0.444 Sum_probs=205.0
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
+|...+.||+|++|.||++... +++.+++|+.........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3666789999999999999876 688999999887665567889999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.... ..+++..+..++.|++.+|+|||+ .+++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999986653 469999999999999999999999 9999999999999999999999999999987544221
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
.....++..|+|||.+.....+.++||||||++++||++|+.|+......+..... .. .......+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-~~~~~~~~------- 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI------AT-NGPPGLRN------- 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH------Hh-cCCCCcCc-------
Confidence 23456889999999999888999999999999999999999998754322211110 00 11111100
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.......+.+++.+|++.+|.+||++.|+++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112456889999999999999999999974
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=295.30 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=207.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|+..+.||+|++|.||+++.. +++.+++|++..... ...+++.+|++.+.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 35777899999999999999877 489999998876644 4467899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++... ..+++..++.++.|+++||+|||+. .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 9999999999654 4689999999999999999999962 7899999999999999999999999999886543221
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......++..|+|||.+....++.++||||||+++|||++|+.|+..........+..+.. . .. .+
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~-~~-----~~---- 221 (264)
T cd06623 156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---D-GP-----PP---- 221 (264)
T ss_pred -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---c-CC-----CC----
Confidence 1224567889999999999999999999999999999999999997654212222222111 1 10 01
Q ss_pred CCChh-HHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 722 KIRPD-SLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 722 ~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..... .+..+.+++.+|++.+|++||++.|+++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122 45678999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.57 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=201.9
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|+||.||+|..+ ++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677789999999999999876 47889999876532 23456788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-cEEEEeeCCCCCCCCCCc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kl~DFGla~~~~~~~~ 640 (828)
+++++|.+++.......+++..++.++.|+++||+|||+ .+++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-- 155 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC--
Confidence 999999999876554568999999999999999999999 8999999999999999885 5699999998765431
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
........|+..|+|||++.+..++.++|+||||++++||++|+.|+...... ++...... +.. .
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~----~---- 220 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-GYF----A---- 220 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-ccC----C----
Confidence 11223346889999999998888999999999999999999999998654322 22222111 111 1
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+.....+.+++.+|++.+|++||++.|++.
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111233456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=286.99 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=204.8
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--------ccHHHHHHHHHHHHcC-CCCceEEEEEEE
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--------QGLAEFQTEIEMLSQF-RHRHLVSLIGYC 549 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 549 (828)
+...++|...+.||.|..+.|-++..+ .|...|+|++..... .-.++-..|+.+|+++ -||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567788899999999999988665 578899997654321 1134456899999998 699999999999
Q ss_pred ccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 550 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
+....+++|+|.|+.|.|.|+|...- .++++...+|+.|+.+|++|||. ..||||||||+|||+|++.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999996544 79999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhcc------CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (828)
|.+..+.. .......+||++|+|||.+.. ..|+...|.|+.||+||-|+.|.+||-... +.. ..
T Consensus 168 GFa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Qml-----ML 237 (411)
T KOG0599|consen 168 GFACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QML-----ML 237 (411)
T ss_pred ceeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHH-----HH
Confidence 99987644 333567899999999999864 368899999999999999999999984221 111 11
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
++..+|+. +.-.|+. .+......+++.+||+.+|.+|-|..|+++.-
T Consensus 238 R~ImeGky-qF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 238 RMIMEGKY-QFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHHhccc-ccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 22233321 1111211 23455678899999999999999999999743
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.97 Aligned_cols=253 Identities=29% Similarity=0.406 Sum_probs=200.5
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCC------
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN------ 553 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------ 553 (828)
.+++|...+.||+|++|.||+|... +++.+++|.+..... ..+++.+|+++++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678899999999999999999875 578899998765543 356789999999999 7999999999996544
Q ss_pred cEEEEEEeccCCcccccccCCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999886533 4578999999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
+...... ........|+..|+|||++.. ..++.++|||||||+++||++|+.||....+... +.. ..
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK----IP 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH----hh
Confidence 8764321 112234568899999998853 3567899999999999999999999964432211 111 00
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... .+.+. ........+.+++.+|+..+|.+||++.|+++
T Consensus 232 -~~~-----~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNP-----PPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccC-----CCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 11111 11224567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=299.31 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=199.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCC---CCceEEEEEEEccCCcEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 559 (828)
.|+..+.||+|+||.||+|... +++.+++|.+... .....+++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4666788999999999999864 6889999987654 3344677889999999997 999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++... .+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988543 68999999999999999999999 999999999999999999999999999997654322
Q ss_pred ccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.......|+..|+|||.+.++ .++.++|||||||++|||++|+.||.......... . +.....+.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~------~~~~~~~~ 221 (277)
T cd06917 156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------L------IPKSKPPR 221 (277)
T ss_pred --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------c------cccCCCCC
Confidence 112345688999999998754 56899999999999999999999997543222110 0 00001111
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+... .....+.+++.+|++.+|++||++.|++.
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 13556889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.43 Aligned_cols=246 Identities=28% Similarity=0.402 Sum_probs=196.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
+.|...+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|+++++.++||||+++.++|...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777789999999999999875 58899999876432 233467889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||++ |+|.+.+.... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9997 57777664333 368999999999999999999999 8999999999999999999999999999876432
Q ss_pred ccceeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 640 QTHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.....++..|+|||++. .+.++.++||||||+++|||++|++|+.......... .....+ .
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~~~~~------~ 231 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQND------S 231 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HHhcCC------C
Confidence 12346788999999874 4568899999999999999999999986543322111 100000 0
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+.+ ........+.+++.+||+.+|.+||++.+++..
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 112345678999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.87 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=200.4
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 344469999999999999764 6889999988765555567789999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
++|.+++.. .++++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....... ...
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~ 172 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR 172 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence 999999865 358999999999999999999999 899999999999999999999999999887543311 112
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||....+.+.. ..... +. .+.+.. .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~~~~-~~-----~~~~~~--~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KRIRD-NL-----PPKLKN--L 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHHh-cC-----CCCCcc--c
Confidence 3356889999999998888999999999999999999999998654332221 11111 10 011110 1
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......+.+++.+|++.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 123457889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=292.24 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=205.6
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILIY 559 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 559 (828)
+|...+.||+|++|.||+|... +++.|++|....... ...+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999876 688999998766542 4567889999999999999999999999888 8899999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++.... .+++.+++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999986554 79999999999999999999999 999999999999999999999999999998754422
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.........++..|+|||.+.....+.++||||||++++||++|+.||....... .-..... ....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~---------~~~~ 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIG---------SSGE 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhcc---------ccCC
Confidence 2111334568889999999988889999999999999999999999997554111 1011111 1111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...++......+.+++.+|++.+|.+||++.|++.
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11223344677899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.70 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=203.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.+|...+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 56777889999999999999754 57889999987655555678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999998543 47899999999999999999999 9999999999999999999999999999875433221
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
......|+..|+|||.+....++.++|||||||++|||++|+.||....+.+.... ....+ .+.. .
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~------~~~~--~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPEL--Q 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC------CCCC--C
Confidence 12334688899999999888899999999999999999999999975433221100 00000 0000 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
........+.+++.+|++.+|.+||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112234568889999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=299.65 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=205.9
Q ss_pred CHHHHHHHh-cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEE
Q 003350 475 PFVAVQEAT-NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549 (828)
Q Consensus 475 ~~~~l~~at-~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (828)
...|.+..+ +.|..-++||+||||.||-++.+ +|+.+|.|++.... .++..-..+|-.+|.+++.+.||.+--.+
T Consensus 175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred HHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 444555544 45788899999999999999765 58899998765432 33445567899999999999999999999
Q ss_pred ccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 550 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
+.++.+|||+..|.+|+|.-||+..+.+.+++..++-++.+|+.||++||+ ..||.||+||+|||||+.|+++|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeecc
Confidence 999999999999999999999999888899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 709 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (828)
|||...+. ....+..+||.+|||||+++++.|+...|+||+||+||||+.|+.||..........- +.+...+
T Consensus 332 GLAvei~~---g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vdrr~~~- 404 (591)
T KOG0986|consen 332 GLAVEIPE---GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VDRRTLE- 404 (591)
T ss_pred ceEEecCC---CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HHHHHhc-
Confidence 99987654 2223445899999999999999999999999999999999999999964332211100 0010000
Q ss_pred CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 710 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
|+ .+++....++...+....|+.+|.+|-.-
T Consensus 405 ------~~---~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 ------DP---EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ------ch---hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 11 12334445567777888899999998543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=300.59 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=199.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35777889999999999999875 57899999876432 233567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998655 368999999999999999999999 99999999999999999999999999999875432
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||......+... .. ..+. .
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~------~-- 215 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE------KI-LEGK------V-- 215 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-hcCC------c--
Confidence 234568899999999988889999999999999999999999997544221110 00 0111 1
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVL 753 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl 753 (828)
.++......+.+++.+|++.+|.+|| ++.|++
T Consensus 216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11222346688999999999999998 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.26 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=206.6
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..+++|...+.||+|++|.||+|..+ ++..+++|.+..... ..+.+.+|++++++++|+|++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45667777789999999999999886 588999998876544 5677899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999997654 479999999999999999999999 999999999999999999999999999987543211
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
. ......++..|+|||++.+..++.++|||||||++|||++|+.|+....+..... . .... ......
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~----~~~~-~~~~~~---- 237 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--L----ITTK-GIPPLK---- 237 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----HHhc-CCCCCc----
Confidence 1 1233457889999999988889999999999999999999999987544332111 1 0111 110000
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
........+.+++.+|++.+|.+||++.++++.
T Consensus 238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 ---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011234568899999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=298.70 Aligned_cols=266 Identities=22% Similarity=0.283 Sum_probs=197.0
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++++|...+.||+|+||.||+|... +++.|++|++..... .....+.+|++++++++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567888899999999999999764 588999998765432 23346789999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+. ++|.+++.... ..+.+.++..++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 67777665433 357889999999999999999999 899999999999999999999999999997643211
Q ss_pred ccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH----------Hhhc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK----------WQNK 708 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~----------~~~~ 708 (828)
. ......++..|+|||++.+. .++.++|||||||++|||++|+.||+........-...|... ....
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1 12334578899999998754 578899999999999999999999975433211111111100 0000
Q ss_pred -CCcccccCccccCCC-----ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 -GQLDQIIDPTLAGKI-----RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 -~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
............... .......+.+++.+|++.+|.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0012456778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=299.56 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=192.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHH-HHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEM-LSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|+||.||+++.. +|+.||+|++.... .....++..|+.. ++.++||||+++++++...+..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36778889999999999999876 58999999876542 2233455566665 666799999999999999999999999
Q ss_pred eccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCC-CEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 561 YMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 561 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|++ |+|.+++... ....+++..++.++.|++.||+|||+ . +++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6887776532 23568999999999999999999998 5 899999999999999999999999999886432
Q ss_pred CCccceeccccccccccChhhhcc----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
. ...+...++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... ...+.. ... +
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~~-~---- 223 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ----VVE-E---- 223 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH----HHh-c----
Confidence 1 11233568889999998864 45689999999999999999999998642211 011111 000 0
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+.+. ....+..+.+++.+|++.+|.+||++.++++
T Consensus 224 -~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011110 1123456889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.85 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=195.1
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|+||.||+|+.. +|+.+|+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3667789999999999999875 58899999876432 22345678899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
++ ++|.+++.... ..+++.+++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 97 57887775433 458999999999999999999999 899999999999999999999999999998643211
Q ss_pred ceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC------Ccccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG------QLDQI 714 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~~ 714 (828)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+......+. .+ .......... .+.+.
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhc
Confidence 112334578899999998764 478999999999999999999888643322111 00 0000000000 00000
Q ss_pred cCc----ccc-----CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 IDP----TLA-----GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ~d~----~l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+. ... ....+.....+.+++.+||+.+|.+|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000 0111234567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=300.23 Aligned_cols=264 Identities=20% Similarity=0.265 Sum_probs=199.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 558 (828)
++|...+.||+|+||.||+|..+ +++.+++|.+..... .....+.+|++++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777789999999999999876 578999998765432 2234577899999999999999999998766 899999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
+||++ ++|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99997 48988876543 369999999999999999999999 89999999999999999999999999999865432
Q ss_pred CccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhH-HH---------HHHH--H
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL-AE---------WAMK--W 705 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l-~~---------~~~~--~ 705 (828)
.. ......++..|+|||.+.+. .++.++|+||||+++|||++|++||......+.... .. |... +
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 11 12334578899999998754 468999999999999999999999976543322111 00 1000 0
Q ss_pred --hhcCCcccccCccccCCCChh-HHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 706 --QNKGQLDQIIDPTLAGKIRPD-SLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 706 --~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.............+...++.. ....+.+++.+|++.+|++||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111112222222 3566889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=303.21 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=196.9
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
|...+.||+|+||.||+++.. ++..+|+|++.... .....++.+|++++++++|+|++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999865 57899999876432 23345788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
++ |+|.+.+.... .+++|.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 97 57777765433 468999999999999999999999 8999999999999999999999999999875432
Q ss_pred ceeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 642 HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.|+......... ..+ ...+. +.
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~----~~~~~------~~ 243 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHI----AQNES------PT 243 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHH----HhccC------CC
Confidence 22346888999999974 467899999999999999999999998654322211 111 11110 00
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.........+.+++.+|++.+|.+||++.++++.+..
T Consensus 244 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 244 ---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0112334568899999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=299.17 Aligned_cols=263 Identities=23% Similarity=0.302 Sum_probs=199.1
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcEEEEEE
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILIYE 560 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 560 (828)
|...+.||+|++|.||+|+.. +++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 455678999999999999876 47899999987653 33456788999999999999999999999877 89999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++ +|.+++.... ..+++.+++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 8888886543 469999999999999999999999 8999999999999999999999999999986544221
Q ss_pred cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc--------
Q 003350 641 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL-------- 711 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------- 711 (828)
...+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||........................
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 11233456788999998764 46789999999999999999999999765443222111100000000000
Q ss_pred ------ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 ------DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.......+...+...+...+.+++.+|++.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000001111111112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=300.09 Aligned_cols=260 Identities=24% Similarity=0.305 Sum_probs=198.4
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
|+..+.||.|++|.||+|... +|+.|++|++.... ......+.+|++++++++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 455688999999999999765 68999999876543 233467889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
+ ++|.+++.......+++.++++++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 689998866554579999999999999999999999 8999999999999999999999999999976432111
Q ss_pred eeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC--------C---
Q 003350 643 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG--------Q--- 710 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~--- 710 (828)
......++..|+|||++.+. .++.++||||||+++|||++|++||....+.+. +........... .
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 12233568899999988654 578999999999999999999999975543221 111111000000 0
Q ss_pred ----cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 711 ----LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 711 ----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......+.. ....+.....+.+++.+|++.+|.+||++.|+++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0112233466889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=299.61 Aligned_cols=264 Identities=22% Similarity=0.267 Sum_probs=197.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788899999999999999875 68899999876542 2334678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-CCcEEEEeeCCCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kl~DFGla~~~~~~~ 639 (828)
|++ ++|.+++.......+++.....++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||+++.....
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 996 588887755444457888999999999999999999 89999999999999985 567999999999764321
Q ss_pred ccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc------c
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL------D 712 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~ 712 (828)
........++..|+|||++.+ ..++.++|||||||++|||+||++||....+.+................. .
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 111233457889999999876 45789999999999999999999999765433221110000000000000 0
Q ss_pred cc-------cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 QI-------IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 ~~-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. ....+. ...+....++.+++.+|++.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000000 011233456889999999999999999999985
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=295.59 Aligned_cols=247 Identities=26% Similarity=0.298 Sum_probs=202.2
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
+|...+.||.|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999876 58899999876532 2346788999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.+++... .++++.++..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998654 468999999999999999999999 899999999999999999999999999987654321
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ .+....... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------cc
Confidence 22345688899999999988899999999999999999999999976543211 111111110 01
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCCh--HHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSM--GDVL 753 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm--~eVl 753 (828)
...+...+..+.+++.+|++.+|.+||+. .|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 12223345778899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=299.34 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=195.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCc-----
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNE----- 554 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 554 (828)
++|+..+.||+|+||.||+|... +++.||+|...... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999875 58899999866542 223467889999999995 6999999999876655
Q ss_pred EEEEEEeccCCcccccccCCC---CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-CCcEEEEeeC
Q 003350 555 MILIYEYMENGTLKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFG 630 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kl~DFG 630 (828)
.++||||+++ +|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 8888875432 2468999999999999999999999 89999999999999998 8999999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh-hHHHHHHHHhhc
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNK 708 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~ 708 (828)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|++||....+.+.. ........ ...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CCh
Confidence 9876432111 1223356788999998865 45799999999999999999999999754332211 11100000 000
Q ss_pred CC---ccccc--------CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 GQ---LDQII--------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 ~~---~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. ..... .+.......+.....+.+++.+|++.+|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00000 000000111234566889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=296.79 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=201.8
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+|+..+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5666788999999999999876 57899999877653 344567899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.... ..+++..+..++.|++.||+|||+ ..+++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 9999999986543 578999999999999999999997 3689999999999999999999999999987542211
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+....... .............. .+.+.
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~~~~-- 225 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PPRLP-- 225 (265)
T ss_pred -hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CCCCC--
Confidence 112668889999999999999999999999999999999999986442110 11111111111110 01111
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.......+.+++.+|+..+|.+||++.+++.
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 -SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0114556889999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=300.05 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=194.4
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3444568999999999999765 57899999876543 234567889999999996 99999999999999999999999
Q ss_pred ccCCcccc---cccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 562 MENGTLKG---HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 562 ~~~gsL~~---~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
+.. +|.+ .+.......+++..+.+++.+++.||+|||+ ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 5444 3333333579999999999999999999997 248999999999999999999999999998754321
Q ss_pred CccceeccccccccccChhhhccC---CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ...-...... + .
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~ 227 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----D 227 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----C
Confidence 1 12334688899999999765 689999999999999999999999864321 1110111110 0 1
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+.+...........+.+++.+|++.+|.+||++.||+..
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1222222223355678999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.87 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=204.0
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCC--CCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNP--RSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 560 (828)
..|+..++||+||.+.||++...+.+.+|+|+... .+.+...-|..|+.+|.+| .|.+||+|++|-..++.++||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 35666789999999999999888888899997553 4566678899999999999 59999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|-+ -+|..+|.........| .+..+..|++.++.++|+ .+|||.||||.|+|+-. |.+||+|||+|........
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 975 49999997766555556 778889999999999999 99999999999999854 5899999999998776444
Q ss_pred cceeccccccccccChhhhccC-----------CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 709 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (828)
.......+||+.||+||.+... +.++++||||+||+||+|+-|++||..- .+...
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~a--------- 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIA--------- 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHH---------
Confidence 5555677899999999998642 2568999999999999999999999632 22111
Q ss_pred CcccccCccccCCCChh-HHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 710 QLDQIIDPTLAGKIRPD-SLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 710 ~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
++..+.||...-+++.- ...++.+++..||+.||.+||+..|+++
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 24456666543333311 1223889999999999999999999985
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=313.13 Aligned_cols=243 Identities=27% Similarity=0.431 Sum_probs=189.7
Q ss_pred cceEeeeCcEEEEEEEec-CCcEEEEEEcC----CCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC--cEEEEEEe
Q 003350 489 SWVIGIGGFGKVYKGELN-DGTKVAVKRGN----PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN--EMILIYEY 561 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ey 561 (828)
..+||+|.|-+||||... +|..||--.++ ..+....+.|..|+.+|+.|+||||++++.++.+.. ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 368999999999999765 46666643221 123455688999999999999999999999986544 47899999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC-CCCcEEEEeeCCCCCCCCCCc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kl~DFGla~~~~~~~~ 640 (828)
|..|+|+.|+.+.+ .++.+.+..|++||++||.|||+. .++|||||||.+||+|+ ..|.|||+|+|||.....
T Consensus 125 ~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--- 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--- 198 (632)
T ss_pred ccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc---
Confidence 99999999997655 688899999999999999999984 47999999999999997 458999999999987533
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.+ ...+.|||.|||||++. ..|.+..||||||++|+||+|+..|+... .+-++.-.+.. .|. .|.-.
T Consensus 199 s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~-SGi-----KP~sl 265 (632)
T KOG0584|consen 199 SH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVT-SGI-----KPAAL 265 (632)
T ss_pred cc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHH-cCC-----CHHHh
Confidence 22 33478999999999987 88999999999999999999999999633 22222111111 111 11111
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+. -.++.++|.+|+.. ..+||++.|++.
T Consensus 266 ~kV~---dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 SKVK---DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hccC---CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1111 12367889999998 999999999985
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.01 Aligned_cols=264 Identities=21% Similarity=0.285 Sum_probs=199.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+|+..+.||.|++|.||+|+.. +++.||||.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4777889999999999999876 588999998775533 23466788999999999999999999999999999999999
Q ss_pred cCCcccccccCCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 563 ENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 563 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
++ +|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 85 8888875433 3468999999999999999999999 899999999999999999999999999997543211
Q ss_pred ceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh-HHHHH--------HHHhhcCCc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAEWA--------MKWQNKGQL 711 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~-l~~~~--------~~~~~~~~~ 711 (828)
.......++..|++||++.+. .++.++|||||||++|||++|+.||......+... ..+.. ..+......
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 112334578899999998654 57899999999999999999999997654332211 11100 000000000
Q ss_pred ccccCc---cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDP---TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...... .......+.....+.+++.+|++.+|.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0000111223456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=283.46 Aligned_cols=251 Identities=21% Similarity=0.313 Sum_probs=199.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
+++|+..+.||+|.|+.||++... .|+.+|+|.+... +....+++.+|+++-+.|+||||++|.....+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 445666678999999999998554 6888888875543 3446788899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC---CCCcEEEEeeCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGP 636 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kl~DFGla~~~~ 636 (828)
|+|.+++|..-+-.. .-.++...-..++||+++|.|+|. ++|||||+||+|+||- ...-+||+|||+|....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997655332 246677888999999999999999 9999999999999994 44569999999998765
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.........||++|||||+++..+|+..+|||+.||+||-|+.|++||-....... .+ + ...+.. -++
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl---ye---~-I~~g~y--d~~ 232 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YE---Q-IKAGAY--DYP 232 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH---HH---H-Hhcccc--CCC
Confidence 34456678899999999999999999999999999999999999999975332221 11 1 011110 011
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.-. +...+...+++.+||..+|.+|.|+.|.+.
T Consensus 233 ~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred Cccc----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111 223455678899999999999999998874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.64 Aligned_cols=247 Identities=22% Similarity=0.334 Sum_probs=207.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.-|+.++.||+|.|..|-++++- .|..||||++....- .....+..|++.|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34667788999999999988653 699999999877643 335678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe-CCCCcEEEEeeCCCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL-DENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl-d~~~~~kl~DFGla~~~~~~~ 639 (828)
.-++|+|.+|+.+.. ..+.+....+++.||+.|+.|+|+ ..+|||||||+||.+ .+-|-+||.|||++..+..
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 999999999997655 459999999999999999999999 999999999999766 5678999999999876533
Q ss_pred ccceeccccccccccChhhhccCCCC-cccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
....+..+|...|-|||.+.+..|+ ++.||||+||+||.|+||++||+...+.+... .++|=.
T Consensus 172 -G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCK 235 (864)
T KOG4717|consen 172 -GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCK 235 (864)
T ss_pred -cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhccc
Confidence 2334567899999999999998876 78999999999999999999998765554322 223322
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. .++.....++.++|..||..+|.+|.+.+||+.
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1 244566778899999999999999999999863
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.84 Aligned_cols=264 Identities=25% Similarity=0.328 Sum_probs=198.2
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCC----
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN---- 553 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 553 (828)
.+.++|+..+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45677888899999999999999876 57899999876543 233456788999999999999999999986654
Q ss_pred ------cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEE
Q 003350 554 ------EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA 627 (828)
Q Consensus 554 ------~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~ 627 (828)
..++|+||+++ +|.+.+... ...+++.+++.++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 676666543 3468999999999999999999999 899999999999999999999999
Q ss_pred eeCCCCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh
Q 003350 628 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
|||++........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||......+... . .....
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~--~-~~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE--L-ISRLC 234 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHh
Confidence 9999986543221 11223346778999998865 457899999999999999999999997543322111 1 11110
Q ss_pred hcC---Ccccc--------cCc------cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 707 NKG---QLDQI--------IDP------TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 707 ~~~---~~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... ....+ .++ ..... ....+..+.+++.+|++.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000 000 00000 0123567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=307.97 Aligned_cols=267 Identities=23% Similarity=0.311 Sum_probs=198.9
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcC-CCCceEEEEEEEcc--CCcE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE--KNEM 555 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~--~~~~ 555 (828)
..++|...+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||++++++|.. ....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567788889999999999999875 5789999987542 223345677899999999 99999999999854 3468
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+||++ ++|.+++... .++|..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5998887543 68899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcc---ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHH------
Q 003350 636 PEIDQT---HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW------ 705 (828)
Q Consensus 636 ~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------ 705 (828)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....+.+...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 12234568899999998764 56789999999999999999999999755433221111000000
Q ss_pred --hhcCCcccccC----ccc--cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 706 --QNKGQLDQIID----PTL--AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 706 --~~~~~~~~~~d----~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
........+++ ... .....+.....+.+++.+|++.+|.+||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000010 000 001112245678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.60 Aligned_cols=266 Identities=22% Similarity=0.264 Sum_probs=196.8
Q ss_pred CCCccceEeeeCcEEEEEEEec---CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN---DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMI 556 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 556 (828)
+|...++||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667789999999999999875 37899999887633 33456778999999999999999999999877 8899
Q ss_pred EEEEeccCCcccccccCC---CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC----CCcEEEEee
Q 003350 557 LIYEYMENGTLKGHLYGS---GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE----NFMAKVADF 629 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~----~~~~kl~DF 629 (828)
+||||+++ +|.+.+... ....+++..++.++.|++.||+|||+ .+++||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666655322 22368899999999999999999999 89999999999999999 999999999
Q ss_pred CCCCCCCCCCc-cceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhh-------hhhHHH
Q 003350 630 GLSKTGPEIDQ-THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-------MVNLAE 700 (828)
Q Consensus 630 Gla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~-------~~~l~~ 700 (828)
|+++....... ........++..|+|||++.+. .++.++|||||||+++||++|++||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543222 1112345678899999988764 57899999999999999999999997543322 111111
Q ss_pred HHHHHhh-----------cCCcccccCccccCCCC---------h--hHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 701 WAMKWQN-----------KGQLDQIIDPTLAGKIR---------P--DSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 701 ~~~~~~~-----------~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
....+.. ........+......++ . ....++.+++.+|++.+|.+||++.|++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111100 00000000000000011 0 23456889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.90 Aligned_cols=242 Identities=25% Similarity=0.325 Sum_probs=186.8
Q ss_pred eEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHH---cCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 491 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLS---QFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
+||+|+||.||++... +++.+|+|.+..... .....+.+|..++. ..+||||+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998754321 22233445544443 4479999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+++.... .+++.++..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||++...... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 999999886543 69999999999999999999999 89999999999999999999999999998754321 1
Q ss_pred eccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+... .. .... .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~~------~~~~----~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TL------TVNV----E 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----hh------cCCc----C
Confidence 223468999999999864 5689999999999999999999999965432221111110 00 0111 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLWN 755 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~~ 755 (828)
.+.....++.+++.+|++.+|.+|| ++.|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2233456788999999999999999 58888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=307.20 Aligned_cols=263 Identities=25% Similarity=0.346 Sum_probs=196.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccC-----CcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 555 (828)
.++|...++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467888899999999999999764 68899999886533 23456688999999999999999999887543 357
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+||+++ +|.+.+.. ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999975 77777643 358999999999999999999999 89999999999999999999999999999764
Q ss_pred CCCCc-cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC---C
Q 003350 636 PEIDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG---Q 710 (828)
Q Consensus 636 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~ 710 (828)
..... ........||..|+|||.+.+ ..++.++|||||||++|||++|++||........ ..+........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~ 233 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQED 233 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHH
Confidence 33111 111233568899999998754 5689999999999999999999999965432211 11111111100 0
Q ss_pred cccccCccc---------cCC-----CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 711 LDQIIDPTL---------AGK-----IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 711 ~~~~~d~~l---------~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
...+.+... ... ..+....++.+++.+|++.+|.+||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000 011234568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.11 Aligned_cols=267 Identities=21% Similarity=0.309 Sum_probs=195.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCC------
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN------ 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (828)
.++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888899999999999999875 58899999875432 222345678999999999999999999986543
Q ss_pred --cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 554 --EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 554 --~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
..++||||+.+ +|.+.+.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999974 7877775433 368999999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCcc--ceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 632 SKTGPEIDQT--HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 632 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|++|+....+................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9765432211 112234578899999998764 4788999999999999999999999765543332222211100000
Q ss_pred CCccc-----ccC----c-----cccCCC-ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 GQLDQ-----IID----P-----TLAGKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 ~~~~~-----~~d----~-----~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.... ..+ + ...... .......+.+++.+|++.+|.+||++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000 0 000000 0011245678999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=288.45 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=205.2
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|++|.||++... +++.+++|++..... ...+++.+|++++++++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677789999999999999875 588999998876533 4567789999999999999999999999988999999999
Q ss_pred ccCCcccccccCCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
+++++|.+++.... ...+++.++..++.+++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986542 3579999999999999999999999 899999999999999999999999999997654321
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.......|++.|+|||.+.+..++.++|+||+|+++++|++|+.|+......+. ...... ..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~-~~--------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------ALKILK-GQ--------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH------HHHHhc-CC---------
Confidence 123345688899999999988999999999999999999999999875532221 111111 11
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
....+......+.+++.+|+..+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11122234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=287.12 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=202.7
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|...+.||+|++|.||++... +++.+++|....... ...+.+.+|++++++++|+|++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667789999999999999765 578999998876654 4567899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998654 469999999999999999999999 89999999999999999999999999999875432221
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.....++..|+|||...+..++.++||||+|++++||++|+.|+....+... .|... . .. .+
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~--~-~~-----~~---- 217 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIV--Q-DD-----HP---- 217 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHh--c-cC-----CC----
Confidence 2345688899999999888899999999999999999999999865432111 11110 0 00 01
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+|++.+|++||++.|++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 122233556889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=293.13 Aligned_cols=246 Identities=27% Similarity=0.356 Sum_probs=197.2
Q ss_pred EeeeCcEEEEEEEecC-CcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 492 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998874 89999998865433 4466788999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc------c
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ------T 641 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~------~ 641 (828)
.+++.... .+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99986544 68999999999999999999999 9999999999999999999999999999876433211 1
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.......++..|+|||.......+.++||||||++++||++|+.||....+.+.. ..... +.. . ..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~-~~~----~--~~- 221 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QNILN-GKI----E--WP- 221 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-CCc----C--CC-
Confidence 1223456788999999998888999999999999999999999999765433221 11111 110 0 00
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
........+.+++.+|++.+|.+||++.++.+.|+
T Consensus 222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 -EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00112566889999999999999999966654443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.57 Aligned_cols=237 Identities=23% Similarity=0.284 Sum_probs=192.6
Q ss_pred EeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
||.|++|.||+++.. +++.+++|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999876 47899999876432 23456789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccc
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (828)
.+++.... .+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 99996543 58999999999999999999999 999999999999999999999999999998754321 12334
Q ss_pred cccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003350 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727 (828)
Q Consensus 648 ~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (828)
.++..|++||.+....++.++|+||||+++|||++|+.|+....... .+...... +......++...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDIL---------KGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHh---------ccCCCCCCCccc
Confidence 68889999999988889999999999999999999999997554211 11111111 000111222233
Q ss_pred HHHHHHHHHhhhhhCCCCCCCh
Q 003350 728 LRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 728 ~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
...+.+++.+|++.+|.+||++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCC
Confidence 5678999999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=293.78 Aligned_cols=260 Identities=24% Similarity=0.299 Sum_probs=195.9
Q ss_pred CCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCc--ccHHHHHHHHHHHHcC---CCCceEEEEEEEccCCc-----
Q 003350 486 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQF---RHRHLVSLIGYCDEKNE----- 554 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 554 (828)
|+..+.||+|+||.||+|+.+. ++.+|+|++..... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4566899999999999998864 88999998864322 2234566788777666 59999999999987776
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.+++|||+.+ +|.+++.......+++.+++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999974 89888866544469999999999999999999999 8999999999999999999999999999877
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc---
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL--- 711 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 711 (828)
..... ......++..|+|||++.+..++.++|||||||++|||++|++||....+.+. +..+..........
T Consensus 157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcC
Confidence 53321 11233578899999999999999999999999999999999999875543321 11111111000000
Q ss_pred ------ccccCcccc---CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 ------DQIIDPTLA---GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......... ....++....+.+++.+|++.+|.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 1111234566789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=290.28 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=197.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-----CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 555 (828)
.+|...+.||+|+||.||+|... +++.+++|..... ..+....+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999865 5889999986432 223456788999999999999999999998653 468
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+||+++++|.+++.... .+++...++++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999986543 58899999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCc-cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 636 PEIDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 636 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
..... ........++..|+|||++.+..++.++|||||||+++||++|+.||......+.. .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~----~~~------- 223 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--FK----IAT------- 223 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--HH----HHc-------
Confidence 32111 11112356889999999999888999999999999999999999999654222111 11 000
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......++......+.+++.+|++ ++..||+..+++.
T Consensus 224 --~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 224 --QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 001112233445678899999998 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.82 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=193.2
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCC-CCceEEEEEEEccC--CcEEEEEE
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEK--NEMILIYE 560 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e 560 (828)
|...+.||+|+||.||+|... +++.+|+|++.... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 445678999999999999765 58899999876542 222234457899999885 99999999999877 88999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|++ ++|.+++.... ..++|.+++.++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 997 58888775533 468999999999999999999999 89999999999999999 999999999998653311
Q ss_pred cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh-----------c
Q 003350 641 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN-----------K 708 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----------~ 708 (828)
......++..|+|||++.. ..++.++|||||||++|||++|++||....+.+.. .+...... .
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHHHhhcc
Confidence 1123457889999997654 56789999999999999999999999765443221 11111110 0
Q ss_pred CCcccccCccccC----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 GQLDQIIDPTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 ~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
........+.... ...+..+..+.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000010000 011234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=305.72 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=198.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC-----Cc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 554 (828)
.++|...+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 456888899999999999999765 5889999987653 233355678899999999999999999987543 35
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999996 6888887544 369999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH--------H
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK--------W 705 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------~ 705 (828)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|++||......+......-... .
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 54321 12234467889999998865 5689999999999999999999999975432221111100000 0
Q ss_pred hhcCCccc-------ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 706 QNKGQLDQ-------IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 706 ~~~~~~~~-------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
...+...+ ..++... ...+....++.+++.+|++.+|.+||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 0001110 0112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=289.80 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=202.8
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+|+..++||+|++|.||+++.. +++.+++|.+... ......++.+|++++++++|+||+++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677789999999999999765 6789999987653 233456788999999999999999999999999999999999
Q ss_pred ccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
+++++|.+++... ....+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 23568999999999999999999999 89999999999999999999999999999875432
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......++..|++||.+.+..++.++|+||||+++|||++|+.||......+.. . . ...+..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~---~-~~~~~~-------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---Y---K-VQRGKY-------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HhcCCC--------
Confidence 223355788999999999989999999999999999999999999765432211 1 0 011111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.........++.+++.+|++.+|.+||++.|+++
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122344567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=302.83 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=197.6
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------ 552 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 552 (828)
..++|...+.||+|+||.||+|... +++.||+|.+... ......++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4577888899999999999999765 6889999987643 233456678899999999999999999988543
Q ss_pred CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
...++|+||+. ++|.+.+.. .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999996 488877643 28899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh-HH--------HHHH
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LA--------EWAM 703 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~-l~--------~~~~ 703 (828)
+..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......+... +. ++..
T Consensus 166 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 865331 11234467889999999999999999999999999999999999997543221110 00 0000
Q ss_pred -------HHhhcC------CcccccCccc----cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 704 -------KWQNKG------QLDQIIDPTL----AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 704 -------~~~~~~------~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...... ...+.+.... ...........+.+++.+||+.+|.+||++.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 0001111110 00011133556789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=308.01 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=203.6
Q ss_pred ccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 488 ESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
+..-||.|+||.|||+..++ +-..|-|.+...+....++|.-|+++|..+.||+||+|++.+...+.++++.|||.||-
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence 33569999999999998765 34457788888888889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceecc
Q 003350 567 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 646 (828)
Q Consensus 567 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 646 (828)
....+..-+ ..|+..++.-++.|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+..... .......
T Consensus 116 VDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDs 189 (1187)
T KOG0579|consen 116 VDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDS 189 (1187)
T ss_pred HhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HHhhhcc
Confidence 988876544 469999999999999999999999 9999999999999999999999999999865322 1222356
Q ss_pred ccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 647 VKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 647 ~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
..||+.|||||+.+. .+|+.++||||||+.|.||..+.+|.....+-.. ...+...+ .|.+.
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------llKiaKSe------PPTLl- 256 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE------PPTLL- 256 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HHHHhhcC------CCccc-
Confidence 789999999998864 5899999999999999999999999865433211 11111111 12222
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
-+..+...+.++..+||..+|..||++.++++
T Consensus 257 -qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 -QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 13466788999999999999999999999985
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.83 Aligned_cols=241 Identities=23% Similarity=0.364 Sum_probs=191.6
Q ss_pred EeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
||+|+||+||++..+ +++.+|+|.+.... ......+..|+++|++++||||+++.+++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 58899999876432 22345667899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccc
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (828)
.+++.......+++.+++.++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 999976655579999999999999999999999 8999999999999999999999999999876432 1112334
Q ss_pred cccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003350 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727 (828)
Q Consensus 648 ~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (828)
.++..|+|||++.+..++.++|||||||+++||++|+.||.......... ..... ... .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~-----~~~------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRR-----TLE------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhc-----ccc------ccccCCccC
Confidence 57889999999988889999999999999999999999996543211110 00000 000 001122233
Q ss_pred HHHHHHHHHhhhhhCCCCCCChHH
Q 003350 728 LRKFGETAEKCLADFGVDRPSMGD 751 (828)
Q Consensus 728 ~~~l~~l~~~Cl~~~p~~RPsm~e 751 (828)
...+.+++.+||+.+|.+||+.+|
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 556789999999999999995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=319.51 Aligned_cols=270 Identities=20% Similarity=0.225 Sum_probs=189.9
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEecC--CcEEEEE------------------EcCCCCcccHHHHHHHHHHHHcCCC
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELND--GTKVAVK------------------RGNPRSQQGLAEFQTEIEMLSQFRH 539 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H 539 (828)
....++|...+.||+|+||.||++..+. +...++| +.. ........+.+|+++|++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 3446789999999999999999986542 2222222 111 112234568899999999999
Q ss_pred CceEEEEEEEccCCcEEEEEEeccCCcccccccCCC---CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcE
Q 003350 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANI 616 (828)
Q Consensus 540 ~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 616 (828)
|||+++++++...+..++|+|++. ++|.+++.... .......+...|+.|++.||+|||+ .+|+||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHE
Confidence 999999999999999999999985 47777665432 1223456778899999999999999 8999999999999
Q ss_pred EeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCC-CCCCCChhhh
Q 003350 617 LLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP-VIDPTLPREM 695 (828)
Q Consensus 617 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~-p~~~~~~~~~ 695 (828)
|++.++.+||+|||+++..... .........||..|+|||++.+..++.++|||||||++|||++|+. |+........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 9999999999999999865432 1222334679999999999999999999999999999999999874 4443322222
Q ss_pred hhHHHHHHHHh--hcC------CcccccCcc-cc---CCCC-----hhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 696 VNLAEWAMKWQ--NKG------QLDQIIDPT-LA---GKIR-----PDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 696 ~~l~~~~~~~~--~~~------~~~~~~d~~-l~---~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+.+....+. .++ .+.+.++.. +. ..+. ......+.+++.+||+.||.+||++.|++..
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 22222111100 000 000000000 00 0000 0123456778999999999999999999863
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=305.26 Aligned_cols=267 Identities=20% Similarity=0.284 Sum_probs=199.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEc----cCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCD----EKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~ 555 (828)
..+|...+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.+|++++||||+++.+++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999765 58899999877542 234567788999999999999999998875 33568
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+||+. ++|.+++.... .+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999996 68998886543 59999999999999999999999 89999999999999999999999999999764
Q ss_pred CCCCc--cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH--------H
Q 003350 636 PEIDQ--THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------K 704 (828)
Q Consensus 636 ~~~~~--~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~ 704 (828)
..... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.............-.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 32111 111234578899999999865 468999999999999999999999997654322211110000 0
Q ss_pred HhhcCCcccccC---cccc---CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 705 WQNKGQLDQIID---PTLA---GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 705 ~~~~~~~~~~~d---~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
....+.+.+..+ .... ....+.....+.+++.+|++.+|.+||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000 0000 00112345678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.60 Aligned_cols=262 Identities=25% Similarity=0.303 Sum_probs=195.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 557 (828)
.++|+..+.||+|+||.||+|... +|+.||+|.+..... .....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 356888899999999999999875 588999998764322 2234567899999999999999999998654 56899
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++ +|.+++.... ..+++.+++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999974 7888775533 469999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc--CCc---
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK--GQL--- 711 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~--- 711 (828)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||....+.+...... ..... ...
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~~ 235 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII---QLLGTPNESIWPG 235 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChhhchh
Confidence 221 1223345788999999865 467899999999999999999999997655433221111 10000 000
Q ss_pred -------ccc-cCccccCCC---ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 -------DQI-IDPTLAGKI---RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 -------~~~-~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... ......... .......+.+++.+|++.+|.+||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000000000 0112456788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=296.15 Aligned_cols=243 Identities=23% Similarity=0.367 Sum_probs=197.6
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCccc
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 568 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~ 568 (828)
.+||+|+||.||++..+ +++.||+|++..........+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 47999999999999775 68899999887655555677899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceecccc
Q 003350 569 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648 (828)
Q Consensus 569 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (828)
+++... .+++.....++.|++.||+|||+ .+++||||||+||++++++.++|+|||++....... .......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 987432 58999999999999999999999 899999999999999999999999999987543311 1123456
Q ss_pred ccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHH
Q 003350 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 728 (828)
Q Consensus 649 gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 728 (828)
|+..|+|||++.+..++.++|+||||+++|||++|+.||......+...... . ...+.+.. .....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-------~-----~~~~~~~~--~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------D-----NLPPKLKN--LHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------h-----hCCcccCC--cccCC
Confidence 8899999999988889999999999999999999999987543332211111 0 01111110 01234
Q ss_pred HHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 729 RKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 729 ~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+.+++.+|++.+|.+||++.+++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 45778899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=294.15 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=200.1
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
|...+.||.|++|.||++... +++.+++|++..... .....+..|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345578999999999999875 688999998765433 24567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++ +|.+++.... ..+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 75 8888876543 479999999999999999999999 899999999999999999999999999997654422 1
Q ss_pred eeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh--cCCcccccC---
Q 003350 643 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN--KGQLDQIID--- 716 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d--- 716 (828)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+...... ..... ........+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF--RTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHcCCCchHhcccchhhhh
Confidence 12334578889999998876 78999999999999999999999997554322211110 00000 000000000
Q ss_pred ------c----cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 ------P----TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ------~----~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+ .......++...++.+++.+|++.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0001112334677899999999999999999999974
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.42 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=194.5
Q ss_pred ceEeee--CcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIG--GFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
..||+| +||+||+++.. +++.||+|...... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999875 68999999876532 33457788999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc--
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-- 642 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~-- 642 (828)
++|.+++.......+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999999876554568999999999999999999999 899999999999999999999999998653321111000
Q ss_pred ---eeccccccccccChhhhccC--CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH-------------
Q 003350 643 ---VSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK------------- 704 (828)
Q Consensus 643 ---~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~------------- 704 (828)
......++..|+|||++.+. .++.++|||||||++|||++|+.||......+. .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccch
Confidence 01112345679999999763 578999999999999999999999975432211 1000000
Q ss_pred -------------------HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 705 -------------------WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 705 -------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
...........+..+...........+.+++.+||+.+|.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000001111111112223456778999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=281.73 Aligned_cols=241 Identities=26% Similarity=0.322 Sum_probs=198.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
-++|+..++||+|.||+|-+++-+ .++.+|+|+++..- ......-..|-++|+..+||.+..|--.+...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 357888899999999999999765 58899999887653 33345567899999999999999998889999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||..+|.|.-+|... ..+++....-+...|..||.|||+ .+||.||||.+|.|||.+|++||+||||++..-
T Consensus 247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence 9999999999998654 368888888889999999999999 999999999999999999999999999998632
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.........+||+.|+|||++....|..+.|+|.+||++|||+|||.||.....+....++- . . |-
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------~----e---d~- 385 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------M----E---DL- 385 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------h----h---hc-
Confidence 33444677899999999999999999999999999999999999999997654333322221 0 0 11
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCC
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRP 747 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 747 (828)
.++.....+...+....|..+|.+|-
T Consensus 386 ---kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 ---KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 12333344566778889999999994
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=288.19 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=189.8
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHH-HHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEM-LSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999775 588999998765432 222334455544 4455899999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999986543 68899999999999999999999 8999999999999999999999999999876432 2
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....++..|+|||.+.+..++.++||||||+++|||++|+.||......+... ... .+... ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-~~~~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD------NIL-SRRIN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-hcccC------CCCccc
Confidence 33467889999999988889999999999999999999999997654332211 110 11100 000111
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
......+.+++.+|++.+|++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 23456788999999999999999876664433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=305.51 Aligned_cols=271 Identities=24% Similarity=0.362 Sum_probs=204.6
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccC------CcEEE
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------NEMIL 557 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 557 (828)
+...+.||+|+||.||+|+.+ .|+.||||.+...+. ...+...+|+++|++++|+|||++++.-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 334478999999999999854 699999998877543 3356677999999999999999999986543 46789
Q ss_pred EEEeccCCcccccccCC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe----CCCCcEEEEeeCCC
Q 003350 558 IYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLS 632 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kl~DFGla 632 (828)
|||||.+|||...|... ....|+..+.+.+..+++.||.|||+ ++|+||||||.||++ |..-..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999763 34679999999999999999999999 999999999999999 33345899999999
Q ss_pred CCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
|.... ....+...||..|++||.+.. +.|+...|.|||||++||.+||..||.+...........|.........+
T Consensus 172 rel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 98654 335678899999999999984 88999999999999999999999999765433221222333322222222
Q ss_pred ccccCccccCC------------CChhHHHHHHHHHHhhhhhCCCCCC--ChHHHHHHHHHHHHh
Q 003350 712 DQIIDPTLAGK------------IRPDSLRKFGETAEKCLADFGVDRP--SMGDVLWNLEYALQL 762 (828)
Q Consensus 712 ~~~~d~~l~~~------------~~~~~~~~l~~l~~~Cl~~~p~~RP--sm~eVl~~L~~~~~~ 762 (828)
.-..+++..+. ........+.......|..+|.+|- ...+....+..+++.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 22222222211 1123344555666667777788887 666666666666654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=294.49 Aligned_cols=245 Identities=26% Similarity=0.375 Sum_probs=194.2
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
|...+.||+|+||.||+|+.. +++.+++|.+... .....+++.+|+++++.++|+|++++.+++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 555678999999999999865 5788999987542 233456788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+. |+|.+.+.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 97 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred cC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 96 68877765433 458999999999999999999999 8999999999999999999999999999876432
Q ss_pred ceeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 642 HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.....++..|+|||++. ...++.++|||||||++|||++|+.|+......+... ...... . +.
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~-~-----~~ 233 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNE-S-----PA 233 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------HHhhcC-C-----CC
Confidence 12345788999999975 3568899999999999999999999986543222111 111110 0 11
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
. ........+.+++.+||+.+|.+||++.+++...
T Consensus 234 ~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1 1123445678899999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=287.16 Aligned_cols=250 Identities=19% Similarity=0.229 Sum_probs=192.9
Q ss_pred HHHHHHHhcCCCccceE--eeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEcc
Q 003350 476 FVAVQEATNNFDESWVI--GIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE 551 (828)
Q Consensus 476 ~~~l~~at~~f~~~~~L--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (828)
..+.....++|...+.+ |+|+||.||++..+ ++..+|+|......... .|+.....+ +|||++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34445555677766666 99999999999765 57889999876432211 122222222 79999999999999
Q ss_pred CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-cEEEEeeC
Q 003350 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFG 630 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kl~DFG 630 (828)
.+..++||||+++++|.+++.... .++|.++..++.|+++||+|||+ .+++||||||+||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999986553 79999999999999999999999 8999999999999999998 99999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ 710 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (828)
+++.... .....++..|+|||++.+..++.++|||||||++|||++|+.||...... ......|.......
T Consensus 156 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~-- 226 (267)
T PHA03390 156 LCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQQKK-- 226 (267)
T ss_pred cceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhhccc--
Confidence 9876432 12346889999999999989999999999999999999999999744322 22223332221100
Q ss_pred cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCC-hHHHHH
Q 003350 711 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-MGDVLW 754 (828)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~eVl~ 754 (828)
. .........+.+++.+||+.+|.+||+ ++|+++
T Consensus 227 ------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ------L----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------C----CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 111234556889999999999999996 588763
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=291.73 Aligned_cols=262 Identities=21% Similarity=0.305 Sum_probs=197.4
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEEec
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
|...+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456688999999999999886 478899998765432 22234567999999999 999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
+|+|.+++.......+++.+++.++.|++.+|+|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 7899998876554578999999999999999999999 899999999999999999999999999997643211
Q ss_pred eeccccccccccChhhhc-cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh-HH---------HHHHHHhhcCCc
Q 003350 643 VSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LA---------EWAMKWQNKGQL 711 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~-l~---------~~~~~~~~~~~~ 711 (828)
......++..|+|||++. ...++.++|+||||++++||++|++||......+... .. .|..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 123345788999999875 4568999999999999999999999986554322211 00 011111000011
Q ss_pred ccccCccc---cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTL---AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+.... .....+.....+.+++.+|++.+|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 10000000 00111122467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=292.53 Aligned_cols=255 Identities=15% Similarity=0.181 Sum_probs=182.2
Q ss_pred cCCCccceEeeeCcEEEEEEEecC----CcEEEEEEcCCCCcccHH-----------HHHHHHHHHHcCCCCceEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRSQQGLA-----------EFQTEIEMLSQFRHRHLVSLIGY 548 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~H~niv~l~g~ 548 (828)
++|...++||+|+||.||+|...+ +..+++|........... ....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568888999999999999998754 345666654333221111 12233445567789999999997
Q ss_pred EccCC----cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 549 CDEKN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 549 ~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
+.... ..++++|++.. ++.+.+... ...++..+..|+.|+++||+|||+ .+++||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence 75443 23566776543 555554332 235788899999999999999999 899999999999999999999
Q ss_pred EEEeeCCCCCCCCCCcc-----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChh-hhhhH
Q 003350 625 KVADFGLSKTGPEIDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR-EMVNL 698 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~-~~~~l 698 (828)
||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999765321111 1122346999999999999999999999999999999999999999755222 11111
Q ss_pred --HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 699 --AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 699 --~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
.++..... ..... ....+..+.+++..|++.+|++||++.++++.|
T Consensus 246 ~~~~~~~~~~---------~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFIKRLH---------EGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHHHhh---------hhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111111 11110 123356788999999999999999999998765
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=288.42 Aligned_cols=241 Identities=23% Similarity=0.290 Sum_probs=186.7
Q ss_pred eEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHH---HHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 491 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIE---MLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
+||+|+||.||++... +++.||+|.+..... .....+..|.. +++...||||+.+.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999765 578999998765321 11222344443 4445689999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+++... ..+++.++..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++..... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~ 151 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence 99999988544 369999999999999999999999 89999999999999999999999999998754321 1
Q ss_pred eccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....|+..|+|||++.++ .++.++|||||||++|||++|+.||............. . .. ..++.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~---~-~~------~~~~~---- 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---M-TL------TMAVE---- 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH---H-hh------ccCCC----
Confidence 2234689999999999754 68999999999999999999999997543221111100 0 00 01111
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
.+......+.+++.+|+..+|.+|| ++.|+++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2223356788999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=291.12 Aligned_cols=255 Identities=24% Similarity=0.283 Sum_probs=198.3
Q ss_pred CCCccceEeeeCcEEEEEEEe----cCCcEEEEEEcCCCC----cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcE
Q 003350 485 NFDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (828)
+|...+.||+|++|.||+++. .+++.+|||.+.... ....+.+.+|++++.++ +||||+++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366678999999999999864 256889999876432 22345688999999999 599999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++||||+++|+|.+++... ..+++..+..++.|++++|+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999998654 368999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccceeccccccccccChhhhccCC--CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
.... ........|+..|+|||.+.+.. .+.++||||||+++|||++|+.||....... ............
T Consensus 156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~----- 227 (288)
T cd05583 156 LAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS----- 227 (288)
T ss_pred cccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-----
Confidence 4321 11223356889999999987654 7899999999999999999999985322111 111111111111
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.+ ..+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 228 --~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01 1122234567889999999999999999988766544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=301.21 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=193.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------C
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------N 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 553 (828)
.++|...+.||+|+||.||+|... +++.||+|++... .......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478888899999999999999864 6899999987643 223345688999999999999999999998644 3
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46999999964 6666541 358899999999999999999999 899999999999999999999999999988
Q ss_pred CCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH--------H
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------K 704 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~ 704 (828)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||................ .
T Consensus 166 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 166 HADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 6432 1223467889999999876 468999999999999999999999997654322111111000 0
Q ss_pred HhhcCCccccc-------CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 705 WQNKGQLDQII-------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 705 ~~~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
........... ...+.. ..+.....+.+++.+|++.+|.+||++.|++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 000000 001234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=296.18 Aligned_cols=260 Identities=22% Similarity=0.222 Sum_probs=193.6
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
+.+|.|+++.||+++. +++.||||++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455556666666655 5889999987654 344567899999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc-----cc
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ-----TH 642 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~-----~~ 642 (828)
.+++.......+++.....++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||.+........ ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 999976544568999999999999999999999 8999999999999999999999999998865432111 11
Q ss_pred eeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHH----hh-------cC
Q 003350 643 VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW----QN-------KG 709 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----~~-------~~ 709 (828)
......++..|+|||++.. ..++.++|||||||++|||++|+.||........ +.+..... .. ..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcC
Confidence 1233457788999999876 3588999999999999999999999975432221 11100000 00 00
Q ss_pred Cccc----ccCccc----cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 710 QLDQ----IIDPTL----AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 710 ~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.... ..++.. ..........++.+++.+||+.+|++||++.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 001100 001122334568889999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=301.22 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=202.0
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCC-----cEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-----EMI 556 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 556 (828)
+|...+.||.|++|.||+|+.. .++.+++|++.... ....+.+.+|++++++++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677789999999999999876 48899999887643 344577899999999999999999999987765 789
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999998 48888886543 79999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCc-cceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh--------
Q 003350 637 EIDQ-THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ-------- 706 (828)
Q Consensus 637 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------- 706 (828)
.... ........++..|+|||++.+. .++.++|+||||+++|+|++|++||......+......-.....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 3221 0112345678899999999887 88999999999999999999999997665433211111000000
Q ss_pred hcCCcccccC---cc---ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 707 NKGQLDQIID---PT---LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 707 ~~~~~~~~~d---~~---l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
........+. .. -.....+.....+.+++.+||+.+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 00 0000112245668899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=298.98 Aligned_cols=246 Identities=26% Similarity=0.341 Sum_probs=207.3
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
-...|.....||+|.|++|.+|+.. .+..||||.+....- ...+.+.+|+++|..++|||||+++.+......+++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567888899999999999999765 589999998876532 3345588999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+.+|.+.++|...+ .+.......+..|+.++++|||+ +.|||||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec--
Confidence 99999999999997765 45668889999999999999999 999999999999999999999999999998754
Q ss_pred CccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
........+|++.|.|||++.+.++ .+++|+||+|++||-|++|..||++..-.+ .-++
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~r 266 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPR 266 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccch
Confidence 3445677899999999999998765 589999999999999999999998643222 1122
Q ss_pred cccCCC--ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 TLAGKI--RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~l~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+.+.+ +.-...++.+++++.|-.+|.+|+++.++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 233332 2233456778899999999999999999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=317.54 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=206.9
Q ss_pred CCCccceEeeeCcEEEEEEEec--------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 485 NFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
+....+.||+|.||.|++|... ....||||.++... ....+.+..|+++|+.+ +|+||+.++|+|..++.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3344459999999999999753 14579999987653 34578899999999999 69999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC------------C--CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC
Q 003350 555 MILIYEYMENGTLKGHLYGSG------------L--PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 620 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~ 620 (828)
.++|.||+..|+|.++|...+ . ..|+..+.+.++.|||.||+||++ .++|||||.++|||+.+
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecC
Confidence 999999999999999997655 1 138999999999999999999999 99999999999999999
Q ss_pred CCcEEEEeeCCCCCCCCCCccceecccc--ccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhh
Q 003350 621 NFMAKVADFGLSKTGPEIDQTHVSTAVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVN 697 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~ 697 (828)
+..+||+|||+|+.....+.... .... -...|||||.+....++.|+|||||||+||||+| |..|+......+ .
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~--~ 530 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE--E 530 (609)
T ss_pred CCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--H
Confidence 99999999999997544333221 1122 3456999999999999999999999999999998 678886532111 1
Q ss_pred HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
+. .+.++|... +.+..+..++.++++.|++.+|.+||+..|+++.++..++
T Consensus 531 l~----~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 531 LL----EFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HH----HHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11 123333211 2234556778899999999999999999999999998544
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=292.65 Aligned_cols=244 Identities=27% Similarity=0.391 Sum_probs=193.1
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
|...+.||+|+||.||+|+.. +++.|++|++.... ....+.+.+|++++++++|||++++.+++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 444567999999999999865 57899999876432 23345788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+. |+|.+++.... .++++.+++.++.|++.+|+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 57777765433 468999999999999999999999 8999999999999999999999999999865322
Q ss_pred ceeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 642 HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.....|+..|+|||++. ...++.++|||||||++|||++|++|+......... . ...... . +.
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~---~~~~~~-~-----~~ 239 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---Y---HIAQND-S-----PT 239 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---H---HHHhcC-C-----CC
Confidence 22456888999999984 466889999999999999999999998654322211 1 111110 0 11
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
. ........+.+++.+|++.+|.+||++.+++..
T Consensus 240 ~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 111223457889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=290.55 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=201.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 558 (828)
++|...+.||+|++|.||++... +++.+++|..... .....+.+..|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778889999999999999875 6889999987653 2333567889999999998 99999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
||++++++|.+++.... .+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999996553 69999999999999999999999 89999999999999999999999999998765432
Q ss_pred Ccc------------------ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHH
Q 003350 639 DQT------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 700 (828)
Q Consensus 639 ~~~------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~ 700 (828)
... .......++..|+|||.+....++.++||||||++++||++|+.|+........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQ 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH
Confidence 211 122334678899999999888899999999999999999999999975542111 11
Q ss_pred HHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCCh----HHHH
Q 003350 701 WAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM----GDVL 753 (828)
Q Consensus 701 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm----~eVl 753 (828)
... . ....++......+.+++.+|++.+|.+||++ .+++
T Consensus 233 ~~~---~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 233 KIL---K-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHH---h-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 100 0 0111223335668899999999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=294.83 Aligned_cols=266 Identities=24% Similarity=0.310 Sum_probs=194.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccC-------
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------- 552 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------- 552 (828)
.++|...++||+|+||.||+|... +++.+|+|++..... .....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888899999999999999875 578999998754322 2234677899999999999999999887433
Q ss_pred -CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 553 -NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 553 -~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
..+++|+||+.. +|...+.... ..+++.++..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999975 6766665432 469999999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCcc---------ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHH
Q 003350 632 SKTGPEIDQT---------HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW 701 (828)
Q Consensus 632 a~~~~~~~~~---------~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~ 701 (828)
++........ ...+...++..|+|||.+.+ ..++.++|||||||++|||++|++||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9764331111 11233467888999998865 4588999999999999999999999976544322211111
Q ss_pred HHHHhhc------CCccccc--------CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 702 AMKWQNK------GQLDQII--------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 702 ~~~~~~~------~~~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
....... ..+.... .+.+.... ......+.+++.+|++.+|.+||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 0000000 01111000 122356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=299.82 Aligned_cols=270 Identities=21% Similarity=0.285 Sum_probs=201.3
Q ss_pred ccCHHHHHHHhcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEE
Q 003350 473 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549 (828)
Q Consensus 473 ~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (828)
+....++..++++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++.+++||||+++.+++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 344567788899999999999999999999975 468899999886532 23346688999999999999999999987
Q ss_pred ccC------CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc
Q 003350 550 DEK------NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 623 (828)
Q Consensus 550 ~~~------~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 623 (828)
... ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+ .+++||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 532 3467888876 67898877433 58999999999999999999999 99999999999999999999
Q ss_pred EEEEeeCCCCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHH-HH
Q 003350 624 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA-EW 701 (828)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~-~~ 701 (828)
+||+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ..
T Consensus 159 ~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 159 LKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred EEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999876432 1234567889999999876 56889999999999999999999999654332211110 00
Q ss_pred H-------HHHhhcCC-------cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 702 A-------MKWQNKGQ-------LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 702 ~-------~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
. ........ +......... .........+.+++.+|++.+|.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00000000 0000000000 0001124467899999999999999999999754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=292.89 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=192.7
Q ss_pred cCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|++|.||+|..++ ++.||||.+.... .....++..|+.++.+.. |+||++++++|......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 456677899999999999998875 8899999986543 233456777887777775 9999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++ +|.+.+.... ..+++..+..++.|+++||+|||+ ..+++||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 95 LMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred ccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 9864 6666554422 379999999999999999999996 1489999999999999999999999999987643211
Q ss_pred cceeccccccccccChhhhccCC----CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
......++..|+|||++.+.. ++.++||||||+++|||++|+.||....... ..+. ...... .
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~~~-~----- 236 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLT----KILQEE-P----- 236 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHH----HHhcCC-C-----
Confidence 122345788999999987553 7899999999999999999999996432111 1111 111111 0
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+.+. .......++.+++.+|++.+|.+||++.+++..
T Consensus 237 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 001234568899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=288.91 Aligned_cols=250 Identities=24% Similarity=0.299 Sum_probs=194.3
Q ss_pred CCCccceEeeeCcEEEEEEEe----cCCcEEEEEEcCCCC----cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcE
Q 003350 485 NFDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (828)
+|...+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|++++.++ +|+||+++.+++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999975 368899999876532 22346688999999999 599999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999998654 368899999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCccceeccccccccccChhhhccC--CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
.... ........|+..|+|||.+... .++.++||||||+++|||++|+.|+...... .....+........
T Consensus 156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~---- 228 (290)
T cd05613 156 HEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE---- 228 (290)
T ss_pred cccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC----
Confidence 3311 1112245688999999998753 4688999999999999999999998643211 11111111111110
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVL 753 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl 753 (828)
+ .++......+.+++.+|++.+|.+|| +..+++
T Consensus 229 ---~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 229 ---P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred ---C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 1 12223345678999999999999997 555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=295.52 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=192.9
Q ss_pred cceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCccc--------------HHHHHHHHHHHHcCCCCceEEEEEEEccCC
Q 003350 489 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG--------------LAEFQTEIEMLSQFRHRHLVSLIGYCDEKN 553 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (828)
.+.||+|+||.||+|... +++.||||.+....... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999865 58899999876442211 124778999999999999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++||||++ |+|.+++... ..+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCcccee
Confidence 9999999997 6898888543 358999999999999999999999 999999999999999999999999999997
Q ss_pred CCCCCC------------ccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHH
Q 003350 634 TGPEID------------QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 700 (828)
Q Consensus 634 ~~~~~~------------~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~ 700 (828)
...... .........++..|+|||++.+. .++.++|||||||++|||++|++||....+.+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~--- 244 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG--- 244 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 643100 01111233468889999998764 47899999999999999999999997654432211
Q ss_pred HHHHHhhcCC---ccc------------ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 701 WAMKWQNKGQ---LDQ------------IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 701 ~~~~~~~~~~---~~~------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.......... ... ...+... ........++.+++.+|++.+|.+||++.|++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111000 000 0000010 011223466889999999999999999999974
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=293.76 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=198.0
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc-CCc
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNE 554 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 554 (828)
+..++++|...+.||+|+||.||++... +++.||+|++... .....+.+..|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999755 6889999987542 22335678899999999999999999998855 567
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++++||+. ++|.+++... ++++.....++.|+++||+|||+ .+++||||||+|||+++++.+||+|||++..
T Consensus 85 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehhc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 899999984 6888887543 47888899999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh-HHH--------HHHH
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAE--------WAMK 704 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~-l~~--------~~~~ 704 (828)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||.......... +.+ |...
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 422 1123457888999998765 578999999999999999999999997554322111 111 1111
Q ss_pred HhhcCCcccccCccccCCCC-----hhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 705 WQNKGQLDQIIDPTLAGKIR-----PDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
........-...-......+ +.....+.+++.+|++.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000011 123467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.46 Aligned_cols=263 Identities=24% Similarity=0.275 Sum_probs=192.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-C--CcEEEEEEcCCC--CcccHHHHHHHHHHHHcC-CCCceEEEEEEEcc----CCc
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-D--GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE----KNE 554 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 554 (828)
+|...+.||+|+||.||+++.. . +..+|+|++... .....+.+.+|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4667789999999999999865 3 678999987643 222356788999999999 59999999987533 245
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++++||+. ++|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788888886 6898888543 368999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcc--ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHH---------H
Q 003350 635 GPEIDQT--HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW---------A 702 (828)
Q Consensus 635 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~---------~ 702 (828)
....... .......||..|+|||++.+ ..++.++|||||||++|||++|++||......+....... .
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4432111 11233568999999998865 4689999999999999999999999976543221111000 0
Q ss_pred HHHhhcC------CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 703 MKWQNKG------QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 703 ~~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+.... .....-...+. ...+.....+.+++.+|++.+|.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000000000 011123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=298.89 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=195.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccC----------
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK---------- 552 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 552 (828)
.+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 56888899999999999999765 5889999988776666677889999999999999999998776443
Q ss_pred ----CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC-CCCcEEEE
Q 003350 553 ----NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVA 627 (828)
Q Consensus 553 ----~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kl~ 627 (828)
...++|+||++ ++|.+++... .+++.....++.|++.||+|||+ .+++||||||+||+++ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5888877432 58899999999999999999999 8999999999999997 55678999
Q ss_pred eeCCCCCCCCCCcc-ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHH
Q 003350 628 DFGLSKTGPEIDQT-HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW 705 (828)
Q Consensus 628 DFGla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (828)
|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+...........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999764321111 11123457889999998754 56889999999999999999999999765443322111100000
Q ss_pred hhc---CC----cccccC-----cc-ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 706 QNK---GQ----LDQIID-----PT-LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 706 ~~~---~~----~~~~~d-----~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... .. ...... +. ......+....++.+++.+|++.+|.+||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 00 000000 00 000011123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=286.68 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=198.7
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
|...+.||+|++|.||+|+.. +++.+++|...... ....+.+..|++++++++|+|++++.+++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 345578999999999999876 48999999887653 334567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
+ ++|.+++.... ..+++.+++.++.+++.||+|||+ .+++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 8 58999986643 469999999999999999999999 8999999999999999999999999999986543221
Q ss_pred eeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh-HHHHHH-----HHhhcCCc---c
Q 003350 643 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAEWAM-----KWQNKGQL---D 712 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~-l~~~~~-----~~~~~~~~---~ 712 (828)
......++..|+|||.+.+. .++.++|||||||+++||++|++||......+... ...... .+..-..+ .
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 12234457789999998766 88999999999999999999999997544322111 000000 00000000 0
Q ss_pred cccCc---cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 QIIDP---TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 ~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+.. .......+.....+.+++.+|++.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 0000011122567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=283.42 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=193.2
Q ss_pred CCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCC-----CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
+|...+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46677899999999999997653 334445543321 222344577899999999999999999999989999999
Q ss_pred EEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 559 YEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||+++++|.+++.. .....+++.+++.++.|+++||.|||+ .+++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988864 233579999999999999999999999 99999999999999986 469999999987653
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.. ........|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+......+ ....... +. .
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~-~~-----~ 222 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIVE-GP-----T 222 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHc-CC-----C
Confidence 31 122334568889999999988889999999999999999999999986433211 1111111 10 1
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+. .+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 12344567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=295.24 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=196.9
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC---
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN--- 553 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--- 553 (828)
....++|...+.||+|+||.||++... ++..||||++... .....+.+.+|+++|++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678988899999999999999754 6889999987543 2223456889999999999999999999886543
Q ss_pred ---cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 554 ---EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 554 ---~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 6788888753 358999999999999999999999 899999999999999999999999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh-hHH--------H
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLA--------E 700 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~-~l~--------~ 700 (828)
++...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......... ... .
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99864321 223467889999999876 46889999999999999999999999754322110 000 0
Q ss_pred HHHHHhhcC------CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 701 WAMKWQNKG------QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 701 ~~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
|...+.... .+.......+ ....+.....+.+++.+|++.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 110000000 0000000000 0111233456889999999999999999999974
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=314.18 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=187.9
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC-----
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK----- 552 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 552 (828)
.+-.++|++.++||+||||.|||++.+ ||+.+|||++... +........+|+.+|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345667888889999999999999877 8999999998766 344456678999999999999999987654220
Q ss_pred --------------------------------------------------------------------------------
Q 003350 553 -------------------------------------------------------------------------------- 552 (828)
Q Consensus 553 -------------------------------------------------------------------------------- 552 (828)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHH
Q 003350 553 ----------------------------------NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598 (828)
Q Consensus 553 ----------------------------------~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 598 (828)
..+|+=||||+.-.|++++..+.... .-...++++++|++||.|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 01345567777666666665443211 3567789999999999999
Q ss_pred HhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC----C------------CCccceeccccccccccChhhhccC
Q 003350 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP----E------------IDQTHVSTAVKGSFGYLDPEYFRRQ 662 (828)
Q Consensus 599 H~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~Y~aPE~~~~~ 662 (828)
|+ .+||||||||.||+||++..+||+|||+|.... . .......+...||.-|+|||++.+.
T Consensus 714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99 999999999999999999999999999998611 0 0011124567899999999999764
Q ss_pred ---CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhh
Q 003350 663 ---QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCL 739 (828)
Q Consensus 663 ---~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 739 (828)
.|+.|+|+||+|||++||+. ||....+.- . +..-.+.+.+..- ..+..+....-..++.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa-----~-iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA-----S-ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHH-----H-HHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 59999999999999999984 565432211 1 0111223332221 1112223344568899999
Q ss_pred hhCCCCCCChHHHHH
Q 003350 740 ADFGVDRPSMGDVLW 754 (828)
Q Consensus 740 ~~~p~~RPsm~eVl~ 754 (828)
+.+|.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999884
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-33 Score=323.79 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=198.3
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
..+-++....+||.|.||.||.|.. ++|...|+|-+... .....+...+|+.+|..++|||+|+.+|+-.+++..++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3445677788999999999999965 46888999965433 34556678899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
.||||++|+|.+.+...+ -+++....-+..|++.|++|||+ .+||||||||.||+|+.+|.+|++|||.|.....
T Consensus 1312 FMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999986544 35566666788999999999999 9999999999999999999999999999987544
Q ss_pred CC--ccceeccccccccccChhhhccC---CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh-hcCCc
Q 003350 638 ID--QTHVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ-NKGQL 711 (828)
Q Consensus 638 ~~--~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-~~~~~ 711 (828)
.. .........||+-|||||++.+. ....++||||+|||++||+||++||..... +|+.-+. ..+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh- 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGH- 1458 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccC-
Confidence 21 11223457899999999999753 356789999999999999999999964322 2332211 1111
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
.| .++.....+-.+++..||+.||.+|-++.|++
T Consensus 1459 ----~P----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1459 ----KP----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred ----CC----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 11 23344556667899999999999996655543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=268.43 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=191.4
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
..||.|..|.|++.+.. .|..+|||.+.... .+..++++..++++..-+ +|.||+.+|||..+....+.||.|.. -
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 46999999999999876 47899999877654 455677778888777665 89999999999999999999999853 3
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceecc
Q 003350 567 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 646 (828)
Q Consensus 567 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 646 (828)
+...|... ..++++...-++...+.+||.||.+ +++|+|||+||+|||+|+.|++||+|||++-.+-+ ....+.
T Consensus 177 ~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAhtr 250 (391)
T KOG0983|consen 177 AEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHTR 250 (391)
T ss_pred HHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---cccccc
Confidence 44444333 2468888888999999999999998 47899999999999999999999999999976533 333456
Q ss_pred ccccccccChhhhcc---CCCCcccceeehhhHHHHHHhcCCCCCCCCh-hhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 647 VKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 647 ~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvl~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
..|.+.|||||.+.- ..|+.++||||||+.|+||.||+.||..... .+... ....++ .|.+.+.
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt------kvln~e------PP~L~~~ 318 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT------KVLNEE------PPLLPGH 318 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH------HHHhcC------CCCCCcc
Confidence 678999999999863 4789999999999999999999999976432 22211 111111 1333221
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......+.+++..||+.|+.+||...++++
T Consensus 319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred --cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 125677999999999999999999999875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=296.55 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=196.8
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc---
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE--- 554 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 554 (828)
...++|...+.||+|++|.||+|+.. +++.||+|++... +....+.+.+|+.++++++|+|++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34677888899999999999999876 5789999987643 22334667889999999999999999987765554
Q ss_pred ---EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 555 ---MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 555 ---~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
.++|+||+ +++|.+++.. ..+++.++..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 5699888854 358999999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh-HHH--------H
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAE--------W 701 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~-l~~--------~ 701 (828)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... +.. +
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9864321 234467889999999865 467899999999999999999999997544322111 000 0
Q ss_pred HHHHhhcCCcccccC-------ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 702 AMKWQNKGQLDQIID-------PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 702 ~~~~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+... .....+. +.+.. ........+.+++.+|++.+|.+|||+.||+.
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSE-SARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred Hhhccch-hHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000 0000000 00000 00122567889999999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=275.78 Aligned_cols=236 Identities=27% Similarity=0.338 Sum_probs=193.4
Q ss_pred EeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 492 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
||+|+||.||++... +++.+++|.+..... .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 488999998765432 2456789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccc
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 647 (828)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99986553 68999999999999999999999 999999999999999999999999999987653321 123345
Q ss_pred cccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003350 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727 (828)
Q Consensus 648 ~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (828)
.++..|++||...+...+.++|+||||+++|||++|+.||......+. .. .... . . ..++...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~---~~~~-~------~----~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YE---KILK-D------P----LRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHhc-C------C----CCCCCCC
Confidence 688899999999888899999999999999999999999965433111 11 1111 0 0 1122223
Q ss_pred HHHHHHHHHhhhhhCCCCCCChHH
Q 003350 728 LRKFGETAEKCLADFGVDRPSMGD 751 (828)
Q Consensus 728 ~~~l~~l~~~Cl~~~p~~RPsm~e 751 (828)
...+.+++.+|+..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 566789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=308.24 Aligned_cols=145 Identities=30% Similarity=0.407 Sum_probs=130.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...++||+|+||.||+|... +++.||||++.... ......+..|+.++..++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999876 58899999876542 233467889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
||+++++|.+++...+ .+++..++.|+.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999986543 58899999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=292.64 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=212.3
Q ss_pred HHHHHHHhcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEc---
Q 003350 476 FVAVQEATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD--- 550 (828)
Q Consensus 476 ~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~--- 550 (828)
+..+..-+.-|.+.++||.|.+|.||+++. ++++..|+|++...... .++...|.++|+.+ .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 333444466788889999999999999975 46888999988766443 46778899999988 6999999999983
Q ss_pred --cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEe
Q 003350 551 --EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 628 (828)
Q Consensus 551 --~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~D 628 (828)
.+++++||||||.+||..|.+.+.....+.|+.+..|++.+++||.+||. ..++|||||-.||||+.++.+||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEee
Confidence 46799999999999999999987667789999999999999999999999 9999999999999999999999999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhccC-----CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (828)
||++..+.. .........||+.|||||++... .|+.++|+||+|++..||--|.+|+....|-.. |..
T Consensus 167 FGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--LF~--- 239 (953)
T KOG0587|consen 167 FGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--LFL--- 239 (953)
T ss_pred eeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--hcc---
Confidence 999987543 22334567899999999999643 567899999999999999999999976654321 100
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.. .|...-.-+..+.+++.++|..||..+-.+||++.++++
T Consensus 240 -------IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 -------IPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------CCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111 122222234678899999999999999999999999985
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=265.27 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=196.9
Q ss_pred HhcCCCcc-ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEc----cCCc
Q 003350 482 ATNNFDES-WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD----EKNE 554 (828)
Q Consensus 482 at~~f~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~----~~~~ 554 (828)
.+++|.+. ++||-|-.|.|-.+..+ .++++|+|.+... ...++|+++--+. .|||||.+++++. ....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35555543 58999999999998765 6889999988754 3346788876555 6999999999874 3456
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC---CCCcEEEEeeCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGL 631 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kl~DFGl 631 (828)
+++|||.|+||.|...+...+...+++.+.-+|..||+.|+.|||+ ..|.||||||+|+|.. .|..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence 7899999999999999988888889999999999999999999999 9999999999999996 456899999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
|+.... .......+-|+.|.|||++...+|+...|+||+||++|-|+||.+||-...... +..-.....+.++
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gq- 283 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQ- 283 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccC-
Confidence 987432 233456778999999999999999999999999999999999999996543211 0000000011111
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+.-+++. ...++...++++..|..+|.+|-|+.|++.
T Consensus 284 y~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 YEFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 01111111 234567788999999999999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=278.02 Aligned_cols=243 Identities=22% Similarity=0.316 Sum_probs=194.3
Q ss_pred cceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCC
Q 003350 489 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 565 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~g 565 (828)
+++||.|.||+||-|+++ +|+.||||.+.+. ..+...++++|+.+|++++||.||.|...|+..+..+.|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 479999999999999765 6999999987654 234457889999999999999999999999999999999999965
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---CCcEEEEeeCCCCCCCCCCccc
Q 003350 566 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 566 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kl~DFGla~~~~~~~~~~ 642 (828)
+..+.+..+....|+...-.-++.||+.||.|||. ++|+|+||||+||||.. --++||+|||.||..++ ..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KS 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecch---hh
Confidence 55555555555679888888899999999999999 99999999999999954 34899999999999765 33
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
....++||+.|+|||+++...|...-|+||.||++|--++|.-||....+ ..+.++ +..-+..+.--
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQ---------NAaFMyPp~PW-- 788 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQ---------NAAFMYPPNPW-- 788 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhh---------ccccccCCCch--
Confidence 45678999999999999999999999999999999999999999964422 111111 00111111111
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
.+.....+++|...|+..-.+|-+...-+
T Consensus 789 --~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 --SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred --hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 23345567888888998888898876654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=302.29 Aligned_cols=209 Identities=25% Similarity=0.308 Sum_probs=183.0
Q ss_pred HHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc
Q 003350 476 FVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551 (828)
Q Consensus 476 ~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (828)
..+++--.++|.+.++||+|+||.|..++.+ .++.+|+|+++.. .......|..|-.+|.--+.+=|++|.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455666788999999999999999999876 4788999998773 33445779999999999999999999988999
Q ss_pred CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
...+|||||||+||+|-..+.... .++.....-++..|.-||.-||+ .|+|||||||+|||||..|++||+|||-
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999996655 68888889999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCCccceeccccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCC
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPT 690 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~ 690 (828)
+-.+.. +..-.....+|||-|.+||+++. +.|...+|+||+||++|||+.|..||...
T Consensus 222 Clkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 222 CLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred HHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 876554 44445567789999999999962 57899999999999999999999999643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=269.83 Aligned_cols=222 Identities=19% Similarity=0.173 Sum_probs=178.1
Q ss_pred eCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcccccccC
Q 003350 495 GGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG 573 (828)
Q Consensus 495 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~ 573 (828)
|.+|.||++... +++.+|+|++...+ .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 789999999765 57899999987543 234555666667899999999999999999999999999999999865
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccc
Q 003350 574 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653 (828)
Q Consensus 574 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y 653 (828)
.. .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y 148 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY 148 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence 43 58999999999999999999999 99999999999999999999999999987654321 1233456789
Q ss_pred cChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHH
Q 003350 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGE 733 (828)
Q Consensus 654 ~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 733 (828)
+|||.+....++.++||||+|+++|||++|+.|+...... . ...... .++......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~----------------~~~~~~----~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I----------------NTHTTL----NIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c----------------cccccc----CCcccCCHHHHH
Confidence 9999998888999999999999999999999876532110 0 000000 122233456788
Q ss_pred HHHhhhhhCCCCCCChHHH
Q 003350 734 TAEKCLADFGVDRPSMGDV 752 (828)
Q Consensus 734 l~~~Cl~~~p~~RPsm~eV 752 (828)
++.+|++.+|.+||++.+.
T Consensus 208 li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHccCCHHHhcCCCcc
Confidence 9999999999999997544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=267.42 Aligned_cols=260 Identities=24% Similarity=0.268 Sum_probs=197.8
Q ss_pred cccCHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcC-CCCceEEEEEE
Q 003350 472 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQF-RHRHLVSLIGY 548 (828)
Q Consensus 472 ~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~ 548 (828)
+.|+-..|+.. ..||.|.||+|+|-.++ .|+..|||++..... ...++++.|.+...+- +.||||+++|.
T Consensus 59 ~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 45665555544 46999999999998765 589999999886643 5677888888866554 79999999999
Q ss_pred EccCCcEEEEEEeccCCcccccc---cCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEE
Q 003350 549 CDEKNEMILIYEYMENGTLKGHL---YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAK 625 (828)
Q Consensus 549 ~~~~~~~~lV~ey~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~k 625 (828)
+..++..++.||.|+- ||..+- +......+++...-+|.....+||.||.++ ..|||||+||+|||||..|.+|
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEe
Confidence 9999999999999964 655433 333345688888889999999999999984 7899999999999999999999
Q ss_pred EEeeCCCCCCCCCCccceeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH
Q 003350 626 VADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (828)
|||||++-.+.. ....+...|...|||||.+.. ..|+.+|||||||++|+|+.||+-|+..-.. ..+...
T Consensus 209 LCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~ 280 (361)
T KOG1006|consen 209 LCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLC 280 (361)
T ss_pred eecccchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHH
Confidence 999999876432 233455678889999999863 3589999999999999999999999864221 111111
Q ss_pred HHhhcCCcccccCccccCCC-ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
... .+.. |.+.... ..+....+..++..|+.++..+||...++.++
T Consensus 281 ~Vv-~gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 QVV-IGDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHH-cCCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 1111 1221111 12345678999999999999999999998754
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=270.93 Aligned_cols=240 Identities=25% Similarity=0.348 Sum_probs=196.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (828)
.+|....+||+|+||.|-+|..+ ..+.+|||+++..-. ...+--..|-++|... +-|.++++..++..-+.+++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46777889999999999999766 357899998876521 2233345677777766 568899999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+.+|+|-.++.+-+ .+.+....-+|..||-||-+||+ ++||.||||.+|||||.+|++||+|||+++..-.
T Consensus 429 MEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred EEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 99999999999987655 57788889999999999999999 9999999999999999999999999999986432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
....+.+.+||+.|+|||.+..+.|....|+|||||+||||+.|++||++..+++.... +.+..
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a---------------I~ehn 566 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA---------------IMEHN 566 (683)
T ss_pred -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---------------HHHcc
Confidence 22335678999999999999999999999999999999999999999998776654321 11221
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCC
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRP 747 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 747 (828)
. .++...+.+...+....+..+|.+|-
T Consensus 567 v--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 V--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred C--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 24445567778888899999999993
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=263.47 Aligned_cols=238 Identities=27% Similarity=0.363 Sum_probs=193.8
Q ss_pred CcEEEEEEEecC-CcEEEEEEcCCCCccc-HHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcccccccC
Q 003350 496 GFGKVYKGELND-GTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG 573 (828)
Q Consensus 496 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~ 573 (828)
+||.||+|+..+ ++.+++|+........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998874 8899999988765544 68899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccc
Q 003350 574 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653 (828)
Q Consensus 574 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y 653 (828)
.. .+++.+++.++.+++++|+|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 43 38999999999999999999999 899999999999999999999999999998754321 23345678899
Q ss_pred cChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHH
Q 003350 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGE 733 (828)
Q Consensus 654 ~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 733 (828)
++||.+....++.++||||||++++||++|+.|+...... ....++. ...... . .........++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~----~~~~~~----~---~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI----GKPKPP----F---PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH----hccCCC----C---ccccccCCHHHHH
Confidence 9999999888999999999999999999999998653211 1111111 111000 0 0000014567889
Q ss_pred HHHhhhhhCCCCCCChHHHHH
Q 003350 734 TAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 734 l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=286.30 Aligned_cols=258 Identities=22% Similarity=0.255 Sum_probs=181.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-----------------cCCcEEEEEEcCCCCcccHHHH--------------HHHH
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-----------------NDGTKVAVKRGNPRSQQGLAEF--------------QTEI 531 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~ 531 (828)
.++|...++||+|+||.||+|.+ .+++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 66899999999999999999964 2356799999876543333333 3477
Q ss_pred HHHHcCCCCce-----EEEEEEEcc--------CCcEEEEEEeccCCcccccccCCC----------------------C
Q 003350 532 EMLSQFRHRHL-----VSLIGYCDE--------KNEMILIYEYMENGTLKGHLYGSG----------------------L 576 (828)
Q Consensus 532 ~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~ey~~~gsL~~~l~~~~----------------------~ 576 (828)
.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888877655 677787743 457899999999999999886421 1
Q ss_pred CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccCh
Q 003350 577 PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656 (828)
Q Consensus 577 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP 656 (828)
..++|..+..++.|++.+|+|||+ .+|+||||||+|||++.++.+||+|||+++..... .........+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeCh
Confidence 235788899999999999999999 89999999999999999999999999999764321 11111223457899999
Q ss_pred hhhccCC----------------------CCcccceeehhhHHHHHHhcCC-CCCCCChh--h----hhhHHHHHHHHhh
Q 003350 657 EYFRRQQ----------------------LTEKSDVYSFGVVLFEVLCARP-VIDPTLPR--E----MVNLAEWAMKWQN 707 (828)
Q Consensus 657 E~~~~~~----------------------~s~ksDVySfGvvl~elltG~~-p~~~~~~~--~----~~~l~~~~~~~~~ 707 (828)
|.+.... ...+.||||+||+++||++|.. |+...... + ...+..|... .
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence 9875432 1235799999999999999975 65432111 0 0112222211 1
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCC---CCCCChHHHHH
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFG---VDRPSMGDVLW 754 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPsm~eVl~ 754 (828)
... .+-.. .........+++.++|..+| .+|+|+.|+++
T Consensus 458 ~~~----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQK----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccC----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111 01111 11234567788999998766 68999999975
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=261.02 Aligned_cols=204 Identities=26% Similarity=0.356 Sum_probs=168.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEec---C--CcEEEEEEcCCCCcc--cHHHHHHHHHHHHcCCCCceEEEEEEEcc-CCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN---D--GTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 554 (828)
...|+....||+|.||.||||.-. + ...+|+|+++..+.. ......+|+.+++.++|||++.|..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 345777789999999999999543 2 236899988765321 13456799999999999999999998866 788
Q ss_pred EEEEEEeccCCcccccccCC---CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC----CcEEEE
Q 003350 555 MILIYEYMENGTLKGHLYGS---GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN----FMAKVA 627 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~----~~~kl~ 627 (828)
.+|++||.+. +|.+.++-. ..+.++...+..|+.||+.|++|||+ .=|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 888877532 23568889999999999999999999 889999999999999877 899999
Q ss_pred eeCCCCCCCCCCccc-eeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCC
Q 003350 628 DFGLSKTGPEIDQTH-VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPT 690 (828)
Q Consensus 628 DFGla~~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~ 690 (828)
|||++|.....-.+. ....++-|..|.|||.+.+ ..||.+.|||+.||++.||+|-++.|...
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999876543333 2245678999999999886 57999999999999999999998887543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=258.42 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=200.3
Q ss_pred HHHHHHHhcCCCccceEeeeCcEEEEEEE-ecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCC
Q 003350 476 FVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN 553 (828)
Q Consensus 476 ~~~l~~at~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 553 (828)
++++-..|. ++||+|.++.|-.++ +.+|..+|||++.+..........+|++++.+. .|+||++|+.+|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 455555554 689999999998884 567999999999888777788899999999999 4999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC---cEEEEeeC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---MAKVADFG 630 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kl~DFG 630 (828)
..|||||-|.+|+|..++++.. .+++.+..++..+||.||.|||. ++|.|||+||+|||..+.. -+||+||.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999999997654 68999999999999999999999 9999999999999996544 48999999
Q ss_pred CCCCCCCCC-----ccceeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh----
Q 003350 631 LSKTGPEID-----QTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV---- 696 (828)
Q Consensus 631 la~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~---- 696 (828)
|..-..... .+......+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+.-..+..
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 875322111 111123567999999999874 346889999999999999999999999765432210
Q ss_pred ----hHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 697 ----NLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 697 ----~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+....-+.+|. .+.-|... .....+..+++...+..++.+|-++.+++.
T Consensus 305 e~Cr~CQ~~LFesIQEGk-YeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGK-YEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccC-CcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11111111111221 11111111 123445667788888899999988888875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=266.56 Aligned_cols=265 Identities=20% Similarity=0.252 Sum_probs=205.5
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC--C----ceEEEEEEEccCC
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH--R----HLVSLIGYCDEKN 553 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~ 553 (828)
..+++|.+..++|+|.||.|-.+..+ .+..||||+++....- .+..+-|+++|+++.+ | -++.+.+|++-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34788888899999999999998655 3689999998765443 3556789999999942 2 3788889999999
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC--------------
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-------------- 619 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-------------- 619 (828)
+.|+|+|.+ +-|+.++|..++..+++..++..|+.|++++++|||+ .+++|-||||+|||+-
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999 4599999998888889999999999999999999999 9999999999999992
Q ss_pred ------CCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChh
Q 003350 620 ------ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR 693 (828)
Q Consensus 620 ------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~ 693 (828)
++..+||+|||-|....+. ...++.|..|.|||++.+-.++.++||||+||||.|+.||...|......
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 1346899999999874331 25677899999999999999999999999999999999999998766544
Q ss_pred hhhhHHHHH--------------HHHhhcCCcc-----------cccCcc--cc--CCCChhHHHHHHHHHHhhhhhCCC
Q 003350 694 EMVNLAEWA--------------MKWQNKGQLD-----------QIIDPT--LA--GKIRPDSLRKFGETAEKCLADFGV 744 (828)
Q Consensus 694 ~~~~l~~~~--------------~~~~~~~~~~-----------~~~d~~--l~--~~~~~~~~~~l~~l~~~Cl~~~p~ 744 (828)
|...+-+.+ ..+...+.++ .+.++. +. -.....+..+|.+++.++|..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 433222211 1111111111 000100 00 011234567799999999999999
Q ss_pred CCCChHHHHHH
Q 003350 745 DRPSMGDVLWN 755 (828)
Q Consensus 745 ~RPsm~eVl~~ 755 (828)
+|+|+.|+++.
T Consensus 396 ~RiTl~EAL~H 406 (415)
T KOG0671|consen 396 RRITLREALSH 406 (415)
T ss_pred ccccHHHHhcC
Confidence 99999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=293.02 Aligned_cols=259 Identities=20% Similarity=0.236 Sum_probs=169.7
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-C----CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEE------Ec
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-D----GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY------CD 550 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 550 (828)
..++|...++||+|+||.||+|++. + +..||+|++...... +.+..| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678899999999999999999875 4 689999987643321 111111 1122222222221111 35
Q ss_pred cCCcEEEEEEeccCCcccccccCCCCC------------------CCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeee
Q 003350 551 EKNEMILIYEYMENGTLKGHLYGSGLP------------------SLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 612 (828)
Q Consensus 551 ~~~~~~lV~ey~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIk 612 (828)
...+.++||||+++++|.+++...... ......+..++.|++.||+|||+ .+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 667899999999999999988643211 11233456799999999999999 899999999
Q ss_pred cCcEEeCC-CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccC----------------------CCCcccc
Q 003350 613 SANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ----------------------QLTEKSD 669 (828)
Q Consensus 613 p~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~ksD 669 (828)
|+|||+++ ++.+||+|||+++.... ..........+|+.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~-~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRV-GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccc-ccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 57999999999986433 122233456789999999966322 2345679
Q ss_pred eeehhhHHHHHHhcCCCCCCCChhh-------hhhHHHHHHHHhhcCCcccccCccccCCC--ChhHHHHHHHHHHhhhh
Q 003350 670 VYSFGVVLFEVLCARPVIDPTLPRE-------MVNLAEWAMKWQNKGQLDQIIDPTLAGKI--RPDSLRKFGETAEKCLA 740 (828)
Q Consensus 670 VySfGvvl~elltG~~p~~~~~~~~-------~~~l~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~ 740 (828)
||||||+||||+++..+.+.....- ...+..|....... ..+.+...+ .........+++.+||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 9999999999999776543221000 01122222111100 000000000 00112235689999999
Q ss_pred hCCCCCCChHHHHH
Q 003350 741 DFGVDRPSMGDVLW 754 (828)
Q Consensus 741 ~~p~~RPsm~eVl~ 754 (828)
.+|.+|||+.|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=283.23 Aligned_cols=239 Identities=21% Similarity=0.268 Sum_probs=191.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 560 (828)
+..|.....+|.|+|+.|-++... +++..+||++..... +-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556677778999999999988664 577889999876622 235677666665 79999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe-CCCCcEEEEeeCCCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL-DENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl-d~~~~~kl~DFGla~~~~~~~ 639 (828)
.+.++-|.+.+..... .. .++..|+.+|+.++.|||+ +++|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999888887755442 22 7788899999999999999 999999999999999 69999999999999875442
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
....+-|..|.|||++....|++++||||||++|||||||+.|+....... .+ ......
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei----~~~i~~----------- 528 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EI----HTRIQM----------- 528 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HH----HHhhcC-----------
Confidence 233456889999999999999999999999999999999999997543321 10 111111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.+....+....+++.+||+.+|.+||+|.++..
T Consensus 529 -~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 529 -PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1222344566788999999999999999999964
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=236.72 Aligned_cols=262 Identities=22% Similarity=0.255 Sum_probs=195.4
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
|+.-++||+|.||+||||+.. .++.||+|+.... ++.-.....+|+-+|+.++|+|||++++....++.+-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444578999999999999765 5789999976544 3334566789999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
.. +|..+...- ...++.+....++.|+++||.|+|+ ..+.|||+||.|.|++.+|+.|++|||+++...-. . .
T Consensus 84 dq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip-v-r 156 (292)
T KOG0662|consen 84 DQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-V-R 156 (292)
T ss_pred hH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc-e-E
Confidence 64 787776443 3468999999999999999999999 99999999999999999999999999999976431 1 1
Q ss_pred eeccccccccccChhhhccC-CCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcc---cccCc
Q 003350 643 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLD---QIIDP 717 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d~ 717 (828)
......-|..|.+|.++-+. -|+...|+||-||++.|+.. |++.|.+....+...-+-|......+++.. ++-|-
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 23445678999999998765 57899999999999999985 666666655554444444444444443322 22232
Q ss_pred cccCCCC---------hhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 TLAGKIR---------PDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~l~~~~~---------~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.....++ +.....=.++..+.+.-+|.+|.++++.++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2221111 111122234555666667888888777653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=263.41 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=192.5
Q ss_pred CCCccceEeeeCcEEEEEEE-ecCCcEEEEEEcCCCC--c-----ccHHHHHHHHHHHHcCCCCceEEEEEEEc-cCCcE
Q 003350 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRS--Q-----QGLAEFQTEIEMLSQFRHRHLVSLIGYCD-EKNEM 555 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~ 555 (828)
+|-..++||+|||+.|||+. +...+.||||+-.... . .-.+...+|.++-+.|.||.||++++|+. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 33445689999999999995 4457789999743321 1 11234668999999999999999999984 56678
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC---CCCcEEEEeeCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLS 632 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kl~DFGla 632 (828)
|-|+|||++.+|.-+|...+ .+++++...|+.||+.||.||.+ .+.+|||-||||.||||- .-|.+||.||||+
T Consensus 544 CTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999999996654 68999999999999999999986 557999999999999994 5578999999999
Q ss_pred CCCCCCCcc-----ceeccccccccccChhhhcc----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH
Q 003350 633 KTGPEIDQT-----HVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 633 ~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (828)
+........ ..+....||..|++||++.- .+++.|.||||.||++|..+.|++||....... +
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--d------ 692 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--D------ 692 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--H------
Confidence 986543222 33456789999999998853 367899999999999999999999997543221 1
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV 752 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV 752 (828)
+..+..+.....-.+ ...+....+...+|++||+..-++|....++
T Consensus 693 -ILqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 693 -ILQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred -HHhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 111222222111111 1123345567788999999999999765554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=255.43 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=192.4
Q ss_pred cceEeeeCcEEEEEEEec-CCcEEEEEEcCC-C-CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc--------CCcEEE
Q 003350 489 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNP-R-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--------KNEMIL 557 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~-~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~l 557 (828)
..+||+|.||.||+|+.+ .|+.||+|+..- . .+.......+|+++|..++|+|++.++..|.. ...++|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 357999999999999765 477889886432 2 22234456899999999999999999988843 335899
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|+++|+. +|...|... ...++..++.+++.++..||.|+|. ..|+|||+||.|+|++.++.+||+|||+++.+..
T Consensus 102 Vf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred eHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 9999987 888777443 3568999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCc--cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC----
Q 003350 638 IDQ--THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ---- 710 (828)
Q Consensus 638 ~~~--~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---- 710 (828)
.+. ....+..+-|..|.+||.+.+ .+++++.|||.-||++.||+||.+-+.+..+.....++.-.-.-..++-
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 221 112345566999999999876 5799999999999999999999988877655544444332111011100
Q ss_pred ----ccccc--CccccCCCC--hhHHH------HHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 711 ----LDQII--DPTLAGKIR--PDSLR------KFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 711 ----~~~~~--d~~l~~~~~--~~~~~------~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+-+.+ .|-..+.++ ++..+ ..++++..++..||.+|+.+.+++.
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 01111 110111110 11122 4678899999999999999998874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=282.90 Aligned_cols=245 Identities=27% Similarity=0.373 Sum_probs=189.5
Q ss_pred CCCccceEeeeCcEE-EEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGK-VYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
-|...+++|.|+.|+ ||+|... |+.||||++-... ..-.++|+..|+.- .|||||+.++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 356667899999885 7999986 7899999986543 34457999999988 6999999999888899999999999
Q ss_pred cCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-----CCcEEEEeeCCCCCC
Q 003350 563 ENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-----NFMAKVADFGLSKTG 635 (828)
Q Consensus 563 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-----~~~~kl~DFGla~~~ 635 (828)
. .+|.+++... ......-...+.+..|+++||++||+ .+||||||||.||||+. ...++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 5999999764 11112224567889999999999999 99999999999999975 358999999999986
Q ss_pred CCCCc-cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhc-CCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 636 PEIDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 636 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
..... -.......||.||+|||++....-+.+.||+|+|||+|..++| .+||......+. ++ +.....+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI------l~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI------LTGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh------hcCccceee
Confidence 54221 1224567899999999999998888999999999999999987 899976543321 10 001111111
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
+ . ...++ ...++|.++++.+|..||++.+|+
T Consensus 735 L-----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 L-----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred e-----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1 0 01122 677899999999999999999998
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=249.23 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=198.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (828)
.++|+..++||+|+|.+|..+++. ..+.+|+|.++.. ..+.....+.|-.+..+. +||.+|.|..++.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357888899999999999999876 4678898876543 334456677788888776 79999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|.||+++|+|--++...+ +|+++...-+...|.-||.|||+ .+||.||||..|||||..|++||.|+|+++....
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999988775554 79999999999999999999999 9999999999999999999999999999987433
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCC-hhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL-PREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
....+.+.+||+.|.|||.+++..|....|+|++||+++||+.|+.||+-.. .....+...+..+..-+.++
T Consensus 404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----- 476 (593)
T KOG0695|consen 404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----- 476 (593)
T ss_pred --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence 3334667899999999999999999999999999999999999999997432 11122333333332222211
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCC
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRP 747 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 747 (828)
.++.....+...+...-|.++|.+|-
T Consensus 477 -----riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 -----RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----cccceeehhhHHHHHHhhcCCcHHhc
Confidence 12333345566778888999999883
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=265.00 Aligned_cols=215 Identities=25% Similarity=0.383 Sum_probs=176.0
Q ss_pred HHHHHHHh---cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCCCceEEEEEE
Q 003350 476 FVAVQEAT---NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGY 548 (828)
Q Consensus 476 ~~~l~~at---~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~ 548 (828)
|..|+++. .-|...+.||-|.||+|.+++.. ....+|.|.+.+.+. ........|-.||.....+=||+|+-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44444443 23556678999999999999654 456789998776543 334557789999999999999999999
Q ss_pred EccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEe
Q 003350 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 628 (828)
Q Consensus 549 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~D 628 (828)
|.+++.+|+||+|+++|++-.+|...+ -+.+....-++.+++.|+++.|. .|+|||||||+|||||.+|++||.|
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeee
Confidence 999999999999999999999987655 46777777888899999999999 9999999999999999999999999
Q ss_pred eCCCCCC---------CCCCcc-------------------------------ceeccccccccccChhhhccCCCCccc
Q 003350 629 FGLSKTG---------PEIDQT-------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKS 668 (828)
Q Consensus 629 FGla~~~---------~~~~~~-------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ks 668 (828)
|||+.-+ .+.+.. ......+||..|+|||++....++.-+
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 9998421 110000 001235799999999999999999999
Q ss_pred ceeehhhHHHHHHhcCCCCCCCChhhh
Q 003350 669 DVYSFGVVLFEVLCARPVIDPTLPREM 695 (828)
Q Consensus 669 DVySfGvvl~elltG~~p~~~~~~~~~ 695 (828)
|+||.|||||||+.|++||....+.+.
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 999999999999999999987766554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=265.98 Aligned_cols=237 Identities=22% Similarity=0.295 Sum_probs=196.4
Q ss_pred cceEeeeCcEEEEEEEecCCc-EEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 489 SWVIGIGGFGKVYKGELNDGT-KVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
...||-||||.|=+.+.+... .+|+|.++.. +....+....|-++|...+.|.||+|+--+.+....|++||-|-+
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 346999999999998876433 3677765543 444566788999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|.|+..|...+ .++..+..-++..+.+|++|||+ ++||.|||||+|.|||.+|-+||.|||.|+.... ...+
T Consensus 505 GElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g~KT 576 (732)
T KOG0614|consen 505 GELWTILRDRG--SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---GRKT 576 (732)
T ss_pred chhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc---CCce
Confidence 99999997654 68888888999999999999999 9999999999999999999999999999998643 3446
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
.+.+||+.|.|||.+.....+.+.|.||+|+++|||++|++||....+-...+++-... |. -.++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------------d~---i~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------------DK---IEFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh------------hh---hhcc
Confidence 67899999999999999999999999999999999999999998877655444332111 11 0123
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCC
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPS 748 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPs 748 (828)
....+...+++++.+..+|.+|-.
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhc
Confidence 334556678899999999999965
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=232.59 Aligned_cols=194 Identities=25% Similarity=0.347 Sum_probs=160.8
Q ss_pred ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 490 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
..||+|++|.|-+-++. +|+..|+|++... ..+..++..+|+.+..+. .+|.+|.++|........++.||.|+. |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 56999999999887664 6899999987754 234466778888877665 799999999999889999999999975 7
Q ss_pred ccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 567 LKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 567 L~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|..+-.+ .....+++...-+||..+.+||.|||+ +..+||||+||+|||++.+|++|+||||++-.+.. ....
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---SiAk 205 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---SIAK 205 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh---hhHH
Confidence 7665432 223568888999999999999999999 46899999999999999999999999999876432 2223
Q ss_pred ccccccccccChhhhcc----CCCCcccceeehhhHHHHHHhcCCCCCC
Q 003350 645 TAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPVIDP 689 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~----~~~s~ksDVySfGvvl~elltG~~p~~~ 689 (828)
+...|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++.
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 34568889999998853 3789999999999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=243.58 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=193.2
Q ss_pred CccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccC-----CcEEEE
Q 003350 487 DESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NEMILI 558 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV 558 (828)
+.++.||-|.||.||..+.. +|+.||+|++...- -...+.+.+|+++|.-++|.|++..++.-.-. .+.+.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44578999999999999765 79999999876542 23356788999999999999999888765332 356788
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
.|.|.. +|...+-.. +.|+-..+.-+..||++||.|||+ .+|.||||||.|.|++.+...||+||||++....
T Consensus 136 TELmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~- 208 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ- 208 (449)
T ss_pred HHHHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch-
Confidence 888864 787777433 468888888999999999999999 9999999999999999999999999999997544
Q ss_pred CccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHH--------HHHhhcC
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA--------MKWQNKG 709 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~ 709 (828)
+.....+...-|-.|.|||.+++ +.|+.+.||||.||++.||+..+..|....+.+...++.-. ++..-+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 33333445567889999999987 57999999999999999999999888877666554443211 1111122
Q ss_pred CcccccCc-----cccC--CC--ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 710 QLDQIIDP-----TLAG--KI--RPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 710 ~~~~~~d~-----~l~~--~~--~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
--..++.. .+.. .+ +...-.+...+.+.++..+|++|.+..+.+..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 11112111 1110 00 11222344566778888899999887777643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=234.59 Aligned_cols=210 Identities=37% Similarity=0.577 Sum_probs=183.2
Q ss_pred EeeeCcEEEEEEEecC-CcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcccc
Q 003350 492 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG 569 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~~ 569 (828)
||+|.+|.||++...+ ++.+++|........ ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 889999998766543 35678999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-CCcEEEEeeCCCCCCCCCCccceecccc
Q 003350 570 HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTAVK 648 (828)
Q Consensus 570 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (828)
++.... ..+++..+..++.+++++|++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 986542 368999999999999999999999 89999999999999999 89999999999986543211 123355
Q ss_pred ccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003350 649 GSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727 (828)
Q Consensus 649 gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 727 (828)
+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 77889999999877 888999999999999998
Q ss_pred HHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 728 LRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 728 ~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357788999999999999999999754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=232.57 Aligned_cols=199 Identities=32% Similarity=0.470 Sum_probs=173.0
Q ss_pred CCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 486 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
|...+.||.|++|.||++...+ ++.+++|........ ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999998875 789999998876554 57789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++..... .+++..+..++.+++++|.+||+ .+++|+||+|+||+++.++.++|+|||++......... .
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 9999999865442 28899999999999999999999 89999999999999999999999999999875442211 2
Q ss_pred eccccccccccChhhh-ccCCCCcccceeehhhHHHHHHhcCCCCCC
Q 003350 644 STAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLCARPVIDP 689 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~-~~~~~s~ksDVySfGvvl~elltG~~p~~~ 689 (828)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2345677889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=223.52 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=191.5
Q ss_pred hcCCCccceEeeeCcEEEEEEE-ecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEEcc--CCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDE--KNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV 558 (828)
.++|+..+++|+|.++.||.|. ..+.++++||.+++... +.+.+|+.+|..|+ ||||++|++...+ .....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4567777899999999999995 45678999999987653 56789999999997 9999999998754 4567899
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-CCcEEEEeeCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPE 637 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kl~DFGla~~~~~ 637 (828)
+||+.+-+..... +.|+...+.....++++||.|+|+ .||+|||+||.|+++|. ....+|+|+|||.+...
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999987766543 468888899999999999999999 99999999999999995 56799999999988654
Q ss_pred CCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH--------HHhhc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------KWQNK 708 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~ 708 (828)
... .+..+.+..|.-||.+-. +.|+..-|+|||||+|.+|+..+.||-..... ..+++..+. .+..+
T Consensus 186 ~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Cce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHH
Confidence 222 223345667889998864 56788999999999999999999998533221 112222221 11111
Q ss_pred CCcccccCccccC--------C----CC----hhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 709 GQLDQIIDPTLAG--------K----IR----PDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 709 ~~~~~~~d~~l~~--------~----~~----~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
-++. +||++.. . ++ .-...+..+++.+.|..|.++|||+.|.+..
T Consensus 262 Y~i~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQID--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccC--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111 2332211 0 00 1123567889999999999999999998753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=238.86 Aligned_cols=131 Identities=25% Similarity=0.363 Sum_probs=111.8
Q ss_pred cCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-----C---CceEEEEEEEc----
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-----H---RHLVSLIGYCD---- 550 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~---- 550 (828)
.+|...++||.|.|++||++.. ...+.||+|+.+.... -.+....||++|++++ | ..||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788899999999999999965 3567899998765432 2455689999999984 3 46999999985
Q ss_pred cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe
Q 003350 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618 (828)
Q Consensus 551 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 618 (828)
.+.+.|||+|++ +-+|..++.....+.++...+.+|+.|++.||.|||.+ .+|||-||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 456899999999 45888888888778899999999999999999999996 479999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-26 Score=251.23 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=204.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
..+|.....+|.|.+|.|||++.. .++..|+|.++..-....+-.+.|+-+++..+||||+.++|.+...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 346777789999999999999765 5889999988877666677788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
|.+|+|++.-+..+ +|++.++..+++...+||+|||+ .+-+|||||-.|||+++.+.+|++|||.+...... -
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--I 166 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh--h
Confidence 99999999887665 79999999999999999999999 89999999999999999999999999998764331 1
Q ss_pred ceeccccccccccChhhh---ccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc-
Q 003350 642 HVSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP- 717 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~- 717 (828)
.......||+.|||||+. +.+.|..++|||+.|+...|+---++|.-...+-.. ..+..+ ..++|
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-------l~LmTk----S~~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-------LFLMTK----SGFQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-------HHHhhc----cCCCCC
Confidence 123467899999999986 467899999999999999999887777543322111 111111 11122
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+.. ......-+-++++.|+..+|++||+++.+++
T Consensus 236 ~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2221 1345667888999999999999999988774
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=219.61 Aligned_cols=256 Identities=20% Similarity=0.315 Sum_probs=185.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEE-EccCCcEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGY-CDEKNEMILIY 559 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~ 559 (828)
.+.|.+.+.||+|.||.+-++.++. .+.+++|-.... ....++|.+|..---.| .|.||+.-+.. +...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4568888999999999999998874 567888876543 34468899998766666 58999988765 56777889999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe-C-CCCcEEEEeeCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL-D-ENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl-d-~~~~~kl~DFGla~~~~~ 637 (828)
||++.|+|.+-+...+ +.+....+++.|++.||.|+|+ ..+||||||.+|||+ + +..++||+|||+.+..+.
T Consensus 102 E~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999998885544 7788889999999999999999 999999999999999 3 345899999999875332
Q ss_pred CCccceeccccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
......-+..|.+||.... -...+.+|||.||++++.++||+.||..... ......+|..-..+.
T Consensus 176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~rk---- 245 (378)
T KOG1345|consen 176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKRK---- 245 (378)
T ss_pred -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhccc----
Confidence 1122334567999998753 2456889999999999999999999973322 222333333221111
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
.+++...++ ....++.++-.+-+...+.+|=-..++.++-...
T Consensus 246 ---~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 246 ---NPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ---CccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 112222222 1234455667777888888886666666555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-26 Score=229.42 Aligned_cols=258 Identities=21% Similarity=0.240 Sum_probs=188.9
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc------CCcE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE------KNEM 555 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 555 (828)
+|.....+|.|.- .|..+... .+++||+|+.... .....+...+|..++..++|+||++++.++.- -.+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 3444456788777 55555332 4789999976543 23445677899999999999999999999843 3467
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|||+|. .+|.+.++ -.++-+.+..|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+..
T Consensus 97 y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhccc
Confidence 99999996 58888876 347788999999999999999999 99999999999999999999999999999864
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh----------------hhHH
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM----------------VNLA 699 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~----------------~~l~ 699 (828)
.. ....+....|..|.|||++.+..+.+..||||.||++.||++|+-.|.+...-+. ..+.
T Consensus 169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 32 2356778899999999999988899999999999999999999987764322111 1111
Q ss_pred HHHHHHhhc-C-----Cccccc-CccccC--CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 700 EWAMKWQNK-G-----QLDQII-DPTLAG--KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 700 ~~~~~~~~~-~-----~~~~~~-d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.-++.+.+. . ...+.+ |..... +.++-......+++.++|..+|++|-++++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 111111110 0 001111 100000 011122445677899999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=243.06 Aligned_cols=195 Identities=21% Similarity=0.365 Sum_probs=164.9
Q ss_pred CCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCc--------ccHHHHHHHHHHHHcCC---CCceEEEEEEEccC
Q 003350 485 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQ--------QGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEK 552 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 552 (828)
.|...+.+|+|+||.|+.+.++. ...|+||.+.+... ...-..-.|+.+|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 46677899999999999998764 56789998765421 11122457999999997 99999999999999
Q ss_pred CcEEEEEEec-cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 553 NEMILIYEYM-ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 553 ~~~~lV~ey~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
+.++|++|-. ++-+|.+++..+ +.+++.+..-|..|++.|+++||+ .+|||||||-+||.+|.+|-+||+|||-
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 9999999986 556888888544 579999999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCC
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVID 688 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~ 688 (828)
+..... ......+||.+|.|||++.+.+| ...-|||++|++||-++...-||.
T Consensus 717 aa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 876432 23456789999999999998776 467899999999999998877763
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=238.49 Aligned_cols=272 Identities=24% Similarity=0.273 Sum_probs=204.3
Q ss_pred cccCHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC------CCceEE
Q 003350 472 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR------HRHLVS 544 (828)
Q Consensus 472 ~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~ 544 (828)
+++.+-|+ .-.+|.+....|+|-|++|.+|... -|..||||++..... ..+.=+.|+++|++|+ ..|.++
T Consensus 422 Yrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 422 YRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 34444444 3467888888999999999999765 378999999886643 2345578999999995 347888
Q ss_pred EEEEEccCCcEEEEEEeccCCcccccccCCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC-C
Q 003350 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-F 622 (828)
Q Consensus 545 l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~ 622 (828)
|+-.|.+.+++|||+|-+. .+|.+.|..-+ .-.|....+..++.|+.-||..|.. .+|+|+||||.|||+++. .
T Consensus 499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcc
Confidence 8889999999999999885 49999997633 3468889999999999999999999 899999999999999865 5
Q ss_pred cEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHH
Q 003350 623 MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA 702 (828)
Q Consensus 623 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~ 702 (828)
.+||||||-|....+.+ .+...-+..|.|||.+.+..|+...|+||.||.||||.||+..|.+....++..+.--+
T Consensus 575 iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 68999999998765422 22334456799999999999999999999999999999999999876655543332211
Q ss_pred -----HHHhhcCCc-ccccCcc--------------------------------ccC--CCC---hhHHHHHHHHHHhhh
Q 003350 703 -----MKWQNKGQL-DQIIDPT--------------------------------LAG--KIR---PDSLRKFGETAEKCL 739 (828)
Q Consensus 703 -----~~~~~~~~~-~~~~d~~--------------------------------l~~--~~~---~~~~~~l~~l~~~Cl 739 (828)
..++++++. .+-+|.. +.+ .++ ......+.++...|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 122222221 1111111 111 122 234566788899999
Q ss_pred hhCCCCCCChHHHHH
Q 003350 740 ADFGVDRPSMGDVLW 754 (828)
Q Consensus 740 ~~~p~~RPsm~eVl~ 754 (828)
..+|.+|-+..+.++
T Consensus 731 ~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 731 ILDPEKRITVNQALK 745 (752)
T ss_pred ccChhhcCCHHHHhc
Confidence 999999999888764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=225.30 Aligned_cols=201 Identities=24% Similarity=0.352 Sum_probs=166.1
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCC
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN 553 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 553 (828)
+....+.|...++||+|.|+.||++.+. ..+.||+|.+...+. .....+|+++|..+ -+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3345667888899999999999999654 357899999887654 35688999999999 5999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-CCcEEEEeeCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLS 632 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kl~DFGla 632 (828)
+.++|+||++.-...+++. .++..++..+...+..||+++|. .|||||||||+|+|.+. -+.-.|.|||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence 9999999999988888873 46688999999999999999999 99999999999999984 457789999999
Q ss_pred CCCCCC-------C-------c----------------------------cceeccccccccccChhhhcc-CCCCcccc
Q 003350 633 KTGPEI-------D-------Q----------------------------THVSTAVKGSFGYLDPEYFRR-QQLTEKSD 669 (828)
Q Consensus 633 ~~~~~~-------~-------~----------------------------~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksD 669 (828)
...... . . ........||+||.|||++.. ...+.+.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 610000 0 0 000123469999999999865 56789999
Q ss_pred eeehhhHHHHHHhcCCCCCC
Q 003350 670 VYSFGVVLFEVLCARPVIDP 689 (828)
Q Consensus 670 VySfGvvl~elltG~~p~~~ 689 (828)
|||-||+++.+++++.||-.
T Consensus 261 iws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred eeeccceeehhhcccccccc
Confidence 99999999999999999843
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-25 Score=268.59 Aligned_cols=196 Identities=17% Similarity=0.223 Sum_probs=138.7
Q ss_pred cCCC-CceEEEEEEE-------ccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEE
Q 003350 536 QFRH-RHLVSLIGYC-------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607 (828)
Q Consensus 536 ~l~H-~niv~l~g~~-------~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 607 (828)
.++| +||.+++++| .+...+++++|++ .++|.++|.... ..+++.+++.++.||++||+|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 3455 5788888877 2334577888988 459999996532 469999999999999999999999 9999
Q ss_pred eeeeecCcEEeCCC-------------------CcEEEEeeCCCCCCCCCCc--------------cceecccccccccc
Q 003350 608 HRDVKSANILLDEN-------------------FMAKVADFGLSKTGPEIDQ--------------THVSTAVKGSFGYL 654 (828)
Q Consensus 608 HrDIkp~NILld~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~Y~ 654 (828)
||||||+||||+.. +.+|++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4455666666553211000 00011245888999
Q ss_pred ChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHH
Q 003350 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGET 734 (828)
Q Consensus 655 aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 734 (828)
|||++.+..++.++|||||||+||||++|.+|+..... ....+... .+.+... ....+...+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~~-----~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQIL-----LNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhhh-----hcCHHHHHH
Confidence 99999999999999999999999999999887642110 11111000 1111111 112334577
Q ss_pred HHhhhhhCCCCCCChHHHHH
Q 003350 735 AEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 735 ~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.+||+.+|.+||+|.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=207.69 Aligned_cols=169 Identities=22% Similarity=0.239 Sum_probs=126.7
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|+|.+++...+ ..++|.+++.|+.|+++||+|||+ .+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc------
Confidence 68888886533 469999999999999999999999 44 999999999999999 9998864331
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+....... ++... ...
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~-------~~~~~-~~~ 132 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPAD-------DPRDR-SNL 132 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccC-------Ccccc-ccH
Confidence 1258899999999999999999999999999999999999986432211 1111111111100 00000 011
Q ss_pred hhHHH--HHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 725 PDSLR--KFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 725 ~~~~~--~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
..... .+.+++.+|++.+|.+||++.|+++.+.....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 12222 58999999999999999999999998876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=218.49 Aligned_cols=169 Identities=20% Similarity=0.156 Sum_probs=130.6
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEec--CCcEEEEEEcCCC-----CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELN--DGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (828)
......+|...++||+|+||+||+|... +++.+|||+.... .....+.|.+|+++|++++|+|+++.+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3455677999999999999999999765 4777899986533 122356689999999999999998543322
Q ss_pred CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeee-ecCcEEeCCCCcEEEEeeC
Q 003350 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV-KSANILLDENFMAKVADFG 630 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI-kp~NILld~~~~~kl~DFG 630 (828)
+..++||||+++++|... . . . ....++.+++++|+|||+ .+|+|||| ||+|||++.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~-~----~---~~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-R-P----H---GDPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-C-c----c---chHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 467999999999999632 1 1 1 124678899999999999 99999999 9999999999999999999
Q ss_pred CCCCCCCCCccc------eeccccccccccChhhhccC
Q 003350 631 LSKTGPEIDQTH------VSTAVKGSFGYLDPEYFRRQ 662 (828)
Q Consensus 631 la~~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~ 662 (828)
+|+......... .-+...+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 998654321111 11356788899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-21 Score=210.07 Aligned_cols=262 Identities=19% Similarity=0.205 Sum_probs=196.5
Q ss_pred CCCccceEeeeCcEEEEEEEecCC--cEEEEEEcCCCCcccHHHHHHHHHHHHcCCC----CceEEEEEEE-ccCCcEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELNDG--TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH----RHLVSLIGYC-DEKNEMIL 557 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 557 (828)
+|...++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999986543 4788887666533332367889999988873 5888888888 57778899
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC-----CcEEEEeeCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-----FMAKVADFGLS 632 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~-----~~~kl~DFGla 632 (828)
||+.+ +.+|.++........++..+.++|+.|++.+|++||+ .+++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 5699997755555689999999999999999999999 999999999999999754 46999999999
Q ss_pred C--CCCCCCcc----ce--eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh-hhHHHHHH
Q 003350 633 K--TGPEIDQT----HV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM-VNLAEWAM 703 (828)
Q Consensus 633 ~--~~~~~~~~----~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~-~~l~~~~~ 703 (828)
+ ........ .. .....||..|.++..+.+...+.+.|+||++.++.|++.|..||........ ..+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 32211111 11 1345699999999999999999999999999999999999999965432221 11111111
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
.. .... .....+..+.++...+-..+..++|....+...|+.+....
T Consensus 255 ----~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 ----KL----LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ----hh----cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 0010 11122345556666666688999999999999888776554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-23 Score=203.34 Aligned_cols=245 Identities=21% Similarity=0.331 Sum_probs=190.9
Q ss_pred eEeeeCcEEEEEEEecCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCccc
Q 003350 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 568 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~ 568 (828)
+|.+...|..|+|+++ |..+++|++... +....++|..|.-.|+-+.||||++++|.|.....+.++..||+.|+|.
T Consensus 197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 5888899999999998 455667765543 2333467899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceecccc
Q 003350 569 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648 (828)
Q Consensus 569 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (828)
..|++...--.+-.+..+++.++|+|++|||+- .+-|.---|.+..|++|++.+++|+- +-+++.- ......
T Consensus 276 nvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf------qe~gr~ 347 (448)
T KOG0195|consen 276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF------QEVGRA 347 (448)
T ss_pred HHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee------eccccc
Confidence 999987766678889999999999999999983 23344446889999999999988752 1111100 011122
Q ss_pred ccccccChhhhccCCCC---cccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003350 649 GSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725 (828)
Q Consensus 649 gt~~Y~aPE~~~~~~~s---~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 725 (828)
-.+.||+||.++..+.+ .++|+|||.++||||.|...||....+-+..-. +.=+.++-.+++
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------------ialeglrv~ipp 412 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------------IALEGLRVHIPP 412 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---------------hhhccccccCCC
Confidence 35789999999876543 689999999999999999999986655443211 111223445667
Q ss_pred hHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 726 DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 726 ~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
.....+.+++.-|+..||.+||....|+-.||+.
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 7788899999999999999999999999888864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-19 Score=196.12 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=196.7
Q ss_pred CCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc---cHHHHHHHHHHHHcCCCC-ceEEEEEEEccCCcEEEEEEe
Q 003350 486 FDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ---GLAEFQTEIEMLSQFRHR-HLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~ey 561 (828)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999877 78899987765432 367899999999999988 799999999777778999999
Q ss_pred ccCCcccccccCCCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-cEEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kl~DFGla~~~~~~~ 639 (828)
+.+++|.+++..... ..+.......+..|++.+++|+|+ .+++||||||+||+++... .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966644321 268899999999999999999999 8899999999999999988 79999999998544322
Q ss_pred ccc----eeccccccccccChhhhcc---CCCCcccceeehhhHHHHHHhcCCCCCCCChh-hhhhHHHHHHHHhhcCCc
Q 003350 640 QTH----VSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR-EMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 640 ~~~----~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~ 711 (828)
... ......||..|+|||.+.. ...+...|+||+|++++++++|+.|+...... .......... ....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL----ELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH----hcCC
Confidence 221 2456789999999999987 68899999999999999999999997654321 0111111111 1100
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
. .................+.+++..|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000001223567889999999999999998887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=185.08 Aligned_cols=267 Identities=16% Similarity=0.228 Sum_probs=198.6
Q ss_pred CCCccceEeeeCcEEEEEEE-ecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEec
Q 003350 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.|.+.++||+|.||..+.|+ +-+++.||||.....++ ..++..|.+..+.| ..++|...+-+..++..-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 57888999999999999995 34689999998665544 35677888888888 4689999988888888889999998
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-----CCcEEEEeeCCCCCCCC
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-----NFMAKVADFGLSKTGPE 637 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-----~~~~kl~DFGla~~~~~ 637 (828)
+-||+|...-.+ ..++.+++..||.|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+....
T Consensus 107 -GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 458887664433 579999999999999999999999 99999999999999953 34689999999997654
Q ss_pred CCccc-----eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 638 IDQTH-----VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 638 ~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
..... ......||.+||+-....+.+.+.+.|+-|+|-+++..|-|..||.+........-- .+.+...
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY------eKIGe~K 255 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY------EKIGETK 255 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH------HHhcccc
Confidence 33221 224567999999999999999999999999999999999999999875433322111 1111111
Q ss_pred cccCc-cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhhhc
Q 003350 713 QIIDP-TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH 768 (828)
Q Consensus 713 ~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~~~ 768 (828)
..... .|...+ +++....++.++. .+-.+-|...-+...+..++.......+
T Consensus 256 r~T~i~~Lc~g~-P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 256 RSTPIEVLCEGF-PEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred ccCCHHHHHhcC-HHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 11111 122222 3344445555543 4667889988888777777766544443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5e-20 Score=180.45 Aligned_cols=261 Identities=18% Similarity=0.215 Sum_probs=195.9
Q ss_pred hcCCCccceEeeeCcEEEEEEE-ecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC-CceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 560 (828)
..+|...++||.|+||.+|.|. ..+|+.||||....... ..++..|.++...|+| ..|..+..+..++..-.|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4568888999999999999995 46799999998765533 2467789999999976 677788888889999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC---CcEEEEeeCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN---FMAKVADFGLSKTGPE 637 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kl~DFGla~~~~~ 637 (828)
.+ +-+|.+.+.-.. ..++.++++-++-|++.-++|+|. +++|||||||+|+|+.-+ ..+.++|||||+....
T Consensus 92 LL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 98 558888764333 468999999999999999999999 999999999999999643 4688999999987544
Q ss_pred CCcc-c----eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 638 IDQT-H----VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 638 ~~~~-~----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
.... + ......||..|.+--.+.+...+.+.|+-|+|.+|....-|..||.+..+....+..+...... +.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK----~s 242 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK----MS 242 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh----cC
Confidence 2221 1 1245679999999888888888999999999999999999999998776544333222111110 00
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
..-..+. ...+.++.-.+.-|-...-++-|...-+-+..+-+
T Consensus 243 -~~ie~LC----~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 243 -TPIEVLC----KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred -CCHHHHh----CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 0001122 22345566777888888888888876655544433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=201.67 Aligned_cols=217 Identities=26% Similarity=0.395 Sum_probs=164.7
Q ss_pred HHcCCCCceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCE-Eeeeee
Q 003350 534 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV-IHRDVK 612 (828)
Q Consensus 534 l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vHrDIk 612 (828)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..++|.....+.++|+.||+|||+ .+| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeec
Confidence 457899999999999999999999999999999999997643 579999999999999999999998 444 999999
Q ss_pred cCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccC-------CCCcccceeehhhHHHHHHhcCC
Q 003350 613 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEVLCARP 685 (828)
Q Consensus 613 p~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDVySfGvvl~elltG~~ 685 (828)
++|+++|..+.+||+|||+.................-..-|.|||.+... ..+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998875421111112222344569999999753 25788999999999999999999
Q ss_pred CCCCCChhhh-hhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 686 VIDPTLPREM-VNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 686 p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
||+.....+. ..++.++.. .-...+.|.+... .+....+..++..|+..+|.+||++.+|-..++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9975332221 222222221 1222233333211 1334468899999999999999999999876665544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-19 Score=180.45 Aligned_cols=138 Identities=15% Similarity=0.144 Sum_probs=106.8
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc--c-------HHH-----------------HHHHHHHHHcCCCCceE
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ--G-------LAE-----------------FQTEIEMLSQFRHRHLV 543 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~niv 543 (828)
..||+|++|.||+|...+|+.||||.++..... . ... ...|++.|.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 679999999999999888999999987654211 1 112 23499999999877653
Q ss_pred EEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHH-HhcCCCCEEeeeeecCcEEeCCCC
Q 003350 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGYAKAVIHRDVKSANILLDENF 622 (828)
Q Consensus 544 ~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDIkp~NILld~~~ 622 (828)
....+.. ...++||||+++++|....... ..+++.+..+++.|++.+|+|| |+ .+|+||||||+|||++ ++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CC
Confidence 3322221 2238999999988776543222 3688999999999999999999 67 8999999999999998 47
Q ss_pred cEEEEeeCCCCCC
Q 003350 623 MAKVADFGLSKTG 635 (828)
Q Consensus 623 ~~kl~DFGla~~~ 635 (828)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-20 Score=216.46 Aligned_cols=253 Identities=21% Similarity=0.223 Sum_probs=185.1
Q ss_pred ccceEeeeCcEEEEEEEec-CCcEEEEEEcC----CC-Ccc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 488 ESWVIGIGGFGKVYKGELN-DGTKVAVKRGN----PR-SQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~----~~-~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
..+++|.|.+|.|+..... ..+..+.|... .. +.. ....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999977776433 23333444322 11 111 11225667888888999999888777777666666699
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|++. +|...+... ..++-.++..+..|+.+|++|+|+ .+|.|||+|++|++++.++.+||+|||.+....-...
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999988654 258888999999999999999999 9999999999999999999999999999976543333
Q ss_pred c--ceeccccccccccChhhhccCCCCc-ccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 641 T--HVSTAVKGSFGYLDPEYFRRQQLTE-KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 641 ~--~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
. .......|+..|+|||++.+.+|.+ ..||||.|+++..|++|+.||......+... .......+.-..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRNIF 547 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccccccc
Confidence 3 5667788999999999999888875 5899999999999999999996543332211 000000000001
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.-...+....+.+...++.++|+.+|.+|-+|.+|++
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1111122455667788899999999999999999975
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-19 Score=182.95 Aligned_cols=172 Identities=16% Similarity=0.149 Sum_probs=133.7
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHH---H------HHHHHHHHHcCCCCceEEEEEEEcc
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA---E------FQTEIEMLSQFRHRHLVSLIGYCDE 551 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~g~~~~ 551 (828)
-..++|...++||.|+||.||.... ++..+|||.+.+......+ . +.+|++.+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3467899999999999999999765 4678999998755332222 2 6799999999999999999887542
Q ss_pred --------CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc
Q 003350 552 --------KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 623 (828)
Q Consensus 552 --------~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 623 (828)
....++||||++|.+|.++. .++. ....+++.+|..||+ .+++||||||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence 23578999999999998763 1222 345689999999999 9999999999999999988
Q ss_pred EEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHH
Q 003350 624 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681 (828)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ell 681 (828)
++|+|||..+...+... ...+.....+..++|+|+||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998875422110 011445556778999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.1e-18 Score=171.05 Aligned_cols=140 Identities=16% Similarity=0.141 Sum_probs=109.6
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCccc--------------------------HHHHHHHHHHHHcCCCCceE
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQG--------------------------LAEFQTEIEMLSQFRHRHLV 543 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~niv 543 (828)
..||+|++|.||+|...+|+.||||.+....... ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 6899999999999988789999999877542110 12235789999999999874
Q ss_pred EEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc
Q 003350 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 623 (828)
Q Consensus 544 ~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 623 (828)
....+... ..+|||||++++++....... ..++..+..+++.|++.+|.+||+ ..+|+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCC
Confidence 44333322 248999999987654432222 357788999999999999999997 36999999999999999 789
Q ss_pred EEEEeeCCCCCCC
Q 003350 624 AKVADFGLSKTGP 636 (828)
Q Consensus 624 ~kl~DFGla~~~~ 636 (828)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-18 Score=169.28 Aligned_cols=185 Identities=17% Similarity=0.102 Sum_probs=139.0
Q ss_pred CccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc----cHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEEe
Q 003350 487 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ----GLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....|.+|+++|++|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997765 5778887776654331 1225789999999995 5889999886 456999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeee-ecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV-KSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI-kp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
+.+.+|.+.+.. ....++.|++++|+++|+ .+|+|||| ||+|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999888654311 124578899999999999 99999999 79999999999999999999986443221
Q ss_pred c----ce-------eccccccccccChhhhccC-CCC-cccceeehhhHHHHHHhcCCCCC
Q 003350 641 T----HV-------STAVKGSFGYLDPEYFRRQ-QLT-EKSDVYSFGVVLFEVLCARPVID 688 (828)
Q Consensus 641 ~----~~-------~~~~~gt~~Y~aPE~~~~~-~~s-~ksDVySfGvvl~elltG~~p~~ 688 (828)
. .. ..-...++.|++|+...-. ..+ ...++++-|+-+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00 0112367888888864322 223 56799999999999999997764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.2e-19 Score=204.40 Aligned_cols=247 Identities=23% Similarity=0.274 Sum_probs=179.0
Q ss_pred CCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC-cccHHHHHHHHHH--HHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS-QQGLAEFQTEIEM--LSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++...+.||.+.|=+|.+|+.+.|. |+||.+.... .-..+.|.++++- ...++|||.+++.-+-......+||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998886 8899876654 3345555544443 4456899999988777777778888888
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC--CCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~--~~~~~ 639 (828)
..+ +|.|.|. .++-|...+..=|+.|++.||..+|. .+|+|||||.+|||++.-.=+.|+||.--+. +++ +
T Consensus 103 vkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe-D 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE-D 175 (1431)
T ss_pred Hhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCC-C
Confidence 865 8888883 33457778888899999999999999 9999999999999999888899999976553 222 1
Q ss_pred ccc----eeccccccccccChhhhccC-----------CCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 640 QTH----VSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 640 ~~~----~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
.+. ...+...-.+|+|||.+... ..+++.||||.||++.||++ |+++|+-. +|..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY-- 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY-- 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH--
Confidence 111 11223334579999987531 26789999999999999987 68888532 22211
Q ss_pred HHhhcCCcccccCcc-ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 704 KWQNKGQLDQIIDPT-LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
+.+. ..|++ +.+.+. -..+..+++.|++.+|.+|-++++.++.-
T Consensus 248 ---r~~~---~~~~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 248 ---RSGN---ADDPEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ---hccC---ccCHHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 1111 11111 111111 12477889999999999999999999763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=175.43 Aligned_cols=231 Identities=21% Similarity=0.270 Sum_probs=150.2
Q ss_pred CCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCC-----------CceEEEEEEE-
Q 003350 486 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH-----------RHLVSLIGYC- 549 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H-----------~niv~l~g~~- 549 (828)
....+.||.|+++.||.++..+ ++.+|||..... .....+++.+|.-....+.+ .-++++--.-
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3445789999999999998864 899999964432 23456777777766655432 1222221111
Q ss_pred -------ccC---C-----cEEEEEEeccCCcccccccC-----CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEee
Q 003350 550 -------DEK---N-----EMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609 (828)
Q Consensus 550 -------~~~---~-----~~~lV~ey~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 609 (828)
... . ..+++|+-+. ++|.+++.. .....+....++.+..|+++.+++||+ .+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 111 1 2367788774 588777531 112345566778888999999999999 999999
Q ss_pred eeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccC--------CCCcccceeehhhHHHHHH
Q 003350 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ--------QLTEKSDVYSFGVVLFEVL 681 (828)
Q Consensus 610 DIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~s~ksDVySfGvvl~ell 681 (828)
||||+|++++.+|.++|+||+.....+. .... ...+..|.+||..... .++.+.|.|++|+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999988765322 1121 3455789999987542 5789999999999999999
Q ss_pred hcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCC
Q 003350 682 CARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDR 746 (828)
Q Consensus 682 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R 746 (828)
||+.||+...+..... ..+ ..+. +.++.+..++...|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~-------------------~~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE-------------------WDF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG-------------------GGG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc-------------------ccc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999998654322111 012 2344 667888999999999999887
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=194.74 Aligned_cols=199 Identities=21% Similarity=0.222 Sum_probs=160.2
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC---CCceEEEEEEEccCCcE
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 555 (828)
.+.-.+.|.+.+.||+|+||.||+|...+|+.||+|.-++...- +|.--.+++.+|+ -+.|..+..++.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 33445678888999999999999999888999999998876542 2333334455555 22333444444567788
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC-------CCCcEEEEe
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-------ENFMAKVAD 628 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-------~~~~~kl~D 628 (828)
+||+||.+-|+|.+++. ..+.++|...+.++.|+++-++.||. .+|||+||||+|+||. +..-++|+|
T Consensus 770 ~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEe
Confidence 99999999999999997 34579999999999999999999999 9999999999999993 344689999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCC
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~ 685 (828)
||.+-.+.-...........+|-.+-.+|...++.++.+.|.|.+.-+++-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999865433333345667889999999999999999999999999999999999973
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-18 Score=190.87 Aligned_cols=225 Identities=22% Similarity=0.238 Sum_probs=174.4
Q ss_pred eEeeeCcEEEEEEE----ecCCcEEEEEEcCCCCccc--HHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEEecc
Q 003350 491 VIGIGGFGKVYKGE----LNDGTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|+|.||.|+..+ .+.+..+|.|.++...... ......|..++..++ ||.++++.-.+..+..++++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999998763 2336678888766543211 124557888899887 9999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|.|...+.... ..+..........+|-+++++|+ .+++|||+|++||+++.+|++|+.|||+++..-...
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999998886554 56677777788889999999999 999999999999999999999999999998753311
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 723 (828)
..+||..|||||++. ......|.||||++++||+||-.||.. +.. ..+.. .. -..
T Consensus 152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~------~~Il~---------~~--~~~ 206 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTM------KRILK---------AE--LEM 206 (612)
T ss_pred --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHH------HHHhh---------hc--cCC
Confidence 128999999999998 567899999999999999999999975 111 11111 01 123
Q ss_pred ChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 724 RPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 724 ~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
+.+.......+....+..+|.+|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 34555566777788888888888554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=164.53 Aligned_cols=136 Identities=18% Similarity=0.207 Sum_probs=106.4
Q ss_pred CccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-----CCCceEEEEEEEccCC---c-EEE
Q 003350 487 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-----RHRHLVSLIGYCDEKN---E-MIL 557 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 557 (828)
...++||+|+||.||. .-+++.. +||+.........+++.+|++++.++ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 2233444 69987765455567899999999999 5799999999997763 3 337
Q ss_pred EEEe--ccCCcccccccCCCCCCCChhhHHHHHHHHHHHH-HHHHhcCCCCEEeeeeecCcEEeCC----CCcEEEEeeC
Q 003350 558 IYEY--MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL-HYLHTGYAKAVIHRDVKSANILLDE----NFMAKVADFG 630 (828)
Q Consensus 558 V~ey--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDIkp~NILld~----~~~~kl~DFG 630 (828)
|+|| +++|+|.+++... .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +..++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 5589999999553 25444 35677888777 99999 99999999999999974 3489999955
Q ss_pred CC
Q 003350 631 LS 632 (828)
Q Consensus 631 la 632 (828)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=162.82 Aligned_cols=141 Identities=16% Similarity=0.135 Sum_probs=111.2
Q ss_pred CCCccceEeeeCcEEEEEEE--ecCCcEEEEEEcCCCCcc------------------------cHHHHHHHHHHHHcCC
Q 003350 485 NFDESWVIGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQ------------------------GLAEFQTEIEMLSQFR 538 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 538 (828)
.|...+.||+|++|.||+|. ..+|+.||+|........ ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778899999999999998 567999999987643210 0123568999999997
Q ss_pred CC--ceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC-EEeeeeecCc
Q 003350 539 HR--HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA-VIHRDVKSAN 615 (828)
Q Consensus 539 H~--niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDIkp~N 615 (828)
+. .+.+++++ ...++||||+++++|....... ..+...+...++.|++.+|++||+ .+ ++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 53 34455543 2358999999998887765332 245666778999999999999999 88 9999999999
Q ss_pred EEeCCCCcEEEEeeCCCCCC
Q 003350 616 ILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 616 ILld~~~~~kl~DFGla~~~ 635 (828)
|+++ ++.++|+|||++...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-16 Score=161.09 Aligned_cols=134 Identities=25% Similarity=0.398 Sum_probs=113.4
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc--------cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ--------GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+.||+|++|.||+|.. .|..+++|+....... ....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5678999976543221 124578899999999999988777777777788999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+++++|.+++.... + ++..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885432 2 889999999999999999 9999999999999999 78999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.4e-16 Score=156.04 Aligned_cols=143 Identities=19% Similarity=0.159 Sum_probs=111.4
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc----------------------cHHHHHHHHHHHHc
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ----------------------GLAEFQTEIEMLSQ 536 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~ 536 (828)
+......|...+.||+|+||.||++...+|+.||||+....... ....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333346677899999999999998888999999975543210 11235678999999
Q ss_pred CCCCc--eEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecC
Q 003350 537 FRHRH--LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 614 (828)
Q Consensus 537 l~H~n--iv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~ 614 (828)
+.|++ +...++. ...++||||+++++|...... .....++.+++.++.++|+ .+++||||||+
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~ 154 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEF 154 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcc
Confidence 98874 4455443 345899999999998765421 3456789999999999999 99999999999
Q ss_pred cEEeCCCCcEEEEeeCCCCCCC
Q 003350 615 NILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 615 NILld~~~~~kl~DFGla~~~~ 636 (828)
||++++++.++|+|||++....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.4e-16 Score=180.62 Aligned_cols=138 Identities=22% Similarity=0.306 Sum_probs=112.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCC--Cc------ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQ------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (828)
...|...++||+|+||.||+|.+.+. .+++|+.... .. ...+.+.+|++++.+++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34445678999999999999987644 3444432111 11 123568899999999999999888888877778
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||+++++|.+++. ....++.+++++|.+||+ .+++||||||+|||+ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998874 467899999999999999 999999999999999 677999999999986
Q ss_pred C
Q 003350 635 G 635 (828)
Q Consensus 635 ~ 635 (828)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.5e-16 Score=156.92 Aligned_cols=130 Identities=25% Similarity=0.365 Sum_probs=106.0
Q ss_pred eEeeeCcEEEEEEEecCCcEEEEEEcCCCCc--------ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ--------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+||+|+||.||+|.+ ++..+++|....... ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 467899997554321 11356778999999999887655555555666779999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
++++|.+.+..... .++.+++.+|.+||+ .+++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743220 889999999999999 9999999999999999 78999999999876
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.6e-15 Score=155.15 Aligned_cols=193 Identities=21% Similarity=0.238 Sum_probs=135.7
Q ss_pred CCCceEEEEEEEcc---------------------------CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHH
Q 003350 538 RHRHLVSLIGYCDE---------------------------KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIG 590 (828)
Q Consensus 538 ~H~niv~l~g~~~~---------------------------~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 590 (828)
+|||||++.+.|.+ ...+|+||.-.+. +|++++.... .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999887632 3457889988764 8999886543 566777888999
Q ss_pred HHHHHHHHHhcCCCCEEeeeeecCcEEe--CCCC--cEEEEeeCCCCCCCC----CCccceeccccccccccChhhhccC
Q 003350 591 SARGLHYLHTGYAKAVIHRDVKSANILL--DENF--MAKVADFGLSKTGPE----IDQTHVSTAVKGSFGYLDPEYFRRQ 662 (828)
Q Consensus 591 ia~gL~yLH~~~~~~ivHrDIkp~NILl--d~~~--~~kl~DFGla~~~~~----~~~~~~~~~~~gt~~Y~aPE~~~~~ 662 (828)
+++|+.|||+ ++|.|||+|++|||+ |+|. ...|+|||++-.... ..........-|...-||||+....
T Consensus 350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999 999999999999999 3443 567899998753211 1111112234577889999998643
Q ss_pred C------CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHH
Q 003350 663 Q------LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAE 736 (828)
Q Consensus 663 ~------~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 736 (828)
. --.|+|.|+.|-+.||+++..-||....+- ..+... +++.++ | ..+..++..+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qL-----P----alp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQL-----P----ALPSRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhC-----C----CCcccCChHHHHHHH
Confidence 2 236999999999999999999999652111 011110 122221 1 223344556788999
Q ss_pred hhhhhCCCCCCChHHH
Q 003350 737 KCLADFGVDRPSMGDV 752 (828)
Q Consensus 737 ~Cl~~~p~~RPsm~eV 752 (828)
..|+.+|.+|++..-.
T Consensus 492 ~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIA 507 (598)
T ss_pred HHhcCCccccCCccHH
Confidence 9999999999986443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.6e-16 Score=171.63 Aligned_cols=172 Identities=27% Similarity=0.367 Sum_probs=128.3
Q ss_pred cEEEEEEeccCCcccccccCC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
.+++.|++|...+|.++|.+. .....+|...+.++.|++.|++| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 478899999999999999643 33568899999999999999999 68999999999999999999999999998
Q ss_pred CCCCCCC----ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhc-CCCCCCCChhhhhhHHHHHHHHhh
Q 003350 633 KTGPEID----QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 633 ~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
....... .....+...||..||+||.+.+.+|+.|+||||||++|+||+.- ...++.. .. ..-.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----~t-----~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----AT-----LTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----Hh-----hhhhh
Confidence 7654322 12234567899999999999999999999999999999999972 2211110 00 01111
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChH
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
.+ .++|....+++. =..+..+++...|.+||+..
T Consensus 474 ~g----~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 474 DG----IIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred cC----CCChHHhhcCcH-----HHHHHHHhcCCCcccCchHH
Confidence 11 222222222222 24678899999999999433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-15 Score=177.10 Aligned_cols=210 Identities=24% Similarity=0.325 Sum_probs=144.1
Q ss_pred HhcCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
...+|+..++|..|++|.||..+++. .+.+|+|+-+.... .+- +|.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li------lRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI------LRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccchh------hhc--cccccCCccee-----------------
Confidence 35678888999999999999998764 56677744222110 000 22222333332
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+-...+...+ +++.. ++.+++|||+ .+|+|||+||+|.+++.-|++|+.|||+++.......
T Consensus 136 ----gDc~tllk~~g--~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG--PLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ----chhhhhcccCC--CCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 33333443322 22222 2778999999 9999999999999999999999999999975322111
Q ss_pred cc-------------eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh
Q 003350 641 TH-------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 641 ~~-------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
+. ....++||+.|.|||++..+.|....|+|++|+++||.+-|+.||.+..+++....+- .
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi------s 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI------S 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh------h
Confidence 10 1134689999999999999999999999999999999999999999887776542211 1
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCC
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP 747 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 747 (828)
.. .++ ++- .+....+..+++.+.|+.+|..|-
T Consensus 273 d~--i~w--pE~----dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DD--IEW--PEE----DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hh--ccc--ccc----CcCCCHHHHHHHHHHHHhChHhhc
Confidence 10 000 100 122345577889999999999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.6e-14 Score=137.24 Aligned_cols=135 Identities=21% Similarity=0.231 Sum_probs=116.1
Q ss_pred cceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC--CceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 489 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
.+.||+|.++.||++...+ ..+++|....... ...+..|+.++..++| .++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999998864 7899998765543 4678899999999976 589999999888889999999999877
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 567 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 567 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
+..+ ++.....++.+++++|++||.....+++|+|++|+||++++.+.+++.|||+++..
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7654 56778889999999999999855557999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.1e-14 Score=140.88 Aligned_cols=136 Identities=20% Similarity=0.177 Sum_probs=98.3
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc--cHHH----------------------HHHHHHHHHcCCCCc--eE
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ--GLAE----------------------FQTEIEMLSQFRHRH--LV 543 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--iv 543 (828)
+.||+|+||.||+|...+++.||||........ .... ...|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 679999999999998888999999987653221 1111 135666666664432 44
Q ss_pred EEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc
Q 003350 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 623 (828)
Q Consensus 544 ~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~ 623 (828)
+.+++ ...++||||++++.+........ ... .+...++.+++.++.++|. ..+|+||||||+||+++ ++.
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCc
Confidence 44443 24589999999865433211111 011 6778999999999999997 36899999999999999 899
Q ss_pred EEEEeeCCCCCC
Q 003350 624 AKVADFGLSKTG 635 (828)
Q Consensus 624 ~kl~DFGla~~~ 635 (828)
++|+|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=143.14 Aligned_cols=134 Identities=20% Similarity=0.193 Sum_probs=104.8
Q ss_pred ceEe-eeCcEEEEEEEecCCcEEEEEEcCCCC-------------cccHHHHHHHHHHHHcCCCCce--EEEEEEEccCC
Q 003350 490 WVIG-IGGFGKVYKGELNDGTKVAVKRGNPRS-------------QQGLAEFQTEIEMLSQFRHRHL--VSLIGYCDEKN 553 (828)
Q Consensus 490 ~~LG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 553 (828)
..|| .||.|+||+.... +..++||+..... ......+.+|++++.+++|+++ +..++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5798 8999999999876 6788998764311 1223567889999999998875 66777654322
Q ss_pred ----cEEEEEEeccC-CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEe
Q 003350 554 ----EMILIYEYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 628 (828)
Q Consensus 554 ----~~~lV~ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~D 628 (828)
..++|+|++++ .+|.+++... .++.. .+.+++.+|.+||+ .+|+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999997 6888887542 34433 35789999999999 9999999999999999999999999
Q ss_pred eCCCCC
Q 003350 629 FGLSKT 634 (828)
Q Consensus 629 FGla~~ 634 (828)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999875
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.5e-13 Score=157.79 Aligned_cols=148 Identities=20% Similarity=0.289 Sum_probs=105.2
Q ss_pred cEEEecCCCcce--ecC-------CceeeeCCCCceeeecC-Ccc--cccccc--CcCCCCCccccceeeeeecC---ce
Q 003350 33 NYLIDCGSRTNT--TVG-------NRVFVADNSASKFLSTP-QNV--VANISE--SVTSSNDSQLYQTARIFTGS---SK 95 (828)
Q Consensus 33 ~~~idCG~~~~~--~~~-------~~~~~~D~~~s~~~~~~-~~~--~~~~~~--~~~~~~~~~~~~t~R~f~~~---~~ 95 (828)
.++||||+.... .+. +|.|.+|.. |.... ..+ ...+.. ..+...|...|+|+|.+... ..
T Consensus 193 ~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~---~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lt 269 (623)
T PLN03150 193 AKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQT---FGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLS 269 (623)
T ss_pred EEEEEecCcccccccCCCCCcccCccccCcCcc---cCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceE
Confidence 579999986432 222 799999966 43221 111 111111 12222466789999999753 36
Q ss_pred eEEeecCCceEEEEEEeeccCCCCcCCccceEEEEeCcEEEEeecCC-------CCcEEEEEEEecCCCcEEEEEecCCC
Q 003350 96 YTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSV-------SSNVFKEFSVNVTSDSLDVIFSPSNN 168 (828)
Q Consensus 96 ~~~~~~~~~~ylvR~~f~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~-------~~~~~~E~~~~~~~~~~~vc~~~~~~ 168 (828)
|.+++.++++|+||+||.--.........-.|||.+|+...+++++. ..++++++.+.+.++.+.|+|+|+..
T Consensus 270 y~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~ 349 (623)
T PLN03150 270 YTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKG 349 (623)
T ss_pred EEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCCC
Confidence 77777889999999999554432223334789999999988887654 25788899998888889999999877
Q ss_pred CcceeeeeeeEEeCC
Q 003350 169 SFAFINALEVVSVPD 183 (828)
Q Consensus 169 ~~pfi~~iE~~~~~~ 183 (828)
+.||||||||+.+-.
T Consensus 350 s~pilNaiEI~~~~~ 364 (623)
T PLN03150 350 THAIINAIEVFEIIT 364 (623)
T ss_pred Ccceeeeeeeeeccc
Confidence 789999999999876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.6e-14 Score=168.41 Aligned_cols=253 Identities=23% Similarity=0.270 Sum_probs=187.4
Q ss_pred CCccceEeeeCcEEEEEEEec--CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEE
Q 003350 486 FDESWVIGIGGFGKVYKGELN--DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 560 (828)
|...+.||+|.|+.|-..... ....+|+|...... .........|..+-..+. |+|++.+++........++..+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 444466999999999877553 24567777665543 233344455777777776 9999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHH-hcCCCCEEeeeeecCcEEeCCCC-cEEEEeeCCCCCCCC-
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-TGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPE- 637 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDIkp~NILld~~~-~~kl~DFGla~~~~~- 637 (828)
|..++++.+.+........+....-....|+..++.|+| . .++.||||||+|.+++..+ ..|++|||+|.....
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999884333234666777889999999999999 6 8999999999999999999 999999999987655
Q ss_pred CCccceeccccc-cccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 638 IDQTHVSTAVKG-SFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 638 ~~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....... ....|.... +.
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~----- 249 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GR----- 249 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---cc-----
Confidence 334444455678 9999999998874 557889999999999999999999875543321 111111110 00
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
.....-........++..+++..+|..|.+.+++.
T Consensus 250 ---~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 ---FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00011122334466778888889999999988875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=148.42 Aligned_cols=144 Identities=22% Similarity=0.266 Sum_probs=103.3
Q ss_pred CCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccH----------------------------------------
Q 003350 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL---------------------------------------- 524 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------- 524 (828)
.|+. +.||.|++|.||+|++++|+.||||...+......
T Consensus 119 ~fd~-~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFEE-KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCCC-cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 4443 68999999999999999999999998776531110
Q ss_pred HHHHHHHHHHHcCC-----CCceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHH-HHHHH
Q 003350 525 AEFQTEIEMLSQFR-----HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR-GLHYL 598 (828)
Q Consensus 525 ~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yL 598 (828)
-+|.+|++.+.+++ ++++.-..-+.......+|||||+++++|.+....... .. .+.+++..+++ .+..+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHH
Confidence 02445666555552 34433222222334567999999999999987643211 12 34567777766 46788
Q ss_pred HhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 599 H~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
|. .+++|+|+||.||++++++.++++|||++....
T Consensus 274 ~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred Hh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88 899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.3e-12 Score=131.29 Aligned_cols=202 Identities=25% Similarity=0.353 Sum_probs=139.1
Q ss_pred HHHHcCCCCceEEEEEEEc-----cCCcEEEEEEeccCCcccccccCCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCC
Q 003350 532 EMLSQFRHRHLVSLIGYCD-----EKNEMILIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAK 604 (828)
Q Consensus 532 ~~l~~l~H~niv~l~g~~~-----~~~~~~lV~ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 604 (828)
.-|-++-|.||+++..|+. +..+..++.|||..|+|.++|.+.. ...+......+++.||..||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3455677999999988874 3456889999999999999997632 3567778888999999999999998 778
Q ss_pred CEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC--CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh
Q 003350 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEI--DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 682 (828)
Q Consensus 605 ~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt 682 (828)
+|+|+++..+.|++..++-+|++----....... ..........+-++|.+||+-...+.+-++|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998887532111100000 00011122346789999999887888899999999999999988
Q ss_pred cCCC-CCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 683 ARPV-IDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 683 G~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+..- -......+ .++.+...+- .+.. ..-..++.+|++..|..||+|++++.
T Consensus 278 lEiq~tnseS~~~------------~ee~ia~~i~-~len-------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVE------------VEENIANVII-GLEN-------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceee------------hhhhhhhhee-eccC-------ccccCcCcccccCCCCCCcchhhhhc
Confidence 7532 11111000 0000000000 0000 00134578999999999999999874
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.2e-12 Score=123.27 Aligned_cols=142 Identities=18% Similarity=0.264 Sum_probs=82.5
Q ss_pred EEEEeecCCCCcCCCCCccccccCCCCcceecccCCcccccC--CcceeccCCCCccCCchhhHhhccccccCCCCCCcc
Q 003350 209 TVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNI--PAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANF 286 (828)
Q Consensus 209 ~~~R~n~Gg~~~~~~~D~~~R~W~~~~~~~~~~~~~~~~~~~--~~i~~~~~~~~~~~~P~~V~~tA~~~~~~~~~~~~l 286 (828)
.++|+|+||+.. .|.....|.+|..|.-+. +.-.... ...............++.+|||+|... -
T Consensus 1 ~~~~IN~Gg~~~---~~~~g~~w~~D~~~~~g~--~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~--------~ 67 (174)
T PF11721_consen 1 VVLRINAGGPAY---TDSSGIVWEADQYYTGGS--WGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP--------S 67 (174)
T ss_dssp EEEEEEETSSSE---EETTTEEE-SSSSSTTSS-------------SSTTS--TTS-HHHHHTTT-----S--------S
T ss_pred CEEEEECCCCcc---cCCCCCEEcCCCCCCCCC--cccccccccccccccccccccCCCchhhhHhhcCCC--------C
Confidence 368999999886 788999999999853222 2000000 000001111223455779999999842 1
Q ss_pred eEEEEeecCCCCceEEEEEeceeeecC------CCceEEEEEEcccccccccCccccccCcccceEEEee-eEeecCCCc
Q 003350 287 NVTWEFDVDSGFQYLVRFHFCDIVSDG------LNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDM-VTVQTASSK 359 (828)
Q Consensus 287 ~ltw~~~~~~~~~ylv~LhFaei~~~~------~~~R~F~I~in~~~~~~~~~~~~~s~~~~~~~~~~~~-~~~~~~~~~ 359 (828)
+++|.+|+.++..|.|.|||||+.... .++|+|||++||+...+++|+... +|+...+....+ .+.+ ..|.
T Consensus 68 ~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~-~G~~~~~~~~~~~~v~v-~dg~ 145 (174)
T PF11721_consen 68 SFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAE-AGGFNKAAVRRFFNVTV-TDGT 145 (174)
T ss_dssp SEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHH-HSSSS---EEEEEEEEE-ETTE
T ss_pred ceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHH-cCCCceEEEEEEEEEEE-eCCc
Confidence 578999966688999999999997666 889999999999999999999888 555444554444 4444 3456
Q ss_pred EEEEec
Q 003350 360 LRISIG 365 (828)
Q Consensus 360 ~~i~l~ 365 (828)
++|.+.
T Consensus 146 L~i~f~ 151 (174)
T PF11721_consen 146 LNIQFV 151 (174)
T ss_dssp EETTEE
T ss_pred EEEEEE
Confidence 666554
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=8e-11 Score=116.07 Aligned_cols=130 Identities=21% Similarity=0.130 Sum_probs=96.5
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceE-EEEEEEccCCcEEEEEEeccCCccc
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV-SLIGYCDEKNEMILIYEYMENGTLK 568 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~ey~~~gsL~ 568 (828)
+.|+.|.++.||+++.. +..+++|....... ....+..|++++..+.+.+++ +++.+.. ...++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 56889999999999876 77899998765432 223467899999988765554 4444433 3457999999998876
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcC--CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 569 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY--AKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 569 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+.. .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 112345678999999999832 22369999999999999 66899999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-10 Score=133.20 Aligned_cols=147 Identities=17% Similarity=0.159 Sum_probs=94.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCccc----------------------------------HH--
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQG----------------------------------LA-- 525 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-- 525 (828)
...|+. +.||.|++|.||+|++++ |+.||||...+.-.+. .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999987 9999999887552110 01
Q ss_pred ----HHHHHHHHHHcCC----CCceEEEEEEE-ccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHH-HH
Q 003350 526 ----EFQTEIEMLSQFR----HRHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR-GL 595 (828)
Q Consensus 526 ----~~~~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL 595 (828)
+|.+|+..+.+++ +.+.+.+-.++ .-....+|||||++|+.+.+.-.-.. ...+ +..++...++ -+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d---~~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTD---MKLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCC---HHHHHHHHHHHHH
Confidence 1344555555542 33333322222 22456789999999999987421111 1111 1222222222 12
Q ss_pred HHHHhcCCCCEEeeeeecCcEEeCCCC----cEEEEeeCCCCCCCC
Q 003350 596 HYLHTGYAKAVIHRDVKSANILLDENF----MAKVADFGLSKTGPE 637 (828)
Q Consensus 596 ~yLH~~~~~~ivHrDIkp~NILld~~~----~~kl~DFGla~~~~~ 637 (828)
..++. .+++|+|+||.||+++.++ .+++.|||++.....
T Consensus 274 ~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 22333 8999999999999999888 999999999976544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-09 Score=112.86 Aligned_cols=142 Identities=18% Similarity=0.298 Sum_probs=112.9
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCC--CceEEEEEEEccCC---cEEEEEEecc
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKN---EMILIYEYME 563 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~ey~~ 563 (828)
+.|+.|..+.||++...+|+.+++|....... ....++..|+++++.+++ .++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778999998765432 234678899999999976 34577788776543 5689999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhc------------------------------------------
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG------------------------------------------ 601 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 601 (828)
+.++.+.+.. ..++..++..++.++++.|..||+.
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876532 2577888889999999999999852
Q ss_pred -----------CCCCEEeeeeecCcEEeCC--CCcEEEEeeCCCCC
Q 003350 602 -----------YAKAVIHRDVKSANILLDE--NFMAKVADFGLSKT 634 (828)
Q Consensus 602 -----------~~~~ivHrDIkp~NILld~--~~~~kl~DFGla~~ 634 (828)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256899999999999998 66789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=123.39 Aligned_cols=166 Identities=16% Similarity=0.204 Sum_probs=125.3
Q ss_pred ecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhH
Q 003350 505 LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR 584 (828)
Q Consensus 505 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~ 584 (828)
..++.+|.|...+...........+-++-|+.++||||++++...+..+..|+|+|-+. .|..++.. +.-...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence 34677888887766655445556778899999999999999999999999999999984 56655533 334556
Q ss_pred HHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCC
Q 003350 585 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664 (828)
Q Consensus 585 ~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 664 (828)
.-.+.||+.||.|||+. .+++|++|.-..|++++.|+.||++|.++........ ......---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 66789999999999973 6799999999999999999999999998865432221 111111223466777654322
Q ss_pred CcccceeehhhHHHHHHhc
Q 003350 665 TEKSDVYSFGVVLFEVLCA 683 (828)
Q Consensus 665 s~ksDVySfGvvl~elltG 683 (828)
-..|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-10 Score=129.95 Aligned_cols=247 Identities=20% Similarity=0.177 Sum_probs=173.5
Q ss_pred CCCccceEee--eCcEEEEEEEe---cCCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEE
Q 003350 485 NFDESWVIGI--GGFGKVYKGEL---NDGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 485 ~f~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 556 (828)
.|.....+|. |.+|.||.+.. .++..+|+|+-+..-. .....=.+|+.....+ .|+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3555678999 99999999976 3578899997443322 2222224566666666 4999999888889999999
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHH----HHHHHHhcCCCCEEeeeeecCcEEeCCC-CcEEEEeeCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR----GLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGL 631 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kl~DFGl 631 (828)
+-.|++. .+|.++.+... ..++....+.+..+... ||.++|. ..++|-|+||.||++..+ ...+++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 9999986 68888876543 23556667777777777 9999999 999999999999999999 8999999999
Q ss_pred CCCCCCCCccce---eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 632 SKTGPEIDQTHV---STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 632 a~~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
............ .....|...|++||... +-++.++|+|++|.+.+|..++.......... .|..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~----- 337 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ----- 337 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc-----
Confidence 987655332211 12335777899999874 56789999999999999999987554322100 1110
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
+.....+ .++......++...+..+++.++..|++.+.+.
T Consensus 338 --~r~~~ip---~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 338 --LRQGYIP---LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred --cccccCc---hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 1111111 111112233444578888999988888876665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.7e-09 Score=104.38 Aligned_cols=136 Identities=13% Similarity=0.098 Sum_probs=96.7
Q ss_pred ceEeeeCcEEEEEEEecC-------CcEEEEEEcCCCC----------------------cccHHHHH----HHHHHHHc
Q 003350 490 WVIGIGGFGKVYKGELND-------GTKVAVKRGNPRS----------------------QQGLAEFQ----TEIEMLSQ 536 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~ 536 (828)
..||.|--+.||.|...+ +..+|||..+... ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997553 4789999532210 01122333 89999999
Q ss_pred CCC--CceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHH-HhcCCCCEEeeeeec
Q 003350 537 FRH--RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGYAKAVIHRDVKS 613 (828)
Q Consensus 537 l~H--~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDIkp 613 (828)
+.. -++..++++ ..-++||||+.+..+....... ..++..+..++..+++.+|..| |+ .++||+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 853 455666654 4568999999765443221111 1244556678889999999999 77 8999999999
Q ss_pred CcEEeCCCCcEEEEeeCCCCCC
Q 003350 614 ANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 614 ~NILld~~~~~kl~DFGla~~~ 635 (828)
.|||+++ +.+.|+|||.+-..
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeC
Confidence 9999974 68999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1e-08 Score=98.39 Aligned_cols=143 Identities=19% Similarity=0.222 Sum_probs=105.8
Q ss_pred ccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC--------cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 488 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
...+|-+|+-+.|+++.+. |+...||.-.... .-..+...+|+++|.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4468999999999999886 7777788533321 122456778999999987555544444455555667899
Q ss_pred EeccC-CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC---cEEEEeeCCCCC
Q 003350 560 EYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---MAKVADFGLSKT 634 (828)
Q Consensus 560 ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kl~DFGla~~ 634 (828)
||+++ .++.+++.........-......+..|-+.+.-||. .+|||+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 478888865443333334447888999999999999 9999999999999996544 468999999864
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.9e-09 Score=105.18 Aligned_cols=140 Identities=24% Similarity=0.366 Sum_probs=84.2
Q ss_pred EEEecCCCcceecCCceeeeCCCCceeeecCCc---------cccccccCcCCCCCccccceeeeeecCceeEEeecCCc
Q 003350 34 YLIDCGSRTNTTVGNRVFVADNSASKFLSTPQN---------VVANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRG 104 (828)
Q Consensus 34 ~~idCG~~~~~~~~~~~~~~D~~~s~~~~~~~~---------~~~~~~~~~~~~~~~~~~~t~R~f~~~~~~~~~~~~~~ 104 (828)
++||||++..+...|.+|.+|.. |.....+ ..............+..|+|.|.=|...+|.+++.++|
T Consensus 3 ~~IN~Gg~~~~~~~g~~w~~D~~---~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G 79 (174)
T PF11721_consen 3 LRINAGGPAYTDSSGIVWEADQY---YTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPNG 79 (174)
T ss_dssp EEEEETSSSEEETTTEEE-SSSS---STTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-E
T ss_pred EEEECCCCcccCCCCCEEcCCCC---CCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCCc
Confidence 78999999886669999999966 3222210 00011122223345678999999776668888877899
Q ss_pred eEEEEEEeeccCCCC----cCCccceEEEEeCcEEEEeecCCC------C-cEEEEE-EEecCCCcEEEEEec-------
Q 003350 105 RHWIRLYFYPFVYQS----YNMSRASFSVSTNDHVLLNNFSVS------S-NVFKEF-SVNVTSDSLDVIFSP------- 165 (828)
Q Consensus 105 ~ylvR~~f~~~~~~~----~~~~~~~f~~~~~~~~~~~~~~~~------~-~~~~E~-~~~~~~~~~~vc~~~------- 165 (828)
.|-|||||-=-.+.. .....=.|||.+||-.++++++.. . +..+++ -+.+.++.|.|+|..
T Consensus 80 ~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~~~ 159 (174)
T PF11721_consen 80 TYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGTLC 159 (174)
T ss_dssp EEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SEEE
T ss_pred EEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCcEE
Confidence 999999994333322 112235799999999999999864 2 567777 456688999999996
Q ss_pred ----CCCCcceeeee
Q 003350 166 ----SNNSFAFINAL 176 (828)
Q Consensus 166 ----~~~~~pfi~~i 176 (828)
...+.|.||||
T Consensus 160 i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 160 IPFIGSYGNPLISAI 174 (174)
T ss_dssp EEEESSSSSSSEEEE
T ss_pred eeccccCCCcEEeeC
Confidence 33456888876
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=7e-09 Score=100.16 Aligned_cols=130 Identities=24% Similarity=0.345 Sum_probs=100.7
Q ss_pred eEeeeCcEEEEEEEecCCcEEEEEEcCCCCc--c------cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ--Q------GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
++++|+-+.+|.+.+. |.++++|.-.+..- . ....-.+|+++|.+++--.|...+=+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775 44566774322211 1 1234568999999987666655555666778889999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
++-.|.+.+... ...++..+-+-+.-||. .+|+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998888543 36677788888889999 9999999999999998775 99999999885
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.8e-10 Score=123.77 Aligned_cols=248 Identities=18% Similarity=0.176 Sum_probs=173.4
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec--CCcEEEEEEcCCCCcccHHHH--HHHHHHHHcC-CCCceEEEEEEEccCCcE
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN--DGTKVAVKRGNPRSQQGLAEF--QTEIEMLSQF-RHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (828)
.-+.+|.....||.|.|+.|++...+ ++..+++|...........+. ..|+.+...+ .|.+++.....+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888899999999999998644 578899998766544332222 3456566555 588888877777777778
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC-CcEEEEeeCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKT 634 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kl~DFGla~~ 634 (828)
++--||++++++...+ .-...++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..+++|||++..
T Consensus 342 ~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence 8999999999887766 222357778899999999999999998 999999999999999876 8889999999864
Q ss_pred CCCCCccceeccccccccc-cChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 635 GPEIDQTHVSTAVKGSFGY-LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
+.... ......+..| .+++......+..+.|++|||.-+.|.+++...-.... .|.. .+.+.
T Consensus 417 ~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~--i~~~~--- 479 (524)
T KOG0601|consen 417 LAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT--IRSGD--- 479 (524)
T ss_pred cceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee--eeccc---
Confidence 22111 1111222334 35666667788899999999999999999875332111 0100 01110
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
....+ .....+..++......++..||...+...+.+
T Consensus 480 ------~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 480 ------TPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ------ccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11111 22356677788888899999998877765443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.8e-08 Score=108.83 Aligned_cols=167 Identities=16% Similarity=0.215 Sum_probs=127.9
Q ss_pred cEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEc----cCCcEEEEEEeccC-Cccccc
Q 003350 497 FGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD----EKNEMILIYEYMEN-GTLKGH 570 (828)
Q Consensus 497 fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~ey~~~-gsL~~~ 570 (828)
-.+.||+..+ ||..+++||++....+.......-+++++++.|.|+|++..++. .+..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578898654 79999999995544443333456688999999999999988774 45678999999986 577665
Q ss_pred ccCC-------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 571 LYGS-------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 571 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
-... .....++..++.++.|++.||.++|+ .|+..+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4321 12357788999999999999999999 8999999999999999999999998888766433
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~ 685 (828)
.. . |-+.. -.+-|.=.||.+++.|.||..
T Consensus 446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 11 0 11111 235688889999999999964
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.2e-09 Score=124.50 Aligned_cols=248 Identities=20% Similarity=0.267 Sum_probs=161.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.+.|...+-+-+|.++.++.+.-.. |...+.|..... .....+....+-.++-..+||-++...--+.-.....||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 3455555667788888888764321 212222211111 111122222333333334556666554445567788999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
++|..+++|...|+..+ ..+..-.......+..+++|||. ..+.|+|++|.|.|...+++.+++|||+.......
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999998765 45555555666677889999998 66999999999999999999999999843321100
Q ss_pred ----C-----------------------c--cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCC
Q 003350 639 ----D-----------------------Q--THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDP 689 (828)
Q Consensus 639 ----~-----------------------~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~ 689 (828)
+ . ........||+.|.+||...+......+|+|++|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0 0112345689999999999999999999999999999999999999987
Q ss_pred CChhhhhhHHHHHHHHhhcCCcccccCccccC-CCChhHHHHHHHHHHhhhhhCCCCCCChH
Q 003350 690 TLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG-KIRPDSLRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 690 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
..+..... .++...... ..+.+......+++...+..+|.+|-.|.
T Consensus 1038 ~tpq~~f~---------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIFE---------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhhh---------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 66544321 011100000 11223344566677888888888886654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.7e-08 Score=102.60 Aligned_cols=141 Identities=13% Similarity=0.080 Sum_probs=102.2
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc-cH----------HHHHHHHHHHHcCCCCce--EEEEEEEcc-----
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ-GL----------AEFQTEIEMLSQFRHRHL--VSLIGYCDE----- 551 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~H~ni--v~l~g~~~~----- 551 (828)
+++-+-....|++..+. |+.+.||+....... .. ..+.+|.+.+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 45555555557777664 778999976443311 11 137789999988854333 344555532
Q ss_pred CCcEEEEEEeccCC-cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-------CCc
Q 003350 552 KNEMILIYEYMENG-TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-------NFM 623 (828)
Q Consensus 552 ~~~~~lV~ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-------~~~ 623 (828)
....+||+|++++- +|.+++......+.+...+..++.+++..+.-||. .+|+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence 33578999999875 78888753222345567788999999999999999 99999999999999975 578
Q ss_pred EEEEeeCCCCC
Q 003350 624 AKVADFGLSKT 634 (828)
Q Consensus 624 ~kl~DFGla~~ 634 (828)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.6e-07 Score=92.07 Aligned_cols=124 Identities=22% Similarity=0.258 Sum_probs=82.5
Q ss_pred EEEEEEecCCcEEEEEEcCCCC---------------------c-----ccHHHHHHHHHHHHcCCCC--ceEEEEEEEc
Q 003350 499 KVYKGELNDGTKVAVKRGNPRS---------------------Q-----QGLAEFQTEIEMLSQFRHR--HLVSLIGYCD 550 (828)
Q Consensus 499 ~Vy~~~~~~~~~vavK~~~~~~---------------------~-----~~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 550 (828)
.||.|...+|..+|||...... . .......+|.+.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999533210 0 0123467899999999765 456666553
Q ss_pred cCCcEEEEEEecc--CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHH-HhcCCCCEEeeeeecCcEEeCCCCcEEEE
Q 003350 551 EKNEMILIYEYME--NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVA 627 (828)
Q Consensus 551 ~~~~~~lV~ey~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDIkp~NILld~~~~~kl~ 627 (828)
.-++||||++ +..+.... ... ++......++.+++..+..+ |. .+|+|+|+.+.|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEE
Confidence 3479999998 54554332 211 22456677888888866664 67 899999999999999988 99999
Q ss_pred eeCCCCC
Q 003350 628 DFGLSKT 634 (828)
Q Consensus 628 DFGla~~ 634 (828)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.7e-07 Score=88.57 Aligned_cols=140 Identities=17% Similarity=0.119 Sum_probs=106.6
Q ss_pred eEeeeCcEEEEEEEecCCcEEEEEEcCCC---C---cccHHHHHHHHHHHHcCCCC--ceEEEEEEEcc----CCcEEEE
Q 003350 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPR---S---QQGLAEFQTEIEMLSQFRHR--HLVSLIGYCDE----KNEMILI 558 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~----~~~~~lV 558 (828)
--|+||.+.|++-.++ |..+-+|+.... + +-....|.+|+..|.++... .+.+++.+... ..+-+||
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3567899999998776 457999976521 1 33567899999999999543 24444422211 2346899
Q ss_pred EEeccC-CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc--EEEEeeCCCCC
Q 003350 559 YEYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM--AKVADFGLSKT 634 (828)
Q Consensus 559 ~ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--~kl~DFGla~~ 634 (828)
+|-+++ -+|.+++......+.+..++..+..++++.+.-||+ .++.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 588888866555567888889999999999999999 99999999999999986666 99999987664
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.6e-08 Score=109.83 Aligned_cols=152 Identities=20% Similarity=0.291 Sum_probs=102.7
Q ss_pred HHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC-C------ccceeccccccccccChhhhc
Q 003350 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI-D------QTHVSTAVKGSFGYLDPEYFR 660 (828)
Q Consensus 588 ~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~-~------~~~~~~~~~gt~~Y~aPE~~~ 660 (828)
+.+++.||.|+|. ..++||++|.|++|.++.++..||+.|+.+...... + .............|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445599999998 478999999999999999999999999987543321 1 111112223456799999999
Q ss_pred cCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhh
Q 003350 661 RQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCL 739 (828)
Q Consensus 661 ~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 739 (828)
....+.++|+||+||++|-+.. |+.-+............ ...+..-...+..+.+.++.+-+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHh
Confidence 9889999999999999999994 44444322111111000 000100011122445666777788899
Q ss_pred hhCCCCCCChHHHHH
Q 003350 740 ADFGVDRPSMGDVLW 754 (828)
Q Consensus 740 ~~~p~~RPsm~eVl~ 754 (828)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.1e-06 Score=89.17 Aligned_cols=258 Identities=14% Similarity=0.151 Sum_probs=155.6
Q ss_pred cceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEE-------ccCCcEEEEEE
Q 003350 489 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYC-------DEKNEMILIYE 560 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~-------~~~~~~~lV~e 560 (828)
.+-||+|+-+.+|-.- .-...+-|+.......... ..+..|... .||-+-.=+.|= ..+...-+.|.
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4679999999999641 1112234554443332222 233344444 455432211110 12222566777
Q ss_pred eccCC-ccccccc----CCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 561 YMENG-TLKGHLY----GSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 561 y~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
.+++. ....++. ....+...|...++.++.+|.+.+-||+ .|-+-+|+.++|+|+.+++.+.|.|=.--...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 76653 2222221 1234568999999999999999999999 89999999999999999999999974432221
Q ss_pred CCCCccceeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhc-CCCCCCCChhhh--hhH-HHHHHHHh
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREM--VNL-AEWAMKWQ 706 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG-~~p~~~~~~~~~--~~l-~~~~~~~~ 706 (828)
.........+|...|.+||.-. +..-+...|.|.+||++++|+.| ++||.+...... .-+ ...+.
T Consensus 168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~--- 241 (637)
T COG4248 168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH--- 241 (637)
T ss_pred ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc---
Confidence 2233345677899999999764 34567889999999999999887 999965321100 000 00000
Q ss_pred hcCCcccccCcc--c---cCCCC-hhHHHHHHHHHHhhhhhC--CCCCCChHHHHHHHHHHHHh
Q 003350 707 NKGQLDQIIDPT--L---AGKIR-PDSLRKFGETAEKCLADF--GVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 707 ~~~~~~~~~d~~--l---~~~~~-~~~~~~l~~l~~~Cl~~~--p~~RPsm~eVl~~L~~~~~~ 762 (828)
+.....-|.. + ...++ .-.+..+..+-.+|+... +.-||+.+..+..|..+.+.
T Consensus 242 --g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 --GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred --ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0000000100 0 00111 123345667778888654 46899999999888766544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=9.8e-07 Score=100.87 Aligned_cols=146 Identities=21% Similarity=0.280 Sum_probs=98.0
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccH------------------------------HH-------
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL------------------------------AE------- 526 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~~------- 526 (828)
..|+. +.|+.++-|.||+|++++|+.||||+..+.-.+.. ++
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34554 68999999999999999999999998765522111 11
Q ss_pred ---HHHHHHHHHcCC-----CCceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHH-HHH
Q 003350 527 ---FQTEIEMLSQFR-----HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG-LHY 597 (828)
Q Consensus 527 ---~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~y 597 (828)
+.+|...+.+++ .+++.-.-=|++-.....|+|||++|-.+.+...-.. ...+ +..++..++++ +..
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q 280 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHH
Confidence 344555555542 3444333333444567899999999988888742222 2344 33333333332 222
Q ss_pred HHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 598 LH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
+-. .+++|+|.+|.||+++.++++.+.|||+......
T Consensus 281 ~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 222 6899999999999999999999999999876544
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.1e-06 Score=96.85 Aligned_cols=146 Identities=25% Similarity=0.347 Sum_probs=96.8
Q ss_pred ccEEEecCCCcc---eec--CCceeeeCC--CCceeeecCCccccccccCcCCCCCccccceeeeeecCc-----eeEEe
Q 003350 32 DNYLIDCGSRTN---TTV--GNRVFVADN--SASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTGSS-----KYTFS 99 (828)
Q Consensus 32 ~~~~idCG~~~~---~~~--~~~~~~~D~--~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~~-----~~~~~ 99 (828)
-.+++|||++.+ ..+ -+|+|.+.. ...+-+.+...+. ..........|...|+|||.-...+ .|-+
T Consensus 179 ~~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~-~~~~~~~~~~P~~V~~TA~~~~~~s~~~nltw~~- 256 (347)
T PF12819_consen 179 TVYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNIN-INSSNNPYDAPSAVYQTARTPSNSSDPLNLTWSF- 256 (347)
T ss_pred EEEeecCCCcccccCCCCCcceeeccccccCccccccccceeee-cccCCccCcChHHHHHhhhcccccccceEEEecc-
Confidence 478999998852 111 579999631 2111222221121 0112234446778899999887654 3444
Q ss_pred ecCCceEEEEEEeeccCCCCc--CCccceEEEEeCcEEEEeecCCC------CcEEEEEEEecCC-CcEEEEEecCCCC-
Q 003350 100 ISGRGRHWIRLYFYPFVYQSY--NMSRASFSVSTNDHVLLNNFSVS------SNVFKEFSVNVTS-DSLDVIFSPSNNS- 169 (828)
Q Consensus 100 ~~~~~~ylvR~~f~~~~~~~~--~~~~~~f~~~~~~~~~~~~~~~~------~~~~~E~~~~~~~-~~~~vc~~~~~~~- 169 (828)
+.++..|+||+|| ++.... +...-.||+.+|+.......+.. .+++..+++.+.+ +.+.|+|.++..+
T Consensus 257 ~~~~~~y~v~lHF--aEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~ 334 (347)
T PF12819_consen 257 VDPGFSYYVRLHF--AEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDST 334 (347)
T ss_pred CCCCccEEEEEEE--eecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCC
Confidence 4778899999999 777664 33247799999997766533331 3346778887765 5799999999776
Q ss_pred -cceeeeeeeEEe
Q 003350 170 -FAFINALEVVSV 181 (828)
Q Consensus 170 -~pfi~~iE~~~~ 181 (828)
.|+|||+||+.+
T Consensus 335 lppiLNalEIy~v 347 (347)
T PF12819_consen 335 LPPILNALEIYKV 347 (347)
T ss_pred cCceeEeeeeEeC
Confidence 799999999864
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.7e-06 Score=88.66 Aligned_cols=134 Identities=24% Similarity=0.218 Sum_probs=95.7
Q ss_pred CccceEeeeCcEEEEEEEecCCcEEEEEEcCCC--------------------C--cccHHHHHHHHHHHHcCCCC--ce
Q 003350 487 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR--------------------S--QQGLAEFQTEIEMLSQFRHR--HL 542 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~H~--ni 542 (828)
.....||.|--+.||.|....|.++|||.-... + .......++|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 345789999999999999999999999931111 0 01123467899999999655 66
Q ss_pred EEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC
Q 003350 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF 622 (828)
Q Consensus 543 v~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 622 (828)
.+.+++ +.-.+||||+++-.|...- ++-+..-.|+..|++-+.-+-. .|+||+|+.+-||+++++|
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence 666654 4557999999986655432 2233444455555555554445 8999999999999999999
Q ss_pred cEEEEeeCCCCC
Q 003350 623 MAKVADFGLSKT 634 (828)
Q Consensus 623 ~~kl~DFGla~~ 634 (828)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999965543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.1e-06 Score=87.64 Aligned_cols=106 Identities=23% Similarity=0.242 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHHcCCCC--ceEEEEEEEccC----CcEEEEEEeccC-CcccccccCCCCCCCChhhHHHHHHHHHHHHH
Q 003350 524 LAEFQTEIEMLSQFRHR--HLVSLIGYCDEK----NEMILIYEYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 596 (828)
Q Consensus 524 ~~~~~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~lV~ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 596 (828)
...+.+|.+.+.++... ...+.+++.... ...++|+|++++ -+|.+++.... .++......++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 34577888888888543 345566665443 245899999987 47888886533 2566778899999999999
Q ss_pred HHHhcCCCCEEeeeeecCcEEeCCCC---cEEEEeeCCCCC
Q 003350 597 YLHTGYAKAVIHRDVKSANILLDENF---MAKVADFGLSKT 634 (828)
Q Consensus 597 yLH~~~~~~ivHrDIkp~NILld~~~---~~kl~DFGla~~ 634 (828)
-||+ .+|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 9999999999999999887 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.9e-05 Score=80.37 Aligned_cols=139 Identities=14% Similarity=0.141 Sum_probs=85.7
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc--eEEEEEEEccCCcEEEEEEeccCCc-
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLIGYCDEKNEMILIYEYMENGT- 566 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~ey~~~gs- 566 (828)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 24467788876533 2345688999999886443 3567777777777889999998863
Q ss_pred ccccc---------------------cCCCCCCCChhhHHHHH-H----------HHHH-HHHHHHh-cCCCCEEeeeee
Q 003350 567 LKGHL---------------------YGSGLPSLSWKQRLEIC-I----------GSAR-GLHYLHT-GYAKAVIHRDVK 612 (828)
Q Consensus 567 L~~~l---------------------~~~~~~~l~~~~~~~i~-~----------~ia~-gL~yLH~-~~~~~ivHrDIk 612 (828)
+...+ |.-............-. . .+.+ ..++|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 11110111111111000 0 0001 1222221 112457899999
Q ss_pred cCcEEeCCCCcEEEEeeCCCCC
Q 003350 613 SANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 613 p~NILld~~~~~kl~DFGla~~ 634 (828)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.8e-05 Score=90.35 Aligned_cols=145 Identities=21% Similarity=0.270 Sum_probs=93.9
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccH---------------------------H----------H
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL---------------------------A----------E 526 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------~----------~ 526 (828)
..|+. +.||.-+.|.||+|++++|+.||||..++.-++.. + +
T Consensus 162 ~~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 162 SEFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred HhcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 34443 68999999999999999999999998766532210 0 1
Q ss_pred HHHHHHHHHcC----CCCc------eEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHH
Q 003350 527 FQTEIEMLSQF----RHRH------LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 596 (828)
Q Consensus 527 ~~~E~~~l~~l----~H~n------iv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 596 (828)
|..|.+-..++ .|-+ |.+++ +.-.....|+||||+|..+.+.-.-.. ..++-..+ +..+.++
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i---~~~l~~~-- 312 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDI---LNKLVEA-- 312 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHH---HHHHHHH--
Confidence 44444443333 3444 22222 234457899999999988877542111 12444433 3333332
Q ss_pred HHHhcCCCCEEeeeeecCcEEeCC----CCcEEEEeeCCCCCCCC
Q 003350 597 YLHTGYAKAVIHRDVKSANILLDE----NFMAKVADFGLSKTGPE 637 (828)
Q Consensus 597 yLH~~~~~~ivHrDIkp~NILld~----~~~~kl~DFGla~~~~~ 637 (828)
|++.-...|++|+|-+|.||+++. ++.+.+-|||+......
T Consensus 313 ~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 313 YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 223222368999999999999984 67899999999886543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=8e-05 Score=75.95 Aligned_cols=153 Identities=18% Similarity=0.180 Sum_probs=100.9
Q ss_pred ccCHHHHHHHhcCCCccceEee---eCcEEEEEEEecCCcEEEEEEcCCCCcccH------------------------H
Q 003350 473 RFPFVAVQEATNNFDESWVIGI---GGFGKVYKGELNDGTKVAVKRGNPRSQQGL------------------------A 525 (828)
Q Consensus 473 ~~~~~~l~~at~~f~~~~~LG~---G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~ 525 (828)
..++..+....++.......|. |.-+.||+|...++..+|||+......... .
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 4566777777777766666554 566689999888899999997654322111 1
Q ss_pred HHHHHHHHHHcCC--CCceEEEEEEEccCCcEEEEEEeccCCcc-cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcC
Q 003350 526 EFQTEIEMLSQFR--HRHLVSLIGYCDEKNEMILIYEYMENGTL-KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602 (828)
Q Consensus 526 ~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ey~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 602 (828)
....|..-|.++. +-.+.+.+++.. -.|||||+....+ .-.|... ++...+...+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~-- 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK-- 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH--
Confidence 1346777777773 344445555432 3699999965311 1112111 22333466666777777776654
Q ss_pred CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 603 ~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
..++||+||..-|||+. ++.+.|+|+|-|...
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 26899999999999999 889999999987653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.9e-05 Score=75.25 Aligned_cols=138 Identities=17% Similarity=0.174 Sum_probs=91.5
Q ss_pred HhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHH---------HHHHHHHHcCCC---CceEEEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEF---------QTEIEMLSQFRH---RHLVSLIGYC 549 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~g~~ 549 (828)
..++|...+++-......|.+-..+ |+.+.+|..........+.| .+++..+.+++. -....++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3566777777777777777776665 68899998766543333332 234444444422 2222322222
Q ss_pred -----ccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 550 -----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 550 -----~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
.-....+|+|||++|..|.+... ++. .++..+++.+.-||+ .|+.|+|..|.|+++++++ +
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-E
Confidence 22345679999999988876531 222 355667788999999 9999999999999999664 9
Q ss_pred EEEeeCCCCC
Q 003350 625 KVADFGLSKT 634 (828)
Q Consensus 625 kl~DFGla~~ 634 (828)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.9e-05 Score=76.85 Aligned_cols=103 Identities=22% Similarity=0.291 Sum_probs=83.0
Q ss_pred HHHHHHHHcCCC-CceEEEEEEEccCCcEEEEEEeccCCcccccccC-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC
Q 003350 528 QTEIEMLSQFRH-RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605 (828)
Q Consensus 528 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 605 (828)
..|.-+|+.+++ +++.+++|+|-. ++|.||...+++...-.. .....-+|.+|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 699999999943 789999987766432100 11124689999999999999999999876666
Q ss_pred EEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 606 VIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 606 ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+.-+|++++|+-+++++++|+.|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.90 E-value=9.3e-05 Score=76.48 Aligned_cols=142 Identities=18% Similarity=0.183 Sum_probs=85.0
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCC--ceEEEEEEE---ccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR--HLVSLIGYC---DEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~---~~~~~~~lV~ey~~~ 564 (828)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.++ ......+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 579999999999998887 68999986654 3456778899988888433 345666644 223347899999999
Q ss_pred Ccccc----------------cc---cCC--CCCCCChhh---------HHHH------------HHHHHH-HHHHHHh-
Q 003350 565 GTLKG----------------HL---YGS--GLPSLSWKQ---------RLEI------------CIGSAR-GLHYLHT- 600 (828)
Q Consensus 565 gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~- 600 (828)
..+.. .+ +.. ......+.. .... ...+.+ .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11 111 111111111 0000 111222 2333332
Q ss_pred ---cCCCCEEeeeeecCcEEeC-CCCcEEEEeeCCCCC
Q 003350 601 ---GYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKT 634 (828)
Q Consensus 601 ---~~~~~ivHrDIkp~NILld-~~~~~kl~DFGla~~ 634 (828)
.....++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2346799999999999999 666668999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00011 Score=76.92 Aligned_cols=139 Identities=16% Similarity=0.147 Sum_probs=85.1
Q ss_pred EeeeCc-EEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEEeccCCcccc
Q 003350 492 IGIGGF-GKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTLKG 569 (828)
Q Consensus 492 LG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ey~~~gsL~~ 569 (828)
|-.|.. ..||+.... +..+.+|+..... ..+..+|++++..+. +--+.+++++....+..++|||++++.+|.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444444 788998765 4678888876543 345678888888873 3445577777766667899999999877764
Q ss_pred cc-------------------cCCCCC--CCC--hhhHHHHHH--------------------HHHHHHHHHHh----cC
Q 003350 570 HL-------------------YGSGLP--SLS--WKQRLEICI--------------------GSARGLHYLHT----GY 602 (828)
Q Consensus 570 ~l-------------------~~~~~~--~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~ 602 (828)
.. |..... +.. +...+.... .+...++.|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 111100 111 001110000 01111222211 12
Q ss_pred CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 603 ~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
...++|+|+.|.|||++++..+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35689999999999999988889999997764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=7.5e-06 Score=92.28 Aligned_cols=181 Identities=19% Similarity=0.124 Sum_probs=130.0
Q ss_pred eEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc-eEEEEEEEccCCcEEEEEEeccCC-ccc
Q 003350 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH-LVSLIGYCDEKNEMILIYEYMENG-TLK 568 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ey~~~g-sL~ 568 (828)
-+++|++++++|.+--..+...++.+... ....-++++|.+++||| .+..++-+..+....++++++..+ +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 46789999999875432223333433222 34467899999999999 666666667777888999999876 222
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceecccc
Q 003350 569 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648 (828)
Q Consensus 569 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 648 (828)
.-.... .-.+...+...+++.-+++|++||+ ..=+|+| ||+..+ ...|..||+....+.... ..+...
T Consensus 324 ~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~ 391 (829)
T KOG0576|consen 324 LEMTVS-EIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI 391 (829)
T ss_pred ccCChh-hHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence 211111 1124445566777888899999998 4458888 777766 578999999987764422 345667
Q ss_pred ccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCC
Q 003350 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 688 (828)
Q Consensus 649 gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~ 688 (828)
+|+.++|||+.....+..+.|+|+.|+-..+|--|-+|-.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9999999999999999999999999998778877776653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00033 Score=86.46 Aligned_cols=147 Identities=16% Similarity=0.291 Sum_probs=92.2
Q ss_pred cceEeeeCcEEEEEEEecCC---cEEEEEEcCCCC-cccHHHHHHHHHHHHcCC-CCce--EEEEEEEccC---CcEEEE
Q 003350 489 SWVIGIGGFGKVYKGELNDG---TKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHL--VSLIGYCDEK---NEMILI 558 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 558 (828)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45788899999999877653 467778755432 223457889999999995 6665 7888888654 467899
Q ss_pred EEeccCCccccc-----------------------ccCCCC---------CCCCh--hhHHHHH---------------H
Q 003350 559 YEYMENGTLKGH-----------------------LYGSGL---------PSLSW--KQRLEIC---------------I 589 (828)
Q Consensus 559 ~ey~~~gsL~~~-----------------------l~~~~~---------~~l~~--~~~~~i~---------------~ 589 (828)
|||+++..+.+. ||.-.. .+..+ .++..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999987654321 111100 01111 0111111 1
Q ss_pred HHHHHHHHHHhcCC--------CCEEeeeeecCcEEeCCC-Cc-EEEEeeCCCCCC
Q 003350 590 GSARGLHYLHTGYA--------KAVIHRDVKSANILLDEN-FM-AKVADFGLSKTG 635 (828)
Q Consensus 590 ~ia~gL~yLH~~~~--------~~ivHrDIkp~NILld~~-~~-~kl~DFGla~~~ 635 (828)
.+.+.+++|..... ..+||+|+++.|||++.+ .. +-|.||+++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 22334556644222 359999999999999853 33 579999998753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00068 Score=68.26 Aligned_cols=129 Identities=21% Similarity=0.313 Sum_probs=89.8
Q ss_pred ccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC----------------cccHHHHHHHHHHHHcCC------CCceEEE
Q 003350 488 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS----------------QQGLAEFQTEIEMLSQFR------HRHLVSL 545 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 545 (828)
....||+|+.-.||. +++.....||...... ....+++.+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346899999999996 4445567788766554 223566777777666665 7889999
Q ss_pred EEEEccCCcEEEEEEeccC--C----cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC
Q 003350 546 IGYCDEKNEMILIYEYMEN--G----TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619 (828)
Q Consensus 546 ~g~~~~~~~~~lV~ey~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld 619 (828)
+|+.+++...-+|+|.+.+ | +|.+++... .++. ...+ .+-+-.+||-+ ..|+.+|++|.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~---~L~~f~~~l~~---~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQ---ALDEFKRYLLD---HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHH---HHHHHHHHHHH---cCCeecCCCcccEEEE
Confidence 9999999999999998743 3 455666333 2444 3333 33344556666 7899999999999995
Q ss_pred CC---C-cEEEEe
Q 003350 620 EN---F-MAKVAD 628 (828)
Q Consensus 620 ~~---~-~~kl~D 628 (828)
.. . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 566776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.001 Score=71.97 Aligned_cols=77 Identities=13% Similarity=0.062 Sum_probs=56.7
Q ss_pred ccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC---CceEEEEEEEcc---CCcEEEEEEe
Q 003350 488 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH---RHLVSLIGYCDE---KNEMILIYEY 561 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lV~ey 561 (828)
..+.||.|..+.||+....++ .+.+|..+... ....|..|.+.|+.+.. -.+.+++++|.. .+..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 346799999999999876655 46667643311 23578899999998853 367788888754 4678999999
Q ss_pred ccCCcc
Q 003350 562 MENGTL 567 (828)
Q Consensus 562 ~~~gsL 567 (828)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00039 Score=67.26 Aligned_cols=127 Identities=18% Similarity=0.221 Sum_probs=86.0
Q ss_pred cceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEE-EEEEEccCCcEEEEEEeccCCcc
Q 003350 489 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS-LIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
.+.|++|++|.||+|.+. |..+|+|.....+. ...+..|+++|..+.-.++.+ ++.|-.+ ++.|||+.+-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcch
Confidence 367999999999999987 55889998766554 467889999999998766654 4443322 345999988777
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeee-cCcEEeCCCCcEEEEeeCCCCC
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK-SANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIk-p~NILld~~~~~kl~DFGla~~ 634 (828)
.+.-... +-++ ...+++.---|.. .+|-|+.|. |..++|-.+..+.|+||.-|..
T Consensus 100 ~~~~~~~-----~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG-----DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc-----cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 6654221 1222 2333444222333 788899886 4444444455999999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0008 Score=70.13 Aligned_cols=139 Identities=16% Similarity=0.182 Sum_probs=77.5
Q ss_pred ceEeeeCcE-EEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCC---ceEEEEEEEccC---CcEEEEEEec
Q 003350 490 WVIGIGGFG-KVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR---HLVSLIGYCDEK---NEMILIYEYM 562 (828)
Q Consensus 490 ~~LG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~ey~ 562 (828)
+.|+.|+.. .||+. +..+++|..... .....+.+|.++|..+... -+..+++.+... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 48875 235677765432 2345788999999887532 234444444332 2358899999
Q ss_pred cCCcccccc------------------cCCCCCC--C-------------ChhhHH--HHH-------HHHHH-HHHH-H
Q 003350 563 ENGTLKGHL------------------YGSGLPS--L-------------SWKQRL--EIC-------IGSAR-GLHY-L 598 (828)
Q Consensus 563 ~~gsL~~~l------------------~~~~~~~--l-------------~~~~~~--~i~-------~~ia~-gL~y-L 598 (828)
+|.++.+.. |.-.... . .|.... .+. .+.+. .++. +
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 987775331 1110000 0 011110 000 01111 1111 1
Q ss_pred Hh--cCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 599 HT--GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 599 H~--~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+. .....++|+|+.+.|||++++...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234599999999999999876667999998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0017 Score=67.63 Aligned_cols=140 Identities=19% Similarity=0.188 Sum_probs=81.5
Q ss_pred ceEeeeCcEEEEEEEecC--CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCce-EEEEEEEccCCcEEEEEEeccCCc
Q 003350 490 WVIGIGGFGKVYKGELND--GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
+.|..|-...+|+....+ ++.+++|......... -.-.+|+.++..+...++ .++++.+. . .++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence 457778888999987764 6788899765432221 222478888888854444 34444333 2 37999999877
Q ss_pred cccc-----------------ccCCCC---------CCC-ChhhHHHHHH----------------------HHHHHHHH
Q 003350 567 LKGH-----------------LYGSGL---------PSL-SWKQRLEICI----------------------GSARGLHY 597 (828)
Q Consensus 567 L~~~-----------------l~~~~~---------~~l-~~~~~~~i~~----------------------~ia~gL~y 597 (828)
+... +|.... ... -|..+..+.. .+.+-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 111110 011 1222112111 11111111
Q ss_pred H----Hh-cCCCCEEeeeeecCcEEeCC-CCcEEEEeeCCCCC
Q 003350 598 L----HT-GYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKT 634 (828)
Q Consensus 598 L----H~-~~~~~ivHrDIkp~NILld~-~~~~kl~DFGla~~ 634 (828)
| .. .....++|+|+.+.|||+++ +..+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 11 12357999999999999998 57899999988764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0013 Score=69.43 Aligned_cols=137 Identities=18% Similarity=0.174 Sum_probs=79.1
Q ss_pred EeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCce-EEEEEEEccCCcEEEEEEeccCCccccc
Q 003350 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYEYMENGTLKGH 570 (828)
Q Consensus 492 LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ey~~~gsL~~~ 570 (828)
+..|-...+|+... +++.+++|..........-...+|.++++.+....+ .++++.+. -.+|+||+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 44577788998874 466888887554332211234678889988864433 33444432 3689999998766532
Q ss_pred -----------------ccCCC--CCCCChhhHH-HHHHH---------HHHHHHHHHh-----cCCCCEEeeeeecCcE
Q 003350 571 -----------------LYGSG--LPSLSWKQRL-EICIG---------SARGLHYLHT-----GYAKAVIHRDVKSANI 616 (828)
Q Consensus 571 -----------------l~~~~--~~~l~~~~~~-~i~~~---------ia~gL~yLH~-----~~~~~ivHrDIkp~NI 616 (828)
||... ..+++...++ ....+ +.+-+..+.. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12211 1122222111 11101 1111222211 1134689999999999
Q ss_pred EeCCCCcEEEEeeCCCCC
Q 003350 617 LLDENFMAKVADFGLSKT 634 (828)
Q Consensus 617 Lld~~~~~kl~DFGla~~ 634 (828)
++++++ +.|+||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0043 Score=69.29 Aligned_cols=74 Identities=20% Similarity=0.232 Sum_probs=53.4
Q ss_pred ceEeeeCcEEEEEEEecCC-cEEEEEEcCCCC-------cccHHHHHHHHHHHHcCC---CCceEEEEEEEccCCcEEEE
Q 003350 490 WVIGIGGFGKVYKGELNDG-TKVAVKRGNPRS-------QQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 558 (828)
+.||.|.+..||++...+| +.++||.-.+.. ....+.+..|.+.|..+. ..++.+++.+. ....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 4689999999999998877 589999744221 123566778888888763 24566677663 3557899
Q ss_pred EEeccCC
Q 003350 559 YEYMENG 565 (828)
Q Consensus 559 ~ey~~~g 565 (828)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999863
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0041 Score=62.26 Aligned_cols=125 Identities=22% Similarity=0.294 Sum_probs=87.9
Q ss_pred cCCCccceEeeeCc-EEEEEEEecCCcEEEEEEcCC---CCc------------------ccHHHHHHHHHHHHcCC---
Q 003350 484 NNFDESWVIGIGGF-GKVYKGELNDGTKVAVKRGNP---RSQ------------------QGLAEFQTEIEMLSQFR--- 538 (828)
Q Consensus 484 ~~f~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 538 (828)
.+|+..+.||.|.- |.|||+++. |+.+|+|.... ... .-...|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67777889999999 999999987 77999998221 100 11234778988888774
Q ss_pred CCce--EEEEEEEccC------------------CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHH
Q 003350 539 HRHL--VSLIGYCDEK------------------NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598 (828)
Q Consensus 539 H~ni--v~l~g~~~~~------------------~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 598 (828)
+.++ ++.+||..-. ....+|.||++... ....+-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhHHHHHHHHHHHH
Confidence 4566 8888887211 12356777665422 12233455677778899
Q ss_pred HhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 599 H~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
|. .+|+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 98 99999999999976 4589999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0022 Score=69.28 Aligned_cols=141 Identities=18% Similarity=0.158 Sum_probs=85.2
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc--eEEEEEEE------ccCCcEEEEEEe
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLIGYC------DEKNEMILIYEY 561 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~ey 561 (828)
+.|..|....+|+....+ ..+++|+.... ...+...|++++..+.+.+ +.+++... ...+..++|+++
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 456667778899987654 46888887642 2345667888888775433 34444321 223456899999
Q ss_pred ccCCccccc--------------ccC--CC--C-----CCCChhhHHH----------HHHHHHHHHHHHHh----cCCC
Q 003350 562 MENGTLKGH--------------LYG--SG--L-----PSLSWKQRLE----------ICIGSARGLHYLHT----GYAK 604 (828)
Q Consensus 562 ~~~gsL~~~--------------l~~--~~--~-----~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~~ 604 (828)
++|..+... +|. .. . ....|..... ....+...++++.+ ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 998765430 011 00 0 1123322211 11123344455443 2345
Q ss_pred CEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 605 AVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 605 ~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+++|+|+.|.|||++++..+.|.||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 799999999999999987788999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0015 Score=79.01 Aligned_cols=198 Identities=19% Similarity=0.209 Sum_probs=134.5
Q ss_pred HHHHHHHHHHHcCCCCceEEEEEEEccCCcEE----EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHh
Q 003350 525 AEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI----LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 600 (828)
Q Consensus 525 ~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 600 (828)
.....|.+.+..+.|+|++.++.|..++...- +.-+++..-++...+.... .++..+.+.+..++.+||+|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence 33456788888999999999999875543332 3346676667776665443 57788999999999999999999
Q ss_pred cCCCCEEeeeeecC---cEEeCCCCcEEEE--eeCCCCCCCCCCccceeccccccccccChhhhccCCCC--cccceeeh
Q 003350 601 GYAKAVIHRDVKSA---NILLDENFMAKVA--DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT--EKSDVYSF 673 (828)
Q Consensus 601 ~~~~~ivHrDIkp~---NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s--~ksDVySf 673 (828)
..+.|.-+..+ +.-.+.++...++ ||+..+..+...... ...-+..+.+||......+. ...|+|.+
T Consensus 305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 56666666555 5566777777777 998887765433221 22234557788877655444 44799999
Q ss_pred hhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 674 GVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 674 Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
|.++..+..|..+-.... . ...+++. .....+.+...+|+..++++|+...+++
T Consensus 379 gll~~~~~~~~~i~~~~~--~----------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA--V----------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc--c----------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 999999998865432110 0 0011111 1111456778899999999999999997
Q ss_pred HHH
Q 003350 754 WNL 756 (828)
Q Consensus 754 ~~L 756 (828)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0049 Score=66.81 Aligned_cols=140 Identities=25% Similarity=0.281 Sum_probs=83.4
Q ss_pred ceEeeeCcEEEEEEEecC-------CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCce-EEEEEEEccCCcEEEEEEe
Q 003350 490 WVIGIGGFGKVYKGELND-------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ey 561 (828)
+.|..|-...+|+....+ ++.+++|+...... ......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345556667899987665 47888998665432 22345678888888754333 345555532 358999
Q ss_pred ccCCccccc-----------------ccCCCCC---------CCChhhHHH--------------------------HHH
Q 003350 562 MENGTLKGH-----------------LYGSGLP---------SLSWKQRLE--------------------------ICI 589 (828)
Q Consensus 562 ~~~gsL~~~-----------------l~~~~~~---------~l~~~~~~~--------------------------i~~ 589 (828)
++|..+... +|..... +.-|....+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 1111111 011111111 111
Q ss_pred HHHHHHHHHHh------cCCCCEEeeeeecCcEEeCCC----CcEEEEeeCCCCC
Q 003350 590 GSARGLHYLHT------GYAKAVIHRDVKSANILLDEN----FMAKVADFGLSKT 634 (828)
Q Consensus 590 ~ia~gL~yLH~------~~~~~ivHrDIkp~NILld~~----~~~kl~DFGla~~ 634 (828)
.+.+-++.|.. .....++|+|+.+.|||++++ +.++++||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 245689999999999999985 8899999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0015 Score=68.82 Aligned_cols=145 Identities=15% Similarity=0.155 Sum_probs=96.6
Q ss_pred cCHHHHHHHhcC---CCccceEeeeCcEEEEEEEecCCcEEEEEEcC--CC---------------Cc-cc----HHHHH
Q 003350 474 FPFVAVQEATNN---FDESWVIGIGGFGKVYKGELNDGTKVAVKRGN--PR---------------SQ-QG----LAEFQ 528 (828)
Q Consensus 474 ~~~~~l~~at~~---f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~---------------~~-~~----~~~~~ 528 (828)
+.+..|+...++ +...+.||-|.-+.||.+...+|++.++|.-. .. .. .+ .-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 455666655543 45678999999999999999889998888311 11 00 11 11245
Q ss_pred HHHHHHHcCCC--CceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCE
Q 003350 529 TEIEMLSQFRH--RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606 (828)
Q Consensus 529 ~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 606 (828)
+|...|+.|.. --+.+.+++ +.-++|||++.+-.|.+.-+-. +..++..-+. .-+--|.. .|+
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~~lm---~~Iv~la~---~Gl 223 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DPPTLYDDLM---GLIVRLAN---HGL 223 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----ChHHHHHHHH---HHHHHHHH---cCc
Confidence 78888888843 223444443 4568999999988887654222 2233333333 33344455 899
Q ss_pred EeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 607 IHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 607 vHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
||+|..--||+++++..++++||--+-
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhh
Confidence 999999999999999999999996543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.011 Score=64.68 Aligned_cols=156 Identities=14% Similarity=0.170 Sum_probs=83.9
Q ss_pred CHHHHHHHhcCCCc-----cceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc--eEEEEE
Q 003350 475 PFVAVQEATNNFDE-----SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLIG 547 (828)
Q Consensus 475 ~~~~l~~at~~f~~-----~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g 547 (828)
+..++......|.. .+.|+.|....+|+....+| .+++|+..... .+....|++++..|...+ +.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCccee
Confidence 34445444445543 24466677778999877655 68888765222 233344555555553211 223332
Q ss_pred ------EEccCCcEEEEEEeccCCccccc--------------ccCCC---------CCCCCh-hhHHHHH---------
Q 003350 548 ------YCDEKNEMILIYEYMENGTLKGH--------------LYGSG---------LPSLSW-KQRLEIC--------- 588 (828)
Q Consensus 548 ------~~~~~~~~~lV~ey~~~gsL~~~--------------l~~~~---------~~~l~~-~~~~~i~--------- 588 (828)
+....+..+++++|++|..+... +|... ...+.| .....-.
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 11234567899999998654210 11100 011222 2211111
Q ss_pred ----HHHHHHHHHHHh----cCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 589 ----IGSARGLHYLHT----GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 589 ----~~ia~gL~yLH~----~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
..+...++.+.. ....++||+|+++.|||++.+...-|+||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 111112233321 1346899999999999999776668999998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.02 Score=62.30 Aligned_cols=156 Identities=16% Similarity=0.157 Sum_probs=89.3
Q ss_pred HHHHHHHhcCCCc-----cceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc--eEEEEEE
Q 003350 476 FVAVQEATNNFDE-----SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLIGY 548 (828)
Q Consensus 476 ~~~l~~at~~f~~-----~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~ 548 (828)
..++....+.|.. .+.++.|....+|+....++ .+++|+..... ..++...|++++..|.... +.+++..
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 3455555445543 24566676678999876555 57788765432 1234556777777764322 3344332
Q ss_pred E------ccCCcEEEEEEeccCCccccc--------------ccC--CC--C------CCCChhhHHH------------
Q 003350 549 C------DEKNEMILIYEYMENGTLKGH--------------LYG--SG--L------PSLSWKQRLE------------ 586 (828)
Q Consensus 549 ~------~~~~~~~lV~ey~~~gsL~~~--------------l~~--~~--~------~~l~~~~~~~------------ 586 (828)
. ...+..++++||++|..+... +|. .+ . ..-.|.....
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 1 224567899999988654311 111 00 0 0012221111
Q ss_pred HHHHHHHHHHHHHh----cCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 587 ICIGSARGLHYLHT----GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 587 i~~~ia~gL~yLH~----~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
....+.+.++++.. ....+++|+|+++.||+++++....|.||+.+..
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 11223344555543 2357899999999999999987778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.024 Score=62.71 Aligned_cols=139 Identities=16% Similarity=0.204 Sum_probs=81.8
Q ss_pred eEeeeCcEEEEEEEecC-----CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceE-EEEEEEccCCcEEEEEEeccC
Q 003350 491 VIGIGGFGKVYKGELND-----GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV-SLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~ey~~~ 564 (828)
.|-.|-.-.+|+....+ ++.+++|............ .+|..++..+...++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34446677888886532 3678899876654433333 6788888888654443 455655332 58999987
Q ss_pred Cccccc-----------------ccCCCC---C-CCChhhHHHHHHHH-----------------HHHHHHHH----h-c
Q 003350 565 GTLKGH-----------------LYGSGL---P-SLSWKQRLEICIGS-----------------ARGLHYLH----T-G 601 (828)
Q Consensus 565 gsL~~~-----------------l~~~~~---~-~l~~~~~~~i~~~i-----------------a~gL~yLH----~-~ 601 (828)
.+|... +|.... . ..-|.+..++..++ ...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 122110 1 12233333332111 11122222 1 2
Q ss_pred CCCCEEeeeeecCcEEeCC-CCcEEEEeeCCCCC
Q 003350 602 YAKAVIHRDVKSANILLDE-NFMAKVADFGLSKT 634 (828)
Q Consensus 602 ~~~~ivHrDIkp~NILld~-~~~~kl~DFGla~~ 634 (828)
....++|+|+++.|||+++ +..++++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2357899999999999986 46899999988765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.04 Score=58.82 Aligned_cols=32 Identities=28% Similarity=0.547 Sum_probs=26.4
Q ss_pred CCEEeeeeecCcEEeCCCCc-EEEEeeCCCCCC
Q 003350 604 KAVIHRDVKSANILLDENFM-AKVADFGLSKTG 635 (828)
Q Consensus 604 ~~ivHrDIkp~NILld~~~~-~kl~DFGla~~~ 635 (828)
..++|+|+++.|||+++++. .-|.||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 569999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.072 Score=57.55 Aligned_cols=122 Identities=17% Similarity=0.254 Sum_probs=76.6
Q ss_pred CcEEEEEEcC-CCCcccHHHHHHHHHHHHcCCC--CceEEEEEEEccCC--cEEEEEEeccCCcccccccCCCCCCCChh
Q 003350 508 GTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKN--EMILIYEYMENGTLKGHLYGSGLPSLSWK 582 (828)
Q Consensus 508 ~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~ey~~~gsL~~~l~~~~~~~l~~~ 582 (828)
++++++++-. ...........+|.++|+.+.- --....+++|.++. ..+.||+|+++..+...+.... ..
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~-----~~ 122 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPES-----LG 122 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCccc-----ch
Confidence 6777777221 1222334555678888887743 23455677786666 7799999999855544332111 00
Q ss_pred hHHHHH-HHHHHHHHHHH--------------------------------------------------hc-----CCCCE
Q 003350 583 QRLEIC-IGSARGLHYLH--------------------------------------------------TG-----YAKAV 606 (828)
Q Consensus 583 ~~~~i~-~~ia~gL~yLH--------------------------------------------------~~-----~~~~i 606 (828)
.+.+ ..+++.|+-|| .. ....+
T Consensus 123 --~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~l 200 (321)
T COG3173 123 --RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVL 200 (321)
T ss_pred --HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCcee
Confidence 1111 24444444444 21 13569
Q ss_pred EeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 607 IHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 607 vHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+|+|+++.|++++.+.-+-|.||+++....
T Consensus 201 vHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 201 VHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 999999999999998889999999988743
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.036 Score=59.35 Aligned_cols=75 Identities=21% Similarity=0.348 Sum_probs=47.8
Q ss_pred CccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC---CCceEEEEEEEccCCcEEEEEEecc
Q 003350 487 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
...+.++.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+++++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 344578889999999987 5578899998662 22356788888888873 4557788888877777899999998
Q ss_pred CC
Q 003350 564 NG 565 (828)
Q Consensus 564 ~g 565 (828)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.013 Score=41.77 Aligned_cols=33 Identities=24% Similarity=0.529 Sum_probs=20.4
Q ss_pred CCCceeEEeehhHHHHHHHHHHhheeeEEeecc
Q 003350 398 SKKHVGVIVGVTIGVSVAALLAGILFMLCRKRR 430 (828)
Q Consensus 398 ~~~~~~iiigivvgv~vl~ll~~i~~~~~rrrr 430 (828)
.++...|.+|+++.++++++++++++++++||+
T Consensus 7 ~~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 7 NSNTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred CCceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 455677778888777666665554555444443
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.1 Score=57.16 Aligned_cols=72 Identities=21% Similarity=0.290 Sum_probs=46.3
Q ss_pred eEeeeCcEEEEEEEecCC-cEEEEEEcCCC------C-cccHHHHHHHHHHHHcCC--CCceE-EEEEEEccCCcEEEEE
Q 003350 491 VIGIGGFGKVYKGELNDG-TKVAVKRGNPR------S-QQGLAEFQTEIEMLSQFR--HRHLV-SLIGYCDEKNEMILIY 559 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--H~niv-~l~g~~~~~~~~~lV~ 559 (828)
.||.|....||++..++| +.|+||.-.+. + +....+..-|.+.|.... -|..+ +++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 378899999999987754 58999953211 1 233455567777777653 34444 44433 445567899
Q ss_pred EeccC
Q 003350 560 EYMEN 564 (828)
Q Consensus 560 ey~~~ 564 (828)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.21 Score=55.82 Aligned_cols=79 Identities=16% Similarity=0.171 Sum_probs=51.8
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCC----Cc---ccHHHHHHHHHHHHcCC---CCceEEEEEEEccCCcEEEEE
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPR----SQ---QGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 559 (828)
+.||.|..-.||+.... +..++||+-... +. .....-..|.+.|+.+. ..++.+++.+|. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 56899999999998764 556899975421 11 12333445567776653 357778888887 4467889
Q ss_pred EeccC--Ccccccc
Q 003350 560 EYMEN--GTLKGHL 571 (828)
Q Consensus 560 ey~~~--gsL~~~l 571 (828)
|++++ ..+++.+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99976 3454433
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.14 Score=55.86 Aligned_cols=136 Identities=22% Similarity=0.280 Sum_probs=81.9
Q ss_pred CcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc------eEEEEEEE--ccC--CcEEEEEEeccCC
Q 003350 496 GFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH------LVSLIGYC--DEK--NEMILIYEYMENG 565 (828)
Q Consensus 496 ~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~--~~~--~~~~lV~ey~~~g 565 (828)
.--.+|+....+|+. ++|..... ....+...|+..|..|.-.. +..+-|-. .-. ...+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445688888877766 78877665 33466677888887773222 22222211 122 3778899999998
Q ss_pred cccc-cc--------------cC--CC--------CCCCChhh-------------HHHHHHHHHHHHHHHHhc----CC
Q 003350 566 TLKG-HL--------------YG--SG--------LPSLSWKQ-------------RLEICIGSARGLHYLHTG----YA 603 (828)
Q Consensus 566 sL~~-~l--------------~~--~~--------~~~l~~~~-------------~~~i~~~ia~gL~yLH~~----~~ 603 (828)
.+.. .- |. .+ .....|.. ......++...+..+.+. ..
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8873 11 10 00 11244431 112333444445544432 22
Q ss_pred CC---EEeeeeecCcEEeCCCCc-EEEEeeCCCCC
Q 003350 604 KA---VIHRDVKSANILLDENFM-AKVADFGLSKT 634 (828)
Q Consensus 604 ~~---ivHrDIkp~NILld~~~~-~kl~DFGla~~ 634 (828)
.. +||+|+.|.||+++.+.. +.+.||+-+..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 33 999999999999999885 88999998764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.12 Score=56.74 Aligned_cols=139 Identities=17% Similarity=0.215 Sum_probs=78.8
Q ss_pred eEeeeCcEEEEEEEecC----CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceE-EEEEEEccCCcEEEEEEeccCC
Q 003350 491 VIGIGGFGKVYKGELND----GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV-SLIGYCDEKNEMILIYEYMENG 565 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~ey~~~g 565 (828)
.|..|=.-.+|+....+ +..|++|........... -.+|..+++.+..-++. ++++++.. + +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCC
Confidence 34445566788876543 237888987665433222 25788888888655553 45555532 2 589999776
Q ss_pred ccccc-----------------ccCCCC---C-CCChhhHHHHHHHH----------------------HHHHHHHHh--
Q 003350 566 TLKGH-----------------LYGSGL---P-SLSWKQRLEICIGS----------------------ARGLHYLHT-- 600 (828)
Q Consensus 566 sL~~~-----------------l~~~~~---~-~l~~~~~~~i~~~i----------------------a~gL~yLH~-- 600 (828)
.|... +|.... . +--|..+.++..++ .+-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 65321 122110 0 11233332222221 111112111
Q ss_pred ---cCCCCEEeeeeecCcEEeCC-CCcEEEEeeCCCCC
Q 003350 601 ---GYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKT 634 (828)
Q Consensus 601 ---~~~~~ivHrDIkp~NILld~-~~~~kl~DFGla~~ 634 (828)
..+.-++|.|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 12235789999999999974 57899999998765
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.0031 Score=78.00 Aligned_cols=159 Identities=15% Similarity=0.055 Sum_probs=113.1
Q ss_pred HHHHHHHHHcCCCCceEEEEEEE--ccCCcEEEEEEeccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHh--
Q 003350 527 FQTEIEMLSQFRHRHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHT-- 600 (828)
Q Consensus 527 ~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~lV~ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~-- 600 (828)
...|...++...|+++.....-. .+..+.+.+++|+..|.+.+.+.+. +.++++..-+...-.+...+..-+|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 34455556667898877655443 3455678899999999999988653 22344444444444443444555454
Q ss_pred cCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHH
Q 003350 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680 (828)
Q Consensus 601 ~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~el 680 (828)
....-.+|+++|+-|.+|..+..+|++++|+.+.... .........+++-|+.|+....-.++.++|+|..|+.+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2335579999999999999999999999999984322 11223345677789999999888999999999999999999
Q ss_pred HhcCCCC
Q 003350 681 LCARPVI 687 (828)
Q Consensus 681 ltG~~p~ 687 (828)
.-|.+++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887665
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.23 Score=53.94 Aligned_cols=32 Identities=16% Similarity=0.233 Sum_probs=28.9
Q ss_pred CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 603 ~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
..+++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999988765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.043 Score=56.04 Aligned_cols=31 Identities=26% Similarity=0.408 Sum_probs=22.0
Q ss_pred CCEEeeeeecCcEEe-CCCCcEEEEeeCCCCC
Q 003350 604 KAVIHRDVKSANILL-DENFMAKVADFGLSKT 634 (828)
Q Consensus 604 ~~ivHrDIkp~NILl-d~~~~~kl~DFGla~~ 634 (828)
..++|+|+.+.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 467899999999999 8899999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.19 Score=54.54 Aligned_cols=31 Identities=29% Similarity=0.381 Sum_probs=26.6
Q ss_pred CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 603 ~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 368999999999999988 5789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.25 E-value=0.42 Score=60.43 Aligned_cols=141 Identities=18% Similarity=0.268 Sum_probs=79.5
Q ss_pred eEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-------CCCceEEEE-----EEEc-cCC--cE
Q 003350 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-------RHRHLVSLI-----GYCD-EKN--EM 555 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~H~niv~l~-----g~~~-~~~--~~ 555 (828)
.|+ |..-.+|+....+|..+++|+....... .....|.++|..| .-|.+++-. .... ..+ ..
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 453 4456788888778888999998765322 3334455555444 233433321 1111 122 45
Q ss_pred EEEEEeccCCcccccc-----------------c----C----CCCCCCChhh-----------------HHHHHHHHHH
Q 003350 556 ILIYEYMENGTLKGHL-----------------Y----G----SGLPSLSWKQ-----------------RLEICIGSAR 593 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l-----------------~----~----~~~~~l~~~~-----------------~~~i~~~ia~ 593 (828)
+-+++|+++..|.+.. + + .....+.|.. ...++.++.+
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 6789999987775411 0 0 0112244432 1122223332
Q ss_pred HHHH----HHhcCCCCEEeeeeecCcEEeCCCC--cEE-EEeeCCCCC
Q 003350 594 GLHY----LHTGYAKAVIHRDVKSANILLDENF--MAK-VADFGLSKT 634 (828)
Q Consensus 594 gL~y----LH~~~~~~ivHrDIkp~NILld~~~--~~k-l~DFGla~~ 634 (828)
..+- ........+||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 1123457899999999999999875 455 999998764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.26 Score=49.76 Aligned_cols=152 Identities=15% Similarity=0.173 Sum_probs=90.0
Q ss_pred eCcEEEEEEEecCCcEEEEEEcCCCCcc-cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCcccccccC
Q 003350 495 GGFGKVYKGELNDGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG 573 (828)
Q Consensus 495 G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~ 573 (828)
++..+.-+++-+-| +..+|++...... ...-|..+.+++.+++ .|++|.. ......-++.|+|-.
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~--------- 138 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYK--------- 138 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccC---------
Confidence 34444444443333 3455655544333 4566788888888875 4666652 234456678888732
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccc
Q 003350 574 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653 (828)
Q Consensus 574 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y 653 (828)
..... ..++..=.+.|.-.|++. .+.+|+|-.|+||+-|..|.+||.|=+..-. .+.-|
T Consensus 139 -----~~i~~-~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~ 197 (308)
T PF07387_consen 139 -----IKINF-SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNM 197 (308)
T ss_pred -----cccch-hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeE
Confidence 00111 112222246777888643 6899999999999999999999999664321 01112
Q ss_pred cChhhhccCCCCcccceeehhhHHHHHHhcC
Q 003350 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 684 (828)
Q Consensus 654 ~aPE~~~~~~~s~ksDVySfGvvl~elltG~ 684 (828)
.--| ....|+++.+-+|=.-++++....
T Consensus 198 vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 198 VNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred Eeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 2211 234567777777777777776543
|
The function of this family is unknown. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.25 Score=53.59 Aligned_cols=138 Identities=18% Similarity=0.182 Sum_probs=90.5
Q ss_pred cceEeeeCcEEEEEEEecCCcEEEEEEcCCC-------C--------------c----cc-HHHHHHHHHHHHcCCCCce
Q 003350 489 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPR-------S--------------Q----QG-LAEFQTEIEMLSQFRHRHL 542 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~-------~--------------~----~~-~~~~~~E~~~l~~l~H~ni 542 (828)
...|..|--+.||.+.-.+|..+|||+.+.. . . .. .-....|++-|.+++.-.|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3568889999999999989999999964321 0 0 00 1123468888888864443
Q ss_pred EEEEEEEccCCcEEEEEEeccCCccc-ccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC
Q 003350 543 VSLIGYCDEKNEMILIYEYMENGTLK-GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN 621 (828)
Q Consensus 543 v~l~g~~~~~~~~~lV~ey~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~ 621 (828)
...--.. -..-.|||+|+....-. -.| ....++......+-.+++.-|.-|-+. .++||.||.--|+|+-+
T Consensus 229 P~PePIl--Lk~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 229 PCPEPIL--LKNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCCCcee--eecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEEC-
Confidence 2110000 01346899998532211 111 123466677778888888888888774 56999999999999854
Q ss_pred CcEEEEeeCCCCC
Q 003350 622 FMAKVADFGLSKT 634 (828)
Q Consensus 622 ~~~kl~DFGla~~ 634 (828)
|.+.|+|-+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 5899999876654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 828 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-121 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-120 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-39 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-28 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-27 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-24 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-24 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-24 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-24 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-24 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-24 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-20 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-20 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-20 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-20 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-20 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-20 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-20 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-20 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-20 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-19 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 596 bits (1539), Expect = 0.0
Identities = 220/324 (67%), Positives = 257/324 (79%), Gaps = 13/324 (4%)
Query: 454 MGSKYSHGTTTSANSNS--------GYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGEL 505
MGSKYS T + ++ S YR P V ++EATNNFD ++IG G FGKVYKG L
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 506 NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 565
DG KVA+KR P S QG+ EF+TEIE LS RH HLVSLIG+CDE+NEMILIY+YMENG
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 566 TLKGHLYGSGLPS--LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 623
LK HLYGS LP+ +SW+QRLEICIG+ARGLHYLHT A+IHRDVKS NILLDENF+
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV 177
Query: 624 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 683
K+ DFG+SK G E+DQTH+ST VKG+ GY+DPEYF + +LTEKSDVYSFGVVLFEVLCA
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 684 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFG 743
R I +LPREMVNLAEWA++ N GQL+QI+DP LA KIRP+SLRKFG+TA KCLA
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 744 VDRPSMGDVLWNLEYALQLQEAVV 767
DRPSMGDVLW LEYAL+LQE+V+
Sbjct: 298 EDRPSMGDVLWKLEYALRLQESVI 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-132
Identities = 104/306 (33%), Positives = 166/306 (54%), Gaps = 20/306 (6%)
Query: 465 SANSNSGYRFPFVAVQEATNNFDESW------VIGIGGFGKVYKGELNDGTKVAVKR--- 515
+ + F F ++ TNNFDE +G GGFG VYKG + + T VAVK+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 516 -GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG- 573
+ +++ +F EI+++++ +H +LV L+G+ + +++ L+Y YM NG+L L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 574 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
G P LSW R +I G+A G+++LH IHRD+KSANILLDE F AK++DFGL++
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR 693
+ QT +++ + G+ Y+ PE R ++T KSD+YSFGVVL E++ P +D R
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH--R 238
Query: 694 EMVNLAEWAMK-WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV 752
E L + + + ++ ID + S+ A +CL + RP + V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 753 LWNLEY 758
L+
Sbjct: 298 QQLLQE 303
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-126
Identities = 118/290 (40%), Positives = 168/290 (57%), Gaps = 6/290 (2%)
Query: 473 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL-AEFQTEI 531
RF +Q A++NF ++G GGFGKVYKG L DGT VAVKR QG +FQTE+
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 532 EMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICI 589
EM+S HR+L+ L G+C E +L+Y YM NG++ L P L W +R I +
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
GSARGL YLH +IHRDVK+ANILLDE F A V DFGL+K THV+TAV+G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRG 197
Query: 650 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR--EMVNLAEWAMKWQN 707
+ G++ PEY + +EK+DV+ +GV+L E++ + D + V L +W
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
+ +L+ ++D L G + + + + + A C ++RP M +V+ LE
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-83
Identities = 78/326 (23%), Positives = 129/326 (39%), Gaps = 34/326 (10%)
Query: 454 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAV 513
MG + H S+ + G + V G FG V+K +L VAV
Sbjct: 1 MGHHHHH---HSSGVDLGTENL----YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAV 52
Query: 514 KRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMILIYEYMENGTLKG 569
K + +Q + + E+ L +H +++ IG ++ LI + E G+L
Sbjct: 53 KIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD 111
Query: 570 HLYGSGLPSLSWKQRLEICIGSARGLHYLHT-------GYAKAVIHRDVKSANILLDENF 622
L +SW + I ARGL YLH G+ A+ HRD+KS N+LL N
Sbjct: 112 FLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168
Query: 623 MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVL 677
A +ADFGL+ + G+ Y+ PE ++ + D+Y+ G+VL
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228
Query: 678 FEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII-----DPTLAGKIRPDS-LRKF 731
+E+ D + M+ E + + + +++ P L + + +
Sbjct: 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288
Query: 732 GETAEKCLADFGVDRPSMGDVLWNLE 757
ET E+C R S G V +
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 81/295 (27%), Positives = 138/295 (46%), Gaps = 36/295 (12%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
IG G FG V++ E + G+ VAVK + + + EF E+ ++ + RH ++V +G
Sbjct: 44 KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
+ + ++ EY+ G+L L+ SG L ++RL + A+G++YLH ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
HR++KS N+L+D+ + KV DFGLS+ + S + G+ ++ PE R + EK
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 668 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP-- 725
SDVYSFGV+L+E+ + P W N Q++ R
Sbjct: 220 SDVYSFGVILWELATLQ------QP------------WGNLNPA-QVVAAVGFKCKRLEI 260
Query: 726 --DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNL 778
+ + E C + RPS ++ L L ++ V P N ++L
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR---PLIKSAV---PPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 5e-66
Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 34/273 (12%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
V+G G FG V K + VA+K+ S+ F E+ LS+ H ++V L G C
Sbjct: 15 VVGRGAFGVVCKAKWR-AKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC- 70
Query: 551 EKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
N + L+ EY E G+L L+G+ LP + + C+ ++G+ YLH+ KA+IHR
Sbjct: 71 -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 610 DVKSANILLDENFM-AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 668
D+K N+LL K+ DFG + D T KGS ++ PE F +EK
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 669 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP--- 725
DV+S+G++L+EV+ R P + G I + RP
Sbjct: 185 DVFSWGIILWEVITRR------KP------------FDEIGGPAFRIMWAVHNGTRPPLI 226
Query: 726 -DSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
+ + +C + RPSM +++ +
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (553), Expect = 6e-64
Identities = 69/330 (20%), Positives = 122/330 (36%), Gaps = 40/330 (12%)
Query: 482 ATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 541
+N +IG G +G VYKG L+ VAVK + ++Q I + H +
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINE-KNIYRVPLMEHDN 68
Query: 542 LVSLIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 596
+ I D + E +L+ EY NG+L +L + W + RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLA 125
Query: 597 YLHT------GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT------GPEIDQTHVS 644
YLHT Y A+ HRD+ S N+L+ + ++DFGLS ++ + +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 645 TAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 697
+ G+ Y+ PE + ++ D+Y+ G++ +E+ + P
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPD----------SLRKFGETAEKCLADFGVDRP 747
+A + + + K RP ++R ET E C R
Sbjct: 246 MAFQTEVGNH-PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 748 SMGDVLWNLEYALQLQEAVVHGDPDENSTN 777
+ + + + E P + +
Sbjct: 305 TAQXAEERMAELMMIWERNKSVSPTAHHHH 334
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-61
Identities = 87/278 (31%), Positives = 135/278 (48%), Gaps = 37/278 (13%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
IG G FG VYKG+ + VAVK N + Q L F+ E+ +L + RH +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
I + ++ E +L HL+ S K+ ++I +ARG+ YLH AK++IHR
Sbjct: 90 TAPQLAI-VTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL---TE 666
D+KS NI L E+ K+ DFGL+ +H + GS ++ PE R Q +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 667 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 726
+SDVY+FG+VL+E++ + LP + N DQII+ G + PD
Sbjct: 205 QSDVYAFGIVLYELMTGQ------LP------------YSNINNRDQIIEMVGRGSLSPD 246
Query: 727 SLR-------KFGETAEKCLADFGVDRPSMGDVLWNLE 757
+ + +CL +RPS +L +E
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 8e-61
Identities = 55/274 (20%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
+ G+++KG G + VK R S + +F E L F H +++ ++G
Sbjct: 17 KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 549 CDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
C LI +M G+L L+ + Q ++ + ARG+ +LHT +
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-- 664
+ S ++++DE+ A+++ + + S + ++ PE +++
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 665 -TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723
+D++SF V+L+E++ +P ++ E MK +G PT I
Sbjct: 188 NRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLR-----PT----I 232
Query: 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
P + + C+ + RP ++ LE
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 8e-61
Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 43/283 (15%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ----GLAEFQTEIEMLSQFRHRHLVSLI 546
+IGIGGFGKVY+ G +VAVK + + + E ++ + +H ++++L
Sbjct: 14 IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
G C ++ + L+ E+ G L L G + + + ARG++YLH +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 607 IHRDVKSANILLDE--------NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
IHRD+KS+NIL+ + N + K+ DFGL++ E +T +A G++ ++ PE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAPEV 185
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718
R ++ SDV+S+GV+L+E+L +P ++ L +
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE------VP------------FRGIDGL-AVAYGV 226
Query: 719 LAGKIRPDSLR----KFGETAEKCLADFGVDRPSMGDVLWNLE 757
K+ F + E C RPS ++L L
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-60
Identities = 71/252 (28%), Positives = 111/252 (44%), Gaps = 49/252 (19%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKR-------GNPRSQQGLAEFQTEIEMLSQFRHRHL 542
IG GGFG V+KG + D + VA+K G + EFQ E+ ++S H ++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
V L G N ++ E++ G L L P + W +L + + A G+ Y+
Sbjct: 86 VKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 603 AKAVIHRDVKSANILLDE-----NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
++HRD++S NI L AKVADFGLS+ H + + G+F ++ PE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPE 196
Query: 658 YFRRQQL--TEKSDVYSFGVVLFEVLC-----------------------ARPVIDPTLP 692
++ TEK+D YSF ++L+ +L RP I P
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256
Query: 693 REMVNLAE--WA 702
+ N+ E W+
Sbjct: 257 PRLRNVIELCWS 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 5e-58
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 38/282 (13%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
+IG G FG+VY G + +VA++ + ++ L F+ E+ Q RH ++V +G
Sbjct: 40 LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
C + +I + TL + + L + +I +G+ YLH AK ++H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 609 RDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL- 664
+D+KS N+ D + DFGL + G +L PE R+
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 665 --------TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ-NKGQLDQII 715
++ SDV++ G + +E+ P + A+ WQ G +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHARE------WPFK--TQPAEAIIWQMGTGMKPNLS 264
Query: 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
+ + C A +RP+ ++ LE
Sbjct: 265 QIGM-----GKEISDI---LLFCWAFEQEERPTFTKLMDMLE 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 9e-58
Identities = 73/280 (26%), Positives = 114/280 (40%), Gaps = 31/280 (11%)
Query: 491 VIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
V+G G FG+ K + G + +K ++ F E++++ H +++ IG
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+ + I EY++ GTL+G + W QR+ A G+ YLH + +IHR
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 610 DVKSANILLDENFMAKVADFGLSK------------TGPEIDQTHVSTAVKGSFGYLDPE 657
D+ S N L+ EN VADFGL++ + V G+ ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717
+ EK DV+SFG+VL E++ LPR M +G LD+ P
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------NVRGFLDRYCPP 246
Query: 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
P S +C RPS + LE
Sbjct: 247 NC-----PPSFFPI---TVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-56
Identities = 78/319 (24%), Positives = 127/319 (39%), Gaps = 35/319 (10%)
Query: 465 SANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL 524
S +S SG P + + IG G +G+V+ G+ G KVAVK +
Sbjct: 18 SQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA-S 75
Query: 525 AEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMILIYEYMENGTLKGHLYGSGLPSLS 580
+TEI RH +++ I + ++ LI +Y ENG+L +L +L
Sbjct: 76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLD 132
Query: 581 WKQRLEICIGSARGLHYLHT-----GYAKAVIHRDVKSANILLDENFMAKVADFGLS--K 633
K L++ S GL +LHT A+ HRD+KS NIL+ +N +AD GL+
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 634 TGPEIDQTHVSTAVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFEVLCARPVI 687
+ G+ Y+ PE Q +D+YSFG++L+EV
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 688 DPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP---------DSLRKFGETAEKC 738
++ + + + + + K+RP + LR+ G+ +C
Sbjct: 253 GIVEEYQL----PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308
Query: 739 LADFGVDRPSMGDVLWNLE 757
A R + V L
Sbjct: 309 WAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-54
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 39/295 (13%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM--LSQFRHRHLVSLIGY 548
+G G +G+V++G G VAVK + R ++ + E E+ RH +++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIAS 70
Query: 549 C----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT---- 600
++ LI Y E G+L +L +L L I + A GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 601 -GYAKAVIHRDVKSANILLDENFMAKVADFGLS--KTGPEIDQTHVSTAVKGSFGYLDPE 657
A+ HRD+KS NIL+ +N +AD GL+ + + G+ Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 658 ------YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711
++ D+++FG+VL+EV + + N
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP----FYDVVPNDPSF 243
Query: 712 DQIIDPTLAGKIRPD---------SLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
+ + + RP+ +L + ++C R + + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-53
Identities = 63/293 (21%), Positives = 126/293 (43%), Gaps = 35/293 (11%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC- 549
IG G FG+V++G+ G +VAVK + R ++ + EI RH +++ I
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 106
Query: 550 ---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-----TG 601
++ L+ +Y E+G+L +L +++ + +++ + +A GL +LH T
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH--VSTAVKGSFGYLDPE-- 657
A+ HRD+KS NIL+ +N +AD GL+ T G+ Y+ PE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 658 ----YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713
+ + +++D+Y+ G+V +E+ + ++ + + +++
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL----PYYDLVPSDPSVEE 279
Query: 714 IIDPTLAGKIRP---------DSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
+ K+RP ++LR + +C G R + + L
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-44
Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 491 VIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
IG G FG+V+ G L D T VAVK A+F E +L Q+ H ++V LIG
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
C +K + ++ E ++ G L G L K L++ +A G+ YL +K IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 668
RD+ + N L+ E + K++DFG+S+ + + + PE + + +S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 669 DVYSFGVVLFEVL 681
DV+SFG++L+E
Sbjct: 297 DVWSFGILLWETF 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 22/199 (11%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
+G G FG+V+ G N TKVAVK S F E ++ Q +H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
++ I I EYMENG+L L L+ + L++ A G+ ++ + IHRD
Sbjct: 79 QEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVS--------TAVKGSFGYLDPEYFRRQ 662
+++ANIL+ + K+ADFGL++ + + T TA PE
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA---------PEAINYG 185
Query: 663 QLTEKSDVYSFGVVLFEVL 681
T KSDV+SFG++L E++
Sbjct: 186 TFTIKSDVWSFGILLTEIV 204
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-43
Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 10/193 (5%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
+G G FG+V+ G N T+VA+K + S + F E +++ + RH LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 247
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
E+ I + EYM G+L L G L Q +++ A G+ Y+ +H
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 668
RD+++ANIL+ EN + KVADFGL++ + + T K + PE + T KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 669 DVYSFGVVLFEVL 681
DV+SFG++L E+
Sbjct: 363 DVWSFGILLTELT 375
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-42
Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 10/193 (5%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
+G G FG+V+ G N T+VA+K + S + F E +++ + RH LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 330
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
E+ I + EYM G+L L G L Q +++ A G+ Y+ +H
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 668
RD+++ANIL+ EN + KVADFGL++ + + T K + PE + T KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 669 DVYSFGVVLFEVL 681
DV+SFG++L E+
Sbjct: 446 DVWSFGILLTELT 458
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-42
Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 10/194 (5%)
Query: 491 VIGIGGFGKVYKGELND-GTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G G +G+VY+G VAVK + + + EF E ++ + +H +LV L+G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLG 283
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
C + +I E+M G L +L +S L + + + YL K I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
HR++ + N L+ EN + KVADFGLS+ D K + PE + + K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 668 SDVYSFGVVLFEVL 681
SDV++FGV+L+E+
Sbjct: 400 SDVWAFGVLLWEIA 413
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-42
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 22/199 (11%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
+G G FG V G+ VAVK S EF E + + + H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
++ + ++ EY+ NG L +L G L Q LE+C G+ +L + IHRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVS--------TAVKGSFGYLDPEYFRRQ 662
+ + N L+D + KV+DFG+++ + +A PE F
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA---------PEVFHYF 180
Query: 663 QLTEKSDVYSFGVVLFEVL 681
+ + KSDV++FG++++EV
Sbjct: 181 KYSSKSDVWAFGILMWEVF 199
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-42
Identities = 65/199 (32%), Positives = 99/199 (49%), Gaps = 26/199 (13%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC- 549
IG G FG V G+ G KVAVK + F E +++Q RH +LV L+G
Sbjct: 28 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+EK + ++ EYM G+L +L G L L+ + + YL +HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 141
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS-------TAVKGSFGYLDPEYFRRQ 662
D+ + N+L+ E+ +AKV+DFGL+K E T + TA PE R +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTA---------PEALREK 189
Query: 663 QLTEKSDVYSFGVVLFEVL 681
+ + KSDV+SFG++L+E+
Sbjct: 190 KFSTKSDVWSFGILLWEIY 208
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 15/227 (6%)
Query: 491 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FGKV N G +VAVK P +A+ + EIE+L H ++V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 545 LIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
G C E + LI E++ +G+LK +L + ++ KQ+L+ + +G+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG--- 143
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRR 661
++ +HRD+ + N+L++ K+ DFGL+K + + V + PE +
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 662 QQLTEKSDVYSFGVVLFEV--LCARPVIDPTLPREMVNLAEWAMKWQ 706
+ SDV+SFGV L E+ C L +M+ M
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-42
Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 14/226 (6%)
Query: 491 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FG V N G VAVK+ +FQ EI++L +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 546 IGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
G + L+ EY+ +G L+ L L + L +G+ YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---S 145
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQ 662
+ +HRD+ + NIL++ K+ADFGL+K + D V + + PE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 663 QLTEKSDVYSFGVVLFEV--LCARPVIDPTLPREMVNLAEWAMKWQ 706
+ +SDV+SFGVVL+E+ C + M+
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 491 VIGIGGFGKVYKGELNDG----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 545
VIG G FG VY GE D + A+K + Q + F E ++ H ++++L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 546 IGYCDEKNEMILI-YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
IG + + YM +G L + + + K + + ARG+ YL +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLA---EQ 143
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-----DPEYF 659
+HRD+ + N +LDE+F KVADFGL++ +I + + L E
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLAR---DILDREYYSVQQHRHARLPVKWTALESL 200
Query: 660 RRQQLTEKSDVYSFGVVLFEVL 681
+ + T KSDV+SFGV+L+E+L
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELL 222
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 491 VIGIGGFGKVYKGELNDG----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 545
VIG G FG VY G L D AVK N +++F TE ++ F H +++SL
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 546 IGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
+G C + +++ YM++G L+ + + + K + + A+G+ YL +K
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA---SK 147
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-----DPEYF 659
+HRD+ + N +LDE F KVADFGL++ ++ + + L E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 660 RRQQLTEKSDVYSFGVVLFEVL 681
+ Q+ T KSDV+SFGV+L+E++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 67/261 (25%), Positives = 120/261 (45%), Gaps = 18/261 (6%)
Query: 432 LPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWV 491
+ + + N + G+ H ++ N V + ++ + V
Sbjct: 37 ICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV 96
Query: 492 IGIGGFGKVYKGELNDG----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLI 546
IG G FG VY G L D AVK N +++F TE ++ F H +++SL+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 547 GYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
G C + +++ YM++G L+ + + + K + + A+G+ +L +K
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKK 212
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-----DPEYFR 660
+HRD+ + N +LDE F KVADFGL++ ++ + + L E +
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 661 RQQLTEKSDVYSFGVVLFEVL 681
Q+ T KSDV+SFGV+L+E++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELM 290
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-41
Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 6/191 (3%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
+G G FG+V+ N TKVAVK P S + F E ++ +H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
++ I I E+M G+L L + ++ A G+ ++ + IHRD
Sbjct: 254 KEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 309
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 670
+++ANIL+ + + K+ADFGL++ + ++ K + PE T KSDV
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 671 YSFGVVLFEVL 681
+SFG++L E++
Sbjct: 369 WSFGILLMEIV 379
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 26/201 (12%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
+G G FG V G+ VA+K + S+ EF E +++ H LV L G
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
C ++ + +I EYM NG L +L +Q LE+C + YL +K +H
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS--------TAVKGSFGYLDPEYFR 660
RD+ + N L+++ + KV+DFGLS+ + + T + PE
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP---------PEVLM 194
Query: 661 RQQLTEKSDVYSFGVVLFEVL 681
+ + KSD+++FGV+++E+
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIY 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 491 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 544
V+G G FG VYKG VA+K S + E E +++ + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
L+G C + + LI + M G L ++ ++ + L C+ A+G++YL +
Sbjct: 82 LLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
++HRD+ + N+L+ K+ DFGL+K ++ + + K ++ E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 665 TEKSDVYSFGVVLFEVL 681
T +SDV+S+GV ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
IG G FG V+ G + KVA+K R S++ +F E E++ + H LV L G
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 71
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
C E+ + L+ E+ME+G L +L + + L +C+ G+ YL VIH
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIH 127
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY--LDPEYFRRQQLTE 666
RD+ + N L+ EN + KV+DFG+++ + +++ F PE F + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 667 KSDVYSFGVVLFEVL 681
KSDV+SFGV+++EV
Sbjct: 185 KSDVWSFGVLMWEVF 199
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-41
Identities = 64/194 (32%), Positives = 99/194 (51%), Gaps = 16/194 (8%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
IG G FG V G+ G KVAVK + F E +++Q RH +LV L+G
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 551 EKNEMI-LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
E+ + ++ EYM G+L +L G L L+ + + YL +HR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST--AVKGSFGYLDPEYFRRQQLTEK 667
D+ + N+L+ E+ +AKV+DFGL+K E T + VK + PE R ++ + K
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVK----WTAPEALREKKFSTK 366
Query: 668 SDVYSFGVVLFEVL 681
SDV+SFG++L+E+
Sbjct: 367 SDVWSFGILLWEIY 380
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 51/199 (25%), Positives = 81/199 (40%), Gaps = 13/199 (6%)
Query: 491 VIGIGGFGKVYKGELN----DGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G FG V +GE + VAVK + + +F E+ + HR+L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
L G + + E G+L L + A G+ YL +
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---S 139
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQ 662
K IHRD+ + N+LL + K+ DFGL + D + K F + PE + +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 663 QLTEKSDVYSFGVVLFEVL 681
+ SD + FGV L+E+
Sbjct: 200 TFSHASDTWMFGVTLWEMF 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 14/215 (6%)
Query: 491 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FG V N G VAVK+ +++ L +F+ EIE+L +H ++V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 546 IGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
G C + LI EY+ G+L+ +L + + L+ +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---T 132
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQ 662
K IHRD+ + NIL++ K+ DFGL+K P+ + V + + PE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 663 QLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREM 695
+ + SDV+SFGVVL+E+ + P M
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 491 VIGIGGFGKVYKGELNDG----TKVAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSL 545
++G G FG+VY+G + VAVK + +F +E ++ H H+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
IG +E+ I I E G L +L + SL + + + + YL +
Sbjct: 79 IGIIEEEPTWI-IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SIN 133
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQ 663
+HRD+ NIL+ K+ DFGLS+ I+ A ++ PE ++
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSR---YIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 664 LTEKSDVYSFGVVLFEVL 681
T SDV+ F V ++E+L
Sbjct: 191 FTTASDVWMFAVCMWEIL 208
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 67/249 (26%), Positives = 104/249 (41%), Gaps = 22/249 (8%)
Query: 454 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVA 512
MGS + H +S N ++ V + ++ +G GGF V E L+DG A
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVIIDN--KHYLFIQKLGEGGFSYVDLVEGLHDGHFYA 58
Query: 513 VKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMILIYEYMENGTLK 568
+KR QQ E Q E +M F H +++ L+ YC K+E L+ + + GTL
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 569 GHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV 626
+ L+ Q L + +G RGL +H K HRD+K NILL + +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVL 175
Query: 627 ADFGLSKTGP-------EIDQTHVSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVV 676
D G + A + + Y PE F + E++DV+S G V
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 677 LFEVLCARP 685
L+ ++
Sbjct: 236 LYAMMFGEG 244
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 14/215 (6%)
Query: 491 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FG V N G VAVK+ +++ L +F+ EIE+L +H ++V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 546 IGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
G C + + LI EY+ G+L+ +L + + L+ +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---T 163
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQ 662
K IHRD+ + NIL++ K+ DFGL+K P+ + V + + PE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 663 QLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREM 695
+ + SDV+SFGVVL+E+ + P M
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 61/198 (30%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 491 VIGIGGFGKVYKGEL----NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 545
IG G FG V++G N VA+K S +F E + QF H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
IG E I I E G L+ L SL + + L YL +K
Sbjct: 82 IGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKR 136
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQ 663
+HRD+ + N+L+ N K+ DFGLS+ ++ + A KG ++ PE ++
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 664 LTEKSDVYSFGVVLFEVL 681
T SDV+ FGV ++E+L
Sbjct: 194 FTSASDVWMFGVCMWEIL 211
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 17/225 (7%)
Query: 491 VIGIGGFGKVYKGELND-----GTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVS 544
+G G FGKV + G VAVK + Q + ++ EI++L H H++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 545 LIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
G C++ + L+ EY+ G+L+ +L S+ Q L G+ YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH--- 151
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRR 661
A+ IHRD+ + N+LLD + + K+ DFGL+K PE + V + PE +
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 662 QQLTEKSDVYSFGVVLFEV--LCARPVIDPTLPREMVNLAEWAMK 704
+ SDV+SFGV L+E+ C PT E++ +A+ M
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 478 AVQEATNNFDESW-----VIGIGGFGKVYKGEL-----NDGTKVAVK--RGNPRSQQGLA 525
A++ F E+ V+G G FG V+KG + V +K +Q
Sbjct: 2 AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQ 60
Query: 526 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 585
+ + H H+V L+G C + + + +Y+ G+L H+ +L + L
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHR-GALGPQLLL 118
Query: 586 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645
+ A+G++YL ++HR++ + N+LL +VADFG++ P D+ + +
Sbjct: 119 NWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
K ++ E + T +SDV+S+GV ++E++
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-40
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 37/213 (17%)
Query: 491 VIGIGGFGKVYKGELND--------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+G G F K++KG + T+V +K + + F M+S+ H+HL
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
V G C +E IL+ E+++ G+L +L + ++ +LE+ A +H+L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE--- 130
Query: 603 AKAVIHRDVKSANILLD--------ENFMAKVADFGLSKTGPEIDQTHVS---TAVKGSF 651
+IH +V + NILL K++D G+S T D
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP----- 185
Query: 652 GYLDPE---YFRRQQLTEKSDVYSFGVVLFEVL 681
PE + L +D +SFG L+E+
Sbjct: 186 ----PECIENPKN--LNLATDKWSFGTTLWEIC 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 491 VIGIGGFGKVYKGELNDGT-----KVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 544
VIG G FG+VYKG L + VA+K +++ +F E ++ QF H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
L G + M++I EYMENG L L S Q + + G A G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NM 166
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS----------TAVKGSFGYL 654
+HRD+ + NIL++ N + KV+DFGLS+ + + + TA
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA-------- 218
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVL 681
PE ++ T SDV+SFG+V++EV+
Sbjct: 219 -PEAISYRKFTSASDVWSFGIVMWEVM 244
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 491 VIGIGGFGKVYKGELNDG------TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G FGKV+ E ++ VAVK S+ +FQ E E+L+ +H+H+V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHL-------------YGSGLPSLSWKQRLEICIGS 591
G C E +++++EYM +G L L L Q L +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
A G+ YL +HRD+ + N L+ + + K+ DFG+S+ D G
Sbjct: 168 AAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----VGGR 219
Query: 652 GYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
L PE ++ T +SDV+SFGVVL+E+ +P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 491 VIGIGGFGKVYKGELNDG-TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
+G G +G+VY+G VAVK + + + EF E ++ + +H +LV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+ +I E+M G L +L +S L + + + YL K IHR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
D+ + N L+ EN + KVADFGLS+ D K + PE + + KSD
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 670 VYSFGVVLFEVL 681
V++FGV+L+E+
Sbjct: 195 VWAFGVLLWEIA 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 490 WVIGIGGFGKVYKGELNDG------TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G FGKV+ E + VAVK + +FQ E E+L+ +H H+V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICI 589
G C + + +I+++EYM++G L L L Q L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
A G+ YL ++ +HRD+ + N L+ N + K+ DFG+S+ D G
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-----VG 192
Query: 650 SFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
L PE ++ T +SDV+SFGV+L+E+ +P
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 491 VIGIGGFGKVYKGELNDG----TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
++G G FG V + +L KVAVK + + + + EF E + +F H H+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 545 LIGYC------DEKNEMILIYEYMENGTLKGHLYGSGLP----SLSWKQRLEICIGSARG 594
L+G ++I +M++G L L S + +L + + + A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ YL ++ IHRD+ + N +L E+ VADFGLS+ +I +G L
Sbjct: 150 MEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSR---KIYSG--DYYRQGCASKL 201
Query: 655 -----DPEYFRRQQLTEKSDVYSFGVVLFEVL 681
E T SDV++FGV ++E++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)
Query: 492 IGIGGFGKVYKGELNDG---TKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FG V +G VA+K +G ++ E E +++ Q + ++V L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
IG C + M+ + E G L L G + E+ + G+ YL K
Sbjct: 76 IGVCQAEALML-VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KN 130
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS----------TAVKGSFGYLD 655
+HRD+ + N+LL AK++DFGLSK D + + A
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA--------- 181
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVL 681
PE ++ + +SDV+S+GV ++E L
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEAL 207
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 491 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVS 544
V+G G FG VYKG VA+K + + E E +++ + H+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
L+G C + I + M G L ++ ++ + L C+ A+G++YL +
Sbjct: 82 LLGICLTSTVQL-ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
++HRD+ + N+L+ K+ DFGL+K ++ + + K ++ E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 665 TEKSDVYSFGVVLFEVL 681
T +SDV+S+GV ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 491 VIGIGGFGKVYKGEL----NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 545
+IG G G+V G L VA+K +++ +F +E ++ QF H +++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
G +++ EYMENG+L L + Q + + G G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLG 171
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
+HRD+ + N+L+D N + KV+DFGLS+ + D + +T K + PE +
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 665 TEKSDVYSFGVVLFEVL 681
+ SDV+SFGVV++EVL
Sbjct: 232 SSASDVWSFGVVMWEVL 248
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 491 VIGIGGFGKVYKGELNDG----TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
++G G FG V +G L KVAVK + + SQ+ + EF +E + F H +++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 545 LIGYCDEKN-----EMILIYEYMENGTLKGHL----YGSGLPSLSWKQRLEICIGSARGL 595
L+G C E + + ++I +M+ G L +L +G + + L+ + A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL- 654
YL + +HRD+ + N +L ++ VADFGLSK +I +G +
Sbjct: 161 EYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSK---KIYSGDYYR--QGRIAKMP 212
Query: 655 ----DPEYFRRQQLTEKSDVYSFGVVLFEVL 681
E + T KSDV++FGV ++E+
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 491 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 543
+G G FG VY+G T+VA+K N S + EF E ++ +F H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHL--------YGSGLPSLSWKQRLEICIGSARGL 595
L+G + ++I E M G LK +L L S + +++ A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL- 654
YL+ A +HRD+ + N ++ E+F K+ DFG+++ E D KG G L
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLLP 203
Query: 655 ----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
PE + T SDV+SFGVVL+E+ L +P
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 491 VIGIGGFGKVYKGELNDG---TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G FG V KG VAVK + E E ++ Q + ++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
IG C+ ++ M+ + E E G L +L + + K +E+ + G+ YL
Sbjct: 84 IGICEAESWML-VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SN 137
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
+HRD+ + N+LL AK++DFGLSK + + T K + PE +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 665 TEKSDVYSFGVVLFEVL 681
+ KSDV+SFGV+++E
Sbjct: 198 SSKSDVWSFGVLMWEAF 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-39
Identities = 73/293 (24%), Positives = 110/293 (37%), Gaps = 27/293 (9%)
Query: 407 GVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSA 466
+TI ++A L+ G L Q + K + + T S
Sbjct: 303 SLTIAENMADLIDG-YCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSV 361
Query: 467 NSNSGYRFPFVAVQEATNNFDESW-----------VIGIGGFGKVYKGEL----NDGTKV 511
+ Y T + IG G FG V++G N V
Sbjct: 362 SETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAV 421
Query: 512 AVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGH 570
A+K S +F E + QF H H+V LIG E I I E G L+
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSF 480
Query: 571 LYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630
L SL + + L YL +K +HRD+ + N+L+ N K+ DFG
Sbjct: 481 LQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 631 LSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
LS+ ++ + A KG ++ PE ++ T SDV+ FGV ++E+L
Sbjct: 537 LSR---YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 491 VIGIGGFGKVYKGELNDG---TKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSL 545
VIG G FG+V K + A+KR S+ +F E+E+L + H ++++L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICIGS 591
+G C+ + + L EY +G L L S +LS +Q L
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 651
ARG+ YL K IHRD+ + NIL+ EN++AK+ADFGLS+ VK +
Sbjct: 152 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 200
Query: 652 GYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 680
G L E T SDV+S+GV+L+E+
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-39
Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 491 VIGIGGFGKVYKGELNDGTK----VAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 545
V+G G FG+V G L +K VA+K +++ +F E ++ QF H +++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
G + ++++ EYMENG+L L + Q + + G A G+ YL
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMG 167
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
+HRD+ + NIL++ N + KV+DFGL + + + + + K + PE ++
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 665 TEKSDVYSFGVVLFEVL 681
T SDV+S+G+VL+EV+
Sbjct: 228 TSASDVWSYGIVLWEVM 244
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 491 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 543
+G G FG+VY+G+++ +VAVK S+Q +F E ++S+F H+++V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYL 598
IG + ++ E M G LK L S SL+ L + A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 599 HTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL- 654
IHRD+ + N LL +AK+ DFG+++ KG L
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGCAMLP 208
Query: 655 ----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
PE F T K+D +SFGV+L+E+ L P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 67/269 (24%), Positives = 112/269 (41%), Gaps = 36/269 (13%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
IG G F VYKG + +VA + ++ F+ E EML +H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 548 Y----CDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
K ++L+ E M +GTLK +L + + K C +GL +LHT
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147
Query: 602 YAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+IHRD+K NI + K+ D GL+ + + + AV G+ ++ PE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY- 202
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQNKGQLDQIIDPTL 719
++ E DVY+FG+ + E+ + P E N A+ + G D
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEY------PYSECQNAAQI-YRRVTSGVKPASFD--- 252
Query: 720 AGKIRPDSLRKFGETAEKCLADFGVDRPS 748
K+ +++ E C+ +R S
Sbjct: 253 --KVAIPEVKEI---IEGCIRQNKDERYS 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 48/278 (17%)
Query: 443 PVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESW-----------V 491
V+++ +S +M S T+ S++ V E D W
Sbjct: 29 QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKP 88
Query: 492 IGIGGFGKVYKGEL--------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRH 541
+G G FG+V E + VAVK +++ L++ +E+EM+ +H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEI 587
+++L+G C + + +I EY G L+ +L +++K +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
ARG+ YL ++ IHRD+ + N+L+ EN + K+ADFGL++ ID
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYK 260
Query: 648 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 680
K + G L PE + T +SDV+SFGV+++E+
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 36/223 (16%)
Query: 491 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 543
+G FGKVYKG L VA+K + EF+ E + ++ +H ++V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICI 589
L+G + + +I+ Y +G L L + +L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
A G+ YL + V+H+D+ + N+L+ + K++D GL + E+
Sbjct: 136 QIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAA--DYYKLL 187
Query: 650 SFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
L PE + + SD++S+GVVL+EV +P
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 68/267 (25%), Positives = 117/267 (43%), Gaps = 55/267 (20%)
Query: 454 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESW-----------VIGIGGFGKVYK 502
MGS + H + + V E D W +G G FG+V
Sbjct: 1 MGSSHHH---HHHSQDPML----AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVM 53
Query: 503 GEL--------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK 552
E + VAVK +++ L++ +E+EM+ +H+++++L+G C +
Sbjct: 54 AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113
Query: 553 NEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICIGSARGLHYL 598
+ +I EY G L+ +L +++K + ARG+ YL
Sbjct: 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL---- 654
++ IHRD+ + N+L+ EN + K+ADFGL++ ID K + G L
Sbjct: 174 A---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKW 225
Query: 655 -DPEYFRRQQLTEKSDVYSFGVVLFEV 680
PE + T +SDV+SFGV+++E+
Sbjct: 226 MAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 491 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 543
+G G FG+VY+G+++ +VAVK S+Q +F E ++S+F H+++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYL 598
IG + ++ E M G LK L S SL+ L + A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 599 HTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL- 654
IHRD+ + N LL +AK+ DFG+++ KG L
Sbjct: 198 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGCAMLP 249
Query: 655 ----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
PE F T K+D +SFGV+L+E+ L P
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 42/224 (18%)
Query: 491 VIGIGGFGKVYKGEL------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 543
+G G FGKV K T VAVK S L + +E +L Q H H++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHL----------------------YGSGLPSLSW 581
L G C + ++LI EY + G+L+G L +L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 582 KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641
+ ++G+ YL ++HRD+ + NIL+ E K++DFGLS+ E D
Sbjct: 150 GDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED-- 204
Query: 642 HVSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 680
+ VK S G + E T +SDV+SFGV+L+E+
Sbjct: 205 ---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 491 VIGIGGFGKVYKGEL------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 542
+G G FGKV + + KVAVK +E++++S +H ++
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHL------------YGSGLPSLSWKQRLEICIG 590
V+L+G C +++I EY G L L + + S + L
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
A+G+ +L +K IHRDV + N+LL +AK+ DFGL++ D + S +
Sbjct: 173 VAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKG 224
Query: 651 FGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 680
L PE T +SDV+S+G++L+E+
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 53/248 (21%), Positives = 94/248 (37%), Gaps = 36/248 (14%)
Query: 460 HGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGN-- 517
H +S F ++ + IG GG KV++ A+K N
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63
Query: 518 PRSQQGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG 575
Q L ++ EI L++ + ++ L Y + ++ E N L L
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122
Query: 576 LPSLS-------WKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 628
S+ WK LE +H +H ++H D+K AN L+ + M K+ D
Sbjct: 123 --SIDPWERKSYWKNMLE-------AVHTIH---QHGIVHSDLKPANFLIVDG-MLKLID 169
Query: 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPE-----------YFRRQQLTEKSDVYSFGVVL 677
FG++ + V + G+ Y+ PE + +++ KSDV+S G +L
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 678 FEVLCARP 685
+ + +
Sbjct: 230 YYMTYGKT 237
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 491 VIGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 542
+G G FG+V + + VAVK + +E+++L H ++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 543 VSLIGYC-DEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEI 587
V+L+G C +++I E+ + G L +L L+ + +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
A+G+ +L ++ IHRD+ + NILL E + K+ DFGL++ + V
Sbjct: 154 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYV 205
Query: 648 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 680
+ L PE + T +SDV+SFGV+L+E+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
IG G FGK + DG + +K + S + E + E+ +L+ +H ++V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
+E + ++ +Y E G L + Q L+ + L ++H + ++
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKIL 147
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
HRD+KS NI L ++ ++ DFG+++ ++ A G+ YL PE + K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYNNK 205
Query: 668 SDVYSFGVVLFEVLCARP 685
SD+++ G VL+E+ +
Sbjct: 206 SDIWALGCVLYELCTLKH 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 491 VIGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 542
+G G FGKV + VAVK P +E+++LS H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHL----------------YGSGLPSLSWKQRLE 586
V+L+G C ++I EY G L L +L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 587 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 646
A+G+ +L +K IHRD+ + NILL + K+ DFGL++ V
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 647 ----VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680
VK ++ PE T +SDV+S+G+ L+E+
Sbjct: 207 ARLPVK----WMAPESIFNCVYTFESDVWSYGIFLWEL 240
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKR---GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
IG G F +VY+ L DG VA+K+ + + A+ EI++L Q H +++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 547 GYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
E NE+ ++ E + G L + + + + + + L ++H ++
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA--VKGSFGYLDPEYFRRQ 662
V+HRD+K AN+ + + K+ D GL + + + A + G+ Y+ PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGR----FFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 663 QLTEKSDVYSFGVVLFEVLCARP 685
KSD++S G +L+E+ +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQS 234
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-36
Identities = 59/265 (22%), Positives = 105/265 (39%), Gaps = 31/265 (11%)
Query: 437 HSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDE-------- 488
+ ++ +G S + PF +E +
Sbjct: 280 PQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI 339
Query: 489 -SWVIGIGGFGKVYKGEL---NDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRH 541
+G G FG V +G VA+K +G ++ E E +++ Q + +
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPY 397
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+V LIG C + M+ + E G L L G + E+ + G+ YL
Sbjct: 398 IVRLIGVCQAEALML-VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE- 454
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-----VKGSFGYLDP 656
K +HR++ + N+LL AK++DFGLSK D + + + +K + P
Sbjct: 455 --KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAP 508
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVL 681
E ++ + +SDV+S+GV ++E L
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 36/217 (16%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRH--RHLVSLI 546
IG GG KV++ A+K N Q L ++ EI L++ + ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLH 599
Y + ++ E N L L S+ WK LE +H +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLE-------AVHTIH 172
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-- 657
++H D+K AN L+ + M K+ DFG++ + V + G+ Y+ PE
Sbjct: 173 ---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 658 ---------YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ +++ KSDV+S G +L+ + +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 65/287 (22%), Positives = 117/287 (40%), Gaps = 48/287 (16%)
Query: 484 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+F E +IG GGFG+V+K + DG +KR ++ + + E++ L++ H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 543 VSLIGY----------------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE 586
V G + + + E+ + GTL+ + L LE
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 587 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 646
+ +G+ Y+H+ K +I+RD+K +NI L + K+ DFGL + + T
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTR 180
Query: 647 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706
KG+ Y+ PE Q ++ D+Y+ G++L E+L E
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKF----FTDL 231
Query: 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
G + I D ++ K L+ DRP+ ++L
Sbjct: 232 RDGIISDIFDKKEKTLLQ------------KLLSKKPEDRPNTSEIL 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 36/217 (16%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRH--RHLVSLI 546
IG GG KV++ A+K N Q L ++ EI L++ + ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLH 599
Y + ++ E N L L S+ WK LE +H +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLE-------AVHTIH 125
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-- 657
++H D+K AN L+ + M K+ DFG++ + V + G+ Y+ PE
Sbjct: 126 ---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 658 ---------YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ +++ KSDV+S G +L+ + +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 42/224 (18%)
Query: 491 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 542
V+G G FGKV +VAVK + +E++M++Q H ++
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHL---------------------YGSGLPSLSW 581
V+L+G C + LI+EY G L +L L L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 582 KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641
+ L A+G+ +L K+ +HRD+ + N+L+ + K+ DFGL++ D
Sbjct: 172 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIM 223
Query: 642 HVSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 680
S V L PE T KSDV+S+G++L+E+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 44/231 (19%)
Query: 491 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 543
IG G FG+V++ T VAVK S A+FQ E ++++F + ++V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHL----------------------YGSGLPSLSW 581
L+G C M L++EYM G L L G P LS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 582 KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641
++L I A G+ YL + +HRD+ + N L+ EN + K+ADFGLS+ D
Sbjct: 174 AEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-- 228
Query: 642 HVSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 685
+ PE + T +SDV+++GVVL+E+ +P
Sbjct: 229 ---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 40/231 (17%)
Query: 483 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 541
++F+E V+G G FG+V K D A+K+ +++ L+ +E+ +L+ H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 542 LVSLIG-YCDEKNEMIL---------IY---EYMENGTLKGHLYGSGLPS---LSWKQRL 585
+V + + +N + ++ EY ENGTL ++ L W+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 586 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK------------ 633
+I L Y+H ++ +IHRD+K NI +DE+ K+ DFGL+K
Sbjct: 124 QIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 634 -TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLC 682
++++A+ G+ Y+ E EK D+YS G++ FE++
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 13/205 (6%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
IG G +G+ K +DG + K + ++ +E+ +L + +H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 548 -YCDEKNEMILIY-EYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHT--G 601
D N + I EY E G L + L + L + L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFR 660
V+HRD+K AN+ LD K+ DFGL++ + T V G+ Y+ PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GTPYYMSPEQMN 189
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
R EKSD++S G +L+E+ P
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMP 214
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-36
Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 48/263 (18%)
Query: 458 YSHGTTTSANSNSGYRFPFVAVQEATNNFDESW-----------VIGIGGFGKVYKGEL- 505
+ H N ++ V E D W +G G FG+V E
Sbjct: 32 HHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAI 91
Query: 506 -------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMI 556
N TKVAVK +++ L++ +E+EM+ +H+++++L+G C + +
Sbjct: 92 GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 151
Query: 557 LIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
+I EY G L+ +L + LS K + ARG+ YL
Sbjct: 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--- 208
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-----DPE 657
+K IHRD+ + N+L+ E+ + K+ADFGL++ ID K + G L PE
Sbjct: 209 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPE 263
Query: 658 YFRRQQLTEKSDVYSFGVVLFEV 680
+ T +SDV+SFGV+L+E+
Sbjct: 264 ALFDRIYTHQSDVWSFGVLLWEI 286
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 59/244 (24%), Positives = 91/244 (37%), Gaps = 19/244 (7%)
Query: 449 GNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG-ELND 507
+ S S S P +F +G G +G+V+K D
Sbjct: 22 SMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKED 81
Query: 508 GTKVAVKRGN--PRSQQGLAEFQTEIEMLSQ-FRHRHLVSLIGYCDEKNEMILIYEYMEN 564
G AVKR R + A E+ + +H V L +E + L E
Sbjct: 82 GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG- 140
Query: 565 GTLKGHL--YGSGLP-SLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN 621
+L+ H +G+ LP + W + L +LH+ + ++H DVK ANI L
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTL----LALAHLHS---QGLVHLDVKPANIFLGPR 193
Query: 622 FMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 681
K+ DFGL E+ +G Y+ PE + +DV+S G+ + EV
Sbjct: 194 GRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELL-QGSYGTAADVFSLGLTILEVA 249
Query: 682 CARP 685
C
Sbjct: 250 CNME 253
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 28/225 (12%)
Query: 484 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRH 541
+F+ +G GGFG V++ + D A+KR P + + E++ L++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 542 LVSLIGYCDEKNEM---------ILIY---EYMENGTLKGHL-YGSGLPSLSWKQRLEIC 588
+V EKN + +Y + LK + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 589 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----------TGPEI 638
+ A + +LH +K ++HRD+K +NI + + KV DFGL +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 683
T G+ Y+ PE + K D++S G++LFE+L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 46/220 (20%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVK-----------------RGNPRSQQGLAEFQTEIEM 533
+ G F K+ E D A+K + +F+ E+++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 534 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-- 591
++ ++ + ++ G +E+ +IYEYMEN ++ + ++ + I +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 592 ----ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
Y+H K + HRDVK +NIL+D+N K++DFG S+ + + +
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIKGSR 211
Query: 648 KGSFGYLDPEYFRRQQLT--EKSDVYSFGVVLFEVLCARP 685
G++ ++ PE+F + K D++S G+ L+ +
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 68/251 (27%), Positives = 112/251 (44%), Gaps = 33/251 (13%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G GGFG V + + G +VA+K +P++++ EI+++ + H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHPNVVSA 77
Query: 546 IGYCDEKNEM------ILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEI--CIGSARGLH 596
D ++ +L EY E G L+ +L L + I SA L
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LR 135
Query: 597 YLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
YLH +IHRD+K NI+L + + K+ D G +K E+DQ + T G+ Y
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGTLQY 189
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713
L PE +++ T D +SFG + FE + P LP +W K + K
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFR---PFLPNW--QPVQWHGKVREKSNEHI 244
Query: 714 IIDPTLAGKIR 724
++ L G ++
Sbjct: 245 VVYDDLTGAVK 255
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
V+G G +G VY G +L++ ++A+K R + EI + +H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87
Query: 550 DEKNEMILIY-EYMENGTLKG---HLYGSGLPSLSW-----KQRLEICIGSARGLHYLHT 600
+N I I+ E + G+L +G + KQ LE GL YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLH- 139
Query: 601 GYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
++HRD+K N+L++ + + K++DFG SK I+ + G+ Y+ PE
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195
Query: 660 RRQQL--TEKSDVYSFGVVLFEVLCARP 685
+ + +D++S G + E+ +P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 34/240 (14%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G GG VY E KVA+K ++ L F+ E+ SQ H+++VS+I
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
+E + L+ EY+E TL ++ G LS + G+ + H ++
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIV 133
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
HRD+K NIL+D N K+ DFG++K E T + + G+ Y PE + + E
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEATDEC 192
Query: 668 SDVYSFGVVLFEVLCARP------------------------VIDPTLPREMVNLAEWAM 703
+D+YS G+VL+E+L P + +P+ + N+ A
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRAT 252
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 45/214 (21%), Positives = 84/214 (39%), Gaps = 27/214 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGY 548
++G G V++G G A+K N S + E E+L + H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 549 --CDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEI--CIGSARGLHYLHTGYA 603
+LI E+ G+L L L + L + + +++L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLR---E 130
Query: 604 KAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
++HR++K NI+ D + K+ DFG ++ E++ ++ G+ YL P+ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPDMY 187
Query: 660 RRQQL--------TEKSDVYSFGVVLFEVLCARP 685
R L D++S GV +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 61/286 (21%), Positives = 98/286 (34%), Gaps = 52/286 (18%)
Query: 491 VIGIGGFGKVYKGELND---GTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVS 544
++G GG G VY+ E D VA+K + Q E + + H+V
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
+ + + ++ + + L L G L+ + + I L H A
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH---AA 153
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
HRDVK NIL+ + A + DFG++ + T + V G+ Y+ PE F
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHA 212
Query: 665 TEKSDVYSFGVVLFEVLCARP----------------------VIDPTLPREMVNLAEWA 702
T ++D+Y+ VL+E L P + P +P +
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARG 272
Query: 703 M-KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP 747
M K +P R + A LA DR
Sbjct: 273 MAK-----------NPED----RYVTCGDLSAAAHAALATADQDRA 303
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 484 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAE-FQTEIEMLSQFRH 539
+F+ +G G FG VY E +A+K + G+ + E+E+ S RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LP-SLSWKQRLEICIGSARGLHY 597
+++ L GY + + LI EY GT+ L + E+ L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA----NALSY 124
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
H +K VIHRD+K N+LL K+ADFG S P G+ YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLC--GTLDYLPPE 177
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ EK D++S GV+ +E L +P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+G GGF K ++ + + A K + + R + EI + H+H+
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-----MSMEISIHRSLAHQHV 77
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSAR-------- 593
V G+ ++ + + ++ E +L ++ L E AR
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLELH--------KRRKALTEP---EARYYLRQIVL 126
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
G YLH VIHRD+K N+ L+E+ K+ DFGL+ T E D G+ Y
Sbjct: 127 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLC-GTPNY 181
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ PE ++ + + DV+S G +++ +L +P
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 45/214 (21%), Positives = 84/214 (39%), Gaps = 27/214 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGY 548
++G G V++G G A+K N S + E E+L + H+++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 549 --CDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEI--CIGSARGLHYLHTGYA 603
+LI E+ G+L L L + L + + +++L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLR---E 130
Query: 604 KAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
++HR++K NI+ D + K+ DFG ++ E++ ++ G+ YL P+ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPDMY 187
Query: 660 RRQQL--------TEKSDVYSFGVVLFEVLCARP 685
R L D++S GV +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 41/248 (16%)
Query: 490 WVIGIGGFGKVYKGELND---GTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLV 543
++G GG +V+ D VAVK R F+ E + + H +V
Sbjct: 18 EILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 544 SLIGYCDEKNEMILIY----EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
++ + + + EY++ TL+ ++ G ++ K+ +E+ + + L++ H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH 133
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST-AVKGSFGYLDPEY 658
+IHRDVK ANI++ KV DFG+++ + + T AV G+ YL PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARP-----------------------VIDPTLPREM 695
R + +SDVYS G VL+EVL P L ++
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 250
Query: 696 VNLAEWAM 703
+ A+
Sbjct: 251 DAVVLKAL 258
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+G GGF K ++ + + A K + + R + EI + H+H+
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-----MSMEISIHRSLAHQHV 103
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSAR-------- 593
V G+ ++ + + ++ E +L ++ L E AR
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELH--------KRRKALTEP---EARYYLRQIVL 152
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
G YLH VIHRD+K N+ L+E+ K+ DFGL+ T E D G+ Y
Sbjct: 153 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLC-GTPNY 207
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ PE ++ + + DV+S G +++ +L +P
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 484 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQ---QGLAE-FQTEIEMLSQFR 538
++FD +G G FG VY E + +A+K +SQ +G+ + EIE+ S R
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLR 72
Query: 539 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LP-SLSWKQRLEICIGSARGLH 596
H +++ + Y ++ + L+ E+ G L L G S E+ A LH
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALH 128
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656
Y H + VIHRD+K N+L+ K+ADFG S P + G+ YL P
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMC---GTLDYLPP 181
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
E + EK D++ GV+ +E L P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 52/261 (19%), Positives = 99/261 (37%), Gaps = 29/261 (11%)
Query: 437 HSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGG 496
HS A + + + G++ + +E + +G G
Sbjct: 11 HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGS 70
Query: 497 FGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEF-QTEIEMLSQFRHRHLVSLIGYCDEKNE 554
FG+V++ + G + AVK + L F E+ + +V L G +
Sbjct: 71 FGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVACAGLSSPRIVPLYG-AVREGP 123
Query: 555 MILIY-EYMENGTLKGHL--YGS---GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
+ I+ E +E G+L + G Q LE GL YLH + ++H
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLH---TRRILH 173
Query: 609 RDVKSANILLDEN-FMAKVADFGLSK--TGPEIDQTHVST-AVKGSFGYLDPEYFRRQQL 664
DVK+ N+LL + A + DFG + + ++ ++ + G+ ++ PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 665 TEKSDVYSFGVVLFEVLCARP 685
K D++S ++ +L
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCH 254
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 24/218 (11%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGY 548
V+ GGF VY+ + + G + A+KR ++ E+ + + H ++V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 549 C-------DEKNEMILIYEYMENGTLKGHLYGSGLP-SLSWKQRLEICIGSARGLHYLHT 600
D L+ + G L L LS L+I + R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVK-------GS 650
+IHRD+K N+LL K+ DFG + T P+ + A+ +
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 651 FGYLDPE---YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
Y PE + + EK D+++ G +L+ + +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 35/231 (15%), Positives = 69/231 (29%), Gaps = 23/231 (9%)
Query: 475 PFVAVQEATNNFDESWVIGIGGFGKVYKGE------LNDGTKVAVKRGNPRSQQGLAEFQ 528
P Q + ++G G F +VY+ + K +K P +
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 529 TEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS---LSWKQRL 585
+E L + +N +L+ E GTL + + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 586 EICIGSARGLHYLHTGYAKAVIHRDVKSANILL-----------DENFMAKVADFGLSKT 634
+ + +H +IH D+K N +L D + + D G S
Sbjct: 176 SFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ + TA + G+ E + + D + ++ +L
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+G G F VY+ ++ G +VA+K + + Q E+++ Q +H +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-----VQNEVKIHCQLKHPSI 73
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR---LEICIGSARGLHYLH 599
+ L Y ++ N + L+ E NG + +L P + R +I G+ YLH
Sbjct: 74 LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGMLYLH 129
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ ++HRD+ +N+LL N K+ADFGL+ T ++ T G+ Y+ PE
Sbjct: 130 ---SHGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLC-GTPNYISPEIA 184
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARP 685
R +SDV+S G + + +L RP
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-30
Identities = 49/214 (22%), Positives = 82/214 (38%), Gaps = 30/214 (14%)
Query: 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLV 543
+F V+G G G + + D VAVKR P E+++L + H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 544 SLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
++ + E TL K + P +Q GL +
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTS-------GLAH 133
Query: 598 LHTGYAKAVIHRDVKSANILLDE-----NFMAKVADFGLSK-TGPEIDQTHVSTAVKGSF 651
LH + ++HRD+K NIL+ A ++DFGL K + V G+
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 652 GYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLC 682
G++ PE + T D++S G V + V+
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-30
Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 27/205 (13%)
Query: 491 VIGIGGFGKVYKGE---LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
I GG G +Y + +G V +K + + A E + L++ H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 546 --IGYCDEKNEMILIY---EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 600
+++ + Y EY+ +LK L + + + L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH- 199
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ +++ D+K NI+L E K+ D G I+ + G+ G+ PE R
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR---INSF---GYLYGTPGFQAPEIVR 250
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
T +D+Y+ G L + P
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLP 274
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 42/143 (29%), Positives = 73/143 (51%), Gaps = 5/143 (3%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
+G G FGKVYK G A K +S++ L ++ EIE+L+ H ++V L+G
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
++ ++ E+ G + + L+ Q +C L++LH +K +IHR
Sbjct: 86 YHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHR 141
Query: 610 DVKSANILLDENFMAKVADFGLS 632
D+K+ N+L+ ++ADFG+S
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVS 164
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 37/221 (16%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYC 549
++G G G V G VAVKR EI++L++ H +++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVIRYYCSE 78
Query: 550 DEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
+ + E L ++ L + + A G+ +LH +
Sbjct: 79 TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134
Query: 605 AVIHRDVKSANILLD-------------ENFMAKVADFGLSK---TGPEIDQTHVSTAVK 648
+IHRD+K NIL+ EN ++DFGL K +G +T+++
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS- 193
Query: 649 GSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLC 682
G+ G+ PE +++LT D++S G V + +L
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 486 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
+ IG G G VY ++ G +VA+++ N + Q EI ++ + ++ ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
+ +E+ ++ EY+ G+L + + Q +C + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT-DVVTET--CMDEGQIAAVCRECLQALEFLH---SN 135
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVKGSFGYLDPEYFRRQ 662
VIHRD+KS NILL + K+ DFG +I ST V G+ ++ PE R+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 663 QLTEKSDVYSFGVVLFE 679
K D++S G++ E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 45/201 (22%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
+G G FG V++ E G K N + EI +++Q H L++L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 550 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
++K EM+LI E++ G L + + +Q E GL ++H
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMH---E 167
Query: 604 KAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
+++H D+K NI+ + K+ DFGL+ +++ + + + PE R
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDR 224
Query: 662 QQLTEKSDVYSFGVVLFEVLC 682
+ + +D+++ GV+ + +L
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLS 245
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
V+G G F +V+ + G A+K + + EI +L + +H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 550 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
+ L+ + + G L +G Y SL +Q L + YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGV-YTEKDASLVIQQVLS-------AVKYLH---E 124
Query: 604 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
++HRD+K N+L +EN + DFGLSK ++Q + + G+ GY+ PE
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVLA 180
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
++ ++ D +S GV+ + +LC P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYP 205
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 486 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
D IG G G V E + G +VAVK + R QQ E+ ++ ++H ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
+ E+ ++ E+++ G L + L+ +Q +C + L YLH A+
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT-DIVSQV--RLNEEQIATVCEAVLQALAYLH---AQ 160
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVKGSFGYLDPEYFRRQ 662
VIHRD+KS +ILL + K++DFG +I + + V G+ ++ PE R
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLV-GTPYWMAPEVISRS 216
Query: 663 QLTEKSDVYSFGVVLFE 679
+ D++S G+++ E
Sbjct: 217 LYATEVDIWSLGIMVIE 233
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 22/231 (9%), Positives = 48/231 (20%), Gaps = 44/231 (19%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
+ +G V+ ++ A+K G S+ L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 547 GYC--------------------------DEKNEMILIYEYM--ENGTLKGHL--YGSGL 576
+L+ + L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 577 PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636
+ R L +K ++H N+ + + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 637 EIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARP 685
Y E+ T + + G+ ++ V C
Sbjct: 246 TRGPASSVPV-----TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 46/229 (20%), Positives = 82/229 (35%), Gaps = 35/229 (15%)
Query: 483 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQ-FR 538
T F E IG G FG V+K + DG A+KR E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 539 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLH 596
H H+V E + M++ EY G+L + + + ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 597 YLHTGYAKAVIHRDVKSANILLDEN-------------------FMAKVADFGLSKTGPE 637
Y+H + +++H D+K +NI + M K+ D G
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182
Query: 638 IDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARP 685
+ +G +L E + K+D+++ + + A P
Sbjct: 183 --RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 32/228 (14%)
Query: 475 PFVAVQEATNNFDESW----VIGIGGFGKVYKG-ELNDGTKVAVK---RGNPRSQQGLAE 526
P + VQ +T F + + V+G G FG+V + G + AVK + + +
Sbjct: 13 PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 527 FQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLS 580
E+++L Q H +++ L + ++K L+ E G L + S
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--------FS 124
Query: 581 WKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPE 637
I G+ Y+H ++HRD+K N+LL ++ ++ DFGLS
Sbjct: 125 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---H 178
Query: 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ + G+ Y+ PE EK DV+S GV+L+ +L P
Sbjct: 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 30/235 (12%), Positives = 67/235 (28%), Gaps = 44/235 (18%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFR-------- 538
V+G + G V + + + E+ L R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 539 --------------HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL---------YGSG 575
+I ++ +M ++ + ++ +L + S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 576 LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635
SL RL++ + R L LH ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQ-----LTEKSDVYSFGVVLFEVLCARP 685
+ + Q +T D ++ G+ ++ + CA
Sbjct: 262 GASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 483 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 541
FD +G G +G VYK G VA+K+ S L E EI ++ Q H
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+V G + ++ ++ EY G++ + +L+ + I + +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHF- 143
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVKGSFGYLDPEYF 659
IHRD+K+ NILL+ AK+ADFG++ ++ T +T + G+ ++ PE
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 660 RRQQLTEKSDVYSFGVVLFE 679
+ +D++S G+ E
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 36/241 (14%), Positives = 74/241 (30%), Gaps = 55/241 (22%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK----------------------------RGNPRSQ 521
V+G + + G V N +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 522 QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM--ILIYEYME--NGTLKGHL--YGSG 575
+ F +++ + + ++ + + + +Y M+ T L + S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 576 LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635
SL RL++ + R L LH ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 636 PEIDQTHVSTAVKGSFGYLDPEYF-----------RRQQLTEKSDVYSFGVVLFEVLCAR 684
+ S G+ PE RR +T D ++ G+V++ + CA
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 685 P 685
Sbjct: 311 L 311
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G G +G+V + + A+K S ++ E+ +L H +++ L
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
+ ++K L+ E + G L + + I G+ YLH ++
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH---KHNIV 158
Query: 608 HRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
HRD+K N+LL +++ + K+ DFGLS + G+ Y+ PE R+ +
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYYIAPEVLRK-KY 214
Query: 665 TEKSDVYSFGVVLFEVLCARP 685
EK DV+S GV+LF +L P
Sbjct: 215 DEKCDVWSIGVILFILLAGYP 235
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 43/205 (20%), Positives = 76/205 (37%), Gaps = 25/205 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
IG G +G+V + + A K+ + + F+ EIE++ H +++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 550 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
++ ++ L+ E G L K I + Y H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV--------FRESDAARIMKDVLSAVAYCH---K 124
Query: 604 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
V HRD+K N L + K+ DFGL+ + G+ Y+ P+
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVLE 181
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
+ D +S GV+++ +LC P
Sbjct: 182 G-LYGPECDEWSAGVMMYVLLCGYP 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 36/216 (16%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRH 541
+G G G+V E KVA++ G+ R +TEIE+L + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGL 595
++ + + D ++ ++ E ME G L L +
Sbjct: 202 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--------LKEATCKLYFYQMLLAV 252
Query: 596 HYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 652
YLH +IHRD+K N+LL +E+ + K+ DFG SK + +T + + G+
Sbjct: 253 QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPT 306
Query: 653 YLDPE---YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
YL PE D +S GV+LF L P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 38/218 (17%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK-------------RGNPRSQQGLAEFQTEIEMLSQ 536
+G G +G+V E N ++ A+K N ++ E EI +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 537 FRHRHLVSLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIG 590
H +++ L ++K L+ E+ E G L + I
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--------FDECDAANIMKQ 154
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAV 647
G+ YLH ++HRD+K NILL + K+ DFGLS + +
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDR 208
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
G+ Y+ PE ++ + EK DV+S GV+++ +LC P
Sbjct: 209 LGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 14/193 (7%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
IG G FG+V+KG + VA+K + ++ + + Q EI +LSQ ++ G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
+ ++ +I EY+ G+ L G L Q I +GL YLH+ + IH
Sbjct: 89 YLKDTKLWIIMEYLGGGSAL-DLLEPG--PLDETQIATILREILKGLDYLHS---EKKIH 142
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVKGSFGYLDPEYFRRQQLTE 666
RD+K+AN+LL E+ K+ADFG++ ++ T + +T V G+ ++ PE ++
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 198
Query: 667 KSDVYSFGVVLFE 679
K+D++S G+ E
Sbjct: 199 KADIWSLGITAIE 211
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 42/219 (19%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRH 541
+G G G+V E KVA+K G+ R +TEIE+L + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIGSA 592
++ + + D ++ ++ E ME G L L + Q L
Sbjct: 77 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLY----FYQMLL------ 125
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
+ YLH +IHRD+K N+LL +E+ + K+ DFG SK + +T + + G
Sbjct: 126 -AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCG 178
Query: 650 SFGYLDPE---YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ YL PE D +S GV+LF L P
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 485 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
++ ++G G FG+V+K E G K+A K R + E + EI +++Q H +L+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 544 SLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
L + KN+++L+ EY++ G L + + L KQ E G+ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------GIRH 202
Query: 598 LHTGYAKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
+H ++H D+K NIL + K+ DFGL++ G+ +L
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNFGTPEFLA 256
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVLC 682
PE ++ +D++S GV+ + +L
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLS 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 26/207 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G G F V + G + A K N + S + + + E + + +H ++V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 548 YCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
E++ L+++ + G L + S + Y H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREF--------YSEADASHCIQQILESIAYCH-- 122
Query: 602 YAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
+ ++HR++K N+LL + K+ADFGL+ E++ + G+ GYL PE
Sbjct: 123 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEV 178
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARP 685
++ ++ D+++ GV+L+ +L P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 39/207 (18%), Positives = 73/207 (35%), Gaps = 33/207 (15%)
Query: 493 GIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRHLVSLIGYC 549
G V G V V+R N + + Q E+ + F H ++V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPS-LSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
NE+ ++ +M G+ K L + ++ I G + L Y+H +H
Sbjct: 96 IADNELWVVTSFMAYGSAK-DLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVH 151
Query: 609 RDVKSANILLDENFMAKVADFGLS----------KTGPEIDQTHVST----AVKGSFGYL 654
R VK+++IL+ + ++ + + + + V +
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS-------- 203
Query: 655 DPEYFRRQQL--TEKSDVYSFGVVLFE 679
PE ++ KSD+YS G+ E
Sbjct: 204 -PEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 28/185 (15%), Positives = 56/185 (30%), Gaps = 24/185 (12%)
Query: 207 FETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAP 266
+ + VN GG D + D + +P
Sbjct: 4 DKVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRASDYGMKLPI-------LRSNPED 53
Query: 267 NTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSW 326
+Y T + ++ + +Y++ F ++ Q F+V ++
Sbjct: 54 QVLYQTERYNED--------SFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGH 105
Query: 327 IAVRDLDLSTYSTNTLAAAYYID------MVTVQTASSKLRISIGRSTLHDTYPDAILNG 380
V+DLD+ ++ A I ++VQ S + + Y + +
Sbjct: 106 TVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCA 165
Query: 381 LEIMK 385
L IMK
Sbjct: 166 LFIMK 170
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 25/168 (14%), Positives = 52/168 (30%), Gaps = 22/168 (13%)
Query: 34 YLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTGS 93
+ ++ G ++ V + D + + + ++ D LYQT R S
Sbjct: 8 WAVNAGGESHVDVHGIHYRKDPLEGRV-GRASDYGMKLPILRSNPEDQVLYQTERYNEDS 66
Query: 94 SKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNV------F 147
Y I G + + L F + + F V N H ++ + + V
Sbjct: 67 FGYDIPIKEEGEYVLVLKFAEVYFAQSQ--QKVFDVRVNGHTVVKDLDIFDRVGHSTAHD 124
Query: 148 KEFSVNVTSDSLDVIFSPSNNS-------------FAFINALEVVSVP 182
+ +++ L V S + + AL ++
Sbjct: 125 EIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKGT 172
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
IG G F KV + G +VA+K + NP S Q L E+ ++ H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL---FREVRIMKILNHPNIVKL 79
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC--IGSARGLHYLHTGYA 603
+ + + LI EY G + +L G + K+ I SA + Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSA--VQYCH---Q 132
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
K ++HRD+K+ N+LLD + K+ADFG S + G+ Y PE F+ ++
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAPELFQGKK 189
Query: 664 LT-EKSDVYSFGVVLFEVLCAR-PVIDPTLP 692
+ DV+S GV+L+ ++ P L
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-27
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 27/207 (13%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
++G G FG+V K + + AVK N + + E+E+L + H +++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 548 YCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
++ + ++ E G L + S I G+ Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR--------FSEHDAARIIKQVFSGITYMH-- 138
Query: 602 YAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
++HRD+K NILL +++ K+ DFGLS Q G+ Y+ PE
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEV 194
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARP 685
R EK DV+S GV+L+ +L P
Sbjct: 195 LRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 53/245 (21%), Positives = 102/245 (41%), Gaps = 16/245 (6%)
Query: 491 VIGIGGFGKVYKGELN-DGTKVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
+G G G V+K G +A K P + + E+++L + ++V
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI---IRELQVLHECNSPYIVGF 96
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
G E+ + E+M+ G+L + + + ++ I +GL YL
Sbjct: 97 YGAFYSDGEISICMEHMDGGSLD-QVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHK 152
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
++HRDVK +NIL++ K+ DFG+S ++ + ++ V G+ Y+ PE + +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYS 208
Query: 666 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725
+SD++S G+ L E+ R I P +E+ + ++ + P
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 726 DSLRK 730
R
Sbjct: 269 MDSRP 273
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
VIG G V KVA+KR N + Q + E EI+ +SQ H ++VS
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL--EICIGSA-----RGLHYLHTG 601
K+E+ L+ + + G++ + + K + E I + GL YLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFG----LSKTGPEIDQTHVSTAVKGSFGYLDPE 657
IHRDVK+ NILL E+ ++ADFG L+ G T V G+ ++ PE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPE 196
Query: 658 YFRRQQL-TEKSDVYSFGVVLFE 679
+ + K+D++SFG+ E
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIE 219
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK------RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G F V K E + G + A K R E + E+ +L Q H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 544 SLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
+L + + +++LI E + G L K L S KQ L+ G++Y
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNY 130
Query: 598 LHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
LH K + H D+K NI+L K+ DFGL+ EI+ + G+ +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEF 184
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC 682
+ PE + L ++D++S GV+ + +L
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 26/203 (12%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGYC 549
+G G +G+V VAVK + + E + EI + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLHTG 601
E N L EY G L + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI--------GMPE--PDAQRFFHQLMAGVVYLH-- 122
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDPEYFR 660
+ HRD+K N+LLDE K++DFGL+ ++ + + G+ Y+ PE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 661 RQQLT-EKSDVYSFGVVLFEVLC 682
R++ E DV+S G+VL +L
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 545
++G G +GKV + + AVK + R G A + EI++L + RH++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 546 --IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GL 595
+ Y +EK +M ++ EY G + ++R +C A GL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-------EKRFPVC--QAHGYFCQLIDGL 122
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
YLH ++ ++H+D+K N+LL K++ G+++ +GS +
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 656 PEYFRRQQLTE--KSDVYSFGVVLFEVLCAR-PVIDPTLPR 693
PE K D++S GV L+ + P + +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK------RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G F V K + G + A K + R E + E+ +L + RH +++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 544 SLIGYCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIGSARG 594
+L + K +++LI E + G L K L + KQ L+ G
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF----LKQILD-------G 120
Query: 595 LHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
+HYLH+ K + H D+K NI+L N K+ DFG++ +I+ + + G+
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGT 174
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 682
++ PE + L ++D++S GV+ + +L
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 24/210 (11%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
VIG G F V + G + AVK + + + E + +H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 545 LIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598
L+ + +++E+M+ L + S L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF----VYSEAVASHYMRQILEALRYC 146
Query: 599 HTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
H +IHRDVK +LL + + K+ FG++ E V G+ ++
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRV-GTPHFMA 201
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE +R+ + DV+ GV+LF +L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCL 231
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G G F V + G + A K N + S + + + E + + +H ++V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 548 YCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIGSARGLHYL 598
E++ L+++ + G L + S +Q LE + Y
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC----IQQILE-------SIAYC 144
Query: 599 HTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
H + ++HR++K N+LL + K+ADFGL+ E++ + G+ GYL
Sbjct: 145 H---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLS 198
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE ++ ++ D+++ GV+L+ +L P
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 48/246 (19%), Positives = 85/246 (34%), Gaps = 55/246 (22%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
IG G +G V E A+K + + + + +TE+ ++ + H ++
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 545 LIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSAR----- 593
L +++ + L+ E G L K ++ C
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 594 ---------------------------GLHYLHTGYAKAVIHRDVKSANILL--DENFMA 624
LHYLH + + HRD+K N L +++F
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209
Query: 625 KVADFGLSK---TGPEIDQTHVSTAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFE 679
K+ DFGLSK + ++T G+ ++ PE + K D +S GV+L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 680 VLCARP 685
+L
Sbjct: 269 LLMGAV 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
+G G FG V+ E + G + +K N RSQ + + + EIE+L H +++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 549 CDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
++ + M ++ E E G L +LS E+ L Y H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGK----ALSEGYVAELMKQMMNALAYFH--- 141
Query: 603 AKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
++ V+H+D+K NIL + K+ DFGL++ ST G+ Y+ PE F
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEVF 198
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARP 685
+R +T K D++S GVV++ +L
Sbjct: 199 KR-DVTFKCDIWSAGVVMYFLLTGCL 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK------RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G F V K E + G + A K R E + E+ +L Q H +++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 544 SLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
+L + + +++LI E + G L K L S KQ L+ G++Y
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNY 130
Query: 598 LHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
LHT K + H D+K NI+L K+ DFGL+ EI+ + G+ +
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEF 184
Query: 654 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC 682
+ PE + L ++D++S GV+ + +L
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 43/221 (19%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK---------RGNPRSQQGLAEFQTEIEMLSQ-FRH 539
++G G V + + AVK Q+ E+++L + H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIG 590
+++ L + L+++ M+ G L K L + + LE
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI----MRALLE---- 135
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
+ LH ++HRD+K NILLD++ K+ DFG S ++D V G+
Sbjct: 136 ---VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGT 186
Query: 651 FGYLDPE------YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
YL PE ++ D++S GV+++ +L P
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 12/150 (8%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIG- 547
++G G +G+VYKG + G A+K + + E + EI ML ++ HR++ + G
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 548 -----YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
+++ L+ E+ G++ + + +L + IC RGL +LH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLS 632
VIHRD+K N+LL EN K+ DFG+S
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G+G FGKV GE G KVAVK R RS + + + EI+ L FRH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLH 599
+ ++ EY+ G L ++ R+E AR + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEE--MEARRLFQQILSAVDYCH 128
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
V+HRD+K N+LLD + AK+ADFGLS D + T+ GS Y PE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSC-GSPNYAAPEVI 182
Query: 660 RRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLPR 693
+ + D++S GV+L+ +LC P D +P
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 9/146 (6%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQG---LAEFQTEIEMLSQFRHRHLVSLI 546
IG G FG VY ++ + VA+K+ + +Q + E+ L + RH + +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
G ++ L+ EY L L + + G+ +GL YLH+ +
Sbjct: 121 GCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNM 175
Query: 607 IHRDVKSANILLDENFMAKVADFGLS 632
IHRDVK+ NILL E + K+ DFG +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK------RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G F V K E + G + A K + R + + E+ +L + +H +++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 544 SLIGYCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIGSARG 594
+L + K ++ILI E + G L K L + KQ L G
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF----LKQILN-------G 126
Query: 595 LHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
++YLH+ + H D+K NI+L K+ DFGL+ +ID + + G+
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGT 180
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
++ PE + L ++D++S GV+ + +L
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 26/203 (12%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGYC 549
+G G +G+V VAVK + + E + EI + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLHTG 601
E N L EY G L + + A+ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI--------GMPE--PDAQRFFHQLMAGVVYLH-- 122
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDPEYFR 660
+ HRD+K N+LLDE K++DFGL+ ++ + + G+ Y+ PE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180
Query: 661 RQQLT-EKSDVYSFGVVLFEVLC 682
R++ E DV+S G+VL +L
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQFRHR--H 541
++G GGFG VY G ++D VA+K + E+ +L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSAR------- 593
++ L+ + + + +LI E E L+ ++ + L E AR
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV---QDLFDF----ITERGALQE---ELARSFFWQVL 159
Query: 594 -GLHYLHTGYAKAVIHRDVKSANILLDENFM-AKVADFGLSKTGPEIDQTHVSTAVKGSF 651
+ + H V+HRD+K NIL+D N K+ DFG + T + G+
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDFD-GTR 212
Query: 652 GYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLC 682
Y PE+ R + + V+S G++L++++C
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 36/204 (17%), Positives = 80/204 (39%), Gaps = 23/204 (11%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
+G G FG V++ E + K + + EI +L+ RHR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 550 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
+ E+++I+E++ + Q E L +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------ALQFLH---S 120
Query: 604 KAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
+ H D++ NI+ + K+ +FG ++ ++ + + Y PE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 662 QQLTEKSDVYSFGVVLFEVLCARP 685
++ +D++S G +++ +L
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGIN 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 27/207 (13%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
++G G FG+V K + + AVK N + + E+E+L + H +++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 548 YCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
++ + ++ E G L + S I G+ Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR--------FSEHDAARIIKQVFSGITYMH-- 138
Query: 602 YAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
++HRD+K NILL +++ K+ DFGLS Q G+ Y+ PE
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEV 194
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARP 685
R EK DV+S GV+L+ +L P
Sbjct: 195 LRG-TYDEKCDVWSAGVILYILLSGTP 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK-------RGNPRSQQGLAE-FQTEIEMLSQ-FRHR 540
VIG G V + G + AVK R +P + + E + E +L Q H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARG 594
H+++LI + + M L+++ M G L K L S K+ I
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL--------SEKETRSIMRSLLEA 212
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ +LH A ++HRD+K NILLD+N +++DFG S ++ + G+ GYL
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYL 266
Query: 655 DPEYFRRQQL------TEKSDVYSFGVVLFEVLCARP 685
PE + ++ D+++ GV+LF +L P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 539
N F + V+G GGFG+V ++ K+ A K + + ++G A E ++L +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 540 RHLVSLIGYCDE-KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARG 594
R +VSL Y E K+ + L+ M G LK H+Y G + + EIC G
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
L LH + +++RD+K NILLD++ +++D GL+ PE V G+ GY+
Sbjct: 299 LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYM 352
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE + ++ T D ++ G +L+E++ +
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
+G G VY+ + A+K + +TEI +L + H +++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 550 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
+ E+ L+ E + G L KG+ Y + + KQ LE + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILE-------AVAYLH---E 166
Query: 604 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
++HRD+K N+L + K+ADFGLSK ++ + V G+ GY PE R
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGYCAPEILR 223
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
+ D++S G++ + +LC
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFE 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 39/214 (18%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVK-----RGNPRSQ-QGLAEFQTEIEMLSQFR----H 539
++G GGFG V+ G L D +VA+K R S E+ +L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSAR----- 593
++ L+ + + + +L+ E L+ ++ K L E G +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDY----ITEKGPLGE---GPSRCFFGQ 147
Query: 594 ---GLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
+ + H+ + V+HRD+K NIL+D AK+ DFG + + G
Sbjct: 148 VVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGAL---LHDEPYTDFD-G 200
Query: 650 SFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLC 682
+ Y PE+ R Q + V+S G++L++++C
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 52/250 (20%), Positives = 97/250 (38%), Gaps = 28/250 (11%)
Query: 450 NSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESW----VIGIGGFGKVYKG-E 504
G + + ++ V+ ++ + + +G G FG V++ E
Sbjct: 119 GKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTE 178
Query: 505 LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564
G A K + + EI+ +S RH LV+L ++ NEM++IYE+M
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 565 GTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618
G L + + +Q + GL ++H +H D+K NI+
Sbjct: 239 GELFEKVADEHNKMSEDEAVEYMRQVCK-------GLCHMHE---NNYVHLDLKPENIMF 288
Query: 619 ---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 675
N + K+ DFGL+ +D G+ + PE + + +D++S GV
Sbjct: 289 TTKRSNEL-KLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 676 VLFEVLCARP 685
+ + +L
Sbjct: 345 LSYILLSGLS 354
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G+G FGKV G+ G KVAVK R RS + + + EI+ L FRH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLH 599
+++ ++ EY+ G L ++ RL+ +R G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDE--KESRRLFQQILSGVDYCH 133
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
V+HRD+K N+LLD + AK+ADFGLS D + T+ GS Y PE
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSC-GSPNYAAPEVI 187
Query: 660 RRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLP 692
+ + D++S GV+L+ +LC P D +P
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-25
Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 539
+ F + V+G GGFG+V+ ++ K+ A K + + ++G E ++L++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 540 RHLVSLIGYCDE-KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL------EICIGSA 592
R +VSL Y E K ++ L+ M G ++ H+Y + +++ +I G
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 652
L +LH + +I+RD+K N+LLD++ +++D GL+ G+ G
Sbjct: 302 --LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPG 354
Query: 653 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
++ PE ++ D ++ GV L+E++ AR
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 33/209 (15%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+G G FG V+ +V VK L + EI +LS+ H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------G 594
+ ++ + + L+ E +G L+ + RL+ A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG---LDLFAF----IDRHPRLDE--PLASYIFRQLVSA 142
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ YL K +IHRD+K NI++ E+F K+ DFG + T G+ Y
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC-GTIEYC 196
Query: 655 DPEYFRRQQLT-EKSDVYSFGVVLFEVLC 682
PE + +++S GV L+ ++
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR-HLVSLI 546
+G G F V + + G + A K + R Q AE EI +L + +++L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLH 599
+ +E+ILI EY G + +S KQ LE G++YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------GVYYLH 148
Query: 600 TGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656
++H D+K NILL K+ DFG+S+ +I + G+ YL P
Sbjct: 149 Q---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMGTPEYLAP 202
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLC 682
E +T +D+++ G++ + +L
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLT 228
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 62/215 (28%), Positives = 84/215 (39%), Gaps = 30/215 (13%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
IG G FG VAVK R Q EI RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLHTGY 602
+ +I EY G L + +G R AR G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAG--------RFSE--DEARFFFQQLLSGVSYCH--- 133
Query: 603 AKAVIHRDVKSANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+ + HRD+K N LLD + K+ DFG SK+ Q + V G+ Y+ PE
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEVLL 190
Query: 661 RQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLPR 693
RQ+ + +DV+S GV L+ +L P DP PR
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 45/207 (21%), Positives = 81/207 (39%), Gaps = 25/207 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE--FQTEIEMLSQFRHRHLVSLIG 547
+G G F V + ++ G + A N + + E + +H ++V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 548 YCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
E+ LI++ + G L + + S + + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYY--------SEADASHCIQQILEAVLHCHQ- 128
Query: 602 YAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
V+HR++K N+LL + K+ADFGL+ +Q G+ GYL PE
Sbjct: 129 --MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFA-GTPGYLSPEV 184
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARP 685
R+ + D+++ GV+L+ +L P
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 55/242 (22%), Positives = 97/242 (40%), Gaps = 57/242 (23%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVK---------------RGNPRSQQGLAEFQT------ 529
IG G +G V ND T A+K R PR +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 530 -----EIEMLSQFRHRHLVSLIGYCD--EKNEMILIYEYMENGTLKGHLYGSGLPSLSWK 582
EI +L + H ++V L+ D ++ + +++E + G + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---------MEVPTL 131
Query: 583 QRLEICIGSAR--------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634
+ L AR G+ YLH + +IHRD+K +N+L+ E+ K+ADFG+S
Sbjct: 132 KPLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEVLCAR-PVIDPT 690
+ +S V G+ ++ PE + + DV++ GV L+ + + P +D
Sbjct: 187 -FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 691 LP 692
+
Sbjct: 245 IM 246
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G G FGKV KVA+K R + + EI L RH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLH 599
+++++ EY G L ++ K+R+ R + Y H
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYI--------VEKKRMTE--DEGRRFFQQIICAIEYCH 125
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
++HRD+K N+LLD+N K+ADFGLS D + T+ GS Y PE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVI 179
Query: 660 RRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLP 692
+ + DV+S G+VL+ +L R P D +P
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 14/174 (8%)
Query: 520 SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL-YGSGLPS 578
S + +I + F ++ V + K + + + LK + L
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 579 LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----- 633
L I I A + +LH +K ++HRD+K +NI + + KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 634 -----TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 682
+ T G+ Y+ PE + K D++S G++LFE+L
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 31/208 (14%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGY 548
+G G F K AVK + R A Q EI L H ++V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 549 CDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEIC--IGSARGLHYLHT 600
++ L+ E + G L K H S + I + SA + ++H
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHF--------SETEASYIMRKLVSA--VSHMHD 124
Query: 601 GYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
V+HRD+K N+L ++N K+ DFG ++ P +Q + T + Y PE
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPE 179
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ E D++S GV+L+ +L +
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 56/235 (23%), Positives = 103/235 (43%), Gaps = 30/235 (12%)
Query: 467 NSNSGYRFPFVAVQEATNNFDE-----SWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRS 520
+ +SG F + + V+G+G GKV + G K A+K
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS- 65
Query: 521 QQGLAEFQTEIEMLSQF-RHRHLVSLIG-YCDEKNEMILIY---EYMENGTLKGHLYGSG 575
+ + E++ Q H+V ++ Y + + + E ME G L + G
Sbjct: 66 ----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG 121
Query: 576 LPSLSWKQRLEIC--IGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFG 630
+ + ++ EI IG+A + +LH + + HRDVK N+L +++ + K+ DFG
Sbjct: 122 DQAFTEREAAEIMRDIGTA--IQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176
Query: 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+K E Q + T + Y+ PE ++ + D++S GV+++ +LC P
Sbjct: 177 FAK---ETTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 34/217 (15%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGY 548
V+G G +V L + AVK + + E+EML Q + HR+++ LI +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 549 CDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
+E++ L++E M G++ + H + + + A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRH--------FNELEASVVVQDVASALDFLHN-- 129
Query: 603 AKAVIHRDVKSANILL---DENFMAKVADFGLSK------TGPEIDQTHVSTAVKGSFGY 653
K + HRD+K NIL ++ K+ DF L I + T GS Y
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEY 187
Query: 654 LDPEYFRRQQLTEKS-----DVYSFGVVLFEVLCARP 685
+ PE D++S GV+L+ +L P
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 67/314 (21%), Positives = 115/314 (36%), Gaps = 47/314 (14%)
Query: 455 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAV 513
GS S G T + G R+ N+ + +G G G+V+K G +AV
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAV 55
Query: 514 KR----GNPRSQQGLAEFQTEIEML-SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 568
K+ GN + + +++++ ++V G ++ + E M K
Sbjct: 56 KQMRRSGNKEENKRI---LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK 112
Query: 569 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 628
L + + ++ + + L+YL VIHRDVK +NILLDE K+ D
Sbjct: 113 --LKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCD 168
Query: 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEVLCA 683
FG+S + G Y+ PE T+ ++DV+S G+ L E+
Sbjct: 169 FGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 684 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID---PTLAGKIR-PDSLRKFGETAEKCL 739
+ + L +++ P L G + + F + CL
Sbjct: 226 QFPYKNCKT---------DFE-----VLTKVLQEEPPLLPGHMGFSGDFQSF---VKDCL 268
Query: 740 ADFGVDRPSMGDVL 753
RP +L
Sbjct: 269 TKDHRKRPKYNKLL 282
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 62/282 (21%), Positives = 111/282 (39%), Gaps = 49/282 (17%)
Query: 491 VIGIGGFGKVYKGELN-DGTKVAVKR----GNPRSQQGLAEFQTEIEM-LSQFRHRHLVS 544
+G G +G V K G +AVKR N + Q+ L ++++ + V+
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL---LMDLDISMRTVDCPFTVT 70
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYL 598
G + ++ + E M+ K Y + Q + I + + L +L
Sbjct: 71 FYGALFREGDVWICMELMDTSLDK--FYKQVIDK---GQTIPEDILGKIAVSIVKALEHL 125
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE- 657
H+ +VIHRDVK +N+L++ K+ DFG+S + G Y+ PE
Sbjct: 126 HS--KLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPER 180
Query: 658 ---YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714
++ + KSD++S G+ + E+ R P W +Q QL Q+
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRF---P--------YDSWGTPFQ---QLKQV 226
Query: 715 ID---PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
++ P L F +CL +RP+ +++
Sbjct: 227 VEEPSPQLPADKFSAEFVDF---TSQCLKKNSKERPTYPELM 265
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQ--- 536
N+F +IG GGFG+VY D K+ A+K + + +QG E MLS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 537 FRHRHLVSLIGYCDE-KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSA 592
+V + Y +++ I + M G L HL G+ S + R EI +G
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILG-- 304
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 652
L ++H + V++RD+K ANILLDE+ +++D GL+ + + H +V G+ G
Sbjct: 305 --LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHG 355
Query: 653 YLDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARP 685
Y+ PE ++ + S D +S G +LF++L
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 539
++F+ IG G FGKV + ND K+ A+K + + + E++++ H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 540 RHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC-IGSARGLH 596
LV+L Y DE++ M ++ + + G L+ HL + +L IC + A L
Sbjct: 75 PFLVNLW-YSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEE-TVKLFICELVMA--LD 129
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656
YL + +IHRD+K NILLDE+ + DF ++ + + T + G+ Y+ P
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAP 183
Query: 657 EYFRRQQLTE--KS-DVYSFGVVLFEVLCARP 685
E F ++ + D +S GV +E+L R
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIE-MLSQFRHRHLVSLIGY 548
IG+G + + + AVK + + EIE +L +H ++++L
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84
Query: 549 CDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
D+ + ++ E M+ G L + S ++ + + + YLH
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKFF--------SEREASAVLFTITKTVEYLH--- 133
Query: 603 AKAVIHRDVKSANILL---DENFMA-KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
A+ V+HRD+K +NIL N + ++ DFG +K + + T + ++ PE
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPC-YTANFVAPEV 191
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARP 685
RQ D++S GV+L+ +L
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 491 VIGIGGFGKVYKGELN-DGTKVAVKR----GNPRSQQGLAEFQTEIE-MLSQFRHRHLVS 544
IG G +G V K G +AVKR + + Q+ + +++ ++ ++V
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK---QLLMDLDVVMRSSDCPYIVQ 85
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYL 598
G + + + E M K Y L + I + + + L++L
Sbjct: 86 FYGALFREGDCWICMELMSTSFDK--FYKYVYSVL--DDVIPEEILGKITLATVKALNHL 141
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE- 657
+IHRD+K +NILLD + K+ DFG+S ++ + T G Y+ PE
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPER 196
Query: 658 ---YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
RQ +SDV+S G+ L+E+ R
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRF 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 31/264 (11%), Positives = 67/264 (25%), Gaps = 54/264 (20%)
Query: 491 VIGIGGFGKVYKGELND---GTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
G + ++ D +VA+ L E + LS+ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
++ + +++ E++ G+L+ S P + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAH---RA 148
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
V + + + + +A +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179
Query: 665 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724
+ D+ G L+ +L R + R + A + D P I
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------ERDTAGQPIEPADID 229
Query: 725 PDSLRKFGETAEKCLADFGVDRPS 748
D + A + + G R +
Sbjct: 230 RDIPFQISAVAARSVQGDGGIRSA 253
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 46/190 (24%), Positives = 90/190 (47%), Gaps = 26/190 (13%)
Query: 454 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVA 512
MG + H ++ F ++ ++ ++G G +G V K + G VA
Sbjct: 1 MGHHHHHHSSGVDLGTENLYF------QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVA 54
Query: 513 VKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGH 570
+K+ + + EI++L Q RH +LV+L+ C +K L++E++++ T+
Sbjct: 55 IKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDD 113
Query: 571 L--YGSGLPSLSWK----QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624
L + +GL + Q + G+ + H + +IHRD+K NIL+ ++ +
Sbjct: 114 LELFPNGLDYQVVQKYLFQII-------NGIGFCH---SHNIIHRDIKPENILVSQSGVV 163
Query: 625 KVADFGLSKT 634
K+ DFG ++T
Sbjct: 164 KLCDFGFART 173
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 49/225 (21%), Positives = 84/225 (37%), Gaps = 40/225 (17%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 539
++F+ VIG G F +V ++ +V A+K + + + ++ F+ E ++L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 540 RHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR---- 593
R + L + DE + L+ EY G L L + I +
Sbjct: 121 RWITQLH-FAFQDENY-LYLVMEYYVGGDLLTLL-----------SKFGERIPAEMARFY 167
Query: 594 ------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
+ +H +HRD+K NILLD ++ADFG AV
Sbjct: 168 LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVY-------SFGVVLFEVLCARP 685
G+ YL PE + + Y + GV +E+ +
Sbjct: 225 -GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 548
IG G +G V+K + G VA+K+ + + EI ML Q +H +LV+L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 549 CDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSARGLHYLHTGY 602
K + L++EY ++ T+ L Y G+P K Q L + +++ H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL-------QAVNFCH--- 119
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQ-TH-VST 645
IHRDVK NIL+ ++ + K+ DFG ++ D V+T
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGY 548
V+G+G GKV + K A+K + + E+E+ + + H+V ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 549 CDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC--IGSARGLHYLHTGY 602
+ + ++++ E ++ G L + G + + ++ EI IG A + YLH+
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHS-- 179
Query: 603 AKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ HRDVK N+L N + K+ DFG +K E + T + Y+ PE
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL 235
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARP 685
++ + D++S GV+++ +LC P
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 38/223 (17%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 539
+F+ VIG G FG+V +L + KV A+K + + A F+ E ++L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 540 RHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR---- 593
+ + +L Y D+ N + L+ +Y G L L + E +
Sbjct: 134 KWITTLH-YAFQDDNN-LYLVMDYYVGGDLLTLL-----------SKFEDRLPEEMARFY 180
Query: 594 ------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
+ +H +HRD+K NIL+D N ++ADFG E S AV
Sbjct: 181 LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 648 KGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEVLCARP 685
G+ Y+ PE + + + D +S GV ++E+L
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 48/209 (22%), Positives = 90/209 (43%), Gaps = 15/209 (7%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRS---QQGLAEFQTEIEMLSQFRH 539
+F ++G G F V ++ A+K R + + E +++S+ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSARGLH 596
V L + ++ Y +NG L ++ G + R EI L
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVSA----LE 144
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656
YLH K +IHRD+K NILL+E+ ++ DFG +K + + + G+ Y+ P
Sbjct: 145 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
E + + SD+++ G ++++++ P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 43/221 (19%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKR--GNPRSQQGLAEFQT---------EIEMLSQFRH 539
I G +G V G ++G VA+KR + + EI +L+ F H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 540 RHLVSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK-------QRLEI 587
+++ L +++ L+ E M T + +S + L
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMR--TDLAQVIHDQRIVISPQHIQYFMYHIL-- 144
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--HVST 645
GLH LH V+HRD+ NILL +N + DF L++ +V+
Sbjct: 145 -----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 646 AVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 685
Y PE + + T+ D++S G V+ E+ +
Sbjct: 197 RW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGN-----PRSQQGLAEFQTEIEMLSQF 537
+++ VIG G FG+V KV A+K + RS A F E ++++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD--SAFFWEERDIMAFA 126
Query: 538 RHRHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---------- 585
+V L Y D++ + ++ EYM G L + +
Sbjct: 127 NSPWVVQLF-YAFQDDRY-LYMVMEYMPGGDLVNLMS---------NYDVPEKWARFYTA 175
Query: 586 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 645
E+ + L +H + IHRDVK N+LLD++ K+ADFG + T
Sbjct: 176 EVVLA----LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 646 AVKGSFGYLDPEYFRRQQLTEK----SDVYSFGVVLFEVLCARP 685
AV G+ Y+ PE + Q D +S GV L+E+L
Sbjct: 229 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 25/155 (16%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQT---EIEMLSQFRH 539
IG G +G VYK G VA+K+ G P T EI +L + H
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS---------TAIREISLLKELNH 61
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
++V L+ +N++ L++E++ LK + S L + +GL + H
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634
+ V+HRD+K N+L++ K+ADFGL++
Sbjct: 121 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 46/157 (29%), Positives = 81/157 (51%), Gaps = 27/157 (17%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR----GNPRSQQGLAEFQT---EIEMLSQFRHRHLV 543
+G G F VYK + N VA+K+ ++ G+ +T EI++L + H +++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNII 75
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSL-----SW-KQRLEICIGSARGLHY 597
L+ K+ + L++++ME L+ + + L ++ L +GL Y
Sbjct: 76 GLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTL-------QGLEY 127
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634
LH ++HRD+K N+LLDEN + K+ADFGL+K+
Sbjct: 128 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 62/246 (25%), Positives = 99/246 (40%), Gaps = 12/246 (4%)
Query: 445 SINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGE 504
+ + M + + S + N F+ ++G G FGKV +
Sbjct: 109 GLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVK 168
Query: 505 LNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC-DEKNEMILIY 559
+ +K+ ++ +A TE +L RH L +L Y + + +
Sbjct: 169 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM 227
Query: 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619
EY G L HL + S + I SA L YLH+ K V++RD+K N++LD
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHS--EKNVVYRDLKLENLMLD 283
Query: 620 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 679
++ K+ DFGL K G I G+ YL PE D + GVV++E
Sbjct: 284 KDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 680 VLCARP 685
++C R
Sbjct: 342 MMCGRL 347
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 7e-18
Identities = 43/199 (21%), Positives = 80/199 (40%), Gaps = 44/199 (22%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 546
+IG G +G VY + N VA+K+ + + EI +L++ + +++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK-RILREITILNRLKSDYIIRLY 91
Query: 547 -----GYCDEKNEMILIYEYME---------NGTLKG-H----LYGSGLPSLSWKQRLEI 587
+ +E+ ++ E + L H LY L
Sbjct: 92 DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY----------NLL-- 139
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
G +++H +IHRD+K AN LL+++ KV DFGL++T T++ +
Sbjct: 140 -----LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 648 KGSFGYLDPEYFRRQQLTE 666
+ + ++QLT
Sbjct: 192 EENEEPGPHNKNLKKQLTS 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 39/160 (24%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKR--------GNP----RSQQGLAEFQTEIEMLSQFRH 539
+G G +G VYK + + G VA+KR G P R EI +L + H
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----------EISLLKELHH 78
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSAR 593
++VSLI + + L++E+ME LK L +GL K Q L R
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLL-------R 130
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
G+ + H ++HRD+K N+L++ + K+ADFGL++
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 50/231 (21%)
Query: 481 EATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQF 537
+ + IG G +G V + + +VA+K+ +P Q + +T EI++L +F
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRF 82
Query: 538 RHRHLVSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ 586
RH +++ + ++ ++ ++ + ME + L L Q L
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLME----------TDLYKLLKTQHLSNDHICY 132
Query: 587 ----ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQT 641
I RGL Y+H+ V+HRD+K +N+LL+ K+ DFGL++ P+ D T
Sbjct: 133 FLYQIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 642 HVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARP 685
T Y+ ++R + T+ D++S G +L E+L RP
Sbjct: 186 GFLT------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 38/160 (23%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQT---EIEMLSQFRH 539
IG G +G V+K VA+KR G P + EI +L + +H
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---------SALREICLLKELKH 60
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSAR 593
+++V L ++ L++E+ + LK + L K Q L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL-------K 112
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
GL + H ++ V+HRD+K N+L++ N K+A+FGL++
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 60/316 (18%), Positives = 120/316 (37%), Gaps = 54/316 (17%)
Query: 443 PVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFV---AVQEATNNFDESWVIGIGGFGK 499
G + S + S + + + + IG G G
Sbjct: 18 IAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGI 77
Query: 500 VYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI------GYC 549
V + VA+K+ P Q A+ + E+ ++ H++++SL+
Sbjct: 78 VCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 550 DEKNEMILIYEYME---NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606
+E ++ L+ E M+ ++ L + L + Q L G+ +LH+ +
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY-QML-------CGIKHLHSA---GI 185
Query: 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--HVSTAVKGSFGYLDPEYFRRQQL 664
IHRD+K +NI++ + K+ DFGL++T +V T Y PE
Sbjct: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGY 240
Query: 665 TEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723
E D++S G ++ E++ + + P R+ ++ Q +++I+ G
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILF----PGRDYID------------QWNKVIE--QLGTP 282
Query: 724 RPDSLRKFGETAEKCL 739
P+ ++K T +
Sbjct: 283 CPEFMKKLQPTVRNYV 298
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEF-QT---EI---EMLSQFRHRHL 542
IG+G +G VYK + + G VA+K P G + E+ L F H ++
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 543 VSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
V L+ D + ++ L++E+++ L+ +L + P L + ++ RGL +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTH 642
LH A ++HRD+K NIL+ K+ADFGL++ ++ T
Sbjct: 136 LH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 62/265 (23%), Positives = 106/265 (40%), Gaps = 56/265 (21%)
Query: 451 SHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESW------VIGIGGFGKVYKGE 504
S TM + +G + + + V + VIG G FG V++ +
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPN-KVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 505 LNDGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGY----CDEKNEMI--L 557
L + +VA+K+ Q F+ E++++ +H ++V L + D+K+E+ L
Sbjct: 61 LVESDEVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115
Query: 558 IYEYMENGTLKGHLY-----GSGLPSLSWK----QRLEICIGSARGLHYLHTGYAKAVIH 608
+ EY+ T+ +P L K Q L R L Y+H+ + H
Sbjct: 116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL-------RSLAYIHS---IGICH 164
Query: 609 RDVKSANILLDENFMA-KVADFGLSKT-GPEIDQTH-VST----AVKGSFGYLDPE-YFR 660
RD+K N+LLD K+ DFG +K + + A PE F
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRA---------PELIFG 215
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
T D++S G V+ E++ +P
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 53/273 (19%), Positives = 110/273 (40%), Gaps = 47/273 (17%)
Query: 481 EATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQ 536
+ IG G G V + VA+K+ P Q A+ + E+ ++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK-RAYRELVLMKC 80
Query: 537 FRHRHLVSLI------GYCDEKNEMILIYEYME---NGTLKGHLYGSGLPSLSWKQRLEI 587
H++++ L+ +E ++ ++ E M+ ++ L + L + Q L
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY-QML-- 137
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
G+ +LH+ +IHRD+K +NI++ + K+ DFGL++T + + T
Sbjct: 138 -----CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPY 186
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQ 706
+ Y PE E D++S G ++ E++ + P + ++
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF----PGTDHID--------- 233
Query: 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCL 739
Q +++I+ G P+ ++K T +
Sbjct: 234 ---QWNKVIE--QLGTPCPEFMKKLQPTVRTYV 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 45/222 (20%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI- 546
++G G +G V G VA+K+ P + A +T EI++L F+H +++++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-RTLREIKILKHFKHENIITIFN 76
Query: 547 ----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE----------ICIGSA 592
+ NE+ +I E M+ + L + Q L
Sbjct: 77 IQRPDSFENFNEVYIIQELMQ----------TDLHRVISTQMLSDDHIQYFIYQTL---- 122
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF- 651
R + LH VIHRD+K +N+L++ N KV DFGL++ E + + S
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 652 -GYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARP 685
++ ++R + + DV+S G +L E+ RP
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 48/167 (28%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNP----RSQQGLAEFQTEIEMLSQFR 538
IG G FG+V+K G KVA+K+ G P R EI++L +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----------EIKILQLLK 74
Query: 539 HRHLVSLIG--------YCDEKNEMILIYEYMENGTLKGHLYGSGLP-SLS-----WKQR 584
H ++V+LI Y K + L++++ E+ L G L + +LS +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 585 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631
L GL+Y+H ++HRD+K+AN+L+ + + K+ADFGL
Sbjct: 134 LN-------GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 47/261 (18%), Positives = 90/261 (34%), Gaps = 54/261 (20%)
Query: 438 SKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQ---EATNNFDESWVIGI 494
+A N G HT+ G + +S + + ++ +IG
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 495 GGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLI--- 546
G +G V + + + VA+K+ + EI +L++ H H+V ++
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC--KRILREIAILNRLNHDHVVKVLDIV 121
Query: 547 --GYCDEKNEMILIYEYME---------NGTLKG-H----LYGSGLPSLSWKQRLEICIG 590
++ +E+ ++ E + L H LY L
Sbjct: 122 IPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY----------NLL----- 166
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS-----KTGPEIDQTHVST 645
G+ Y+H+ ++HRD+K AN L++++ KV DFGL+
Sbjct: 167 --VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 646 AVKGSFGYLDPEYFRRQQLTE 666
+ ++QLT
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTG 242
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 36/162 (22%), Positives = 68/162 (41%), Gaps = 13/162 (8%)
Query: 524 LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ 583
+ + + + R L S+ + + + + + + L+ +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 584 RLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643
+ A+G+ +L ++ IHRD+ + NILL E + K+ DFGL++ D
Sbjct: 195 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKD 246
Query: 644 STAVKGSFGYLD-----PEYFRRQQLTEKSDVYSFGVVLFEV 680
V+ L PE + T +SDV+SFGV+L+E+
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 29/152 (19%), Positives = 56/152 (36%), Gaps = 18/152 (11%)
Query: 491 VIGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 542
+G G FG+V + + VAVK + +E+++L H ++
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 543 VSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
V+L+G C +++I E+ + G L +L +R E +G +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQGK 139
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
I D+K + + + + F K
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 46/209 (22%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 546
+G G +G V + G KVA+K+ P + A+ + E+ +L +H +++ L+
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-RAYRELLLLKHMQHENVIGLL 89
Query: 547 ------GYCDEKNEMILIYEYME---NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
+ L+ +M+ + + L + Q L +GL Y
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY-QML-------KGLKY 141
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
+H+ V+HRD+K N+ ++E+ K+ DFGL++ +V T Y PE
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPE 193
Query: 658 -YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ D++S G ++ E+L +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 39/160 (24%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKR--------GNP----RSQQGLAEFQTEIEMLSQFRH 539
IG G +G VYK + N G A+K+ G P R EI +L + +H
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----------EISILKELKH 59
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSAR 593
++V L K ++L++E+++ LK L GL S++ K Q L
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLL-------N 111
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
G+ Y H + V+HRD+K N+L++ K+ADFGL++
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 23/160 (14%)
Query: 484 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRH 539
+ + +G G + VYKG VA+K ++G T E+ +L +H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKH 59
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSAR 593
++V+L + + L++EY++ LK +L G+ + + K Q L R
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL-------R 111
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
GL Y H + V+HRD+K N+L++E K+ADFGL++
Sbjct: 112 GLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLIG 547
+G G + VYKG G VA+K S++G T EI ++ + +H ++V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRLYD 70
Query: 548 YCDEKNEMILIYEYMEN---GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
+N++ L++E+M+N + G+ L +GL + H
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-- 128
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLS 632
++HRD+K N+L+++ K+ DFGL+
Sbjct: 129 -ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 25/207 (12%)
Query: 491 VIGIGGFGKVY---KGELNDGTKV-AVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
V+G G FGKV+ K +D ++ A+K + + + E ++L + H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 545 LIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSARGLHYL 598
L Y + K + LI +++ G L L + + + E+ + L +L
Sbjct: 91 LH-YAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALA----LDHL 142
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
H + +I+RD+K NILLDE K+ DFGLSK ID + + G+ Y+ PE
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEV 197
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARP 685
R+ T+ +D +SFGV++FE+L
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 479 VQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKR--GNPRSQQGLAEFQTEIEMLS 535
++ + F + G G FG V G+ G VA+K+ +PR + E Q ++ L+
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN--RELQ-IMQDLA 74
Query: 536 QFRHRHLVSLIGY-----CDEKNEM--ILIYEYMENGTLKGHL-----YGSGLPSLSWK- 582
H ++V L Y ++ ++ ++ EY+ + TL P + K
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKV 133
Query: 583 ---QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEI 638
Q + R + LH V HRD+K N+L++ + K+ DFG +K
Sbjct: 134 FLFQLI-------RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP- 184
Query: 639 DQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ +V+ S Y PE F Q T D++S G + E++ P
Sbjct: 185 SEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRH 539
N+FD ++G G FGKV + +++ ++ +A TE +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 540 RHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSARG 594
L +L Y ++ + + EY G L HL + + + EI
Sbjct: 65 PFLTALK-YAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA---- 117
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSF-G 652
L YLH ++ V++RD+K N++LD++ K+ DFGL K G + +F G
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-------TFCG 167
Query: 653 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
YL PE D + GVV++E++C R
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 34/194 (17%)
Query: 459 SHGTTTSANSNSGYRFPFVAVQEATN--NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR 515
H T A + A AT+ + +G G +G+VYK + VA+KR
Sbjct: 7 HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66
Query: 516 --------GNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564
G P T E+ +L + +HR+++ L + + LI+EY EN
Sbjct: 67 IRLEHEEEGVPG---------TAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624
LK ++ P +S + G+++ H+ + +HRD+K N+LL + +
Sbjct: 118 -DLKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDAS 171
Query: 625 -----KVADFGLSK 633
K+ DFGL++
Sbjct: 172 ETPVLKIGDFGLAR 185
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 52/221 (23%)
Query: 491 VIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGY 548
VIG G FG VY+ +L D G VA+K+ Q F+ E++++ + H ++V L +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 549 ----CDEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRLE----------ICIGSA 592
++K+E+ L + +Y+ T+ KQ L +
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA----KQTLPVIYVKLYMYQLF---- 166
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMA-KVADFGLSKT-GPEIDQTH-VST---- 645
R L Y+H+ + HRD+K N+LLD + K+ DFG +K + +
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 646 AVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 685
A PE F T DV+S G VL E+L +P
Sbjct: 224 A---------PELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGT--------KVAVKRGNPRSQQGLAEFQTEIEMLS 535
F+ V+G GG+GKV++ G KV K R+ + A + E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 536 QFRHRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI 589
+ +H +V LI Y K + LI EY+ G L L G+ EI +
Sbjct: 77 EVKHPFIVDLI-YAFQTGGK--LYLILEYLSGGELFMQLEREGIFMED-TACFYLAEISM 132
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
L +LH K +I+RD+K NI+L+ K+ DFGL K I V+ G
Sbjct: 133 A----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHTFCG 183
Query: 650 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ Y+ PE R D +S G +++++L P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 31/172 (18%)
Query: 492 IGIGGFGKVYKG--ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRH 541
IG G +GKV+K N G VA+KR G P S + E + L F H +
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREVAV-LRHLETFEHPN 75
Query: 542 LVSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR----LEICIGSA 592
+V L D + ++ L++E+++ L +L P + + ++
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL---- 130
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHV 643
RGL +LH + V+HRD+K NIL+ + K+ADFGL++ ++ T V
Sbjct: 131 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 14/206 (6%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 539
+ FD +G G FG+V + + A+K + + L + + E +L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
LV L + + + ++ EY+ G + HL G S + I YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLH 158
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ +I+RD+K N+L+D+ +V DFG +K T T L PE
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP-----EALAPEII 210
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARP 685
+ + D ++ GV+++E+ P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 44/216 (20%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 546
+G G +G V + G KVA+K+ P + A+ + E+ +L RH +++ L+
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RAYRELRLLKHMRHENVIGLL 90
Query: 547 ------GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE----------ICIG 590
D+ + L+ +M + L L ++L +
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMG----------TDLGKLMKHEKLGEDRIQFLVYQML-- 138
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
+GL Y+H +IHRD+K N+ ++E+ K+ DFGL++ +V T
Sbjct: 139 --KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190
Query: 651 FGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 685
Y PE + T+ D++S G ++ E++ +
Sbjct: 191 --YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 4e-16
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 538
+F+ V+G G FGKV E ++ +K+ + E +L+ +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 539 HRHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSARGL 595
L L C + + + EY+ G L H+ G EI IG L
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----L 455
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G-- 652
+L +K +I+RD+K N++LD K+ADFG+ K T T +F G
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TK---TFCGTP 506
Query: 653 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
Y+ PE Q + D ++FGV+L+E+L +
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 30/160 (18%)
Query: 492 IGIGGFGKVYKG---ELNDGTKVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 544
+G G +G VYK + D A+K+ G S EI +L + +H +++S
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 82
Query: 545 LIGYCDEKNEMI--LIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGS-----ARGL 595
L + L+++Y E+ L + + + + Q + S G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 596 HYLHTGYAKAVIHRDVKSANILLDENFMA----KVADFGL 631
HYLH A V+HRD+K ANIL+ K+AD G
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 538
+F+ V+G G FGKV E ++ +K+ + E +L+ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 539 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 593
L L C ++ + + EY+ G L H+ G EI IG
Sbjct: 80 PPFLTQLH-SCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG--- 133
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSF- 651
L +L +K +I+RD+K N++LD K+ADFG+ K + T +F
Sbjct: 134 -LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-------TFC 182
Query: 652 G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
G Y+ PE Q + D ++FGV+L+E+L +
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 538
+FD VIG G + KV L ++ VK+ + + QTE + Q
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 539 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 593
H LV L C + + + + EY+ G L H+ + EI +
Sbjct: 69 HPFLVGLH-SCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--- 122
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSF- 651
L+YLH + +I+RD+K N+LLD K+ D+G+ K G D T +F
Sbjct: 123 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-------TFC 171
Query: 652 G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
G Y+ PE R + D ++ GV++FE++ R
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 80.3 bits (197), Expect = 2e-15
Identities = 80/489 (16%), Positives = 150/489 (30%), Gaps = 126/489 (25%)
Query: 367 STLHDTYPDAILNGLEIMK----MKNLQGSLGNSSSKKHVGVIVGVTIGVSVAALLAGIL 422
Y D + + K++Q + SK+ + I+ VS L
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL---F 68
Query: 423 FMLCRKRRQLPQ------LGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRF-- 474
+ L K+ ++ Q L + ++ I + N F
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK 128
Query: 475 -------PFVAVQEATNNF-DESWVI--GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL 524
P++ +++A V+ G+ G GK T VA+ Q
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK---------TWVALDVCLSYKVQCK 179
Query: 525 AEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI-----LIYEYMENGTLKG-HLYGSGLPS 578
+F+ I L+ + C+ ++ L+Y+ N T + H L
Sbjct: 180 MDFK--IFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 579 LSWKQRLEICIGSARGLHYLHTGYAKA-VIHRDVKSANILLDENFMAKVADFGLSKTGPE 637
S + L R L Y ++ +V++A F +
Sbjct: 228 HSIQAEL-------RRL-LKSKPYENCLLVLLNVQNAKAW--NAF-----NLSC------ 266
Query: 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPV-IDPT-LPR 693
+ ++T K +L L S + EV L + + P LPR
Sbjct: 267 --KILLTTRFKQVTDFLSAATTTHISLDHHSM----TLTPDEVKSLLLKYLDCRPQDLPR 320
Query: 694 EMVN------------LAEWAMKWQN-----KGQLDQIIDPTLAGKIRPDSLRK-FGETA 735
E++ + + W N +L II+ +L + P RK F
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN-VLEPAEYRKMF---- 375
Query: 736 EKCLADF--GVDRPSMG-DVLW-NLEYALQLQEAVVH---------GDPDENSTNLIG-- 780
L+ F P++ ++W ++ VV+ P E++ ++
Sbjct: 376 -DRLSVFPPSAHIPTILLSLIWFDVIK--SDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 781 -ELSPQIHN 788
EL ++ N
Sbjct: 433 LELKVKLEN 441
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 71/623 (11%), Positives = 153/623 (24%), Gaps = 214/623 (34%)
Query: 127 FSVSTNDH-------VLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVV 179
F + + V + F F D I S ++
Sbjct: 9 FETGEHQYQYKDILSVFEDAF------VDNFDCKDVQDMPKSILSKEEID-------HII 55
Query: 180 SVPDQ---------LITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRT 230
D + + V + E V R
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQEEM---------VQKFVEEVLR------------------ 88
Query: 231 WVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTA-TRMNSDDDPNANFNVT 289
+ FL++ K+ P S +Y R+ +D+ A +NV+
Sbjct: 89 --INYKFLMSP--IKTEQRQP------------SMMTRMYIEQRDRLYNDNQVFAKYNVS 132
Query: 290 WEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYI---------DSWIA---VRDLDLSTY 337
R + L +L + +W+A +
Sbjct: 133 -------------RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK 179
Query: 338 STNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLGNSS 397
+++++ + + L +L L N +SS
Sbjct: 180 MDF---KIFWLNLKNCNSPETVL---------------EMLQKLLYQIDPNWTSRSDHSS 221
Query: 398 SKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKA-------WIPVSIN--G 448
+ K I + RR L + + N
Sbjct: 222 NIKL------------------RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN 263
Query: 449 GNSHTMGSKYSHGTTTS----ANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGE 504
+ + TT + S +++ + V + K
Sbjct: 264 LSCKIL-------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL--LLKYLDCR 314
Query: 505 LNDGTKVAVKRGNPRSQQGLAEF-QTEIEMLSQFRHRHLVSLIGYCDEKNEMI-LIYEYM 562
D + + NPR +AE + + ++H + CD+ +I +
Sbjct: 315 PQDLPREVLT-TNPRRLSIIAESIRDGLATWDNWKHVN-------CDKLTTIIESSLNVL 366
Query: 563 ENGTLKGHLY--------GSGLPS--LS--WKQRLEICI---------------GSARGL 595
E + ++ + +P+ LS W ++ +
Sbjct: 367 EPAEYR-KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425
Query: 596 HYLHTGYAKAVIHRDVKSA--NILLDE-NFMAKVADFGLSKTGPEIDQ---THVSTAVKG 649
+ + Y + + + + A ++D N L P +DQ +H
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP--PYLDQYFYSH------- 476
Query: 650 SFGYLDPEYFRRQQLTEKSDVYS 672
G+ + + + E+ ++
Sbjct: 477 -IGH----HLKNIEHPERMTLFR 494
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 538
+NF+ V+G G FGKV + + + +K+ + TE +LS
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 539 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 593
H L L C ++ + + E++ G L H+ S + + EI
Sbjct: 83 HPFLTQLF-CCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA--- 136
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G 652
L +LH K +I+RD+K N+LLD K+ADFG+ K G T TA +F G
Sbjct: 137 -LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TA---TFCG 186
Query: 653 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
Y+ PE + D ++ GV+L+E+LC
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 42/196 (21%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFR-HRHLVSL 545
+G G +G V+K + G VAVK+ + A+ +T EI +L++ H ++V+L
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-RTFREIMILTELSGHENIVNL 74
Query: 546 --IGYCDEKNEMILIYEYME---NGTLKG------H----LYGSGLPSLSWKQRLEICIG 590
+ D ++ L+++YME + ++ H +Y Q +
Sbjct: 75 LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY----------QLI----- 119
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
+ + YLH+G ++HRD+K +NILL+ KVADFGLS++ I + + + +
Sbjct: 120 --KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 651 FGYLDPEYFRRQQLTE 666
+ + + LT+
Sbjct: 175 ENTENFDD-DQPILTD 189
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 45/206 (21%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIE-MLSQFRHRHLVSLIGY 548
V+G+G GKV + K A+K Q + + E+E + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 549 CDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC--IGSARGLHYLHTGY 602
+ + ++++ E ++ G L + G + + ++ EI IG A + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLH--- 134
Query: 603 AKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ + HRDVK N+L N + K+ DFG + E
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KET--------------------- 170
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARP 685
++ + D++S GV+++ +LC P
Sbjct: 171 TGEKYDKSCDMWSLGVIMYILLCGYP 196
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 55/288 (19%), Positives = 109/288 (37%), Gaps = 92/288 (31%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR---GNPRSQQGLAEFQT--EIEMLSQFRHRHLVS 544
+G GG G V+ + + +VA+K+ +P+S + EI+++ + H ++V
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK-----HALREIKIIRRLDHDNIVK 72
Query: 545 LI--------------GYCDEKNEMILIYEYME--------NGTL-KGH----LYGSGLP 577
+ G E N + ++ EYME G L + H +Y
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY----- 127
Query: 578 SLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKT-G 635
Q L RGL Y+H+ V+HRD+K AN+ ++ E+ + K+ DFGL++
Sbjct: 128 -----QLL-------RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 636 PEIDQTHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARPVID 688
P + L +++R T+ D+++ G + E+L + +
Sbjct: 173 PHYSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL-- 224
Query: 689 PTLP-REMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETA 735
+ Q+ I++ + + ++
Sbjct: 225 --FAGAHELE------------QMQLILE--SIPVVHEEDRQELLSVI 256
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 538
+FD VIG G + KV L ++ VK+ + + QTE + Q
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 539 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 593
H LV L C + + + + EY+ G L H+ + EI +
Sbjct: 112 HPFLVGLH-SCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--- 165
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSF- 651
L+YLH + +I+RD+K N+LLD K+ D+G+ K G D T +F
Sbjct: 166 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-------TFC 214
Query: 652 G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
G Y+ PE R + D ++ GV++FE++ R
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 60/209 (28%), Positives = 85/209 (40%), Gaps = 30/209 (14%)
Query: 491 VIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQ-FRHRHLVSL 545
VIG G FGKV AVK + ++ +E +L + +H LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 546 IGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSARGLHYLHT 600
+ +K +L +Y+ G L HL + EI L YLH
Sbjct: 105 H-FSFQTADKLYFVL--DYINGGELFYHLQRERCFLEPRARFYAAEIASA----LGYLH- 156
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G---YLDP 656
+ +++RD+K NILLD + DFGL K E + T T +F G YL P
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---T---STFCGTPEYLAP 208
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
E +Q D + G VL+E+L P
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 546
+G G +G V + G +VAVK+ P A+ +T E+ +L +H +++ L+
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYRELRLLKHMKHENVIGLL 94
Query: 547 ------GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARG 594
+E N++ L+ M + L ++ Q+L + RG
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLMG----------ADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
L Y+H+ +IHRD+K +N+ ++E+ K+ DFGL++ + +V+T Y
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YR 196
Query: 655 DPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 685
PE + D++S G ++ E+L R
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 46/222 (20%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAEFQ-----TEIEMLSQF 537
+F +G G FG+V+ + A+K + + + Q E MLS
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 538 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----------EI 587
H ++ + G + ++ +I +Y+E G L L S R E+
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--------RFPNPVAKFYAAEV 115
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
C+ L YLH +K +I+RD+K NILLD+N K+ DFG +K P D T+
Sbjct: 116 CLA----LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTY----- 161
Query: 648 KGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
+ G Y+ PE + + D +SFG++++E+L
Sbjct: 162 --TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 538
+F ++G G FGKV+ E + A+K+ + E +LS +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 539 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 593
H L + E ++ EY+ G L H+ LS EI +G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG--- 130
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G 652
L +LH +K +++RD+K NILLD++ K+ADFG+ K D T +F G
Sbjct: 131 -LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TN---TFCG 180
Query: 653 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
Y+ PE Q+ D +SFGV+L+E+L +
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 46/205 (22%), Positives = 94/205 (45%), Gaps = 38/205 (18%)
Query: 492 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSL--IG 547
+G G + +V++ + + KV VK P ++ + + EI++L R ++++L I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHT 600
L++E++ N K LY +L+ + L + L Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFK-QLY----QTLTDYDIRFYMYEIL-------KALDYCHS 148
Query: 601 GYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTG-PEIDQTH-VSTAVKGSFGYLDPE 657
++HRDVK N+++D E+ ++ D+GL++ P + V++ + PE
Sbjct: 149 ---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPE 200
Query: 658 YFRRQQLTEKS-DVYSFGVVLFEVL 681
Q+ + S D++S G +L ++
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMI 225
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 44/249 (17%), Positives = 90/249 (36%), Gaps = 76/249 (30%)
Query: 491 VIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLI 546
+G G FG V + + G + A+K+ L + + E++++ H +++ L+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 547 GY--------------------------------------CDEKNEMILIYEYMENGTLK 568
Y + + +I EY+ + TL
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 569 GHLYGSGLPSLSWKQRLE----------ICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618
L + + + + R + ++H+ + HRD+K N+L+
Sbjct: 126 KVLKSF----IRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLV 174
Query: 619 D-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVV 676
+ ++ K+ DFG +K + V+ S Y PE + T D++S G V
Sbjct: 175 NSKDNTLKLCDFGSAKKLIP-SEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 677 LFEVLCARP 685
E++ +P
Sbjct: 232 FGELILGKP 240
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGT--------KVAVKRGNPRSQQGLAEFQTEIEMLS 535
NF+ V+G G +GKV+ G KV K + + +TE ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 536 QFRHRH-LVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EIC 588
R LV+L Y + K +IL +Y+ G L HL + ++ EI
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLIL--DYINGGELFTHLSQRERFTEHEV-QIYVGEIV 169
Query: 589 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG--PEIDQTHVSTA 646
+ L +LH +I+RD+K NILLD N + DFGLSK E ++ +
Sbjct: 170 LA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY---- 218
Query: 647 VKGSF-G---YLDPEYFRRQQL--TEKSDVYSFGVVLFEVLCARP 685
F G Y+ P+ R + D +S GV+++E+L
Sbjct: 219 ---DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 5e-13
Identities = 35/200 (17%), Positives = 54/200 (27%), Gaps = 53/200 (26%)
Query: 482 ATNNFDESWVIGIGGFGKVYKGELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEM 533
T IG G FG+V++ D T VA+K N Q+ E EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 534 L-----------------SQFRHRHLV------SLIGYCDE----------------KNE 554
H V L+ D ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 614
+ ++ E+ G L S I L HRD+
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWG 191
Query: 615 NILLDENFMAKVADFGLSKT 634
N+LL + + K+ K+
Sbjct: 192 NVLLKKTSLKKLHYTLNGKS 211
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 64/307 (20%), Positives = 120/307 (39%), Gaps = 73/307 (23%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFR-------- 538
+G G F V+ + + + T VA+K RG+ ++ + EI++L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDADNTKED 81
Query: 539 ---HRHLVSLIGYCDEKNE----MILIYEYMENGTLKGHLY-------GSGLPSLSW--- 581
H++ L+ + + K +++++E L +L G+P L +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIP-LIYVKQ 135
Query: 582 --KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE------NFMAKVADFGLSK 633
KQ L GL Y+H +IH D+K N+L++ K+AD G +
Sbjct: 136 ISKQLLL-------GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR 693
E H + +++ Y PE +D++S ++FE++ + +P
Sbjct: 187 WYDE----HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP---- 237
Query: 694 EMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
E ++ + QII+ L G++ P L + G+ G+ R
Sbjct: 238 -----DEGHSYTKDDDHIAQIIE--LLGEL-PSYLLRNGKYTRTFFNSRGLLRNISKLKF 289
Query: 754 WNLEYAL 760
W LE L
Sbjct: 290 WPLEDVL 296
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 41/209 (19%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR------ 540
VIG G FG+V K VA+K R R +Q EI +L R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTM 159
Query: 541 HLVSLIGYCDEKNEMILI--------YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 592
+++ ++ +N + + YE ++ +G S +
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG---------FSLPLVRKFAHSIL 210
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGS 650
+ L LH +IH D+K NILL + + KV DFG S + V T ++
Sbjct: 211 QCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVYTYIQSR 263
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFE 679
F Y PE + D++S G +L E
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 33/157 (21%), Positives = 56/157 (35%), Gaps = 30/157 (19%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLIGYC 549
IG G FG +++G L + +VA+K RS E + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYFG 75
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSL--------SWKQRLEICIGSARGLHYLHTG 601
E +L+ ++ L G L L S K + +H
Sbjct: 76 QEGLHNVLV---ID-------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE- 124
Query: 602 YAKAVIHRDVKSANILLDENFMAK-----VADFGLSK 633
K++++RD+K N L+ V DFG+ K
Sbjct: 125 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 34/176 (19%), Positives = 62/176 (35%), Gaps = 50/176 (28%)
Query: 492 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551
IG GGFG +Y ++N V +++ + L + + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDA------------PCVVKVEPS-DNGPLFTELKFYQR 89
Query: 552 KNEMILIYEYMENGTLKG----HLYGSGL-----------------PSL----------- 579
+ I +++ LK +GSGL L
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149
Query: 580 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV--ADFGLSK 633
S K L++ + L Y+H +H D+K++N+LL+ +V D+GL+
Sbjct: 150 SRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 26/165 (15%), Positives = 57/165 (34%), Gaps = 28/165 (16%)
Query: 492 IGIGGFGKVYKGE---------LNDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFR 538
G +Y+ K ++K G ++Q + + +++++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 539 HRHLVSLIG-----YC--DEKNEMILIYEYMENGT-LKGHLYGSGLPSLSWKQRLEICIG 590
+ L+ + L+ + G L+ L S LS + L++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 591 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV--ADFGLSK 633
L +LH +H +V + NI +D ++V A +G +
Sbjct: 168 LLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 41/157 (26%), Positives = 61/157 (38%), Gaps = 32/157 (20%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI---G 547
IG G FG +Y G + G +VA+K +++ E ++ + + I G
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSL--------SWKQRLEICIGSARGLHYLH 599
+ N M+ ME L G L L S K L + + Y+H
Sbjct: 75 AEGDYNVMV-----ME-------LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 600 TGYAKAVIHRDVKSANILLDENFMAK---VADFGLSK 633
+K IHRDVK N L+ + DFGL+K
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 47/215 (21%), Positives = 77/215 (35%), Gaps = 39/215 (18%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR------ 540
+IG G FG+V K + VA+K + Q E+ +L
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKY 116
Query: 541 HLVSLIGYCDEKNEMILI--------YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 592
++V L + +N + L+ Y+ + N +G +S +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG---------VSLNLTRKFAQQMC 167
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 650
L +L T +IH D+K NILL + K+ DFG S + ++
Sbjct: 168 TALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFG-SSC---QLGQRIYQYIQSR 222
Query: 651 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 685
F Y PE D++S G +L E+ P
Sbjct: 223 F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 45/211 (21%), Positives = 72/211 (34%), Gaps = 41/211 (19%)
Query: 454 MGSKYSHGTTTSANSNSGYRF--PFVAVQEATNNFDESWV----IGIGGFGKVYKGE-LN 506
M + H + + + Y PF + + WV IG GGFG +Y N
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTN 60
Query: 507 DGTKVA---VKRGNPRSQQGLAEFQTEI-----EMLSQFRHRHLVSLIG-----YCDEKN 553
K A VK + +E + + + ++ R + +G
Sbjct: 61 KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120
Query: 554 EMILIYEY--MENGTLKGHLYGSGLPSL-------SWKQRLEICIGSARGLHYLHTGYAK 604
Y + ME G L + L++ I L Y+H
Sbjct: 121 FKGRSYRFMVME-------RLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---EN 170
Query: 605 AVIHRDVKSANILLDENFMAKV--ADFGLSK 633
+H D+K+AN+LL +V AD+GLS
Sbjct: 171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 40/160 (25%), Positives = 60/160 (37%), Gaps = 36/160 (22%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLIGYC 549
IG G FG++ G+ L VA+K +S+ E Q + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSL-----------SWKQRLEICIGSARGLHYL 598
++ +E L G PSL S K L I I + Y+
Sbjct: 75 PCGKYNAMV---LE-------LLG---PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 599 HTGYAKAVIHRDVKSANILL--DENFMAKVA---DFGLSK 633
H+ K +I+RDVK N L+ N +V DF L+K
Sbjct: 122 HS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 59/372 (15%), Positives = 101/372 (27%), Gaps = 136/372 (36%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR--------HR 540
+G G F V+ + VA+K + + EI +L R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA---LDEIRLLKSVRNSDPNDPNRE 101
Query: 541 HLVSLIGY-----------CDEKNEMILIYEYM-EN-GTLKGHLYGSGLPSLSWKQRLEI 587
+V L+ C +++E + + GLP K+ I
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-------MVFEVLGHHLLKWIIKSNYQGLPLPCVKK---I 151
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILL----------------------------- 618
+GL YLHT +IH D+K NILL
Sbjct: 152 IQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 619 --------------------DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
E K+AD G + + + T Y E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEV 264
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR----------EMVNL-----AEWAM 703
+D++S + FE+ + +P ++ L + +
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 704 KWQN-------KGQLDQIIDPTLAGKIRPDSL-------RKFGETAEKCLADFGV----- 744
+ KG L I K++P L ++ + DF +
Sbjct: 325 AGKYSKEFFTKKGDLKHIT------KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378
Query: 745 ---DRPSMGDVL 753
R + + L
Sbjct: 379 IPEKRATAAECL 390
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 34/147 (23%), Positives = 67/147 (45%), Gaps = 12/147 (8%)
Query: 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYC 549
IG G FG++Y G + +VA+K N +++ + E ++ + + ++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
E + +L+ + + G L+ LS K L + + ++H+ K+ +HR
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127
Query: 610 DVKSANILLDENFMAK---VADFGLSK 633
D+K N L+ A + DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 50/228 (21%), Positives = 85/228 (37%), Gaps = 57/228 (25%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR-----H 541
+G G FG+V + +++ AVK R + ++ + E ++L + ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLY----GSGLPSLSWKQRLEICIGSARGLHY 597
+V G + M LI+E L LY + + CI + L+Y
Sbjct: 98 IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVK----GSF 651
L ++ H D+K NILLD+ + K T + Q + ST +K G
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 652 GYLD--------------PE------YFRRQQLTEKSDVYSFGVVLFE 679
+ PE + SD++SFG VL E
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 46/233 (19%), Positives = 78/233 (33%), Gaps = 71/233 (30%)
Query: 491 VIGIGGFGKVYKG--ELNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR----- 540
+G G FGKV + ++VA+K R + + + EI +L + + +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 541 -HLVSLIGYCDEKNEMIL--------IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS 591
V + + + M + +E+++ + +
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP---------YPLPHVRHMAYQL 132
Query: 592 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMA-------------------KVADFGLS 632
L +LH + H D+K NIL + +VADFG S
Sbjct: 133 CHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-S 188
Query: 633 KTGPEIDQTHVSTAVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFE 679
T D H +T V Y PE + + DV+S G +LFE
Sbjct: 189 AT---FDHEHHTTIVATRH-YRPPEVILELGW------AQPCDVWSIGCILFE 231
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 42/227 (18%), Positives = 86/227 (37%), Gaps = 59/227 (25%)
Query: 491 VIGIGGFGKVYKG--ELNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR----- 540
+G G FGKV + G VAVK + R + ++EI++L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 541 -HLVSLIGYCDEKNEMILIYEYMENGT---LKGHLYGSGLPSLSWKQRLEICIGSARGLH 596
V ++ + + + +++E + T +K + + L ++ + + ++
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF-LPFR-LDHIRK--MAYQICKSVN 132
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK----GSFG 652
+LH+ + H D+K NIL ++ + + ++T ++ +K GS
Sbjct: 133 FLHS---NKLTHTDLKPENILFVQSDYTEAYN----PKIKRDERTLINPDIKVVDFGSAT 185
Query: 653 YLD--------------PE------YFRRQQLTEKSDVYSFGVVLFE 679
Y D PE + ++ DV+S G +L E
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE 226
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 828 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.85 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.75 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.61 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.5 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.5 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.07 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.95 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.62 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.49 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.43 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.7 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.05 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.72 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.19 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.17 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.06 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.94 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=457.37 Aligned_cols=260 Identities=28% Similarity=0.448 Sum_probs=211.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...+.||+|+||.||+|+++ +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 478899999988877778899999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCC-------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 558 IYEYMENGTLKGHLYGSG-------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
|||||++|+|.++|+... ..+++|.++++|+.|||+||+|||+ ++||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999996532 2469999999999999999999999 999999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||+++.....+.....+...||+.|||||++.+..++.++|||||||+||||+| |+.||......+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----- 272 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC----- 272 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH-----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH-----
Confidence 9999999997654444444556789999999999999999999999999999999999 8999986654432211
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
...+. . ...+..++.++.+++.+||+.+|++||||.||++.|+.+.+.
T Consensus 273 --i~~g~-----~----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 --ITQGR-----E----LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --HHHTC-----C----CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHcCC-----C----CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11111 0 112344566789999999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=454.96 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=217.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...+.||+|+||.||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677789999999999999864 467899999988877778899999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCC-----------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEE
Q 003350 558 IYEYMENGTLKGHLYGS-----------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV 626 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl 626 (828)
|||||++|+|.++|+.. ....++|.++++|+.|||+||+|||+ ++||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999653 23579999999999999999999999 99999999999999999999999
Q ss_pred EeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHH
Q 003350 627 ADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKW 705 (828)
Q Consensus 627 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 705 (828)
+|||+|+.....+.........||+.|||||++.++.++.|+|||||||+||||+| |+.||......+....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~------- 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC------- 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------
Confidence 99999986544333333345679999999999999999999999999999999998 8999986654432211
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
...+.. ...+..++.++.+++.+||+.+|.+||||.||++.|+.+.+.
T Consensus 243 i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111211 112344567789999999999999999999999999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=449.38 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=211.9
Q ss_pred CCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 486 FDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
+...+.||+|+||.||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+.+..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 344578999999999999863 46789999987653 34468899999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 559 YEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
||||++|+|.++|.... ...++|.++++|+.|||+||+|||+ .+||||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCE
Confidence 99999999999996432 2459999999999999999999999 999999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||+++.....+.....+...||+.|||||++.++.++.++|||||||+||||+| |+.||......+... .
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~---~-- 259 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE---M-- 259 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH---H--
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH---H--
Confidence 9999999987544333334456789999999999999999999999999999999998 899998665443221 1
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
...+.. ...+.+++..+.+++.+||+.+|.+||+|.||++.|+.
T Consensus 260 --i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 260 --IRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp --HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred --HHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 112211 12344567788999999999999999999999998864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=440.63 Aligned_cols=259 Identities=28% Similarity=0.496 Sum_probs=206.1
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
+++...+.||+|+||+||+|++++ .||||.++.. +.+..++|.+|+++|++++|||||+++|+|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456677899999999999998763 5999987654 34556789999999999999999999999865 568999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
|++|+|.++|+... .+++|.++++|+.|||+||+|||+ ++||||||||+||||++++++||+|||+|+........
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999997654 469999999999999999999999 89999999999999999999999999999876543334
Q ss_pred ceeccccccccccChhhhcc---CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 642 HVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.......||+.|||||++.+ +.++.|+|||||||+||||+||+.||......+.. ......+ ...|.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~----~~~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRG----YASPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTT----CCCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC----CCCCC
Confidence 44556789999999999964 46899999999999999999999999765432211 1111111 11222
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
+. ....+++..+.+++.+||+.+|.+||||.||++.|+.+.
T Consensus 259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 21 233456678899999999999999999999999987653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=437.37 Aligned_cols=263 Identities=23% Similarity=0.347 Sum_probs=216.5
Q ss_pred HhcCCCccceEeeeCcEEEEEEEecC------CcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCC-CceEEEEEEEcc-C
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRH-RHLVSLIGYCDE-K 552 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~-~ 552 (828)
..++|...+.||+|+||.||+|++.. ++.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+ +
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 35678888999999999999997642 36899999876543 446789999999999965 899999999966 4
Q ss_pred CcEEEEEEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe
Q 003350 553 NEMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 618 (828)
+.+++|||||++|+|.++|+... ...++|.+++.|+.|||+||+|||+ ++||||||||+||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceee
Confidence 57899999999999999996432 2458999999999999999999999 999999999999999
Q ss_pred CCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhh
Q 003350 619 DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVN 697 (828)
Q Consensus 619 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~ 697 (828)
++++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+.
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-- 296 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 296 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999997654333344556789999999999999999999999999999999998 8999976543221
Q ss_pred HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
......++. ....+..++.++.+++.+||+.+|.+|||+.||++.|+.+++.
T Consensus 297 ----~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 ----FCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp ----HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 111112221 1122334556788999999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=433.02 Aligned_cols=251 Identities=23% Similarity=0.385 Sum_probs=206.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|+||.||+|+.. +|+.||||++... .....+.|.+|+++|++++|||||++++++.+.+.+++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57888999999999999999865 6899999998654 33446789999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
||++|+|.++|...+...+++.+++.|+.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+.... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence 9999999999976665678999999999999999999999 9999999999999999999999999999987532 1
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
....+..+||+.|||||++.+..|+.++|||||||+||||+||++||......+.. ..... +.. +
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~~i~~-~~~-----~--- 243 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV------LKIIS-GSF-----P--- 243 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHH-TCC-----C---
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHHHc-CCC-----C---
Confidence 22234568999999999999999999999999999999999999999865443321 11111 111 1
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223445678899999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=428.52 Aligned_cols=259 Identities=21% Similarity=0.240 Sum_probs=211.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+.|...++||+|+||.||+|+.. +|+.||||+++.... +.+|+++|++++|||||++++++.+++.++||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777789999999999999875 589999999875432 247999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-cEEEEeeCCCCCCCCCCcc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kl~DFGla~~~~~~~~~ 641 (828)
++|+|.++|...+ .+++.++..++.||+.||+|||+ ++||||||||+||||+.++ ++||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997543 69999999999999999999999 9999999999999999987 6999999999875432211
Q ss_pred ---ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 642 ---HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 642 ---~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
......+||+.|||||++.+..++.++|||||||+||||+||++||......+.... ..... +.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~~-------~~ 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK------IASEP-------PP 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH------HHHSC-------CG
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH------HHcCC-------CC
Confidence 112346799999999999999999999999999999999999999976544332211 11111 00
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
+ ..+++..+..+.+++.+||+.+|.+|||+.|+++.|..+++....+
T Consensus 275 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l 321 (336)
T 4g3f_A 275 I-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321 (336)
T ss_dssp G-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSS
T ss_pred c-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhc
Confidence 0 1233455667889999999999999999999999999888765443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=428.08 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=209.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
..|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+.++||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888889999999999999875 68999999987655555677899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++++||+|||+|+..... ..
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP 225 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SC
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CC
Confidence 999999998653 59999999999999999999999 99999999999999999999999999999875432 22
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
..+..+||+.|||||++.+..|+.++|||||||+||||++|++||....+.+....+ ..+ ..+.+ .
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~-----~~~~~--~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDN-----LPPRL--K 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHS-----SCCCC--S
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcC-----CCCCC--C
Confidence 345678999999999999999999999999999999999999999765543322111 111 11111 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
........+.+++.+||+.||.+|||+.|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11344567889999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=430.08 Aligned_cols=269 Identities=24% Similarity=0.344 Sum_probs=201.4
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC----cEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 559 (828)
+++...+.||+|+||.||+|+++ |+.||||++...... ...+..|+..+.+++|||||+++|+|.+.+ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 34666789999999999999885 899999998654321 122344666667889999999999997653 589999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhc-----CCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG-----YAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
|||++|+|.++|+.. +++|.++++|+.|+|+||+|||+. +.++||||||||+|||||.++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999754 599999999999999999999973 134999999999999999999999999999986
Q ss_pred CCCCCcc--ceeccccccccccChhhhccC------CCCcccceeehhhHHHHHHhcCCCCCCCChhh----h-----hh
Q 003350 635 GPEIDQT--HVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE----M-----VN 697 (828)
Q Consensus 635 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGvvl~elltG~~p~~~~~~~~----~-----~~ 697 (828)
....... .......||+.|||||++.+. .++.|+|||||||+||||+||++|+......+ . ..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 5432211 122346799999999999754 46789999999999999999988764322111 0 01
Q ss_pred HHHHHHHHhhcCCcccccCccccCC-CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 698 LAEWAMKWQNKGQLDQIIDPTLAGK-IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
.... ...... +.++|.+... ...+.+..+.+++.+||+.+|.+||||.||++.|+++.+.
T Consensus 238 ~~~~-~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEM-RKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHH-HHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHH-HHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1111 111111 1122322211 1235677899999999999999999999999999987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=419.74 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=210.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...++||+|+||+||+|+.. +++.||||.+... .....+.+.+|+++|++++|||||++++++.+.+.+++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56899999999999999999865 6899999988643 2334678999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
|||++|+|.+++...+ .+++.+...++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999996543 69999999999999999999999 999999999999999999999999999999765433
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........+||+.|||||++.+..|+.++||||+||+||||+||++||......+... .... +. .
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~------~i~~-~~------~-- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA------KIIK-LE------Y-- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH-TC------C--
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHc-CC------C--
Confidence 3444566789999999999999999999999999999999999999998654433221 1111 11 1
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
.++.....++.+++.+||+.||.+|||+.|++
T Consensus 252 --~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12223345678999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=413.92 Aligned_cols=244 Identities=27% Similarity=0.404 Sum_probs=195.8
Q ss_pred CccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc----CCcEEEEE
Q 003350 487 DESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE----KNEMILIY 559 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 559 (828)
...+.||+|+||.||+|... ++..||+|++... .....+.|.+|+++|++++|||||+++++|.. +..++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34568999999999999875 5889999987643 34446789999999999999999999999854 45689999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC--EEeeeeecCcEEeC-CCCcEEEEeeCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA--VIHRDVKSANILLD-ENFMAKVADFGLSKTGP 636 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILld-~~~~~kl~DFGla~~~~ 636 (828)
|||++|+|.+++... ..+++.++..|+.||+.||+|||+ ++ ||||||||+||||+ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999754 369999999999999999999998 66 99999999999998 47999999999998643
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
. ......+||+.|||||++.+ .++.++|||||||+||||+||++||........ + ... ...+.. .
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~---~~~-i~~~~~----~ 248 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---YRR-VTSGVK----P 248 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---HHH-HTTTCC----C
T ss_pred C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--H---HHH-HHcCCC----C
Confidence 2 22345789999999999864 699999999999999999999999965432211 1 111 111110 1
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+... ...+.++.+++.+||+.+|.+|||+.|+++
T Consensus 249 ~~~~----~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ASFD----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGG----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 222345788999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=429.28 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=210.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+.|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+.++||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888899999999999999875 68999999987766666677899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.+++... .+++.++..|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+..... ..
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP 302 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CC
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCC--Cc
Confidence 999999998643 49999999999999999999999 99999999999999999999999999999875432 22
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||....+.+....+ ..+ ..+.+.
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~-----~~~~~~-- 368 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDN-----LPPRLK-- 368 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHS-----CCCCCS--
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcC-----CCCCCc--
Confidence 345678999999999999999999999999999999999999999765543332211 111 111111
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
........+.+++.+||+.||.+|||+.|+++
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11234566889999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=402.16 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=192.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999865 68999999886542 334567999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+ +|+|.+++...+ .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-- 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC--
Confidence 999 689999986543 69999999999999999999999 9999999999999999999999999999987543
Q ss_pred ccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
........||+.|||||++.+..+ +.++||||+||++|||+||+.||......+... ... .+. .
T Consensus 165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~------~i~-~~~------~- 229 (275)
T 3hyh_A 165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK------NIS-NGV------Y- 229 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-HTC------C-
T ss_pred -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-cCC------C-
Confidence 222345789999999999998776 589999999999999999999997654332211 111 111 1
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.++...+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122334567899999999999999999999763
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=410.54 Aligned_cols=291 Identities=73% Similarity=1.188 Sum_probs=260.6
Q ss_pred cccCHHHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc
Q 003350 472 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551 (828)
Q Consensus 472 ~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (828)
.++++.++..++++|...+.||+|+||.||+|+.++++.||||+.........+.+.+|++++++++||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 46777788889999999999999999999999988899999999888777778899999999999999999999999999
Q ss_pred CCcEEEEEEeccCCcccccccCCCC--CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 552 KNEMILIYEYMENGTLKGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
.+..++||||+++|+|.+++..... ..++|.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999976542 359999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 709 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (828)
|+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+......|.......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 99986544333333455678999999999999999999999999999999999999998887777788888888777778
Q ss_pred CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhh
Q 003350 710 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 765 (828)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~ 765 (828)
.+...+++.+......+.+..+.+++.+||+.+|.+||++.||++.|+.+++.++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 88888888888788889999999999999999999999999999999999887653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=410.70 Aligned_cols=242 Identities=24% Similarity=0.304 Sum_probs=195.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|+..+.||+|+||+||+|+.. .++.||||.+.... ......+.+|+++|++++|||||++++++.+.+.+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46888899999999999999752 46789999886542 2234568899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|||||++|+|.+++...+ .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++++||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997643 69999999999999999999999 9999999999999999999999999999986433
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.........||+.|||||++.+..++.++|||||||+||||+||++||......+.... ... +..
T Consensus 179 --~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~------i~~-~~~------ 243 (304)
T 3ubd_A 179 --HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM------ILK-AKL------ 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHH-CCC------
T ss_pred --CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH------HHc-CCC------
Confidence 12234457899999999999999999999999999999999999999986654433211 111 111
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
.++...+.++.+++.+||+.+|.+|||+
T Consensus 244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1223345668899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=391.79 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=187.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCC--------
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-------- 553 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 553 (828)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888899999999999999865 68999999886543 344577999999999999999999999986544
Q ss_pred ----cEEEEEEeccCCcccccccCCCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEe
Q 003350 554 ----EMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 628 (828)
Q Consensus 554 ----~~~lV~ey~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~D 628 (828)
.+++|||||++|+|.+++..... ...++..++.|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976542 345677789999999999999999 9999999999999999999999999
Q ss_pred eCCCCCCCCCCcc----------ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhH
Q 003350 629 FGLSKTGPEIDQT----------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 698 (828)
Q Consensus 629 FGla~~~~~~~~~----------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l 698 (828)
||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||... .+....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 9999875432211 11234579999999999999999999999999999999996 66421 111111
Q ss_pred HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 699 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. .. ...... |.. ..+....+.+++.+||+.+|.+|||+.|+++
T Consensus 237 ~---~~-~~~~~~-----p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 L---TD-VRNLKF-----PPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H---HH-HHTTCC-----CHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---HH-HhcCCC-----CCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 11 111111 000 1223345678999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=389.11 Aligned_cols=286 Identities=41% Similarity=0.692 Sum_probs=247.6
Q ss_pred cccCHHHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEc
Q 003350 472 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550 (828)
Q Consensus 472 ~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 550 (828)
..|++.++..+.++|...++||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||++++++|.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 57899999999999999999999999999999988899999999876532 22346899999999999999999999999
Q ss_pred cCCcEEEEEEeccCCcccccccCCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEe
Q 003350 551 EKNEMILIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 628 (828)
Q Consensus 551 ~~~~~~lV~ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~D 628 (828)
..+..++||||+++|+|.+++.... ...++|..++.|+.|++.||+|||+.+..+|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997643 34599999999999999999999993333999999999999999999999999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCC--hhhhhhHHHHHHHHh
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL--PREMVNLAEWAMKWQ 706 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~--~~~~~~l~~~~~~~~ 706 (828)
||+++.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||+... .........|.....
T Consensus 178 fg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDY-KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCS-SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCc-ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 999987543 22333455679999999999999999999999999999999999999996321 223345677777777
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
....+..+.+..+......+.+..+.+++.+|++.+|.+|||+.||+++|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 7778888888888888888999999999999999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=396.99 Aligned_cols=265 Identities=21% Similarity=0.298 Sum_probs=203.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEcc------CCc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE------KNE 554 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 554 (828)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 56888899999999999999875 68999999987543 3345678899999999999999999998753 467
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
++||||||+ |+|.+++... ..+++.++..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999996 6899999654 379999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCC--ccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 635 GPEID--QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 635 ~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
..... ........+||+.|+|||++.+. .++.++||||+||++|||++|++||......+....+............
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 53321 22234567899999999998875 5699999999999999999999999876554433222111100000000
Q ss_pred ccc-----------cCccccC---CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQI-----------IDPTLAG---KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~-----------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+ +.+.... ...+.....+.+++.+||+.||.+|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000 001123456789999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=383.71 Aligned_cols=201 Identities=23% Similarity=0.355 Sum_probs=171.6
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcE
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (828)
...++|...+.||+|+||.||+|+.+ .++.||||++.... ...++.+|+++|..+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999753 46789999886553 346688999999998 699999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC-CcEEEEeeCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKT 634 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kl~DFGla~~ 634 (828)
++||||+++|+|.+++. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999982 48999999999999999999999 999999999999999877 7999999999975
Q ss_pred CCCCCc--------------------------cceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCC
Q 003350 635 GPEIDQ--------------------------THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVI 687 (828)
Q Consensus 635 ~~~~~~--------------------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~ 687 (828)
...... ....+..+||+.|+|||++.+. .++.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 432111 0112345799999999999775 5899999999999999999999999
Q ss_pred CCCC
Q 003350 688 DPTL 691 (828)
Q Consensus 688 ~~~~ 691 (828)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=404.61 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=211.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+|+.. +|+.||+|.+........+.+.+|+++|+.++|||||++++++.+.+.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 467999999999999999999875 6899999998877666677899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC--CcEEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN--FMAKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~--~~~kl~DFGla~~~~~~~ 639 (828)
|++|+|.++|.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 99999999986543 469999999999999999999999 999999999999999854 8999999999987643
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.......+||+.|||||++.+..|+.++||||+||+||||++|++||......+....+ . .... .+++..
T Consensus 310 -~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i------~-~~~~--~~~~~~ 379 (573)
T 3uto_A 310 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------K-SCDW--NMDDSA 379 (573)
T ss_dssp -TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------H-TTCC--CCCSGG
T ss_pred -CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------H-hCCC--CCCccc
Confidence 22334568999999999999999999999999999999999999999876544332111 1 1110 011111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. ......+.+++.+||+.+|.+||++.|+++
T Consensus 380 ~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 F----SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp G----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 223456788999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=378.25 Aligned_cols=262 Identities=26% Similarity=0.451 Sum_probs=217.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec--------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccC
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK 552 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 552 (828)
.++|...+.||+|+||.||+|+.. ++..||||++.... ....+++.+|+++|+++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357788899999999999999752 35679999987653 34467899999999999 899999999999999
Q ss_pred CcEEEEEEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe
Q 003350 553 NEMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 618 (828)
+..++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997543 2358999999999999999999999 999999999999999
Q ss_pred CCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhh
Q 003350 619 DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVN 697 (828)
Q Consensus 619 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~ 697 (828)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986544333233345567889999999999999999999999999999999 999997654433221
Q ss_pred HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
. ...+. ....+..+...+.+++.+||+.+|.+||++.|+++.|+.+++..
T Consensus 317 ~-------~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 317 L-------LKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp H-------HHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H-------HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 11111 11123345567889999999999999999999999999988765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=398.93 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=199.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHH---HHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEF---QTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
++|...++||+|+||.||+|+.. +|+.||||.+.... ......+ ..++.+++.++|||||++++++.+.+.++
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57889999999999999999876 58999999875321 1122223 34567778889999999999999999999
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
||||||++|+|.++|...+ .+++..+..++.||+.||+|||+ .+||||||||+||||+.++++||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999997643 69999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.. .....+||+.|||||++.+ ..|+.++||||+||+||||++|++||......+...+..... . .
T Consensus 344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~-~------ 409 (689)
T 3v5w_A 344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T-M------ 409 (689)
T ss_dssp SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---H-C------
T ss_pred CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---C-C------
Confidence 31 2345689999999999975 579999999999999999999999997543222211111111 1 1
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCC-----hHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW 754 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eVl~ 754 (828)
.. .++.....++.+++.+||+.+|.+|++ +.||++
T Consensus 410 ~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01 122334566889999999999999998 566653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.06 Aligned_cols=281 Identities=36% Similarity=0.646 Sum_probs=231.7
Q ss_pred cccCHHHHHHHhcCCCcc------ceEeeeCcEEEEEEEecCCcEEEEEEcCCC----CcccHHHHHHHHHHHHcCCCCc
Q 003350 472 YRFPFVAVQEATNNFDES------WVIGIGGFGKVYKGELNDGTKVAVKRGNPR----SQQGLAEFQTEIEMLSQFRHRH 541 (828)
Q Consensus 472 ~~~~~~~l~~at~~f~~~------~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~n 541 (828)
..|++.++..++++|+.. +.||+|+||.||+|.. +++.||||++... .....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 578999999999999988 8999999999999987 4789999987653 2344678999999999999999
Q ss_pred eEEEEEEEccCCcEEEEEEeccCCcccccccCC-CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC
Q 003350 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 620 (828)
Q Consensus 542 iv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~ 620 (828)
|+++++++...+..++||||+++++|.+++... ....++|..++.++.|++.||+|||+ .+++||||||+|||++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998643 23569999999999999999999999 89999999999999999
Q ss_pred CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHH
Q 003350 621 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 700 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~ 700 (828)
++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|++||......+.. ..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--TH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--HH
Confidence 99999999999987554333333445679999999998864 5899999999999999999999999765433221 12
Q ss_pred HHHHHhh-cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 701 WAMKWQN-KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 701 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
+...... ...+...+++.+. .........+.+++.+|++.+|.+||++.+|++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2222211 2233444444442 345677888999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=367.23 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=214.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
++|...++||+|+||.||+|... +++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46777899999999999999875 58899999988777777889999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999997643 469999999999999999999999 999999999999999999999999999998654322111
Q ss_pred ------------eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh---hHHHHHHHHhh
Q 003350 643 ------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV---NLAEWAMKWQN 707 (828)
Q Consensus 643 ------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~---~l~~~~~~~~~ 707 (828)
......||+.|+|||++.+..++.++|||||||++|||++|..|+....+.... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~------ 239 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF------ 239 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc------
Confidence 112457999999999999999999999999999999999999988654332211 11111
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
.+. ..+...+..+.+++.+|++.+|.+||++.|+++.|+.+.+..
T Consensus 240 -------~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 240 -------LDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -------HHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------ccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 001 112233456888999999999999999999999999876554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=367.35 Aligned_cols=262 Identities=25% Similarity=0.401 Sum_probs=213.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...++||+|+||.||+|... .+..||||++... .....+.|.+|++++++++||||+++++++...+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 346777899999999999999874 3556999998765 34456789999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999996543 469999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCc-cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 638 IDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 638 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..... ..+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~~~------ 270 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-------EEG------ 270 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------HTT------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-------HcC------
Confidence 221 122234456888999999999999999999999999999999 99999765443322111 111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
.....+...+..+.+++.+||+.+|.+||++.||++.|+.+++..+
T Consensus 271 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 271 ---YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ---CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0111223455678899999999999999999999999999876544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=364.39 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=206.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...+.||+|+||.||+|+. .++.||||++.... ....++|.+|++++++++||||+++++++...+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 56788889999999999999987 48899999987653 3445678999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCC--EEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKA--VIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|+++|+|.+++..... ..+++.+++.++.|+++||+|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999976432 348999999999999999999999 78 99999999999999999999999999986432
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+...... ....
T Consensus 192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~------~~~~------- 256 (309)
T 3p86_A 192 --TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG------FKCK------- 256 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH------HSCC-------
T ss_pred --cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcCC-------
Confidence 1112345679999999999999999999999999999999999999998665443221111 0100
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
....+......+.+++.+||+.+|.+||++.|+++.|+.+++.
T Consensus 257 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 257 --RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0122234456788999999999999999999999999887653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=361.08 Aligned_cols=261 Identities=23% Similarity=0.318 Sum_probs=217.2
Q ss_pred cccCHHHHHHHhcC----------CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCC
Q 003350 472 YRFPFVAVQEATNN----------FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR 540 (828)
Q Consensus 472 ~~~~~~~l~~at~~----------f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 540 (828)
..++.++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45888999988875 566679999999999999876 6899999998877767778899999999999999
Q ss_pred ceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC
Q 003350 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 620 (828)
Q Consensus 541 niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~ 620 (828)
||+++++++...+..++||||+++++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECC
Confidence 9999999999999999999999999999998643 59999999999999999999999 89999999999999999
Q ss_pred CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHH
Q 003350 621 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 700 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~ 700 (828)
++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~---~ 251 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---K 251 (321)
T ss_dssp TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H
T ss_pred CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 9999999999998654321 1234567999999999999999999999999999999999999999765433221 1
Q ss_pred HHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 701 WAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 701 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... .. ..+.+. ........+.+++.+||+.+|.+||++.|+++
T Consensus 252 ---~~~-~~-----~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 ---RLR-DS-----PPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---HHH-HS-----SCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHh-cC-----CCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 11 111111 11233556889999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=372.53 Aligned_cols=264 Identities=25% Similarity=0.415 Sum_probs=205.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...++||+|+||.||+|+.. ++..||||.+... .....++|.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357888899999999999999875 4678999998765 34456789999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999997543 469999999999999999999999 8999999999999999999999999999987543
Q ss_pred CCccc-eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 638 IDQTH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 638 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
..... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+.... ...+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-------i~~~------ 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-------VDEG------ 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-------HHTT------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcC------
Confidence 22111 1223346788999999999999999999999999999998 9999976544332111 1111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
.....+..++..+.+++.+|++.+|.+||++.||++.|+.+++.....
T Consensus 267 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~ 314 (373)
T 2qol_A 267 ---YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSL 314 (373)
T ss_dssp ---EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGG
T ss_pred ---CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcccc
Confidence 111122345677899999999999999999999999999988765433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=354.02 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=213.7
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46777899999999999999988889999999876543 35779999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.... ..+++..++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++.... .....
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTS 163 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC-HHHHS
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccc-ccccc
Confidence 999999996543 469999999999999999999999 9999999999999999999999999999986433 11222
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+... .... + .. ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~------~~~~-~-----~~----~~ 227 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE------DIST-G-----FR----LY 227 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHT-T-----CC----CC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH------HHhc-C-----cc----CC
Confidence 334567888999999999999999999999999999999 999997654433211 1111 1 00 11
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.+......+.+++.+|++.+|.+||++.|+++.|+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 122335568899999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=372.62 Aligned_cols=268 Identities=27% Similarity=0.366 Sum_probs=210.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC----cEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 558 (828)
.++|...++||+|+||.||+|+.. ++.||||++..... ....+..|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 457888899999999999999876 78999999865432 3445667999999999999999999997644 47999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCC----------CEEeeeeecCcEEeCCCCcEEEEe
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK----------AVIHRDVKSANILLDENFMAKVAD 628 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivHrDIkp~NILld~~~~~kl~D 628 (828)
|||+++|+|.+++... .++|.+++.++.|+++||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999654 49999999999999999999998 6 999999999999999999999999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh-------
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV------- 696 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~------- 696 (828)
||+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999976544333333345679999999999986 35667899999999999999999999754332211
Q ss_pred ---hHHHHHHHHhhcCCcccccCccccCCC-ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 697 ---NLAEWAMKWQNKGQLDQIIDPTLAGKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 697 ---~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
....+....... . ..+.+.... ....+..+.+++.+||+.+|.+|||+.||++.|+++.+..
T Consensus 255 ~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVVVHK-K----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHHTTS-C----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhhhcc-c----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111111111111 1 111111111 1245677999999999999999999999999999887653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=376.89 Aligned_cols=260 Identities=27% Similarity=0.395 Sum_probs=212.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...+.||+|+||.||+|+.. +++.||||.+.... ....++|.+|+++|++++||||++++++|...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356777899999999999999886 68999999987543 3334578899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++|+|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999996533 358999999999999999999999 9999999999999999999999999999986433111
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........++..|+|||.+..+.++.++|||||||++|||+| |+.||......+... ....+.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-------~~~~~~--------- 332 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-------FVEKGG--------- 332 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-------HHHTTC---------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCC---------
Confidence 111122345778999999999999999999999999999998 999997654433221 111111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
....+..++..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0112233456788999999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.57 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=209.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45788889999999999999986 46899999998766555677899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|+|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 9999999999654 48999999999999999999999 899999999999999999999999999998654322
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+..... ...+. +.+
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~------~~~-- 236 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGT------PEL-- 236 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCS------CCC--
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC------CCC--
Confidence 2234567999999999999999999999999999999999999999765443321111 11110 000
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+||+.+|.+||++.|+++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112344567889999999999999999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=370.19 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=217.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec--------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccC
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK 552 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 552 (828)
.++|...+.||+|+||.||+|+.. .+..||||++.... ....+++.+|+++++++ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457888899999999999999752 23679999987653 34467899999999999 999999999999999
Q ss_pred CcEEEEEEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe
Q 003350 553 NEMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 618 (828)
+..++||||+++|+|.+++.... ...+++.+++.|+.|+++||+|||+ .+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 99999999999999999996543 2459999999999999999999999 899999999999999
Q ss_pred CCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhh
Q 003350 619 DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVN 697 (828)
Q Consensus 619 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~ 697 (828)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987654333333455678899999999999999999999999999999999 999997654433211
Q ss_pred HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
. ...+. ....+......+.+++.+||+.+|.+||++.||++.|+.++...
T Consensus 305 ------~-~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 305 ------L-LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp ------H-HHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ------H-HHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1 11111 11112334567889999999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=372.67 Aligned_cols=272 Identities=22% Similarity=0.342 Sum_probs=218.1
Q ss_pred cCHHHHHHHhcCCCccceEeeeCcEEEEEEEe------cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEE
Q 003350 474 FPFVAVQEATNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSL 545 (828)
Q Consensus 474 ~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 545 (828)
+.........++|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 33445555678899999999999999999973 245789999987653 34456799999999999 89999999
Q ss_pred EEEEccCC-cEEEEEEeccCCcccccccCCCC------------------------------------------------
Q 003350 546 IGYCDEKN-EMILIYEYMENGTLKGHLYGSGL------------------------------------------------ 576 (828)
Q Consensus 546 ~g~~~~~~-~~~lV~ey~~~gsL~~~l~~~~~------------------------------------------------ 576 (828)
+++|.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99997755 48999999999999999975432
Q ss_pred ----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 577 ----------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 577 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
..+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 128999999999999999999999 8999999999999999999999999999987644333
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. . .....+.
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~----~~~~~~~--------- 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C----RRLKEGT--------- 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--H----HHHHHTC---------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--H----HHHHcCC---------
Confidence 334455678999999999999999999999999999999998 99999765432211 1 1111111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
....+......+.+++.+||+.+|.+||++.|+++.|+.+++..
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 01112234556889999999999999999999999999988643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=365.16 Aligned_cols=267 Identities=25% Similarity=0.372 Sum_probs=210.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-----cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc--CCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 555 (828)
.++|...+.||+|+||.||+|++ .+++.||||++........+.|.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35677889999999999999984 2588999999988777777889999999999999999999999854 3568
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997653 359999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCc-cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh---------hhHHHHHHHH
Q 003350 636 PEIDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM---------VNLAEWAMKW 705 (828)
Q Consensus 636 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~---------~~l~~~~~~~ 705 (828)
..... ........+|..|+|||.+.+..++.++||||||+++|||+||..|+........ ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 43221 1223345578889999999999999999999999999999999998864321100 0001111111
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
...+ .....+..++..+.+++.+||+.+|.+||++.|+++.|+.+.+.
T Consensus 245 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 245 LKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred Hhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1111 11122344567789999999999999999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=363.14 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=206.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCc----EEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...++||+|+||.||+|+.. +++ +||+|.+... .....++|.+|++++++++||||++++++|... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 46788899999999999999864 343 4688887644 335568899999999999999999999999875 4789
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|+||+++|+|.+++.... ..+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999997644 469999999999999999999999 8999999999999999999999999999986544
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
...........+|..|+|||++.+..++.++|||||||++|||+| |+.||......+...... .+.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~------ 236 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE------ 236 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cCC------
Confidence 333333345567889999999999999999999999999999999 999998665443222111 110
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
....+..+...+.+++.+||+.+|.+||++.|+++.|+.+.+...
T Consensus 237 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 281 (327)
T 3poz_A 237 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred ---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence 111223455678899999999999999999999999998876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=358.95 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=216.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEe------cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
.++|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 56788889999999999999975 235789999987643 34567889999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCC----------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeec
Q 003350 556 ILIYEYMENGTLKGHLYGSGL----------------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS 613 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp 613 (828)
++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ .+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999975432 348999999999999999999999 8999999999
Q ss_pred CcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCCh
Q 003350 614 ANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLP 692 (828)
Q Consensus 614 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~ 692 (828)
+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987544333223344567889999999999999999999999999999999 9999976654
Q ss_pred hhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 693 REMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 693 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
.+..... ..+. ....+...+..+.+++.+||+.+|.+||++.|+++.|+++++.
T Consensus 259 ~~~~~~~-------~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ERLFNLL-------KTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGHHHHH-------HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHh-------hcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 4322211 1111 0112234456788999999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=372.37 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=215.3
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
++|...+.||+|+||.||+|++. +++.||||++... ......++.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56788899999999999999853 4678999998654 3445667899999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCC-----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC---cEEEEe
Q 003350 557 LIYEYMENGTLKGHLYGSG-----LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---MAKVAD 628 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kl~D 628 (828)
+||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999996532 2459999999999999999999999 9999999999999999554 599999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhh
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... . .
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~------i-~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF------V-T 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH------H-H
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------H-H
Confidence 999974322112222334568999999999999999999999999999999998 9999976544332211 1 1
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhhhc
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH 768 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~~~ 768 (828)
.+. ....+...+..+.+++.+||+.+|.+||++.||++.|+.+.+..+....
T Consensus 301 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~ 352 (367)
T 3l9p_A 301 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT 352 (367)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTC
T ss_pred cCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccC
Confidence 111 0111233456688999999999999999999999999998877665543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.87 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=212.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.++|...+.||+|+||.||+|+.+++..||+|++..... ..+++.+|++++.+++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 456788899999999999999998888999999876543 3577999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++..... ...
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYV 160 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-CEE
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchh-hhh
Confidence 9999999996543 359999999999999999999999 99999999999999999999999999999865432 222
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+... ...... ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~---~~------- 224 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQGH---RL------- 224 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHTTC---CC-------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------HHHcCC---CC-------
Confidence 2334557788999999999899999999999999999999 999997654433211 111110 00
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
..+......+.+++.+|++.+|.+||++.|+++.|+.+.
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111223456889999999999999999999999987754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.65 Aligned_cols=261 Identities=23% Similarity=0.344 Sum_probs=208.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCc----EEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...++||+|+||.||+|+.. +++ +||+|.+.... ....+.+.+|+.++++++||||++++++|. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46777889999999999999864 343 48888775443 333456789999999999999999999986 567899
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999997643 469999999999999999999999 8999999999999999999999999999987655
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
...........||..|+|||++.+..++.++|||||||++|||+| |+.||......+...... .+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~----- 235 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-------KGER----- 235 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-------TTCB-----
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCCC-----
Confidence 444434455678889999999999999999999999999999999 999998654433222111 1110
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 765 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~ 765 (828)
...+......+.+++.+||+.+|.+||++.|+++.|+.+.+....
T Consensus 236 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~ 280 (325)
T 3kex_A 236 ----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280 (325)
T ss_dssp ----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHH
T ss_pred ----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 011122334577899999999999999999999999988665443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=382.99 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=212.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.++|...+.||+|+||.||+|.++++..||||++.... ...++|.+|+++|++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45678889999999999999999888999999988654 34788999999999999999999999986 56789999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~-~~~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYT 340 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC-HHHH
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC-Ccee
Confidence 99999999976544468999999999999999999999 8999999999999999999999999999987533 1111
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......+|..|+|||++....++.++|||||||+||||+| |+.||......+.... + ..+. ..
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~------i-~~~~---------~~ 404 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA------L-ERGY---------RM 404 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH------H-HHTC---------CC
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH------H-HcCC---------CC
Confidence 1233456789999999999999999999999999999999 9999976544332211 1 1110 01
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
..+..++..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 122345667889999999999999999999999887643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=352.79 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=211.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.++|...+.||+|+||.||+|+..++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457788899999999999999998888999999876543 3577999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYT 176 (283)
T ss_dssp TTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC-HHHH
T ss_pred CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc-cccc
Confidence 9999999996633 359999999999999999999999 9999999999999999999999999999986533 1112
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+... .... + .. .
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~------~~~~-~-----~~----~ 240 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------HIAQ-G-----LR----L 240 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHT-T-----CC----C
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH------HHhc-c-----cC----C
Confidence 2234457788999999999999999999999999999998 999997654433221 1111 1 00 1
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
..+......+.+++.+||+.+|.+||++.|+++.|+++++.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11122345688999999999999999999999999988754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.52 Aligned_cols=264 Identities=28% Similarity=0.421 Sum_probs=214.9
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccC
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 552 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (828)
....++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.|.+|++++++++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344678999999999999999999875 34789999987653 34467899999999999999999999999999
Q ss_pred CcEEEEEEeccCCcccccccCCC----------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeee
Q 003350 553 NEMILIYEYMENGTLKGHLYGSG----------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD 610 (828)
+..++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+ .+|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 99999999999999999986532 1569999999999999999999999 8999999
Q ss_pred eecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCC
Q 003350 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDP 689 (828)
Q Consensus 611 Ikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~ 689 (828)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999976433222222345568899999999999999999999999999999999 9999976
Q ss_pred CChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 690 TLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 690 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
....+... . ...+... ..+...+..+.+++.+||+.+|.+||++.|+++.|+++.+.
T Consensus 280 ~~~~~~~~------~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAHEEVIY------Y-VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCHHHHHH------H-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CChHHHHH------H-HhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 54333211 1 1111111 12234456788999999999999999999999999886543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=355.55 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=206.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|...+.||+|+||.||+|+.. +++.||+|.+... .....+.|.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 356888899999999999999865 6889999987543 234457789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++++|.+++.... ++++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999996543 69999999999999999999999 99999999999999999999999999999875432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. ....... . +.
T Consensus 165 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~-~-----~~ 231 (294)
T 4eqm_A 165 S-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQDS-V-----PN 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSSC-C-----CC
T ss_pred c-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhcc-C-----CC
Confidence 1 12233467999999999999999999999999999999999999999765433211 1111111 0 11
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCC-ChHHHHHHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRP-SMGDVLWNLEYAL 760 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~eVl~~L~~~~ 760 (828)
.......+.+..+.+++.+|++.+|.+|| ++.++.+.|+.++
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 11112234456788999999999999998 8888887776543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=360.48 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=206.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788889999999999999987 47899999987643 3345677889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++...+ .+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-- 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence 9999999999986543 58999999999999999999999 9999999999999999999999999999976432
Q ss_pred ccceeccccccccccChhhhccCCCC-cccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
........||+.|+|||++.+..++ .++|||||||++|||++|+.||......+... .... +..
T Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i~~-~~~------- 231 (328)
T 3fe3_A 167 -GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE------RVLR-GKY------- 231 (328)
T ss_dssp -SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH-CCC-------
T ss_pred -CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHh-CCC-------
Confidence 1223456799999999999888765 89999999999999999999998665433221 1111 110
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+||+.+|.+|||+.|+++
T Consensus 232 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 112233556889999999999999999999964
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=357.07 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=215.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEe------cCCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45688889999999999999975 2467899999876543 3467799999999999 99999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCC----------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe
Q 003350 555 MILIYEYMENGTLKGHLYGSGL----------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 618 (828)
.++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999975432 258999999999999999999999 899999999999999
Q ss_pred CCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhh
Q 003350 619 DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVN 697 (828)
Q Consensus 619 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~ 697 (828)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence 9999999999999987654333333445567889999999999999999999999999999999 99999765432211
Q ss_pred HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
.. ..... .....+...+..+.+++.+|++.+|.+||++.|+++.|+++++.
T Consensus 258 -~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 258 -YK----MIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -HH----HHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HH----HhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 11111 00111233456788999999999999999999999999988764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=384.04 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=215.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
..+|...+.||+|+||.||+|.+.. +..||||.+..... ..++|.+|+++|++++||||++++++|......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4567778899999999999998874 78999999876543 468899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|+|.+++.......+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TY 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCC-ce
Confidence 999999999987655679999999999999999999999 99999999999999999999999999999875432 22
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.......+|..|+|||++....++.++|||||||+||||+| |+.||......+.... ...+ ..
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~~---------~~ 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------LEKD---------YR 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------HHTT---------CC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcC---------CC
Confidence 22334557789999999999999999999999999999999 9999976544332211 1111 11
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
...+..++..+.+++.+||+.+|.+||++.||++.|+.++
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1223345667889999999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=373.43 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=210.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC-cEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-EMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~ey 561 (828)
.++|...+.||+|+||.||+|... ++.||||.++... ..+.|.+|+++|++++||||++++++|.... ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356777889999999999999886 7899999987654 3578999999999999999999999986654 79999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|+|.+++.......+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999987655568999999999999999999999 99999999999999999999999999999854321
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.....++..|+|||++.+..++.++|||||||+||||+| |+.||......+.... ...+. .
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~---------~ 404 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGY---------K 404 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-------HHTTC---------C
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC---------C
Confidence 123367889999999999999999999999999999998 9999976544332211 11111 1
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
...+..++..+.+++.+||+.+|.+||++.++++.|+.+.+.
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 122344567788999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=358.42 Aligned_cols=263 Identities=26% Similarity=0.386 Sum_probs=198.9
Q ss_pred HhcCCCccceEeeeCcEEEEEEEecCC----cEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELNDG----TKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
..++|...+.||+|+||.||+|+.... ..||||.+... .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 356788899999999999999987643 27999998764 344567899999999999999999999999776655
Q ss_pred ------EEEEEeccCCcccccccCC----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEE
Q 003350 556 ------ILIYEYMENGTLKGHLYGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAK 625 (828)
Q Consensus 556 ------~lV~ey~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~k 625 (828)
++||||+++|+|.+++... ....+++.+++.++.|+++||+|||+ .+|+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 9999999999999998542 22369999999999999999999999 8999999999999999999999
Q ss_pred EEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHH
Q 003350 626 VADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 704 (828)
|+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~------ 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY------ 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH------
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH------
Confidence 999999987544333333345567889999999999999999999999999999999 9999976554332211
Q ss_pred HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 705 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
..... ....+...+..+.+++.+||+.+|.+||++.|+++.|+++++-.
T Consensus 252 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 LIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111 01122344567889999999999999999999999999988654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=348.34 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=212.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.++|...+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 35677889999999999999998888899999987654 346789999999999999999999999864 5689999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++++|.+++.......+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++..... ...
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYT 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEE
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc-ccc
Confidence 99999999965433469999999999999999999999 99999999999999999999999999999875432 112
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... .. ..+. ..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~~-~~~~-----~~---- 229 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ------NL-ERGY-----RM---- 229 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH------HH-HTTC-----CC----
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH------HH-hccc-----CC----
Confidence 2234557889999999998999999999999999999999 899997654433211 11 1110 01
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
..+...+..+.+++.+|++.+|.+||++.++++.|+.+....
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 112234567889999999999999999999999999887654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.29 Aligned_cols=263 Identities=25% Similarity=0.452 Sum_probs=216.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec--------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccC
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK 552 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 552 (828)
.++|...+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888899999999999999863 46789999987653 34467789999999999 899999999999999
Q ss_pred CcEEEEEEeccCCcccccccCCCC--------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe
Q 003350 553 NEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 618 (828)
+..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 999999999999999999975431 348999999999999999999999 899999999999999
Q ss_pred CCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhh
Q 003350 619 DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVN 697 (828)
Q Consensus 619 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~ 697 (828)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987654333233344567889999999999999999999999999999999 999997654433221
Q ss_pred HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
. . ..+.. ...+......+.+++.+|++.+|.+||++.|+++.|+.+++...
T Consensus 271 ~------~-~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 271 L------L-KEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp H------H-HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H------H-hcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1 1 11110 11223345678899999999999999999999999999887653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=348.93 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=201.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC----CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...+.||+|+||.||+|.... +..||+|...... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4578888999999999999998642 4579999987643 344677999999999999999999999985 467899
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999996543 469999999999999999999999 8999999999999999999999999999987543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.. ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+.... .. .+.
T Consensus 169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~------i~-~~~------ 234 (281)
T 1mp8_A 169 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR------IE-NGE------ 234 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH------HH-TTC------
T ss_pred cc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH------HH-cCC------
Confidence 21 112234457789999999999999999999999999999996 9999976554332211 11 111
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
....+...+..+.+++.+|++.+|.+||++.|+++.|+.+++..
T Consensus 235 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 235 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01122344567889999999999999999999999999988654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=362.93 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=211.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEe------cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
.++|...+.||+|+||.||+|+. .++..||||.+.... ....+.+.+|++++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788889999999999999985 245689999987542 33457789999999999 89999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCC---------------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeec
Q 003350 555 MILIYEYMENGTLKGHLYGSGL---------------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS 613 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp 613 (828)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+ .+|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 9999999999999999976432 248999999999999999999999 9999999999
Q ss_pred CcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCCh
Q 003350 614 ANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLP 692 (828)
Q Consensus 614 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~ 692 (828)
+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999986543333333445668889999999999999999999999999999998 9999976543
Q ss_pred hhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 693 REMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 693 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
.+.. . .....+ .....+......+.+++.+||+.+|.+||++.|+++.|+.++...
T Consensus 281 ~~~~--~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 281 DANF--Y----KLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SHHH--H----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHH--H----HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 2211 1 111111 111122334567889999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=377.99 Aligned_cols=256 Identities=28% Similarity=0.424 Sum_probs=207.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.++|...+.||+|+||.||+|.++++..||||.+..... ..++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 456777889999999999999998888899999886543 35789999999999999999999999976 6789999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYT 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC-cee
Confidence 99999999975433469999999999999999999999 99999999999999999999999999999875431 112
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......+|..|+|||++....++.++|||||||++|||++ |+.||......+.... ...+. ..
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~---------~~ 400 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VERGY---------RM 400 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC---------CC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC---------CC
Confidence 2234557889999999999999999999999999999999 9999976554332211 11110 11
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
..+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 123445667889999999999999999999998887654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.68 Aligned_cols=266 Identities=16% Similarity=0.170 Sum_probs=213.4
Q ss_pred cCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...+.||+|+||.||+|+. .+++.||||.+..... .+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5688889999999999999986 4689999998765433 24688999999999 999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc-----EEEEeeCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM-----AKVADFGLSKTGP 636 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~-----~kl~DFGla~~~~ 636 (828)
+ +++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 87 L-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9 899999997542 469999999999999999999999 89999999999999999887 9999999998653
Q ss_pred CCCccc-----eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 637 EIDQTH-----VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 637 ~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.................
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 322111 124567999999999999999999999999999999999999999865443332222221111111000
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
+.+. ...+ .+.+++.+|++.+|.+||++.+|.+.|+.+.+.....
T Consensus 242 -----~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 242 -----EVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp -----HHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -----HHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 0011 1123 7899999999999999999999999999887665443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=350.22 Aligned_cols=262 Identities=27% Similarity=0.386 Sum_probs=220.3
Q ss_pred HhcCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
..++|...+.||+|+||.||+|.... +..||+|.+.... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35678888999999999999998764 7899999987543 346789999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~-~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS-SS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC-Cc
Confidence 9999999999987666679999999999999999999999 8999999999999999999999999999987553 22
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..... ... .
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-------~~~---------~ 229 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKD---------Y 229 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------HTT---------C
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcc---------C
Confidence 233445567889999999999999999999999999999999 99999765443322111 110 1
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
....+...+..+.+++.+|++.+|.+||++.|+++.|+.+.+...
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111223445678899999999999999999999999999887654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.95 Aligned_cols=249 Identities=29% Similarity=0.499 Sum_probs=196.3
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCc----ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ----QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...++||+|+||.||+|... ++.||||.+..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 46788899999999999999876 88999998765432 33577899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC---EEeeeeecCcEEeCC--------CCcEEEEe
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA---VIHRDVKSANILLDE--------NFMAKVAD 628 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---ivHrDIkp~NILld~--------~~~~kl~D 628 (828)
||+++++|.+++.. ..+++.+++.++.|+++||+|||+ .+ ++||||||+|||++. ++.+||+|
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999853 368999999999999999999999 66 999999999999986 77899999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
||+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .....
T Consensus 160 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~ 229 (271)
T 3dtc_A 160 FGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVAMN 229 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHTS
T ss_pred CCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhhcC
Confidence 9999864331 1234578999999999999999999999999999999999999997654332211 11111
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
......+...+..+.+++.+|++.+|.+||++.|+++.|+.
T Consensus 230 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 ---------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11112233445678899999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.65 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=212.9
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||+|...+++.||+|.+..... ..+++.+|++++++++||||+++++++...+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46777889999999999999988888999999876543 34789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.... .....
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~-~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTS 161 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC-HHHHS
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccc-ccccc
Confidence 999999996543 468999999999999999999999 9999999999999999999999999999986432 11122
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..... +. . ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~i~~-~~-----~----~~ 225 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDIST-GF-----R----LY 225 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHT-TC-----C----CC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH------HHHhc-CC-----c----CC
Confidence 234567889999999999999999999999999999999 89999765433221 11111 10 0 01
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.+......+.+++.+|++.+|.+||++.|+++.|+++.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122335568899999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=357.26 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=204.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357888899999999999999876 689999998765432 334668899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++|+|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999999654 369999999999999999999999 9999999999999999999999999999986543233
Q ss_pred cceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....|. .... ...
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~----~~~~---~~~--- 229 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK----EKKT---YLN--- 229 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHH----TTCT---TST---
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHh----cccc---cCC---
Confidence 333446689999999999987775 789999999999999999999997543321 1111111 1100 000
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
........+.+++.+||+.+|.+||++.|+++
T Consensus 230 ---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 01233556788999999999999999999964
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.65 Aligned_cols=251 Identities=21% Similarity=0.330 Sum_probs=207.5
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.+ ++.||||.+.... ....+.|.+|++++++++||||+++++++... ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46778899999999999999986 8899999987653 34467799999999999999999999999876 7889999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC--EEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA--VIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||+++|+|.+++.......+++.+++.++.|+++||+|||+ .+ ++||||||+|||++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 99999999999987665579999999999999999999998 77 9999999999999999999999999876422
Q ss_pred CCccceeccccccccccChhhhccCCCCc---ccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTE---KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.....||+.|+|||.+.+...+. ++|||||||++|||++|+.||......+.. ......+
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~----- 227 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALEG----- 227 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHSC-----
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhcC-----
Confidence 12346899999999998765444 899999999999999999999765433221 1111111
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
..+ ..+...+..+.+++.+||+.+|.+||++.|+++.|+.+.
T Consensus 228 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 LRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111 222344567889999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=347.92 Aligned_cols=264 Identities=24% Similarity=0.353 Sum_probs=202.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHc--CCCCceEEEEEEEcc----CCcEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ--FRHRHLVSLIGYCDE----KNEMI 556 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~----~~~~~ 556 (828)
.++|...+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788889999999999999987 5899999998643 34566677777776 799999999998643 45689
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY-----AKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
+||||+++|+|.+++.. ..+++..+++++.|++.||+|||... ..+|+||||||+|||++.++.+||+|||+
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 99999999999999954 35999999999999999999999210 28999999999999999999999999999
Q ss_pred CCCCCCCCccc--eeccccccccccChhhhccC------CCCcccceeehhhHHHHHHhc----------CCCCCCCChh
Q 003350 632 SKTGPEIDQTH--VSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCA----------RPVIDPTLPR 693 (828)
Q Consensus 632 a~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGvvl~elltG----------~~p~~~~~~~ 693 (828)
++......... ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||....+.
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 97543321111 12335799999999999876 455799999999999999999 7887654332
Q ss_pred hhhhHHHHHHHHhhcCCcccccCccccC-CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 694 EMVNLAEWAMKWQNKGQLDQIIDPTLAG-KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 694 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
+.. ............. .+.+.. ......+..+.+++.+||+.+|.+|||+.||++.|+++
T Consensus 240 ~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPS-FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCC-HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccc-hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 211 1111111111111 111110 12234678899999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=355.50 Aligned_cols=247 Identities=24% Similarity=0.308 Sum_probs=206.1
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888899999999999999876 5899999987643 2234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 9999999999986543 68999999999999999999999 99999999999999999999999999999864321
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... . .
T Consensus 159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~i~~~-~------~-- 222 (337)
T 1o6l_A 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------LILME-E------I-- 222 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHC-C------C--
T ss_pred -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH------HHHcC-C------C--
Confidence 122345679999999999999999999999999999999999999997654332211 11111 1 0
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
.++......+.+++.+||+.+|.+|| ++.|+++
T Consensus 223 --~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 12233456688999999999999999 8888875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=346.04 Aligned_cols=265 Identities=16% Similarity=0.156 Sum_probs=212.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|++++.++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35688889999999999999986 4689999998765432 24578899999999 89999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc-----EEEEeeCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM-----AKVADFGLSKTG 635 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~-----~kl~DFGla~~~ 635 (828)
|+ +++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999997543 359999999999999999999999 99999999999999987776 999999999865
Q ss_pred CCCCcc-----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003350 636 PEIDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ 710 (828)
Q Consensus 636 ~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (828)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 432211 123456799999999999999999999999999999999999999976543322222221111111111
Q ss_pred cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 711 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
. +.+ ....+..+.+++.+|++.+|.+||++.+|++.|+++++..
T Consensus 242 ~-----~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 242 L-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp H-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-----HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 1 011 1233567889999999999999999999999999887654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=351.07 Aligned_cols=263 Identities=22% Similarity=0.283 Sum_probs=203.9
Q ss_pred HhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..++|...+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 356788889999999999999998889999999886543 233567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||++ |+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 172 (311)
T 3niz_A 99 EFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP- 172 (311)
T ss_dssp ECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-
T ss_pred cCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC-
Confidence 9998 48888876543 469999999999999999999999 99999999999999999999999999999865421
Q ss_pred ccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC---cc---
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ---LD--- 712 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~--- 712 (828)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ........ ..
T Consensus 173 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 -VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI---FSILGTPNPREWPQVQ 248 (311)
T ss_dssp -CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH---HHHHCCCCTTTSGGGT
T ss_pred -cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHHCCCChHHhhhhh
Confidence 122344578999999999876 56899999999999999999999999765544332111 11111100 00
Q ss_pred ----------cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 ----------QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 ----------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+........+....++.+++.+||+.+|.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000011223456889999999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.22 Aligned_cols=270 Identities=18% Similarity=0.248 Sum_probs=211.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCC--cEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN--EMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 559 (828)
++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46788899999999999999876 48999999987543 344677889999999999999999999987654 789999
Q ss_pred EeccCCcccccccCCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe----CCCCcEEEEeeCCCCC
Q 003350 560 EYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKT 634 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kl~DFGla~~ 634 (828)
||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997643 2349999999999999999999999 899999999999999 8888999999999987
Q ss_pred CCCCCccceeccccccccccChhhhc--------cCCCCcccceeehhhHHHHHHhcCCCCCCCChhh-hhhHHHHHHHH
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFR--------RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-MVNLAEWAMKW 705 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~ 705 (828)
..... ......||..|+|||++. +..++.++|||||||++|||++|+.||....... ......-...-
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 54321 223457999999999986 4788999999999999999999999996543222 11211111111
Q ss_pred hhcCCcccccC---------cc--ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 706 QNKGQLDQIID---------PT--LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 706 ~~~~~~~~~~d---------~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
.....+..+.+ +. ............+.+++.+||+.+|.+||++.|+++...+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111111100 01 11134466778899999999999999999999999887753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=353.81 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=207.0
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc------ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (828)
..++|...+.||+|+||.||+++.. +|+.||+|.+..... ...+.+.+|+.+|++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467888899999999999999876 589999998765432 235789999999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC----cEEEEeeC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF----MAKVADFG 630 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kl~DFG 630 (828)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999999654 369999999999999999999999 9999999999999998877 79999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ 710 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (828)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+... ... .+.
T Consensus 165 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~------~i~-~~~ 234 (361)
T 2yab_A 165 LAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NIT-AVS 234 (361)
T ss_dssp SCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHH-TTC
T ss_pred CceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-hcC
Confidence 99875431 12345679999999999999999999999999999999999999997654433211 111 110
Q ss_pred cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 711 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. -+++... ......+.+++.+||+.+|.+||++.|+++
T Consensus 235 ~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y--DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C--CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C--CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0111111 123456789999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.50 Aligned_cols=256 Identities=29% Similarity=0.486 Sum_probs=202.0
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||+|+.. ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46777899999999999999876 788999998654 345789999999999999999999998874 5799999999
Q ss_pred CCcccccccCCCC-CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc-EEEEeeCCCCCCCCCCcc
Q 003350 564 NGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM-AKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 564 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~-~kl~DFGla~~~~~~~~~ 641 (828)
+|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---- 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---- 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence 9999999976542 35889999999999999999999865578999999999999998886 79999999976432
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..|.. . .+. .+.
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~--~-~~~-----~~~--- 224 (307)
T 2eva_A 159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAV--H-NGT-----RPP--- 224 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHH--H-TTC-----CCC---
T ss_pred -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHH--h-cCC-----CCC---
Confidence 123346899999999999999999999999999999999999999754322111 11111 1 111 111
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
.....+..+.+++.+|++.+|.+||++.|+++.|+.+.+..
T Consensus 225 -~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 225 -LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp -CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred -cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11233556889999999999999999999999999876544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=352.40 Aligned_cols=261 Identities=24% Similarity=0.370 Sum_probs=205.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCc----EEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
.++|...++||+|+||.||+|... +++ +|++|.+... .....+++.+|++++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 356888899999999999999864 343 4688877544 3455788999999999999999999999998754 88
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997644 469999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
............+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+..... ..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~~~~----- 236 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGE----- 236 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTC-----
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCC-----
Confidence 4333333344567889999999999999999999999999999999 99999866544432211 1111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
....+......+.+++.+||+.+|.+||++.|+++.|+.+.+...
T Consensus 237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 111223445678899999999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.56 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=205.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc------ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
.++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++|++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888899999999999999876 588999998764422 2367899999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC----cEEEEeeCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF----MAKVADFGL 631 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kl~DFGl 631 (828)
++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999654 469999999999999999999999 9999999999999999887 899999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ... ..
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------~~~-~~ 234 (326)
T 2y0a_A 165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------SAV-NY 234 (326)
T ss_dssp CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHT-CC
T ss_pred CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------Hhc-CC
Confidence 98754311 234467999999999999999999999999999999999999999765443321111 110 00
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+... ......+.+++.+||+.+|.+|||+.|+++
T Consensus 235 --~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 --EFEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --CCCHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CcCcccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0011111 123456789999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=357.79 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=208.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+|... +++.||+|.+..........+.+|+++|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467889999999999999999875 5889999998876665667899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC--CCcEEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE--NFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~--~~~~kl~DFGla~~~~~~~ 639 (828)
+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 99999999986543 469999999999999999999999 99999999999999974 578999999999875432
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... .. ..++
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~------~i~~~-~~--~~~~-- 271 (387)
T 1kob_A 205 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------NVKRC-DW--EFDE-- 271 (387)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHHC-CC--CCCS--
T ss_pred --cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH------HHHhC-CC--CCCc--
Confidence 12334579999999999999999999999999999999999999998654332211 11111 00 0111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.........+.+++.+||+.+|.+||++.|+++
T Consensus 272 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 --DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp --STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111234566889999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=343.45 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=210.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC----CcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...+.||+|+||.||+|+..+ +..||+|.+... .....+.+.+|++++++++||||+++++++.+. ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4578888999999999999997642 346999998765 334567899999999999999999999998654 5689
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++++|.+++.... ..+++..++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999996543 458999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.. ........+|..|+|||++.+..++.++||||||+++|||++ |+.||......+..... ..+..
T Consensus 166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-------~~~~~----- 232 (281)
T 3cc6_A 166 ED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-------EKGDR----- 232 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-------HHTCC-----
T ss_pred cc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-------hcCCC-----
Confidence 21 112334567889999999999999999999999999999998 99999755443322111 11100
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
...+......+.+++.+|++.+|.+||++.|+++.|+.+.+..+.+
T Consensus 233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~i 278 (281)
T 3cc6_A 233 ----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278 (281)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhhh
Confidence 0112233456889999999999999999999999999998876544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=345.72 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=197.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--------------------------ccHHHHHHHHHHHH
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--------------------------QGLAEFQTEIEMLS 535 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 535 (828)
.++|...+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357888899999999999999865 588999998765421 12356889999999
Q ss_pred cCCCCceEEEEEEEcc--CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeec
Q 003350 536 QFRHRHLVSLIGYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS 613 (828)
Q Consensus 536 ~l~H~niv~l~g~~~~--~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp 613 (828)
+++||||+++++++.. .+..++||||+++++|.+++.. ..+++.+++.++.|+++||+|||+ .+|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence 9999999999999976 6689999999999999987643 369999999999999999999999 8999999999
Q ss_pred CcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCC---CCcccceeehhhHHHHHHhcCCCCCCC
Q 003350 614 ANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVIDPT 690 (828)
Q Consensus 614 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVySfGvvl~elltG~~p~~~~ 690 (828)
+|||++.++.+||+|||+++..... ........||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999865432 22234567999999999997665 478899999999999999999999755
Q ss_pred ChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 691 LPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 691 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..... ...... .... . .........+.+++.+||+.+|.+||++.|+++
T Consensus 244 ~~~~~------~~~~~~-~~~~----~----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIMCL------HSKIKS-QALE----F----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHHHH------HHHHHH-CCCC----C----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHHHH------HHHHhc-ccCC----C----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 33221 111111 1100 0 011233556889999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=350.46 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=207.3
Q ss_pred cCCCccceEeeeCcEEEEEEEecC-----CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND-----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...++||+|+||.||+|.... +..||||.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 355667899999999999997653 2469999987653 3445678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999996543 469999999999999999999999 8999999999999999999999999999987543
Q ss_pred CCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 638 IDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 638 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.... .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+... . ...+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~------~-~~~~~----- 267 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK------A-INDGF----- 267 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------H-HHTTC-----
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH------H-HHCCC-----
Confidence 2211 11223456789999999999999999999999999999999 999997654332211 1 11110
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
....+...+..+.+++.+||+.+|.+||++.|+++.|+.+++.....
T Consensus 268 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 268 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 01112344567889999999999999999999999999988765544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=342.24 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=212.3
Q ss_pred CCCccc-eEeeeCcEEEEEEEec---CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 485 NFDESW-VIGIGGFGKVYKGELN---DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 485 ~f~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
+|...+ .||+|+||.||+|... ++..||||.+.... ....+++.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344444 8999999999999753 57889999987653 34567899999999999999999999999 556799999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++.... ..+++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp ECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999986543 469999999999999999999999 899999999999999999999999999998754322
Q ss_pred cc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 640 QT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 640 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.... ...+.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------i~~~~------- 230 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGK------- 230 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------HHTTC-------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-------HhcCC-------
Confidence 21 11233457899999999998899999999999999999998 9999976544332111 11111
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
....+...+..+.+++.+|++.+|.+||++.|+++.|+.++...+.-
T Consensus 231 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 231 --RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred --cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 01123345667899999999999999999999999999988766543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.00 Aligned_cols=271 Identities=22% Similarity=0.339 Sum_probs=217.4
Q ss_pred CHHHHHHHhcCCCccceEeeeCcEEEEEEEe------cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEE
Q 003350 475 PFVAVQEATNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLI 546 (828)
Q Consensus 475 ~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~ 546 (828)
.........++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344444567899999999999999999974 246889999987653 33456789999999999 799999999
Q ss_pred EEEccCC-cEEEEEEeccCCcccccccCCCC--------------CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeee
Q 003350 547 GYCDEKN-EMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611 (828)
Q Consensus 547 g~~~~~~-~~~lV~ey~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI 611 (828)
+++...+ ..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+ .+|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence 9987654 58999999999999999976442 228899999999999999999999 89999999
Q ss_pred ecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCC
Q 003350 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPT 690 (828)
Q Consensus 612 kp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~ 690 (828)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654333333445678899999999999999999999999999999998 99999755
Q ss_pred ChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 691 LPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 691 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
...+.. .. . ...+.. . ..+......+.+++.+||+.+|.+||++.|+++.|+.+++..
T Consensus 255 ~~~~~~--~~---~-~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDEEF--CR---R-LKEGTR-----M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSHHH--HH---H-HHHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhHHH--HH---H-hccCcc-----C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 432211 11 1 111110 0 112233556889999999999999999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.87 Aligned_cols=253 Identities=16% Similarity=0.232 Sum_probs=208.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467888899999999999999876 57899999887543 3456788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC--CCcEEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE--NFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~--~~~~kl~DFGla~~~~~~~ 639 (828)
+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 99999999996543 469999999999999999999999 99999999999999987 789999999999875432
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.......||+.|+|||++.+..++.++|||||||++|||++|++||......+... ...... . ..++..
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i~~~~-~--~~~~~~ 226 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------NIMNAE-Y--TFDEEA 226 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTC-C--CCCHHH
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH------HHHcCC-C--CCChhh
Confidence 22345679999999999998889999999999999999999999997654433211 111111 0 001111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
. .+.+..+.+++.+||+.+|.+|||+.|+++.-
T Consensus 227 ~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred h----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 1 12345688999999999999999999998743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.00 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=214.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC------CcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
.++|...+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 5678888999999999999998642 2479999987653 34467789999999999 89999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSG------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF 622 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 622 (828)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 999999999999999986421 2468999999999999999999999 8999999999999999999
Q ss_pred cEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHH
Q 003350 623 MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEW 701 (828)
Q Consensus 623 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~ 701 (828)
.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......... ..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~~- 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--YK- 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--HH-
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--HH-
Confidence 999999999986543222223344567889999999999999999999999999999998 99999765432211 11
Q ss_pred HHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 702 AMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 702 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
....+. ....+...+..+.+++.+||+.+|.+||++.|+++.|+.+.+..+
T Consensus 279 ---~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 279 ---LVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp ---HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---HHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 111110 011122335668899999999999999999999999998876553
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=379.92 Aligned_cols=256 Identities=28% Similarity=0.430 Sum_probs=211.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.++|...++||+|+||.||+|.++++..||||++..... ..++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 456777889999999999999998888899999876543 45789999999999999999999999976 6789999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.++|.......+++.+++.|+.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYT 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC-HHHH
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC-Ccee
Confidence 99999999975433469999999999999999999999 9999999999999999999999999999987543 1111
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......++..|+|||++....++.++|||||||+||||++ |+.||......+.... ...+. ..
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~---------~~ 483 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VERGY---------RM 483 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-------HHTTC---------CC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC---------CC
Confidence 1233457789999999999999999999999999999999 9999976544332211 11111 01
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
..+..++..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 122345667889999999999999999999998887643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=357.46 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=201.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...++||+|+||.||+|+.. +++.||||++... .....+.+.+|.++|..+ +||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468899999999999999999876 5889999987643 223456788999999988 79999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999996543 69999999999999999999999 8999999999999999999999999999986432
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... .
T Consensus 177 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~-~------- 240 (353)
T 3txo_A 177 --NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE------AILND-E------- 240 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHC-C-------
T ss_pred --CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH------HHHcC-C-------
Confidence 1222445689999999999999999999999999999999999999998665443221 11111 1
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCCh------HHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSM------GDVLW 754 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm------~eVl~ 754 (828)
..++......+.+++.+||+.+|.+||++ .|+++
T Consensus 241 ---~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ---VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01222345568889999999999999998 66654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=357.93 Aligned_cols=275 Identities=24% Similarity=0.330 Sum_probs=212.5
Q ss_pred cCCCccceEeeeCcEEEEEEEe-----cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEc--cCCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD--EKNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 556 (828)
++|...+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4677889999999999999984 357899999998877777788999999999999999999999885 556789
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999996533 359999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 637 EIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 637 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.|+......... ...+.........+.+.+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHHHh
Confidence 32221 1233456888999999999999999999999999999999999998643221100 000000000000000111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
........+...+..+.+++.+||+.+|.+||++.|+++.|+.+....
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111112233455677899999999999999999999999998865443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.10 Aligned_cols=265 Identities=26% Similarity=0.377 Sum_probs=214.7
Q ss_pred HHHHHhcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEc
Q 003350 478 AVQEATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550 (828)
Q Consensus 478 ~l~~at~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 550 (828)
+.+...++|...+.||+|+||.||+|+.. .++.||||.+.... .....++.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34455678899999999999999999754 36789999987543 334567899999999999999999999999
Q ss_pred cCCcEEEEEEeccCCcccccccCC--------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC
Q 003350 551 EKNEMILIYEYMENGTLKGHLYGS--------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF 622 (828)
Q Consensus 551 ~~~~~~lV~ey~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 622 (828)
..+..++||||+++|+|.+++... ....+++.++++++.|++.||+|||+ .+|+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCC
Confidence 999999999999999999998642 12467999999999999999999999 8999999999999999999
Q ss_pred cEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHH
Q 003350 623 MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEW 701 (828)
Q Consensus 623 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~ 701 (828)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---- 251 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR---- 251 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH----
Confidence 999999999986433222222234457889999999999999999999999999999999 899987654332211
Q ss_pred HHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 702 AMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 702 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.. ..+.. ...+...+..+.+++.+|++.+|.+||++.|+++.|+++++
T Consensus 252 --~~-~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 --FV-MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HH-HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HH-HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 11111 01123445678899999999999999999999999987644
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=347.95 Aligned_cols=267 Identities=28% Similarity=0.407 Sum_probs=204.1
Q ss_pred HHHHHhcCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc
Q 003350 478 AVQEATNNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551 (828)
Q Consensus 478 ~l~~at~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (828)
++....++|...+.||+|+||.||+|... .+..||+|.+... .....+.+.+|++++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33444667888899999999999999764 2458999998754 33446779999999999999999999999976
Q ss_pred CC-----cEEEEEEeccCCcccccccC----CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC
Q 003350 552 KN-----EMILIYEYMENGTLKGHLYG----SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF 622 (828)
Q Consensus 552 ~~-----~~~lV~ey~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~ 622 (828)
.+ ..++||||+++|+|.+++.. .....+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence 54 35999999999999999843 233569999999999999999999999 8999999999999999999
Q ss_pred cEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHH
Q 003350 623 MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEW 701 (828)
Q Consensus 623 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~ 701 (828)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--- 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY--- 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH---
Confidence 999999999986543222223344567889999999999999999999999999999999 8899976544332211
Q ss_pred HHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 702 AMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 702 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
.. .+. .+ ..+...+..+.+++.+||+.+|.+||++.++++.|+.+++..
T Consensus 262 ---~~-~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 262 ---LL-HGH-----RL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ---HH-TTC-----CC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HH-cCC-----CC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 110 01 122334567889999999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.09 Aligned_cols=273 Identities=14% Similarity=0.176 Sum_probs=209.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC------CcEEEEEEcCCCCcccH-----------HHHHHHHHHHHcCCCCceEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRSQQGL-----------AEFQTEIEMLSQFRHRHLVSL 545 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l 545 (828)
.++|...++||+|+||.||+|.+.. ++.||||.+........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578888999999999999998764 47899999776543211 123345666778889999999
Q ss_pred EEEEccC----CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC--
Q 003350 546 IGYCDEK----NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-- 619 (828)
Q Consensus 546 ~g~~~~~----~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-- 619 (828)
++++... ...++||||+ +++|.+++.... ..+++.+++.|+.|++.||+|||+ .+|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 9998664 4589999999 999999997643 469999999999999999999999 8999999999999999
Q ss_pred CCCcEEEEeeCCCCCCCCCCcc-----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhh
Q 003350 620 ENFMAKVADFGLSKTGPEIDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694 (828)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~ 694 (828)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999765331111 11134559999999999999999999999999999999999999997432221
Q ss_pred hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 695 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
. ...+.... ....+.+++++.+.. ...+..+.+++..|++.+|.+||++.++++.|+.+++.....
T Consensus 269 ~--~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 269 K--YVRDSKIR-YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp H--HHHHHHHH-HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred H--HHHHHHHH-hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1 11111111 111233333333321 233567889999999999999999999999999988765433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.32 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=200.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCC--CceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 558 (828)
.++|...+.||+|+||.||++...+++.||||++... .....+.+.+|+++|.+++| +||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3457888999999999999999888999999987644 34446789999999999976 9999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|| +.+++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 5678999999764 369999999999999999999999 8999999999999997 578999999999876543
Q ss_pred CccceeccccccccccChhhhcc-----------CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~---- 231 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH---- 231 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHH----
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHH----
Confidence 33333445679999999999965 678999999999999999999999997532211 1111
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHH
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~ 757 (828)
.++++.....++......+.+++.+||+.+|.+||++.|+++...
T Consensus 232 -----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 232 -----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp -----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -----HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 112222222233333456889999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=354.01 Aligned_cols=254 Identities=20% Similarity=0.316 Sum_probs=207.5
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
...++|...+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44577999999999999999999875 5889999988654 33445778999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC---CcEEEEeeCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN---FMAKVADFGLSKT 634 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kl~DFGla~~ 634 (828)
||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 106 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999998654 368999999999999999999999 899999999999999865 4599999999987
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+... .. ..+... .
T Consensus 181 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~------~i-~~~~~~-~ 249 (362)
T 2bdw_A 181 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA------QI-KAGAYD-Y 249 (362)
T ss_dssp CTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-HHTCCC-C
T ss_pred ecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH-HhCCCC-C
Confidence 5432 12345679999999999999999999999999999999999999997654332211 11 111110 0
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+ ........+.+++.+||+.+|.+||++.|+++.
T Consensus 250 ~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Ccc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 012335668899999999999999999999853
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=368.89 Aligned_cols=263 Identities=22% Similarity=0.245 Sum_probs=210.3
Q ss_pred cCHHHHHHHhcCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEE
Q 003350 474 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549 (828)
Q Consensus 474 ~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (828)
+.+.+++...++|...++||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445566667899999999999999999998864 7899999876421 11223488999999999999999999999
Q ss_pred ccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 550 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
.+.+..++|||||++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999997633 469999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHH-HHHH
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA-EWAM 703 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~-~~~~ 703 (828)
|+++.... ..........||+.|+|||++. ...++.++|||||||++|||++|++||......+....+ .+..
T Consensus 220 Gla~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 220 GSCLKLME-DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp TTCEECCT-TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhccc-CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 99976543 2222334568999999999997 467899999999999999999999999866544332111 1100
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCC--CCChHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVD--RPSMGDVLW 754 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eVl~ 754 (828)
. -. -|.. .......+.+++.+||..+|++ ||++.|+++
T Consensus 299 ~----~~-----~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 R----FQ-----FPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp H----CC-----CCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred c----cc-----CCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0 00 0111 1123456788999999887877 999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.90 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=203.9
Q ss_pred cCCCccceEeeeCcEEEEEEEecC-C-------cEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND-G-------TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
++|...+.||+|+||.||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 467788999999999999997653 3 47999998777667778899999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc--------EEEE
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM--------AKVA 627 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--------~kl~ 627 (828)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999997643 348999999999999999999999 99999999999999998887 9999
Q ss_pred eeCCCCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcC-CCCCCCChhhhhhHHHHHHHH
Q 003350 628 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKW 705 (828)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~ 705 (828)
|||+++.... .....||..|+|||++.+ ..++.++|||||||++|||++|. +|+.......... ..
T Consensus 164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~------~~ 231 (289)
T 4fvq_A 164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ------FY 231 (289)
T ss_dssp CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HH
T ss_pred cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH------Hh
Confidence 9999876432 223458899999999987 77999999999999999999965 5554332222111 11
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
..... .+......+.+++.+||+.+|.+||++.|+++.|+.++.
T Consensus 232 ~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 EDRHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HTTCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hccCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 111123447889999999999999999999999987553
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.20 Aligned_cols=272 Identities=25% Similarity=0.368 Sum_probs=210.0
Q ss_pred CCccceEeeeCcEEEEEEEec-----CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEcc--CCcEEE
Q 003350 486 FDESWVIGIGGFGKVYKGELN-----DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMIL 557 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 557 (828)
|...+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+++|++++||||+++++++.. ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 477789999999999998653 57899999987653 3446779999999999999999999999976 467899
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999654 38999999999999999999999 8999999999999999999999999999987644
Q ss_pred CCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.... .......+|..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.........+.+.++
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHHh
Confidence 2221 22344568889999999999999999999999999999999999986432110 000000000000000011111
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
.......+...+..+.+++.+||+.+|.+||++.|+++.|+.+.+..+
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111122234456778999999999999999999999999998776543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=345.20 Aligned_cols=263 Identities=27% Similarity=0.414 Sum_probs=207.9
Q ss_pred cCCCccceEeeeCcEEEEEEEe-----cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccC--CcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 555 (828)
++|...+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477788999999999999983 358899999987543 34567899999999999999999999999766 678
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999995543 459999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChh---------hhhhHHHHHHHH
Q 003350 636 PEIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR---------EMVNLAEWAMKW 705 (828)
Q Consensus 636 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~ 705 (828)
...... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 255 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT- 255 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH-
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH-
Confidence 442221 2234566888999999999999999999999999999999999886422110 00011111111
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
...+ .....+...+..+.+++.+||+.+|.+||++.|+++.|+.++
T Consensus 256 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hhcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111 111223445667899999999999999999999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=343.91 Aligned_cols=251 Identities=29% Similarity=0.492 Sum_probs=203.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCccc-------HHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG-------LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
++|...+.||+|+||.||+|+.. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 56888899999999999999875 68899999986543221 267899999999999999999999997655
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC--EEeeeeecCcEEeCCCCc-----EEEEe
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA--VIHRDVKSANILLDENFM-----AKVAD 628 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILld~~~~-----~kl~D 628 (828)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 69999999999999886544 469999999999999999999999 78 999999999999988776 99999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhc--cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||......+... .. ...
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~---~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-IN---MIR 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HH---HHH
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HH---HHh
Confidence 999985332 234567999999999984 4567899999999999999999999997554332211 11 111
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
... .....+...+..+.+++.+||+.+|.+||++.|+++.|++
T Consensus 244 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111 1112233445678999999999999999999999998875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=346.44 Aligned_cols=278 Identities=26% Similarity=0.374 Sum_probs=210.3
Q ss_pred ccCHHHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC--CCCceEEEEEEEc
Q 003350 473 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF--RHRHLVSLIGYCD 550 (828)
Q Consensus 473 ~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~ 550 (828)
..+...-....++|...+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++.
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 4555556667789999999999999999999886 899999998543 234556666666655 9999999999997
Q ss_pred cC----CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCCEEeeeeecCcEEeCCC
Q 003350 551 EK----NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY-----AKAVIHRDVKSANILLDEN 621 (828)
Q Consensus 551 ~~----~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDIkp~NILld~~ 621 (828)
.. ...++||||+++|+|.+++... .+++.+++.++.|++.||+|||+.+ ..+|+||||||+|||++.+
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 76 7899999999999999999654 5899999999999999999999820 1299999999999999999
Q ss_pred CcEEEEeeCCCCCCCCCCccc--eeccccccccccChhhhccCCCCcc------cceeehhhHHHHHHhc----------
Q 003350 622 FMAKVADFGLSKTGPEIDQTH--VSTAVKGSFGYLDPEYFRRQQLTEK------SDVYSFGVVLFEVLCA---------- 683 (828)
Q Consensus 622 ~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~k------sDVySfGvvl~elltG---------- 683 (828)
+.+||+|||+++......... ......||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999997653322111 1234579999999999987766665 9999999999999999
Q ss_pred CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC-CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 684 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK-IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 684 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
+.||....+... ....+. ....... ..+..... ...+++..+.+++.+||+.+|.+||++.||++.|+.+.+.
T Consensus 259 ~~p~~~~~~~~~-~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 259 QLPYHDLVPSDP-SYEDMR-EIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CCTTTTTSCSSC-CHHHHH-HHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccHhhhcCCCC-chhhhH-HHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 556644322211 111111 1111111 11111111 1136778899999999999999999999999999998765
Q ss_pred h
Q 003350 763 Q 763 (828)
Q Consensus 763 ~ 763 (828)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=343.77 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=201.4
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46788899999999999999988899999999865432 2346788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++ +|.+++.... ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--V 154 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--c
Confidence 985 8988886543 468999999999999999999999 89999999999999999999999999999764321 1
Q ss_pred ceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC---C---ccc-
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG---Q---LDQ- 713 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~~~- 713 (828)
.......||+.|+|||++.+. .++.++|||||||++|||++|++||......+... .. ....... . ..+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RI-FRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HH-HHHHCCCCTTTSTTGGGS
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HH-HHHHCCCChhhchhhhcc
Confidence 122345689999999999764 58999999999999999999999998655433221 11 1111100 0 000
Q ss_pred -ccCcccc-------CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 714 -IIDPTLA-------GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 714 -~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..++... ..........+.+++.+||+.+|.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111110 0111234567889999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.60 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=193.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|...++||+|+||+||+|+.. +++.||||++.... .....++..|+..+.++ +||||++++++|.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367899999999999999999876 68999999876543 23344455666666555 999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+ +++|.+++.... ..++|.+++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~- 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT- 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc-
Confidence 9999 679988886543 469999999999999999999999 8999999999999999999999999999986543
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
........||+.|+|||++.+ .++.++|||||||++|||++|+.|+..... |. . ...+. ..+.
T Consensus 210 --~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~-~-~~~~~----~~~~ 272 (311)
T 3p1a_A 210 --AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQ-Q-LRQGY----LPPE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HH-H-HTTTC----CCHH
T ss_pred --CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HH-H-HhccC----CCcc
Confidence 222345569999999999875 799999999999999999999766543211 10 0 11111 1111
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+. ......+.+++.+||+.+|.+||++.|+++
T Consensus 273 ~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 21 223466889999999999999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=343.76 Aligned_cols=260 Identities=32% Similarity=0.553 Sum_probs=197.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...++||+|+||.||+|+... .||+|.+.... ....+.|.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4568888999999999999998753 59999876543 34467899999999999999999999976 4556899999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999996544 469999999999999999999999 8999999999999999999999999999986543233
Q ss_pred cceeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 641 THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+. +.. ....+... +
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~~~~~----~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIE----MVGRGSLS----P 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHH----HHHHTSCC----C
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHH----HhcccccC----c
Confidence 33334567999999999986 56788999999999999999999999976543221 111 11111111 1
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
.+ ......++..+.+++.+||+.+|.+||++.|+++.|+++.
T Consensus 246 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11 1122345677899999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=375.23 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=204.3
Q ss_pred eEeeeCcEEEEEEEec---CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 491 VIGIGGFGKVYKGELN---DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 491 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 45679999987653 3457889999999999999999999999976 56999999999999
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc-ceec
Q 003350 567 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-HVST 645 (828)
Q Consensus 567 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~-~~~~ 645 (828)
|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 422 L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999996543 469999999999999999999999 89999999999999999999999999999875432211 1122
Q ss_pred cccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 646 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 646 ~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
...+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+.... ...+. ....+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-------i~~~~---------~~~~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGK---------RMECP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-------HHTTC---------CCCCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHcCC---------CCCCC
Confidence 3446789999999999999999999999999999998 9999986654432211 11111 11223
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
..++..+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 445677899999999999999999999999999876554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=360.62 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=206.5
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
...++|...+.||+|+||.||+|... +|+.+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34667889999999999999999764 68999999876543 2345678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC---CCCcEEEEeeCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKT 634 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kl~DFGla~~ 634 (828)
||||+++|+|.+.+.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 88 v~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999987653 69999999999999999999999 9999999999999998 567899999999987
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.... ........||+.|+|||++.+..++.++|||||||++|||++|++||......+.... ...+.. ..
T Consensus 163 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~-------i~~~~~-~~ 232 (444)
T 3soa_A 163 VEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ-------IKAGAY-DF 232 (444)
T ss_dssp CCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHHTCC-CC
T ss_pred ecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH-------HHhCCC-CC
Confidence 5432 2223456799999999999999999999999999999999999999976543332211 111111 00
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+ ........+.+++.+||+.+|.+||++.|+++
T Consensus 233 ~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Ccc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011 11233566889999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=354.66 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=191.8
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
....++|...+.||+|+||.||+|+.. +++.||||.+.... ..+.+.+|+++|++++||||+++++++...+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345678999999999999999999886 47899999987543 346788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---CCcEEEEeeCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVADFGLSKTG 635 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kl~DFGla~~~ 635 (828)
|||+++|+|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++..
T Consensus 127 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp ECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999986543 68999999999999999999999 89999999999999975 889999999999865
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. + ....... ..
T Consensus 202 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~~i~~~-~~---- 268 (349)
T 2w4o_A 202 EH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---FRRILNC-EY---- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---HHHHHTT-CC----
T ss_pred Cc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---HHHHHhC-CC----
Confidence 32 2223456799999999999999999999999999999999999999975433221 1 1111111 10
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
........+....+.+++.+||+.+|.+||++.|+++
T Consensus 269 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 --YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011112334567889999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.54 Aligned_cols=261 Identities=25% Similarity=0.329 Sum_probs=209.5
Q ss_pred cCCCccc-eEeeeCcEEEEEEEec---CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESW-VIGIGGFGKVYKGELN---DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
++|...+ .||+|+||.||+|... .++.||||.+.... ....+++.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 8999999999999542 36789999987653 23367899999999999999999999999 6678899
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++++|.+++.... .+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 95 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999997643 69999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 638 IDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 638 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ...+.
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~~----- 237 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGE----- 237 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC-----
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcCC-----
Confidence 2221 11233456789999999998889999999999999999999 9999986554332111 11111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~ 766 (828)
....+...+..+.+++.+|++.+|.+||++.|+++.|+.+.......
T Consensus 238 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 238 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 01122344567899999999999999999999999999988766544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.68 Aligned_cols=260 Identities=28% Similarity=0.434 Sum_probs=205.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC----CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEE-ccCCcEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYC-DEKNEMI 556 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~ 556 (828)
..+|...++||+|+||.||+|+..+ ...+|+|.+.... ....+.+.+|++++++++||||++++++| ...+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3457778999999999999998642 2368999887643 34467899999999999999999999986 4566789
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999996543 468999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCc--cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 637 EIDQ--THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 637 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+......+.. ... . .+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~---~-~~~--- 249 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYL---L-QGR--- 249 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHH---H-TTC---
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHH---h-cCC---
Confidence 3221 112334567889999999999999999999999999999999 56666544332221 110 1 110
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
....+...+..+.+++.+|++.+|.+||++.|+++.|+.++..
T Consensus 250 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0011223345688999999999999999999999999988754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=357.21 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=199.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...++||+|+||.||+++.. +++.||+|++... .....+.+..|..+|.++ +||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357888899999999999999876 5789999987643 223345678899999887 89999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+||||+.++++||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999986543 69999999999999999999999 9999999999999999999999999999986332
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh--hhHHHHHHHHhhcCCccccc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM--VNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~ 715 (828)
.........||+.|+|||++.+..++.++|||||||++|||++|++||......+. .....+.........
T Consensus 206 --~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 206 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp --TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred --CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 12234567899999999999999999999999999999999999999964322111 111111111111111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
..++......+.+++.+||+.+|.+||++
T Consensus 279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 01223345668899999999999999996
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=356.57 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=199.5
Q ss_pred ccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 488 ESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
..++||+|+||.||+|... +|+.||+|++........+++.+|+++|++++||||+++++++...+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3568999999999999865 689999999987766667889999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe--CCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 567 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 567 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl--d~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 173 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~ 245 (373)
T 2x4f_A 173 LFDRIIDES-YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL 245 (373)
T ss_dssp EHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence 999886543 358999999999999999999999 999999999999999 677899999999998754322 22
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 724 (828)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+..... . +.+...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i~~~~~--~-~~~~~~---- 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN------NILACRW--D-LEDEEF---- 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTCC--C-SCSGGG----
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhccC--C-CChhhh----
Confidence 34569999999999998999999999999999999999999997654433211 1111100 0 011111
Q ss_pred hhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 725 PDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 725 ~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......+.+++.+||+.+|.+||++.|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 223456889999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=357.86 Aligned_cols=272 Identities=21% Similarity=0.228 Sum_probs=213.4
Q ss_pred cccCHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-----CCceEEE
Q 003350 472 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-----HRHLVSL 545 (828)
Q Consensus 472 ~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l 545 (828)
..+++.+.....++|...++||+|+||.||+|+.. +++.||||++... ....+.+..|++++++++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34555666666789999999999999999999874 6889999998743 344567788999999996 9999999
Q ss_pred EEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-----
Q 003350 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE----- 620 (828)
Q Consensus 546 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~----- 620 (828)
++++...+..++||||+ +++|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccc
Confidence 99999999999999999 8999999987666679999999999999999999999 99999999999999986
Q ss_pred --------------------CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHH
Q 003350 621 --------------------NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 680 (828)
Q Consensus 621 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~el 680 (828)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 78999999999986433 12345789999999999999999999999999999999
Q ss_pred HhcCCCCCCCChhhhhhHHHHHH---------HHhhcCCcccccC-ccccCCCC--------------------hhHHHH
Q 003350 681 LCARPVIDPTLPREMVNLAEWAM---------KWQNKGQLDQIID-PTLAGKIR--------------------PDSLRK 730 (828)
Q Consensus 681 ltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~~~~~d-~~l~~~~~--------------------~~~~~~ 730 (828)
++|+.||......+......... ..... .....++ ..+....+ ......
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT-NGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTS-GGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhc-cCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999998765444322221110 00000 0000000 00000000 001256
Q ss_pred HHHHHHhhhhhCCCCCCChHHHHH
Q 003350 731 FGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 731 l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.+++.+||+.+|.+|||+.|+++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCCCHHHHhc
Confidence 779999999999999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=349.88 Aligned_cols=266 Identities=26% Similarity=0.381 Sum_probs=210.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
.++|...+.||+|+||.||+|+.. +++.||||.+... ......++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 467888899999999999999742 4678999998754 344567789999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCC-----CCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---CCcEEEE
Q 003350 556 ILIYEYMENGTLKGHLYGSGL-----PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVA 627 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kl~ 627 (828)
++||||+++++|.+++..... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975432 458999999999999999999999 89999999999999984 4569999
Q ss_pred eeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHh
Q 003350 628 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. .+ .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~----~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EF----V 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HH----H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---HH----H
Confidence 9999875332222222334568899999999999999999999999999999998 99999765433221 11 1
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhhhh
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVV 767 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~~~ 767 (828)
..+.. ...+......+.+++.+||+.+|.+||++.|+++.|+.+.+..+...
T Consensus 259 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 310 (327)
T 2yfx_A 259 TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310 (327)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHT
T ss_pred hcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhc
Confidence 11110 01123345678899999999999999999999999998877665443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.25 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=204.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+++.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999875 68999999876431 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 9999999999997543 68999999999999999999999 9999999999999999999999999999986533
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ...... . .
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~-~------~-- 220 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------EKILNA-E------L-- 220 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHC-C------C--
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHHhC-C------C--
Confidence 123567999999999999999999999999999999999999999765433221 111111 1 0
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
.++......+.+++.+||+.+|.+|| ++.|+++
T Consensus 221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 12233455688999999999999999 7888864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.95 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=200.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999875 58899999876543 3345778899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++ +|.+.+.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-- 154 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence 9986 5555554332 469999999999999999999999 89999999999999999999999999999865431
Q ss_pred cceeccccccccccChhhhccCC-CCcccceeehhhHHHHHHhcCCCCCCC-ChhhhhhHHHHHHHHhh--cCCc---cc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPT-LPREMVNLAEWAMKWQN--KGQL---DQ 713 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvl~elltG~~p~~~~-~~~~~~~l~~~~~~~~~--~~~~---~~ 713 (828)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.|+... ...+. +......... .... .+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhhhhhcc
Confidence 12234567899999999998765 899999999999999999988775433 22221 1111111100 0000 00
Q ss_pred ccC---------ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 714 IID---------PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 714 ~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+ ........+.....+.+++.+||+.+|.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00001122345567889999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=364.07 Aligned_cols=258 Identities=22% Similarity=0.236 Sum_probs=206.9
Q ss_pred HHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccC
Q 003350 477 VAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 552 (828)
Q Consensus 477 ~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (828)
.+++...++|...++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455678999999999999999999876 58899999875421 12234578999999999999999999999999
Q ss_pred CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999998653 48999999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCC----CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
+..... .........||+.|+|||++.+.. ++.++|||||||++|||++|++||......+....+. .....
T Consensus 216 ~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~~~~~ 291 (410)
T 3v8s_A 216 MKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---NHKNS 291 (410)
T ss_dssp EECCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---THHHH
T ss_pred EeeccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH---hcccc
Confidence 875432 222234678999999999998765 7899999999999999999999998655433221110 00000
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCC--CCChHHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVD--RPSMGDVLW 754 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~eVl~ 754 (828)
+.-.........+.+++.+||+.+|.+ ||++.||++
T Consensus 292 ----------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 292 ----------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ----------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ----------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 000001123456888999999998988 999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=346.47 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=202.4
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-----cccHHHHHHHHHHHHcCC---CCceEEEEEEEccC
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-----QQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEK 552 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 552 (828)
..++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3678999999999999999999864 68899999875322 122345677887777664 99999999999765
Q ss_pred C-----cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEE
Q 003350 553 N-----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA 627 (828)
Q Consensus 553 ~-----~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~ 627 (828)
. ..++||||++ |+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999997 599999987766669999999999999999999999 899999999999999999999999
Q ss_pred eeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh
Q 003350 628 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|++||......+.............
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999986533 2223456799999999999999999999999999999999999999987654433221111100000
Q ss_pred cCCcccc-------cCcccc---CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 708 KGQLDQI-------IDPTLA---GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 708 ~~~~~~~-------~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
....... +.+... ....++....+.+++.+||+.+|.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1100000 000000 0011234567889999999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.32 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=195.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEe----cCCcEEEEEEcCCCC----cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (828)
.++|...++||+|+||.||+++. .+++.||+|++.... ......+.+|+++|++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788889999999999999986 468899999987642 2334567899999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999986543 58999999999999999999999 8999999999999999999999999999975
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... .
T Consensus 171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~~~-~---- 237 (327)
T 3a62_A 171 SIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID------KILKC-K---- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHT-C----
T ss_pred ccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhC-C----
Confidence 432 1122345679999999999999999999999999999999999999997654432211 11111 0
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
..++......+.+++.+||+.+|.+|| ++.|+++
T Consensus 238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 012233456788999999999999999 6667654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=358.26 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=199.8
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCC--CCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFR--HRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||++...+++.||||++... .....+.+.+|+++|.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458888999999999999999888999999987644 3445678999999999996 599999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
| +.+++|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56889999997654 68999999999999999999999 8999999999999996 5799999999998764422
Q ss_pred ccceeccccccccccChhhhcc-----------CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~---- 279 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA---- 279 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHH----
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHH----
Confidence 2223345679999999999865 468999999999999999999999997543211 11111
Q ss_pred CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 709 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
++++.....++......+.+++.+||+.+|.+||++.|+++..
T Consensus 280 -----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 280 -----IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp -----HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1122221122222345688999999999999999999998654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=353.83 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=205.2
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCc
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 554 (828)
....++|...++||+|+||.||+|+.+ +++.||||++.... ....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 344678999999999999999999876 58899999886431 23456778899999877 99999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999996543 68999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .... +.
T Consensus 168 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~i~~-~~---- 234 (345)
T 1xjd_A 168 NMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH------SIRM-DN---- 234 (345)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH-CC----
T ss_pred cccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH------HHHh-CC----
Confidence 4321 122445789999999999999999999999999999999999999998655433221 1111 10
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChH-HHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMG-DVL 753 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-eVl 753 (828)
+ .++......+.+++.+||+.+|.+||++. |++
T Consensus 235 --~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 --P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 12223355688999999999999999997 664
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.27 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=206.3
Q ss_pred CCCccceEeeeCcEEEEEEEecC----CcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE-EEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM-ILI 558 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 558 (828)
.|...++||+|+||.||+|...+ +..+|+|.+..... ...+.+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35556899999999999997532 23799998876433 4467899999999999999999999999766655 999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
+||+.+|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 568999999999999999999999 89999999999999999999999999999865432
Q ss_pred C--ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcC-CCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 639 D--QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 639 ~--~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
. .........+|..|+|||.+.+..++.++||||||+++|||++|. +|+......+... .. ..+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~---~~----~~~~----- 245 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH---FL----AQGR----- 245 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH---HH----HTTC-----
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH---Hh----hcCC-----
Confidence 1 112223456889999999999999999999999999999999955 5554443332211 11 1111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
....+...+..+.+++.+|++.+|.+||++.|+++.|+++++..
T Consensus 246 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 01112234567889999999999999999999999999887654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=346.14 Aligned_cols=278 Identities=23% Similarity=0.381 Sum_probs=216.4
Q ss_pred cccCHHHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHc--CCCCceEEEEEEE
Q 003350 472 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ--FRHRHLVSLIGYC 549 (828)
Q Consensus 472 ~~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~ 549 (828)
...++.......++|...+.||+|+||.||+|+.. ++.||||.+... ..+.+.+|++++.. ++||||+++++++
T Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 45666667777889999999999999999999885 899999998643 34678889999887 7999999999999
Q ss_pred ccCC----cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcC-----CCCEEeeeeecCcEEeCC
Q 003350 550 DEKN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY-----AKAVIHRDVKSANILLDE 620 (828)
Q Consensus 550 ~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDIkp~NILld~ 620 (828)
.... ..++||||+++|+|.+++... .+++.+++.++.|++.||+|||... ..+|+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence 7765 899999999999999999653 5899999999999999999999210 189999999999999999
Q ss_pred CCcEEEEeeCCCCCCCCCCccc--eeccccccccccChhhhccC------CCCcccceeehhhHHHHHHhc---------
Q 003350 621 NFMAKVADFGLSKTGPEIDQTH--VSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCA--------- 683 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGvvl~elltG--------- 683 (828)
++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 9999999999997643322111 22445799999999999765 234789999999999999999
Q ss_pred -CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC-CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 684 -RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK-IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 684 -~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
+.||....+.+ .....+....... . ..+.+... ...+....+.+++.+||+.+|.+||++.||++.|+.+.+
T Consensus 263 ~~~p~~~~~~~~-~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 263 YQLPYYDLVPSD-PSVEEMRKVVCEQ-K----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCCTTTTTSCSS-CCHHHHHHHHTTS-C----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCccccCcCc-ccHHHHHHHHHHH-H----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 66775433221 1112222221111 1 11211111 123567789999999999999999999999999998875
Q ss_pred h
Q 003350 762 L 762 (828)
Q Consensus 762 ~ 762 (828)
.
T Consensus 337 ~ 337 (342)
T 1b6c_B 337 Q 337 (342)
T ss_dssp T
T ss_pred H
Confidence 4
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=355.95 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=197.7
Q ss_pred CCCccceEeeeCcEEEEEEEec--CC--cEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEc-cCCcEEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN--DG--TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD-EKNEMILI 558 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV 558 (828)
.|...++||+|+||.||+|+.. ++ ..||||.+... .....++|.+|+.++++++||||++++++|. ..+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566689999999999999764 22 46899988654 3345678999999999999999999999875 45678999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999996543 468999999999999999999999 89999999999999999999999999999865332
Q ss_pred Ccc--ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 639 DQT--HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 639 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
... .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+.. ... ..+.. .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~~----~~~~~--~- 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYL----LQGRR--L- 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HHH----HTTCC--C-
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HHH----HcCCC--C-
Confidence 111 12234567889999999999999999999999999999999 67788654433221 111 11110 0
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
..+..++..+.+++.+||+.+|.+||++.|+++.|+.++..
T Consensus 316 ------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 316 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11223456788999999999999999999999999987754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=351.42 Aligned_cols=253 Identities=22% Similarity=0.272 Sum_probs=203.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-----CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
.++|...+.||+|+||.||+|... +++.||||.+... .....+.+.+|++++++++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 456888899999999999999875 6899999987532 1224678999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc---EEEEeeCC
Q 003350 557 LIYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM---AKVADFGL 631 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kl~DFGl 631 (828)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887542 23458999999999999999999999 99999999999999986654 99999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.. .... +..
T Consensus 180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~---~i~~-~~~ 249 (351)
T 3c0i_A 180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFE---GIIK-GKY 249 (351)
T ss_dssp CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHH---HHHH-TCC
T ss_pred eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHH---HHHc-CCC
Confidence 9875432 12234567999999999999999999999999999999999999999754211 111 1111 110
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..++... ......+.+++.+||+.+|.+||++.|+++
T Consensus 250 --~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 --KMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111111 123456889999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.57 Aligned_cols=267 Identities=25% Similarity=0.370 Sum_probs=212.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-----cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC--cE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN--EM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 555 (828)
.++|...+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34577889999999999999984 358899999998877777788999999999999999999999986544 78
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997653 459999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh---------hhHHHHHHHH
Q 003350 636 PEIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM---------VNLAEWAMKW 705 (828)
Q Consensus 636 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~---------~~l~~~~~~~ 705 (828)
...... .......++..|+|||.+.+..++.++||||||+++|||+||+.|+......-. ..........
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 442221 112344577889999999998999999999999999999999988753211000 0000011111
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
...+ .....+...+..+.+++.+||+.+|.+||++.|+++.|+.+.+.
T Consensus 276 ~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 276 LKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcC---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 11112334566789999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.21 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=203.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999876 5789999987543 2234577889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-- 167 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC--
Confidence 999999999999754 369999999999999999999999 9999999999999999999999999999987543
Q ss_pred ccceeccccccccccChhhhcc---CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+..... ..
T Consensus 168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~-------- 235 (384)
T 4fr4_A 168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---TT-------- 235 (384)
T ss_dssp -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---HC--------
T ss_pred -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---hc--------
Confidence 222345789999999999964 458999999999999999999999997544333222222111 10
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCC-hHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-MGDVL 753 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~eVl 753 (828)
...++......+.+++.+||+.+|.+||+ +.++.
T Consensus 236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 01123344567889999999999999998 56554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=341.15 Aligned_cols=253 Identities=29% Similarity=0.430 Sum_probs=202.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc-CCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+++.. ++.||||.+.... ..+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 457888899999999999999875 8899999987543 45789999999999999999999999754 4578999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++.......+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 999999999965443348899999999999999999999 89999999999999999999999999998764321
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+... . ...+ ..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~------~-~~~~---------~~ 232 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP------R-VEKG---------YK 232 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH------H-HTTT---------CC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------H-HhcC---------CC
Confidence 223457889999999999999999999999999999998 999997654332211 1 1111 01
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
...+...+..+.+++.+|++.+|.+||++.|+++.|+.+...
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 112234456788999999999999999999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.65 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=191.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 356888899999999999999875 58899999876543 2334678899999999999999999999999999999999
Q ss_pred eccCCcccccccCC----CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 561 YMENGTLKGHLYGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 561 y~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
|++ |+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999888532 22468999999999999999999999 899999999999999999999999999998653
Q ss_pred CCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc-
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI- 714 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~- 714 (828)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+......-.............
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 211 12234578999999999976 46899999999999999999999999876554332211100000000000000
Q ss_pred ----cCccc------------cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 ----IDPTL------------AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ----~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+.+ ...........+.+++.+||+.+|.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 00011123456889999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.90 Aligned_cols=259 Identities=30% Similarity=0.468 Sum_probs=208.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcE--EEEEEcCCC-CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTK--VAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...+.||+|+||.||+|+.. ++.. +|+|.+... .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888899999999999999765 4554 499987653 334456789999999999 999999999999999999999
Q ss_pred EEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 559 YEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
|||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997543 2469999999999999999999999 999999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||+++.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. .
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E 252 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------H
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH------H
Confidence 9999999875321 112234457889999999998899999999999999999998 99999765433221 1
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
.. ..+ .....+......+.+++.+||+.+|.+||++.|+++.|+.+++...
T Consensus 253 ~~-~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 KL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HG-GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred Hh-hcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11 111 0111223445678899999999999999999999999998876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.95 Aligned_cols=244 Identities=21% Similarity=0.313 Sum_probs=205.1
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888899999999999999876 68999999875432 234577889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999997543 58999999999999999999999 99999999999999999999999999999865331
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.....||+.|+|||++.+..++.++|||||||++|||++|++||......+... .+.. +..
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~i~~-~~~-------- 255 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------KIVS-GKV-------- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH-CCC--------
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH------HHHc-CCC--------
Confidence 234679999999999999999999999999999999999999997654433211 1111 110
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCC-----hHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eVl~ 754 (828)
.++......+.+++.+||+.+|.+||+ +.|+++
T Consensus 256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 122334566889999999999999998 777764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=342.34 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=201.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888899999999999999876 489999998765433 335678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-- 155 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--
Confidence 99999999887644 368999999999999999999999 89999999999999999999999999999865431
Q ss_pred cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH---------HHhhcCC
Q 003350 641 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM---------KWQNKGQ 710 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~ 710 (828)
........||..|+|||++.+ ..++.++|||||||++|||++|++||......+......... .+.....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 122345578999999999976 678999999999999999999999998765544332221110 0000000
Q ss_pred cc--cccCccccCC---CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 711 LD--QIIDPTLAGK---IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 711 ~~--~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. .+.++..... ..+.....+.+++.+||+.+|.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0011100000 00234556889999999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.64 Aligned_cols=243 Identities=22% Similarity=0.309 Sum_probs=202.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEecC-CcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...++||+|+||.||+|+... ++.||+|.+... .....+.+..|.++|..+ +||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4678889999999999999998764 788999987643 223456788999999988 89999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++...+ .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999996543 58999999999999999999999 8999999999999999999999999999986432
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.........||+.|+|||++.+..++.++|||||||++|||++|++||......+... ..... . .
T Consensus 174 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~-~------~ 238 (353)
T 2i0e_A 174 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------SIMEH-N------V 238 (353)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHC-C------C
T ss_pred --CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH------HHHhC-C------C
Confidence 1122345689999999999999999999999999999999999999998654433211 11111 1 0
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
.++......+.+++.+||+.+|.+||++
T Consensus 239 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 239 ----AYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1223345678899999999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=355.05 Aligned_cols=269 Identities=20% Similarity=0.249 Sum_probs=204.5
Q ss_pred hcCCCccceEeee--CcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIG--GFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...++||+| +||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4568888999999 99999999876 6899999987654 23445778899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999977655679999999999999999999999 9999999999999999999999999998864321
Q ss_pred CCc-----cceeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhH-HH-HHHHHhh-
Q 003350 638 IDQ-----THVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL-AE-WAMKWQN- 707 (828)
Q Consensus 638 ~~~-----~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l-~~-~~~~~~~- 707 (828)
... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||......+.... .. .......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 111 111233478999999999987 6799999999999999999999999976433222100 00 0000000
Q ss_pred -----------------cCCcccccC---cc------ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 708 -----------------KGQLDQIID---PT------LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 708 -----------------~~~~~~~~d---~~------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.......+. +. ............+.+++.+||+.+|.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000000000 00 000112233466889999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=349.41 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=197.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCC-------
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN------- 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 553 (828)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888899999999999999886 68999999986543 345678999999999999999999999985543
Q ss_pred --------------------------------------------------cEEEEEEeccCCcccccccCCCC-CCCChh
Q 003350 554 --------------------------------------------------EMILIYEYMENGTLKGHLYGSGL-PSLSWK 582 (828)
Q Consensus 554 --------------------------------------------------~~~lV~ey~~~gsL~~~l~~~~~-~~l~~~ 582 (828)
..++||||+++|+|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27999999999999999976432 446777
Q ss_pred hHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc----------ceecccccccc
Q 003350 583 QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT----------HVSTAVKGSFG 652 (828)
Q Consensus 583 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 652 (828)
.++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 899999999999999999 99999999999999999999999999999875442211 12234579999
Q ss_pred ccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHH
Q 003350 653 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFG 732 (828)
Q Consensus 653 Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 732 (828)
|+|||++.+..++.++|||||||++|||++|..|+. +...... . ...... +. ........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~---~-~~~~~~-----~~----~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIIT---D-VRNLKF-----PL----LFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHH---H-HHTTCC-----CH----HHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHH---H-hhccCC-----Cc----ccccCChhHH
Confidence 999999999999999999999999999999876542 1111111 0 111110 00 0123345678
Q ss_pred HHHHhhhhhCCCCCCChHHHHH
Q 003350 733 ETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 733 ~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+++.+||+.+|.+||++.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 8999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=347.98 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=200.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...+.||+|+||.||+++.. +++.||+|++... .....+.+.+|.+++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888899999999999999876 5889999987653 233456788999999988 899999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999986543 69999999999999999999999 99999999999999999999999999999864321
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh--hhHHHHHHHHhhcCCcccccC
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM--VNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d 716 (828)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ................
T Consensus 164 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----- 236 (345)
T 3a8x_A 164 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----- 236 (345)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred --CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence 1224456899999999999999999999999999999999999999964321110 0001111111111111
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
.++......+.+++.+||+.+|.+||++
T Consensus 237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 -----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1223345668899999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=347.50 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=196.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc----
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE---- 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 554 (828)
.++|...+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45788889999999999999986 468999999987653 2335678999999999999999999999865543
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||+++++|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999996543 69999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 635 GPEIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 635 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+.. .........
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~-- 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI-- 237 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC--
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCC--
Confidence 5432211 1223456899999999999999999999999999999999999999765543321 111111110
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+.. .....+..+.+++.+||+.+|.+||++.+++.
T Consensus 238 --~~~~---~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 238 --PPSA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp --CHHH---HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred --Cccc---ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0100 01223566889999999999999998777664
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=351.92 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=201.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.+.|...+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34578889999999999999986 468999999886543 23356789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||++ |+|.+++.... ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 99997 68888775432 469999999999999999999999 8999999999999999999999999999986532
Q ss_pred CccceeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.....||+.|+|||++. ...++.++|||||||++|||++|++||......+.. .......
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~------ 269 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE------ 269 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC------
Confidence 23457999999999985 567899999999999999999999999755432211 1111111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+.+ ........+.+++.+||+.+|.+||++.++++.
T Consensus 270 ~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111 112334568899999999999999999999854
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=334.26 Aligned_cols=252 Identities=19% Similarity=0.270 Sum_probs=206.4
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
..++|...+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567888899999999999999876 467899999876655667889999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe---CCCCcEEEEeeCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kl~DFGla~~~~~ 637 (828)
|+++++|.+++.... .+++.+++.++.|++.||+|||+ .+++||||||+|||+ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999886543 58999999999999999999999 999999999999999 8889999999999976543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
. .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+... ... .+... ...
T Consensus 162 ~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~-~~~~~--~~~ 228 (277)
T 3f3z_A 162 G---KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML------KIR-EGTFT--FPE 228 (277)
T ss_dssp T---SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-HCCCC--CCH
T ss_pred c---cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-hCCCC--CCc
Confidence 2 22345579999999999865 48999999999999999999999997654433211 111 11100 000
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
... ......+.+++.+||+.+|.+||++.|+++.
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 1234568899999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=337.96 Aligned_cols=267 Identities=19% Similarity=0.254 Sum_probs=206.7
Q ss_pred HhcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEE-ccCCcEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC-DEKNEMILIY 559 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 559 (828)
..++|...+.||+|+||.||+|+. .+++.||||........ +++.+|++++++++|++++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 46889999986544322 3578899999999988877766655 6777889999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe---CCCCcEEEEeeCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGP 636 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kl~DFGla~~~~ 636 (828)
||+ +++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 899999986433 369999999999999999999999 899999999999999 789999999999998654
Q ss_pred CCCcc-----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 637 EIDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 637 ~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 32221 1223567999999999999999999999999999999999999999765433322222211111111000
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
+.+. ...+..+.+++.+|++.+|.+||++.++++.|+.+++...
T Consensus 240 -----~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 -----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----hhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0011 1224568899999999999999999999999999887654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.44 Aligned_cols=260 Identities=22% Similarity=0.234 Sum_probs=202.6
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-----CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 552 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (828)
+....++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 5567788999999999999999999875 5789999986532 344567899999999999999999999999999
Q ss_pred CcEEEEEEeccCCcccccccCC--------------------------------------CCCCCChhhHHHHHHHHHHH
Q 003350 553 NEMILIYEYMENGTLKGHLYGS--------------------------------------GLPSLSWKQRLEICIGSARG 594 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~g 594 (828)
+..++||||+++|+|.+++... ....+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988520 01124567888999999999
Q ss_pred HHHHHhcCCCCEEeeeeecCcEEeCCCC--cEEEEeeCCCCCCCCCCc--cceeccccccccccChhhhcc--CCCCccc
Q 003350 595 LHYLHTGYAKAVIHRDVKSANILLDENF--MAKVADFGLSKTGPEIDQ--THVSTAVKGSFGYLDPEYFRR--QQLTEKS 668 (828)
Q Consensus 595 L~yLH~~~~~~ivHrDIkp~NILld~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~--~~~s~ks 668 (828)
|+|||+ .+|+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 8999999999999998776 899999999975432111 112345679999999999975 6789999
Q ss_pred ceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCC
Q 003350 669 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS 748 (828)
Q Consensus 669 DVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 748 (828)
|||||||++|||++|+.||......+... ....... ....+. .......+.+++.+||+.+|.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~------~~~~~~~--~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKKL--CFENPN-----YNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCC--CTTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHH------HHHhccc--ccCCcc-----cccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999997655433211 1111110 000111 1223567889999999999999999
Q ss_pred hHHHHH
Q 003350 749 MGDVLW 754 (828)
Q Consensus 749 m~eVl~ 754 (828)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.69 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=203.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457888899999999999999776 57799999875432 22356788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999986543 58999999999999999999999 89999999999999999999999999998654321
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..... ... .
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~-------~-- 223 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------SRV-------E-- 223 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHT-------C--
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH------HhC-------C--
Confidence 224457899999999999999999999999999999999999999865433322111 110 0
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
...+......+.+++.+||+.+|.+||++.|+++.-
T Consensus 224 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 224 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp --CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred --CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 112223455688999999999999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=347.10 Aligned_cols=270 Identities=24% Similarity=0.362 Sum_probs=198.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHH--HcCCCCceEEEEEEEc-----cCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEML--SQFRHRHLVSLIGYCD-----EKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~g~~~-----~~~~~ 555 (828)
.++|...+.||+|+||.||+|+. +++.||||++.... ...+..|.+++ ..++||||+++++.+. .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35788889999999999999977 58999999986432 34455555554 4589999999998542 33467
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcC------CCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY------AKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
++||||+++|+|.+++.... .++..++.++.|+++||+|||+.+ ..+|+||||||+|||++.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999996543 589999999999999999999821 119999999999999999999999999
Q ss_pred CCCCCCCCCC------ccceeccccccccccChhhhcc-------CCCCcccceeehhhHHHHHHhcCCCCCCCChhhh-
Q 003350 630 GLSKTGPEID------QTHVSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM- 695 (828)
Q Consensus 630 Gla~~~~~~~------~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~- 695 (828)
|+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9997654311 1112234579999999999976 4567899999999999999999776543221110
Q ss_pred h-----------hHHHHHHHHhhcCCcccccCccccCC--CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 696 V-----------NLAEWAMKWQNKGQLDQIIDPTLAGK--IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 696 ~-----------~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
. ....+. ........ .+.+... .....+..+.+++.+||+.+|.+|||+.|+++.|++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQ-VLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCTTHHHHCSSCCHHHHH-HHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhhhcccCCCchHHHHH-hhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 0 001111 11111111 1111111 1234667899999999999999999999999999998865
Q ss_pred hh
Q 003350 763 QE 764 (828)
Q Consensus 763 ~~ 764 (828)
.+
T Consensus 320 ~~ 321 (336)
T 3g2f_A 320 WE 321 (336)
T ss_dssp CC
T ss_pred HH
Confidence 53
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=353.57 Aligned_cols=273 Identities=19% Similarity=0.259 Sum_probs=213.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCC--cEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN--EMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 559 (828)
++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46778899999999999999876 48999999987543 234677889999999999999999999987654 789999
Q ss_pred EeccCCcccccccCCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe----CCCCcEEEEeeCCCCC
Q 003350 560 EYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKT 634 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kl~DFGla~~ 634 (828)
||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997643 2349999999999999999999999 899999999999999 8888899999999987
Q ss_pred CCCCCccceeccccccccccChhhhcc--------CCCCcccceeehhhHHHHHHhcCCCCCCCChhh-hhhHHHHHHHH
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRR--------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-MVNLAEWAMKW 705 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~ 705 (828)
... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ......-...-
T Consensus 166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 543 122335679999999999875 567889999999999999999999996533211 11111111110
Q ss_pred hhcCCccccc-----------CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 706 QNKGQLDQII-----------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 706 ~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
.....+..+- +......+.......+.+++.+||+.+|.+||++.|+++.++.+++.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0001110000 00111233466778899999999999999999999999999988764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=336.03 Aligned_cols=266 Identities=19% Similarity=0.255 Sum_probs=209.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEE-ccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC-DEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~e 560 (828)
.++|...+.||+|+||.||+|+. .+++.||||++...... +++.+|++++++++|++++..+.++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788889999999999999986 46899999987655432 4688999999999988876666655 66778899999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe---CCCCcEEEEeeCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kl~DFGla~~~~~ 637 (828)
|+ +++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 899999996433 469999999999999999999999 999999999999999 4889999999999986543
Q ss_pred CCcc-----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 638 IDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 638 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-
Confidence 2221 1124567999999999999999999999999999999999999999764432222222111111000000
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
+.+. ...+..+.+++.+|++.+|.+||++.+|++.|+.+.+...
T Consensus 240 ----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 ----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----HHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0111 2234568899999999999999999999999999876653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=360.77 Aligned_cols=261 Identities=22% Similarity=0.259 Sum_probs=207.6
Q ss_pred CHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEc
Q 003350 475 PFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550 (828)
Q Consensus 475 ~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 550 (828)
.+.+++...++|...++||+|+||.||+++.. +++.||+|++.... ....+.+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556788999999999999999999875 68999999986421 122345789999999999999999999999
Q ss_pred cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 551 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
+.+..++||||+++|+|.+++...+ ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999996543 369999999999999999999999 999999999999999999999999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhc-------cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHH-HHH
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA-EWA 702 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~-~~~ 702 (828)
+++.... ..........||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+ .+.
T Consensus 208 la~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 208 SCLKLRA-DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TCEECCT-TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hheeccC-CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 9987543 2222234568999999999997 357899999999999999999999999866544322111 110
Q ss_pred HHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCC---CChHHHHH
Q 003350 703 MKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDR---PSMGDVLW 754 (828)
Q Consensus 703 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Psm~eVl~ 754 (828)
.. ..-|.. ....+..+.+++.+||. +|.+| |++.|+++
T Consensus 287 ~~---------~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 EH---------LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HH---------CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cC---------cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00 000111 12334568899999999 99988 58888753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.40 Aligned_cols=266 Identities=16% Similarity=0.188 Sum_probs=208.7
Q ss_pred cCCCccceEeeeCcEEEEEEEecC---------CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEE----------
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND---------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS---------- 544 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 544 (828)
++|...+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578888999999999999998763 789999998654 35789999999999999987
Q ss_pred -----EEEEEcc-CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe
Q 003350 545 -----LIGYCDE-KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 618 (828)
Q Consensus 545 -----l~g~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl 618 (828)
+++++.. ....++||||+ +++|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 6777765 77899999999 9999999976544579999999999999999999999 899999999999999
Q ss_pred CCCC--cEEEEeeCCCCCCCCCCcc-----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCC
Q 003350 619 DENF--MAKVADFGLSKTGPEIDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL 691 (828)
Q Consensus 619 d~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~ 691 (828)
+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999865431111 11234579999999999999999999999999999999999999997543
Q ss_pred hhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 692 PREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 692 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
+.. ..+......+... .....+.... ....+..+.+++.+||+.+|.+||++.++++.|+++++...
T Consensus 273 ~~~-~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PNT-EDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCH-HHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCH-HHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 221 1111211111111 1111111110 01234668899999999999999999999999999876654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=350.14 Aligned_cols=247 Identities=22% Similarity=0.317 Sum_probs=202.5
Q ss_pred cCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788889999999999999987 468999999875421 122457889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+ +|+|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999 689998886543 69999999999999999999999 89999999999999999999999999999865432
Q ss_pred ccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+.. +.+...
T Consensus 162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~~ 223 (336)
T 3h4j_B 162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNSC 223 (336)
T ss_dssp --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCSS
T ss_pred --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHcC
Confidence 22345679999999999987765 78999999999999999999999754322111 000000
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
....+......+.+++.+||+.+|.+|||+.|+++.-
T Consensus 224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 0112333456788999999999999999999998643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.02 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=201.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999875 68899999986542 23357789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
+||+++++|.+++.... .+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999996543 68999999999999999999999 89999999999999999999999999999865432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ..+
T Consensus 188 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~----~~~- 254 (309)
T 2h34_A 188 K-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-------GAHINQAI----PRP- 254 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-------HHHHHSCC----CCG-
T ss_pred c-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-------HHHhccCC----CCc-
Confidence 1 1223345789999999999999999999999999999999999999975432211 11111110 001
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCC-ChHHHHHHHHHHHHh
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRP-SMGDVLWNLEYALQL 762 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~eVl~~L~~~~~~ 762 (828)
.......+..+.+++.+||+.+|.+|| ++.++++.|+.+++.
T Consensus 255 --~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 --STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp --GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred --cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 011233455688999999999999999 999999988876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=374.42 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=202.1
Q ss_pred ceEeeeCcEEEEEEEec---CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELN---DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
+.||+|+||.||+|.+. .++.||||+++... ....++|.+|+++|++++||||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999987543 3446889999999999999999999999964 568999999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc-cce
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ-THV 643 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~-~~~ 643 (828)
|+|.+++... ..+++.+++.|+.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999654 369999999999999999999999 8999999999999999999999999999986543221 122
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+.... ...+. ...
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-------i~~~~---------~~~ 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGE---------RMG 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC---------CCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC---------CCC
Confidence 334557889999999999999999999999999999998 9999987654432211 11111 112
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.+..++..+.+++.+||+.+|.+||++.+|++.|+....
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 233456778999999999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.80 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=206.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc------ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
.++|...+.||+|+||.||+|+.. +++.||+|.+..... ...+++.+|++++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888899999999999999876 588999998765432 1367899999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC----cEEEEeeCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF----MAKVADFGL 631 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kl~DFGl 631 (828)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999654 368999999999999999999999 8999999999999999888 799999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .... ..
T Consensus 166 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~i~~-~~- 234 (321)
T 2a2a_A 166 AHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NITS-VS- 234 (321)
T ss_dssp CEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHT-TC-
T ss_pred ceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHh-cc-
Confidence 9865431 12244579999999999999999999999999999999999999997654433211 1111 00
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...++... ......+.+++.+||+.+|.+||++.|+++
T Consensus 235 -~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 -YDFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CCCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -cccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00111111 123456889999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=339.51 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=201.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
..+|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 356888899999999999999864 6899999988753 334467789999999999999999999999999999999
Q ss_pred EEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 559 YEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
|||+++++|.+++.. .....+++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864 223568999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.. ........||..|+|||++.+..++.++||||||+++|||++|+.||...... ......... .....
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~~~~~---- 256 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-QCDYP---- 256 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHH-TTCSC----
T ss_pred CC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhh-cccCC----
Confidence 31 11223456899999999999999999999999999999999999998643211 111111111 11111
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
.+ ........+.+++.+||+.+|.+||++.+|++.|+++....+
T Consensus 257 -~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 -PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 01 112335568899999999999999999999999998776553
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=348.98 Aligned_cols=254 Identities=16% Similarity=0.164 Sum_probs=207.3
Q ss_pred HhcCCCccceEeeeCcEEEEEEE------ecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC---CCceEEEEEEEccC
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGE------LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEK 552 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 552 (828)
..++|...++||+|+||.||+|. ..+++.||||++.... ..++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35678888999999999999994 3468899999987653 457788888888887 99999999999999
Q ss_pred CcEEEEEEeccCCcccccccCC---CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---------
Q 003350 553 NEMILIYEYMENGTLKGHLYGS---GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE--------- 620 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~--------- 620 (828)
+..++||||+++|+|.+++... ....++|.+++.|+.|+++||+|||+ .+|+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999641 23569999999999999999999999 89999999999999998
Q ss_pred --CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhH
Q 003350 621 --NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 698 (828)
Q Consensus 621 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l 698 (828)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999975433233344566789999999999999999999999999999999999999985322111
Q ss_pred HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCC-CChHHHHHHHHHHHHh
Q 003350 699 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDR-PSMGDVLWNLEYALQL 762 (828)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Psm~eVl~~L~~~~~~ 762 (828)
..++..+... .....+.+++..|++.+|.+| |++.++.+.|+..++.
T Consensus 293 --------------~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 --------------CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------------EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0011111111 124557788999999999998 6788888888887654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.02 Aligned_cols=252 Identities=20% Similarity=0.312 Sum_probs=205.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
.++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888899999999999999875 5889999987543 3344577889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc---EEEEeeCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM---AKVADFGLSKTGP 636 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kl~DFGla~~~~ 636 (828)
||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999888654 368999999999999999999999 89999999999999986655 9999999997654
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... . .+.. ....
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~------~-~~~~-~~~~ 228 (284)
T 3kk8_A 160 DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI------K-AGAY-DYPS 228 (284)
T ss_dssp SS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HTCC-CCCT
T ss_pred cC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH------H-hccc-cCCc
Confidence 31 2233467999999999999999999999999999999999999999765443322111 1 1110 0000
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+ ........+.+++.+||+.+|.+||++.|+++.
T Consensus 229 ~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred h-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1 112334568899999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=334.59 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=206.0
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..++|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467888899999999999999876 68899999876432 344578899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999999654 368999999999999999999999 999999999999999999999999999997643322
Q ss_pred ccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.........||..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....|.. ... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~~~---~~--- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----KKT---YL--- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT----TCT---TS---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh----ccc---cc---
Confidence 2223345678999999999987765 7899999999999999999999976543211 1122211 100 00
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.........+.+++.+||+.+|.+||++.|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011233556789999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=362.00 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=196.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|...++||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999865 6889999987643 333456778999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ ..+|+||||||+||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence 99999999999986543 68999999999999999999995 26899999999999999999999999999986432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ... . .
T Consensus 302 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~-~------~- 366 (446)
T 4ejn_A 302 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME-E------I- 366 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC-C------C-
T ss_pred -CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhC-C------C-
Confidence 122234578999999999999999999999999999999999999999765443322111 111 0 0
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
.++......+.+++.+||+.+|.+|| ++.|+++
T Consensus 367 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 12233456688999999999999999 9999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.89 Aligned_cols=260 Identities=21% Similarity=0.251 Sum_probs=207.9
Q ss_pred HHHHHHHhcCCCcc-ceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcC-CCCceEEEEEEEc
Q 003350 476 FVAVQEATNNFDES-WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD 550 (828)
Q Consensus 476 ~~~l~~at~~f~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 550 (828)
+...+...++|... +.||+|+||.||+|... +++.||+|.+... ......++.+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34455666677766 88999999999999876 5899999987653 334467899999999999 5699999999999
Q ss_pred cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---CCcEEEE
Q 003350 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVA 627 (828)
Q Consensus 551 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kl~ 627 (828)
..+..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999999977655679999999999999999999999 89999999999999998 7899999
Q ss_pred eeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh
Q 003350 628 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 628 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ..
T Consensus 177 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~ 247 (327)
T 3lm5_A 177 DFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI------SQ 247 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH
T ss_pred eCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH------Hh
Confidence 99999875431 1233467999999999999999999999999999999999999999765443321111 00
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. ...............+.+++.+||+.+|.+||++.|+++
T Consensus 248 ~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 V-------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp T-------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c-------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 001111112334566889999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=341.50 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=205.5
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc---------
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--------- 551 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 551 (828)
...+|...+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567888899999999999999886 68999999987654 356789999999999999999998854
Q ss_pred -------CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 552 -------KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 552 -------~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
....++||||+++|+|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 4558999999999999999976544579999999999999999999999 899999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (828)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..|+... . .+...
T Consensus 162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~---~~~~~ 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S---KFFTD 230 (284)
T ss_dssp EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H---HHHHH
T ss_pred EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H---HHHHH
Confidence 999999998654321 233456999999999999999999999999999999999998876311 1 11111
Q ss_pred HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 705 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
...+. ++......+.+++.+||+.+|.+||++.|+++.|+.+.+.
T Consensus 231 -~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 231 -LRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -HHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -hhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111 1122345578899999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.32 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=179.4
Q ss_pred cceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 489 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
.++||+|+||.||+|... +++.||||++... ....+.+|++++.++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999876 5899999998543 3567889999999997 9999999999999999999999999999
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC---cEEEEeeCCCCCCCCCCccce
Q 003350 567 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---MAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 567 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~kl~DFGla~~~~~~~~~~~ 643 (828)
|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++..... ...
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~ 165 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQP 165 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCc
Confidence 99999764 369999999999999999999999 9999999999999997665 8999999999865432 222
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh-hHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+.... ...+... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~~--~~~~---- 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDFS--FEGE---- 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCCC--CCSH----
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCCC--CCcc----
Confidence 34567899999999999999999999999999999999999999754332111 11111111 1111110 0000
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
........+.+++.+||+.+|.+||++.|++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 0022356788999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.15 Aligned_cols=258 Identities=20% Similarity=0.286 Sum_probs=191.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEE--------ccC
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYC--------DEK 552 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~--------~~~ 552 (828)
..+|...++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457888899999999999999865 68999999987666666788999999999996 99999999998 344
Q ss_pred CcEEEEEEeccCCcccccccC-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC--EEeeeeecCcEEeCCCCcEEEEee
Q 003350 553 NEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHYLHTGYAKA--VIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILld~~~~~kl~DF 629 (828)
...++|+||+. |+|.+++.. .....+++.+++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 56899999996 799998864 223469999999999999999999999 77 999999999999999999999999
Q ss_pred CCCCCCCCCCccc----------eeccccccccccChhhh---ccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh
Q 003350 630 GLSKTGPEIDQTH----------VSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV 696 (828)
Q Consensus 630 Gla~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~---~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~ 696 (828)
|+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 9998754322111 11244589999999998 567789999999999999999999999964322110
Q ss_pred hHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 697 NLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 697 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
.+..............+.+++.+||+.+|.+||++.|+++.|+.+.+..
T Consensus 262 ------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 262 ------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0001111111122334778999999999999999999999999877543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=349.82 Aligned_cols=253 Identities=22% Similarity=0.241 Sum_probs=194.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+++.. +++.||||++...... .+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457888899999999999999876 6889999998754332 36788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc--EEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM--AKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--~kl~DFGla~~~~~~~ 639 (828)
+++|+|.+++...+ .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999986543 59999999999999999999999 99999999999999987765 99999999975322
Q ss_pred ccceeccccccccccChhhhccCCCCcc-cceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEK-SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
........||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ........... .
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~---------~ 238 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSV---------K 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTT---------C
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcC---------C
Confidence 112344579999999999988887655 8999999999999999999975433211 11111111111 0
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
............+.+++.+||+.+|.+|||+.|+++.
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000111234568899999999999999999999865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=364.44 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=207.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|...++||+|+||.||+|+.. +|+.||+|++... .......+.+|+++|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999875 6899999987543 123456788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++.......+++..++.++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999987665669999999999999999999999 89999999999999999999999999999875432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh-hHHHHHHHHhhcCCcccccCc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.......||+.|+|||++.+..++.++|||||||++|||++|++||......... .+..... ..
T Consensus 340 ---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----~~-------- 404 (576)
T 2acx_A 340 ---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EV-------- 404 (576)
T ss_dssp ---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH----HC--------
T ss_pred ---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh----cc--------
Confidence 1234458999999999999989999999999999999999999999765322111 1111111 10
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
...++......+.+++.+||+.+|.+|| ++.||++
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0112233456788999999999999999 6778764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=357.79 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=205.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46788899999999999999876 68999999876432 233567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 999999999999654 369999999999999999999999 99999999999999999999999999999875431
Q ss_pred ccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+.. .... .+.
T Consensus 170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~------~~i~-~~~-------- 232 (476)
T 2y94_A 170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF------KKIC-DGI-------- 232 (476)
T ss_dssp --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH------HHHH-TTC--------
T ss_pred --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH------HHHh-cCC--------
Confidence 22345679999999999988765 68999999999999999999999765432211 1111 111
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
. ..+......+.+++.+||+.+|.+|||+.|+++.
T Consensus 233 ~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 1122234568899999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=335.80 Aligned_cols=251 Identities=26% Similarity=0.348 Sum_probs=199.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+++|++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356888899999999999999875 58899999876543 3446889999999999999999999999999999999999
Q ss_pred eccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe---CCCCcEEEEeeCCCCCC
Q 003350 561 YMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTG 635 (828)
Q Consensus 561 y~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kl~DFGla~~~ 635 (828)
|+++|+|.+++... ....+++..++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988542 23569999999999999999999999 899999999999999 55688999999999865
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.. ........||+.|+|||.+. +.++.++|||||||++|||++|+.||......+...... ...
T Consensus 178 ~~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~------~~~------ 241 (285)
T 3is5_A 178 KS---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT------YKE------ 241 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC------
T ss_pred CC---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc------cCC------
Confidence 43 12234567999999999985 578999999999999999999999998655433221111 110
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+..... .......+.+++.+||+.+|.+||++.|+++
T Consensus 242 -~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 -PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0112456788999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.19 Aligned_cols=267 Identities=21% Similarity=0.267 Sum_probs=199.6
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcc-----cHHHHHHHHHHHHcCCCCceEEEEEEEccCC
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ-----GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN 553 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (828)
....++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344678999999999999999999876 5899999998754221 1246789999999999999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++||||+++ +|.+++.... ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999985 8888886543 468999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh--cCC
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN--KGQ 710 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~ 710 (828)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|++||......+.. ......... ...
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~--~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--TRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHcCCCChhh
Confidence 754322 223456789999999999754 5899999999999999999999999766543322 111111110 000
Q ss_pred ccc---ccCc---cccCCCC-----hhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 711 LDQ---IIDP---TLAGKIR-----PDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 711 ~~~---~~d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
... ..+. ......+ ......+.+++.+||+.+|.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000 0000001 2334678999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.10 Aligned_cols=252 Identities=20% Similarity=0.331 Sum_probs=192.7
Q ss_pred cCCCcc-ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHH-cCCCCceEEEEEEEcc----CCcEE
Q 003350 484 NNFDES-WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLS-QFRHRHLVSLIGYCDE----KNEMI 556 (828)
Q Consensus 484 ~~f~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~ 556 (828)
++|... ++||+|+||.||++... +++.||||++... ..+.+|++++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455554 68999999999999875 5889999998632 45678888874 4589999999998864 66789
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---CCcEEEEeeCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVADFGLSK 633 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kl~DFGla~ 633 (828)
+||||+++|+|.+++.......+++.++..|+.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999987655679999999999999999999999 89999999999999997 7899999999998
Q ss_pred CCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh-hHHHHHHHHhhcCCcc
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQLD 712 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~ 712 (828)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ..+...
T Consensus 213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~ 285 (400)
T 1nxk_A 213 ETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYE 285 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCC
T ss_pred ccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCccc
Confidence 6432 12234567899999999999999999999999999999999999999755432211 111111 111100
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
+...........+.+++.+||+.+|.+||++.|+++.-
T Consensus 286 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 286 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00001123456688999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=352.42 Aligned_cols=267 Identities=24% Similarity=0.354 Sum_probs=193.2
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCC-CCceEEEEEEEccC--Cc
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEK--NE 554 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~ 554 (828)
...++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|.++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999865 6899999988653 3344567889999999997 99999999998643 47
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++|||||+ ++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999998 6899888653 58999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCC-------------------ccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhh
Q 003350 635 GPEID-------------------QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694 (828)
Q Consensus 635 ~~~~~-------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~ 694 (828)
..... .....+...||+.|+|||++.+ ..++.++|||||||++|||++|++||......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 43210 1112344679999999999986 678999999999999999999999998765433
Q ss_pred hhhHHHHHHHHhhcCCccccc------------------CccccC------------CCChhHHHHHHHHHHhhhhhCCC
Q 003350 695 MVNLAEWAMKWQNKGQLDQII------------------DPTLAG------------KIRPDSLRKFGETAEKCLADFGV 744 (828)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~------------------d~~l~~------------~~~~~~~~~l~~l~~~Cl~~~p~ 744 (828)
......-.........+..+. ...... .........+.+++.+||+.+|.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 322111000000000000000 000000 00012345688999999999999
Q ss_pred CCCChHHHHH
Q 003350 745 DRPSMGDVLW 754 (828)
Q Consensus 745 ~RPsm~eVl~ 754 (828)
+|||+.|+++
T Consensus 319 ~R~t~~e~l~ 328 (388)
T 3oz6_A 319 KRISANDALK 328 (388)
T ss_dssp GSCCHHHHTT
T ss_pred cCCCHHHHhC
Confidence 9999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.17 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=202.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC----cccHHHHHHHHHHHHcCCCCceEEEEEEE--ccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRHRHLVSLIGYC--DEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~ 555 (828)
.++|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 467899999999999999999875 57899999886532 23457899999999999999999999998 556689
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++||||++++ |.+++.......+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 7777765555679999999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCccceeccccccccccChhhhccCC--CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
.............||..|+|||++.+.. .+.++||||||+++|||++|+.||......+... .. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~i-~~~~--- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE------NI-GKGS--- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HH-HHCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH------HH-hcCC---
Confidence 4333333344567999999999997644 3789999999999999999999998654332211 11 1111
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
. ..+......+.+++.+|++.+|.+||++.|+++.
T Consensus 230 ---~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ---Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 1223345668899999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=333.68 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=202.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC------cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
++|...+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888899999999999999876 58999999865432 123678999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC----cEEEEeeCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF----MAKVADFGLS 632 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kl~DFGla 632 (828)
+||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999653 368999999999999999999999 8999999999999998877 8999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+... ... ...
T Consensus 160 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-~~~-- 227 (283)
T 3bhy_A 160 HKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------NIS-AVN-- 227 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH-TTC--
T ss_pred eeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH------HhH-hcc--
Confidence 865331 12234568999999999999999999999999999999999999997654332211 111 100
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...++... ......+.+++.+|++.+|.+||++.|+++
T Consensus 228 ~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YDFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00111111 123456889999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=333.85 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=184.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45788889999999999999987 468999999875432 22357789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++++|.+++.... ..+++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999987543 469999999999999999999999 89999999999999999999999999999865432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... .+....
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~ 228 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhcc
Confidence 11 1234568999999999999899999999999999999999999997543222110 011000
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. ..+......+.+++.+||+.+|.+||++.|+++
T Consensus 229 ~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 Y--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0 122334567889999999999999999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=347.64 Aligned_cols=263 Identities=17% Similarity=0.175 Sum_probs=197.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCCCccc-----------HHHHHHHHHHHHcCCCCceEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRSQQG-----------LAEFQTEIEMLSQFRHRHLVSLIGY 548 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~ 548 (828)
++|...+.||+|+||.||+|... .+..+|||+........ ...+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999875 46789999877654221 1336678899999999999999999
Q ss_pred Ecc----CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC--
Q 003350 549 CDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-- 622 (828)
Q Consensus 549 ~~~----~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-- 622 (828)
+.. ....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence 977 77899999999 999999997654 79999999999999999999999 8999999999999998887
Q ss_pred cEEEEeeCCCCCCCCCCc-----cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhh
Q 003350 623 MAKVADFGLSKTGPEIDQ-----THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 697 (828)
Q Consensus 623 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~ 697 (828)
.+||+|||+++....... ........||..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~- 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA- 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-
Confidence 999999999976532111 11124457999999999999999999999999999999999999999642221111
Q ss_pred HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.......... .+...+..... ....+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 270 ~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 270 VQTAKTNLLD--ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp HHHHHHHHHH--TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred HHHHHHhhcc--cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111111110 00000000000 01345578899999999999999999999988875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.16 Aligned_cols=248 Identities=21% Similarity=0.339 Sum_probs=205.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56778899999999999999876 4788999987543 2344677899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++... ..+++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999988653 368999999999999999999999 899999999999999999999999999998654211
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..... .. .
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~-~~------~-- 232 (294)
T 2rku_A 170 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKK-NE------Y-- 232 (294)
T ss_dssp --CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT-TC------C--
T ss_pred --cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhh-cc------C--
Confidence 1234467899999999999999999999999999999999999999765433221 11111 10 0
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+......+.+++.+|++.+|.+||++.|+++.
T Consensus 233 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 --SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1122334568889999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.77 Aligned_cols=250 Identities=28% Similarity=0.397 Sum_probs=207.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.+.|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 346888899999999999999765 68899999876543 3456889999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.+++.. ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999999854 358999999999999999999999 899999999999999999999999999997654321
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... . .... .+.+
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~-~~~~-----~~~~- 239 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------I-PKNN-----PPTL- 239 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------H-HHSC-----CCCC-
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH------h-hcCC-----CCCC-
Confidence 123456789999999999999999999999999999999999999976543322111 1 1111 1111
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
.......+.+++.+||+.+|.+||++.|+++..
T Consensus 240 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 223345688999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.83 Aligned_cols=264 Identities=22% Similarity=0.335 Sum_probs=197.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCccc-HHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...+.||+|+||.||+|+.. +++.||+|++....... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46788899999999999999876 68899999886543221 22456799999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
++ |+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 154 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC--c
Confidence 97 58988886544 469999999999999999999999 99999999999999999999999999999864321 1
Q ss_pred ceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc---
Q 003350 642 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP--- 717 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--- 717 (828)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.......................
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 22334578999999999876 57899999999999999999999999876554432222111100001111111100
Q ss_pred ------cccC----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 ------TLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ------~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.... ...+.....+.+++.+||+.+|.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 001123456789999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.84 Aligned_cols=260 Identities=27% Similarity=0.318 Sum_probs=204.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEc----cCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD----EKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~l 557 (828)
.++|...+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46788889999999999999987 468999999887666666788999999999999999999999986 3457899
Q ss_pred EEEeccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
|+||+++|+|.+++... ....+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998652 23579999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCCccc-------eeccccccccccChhhhccCC---CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHH
Q 003350 636 PEIDQTH-------VSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW 705 (828)
Q Consensus 636 ~~~~~~~-------~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (828)
....... ......||+.|+|||++.... ++.++|||||||++|||++|+.||....... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHH----
Confidence 3211000 012345799999999987543 6899999999999999999999985321110 011110
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
... .............+.+++.+||+.+|.+||++.|+++.|+.+
T Consensus 260 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 260 VQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 000 000111233456788999999999999999999999988763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.14 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=204.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888899999999999999876 57889999875431 223567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++.+++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999986543 58999999999999999999999 89999999999999999999999999998764321
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......||..|+|||++.+..++.++||||||+++|||++|+.||......+... .... . +.
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~-~------~~-- 229 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIVN-V------DL-- 229 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHT-T------CC--
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHhc-c------cc--
Confidence 1234578999999999999999999999999999999999999997654332211 1111 0 11
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.++......+.+++.+|++.+|.+||++.|+++.
T Consensus 230 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 --KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1223345668899999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=351.08 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=194.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHH-HHcCCCCceEEEEEEEccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEM-LSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.++|...++||+|+||.||+++.+ +++.||+|++.... ....+.+..|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357888899999999999999876 57899999876542 2234556677776 577899999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999996543 68899999999999999999999 9999999999999999999999999999985322
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... . .
T Consensus 192 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~-~------~ 256 (373)
T 2r5t_A 192 --HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD------NILNK-P------L 256 (373)
T ss_dssp --CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH------HHHHS-C------C
T ss_pred --CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHhc-c------c
Confidence 1222445689999999999999999999999999999999999999997654433211 11111 0 0
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl 753 (828)
.++......+.+++.+||+.+|.+||++.+.+
T Consensus 257 ----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 ----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 12233455688999999999999999986443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=337.26 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=204.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+++.. +++.||+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888899999999999999875 6899999998766554556789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe---CCCCcEEEEeeCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kl~DFGla~~~~~~ 638 (828)
+++++|.+++.... .+++.++..++.|++.||+|||+ .+++||||||+|||+ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 99999999886543 68999999999999999999999 899999999999999 7889999999999976432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ... ++.. .
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~i~-~~~~------~ 225 (304)
T 2jam_A 162 ---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE------KIK-EGYY------E 225 (304)
T ss_dssp ---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHH-HCCC------C
T ss_pred ---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-cCCC------C
Confidence 12234568999999999999999999999999999999999999997654332211 111 1110 0
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.........+..+.+++.+||+.+|.+||++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111123345678899999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.51 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=199.8
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
+|....+||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3455569999999999999864 688999999887766667889999999999999999999999999999999999999
Q ss_pred CCcccccccCCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-CCcEEEEeeCCCCCCCCCCcc
Q 003350 564 NGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 564 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+|||++. ++.+||+|||+++......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999997542 3457789999999999999999999 89999999999999987 8999999999998654311
Q ss_pred ceeccccccccccChhhhccCC--CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.......||..|+|||++.+.. ++.++||||||+++|||++|+.||......... .+..... ...+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~-------~~~~-- 245 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGMF-------KVHP-- 245 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHHH-------CCCC--
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhccc-------cccc--
Confidence 1233457899999999997653 889999999999999999999999643221111 0000000 0111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+||+.+|.+||++.|+++
T Consensus 246 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 --EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222344567889999999999999999999963
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.92 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=203.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEE--ccCCcEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYC--DEKNEMIL 557 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~l 557 (828)
.++|...+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|++++++++||||+++++++ ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888899999999999999875 6899999988654 334467789999999999999999999987 45678999
Q ss_pred EEEeccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcCCCC-----EEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 558 IYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKA-----VIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
||||+++++|.+++... ....+++.+++.++.|++.||+|||+ .+ ++||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999653 23459999999999999999999999 66 9999999999999999999999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ 710 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (828)
+++..... ........||..|+|||.+.+..++.++||||||+++|||++|+.||......+.. . . ...+.
T Consensus 162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~-i~~~~ 232 (279)
T 2w5a_A 162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---G---K-IREGK 232 (279)
T ss_dssp HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H-HHHTC
T ss_pred hheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH---H---H-Hhhcc
Confidence 99765431 11223456899999999999999999999999999999999999999865433221 1 1 11111
Q ss_pred cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 711 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
.. ..+......+.+++.+||+.+|.+||++.|+++.+
T Consensus 233 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 233 FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11 12233456788999999999999999999997544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.53 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=197.8
Q ss_pred cCCCc-cceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDE-SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~-~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 560 (828)
+.|.. .++||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45655 368999999999999864 6899999998776666678899999999985 79999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc---EEEEeeCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM---AKVADFGLSKTGPE 637 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kl~DFGla~~~~~ 637 (828)
|+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999996543 68999999999999999999999 89999999999999998776 99999999976432
Q ss_pred CCc-----cceeccccccccccChhhhcc-----CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhh--------hHH
Q 003350 638 IDQ-----THVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV--------NLA 699 (828)
Q Consensus 638 ~~~-----~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~--------~l~ 699 (828)
... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.. ...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 111 111223569999999999975 56889999999999999999999999765332100 000
Q ss_pred HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 700 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.........+... +..... ......+.+++.+||+.+|.+||++.|+++
T Consensus 247 ~~~~~~i~~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKYE--FPDKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCcc--cCchhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000111111100 000000 123456889999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=343.50 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=201.8
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..++|...+.||+|+||.||++... +++.||||.+...... +.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567888899999999999999876 5889999998765432 35688888887 7999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC----CcEEEEeeCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN----FMAKVADFGLSKTG 635 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~----~~~kl~DFGla~~~ 635 (828)
||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999996553 69999999999999999999999 899999999999998433 35999999999865
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.. .. ..+..
T Consensus 171 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i-~~~~~---- 240 (342)
T 2qr7_A 171 RAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RI-GSGKF---- 240 (342)
T ss_dssp BCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HH-HHCCC----
T ss_pred cCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HH-ccCCc----
Confidence 4321 22345678999999999988889999999999999999999999997543222211111 11 11111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+...........+.+++.+||+.+|.+||++.|+++.
T Consensus 241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111223345678899999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=356.54 Aligned_cols=265 Identities=18% Similarity=0.232 Sum_probs=210.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC-CceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...++||+|+||.||+|+. .+++.||||++...... .++..|++++..++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36788889999999999999986 46899999987654332 357899999999987 556666677788888999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe---CCCCcEEEEeeCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kl~DFGla~~~~~ 637 (828)
|+ +++|.+++.... ..+++.+++.|+.||+.||+|||+ .+|+||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 899999996433 469999999999999999999999 899999999999999 6889999999999986543
Q ss_pred CCcc-----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 638 IDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 638 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
.... .......||..|+|||++.+..++.++|||||||+||||++|+.||.......................+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 2211 11235679999999999999999999999999999999999999998654433322222222111111111
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
.+. ...+.++.+++.+|++.+|.+||++.+|++.|+.+++..
T Consensus 239 -----~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 239 -----ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -----HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 111 122456889999999999999999999999999988754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=333.53 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=199.6
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 557 (828)
..++|...+.||+|+||.||+|... +++.||+|.+... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567888899999999999999876 6899999987754 234467788999999999 99999999999999999999
Q ss_pred EEEeccCCcccccccCCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---------------
Q 003350 558 IYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE--------------- 620 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~--------------- 620 (828)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999996532 2468999999999999999999999 89999999999999984
Q ss_pred ----CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhh
Q 003350 621 ----NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 695 (828)
Q Consensus 621 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~ 695 (828)
...+||+|||++...... ....||..|+|||.+.+. .++.++|||||||++|||++|++++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 448999999999875431 234589999999999865 667899999999999999999987643211
Q ss_pred hhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 696 VNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 696 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+ .....+.. + ..+......+.+++.+||+.+|.+||++.|+++
T Consensus 237 -----~--~~~~~~~~-----~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -----W--HEIRQGRL-----P----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----H--HHHHTTCC-----C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----H--HHHHcCCC-----C----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 00111111 1 122334566889999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.89 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=199.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEec--CCc--EEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN--DGT--KVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
.++|...+.||+|+||.||+|++. +++ .||||.+... .....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356888899999999999999853 233 6899987654 2345678999999999999999999999997765 8
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+||+++++|.+++.... ..+++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999986542 358999999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 636 PEIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 636 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
...... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~~--- 242 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEGE--- 242 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSCC---
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------HHHHccCC---
Confidence 442221 12234567889999999998889999999999999999999 99999765443221 11111110
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
........+..+.+++.+|++.+|.+||++.++++.|+++.
T Consensus 243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 01112344567889999999999999999999999988754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.57 Aligned_cols=249 Identities=20% Similarity=0.331 Sum_probs=206.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457888899999999999999876 4789999987543 234467789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++++|.+++... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988653 368999999999999999999999 89999999999999999999999999999865421
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||......+... ..... . .
T Consensus 195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~-~------~- 258 (335)
T 2owb_A 195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKN-E------Y- 258 (335)
T ss_dssp T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHT-C------C-
T ss_pred c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHhcC-C------C-
Confidence 1 12344679999999999999999999999999999999999999997654332211 11111 1 0
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+......+.+++.+||+.+|.+||++.|+++.
T Consensus 259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122334567889999999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=342.74 Aligned_cols=264 Identities=20% Similarity=0.242 Sum_probs=194.9
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
...++|...++||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999765 689999999875533 234567899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe-----CCCCcEEEEeeCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL-----DENFMAKVADFGLS 632 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl-----d~~~~~kl~DFGla 632 (828)
||||++ |+|.+++.... .+++.+++.|+.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||++
T Consensus 111 v~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999998 59999986554 59999999999999999999999 899999999999999 55666999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh--cC
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN--KG 709 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~ 709 (828)
+..... ........||+.|+|||++.+. .++.++|||||||++|||++|++||......+... ........ ..
T Consensus 185 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF--KIFEVLGLPDDT 260 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTT
T ss_pred cccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH--HHHHHhCCCchh
Confidence 764321 1123445689999999999874 58999999999999999999999998665433221 11111100 00
Q ss_pred Cccc-------------ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 710 QLDQ-------------IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 710 ~~~~-------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.... .....+...........+.+++.+||+.+|.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 00000000001113466889999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=346.49 Aligned_cols=271 Identities=21% Similarity=0.243 Sum_probs=203.5
Q ss_pred ccCHHHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCc-----------ccHHHHHHHHHHHHcCCCCc
Q 003350 473 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ-----------QGLAEFQTEIEMLSQFRHRH 541 (828)
Q Consensus 473 ~~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~n 541 (828)
+....++....++|...+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456788899999999999999999999999988899999998754321 12378899999999999999
Q ss_pred eEEEEEEEc-----cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcE
Q 003350 542 LVSLIGYCD-----EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANI 616 (828)
Q Consensus 542 iv~l~g~~~-----~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NI 616 (828)
|+++++++. .....++||||++ |+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI 165 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence 999999983 3446899999998 68888886543 469999999999999999999999 8999999999999
Q ss_pred EeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhh
Q 003350 617 LLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 695 (828)
Q Consensus 617 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~ 695 (828)
|++.++.+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999975432 122344678999999999877 6789999999999999999999999987654332
Q ss_pred hhHHHHHHHHhhcCCc-----------ccccCcccc-------CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 696 VNLAEWAMKWQNKGQL-----------DQIIDPTLA-------GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 696 ~~l~~~~~~~~~~~~~-----------~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..... ........ ...+...+. ....+.....+.+++.+||+.+|.+|||+.|+++
T Consensus 243 ~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIV---EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHH---HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHH---HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 21110 00000000 000000000 0011233456889999999999999999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=353.69 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=196.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------C
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------N 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 553 (828)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+++|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888999999999999999765 5889999998654 334467788999999999999999999999544 4
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++||||+++ +|.+.+.. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 57999999986 46665532 48999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHH------------
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW------------ 701 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~------------ 701 (828)
.... ....+...||+.|+|||++.+..++.++|||||||++|||++|++||......+....+..
T Consensus 213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 7533 2223556899999999999999999999999999999999999999987654332211110
Q ss_pred ----HHHHhhcC-C-----cccccCccccCCC---ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 702 ----AMKWQNKG-Q-----LDQIIDPTLAGKI---RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 702 ----~~~~~~~~-~-----~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+.... . ....+...+.... .......+.+++.+||+.+|.+|||+.|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 0 0000000000000 0112567899999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=345.41 Aligned_cols=244 Identities=19% Similarity=0.277 Sum_probs=202.3
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--------ccHHHHHHHHHHHHcCCCCceEEEEEEEcc
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (828)
...++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34678899999999999999999864 688999998765431 123457789999999999999999999999
Q ss_pred CCcEEEEEEeccCC-cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 552 KNEMILIYEYMENG-TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 552 ~~~~~lV~ey~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
.+..++||||+..| +|.+++.... .+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 99999999999777 9999986543 69999999999999999999999 899999999999999999999999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 709 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 709 (828)
+++..... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 176 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 176 SAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred cceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99875432 12334679999999999988876 88999999999999999999999642110
Q ss_pred CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 710 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 710 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..... ..+......+.+++.+||+.+|.+||++.|+++.
T Consensus 237 -----~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 1112234568899999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.44 Aligned_cols=241 Identities=16% Similarity=0.156 Sum_probs=190.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCC---CCcccHHHHHHHH---HHHHcCCCCceEEEE-------EE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNP---RSQQGLAEFQTEI---EMLSQFRHRHLVSLI-------GY 548 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 548 (828)
.++|...+.||+|+||.||+|+.. +|+.||||++.. ......+.+.+|+ ++|++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 456778899999999999999864 689999999763 2344567899999 555666899999988 66
Q ss_pred EccCC-----------------cEEEEEEeccCCcccccccCCC-----CCCCChhhHHHHHHHHHHHHHHHHhcCCCCE
Q 003350 549 CDEKN-----------------EMILIYEYMENGTLKGHLYGSG-----LPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606 (828)
Q Consensus 549 ~~~~~-----------------~~~lV~ey~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 606 (828)
+...+ ..++||||+ +|+|.+++.... ...++|..++.|+.|+++||+|||+ .+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 65543 288999999 689999996432 1235568899999999999999999 899
Q ss_pred EeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccC-----------CCCcccceeehhh
Q 003350 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGV 675 (828)
Q Consensus 607 vHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDVySfGv 675 (828)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986322 2345567 999999999887 8999999999999
Q ss_pred HHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 676 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 676 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
++|||++|+.||......+. ...+... ....+..+.+++.+||+.+|.+||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999964432211 1111110 1233456889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=343.22 Aligned_cols=265 Identities=22% Similarity=0.341 Sum_probs=202.2
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...++||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888899999999999999876 488999998755432 335668899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp CCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 999999988865443 59999999999999999999999 89999999999999999999999999999865431
Q ss_pred cceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHH---------HHHHHhhcCC
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE---------WAMKWQNKGQ 710 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~~~~~~~ 710 (828)
........||..|+|||++.+. .++.++|||||||++|||++|++||......+...... +...+.....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 1223455789999999999875 78999999999999999999999998765433221110 0000001111
Q ss_pred cccccCccccCCC-----ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 711 LDQIIDPTLAGKI-----RPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 711 ~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
......+.+.... .+.....+.+++.+||+.+|.+||++.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111111 12345678999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=347.66 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=205.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356888899999999999999876 6889999988765 33446778999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCC-CEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
|+++++|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 184 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999996543 58999999999999999999998 5 899999999999999999999999999864321
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH----------------
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM---------------- 703 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~---------------- 703 (828)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.........
T Consensus 185 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp --HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred --ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 12334579999999999999999999999999999999999999997655433211110000
Q ss_pred -------HHhhcCCcccccCcc----ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 704 -------KWQNKGQLDQIIDPT----LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 704 -------~~~~~~~~~~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.........+.++.. ............+.+++.+||+.+|.+|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000000000 0000112235568899999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=339.59 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=207.3
Q ss_pred HHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--------ccHHHHHHHHHHHHcC-CCCceEEE
Q 003350 476 FVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--------QGLAEFQTEIEMLSQF-RHRHLVSL 545 (828)
Q Consensus 476 ~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l 545 (828)
........++|...+.||+|+||.||+|+.. +|+.||||.+..... ...+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445566778999999999999999999886 689999998765431 1245678999999999 79999999
Q ss_pred EEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEE
Q 003350 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAK 625 (828)
Q Consensus 546 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~k 625 (828)
++++......++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+|
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999998653 369999999999999999999999 8999999999999999999999
Q ss_pred EEeeCCCCCCCCCCccceeccccccccccChhhhcc------CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHH
Q 003350 626 VADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA 699 (828)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~ 699 (828)
|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 241 l~DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~- 316 (365)
T 2y7j_A 241 LSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM- 316 (365)
T ss_dssp ECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred EEecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH-
Confidence 9999999865432 12345679999999999864 3588999999999999999999999976543222111
Q ss_pred HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 700 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+... ...+.. ......+.+++.+||+.+|.+||++.|+++
T Consensus 317 ------i~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 ------IMEGQYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ------HHHTCCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------HHhCCCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111100 000000 122456889999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=340.90 Aligned_cols=260 Identities=26% Similarity=0.394 Sum_probs=202.7
Q ss_pred cCHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEcc
Q 003350 474 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE 551 (828)
Q Consensus 474 ~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 551 (828)
+.+.++....++|...+.||+|+||.||+|+.. +++.||||.+..... ..+.+.+|+++++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 444455566788999999999999999999874 688999999865433 347789999999999 89999999999866
Q ss_pred ------CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEE
Q 003350 552 ------KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAK 625 (828)
Q Consensus 552 ------~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~k 625 (828)
.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence 5688999999999999999976554579999999999999999999999 8999999999999999999999
Q ss_pred EEeeCCCCCCCCCCccceeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHH
Q 003350 626 VADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 700 (828)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~ 700 (828)
|+|||++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--- 244 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--- 244 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---
Confidence 99999998653311 1223457899999999997 5678999999999999999999999997654332211
Q ss_pred HHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 701 WAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 701 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..... . .+.+ ........+.+++.+||+.+|.+||++.|+++
T Consensus 245 ---~~~~~-~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 ---LIPRN-P-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ---HHHHS-C-----CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HhhcC-c-----cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 1 1111 11233456889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=340.70 Aligned_cols=267 Identities=23% Similarity=0.323 Sum_probs=201.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEcc--------
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-------- 551 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 551 (828)
.++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 357888899999999999999874 689999998765432 334678899999999999999999999876
Q ss_pred CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
.+..++||||+++ +|.+.+.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4568999999985 7777775543 469999999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCC--ccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 632 SKTGPEID--QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 632 a~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||......+..............
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98654221 1222345678999999999876 45899999999999999999999999876554433222211110000
Q ss_pred CCcccccCcccc-------C-CCC-hh------HHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 GQLDQIIDPTLA-------G-KIR-PD------SLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 ~~~~~~~d~~l~-------~-~~~-~~------~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......-+.... . ... .+ ....+.+++.+||+.+|.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000000000000 0 000 01 1244789999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=366.99 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=209.4
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
..++|...+.||+|+||.||+|.+. .+..||||.+.... ....+.|.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3467888899999999999999864 24679999987643 344578999999999999999999999985 45689
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999997543 469999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |++||......+... .......
T Consensus 543 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~------~i~~~~~----- 610 (656)
T 2j0j_A 543 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG------RIENGER----- 610 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHHTCC-----
T ss_pred CCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHcCCC-----
Confidence 322 222234567889999999999999999999999999999997 999997654433211 1111110
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
...+...+..+.+++.+||+.+|.+||++.|+++.|+.+++..
T Consensus 611 -----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 611 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1122344567889999999999999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=357.38 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=203.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...++||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+++|++++||||+++++++......++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56788889999999999999875 58999999876432 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCC--CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986543 4569999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
.. .......||+.|+|||++.+..++.++|||||||++|||++|++||....... ............ .
T Consensus 342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~-~------- 409 (543)
T 3c4z_A 342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQ-A------- 409 (543)
T ss_dssp TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHC-C-------
T ss_pred CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhc-c-------
Confidence 21 12344589999999999999999999999999999999999999997643211 111111111111 0
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMG 750 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 750 (828)
..++......+.+++.+||+.+|.+||++.
T Consensus 410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ---cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 112234456788999999999999999763
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=352.32 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=192.4
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--------cccHHHHHHHHHHHHcCCCCceEEEEEEEcc
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 551 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 551 (828)
...++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999775 57899999875431 1223357899999999999999999999854
Q ss_pred CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC---CcEEEEe
Q 003350 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN---FMAKVAD 628 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kl~D 628 (828)
+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.+ ..+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence 5589999999999999998654 369999999999999999999999 899999999999999654 4599999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhcc---CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHH
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW 705 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (828)
||+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||....... .+...
T Consensus 286 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~---- 356 (419)
T 3i6u_A 286 FGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ---- 356 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----
T ss_pred cccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----
Confidence 999987543 223345679999999999853 678899999999999999999999997543221 11111
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+... ..+... ......+.+++.+||+.+|.+||++.|+++
T Consensus 357 i~~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCC--CCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111100 001111 123456889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=347.05 Aligned_cols=255 Identities=24% Similarity=0.296 Sum_probs=203.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEe----cCCcEEEEEEcCCCC----cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCC
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 553 (828)
.++|...++||+|+||.||+++. .+++.||||++.... ....+.+.+|+++|.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788889999999999999987 368999999876532 22345677899999999 6999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++||||+++|+|.+++.... .+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999996543 68999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
.... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 208 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~--- 281 (355)
T 1vzo_A 208 EFVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 281 (355)
T ss_dssp ECCG-GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC---
T ss_pred eccc-CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc---
Confidence 6533 22222345679999999999985 3578999999999999999999999975432211 11111111111
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLWNL 756 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~~L 756 (828)
. ..++.+....+.+++.+||+.+|.+|| ++.|+++..
T Consensus 282 ----~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ----E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 112334456688999999999999999 888887543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=351.85 Aligned_cols=202 Identities=23% Similarity=0.273 Sum_probs=176.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcC------CCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF------RHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 555 (828)
..+|...++||+|+||.||+|... +++.||||++... ....+++.+|+++++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456888899999999999999765 5889999998754 33356778898888877 577999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc--EEEEeeCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM--AKVADFGLSK 633 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~--~kl~DFGla~ 633 (828)
++||||+. ++|.+++.......+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 699999977666679999999999999999999999 89999999999999999887 9999999997
Q ss_pred CCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhh
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~ 694 (828)
.... ......||+.|+|||++.+..++.++|||||||++|||++|++||......+
T Consensus 251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 251 YEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp ETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 6432 1234578999999999999999999999999999999999999998765443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=328.99 Aligned_cols=247 Identities=27% Similarity=0.395 Sum_probs=196.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56888899999999999999876 68999999876432 234567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++.... .+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 9999999999996543 58999999999999999999999 89999999999999999999999999999875431
Q ss_pred ccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......+... .. ..+. .
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~-~~~~------~- 228 (276)
T 2h6d_A 165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK------KI-RGGV------F- 228 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-HHCC------C-
T ss_pred --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------Hh-hcCc------c-
Confidence 12234568999999999987765 689999999999999999999997654322211 11 1110 0
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+......+.+++.+||+.+|.+||++.|+++.
T Consensus 229 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ---YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122334568899999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.41 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=196.2
Q ss_pred CCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc----CCcEEEE
Q 003350 486 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE----KNEMILI 558 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV 558 (828)
|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 556678999999999999875 5788999987643 34456778999999999999999999998854 4568999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC--EEeeeeecCcEEeC-CCCcEEEEeeCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA--VIHRDVKSANILLD-ENFMAKVADFGLSKTG 635 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILld-~~~~~kl~DFGla~~~ 635 (828)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+ ++||||||+|||++ +++.+||+|||++...
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999654 368999999999999999999999 77 99999999999998 8899999999999764
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.. .......||+.|+|||++. +.++.++|||||||++|||++|+.||........ ..... ..+..
T Consensus 183 ~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~-~~~~~---- 247 (290)
T 1t4h_A 183 RA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRV-TSGVK---- 247 (290)
T ss_dssp CT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHH-TTTCC----
T ss_pred cc----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHH-hccCC----
Confidence 33 1233457999999999886 5689999999999999999999999975433221 11111 11110
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.... +......+.+++.+||+.+|.+||++.|+++
T Consensus 248 ~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 PASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111 1122356889999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=356.03 Aligned_cols=194 Identities=24% Similarity=0.373 Sum_probs=154.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEc-----cCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD-----EKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-----~~~~ 554 (828)
.++|...++||+|+||.||+|... +++.||||++... .....+.+.+|+++|++++||||+++++++. ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367889999999999999999765 6889999988653 3344677899999999999999999999984 3357
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 999999985 6999988654 369999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCcc-------------------------ceeccccccccccChhhh-ccCCCCcccceeehhhHHHHHHh
Q 003350 635 GPEIDQT-------------------------HVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLC 682 (828)
Q Consensus 635 ~~~~~~~-------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVySfGvvl~ellt 682 (828)
....... ...+...||+.|+|||++ ....++.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 5421110 123456789999999986 46679999999999999999999
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=336.51 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=187.5
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3567888999999999999999864 58899999886543 334567889999999999999999999999999999999
Q ss_pred EeccCCcccccccC------CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 560 EYMENGTLKGHLYG------SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 560 ey~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
||+++++|.+++.. .....+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999863 123469999999999999999999999 899999999999999999999999999987
Q ss_pred CCCCCC---ccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc-
Q 003350 634 TGPEID---QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK- 708 (828)
Q Consensus 634 ~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~- 708 (828)
...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... ......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-----LTLQNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HHHTSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-----HHhccCC
Confidence 643211 1112234579999999999876 578999999999999999999999997654433211 011110
Q ss_pred CCc-ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 GQL-DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 ~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... ....++.. .......+.+++.+||+.+|.+||++.|+++
T Consensus 245 ~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 01111111 1233456889999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=342.24 Aligned_cols=262 Identities=20% Similarity=0.227 Sum_probs=203.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC--------CCceEEEEEEEc---
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR--------HRHLVSLIGYCD--- 550 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 550 (828)
.++|...++||+|+||.||+|+.. +++.||||++... ....+.+.+|+++|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 467899999999999999999764 5889999998754 344577889999999985 788999999987
Q ss_pred -cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCC-CEEeeeeecCcEEeCCCC------
Q 003350 551 -EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENF------ 622 (828)
Q Consensus 551 -~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~------ 622 (828)
.....++||||+ +++|.+++.......+++.+++.|+.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 667899999999 5677666655554679999999999999999999999 7 999999999999999775
Q ss_pred -------------------------------------------cEEEEeeCCCCCCCCCCccceeccccccccccChhhh
Q 003350 623 -------------------------------------------MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659 (828)
Q Consensus 623 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 659 (828)
.+||+|||+++.... ......||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhh
Confidence 899999999986532 13345789999999999
Q ss_pred ccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhH---HHHHHHHhhc--------CC-cccccCc----------
Q 003350 660 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL---AEWAMKWQNK--------GQ-LDQIIDP---------- 717 (828)
Q Consensus 660 ~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l---~~~~~~~~~~--------~~-~~~~~d~---------- 717 (828)
.+..++.++|||||||+||||++|+.||......+.... .......... +. ..+.+..
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999976543321111 1111111000 00 0000000
Q ss_pred c---------ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 T---------LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~---------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. -......+....+.+++.+||+.+|.+|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 001234566778999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=350.55 Aligned_cols=199 Identities=25% Similarity=0.345 Sum_probs=166.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC-----Cc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 554 (828)
.++|...++||+|+||.||+|... +++.||||++... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 457888899999999999999875 5789999998754 334457889999999999999999999999765 57
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||++ |+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999997 5999998654 369999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCcc--------------------ceeccccccccccChhhh-ccCCCCcccceeehhhHHHHHHhcCCCC
Q 003350 635 GPEIDQT--------------------HVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLCARPVI 687 (828)
Q Consensus 635 ~~~~~~~--------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVySfGvvl~elltG~~p~ 687 (828)
....... ...+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 5432211 123567899999999986 5667999999999999999999854443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=331.45 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=201.2
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
..++|...+.||+|+||.||+|... +|+.||+|.+.... ..+++.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888899999999999999876 58999999987643 34678999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 99999999998632 2469999999999999999999999 99999999999999999999999999999765331
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
........||..|+|||.+.+..++.++||||||+++|||++|+.||.......... ..... . .+..
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~-~-----~~~~- 245 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MIPTN-P-----PPTF- 245 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHS-C-----CCCC-
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcC-C-----Cccc-
Confidence 112334578999999999999999999999999999999999999997654322111 11111 1 0111
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+||+.+|.+||++.++++
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112233567889999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=334.36 Aligned_cols=262 Identities=19% Similarity=0.270 Sum_probs=206.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEe--cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc------eEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL--NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH------LVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 554 (828)
.++|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788889999999999999986 35889999998754 334577889999999987654 9999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC--------------
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-------------- 620 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-------------- 620 (828)
.++||||+ +++|.+++......++++.+++.++.|+++||+|||+ .+|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 8899999977665679999999999999999999999 89999999999999987
Q ss_pred -----CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh
Q 003350 621 -----NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 695 (828)
Q Consensus 621 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~ 695 (828)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 67899999999986432 12345789999999999999999999999999999999999999987654443
Q ss_pred hhHHHHHHH-----HhhcCCcccc---------------------cCccc-cCCCChhHHHHHHHHHHhhhhhCCCCCCC
Q 003350 696 VNLAEWAMK-----WQNKGQLDQI---------------------IDPTL-AGKIRPDSLRKFGETAEKCLADFGVDRPS 748 (828)
Q Consensus 696 ~~l~~~~~~-----~~~~~~~~~~---------------------~d~~l-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 748 (828)
......... +......... ..+.. ...........+.+++.+||+.+|.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 222211100 0000000000 00000 01122345678999999999999999999
Q ss_pred hHHHHH
Q 003350 749 MGDVLW 754 (828)
Q Consensus 749 m~eVl~ 754 (828)
+.|+++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=343.06 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=196.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------C
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------N 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 553 (828)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++|++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 457888899999999999999874 6899999998653 233456788999999999999999999999765 3
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 7899999865 358999999999999999999999 999999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH---------
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------- 703 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~--------- 703 (828)
.... ..+...||+.|+|||++.+ ..++.++||||+||+++||++|++||......+.........
T Consensus 177 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 177 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 7432 1344678999999999887 689999999999999999999999998665433221111000
Q ss_pred --------HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 704 --------KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 704 --------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+... +.......+. .........+.+++.+||+.+|.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 252 RLQSDEAKNYMKG--LPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp TCSCHHHHHHHHH--SCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhHHHHHHHHh--CCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000 0000001111 111234567889999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.53 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=200.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467888899999999999999886 5889999998877777788999999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++..... ..
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TL 171 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HH
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccc--cc
Confidence 99999999886533 359999999999999999999999 8999999999999999999999999998753211 11
Q ss_pred ceeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 642 HVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.......||..|+|||++. ...++.++||||||+++|||++|+.|+......+.. ........ ...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~-~~~-- 242 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSDP-PTL-- 242 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSCC-CCC--
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhccCC-ccc--
Confidence 1123456899999999984 567899999999999999999999999765433211 11111110 000
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+......+.+++.+||+.+|.+||++.|+++
T Consensus 243 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 -----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 112334567889999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.88 Aligned_cols=253 Identities=11% Similarity=0.004 Sum_probs=184.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHH---HHHHcCCCCceEEEE-------EE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEI---EMLSQFRHRHLVSLI-------GY 548 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 548 (828)
..+|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+ ++|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345778899999999999999865 689999999877543 3355677885 45555 799988855 34
Q ss_pred EccC-----------------CcEEEEEEeccCCcccccccCCCCCCCChhhH------HHHHHHHHHHHHHHHhcCCCC
Q 003350 549 CDEK-----------------NEMILIYEYMENGTLKGHLYGSGLPSLSWKQR------LEICIGSARGLHYLHTGYAKA 605 (828)
Q Consensus 549 ~~~~-----------------~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ 605 (828)
+... ...++||||++ |+|.+++...+ ..+.+..+ +.++.|+++||+|||+ .+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 4322 34899999999 89999997542 23566777 8889999999999999 99
Q ss_pred EEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhc
Q 003350 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCA 683 (828)
Q Consensus 606 ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG 683 (828)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999986532 1224567799999999987 6899999999999999999999
Q ss_pred CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 684 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 684 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.||....+..... ......................+..+.+++.+||+.+|.+||++.|+++
T Consensus 290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99997654322110 0000000111111111112345677889999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=334.74 Aligned_cols=264 Identities=24% Similarity=0.315 Sum_probs=202.9
Q ss_pred HhcCCCccceEeeeCcEEEEEEEe--cCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcC---CCCceEEEEEEEc----
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGEL--NDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQF---RHRHLVSLIGYCD---- 550 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 550 (828)
+.++|...+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457889999999999999999987 357899999875322 11223456777777665 8999999999986
Q ss_pred -cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 551 -EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 551 -~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
.....++||||++ |+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 5678899999998 699999977655669999999999999999999999 89999999999999999999999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh--
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN-- 707 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-- 707 (828)
|+++.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+..... ......
T Consensus 165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--~~~~~~~~ 239 (326)
T 1blx_A 165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI--LDVIGLPG 239 (326)
T ss_dssp CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCC
T ss_pred cccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHHcCCCC
Confidence 99986532 22234567899999999999999999999999999999999999999866543322111 111000
Q ss_pred cCCcc-------cccC---ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 708 KGQLD-------QIID---PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 708 ~~~~~-------~~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..... ..+. ......+.......+.+++.+||+.+|.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000 00001122344567889999999999999999999963
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.34 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=187.3
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
.++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 457888899999999999999874 689999999876532 22333455556688899999999999999999999999
Q ss_pred EeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCC-CEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 560 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 560 ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
||++ |+|.+++.. .....+++.+++.++.|++.||+|||+ . +++||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588877753 233579999999999999999999999 7 99999999999999999999999999998653
Q ss_pred CCCccceeccccccccccChhhh----ccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
.. .......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ..+. .......
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~~~~-- 231 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLK----QVVEEPS-- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHH----HHHHSCC--
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHH----HHhccCC--
Confidence 31 122344799999999996 45678999999999999999999999997532211 1111 1111110
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+. .........+.+++.+||+.+|.+||++.|+++.
T Consensus 232 ----~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 232 ----PQ---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ----CC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----CC---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11 1112345668899999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=327.75 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=204.3
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---------cccHHHHHHHHHHHHcCC-CCceEEEEEEEc
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---------QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCD 550 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 550 (828)
..++|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467888899999999999999875 58899999886543 122456889999999995 999999999999
Q ss_pred cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 551 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
..+..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999654 368999999999999999999999 999999999999999999999999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhc------cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (828)
++...... .......||+.|+|||++. ...++.++||||||+++|||++|+.||......+... .
T Consensus 170 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~ 240 (298)
T 1phk_A 170 FSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR------M 240 (298)
T ss_dssp TCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------H
T ss_pred chhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH------H
Confidence 99865431 1234467899999999985 4568899999999999999999999997654332211 1
Q ss_pred HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 705 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... +... .........+..+.+++.+||+.+|.+||++.|+++
T Consensus 241 ~~~-~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMS-GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hhc-CCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 1100 000111234567889999999999999999999964
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.88 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=199.9
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCC--CCceEEEEEEEccCCc
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFR--HRHLVSLIGYCDEKNE 554 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 554 (828)
+....++|...+.||+|+||.||++...+++.||||.+... .....+.+.+|++++.+++ |+||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 34445678888999999999999999888999999987643 3445678899999999997 5999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||| +.+++|.+++.... .+++.+++.++.|+++||+|||+ .+|+||||||+|||+++ +.+||+|||+++.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999999 66789999997543 68999999999999999999999 89999999999999965 8999999999987
Q ss_pred CCCCCccceeccccccccccChhhhcc-----------CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRR-----------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 703 (828)
..............||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~ 250 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH 250 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHH
Confidence 544222222345579999999999875 478899999999999999999999997543211 1111
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHH
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L 756 (828)
.. +++.....++......+.+++.+||+.+|.+||++.|+++.-
T Consensus 251 ~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 251 AI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HH---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11 111111122223345688999999999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=353.71 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=200.7
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
..++|...+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++||||++++++|......++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456888899999999999999876 68899999876542 33457789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---CCcEEEEeeCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVADFGLSKTG 635 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kl~DFGla~~~ 635 (828)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++..
T Consensus 115 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 115 MECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999988654 368999999999999999999999 89999999999999976 455999999999875
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
... .......||+.|+|||++. +.++.++|||||||++|||++|++||......+..... ..+.. ...
T Consensus 190 ~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~-~~~ 257 (494)
T 3lij_A 190 ENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-------EKGKY-TFD 257 (494)
T ss_dssp BTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCC-CCC
T ss_pred CCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCC-CCC
Confidence 431 2234567999999999986 57999999999999999999999999876544322111 11110 000
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+.. ...+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 258 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111 1234568899999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=337.37 Aligned_cols=262 Identities=19% Similarity=0.236 Sum_probs=193.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC------
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN------ 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (828)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467888899999999999999765 5889999988653 3344567889999999999999999999997654
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++||||++ |+|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999997 47888774 248999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHH-------------
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE------------- 700 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~------------- 700 (828)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 176 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 176 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 6432 122345679999999999999999999999999999999999999998654432211100
Q ss_pred ---HHHHHhhcC-C-----cccccCccccCCC---ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 701 ---WAMKWQNKG-Q-----LDQIIDPTLAGKI---RPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 701 ---~~~~~~~~~-~-----~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
....+.... . ..+.+........ .......+.+++.+||+.+|.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 0 0000000000000 01235678999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=344.22 Aligned_cols=264 Identities=18% Similarity=0.224 Sum_probs=197.4
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc-------
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE------- 551 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------- 551 (828)
+...++|...+.||+|+||.||+|.. .+++.||||++...... ..+|+++|+.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999976 46899999987654322 3479999999999999999999843
Q ss_pred -------------------------------CCcEEEEEEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHH
Q 003350 552 -------------------------------KNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYL 598 (828)
Q Consensus 552 -------------------------------~~~~~lV~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL 598 (828)
....++||||++ |+|.+.+.. .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 234889999998 587777653 2335799999999999999999999
Q ss_pred HhcCCCCEEeeeeecCcEEeC-CCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccC-CCCcccceeehhhH
Q 003350 599 HTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVV 676 (828)
Q Consensus 599 H~~~~~~ivHrDIkp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvv 676 (828)
|+ .+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++|||||||+
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99 9999999999999998 68999999999998653322 23345789999999998764 58999999999999
Q ss_pred HHHHHhcCCCCCCCChhhhhhHHHHH---------HHHhh---cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCC
Q 003350 677 LFEVLCARPVIDPTLPREMVNLAEWA---------MKWQN---KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGV 744 (828)
Q Consensus 677 l~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~ 744 (828)
+|||++|++||......+........ ..... +..............++...+..+.+++.+||+.+|.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999876544322111100 00000 0000000011111112233456688999999999999
Q ss_pred CCCChHHHHH
Q 003350 745 DRPSMGDVLW 754 (828)
Q Consensus 745 ~RPsm~eVl~ 754 (828)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=354.56 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=205.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
.++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457888899999999999999876 68999999875432 34567899999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe---CCCCcEEEEeeCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTG 635 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---d~~~~~kl~DFGla~~~ 635 (828)
+||+.+|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999986543 69999999999999999999999 899999999999999 56789999999999765
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
... .......||+.|+|||++.+ .++.++|||||||++|||++|++||......+....+ ..+...- .
T Consensus 180 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~~-~ 247 (484)
T 3nyv_A 180 EAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-------EKGKYTF-E 247 (484)
T ss_dssp CCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCCC-C
T ss_pred ccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCCCCC-C
Confidence 331 12344579999999999865 6999999999999999999999999876544322111 1111100 0
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+ .....+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 248 ~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 LP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp SG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Cc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 01 012345668899999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.83 Aligned_cols=213 Identities=23% Similarity=0.272 Sum_probs=179.6
Q ss_pred cCHHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CC-----ceEEEE
Q 003350 474 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HR-----HLVSLI 546 (828)
Q Consensus 474 ~~~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~ 546 (828)
+.+.......++|...++||+|+||.||+|... +++.||||++... .....++..|++++..++ |+ +|++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 333344455678999999999999999999865 5789999998753 334567788999998885 44 499999
Q ss_pred EEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC--CCCcE
Q 003350 547 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD--ENFMA 624 (828)
Q Consensus 547 g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld--~~~~~ 624 (828)
+++...+..++||||++ |+|.+++.......+++..+..++.|++.||+|||. +..+|+||||||+|||++ .++.+
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcE
Confidence 99999999999999996 599999987665679999999999999999999994 127899999999999994 57889
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhh
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~ 694 (828)
||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||+||++||......+
T Consensus 201 kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 201 KIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp EECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999987533 1234678999999999999999999999999999999999999998765443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=333.49 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=197.3
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc--------ccHHHHHHHHHHHHcCCCCceEEEEEEEccC
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 552 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 552 (828)
..++|...+.||+|+||.||+|... +++.||||.+..... .....+.+|+++|++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567888999999999999999875 578999998765321 2234588999999999999999999998765
Q ss_pred CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc---EEEEee
Q 003350 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM---AKVADF 629 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kl~DF 629 (828)
. .++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 89999999999999998654 469999999999999999999999 89999999999999987654 999999
Q ss_pred CCCCCCCCCCccceeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
|+++.... ........||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+.....
T Consensus 162 g~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~--- 233 (322)
T 2ycf_A 162 GHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT--- 233 (322)
T ss_dssp TTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH---
T ss_pred ccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH---
Confidence 99987543 12223456899999999974 4678999999999999999999999997543221 1111111
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+... ..+... ......+.+++.+||+.+|.+||++.|+++
T Consensus 234 -~~~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 -SGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -hCccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11100 011111 123456889999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=340.00 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=201.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccC-----CcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 555 (828)
.++|...++||+|+||.||+|... +++.||||++.... ....+.+.+|+++|.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457888899999999999999865 68899999987543 33457789999999999999999999998654 468
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++|+||++ |+|.+++... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 5999988653 59999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCc-cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC---
Q 003350 636 PEIDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ--- 710 (828)
Q Consensus 636 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 710 (828)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||......+...... .......
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~ 255 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQED 255 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCHHH
Confidence 43111 111244579999999998764 458999999999999999999999998765444322111 0000000
Q ss_pred ccc------------ccCcccc--CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 711 LDQ------------IIDPTLA--GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 711 ~~~------------~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.. ...+... ....+.....+.+++.+||+.+|.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000000 0011223456889999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=349.84 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=202.4
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-------------ccHHHHHHHHHHHHcCCCCceEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-------------QGLAEFQTEIEMLSQFRHRHLVSLIG 547 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 547 (828)
..++|...++||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+++|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999876 578999998765321 33577899999999999999999999
Q ss_pred EEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC---cE
Q 003350 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---MA 624 (828)
Q Consensus 548 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~---~~ 624 (828)
++......++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999886543 69999999999999999999999 8999999999999998775 69
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (828)
||+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++|++||......+....+
T Consensus 189 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----- 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV----- 259 (504)
T ss_dssp EECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----
T ss_pred EEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----
Confidence 99999999875432 2234567999999999986 56999999999999999999999999876544322211
Q ss_pred HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 705 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+... .+.... ...+..+.+++.+||+.+|.+|||+.|+++
T Consensus 260 --~~~~~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 --EKGKYY--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp --HHCCCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HcCCCC--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111110 010000 123456889999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=365.74 Aligned_cols=244 Identities=22% Similarity=0.296 Sum_probs=203.5
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 556 (828)
..++|...++||+|+||.||+|+.. +++.||||++... .....+.+..|.++|..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467888999999999999999876 5789999987643 223356788999999988 7999999999999999999
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||+++|+|.+++...+ .+++.+++.++.||+.||+|||+ .+|+||||||+||||+.++++||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999997643 69999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.. ........||+.|+|||++.+..++.++|||||||+||||++|++||......+... .+.. +.
T Consensus 494 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~-~~------ 558 (674)
T 3pfq_A 494 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------SIME-HN------ 558 (674)
T ss_dssp CT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHS-SC------
T ss_pred cC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH------HHHh-CC------
Confidence 21 222456789999999999999999999999999999999999999998655433221 1111 11
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
..++.....++.+++.+||+.+|.+||++
T Consensus 559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 11233445678899999999999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=335.38 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=196.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEc-----------
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD----------- 550 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 550 (828)
.++|...+.||+|+||.||+|... +++.||+|++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 356888899999999999999876 48999999988777777788999999999999999999999873
Q ss_pred ---cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC-CCCcEEE
Q 003350 551 ---EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKV 626 (828)
Q Consensus 551 ---~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kl 626 (828)
+....++||||++ |+|.+++.. .++++..++.++.|+++||+|||+ .+|+||||||+|||++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999998 699999854 358999999999999999999999 8999999999999997 6779999
Q ss_pred EeeCCCCCCCCCCc-cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH
Q 003350 627 ADFGLSKTGPEIDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 627 ~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (828)
+|||+++....... ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+...... ..
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~--~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL--ES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hh
Confidence 99999987543111 112234567899999998875 688999999999999999999999998765433221110 00
Q ss_pred Hhh---------cCCcccccCccccC------CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 705 WQN---------KGQLDQIIDPTLAG------KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 705 ~~~---------~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... ...+...+...... ...+.....+.+++.+||+.+|.+||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 00000000000000 011234567889999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=328.30 Aligned_cols=256 Identities=18% Similarity=0.232 Sum_probs=199.2
Q ss_pred cCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEEcc--CCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDE--KNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 559 (828)
++|...++||+|+||.||+|+. .+++.||||.+.... .+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688889999999999999976 468999999987543 467899999999997 9999999999977 67789999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-cEEEEeeCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEI 638 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kl~DFGla~~~~~~ 638 (828)
||+++++|.+++. .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999883 48899999999999999999999 9999999999999999776 8999999999865432
Q ss_pred CccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHH--------HHhhcC
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------KWQNKG 709 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~ 709 (828)
. ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ .+..... ......
T Consensus 185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHT
T ss_pred C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHh
Confidence 1 2344578999999999977 6789999999999999999999999954432211 1111110 000000
Q ss_pred Cc------ccc--------cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 710 QL------DQI--------IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 710 ~~------~~~--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. .+. .+..............+.+++.+||+.+|.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000 0000111111224567899999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=352.05 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=203.5
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
..++|...++||+|+||.||+|+.. +++.||||++... .......+.+|+++|++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567888999999999999999875 6889999987532 223467889999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC---CCCcEEEEeeCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTG 635 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kl~DFGla~~~ 635 (828)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999886543 69999999999999999999999 9999999999999995 5668999999999865
Q ss_pred CCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
... .......||+.|+|||++.+ .++.++|||||||++|||++|++||......+..... ..+.... .
T Consensus 175 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~~-~ 242 (486)
T 3mwu_A 175 QQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------ETGKYAF-D 242 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCCS-C
T ss_pred CCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCCC-C
Confidence 331 22345679999999999875 5999999999999999999999999766543322111 1111100 0
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+. ....+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 243 ~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred Ccc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 010 12335668899999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=336.76 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=205.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc-----------------cHHHHHHHHHHHHcCCCCceEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ-----------------GLAEFQTEIEMLSQFRHRHLVSL 545 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l 545 (828)
.++|...+.||+|+||.||+|.. +++.||||.+...... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45788889999999999999988 8999999987543211 12789999999999999999999
Q ss_pred EEEEccCCcEEEEEEeccCCccccc------ccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC
Q 003350 546 IGYCDEKNEMILIYEYMENGTLKGH------LYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619 (828)
Q Consensus 546 ~g~~~~~~~~~lV~ey~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld 619 (828)
++++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||+|||+ ..+++||||||+|||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999999 655445689999999999999999999996 36899999999999999
Q ss_pred CCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccC-CCCc-ccceeehhhHHHHHHhcCCCCCCCChhhhhh
Q 003350 620 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTE-KSDVYSFGVVLFEVLCARPVIDPTLPREMVN 697 (828)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-ksDVySfGvvl~elltG~~p~~~~~~~~~~~ 697 (828)
.++.+||+|||+++..... ......||..|+|||.+.+. .++. ++|||||||++|||++|+.||....... .
T Consensus 187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~ 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--E 260 (348)
T ss_dssp TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--H
T ss_pred CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H
Confidence 9999999999999865331 34456799999999999877 6666 9999999999999999999997654311 1
Q ss_pred HHHHHHHHhhcCCcccc------cCc---cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 698 LAEWAMKWQNKGQLDQI------IDP---TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 698 l~~~~~~~~~~~~~~~~------~d~---~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.. .. ..+..... ..+ .............+.+++.+||+.+|.+||++.|+++
T Consensus 261 ~~~---~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFN---NI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH---HH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH---HH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 11 11111000 000 0000011334567889999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=342.51 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=184.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------C
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------N 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 553 (828)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++|+.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 467888899999999999999764 6899999998654 334467788999999999999999999998653 5
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++|+|++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 6899998854 369999999999999999999999 999999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
.... ..+...||..|+|||++.+ ..++.++|||||||++|||++|++||......+..............+.+.
T Consensus 181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 6432 1344678999999999987 688999999999999999999999998765433222111100000000000
Q ss_pred cccCc-------ccc--CC-----CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 QIIDP-------TLA--GK-----IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 ~~~d~-------~l~--~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+... .+. .. ........+.+++.+||+.+|.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000 000 00 00122456789999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=337.87 Aligned_cols=271 Identities=19% Similarity=0.205 Sum_probs=193.5
Q ss_pred HHHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc
Q 003350 476 FVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE 554 (828)
Q Consensus 476 ~~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 554 (828)
........++|...+.||+|+||.||+|+.. +++.||||++..... ....+.+|++.+..++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3556777889999999999999999999875 589999998755432 23456788889999999999999999865433
Q ss_pred -------EEEEEEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHH--hcCCCCEEeeeeecCcEEeCC-CC
Q 003350 555 -------MILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLH--TGYAKAVIHRDVKSANILLDE-NF 622 (828)
Q Consensus 555 -------~~lV~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDIkp~NILld~-~~ 622 (828)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||+||| + .+|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCC
Confidence 7899999986 54444322 23356899999999999999999999 7 89999999999999996 89
Q ss_pred cEEEEeeCCCCCCCCCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHH
Q 003350 623 MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW 701 (828)
Q Consensus 623 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~ 701 (828)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.......
T Consensus 170 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp EEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 99999999998754322 23355789999999998665 489999999999999999999999987654433221110
Q ss_pred ---------HHHHhhcCCcccccCc------cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 702 ---------AMKWQNKGQLDQIIDP------TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 702 ---------~~~~~~~~~~~~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
...+..........+. .............+.+++.+||+.+|.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000000000 0011122235678999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.08 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=194.3
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc------EEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE------MIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 557 (828)
.+|...++||+|+||.||+|+...+..+|+|++...... ..+|+++|+.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 467888999999999999999877777999987654322 2379999999999999999999854433 789
Q ss_pred EEEeccCCccccccc-CCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC-CCCcEEEEeeCCCCCC
Q 003350 558 IYEYMENGTLKGHLY-GSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTG 635 (828)
Q Consensus 558 V~ey~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~kl~DFGla~~~ 635 (828)
||||++++.+..... ......+++..+..++.|+++||+|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998754433322 1223469999999999999999999999 9999999999999999 8999999999999865
Q ss_pred CCCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHH---------
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW--------- 705 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------- 705 (828)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|++||......+... ......
T Consensus 193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV--EIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHH
T ss_pred cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHH
Confidence 3311 23345789999999998764 58999999999999999999999998765433221 111100
Q ss_pred -hh----cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 706 -QN----KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 706 -~~----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. ......+....+...+.......+.+++.+||+.+|.+||++.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 00000000001111122234567899999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=344.71 Aligned_cols=258 Identities=23% Similarity=0.275 Sum_probs=193.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------CcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------NEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 556 (828)
.+|...++||+|+||.||+|+.. +++.||||++..... .+.+|+++|++++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35778899999999999999885 589999998765432 234799999999999999999988432 2367
Q ss_pred EEEEeccCCcccccccC--CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC-CcEEEEeeCCCC
Q 003350 557 LIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSK 633 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~-~~~kl~DFGla~ 633 (828)
+||||+++ +|.+.+.. .....+++..++.++.|+++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999985 56555532 223579999999999999999999999 999999999999999955 678999999998
Q ss_pred CCCCCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh------
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ------ 706 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------ 706 (828)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|++||......+. +.+....+.
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 653311 12345789999999999764 799999999999999999999999987654332 222111100
Q ss_pred --h-cCCcccccCccccC-----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 707 --N-KGQLDQIIDPTLAG-----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 707 --~-~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. .....+..-+.+.. .+.......+.+++.+||+.+|.+||++.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 00111111111110 122334567889999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.66 Aligned_cols=262 Identities=25% Similarity=0.318 Sum_probs=200.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccC-----CcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 555 (828)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888899999999999999876 58899999987543 33456788999999999999999999998654 678
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~ 635 (828)
++||||++ ++|.+++... .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 6999888653 58999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCccc--------eeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh
Q 003350 636 PEIDQTH--------VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 636 ~~~~~~~--------~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||......+..... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---FGII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHh
Confidence 4311110 1223578999999998764 78899999999999999999999999866543321111 1111
Q ss_pred hcCC----cccccCcc-------cc-------CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 707 NKGQ----LDQIIDPT-------LA-------GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 707 ~~~~----~~~~~d~~-------l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.... ...+..+. +. ....+.....+.+++.+||+.+|.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1000 00000000 00 0001234566889999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.52 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=193.9
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc---------
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--------- 551 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 551 (828)
..++|...+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467888899999999999999875 6899999988542 3445778999999999999999999998754
Q ss_pred ----CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEE
Q 003350 552 ----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA 627 (828)
Q Consensus 552 ----~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~ 627 (828)
....++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+ .+++||||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 457899999999999999997543 457889999999999999999999 899999999999999999999999
Q ss_pred eeCCCCCCCCCC------------ccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhh
Q 003350 628 DFGLSKTGPEID------------QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694 (828)
Q Consensus 628 DFGla~~~~~~~------------~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~ 694 (828)
|||+++...... .........||..|+|||++.+. .++.++|||||||++|||++ |+... .+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--ME 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hh
Confidence 999998654211 01122345689999999999864 78999999999999999998 44321 11
Q ss_pred hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 695 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 695 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.... ...+.. . ...+...+....+..+.+++.+||+.+|.+||++.|+++
T Consensus 234 ~~~~---~~~~~~-~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RVNI---LKKLRS-V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHH---HHHHHS-T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH---HHhccc-c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111 111111 0 111222233445667889999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.28 Aligned_cols=262 Identities=23% Similarity=0.373 Sum_probs=202.2
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
....++|...+.||+|+||.||+|+.++ .+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3345678888999999999999998764 48999876542 2334567889999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
|+||+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+|||++ ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp ECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred EeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 999999999999996643 469999999999999999999999 8999999999999998 67999999999876432
Q ss_pred CC---ccceeccccccccccChhhhcc---------CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHH
Q 003350 638 ID---QTHVSTAVKGSFGYLDPEYFRR---------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW 705 (828)
Q Consensus 638 ~~---~~~~~~~~~gt~~Y~aPE~~~~---------~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 705 (828)
.. .........||..|+|||.+.. ..++.++|||||||++|||++|+.||......+.. ...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII------WQM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH------HHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHh
Confidence 11 1122234568999999999874 45789999999999999999999999765443221 111
Q ss_pred hhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 706 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 706 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
..+. .+... ....+..+.+++.+|++.+|.+||++.++++.|+.+.+..
T Consensus 256 -~~~~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 -GTGM-----KPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -HTTC-----CCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -ccCC-----CCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 11111 1122345788999999999999999999999998876544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=331.98 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=196.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc------
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE------ 554 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 554 (828)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56788899999999999999875 68999999986543 3335678899999999999999999999977654
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||++ ++|.+++. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 68888873 248999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcC----
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG---- 709 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---- 709 (828)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...... ......
T Consensus 176 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~ 247 (353)
T 3coi_A 176 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL---KVTGVPGTEF 247 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH---HHHCBCCHHH
T ss_pred CCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCCCHHH
Confidence 432 1234578999999999987 688999999999999999999999998655433211110 000000
Q ss_pred --------------CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 710 --------------QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 710 --------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+.....+.+ ..........+.+++.+||+.+|.+||++.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000011 1122344667899999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.67 Aligned_cols=259 Identities=19% Similarity=0.273 Sum_probs=197.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE----
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM---- 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 555 (828)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888899999999999999865 68999999987643 33357788999999999999999999999877655
Q ss_pred --EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 556 --ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 556 --~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
++||||++ ++|.+++. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999998 68888773 248999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+......-...........
T Consensus 193 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 193 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 6432 1334578999999999987 789999999999999999999999998655433221110000000000000
Q ss_pred cc-----------cCccccC---CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 713 QI-----------IDPTLAG---KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 713 ~~-----------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+ +...... ...+.....+.+++.+||+.+|.+||++.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 0000000 001233567889999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=330.55 Aligned_cols=262 Identities=19% Similarity=0.237 Sum_probs=203.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CC-cEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc------eEEEEEEEccCCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DG-TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH------LVSLIGYCDEKNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 554 (828)
.++|...+.||+|+||.||+|... ++ +.||+|.+... ....+.+.+|++++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467888899999999999999875 34 78999998754 334567889999999997766 9999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe----------------
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---------------- 618 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl---------------- 618 (828)
.++||||+ +++|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 5677777766555679999999999999999999999 899999999999999
Q ss_pred ---CCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh
Q 003350 619 ---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 695 (828)
Q Consensus 619 ---d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~ 695 (828)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5688999999999986432 12345799999999999999999999999999999999999999987654433
Q ss_pred hhHHHHHHH-----HhhcCCcccc-cCcc---------------------ccCCCChhHHHHHHHHHHhhhhhCCCCCCC
Q 003350 696 VNLAEWAMK-----WQNKGQLDQI-IDPT---------------------LAGKIRPDSLRKFGETAEKCLADFGVDRPS 748 (828)
Q Consensus 696 ~~l~~~~~~-----~~~~~~~~~~-~d~~---------------------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 748 (828)
......... +......... .... ............+.+++.+||+.+|.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 222111100 0000000000 0000 000112344567899999999999999999
Q ss_pred hHHHHH
Q 003350 749 MGDVLW 754 (828)
Q Consensus 749 m~eVl~ 754 (828)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999963
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=333.17 Aligned_cols=261 Identities=19% Similarity=0.248 Sum_probs=200.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-----------CCceEEEEEEEcc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-----------HRHLVSLIGYCDE 551 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 551 (828)
++|...+.||+|+||.||+|+.. +++.||||.+... ....+.+.+|++++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 56888899999999999999864 6899999998743 334567889999999886 8999999999875
Q ss_pred CC----cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCC-CEEeeeeecCcEEe------CC
Q 003350 552 KN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILL------DE 620 (828)
Q Consensus 552 ~~----~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDIkp~NILl------d~ 620 (828)
.+ ..++||||+ +++|.+++.......+++..++.++.|++.||+|||+ . +|+||||||+|||+ +.
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 44 789999999 8899999977655679999999999999999999999 7 99999999999999 44
Q ss_pred CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh----h
Q 003350 621 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM----V 696 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~----~ 696 (828)
.+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 174 ~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 55899999999986532 12345789999999999999999999999999999999999999975432211 1
Q ss_pred hHHHHHHHH-----------------hhcC-CcccccCcc---------ccCCCChhHHHHHHHHHHhhhhhCCCCCCCh
Q 003350 697 NLAEWAMKW-----------------QNKG-QLDQIIDPT---------LAGKIRPDSLRKFGETAEKCLADFGVDRPSM 749 (828)
Q Consensus 697 ~l~~~~~~~-----------------~~~~-~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 749 (828)
.+....... .... ....+.... -...++......+.+++.+||+.+|.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 111111000 0000 000000000 0112445677889999999999999999999
Q ss_pred HHHHH
Q 003350 750 GDVLW 754 (828)
Q Consensus 750 ~eVl~ 754 (828)
.|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=331.11 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=175.2
Q ss_pred HhcCCCcc-ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc----CCcE
Q 003350 482 ATNNFDES-WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE----KNEM 555 (828)
Q Consensus 482 at~~f~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 555 (828)
..++|... ++||+|+||.||+|... +++.||||++.... ....+....+..+.||||+++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 35677774 57999999999999876 68999999986531 222233344667799999999999865 4558
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---CCcEEEEeeCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVADFGLS 632 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kl~DFGla 632 (828)
++||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999999987665679999999999999999999999 89999999999999976 456999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ......+
T Consensus 179 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~--- 248 (336)
T 3fhr_A 179 KETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG--- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc---
Confidence 86432 1223457899999999998888999999999999999999999999654332211000 0000000
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
...............+.+++.+||+.+|.+||++.|+++.
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001111112345678899999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.42 Aligned_cols=264 Identities=22% Similarity=0.259 Sum_probs=181.8
Q ss_pred CCCc-cceEeeeCcEEEEEEEec---CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEE--ccCCcEEEE
Q 003350 485 NFDE-SWVIGIGGFGKVYKGELN---DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC--DEKNEMILI 558 (828)
Q Consensus 485 ~f~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~lV 558 (828)
.|.. .++||+|+||.||+|+.. +++.||||++..... ...+.+|+++|++++||||+++++++ ......++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3443 458999999999999865 478899999875433 35688999999999999999999999 457789999
Q ss_pred EEeccCCcccccccC-------CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEe----CCCCcEEEE
Q 003350 559 YEYMENGTLKGHLYG-------SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVA 627 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILl----d~~~~~kl~ 627 (828)
|||++ |+|.+++.. .....+++..++.|+.|++.||+|||+ .+|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99997 588777742 122359999999999999999999999 899999999999999 778999999
Q ss_pred eeCCCCCCCCCCc-cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhh-------hhhH
Q 003350 628 DFGLSKTGPEIDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-------MVNL 698 (828)
Q Consensus 628 DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~-------~~~l 698 (828)
|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||....... ...+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987543211 122345679999999999987 458999999999999999999999997543311 1111
Q ss_pred HHHHHHHhh--cCCcccc------------cCccccCC---------CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 699 AEWAMKWQN--KGQLDQI------------IDPTLAGK---------IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 699 ~~~~~~~~~--~~~~~~~------------~d~~l~~~---------~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......+.. ......+ +....... ........+.+++.+||+.+|.+|||+.|+++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111100 0000000 00000000 00011345788999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.36 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=204.3
Q ss_pred HHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 480 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 480 ~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
....++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 445678999999999999999999876 6889999987543 2345678999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCC---CcEEEEeeCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN---FMAKVADFGLSK 633 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~---~~~kl~DFGla~ 633 (828)
+|+||+++++|.+++.... .+++.+++.++.|++.||+|||+ .+++||||||+||+++.+ +.+||+|||+++
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999886543 68999999999999999999999 899999999999999754 479999999998
Q ss_pred CCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
...... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+... .. ..+...
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~- 240 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK------RV-ETGKYA- 240 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-HHCCCC-
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH------HH-HcCCCC-
Confidence 653311 1233458899999999865 58999999999999999999999997654433211 11 111110
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+.... ...+..+.+++.+||+.+|.+||++.|+++.
T Consensus 241 -~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 -FDLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -CCSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -CCchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000000 1234568899999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=327.40 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=180.3
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHH-HHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIE-MLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 56778899999999999999875 68999999887653 333455666666 7777899999999999999999999999
Q ss_pred eccCCcccccccC---CCCCCCChhhHHHHHHHHHHHHHHHHhcCCC-CEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 561 YMENGTLKGHLYG---SGLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 561 y~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
|+++ +|.+++.. .....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9985 77777642 223579999999999999999999999 7 99999999999999999999999999998653
Q ss_pred CCCccceeccccccccccChhhh----ccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
.. .......||+.|+|||++ .+..++.++|||||||++|||++|+.||........ . . ..+.
T Consensus 178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~----~--~~~~ 243 (327)
T 3aln_A 178 DS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q----L--TQVV 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCC
T ss_pred cc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H----H--HHHh
Confidence 31 122334699999999998 456789999999999999999999999975321100 0 0 0011
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
....+.+...........+.+++.+||+.+|.+||++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1111112221223345678999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=339.46 Aligned_cols=251 Identities=21% Similarity=0.253 Sum_probs=188.6
Q ss_pred CCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEecc
Q 003350 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++|.++ +||||+++++++...+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34556889999999998776667999999987543 345678999999876 89999999999999999999999996
Q ss_pred CCcccccccCCCCC-----CCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-------------CCcEE
Q 003350 564 NGTLKGHLYGSGLP-----SLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-------------NFMAK 625 (828)
Q Consensus 564 ~gsL~~~l~~~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-------------~~~~k 625 (828)
|+|.+++...... ..++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999764321 12455678899999999999999 89999999999999965 45899
Q ss_pred EEeeCCCCCCCCCCcc--ceeccccccccccChhhhcc-------CCCCcccceeehhhHHHHHHh-cCCCCCCCChhhh
Q 003350 626 VADFGLSKTGPEIDQT--HVSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREM 695 (828)
Q Consensus 626 l~DFGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~ 695 (828)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......+.
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999875432211 11234679999999999975 678999999999999999999 9999975433221
Q ss_pred hhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 696 VNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 696 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. .. ..... +.+...........+.+++.+||+.+|.+||++.||++
T Consensus 249 -~i---~~---~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 -NI---IR---GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HH---HH---TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HH---hc---CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 11 00000 11111123456678999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=326.07 Aligned_cols=244 Identities=22% Similarity=0.357 Sum_probs=191.5
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcc------cHHHHHHHHHHHHcC----CCCceEEEEE
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ------GLAEFQTEIEMLSQF----RHRHLVSLIG 547 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~g 547 (828)
.....++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4455678999999999999999999764 6889999998655321 223456799999988 8999999999
Q ss_pred EEccCCcEEEEEEe-ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC-CCCcEE
Q 003350 548 YCDEKNEMILIYEY-MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAK 625 (828)
Q Consensus 548 ~~~~~~~~~lV~ey-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~k 625 (828)
++...+..++|+|+ +.+++|.+++.... .+++.+++.++.|+++||+|||+ .+|+||||||+|||++ .++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 99999999999999 78999999996543 69999999999999999999999 8999999999999999 889999
Q ss_pred EEeeCCCCCCCCCCccceeccccccccccChhhhccCCCC-cccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH
Q 003350 626 VADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (828)
|+|||+++..... ......||..|+|||++.+..+. .++|||||||++|||++|+.||..... .
T Consensus 181 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~------ 245 (312)
T 2iwi_A 181 LIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I------ 245 (312)
T ss_dssp ECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H------
T ss_pred EEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H------
Confidence 9999999875431 12345689999999999877764 599999999999999999999964210 0
Q ss_pred HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 705 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... . . .++......+.+++.+||+.+|.+||++.|+++
T Consensus 246 -~~~-~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 -LEA-E------L----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHT-C------C----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hhh-c------c----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 0 122334556889999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.97 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=198.6
Q ss_pred HHHHHHhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcc------cHHHHHHHHHHHHcCC--CCceEEEEE
Q 003350 477 VAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ------GLAEFQTEIEMLSQFR--HRHLVSLIG 547 (828)
Q Consensus 477 ~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g 547 (828)
.+.....++|...+.||+|+||.||+|+.. +++.||||.+...... ..+.+.+|++++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344455678999999999999999999764 6889999987643211 1245678999999996 599999999
Q ss_pred EEccCCcEEEEEEeccC-CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC-CCCcEE
Q 003350 548 YCDEKNEMILIYEYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAK 625 (828)
Q Consensus 548 ~~~~~~~~~lV~ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-~~~~~k 625 (828)
++...+..++|+|++.+ ++|.+++... ..+++.+++.++.|+++||+|||+ .+|+||||||+|||++ +++.+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999999976 8999998654 368999999999999999999999 9999999999999999 789999
Q ss_pred EEeeCCCCCCCCCCccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHH
Q 003350 626 VADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 704 (828)
Q Consensus 626 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 704 (828)
|+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 191 L~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------ 254 (320)
T 3a99_A 191 LIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------ 254 (320)
T ss_dssp ECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------
T ss_pred EeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------
Confidence 9999999875431 2234569999999999987766 6889999999999999999999964210
Q ss_pred HhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 705 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 705 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... +.. ..+......+.+++.+||+.+|.+||++.|+++
T Consensus 255 ~~~-~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 IIR-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHH-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhc-ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 011233456889999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.80 Aligned_cols=250 Identities=23% Similarity=0.278 Sum_probs=189.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
..+|...++||+|+||+||.....+++.||||++...... .+.+|+++|+++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4468888999999999966555567899999998765433 356899999999 899999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC-----CCCcEEEEeeCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-----ENFMAKVADFGLSKTGP 636 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld-----~~~~~kl~DFGla~~~~ 636 (828)
++ |+|.+++.... ..+.+.+++.++.|+++||+|||+ .+|+||||||+|||++ ....+||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 96 69999997654 345666788999999999999999 8999999999999994 33468899999998754
Q ss_pred CCCc-cceeccccccccccChhhhc---cCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 637 EIDQ-THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 637 ~~~~-~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
.... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||......... ........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGACSL 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccCCc
Confidence 3211 12234567999999999997 4677889999999999999999 89998644322211 11111110
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... .........+.+++.+||+.+|.+||++.||++
T Consensus 248 -~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 -DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 111234556789999999999999999999994
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=348.56 Aligned_cols=243 Identities=19% Similarity=0.282 Sum_probs=196.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec--CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCc-----
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN--DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE----- 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 554 (828)
.++|...++||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999875 5899999988654 33445678999999999999999999999977665
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||+++++|.+++.. .++|.+++.|+.||++||+|||+ .+|+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999987743 69999999999999999999999 899999999999999986 899999999987
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.... ....||++|+|||++.+.. +.++|||||||++|||++|.+|+....... +
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~--- 284 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------L--- 284 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------C---
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------c---
Confidence 5431 3457999999999997654 899999999999999999998876321110 0
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCC-hHHHHHHHHHHHHhh
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-MGDVLWNLEYALQLQ 763 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~eVl~~L~~~~~~~ 763 (828)
.. ..........+.+++.+||+.+|.+||+ +.++.+.|..+++..
T Consensus 285 ~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 285 PE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp CT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred cc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 00 0000122356889999999999999995 666767777766543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.83 Aligned_cols=252 Identities=22% Similarity=0.275 Sum_probs=179.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-cc-HHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QG-LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
.++|...+.||+|+||.||+|... +++.||||.+..... .. .+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456888899999999999999875 689999999875532 22 333445556788889999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCC-CEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
||+ ++.+..+. ......+++..++.++.|+++||+|||+ . +++||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 34444433 3223469999999999999999999998 5 8999999999999999999999999999764331
Q ss_pred CccceeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..........
T Consensus 179 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~--- 247 (318)
T 2dyl_A 179 ---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-----VLTKVLQEEP--- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHHHHSCC---
T ss_pred ---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-----HHHHHhccCC---
Confidence 1223456899999999994 56788999999999999999999999975322111 1111111110
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
+.+. ........+.+++.+||+.+|.+||++.|+++.
T Consensus 248 ---~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 ---PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ---CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1110 011234568899999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=334.41 Aligned_cols=241 Identities=17% Similarity=0.157 Sum_probs=182.2
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCC-Cc----------e-----
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRH-RH----------L----- 542 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~n----------i----- 542 (828)
+.+|...++||+|+||.||+|+.. +|+.||||++..... ...+.|.+|+.+++.++| +| +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345677789999999999999854 689999998874332 235789999999999987 21 1
Q ss_pred E------EEEEEEcc-----CCcEEEEEEeccCCccccccc-----CCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCE
Q 003350 543 V------SLIGYCDE-----KNEMILIYEYMENGTLKGHLY-----GSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 606 (828)
Q Consensus 543 v------~l~g~~~~-----~~~~~lV~ey~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 606 (828)
+ .+..++.. ....+++|+++ .++|.+++. ......+++..++.|+.|+++||+|||+ .+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 1 11111111 22456777765 579998884 2333568899999999999999999999 999
Q ss_pred EeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhh----------ccCCCCcccceeehhhH
Q 003350 607 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF----------RRQQLTEKSDVYSFGVV 676 (828)
Q Consensus 607 vHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~ksDVySfGvv 676 (828)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999886432 1345567 999999999 55568899999999999
Q ss_pred HHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 677 LFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 677 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+|||+||+.||......+. ...++.. . ...+..+.+++.+||+.+|.+||++.|+++
T Consensus 307 l~elltg~~Pf~~~~~~~~---------------~~~~~~~----~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG---------------SEWIFRS----C--KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC---------------SGGGGSS----C--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhh---------------HHHHHhh----c--ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999975433221 1111110 0 123466889999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=344.53 Aligned_cols=269 Identities=24% Similarity=0.324 Sum_probs=205.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc------CCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE------KNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 554 (828)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367899999999999999999874 5889999988754 34456779999999999999999999999865 678
Q ss_pred EEEEEEeccCCcccccccCCC-CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCc---EEEEeeC
Q 003350 555 MILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM---AKVADFG 630 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~---~kl~DFG 630 (828)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997643 3469999999999999999999999 89999999999999987664 9999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ 710 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (828)
+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ..|.........
T Consensus 170 ~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred cccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence 99875432 2234567999999999999999999999999999999999999999754221 111111111000
Q ss_pred cccccCc------------cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHH-----HHHHHHHHHHh
Q 003350 711 LDQIIDP------------TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGD-----VLWNLEYALQL 762 (828)
Q Consensus 711 ~~~~~d~------------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~e-----Vl~~L~~~~~~ 762 (828)
....... .............+.+++.+||+.+|.+||++.| ..+.++.+++.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0000000 0112234567888999999999999999999988 44566665543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.93 Aligned_cols=230 Identities=13% Similarity=0.066 Sum_probs=184.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +++.||||.+..... ...+.|.+|++++.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999876 489999999876533 33578899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++... ....+..+|+.|++.||+|||+ .+|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999998432 3556789999999999999999 999999999999999999999997443
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
|++| ++.++|||||||++|||+||+.||......+.... ....+....
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~ 222 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQP 222 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCB
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCC
Confidence 3332 68899999999999999999999976543221100 000000000
Q ss_pred --cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 720 --AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 720 --~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
........+..+.+++.+||+.+|.+| |+.|+++.|+.+...
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 001112345678999999999999999 999999999987644
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=302.76 Aligned_cols=228 Identities=20% Similarity=0.354 Sum_probs=179.7
Q ss_pred hcCCCcc-ceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHH-HcCCCCceEEEEEEEcc----CCcE
Q 003350 483 TNNFDES-WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEML-SQFRHRHLVSLIGYCDE----KNEM 555 (828)
Q Consensus 483 t~~f~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~ 555 (828)
.++|... ++||+|+||.||++... +++.||+|++... ..+.+|++++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3456555 78999999999999874 6889999998542 4577889888 66699999999999876 6788
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---CCcEEEEeeCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVADFGLS 632 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kl~DFGla 632 (828)
++||||+++|+|.+++.......+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999987665679999999999999999999999 99999999999999998 789999999998
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
+... +..++.++|||||||++|||++|+.||......... .....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence 6532 134678999999999999999999999654322110 00000
Q ss_pred cccCccccCCCC----hhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 713 QIIDPTLAGKIR----PDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 713 ~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.+..... ..+ ......+.+++.+||+.+|.+||++.|+++.
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 111 2335678899999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-34 Score=311.70 Aligned_cols=242 Identities=19% Similarity=0.152 Sum_probs=184.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC--------cccHHHHHHHHHHHHcCC---------CCceEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--------QQGLAEFQTEIEMLSQFR---------HRHLVSL 545 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 545 (828)
.++|...+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+++|++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677789999999999999987 58999999876542 234578899999999885 8888888
Q ss_pred EEEEc------------------------------cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHH
Q 003350 546 IGYCD------------------------------EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 595 (828)
Q Consensus 546 ~g~~~------------------------------~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 595 (828)
.+.+. ..+..++||||+++|++.+.+.+ ..+++.+++.|+.|++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77642 26789999999999987777744 3589999999999999999
Q ss_pred HHHH-hcCCCCEEeeeeecCcEEeCCCC--------------------cEEEEeeCCCCCCCCCCccceecccccccccc
Q 003350 596 HYLH-TGYAKAVIHRDVKSANILLDENF--------------------MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654 (828)
Q Consensus 596 ~yLH-~~~~~~ivHrDIkp~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 654 (828)
+||| + .+|+||||||+|||++.++ .+||+|||+++.... ....||+.|+
T Consensus 175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTT
T ss_pred HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeeccc
Confidence 9999 8 8999999999999999887 999999999986432 2347999999
Q ss_pred ChhhhccCCCCcccceeehhhH-HHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHH
Q 003350 655 DPEYFRRQQLTEKSDVYSFGVV-LFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGE 733 (828)
Q Consensus 655 aPE~~~~~~~s~ksDVySfGvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 733 (828)
|||++.+.. +.++||||+|++ .+++++|..||... ..+............. ..............++.+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhcc----CcccchhhhhhcCHHHHH
Confidence 999998666 899999998777 77889999887321 0000000111111000 000111112456788999
Q ss_pred HHHhhhhhCCCCCCChHHHH
Q 003350 734 TAEKCLADFGVDRPSMGDVL 753 (828)
Q Consensus 734 l~~~Cl~~~p~~RPsm~eVl 753 (828)
++.+||+.+ |+.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999865 888876
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-28 Score=284.21 Aligned_cols=184 Identities=20% Similarity=0.119 Sum_probs=129.6
Q ss_pred EeeeCcEEEEEEE-ecCCcEEEEEEcCCCC----------cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEEE
Q 003350 492 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRS----------QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 492 LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 559 (828)
.+.|++|.+..++ .--|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4456666555543 2247789999875431 22356799999999999 7999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||++|++|.+.|...+ +++.. +|+.||+.||+|||+ ++||||||||+||||++++++||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~- 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD- 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC-
Confidence 9999999999997654 45543 589999999999999 99999999999999999999999999999875432
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCC
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 686 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p 686 (828)
........||++|+|||++.+ ++..++|+||+|+++++|.++..+
T Consensus 393 -~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 -CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 222345789999999999865 567889999999999888776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-25 Score=258.24 Aligned_cols=184 Identities=17% Similarity=0.202 Sum_probs=145.6
Q ss_pred ccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcc--------cHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 488 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ--------GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..++||+|+||.||+|... ++.+++|+....... ..+.|.+|+++|++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3568999999999999554 678899875543211 1345899999999999999996666666777789999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++++|.+++.. ++.++.|+++||+|||+ .+|+||||||+|||++. ++||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999854 56899999999999999 99999999999999999 99999999999765421
Q ss_pred ccc-----eeccccccccccChhhhcc--CCCCcccceeehhhHHHHHHhcCCCC
Q 003350 640 QTH-----VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVI 687 (828)
Q Consensus 640 ~~~-----~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVySfGvvl~elltG~~p~ 687 (828)
... ......||+.|+|||++.. ..|+.+.|+|+..+-.++.+.++.++
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 111 1235679999999999986 67888999999999998888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.3e-22 Score=210.00 Aligned_cols=151 Identities=13% Similarity=0.048 Sum_probs=120.4
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCc------------------ccHHHHHHHHHHHHcCCCC
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ------------------QGLAEFQTEIEMLSQFRHR 540 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~ 540 (828)
+......|...+.||+|+||.||+|...+|+.||||.+..... .....+.+|+++|++++|+
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~ 164 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 164 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCC
Confidence 3344455667789999999999999987799999999864321 1345689999999999954
Q ss_pred ceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC
Q 003350 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 620 (828)
Q Consensus 541 niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~ 620 (828)
++.+++.. +..++||||+++|+|.+ +. ......++.|+++||+|||+ .+|+||||||+|||++
T Consensus 165 ---~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 165 ---AVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp ---SSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-
T ss_pred ---CcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-
Confidence 44444433 56699999999999998 42 13456799999999999999 9999999999999999
Q ss_pred CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhcc
Q 003350 621 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 661 (828)
++.+||+|||+++. +..++|||++.+
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999864 235789998853
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=192.27 Aligned_cols=155 Identities=17% Similarity=0.164 Sum_probs=118.0
Q ss_pred EEEEEeecCCCCcCCCCCccccccCCCCcceecccCCcccccCCcceeccCCCCccCCchhhHhhccccccCCCCCCcce
Q 003350 208 ETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFN 287 (828)
Q Consensus 208 ~~~~R~n~Gg~~~~~~~D~~~R~W~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~P~~V~~tA~~~~~~~~~~~~l~ 287 (828)
+++||+||||+.++ |..+|.|.+|..|...+... .. ...+.+ .....+|+.||+|||... -+
T Consensus 5 ~~~~~INcGg~~~~---d~~gr~w~~D~~~~~~g~~~-~~--~~~~~~----~~~~~~~~~lY~TaR~~~--------~~ 66 (174)
T 2jwp_A 5 KVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRAS-DY--GMKLPI----LRSNPEDQVLYQTERYNE--------DS 66 (174)
T ss_dssp HEEEEEEETSSSEE---ETTTEEECSSCSSTTCCCCC-CC--CTTSCC----SSSCHHHHHTTTCCCCCC--------SC
T ss_pred cEEEEEECCCCCcc---CCCCCEEcCCcCcccCCccc-cc--ccceEe----cccCCCCchhhhhhccCC--------CC
Confidence 57899999998875 78999999998754222111 00 111111 113467899999999865 26
Q ss_pred EEEEeecCCCCceEEEEEeceeeecCCCceEEEEEEcccccccccCccccccCcccceEEEeeeEee------------c
Q 003350 288 VTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQ------------T 355 (828)
Q Consensus 288 ltw~~~~~~~~~ylv~LhFaei~~~~~~~R~F~I~in~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~------------~ 355 (828)
++|.+|++++..|+|+|||||+...+.++|+||||+||+.+.+++|+... +|. ..++++++.+.+ .
T Consensus 67 ~tY~f~v~~~G~Y~VrLhF~ei~~~~~~~rvFdV~ing~~~l~~fdi~~~-ag~-~~~~~~~~~~~v~~~~l~i~~~~~~ 144 (174)
T 2jwp_A 67 FGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDR-VGH-STAHDEIIPISIKKGKLSVQGEVST 144 (174)
T ss_dssp EEEEEECCSCEEEEEEEEEECCSCCCSSSSCEEEEETTEEEEEEECHHHH-HSS-SSCEEEEEEEEEETTEEEETTEEEE
T ss_pred eEEEEEeCCCeEEEEEEEEeccccCCCCCeEeEEEECCEEeecCcCHHHh-hCC-CeeEEEEEEEEEecCceeeeeeecc
Confidence 89999999889999999999998888899999999999999999999888 444 568888877653 2
Q ss_pred CCCcEEEEeccCCCCCCCCCcccccceeeec
Q 003350 356 ASSKLRISIGRSTLHDTYPDAILNGLEIMKM 386 (828)
Q Consensus 356 ~~~~~~i~l~~~~~s~~~p~~ilng~ei~~~ 386 (828)
..|.++|++.|.. ..+|++||+||++.
T Consensus 145 ~~g~L~I~f~p~~----~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 145 FTGKLSVEFVKGY----YDNPKVCALFIMKG 171 (174)
T ss_dssp CCSEEEEEEECSS----SCSSSEEEEEEESS
T ss_pred cCCeEEEEEeccC----CCCcEEEEEEEEeC
Confidence 4677999998642 23569999999974
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.1e-19 Score=173.19 Aligned_cols=146 Identities=16% Similarity=0.197 Sum_probs=111.4
Q ss_pred ccEEEecCCCcceecCCceeeeCCCCceeeecCCcccc--ccccCcCCCCCccccceeeeeecCceeEEeecCCceEEEE
Q 003350 32 DNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVA--NISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIR 109 (828)
Q Consensus 32 ~~~~idCG~~~~~~~~~~~~~~D~~~s~~~~~~~~~~~--~~~~~~~~~~~~~~~~t~R~f~~~~~~~~~~~~~~~ylvR 109 (828)
..|+||||++..+...+|+|.+|.. |...|..... ++........++..|+|+|+||...+|.+++.++|+|+||
T Consensus 6 ~~~~INcGg~~~~d~~gr~w~~D~~---~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~Vr 82 (174)
T 2jwp_A 6 VIWAVNAGGESHVDVHGIHYRKDPL---EGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLV 82 (174)
T ss_dssp EEEEEEETSSSEEETTTEEECSSCS---STTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCSCEEEEEECCSCEEEEEE
T ss_pred EEEEEECCCCCccCCCCCEEcCCcC---cccCCcccccccceEecccCCCCchhhhhhccCCCCeEEEEEeCCCeEEEEE
Confidence 4689999998766558999999966 4322211100 1111111223466899999999988999999889999999
Q ss_pred EEeeccCCCCcCCccceEEEEeCcEEEEeecCCC------CcEEEEEEEec-------------CCCcEEEEEecCCCCc
Q 003350 110 LYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVS------SNVFKEFSVNV-------------TSDSLDVIFSPSNNSF 170 (828)
Q Consensus 110 ~~f~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~------~~~~~E~~~~~-------------~~~~~~vc~~~~~~~~ 170 (828)
+||..-.+.+ .....|||.+|+.+++++++.. .++.+|+.+.+ .++.+.|+|.|...+.
T Consensus 83 LhF~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~ 160 (174)
T 2jwp_A 83 LKFAEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDN 160 (174)
T ss_dssp EEEECCSCCC--SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCS
T ss_pred EEEeccccCC--CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCC
Confidence 9998888754 3458999999999999999864 37888888864 5678999999876779
Q ss_pred ceeeeeeeEEeC
Q 003350 171 AFINALEVVSVP 182 (828)
Q Consensus 171 pfi~~iE~~~~~ 182 (828)
||||||||++-+
T Consensus 161 a~inaIEI~~~~ 172 (174)
T 2jwp_A 161 PKVCALFIMKGT 172 (174)
T ss_dssp SSEEEEEEESSC
T ss_pred cEEEEEEEEeCc
Confidence 999999999753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.2e-18 Score=177.67 Aligned_cols=136 Identities=19% Similarity=0.153 Sum_probs=105.8
Q ss_pred CCccceEeeeCcEEEEEEEe-cCCcE--EEEEEcCCCCcc------------------------cHHHHHHHHHHHHcCC
Q 003350 486 FDESWVIGIGGFGKVYKGEL-NDGTK--VAVKRGNPRSQQ------------------------GLAEFQTEIEMLSQFR 538 (828)
Q Consensus 486 f~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 538 (828)
|...+.||+|+||.||+|.. .+|+. ||||.+...... ....+.+|+++|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45668999999999999987 67888 999986543211 1136789999999998
Q ss_pred CCce--EEEEEEEccCCcEEEEEEeccC-C----cccccccCCCCCCCChhhHHHHHHHHHHHHHHHH-hcCCCCEEeee
Q 003350 539 HRHL--VSLIGYCDEKNEMILIYEYMEN-G----TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-TGYAKAVIHRD 610 (828)
Q Consensus 539 H~ni--v~l~g~~~~~~~~~lV~ey~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrD 610 (828)
|+++ ..++.+ +..+|||||+.+ | +|.+.... .++.....++.|++.+|.||| + .+|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 7753 344443 356899999942 4 45544321 345678899999999999999 8 8999999
Q ss_pred eecCcEEeCCCCcEEEEeeCCCCCC
Q 003350 611 VKSANILLDENFMAKVADFGLSKTG 635 (828)
Q Consensus 611 Ikp~NILld~~~~~kl~DFGla~~~ 635 (828)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-15 Score=167.00 Aligned_cols=143 Identities=12% Similarity=0.128 Sum_probs=104.2
Q ss_pred HHHHHHhcC---CCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCc--------------ccHH--------HHHHHH
Q 003350 477 VAVQEATNN---FDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ--------------QGLA--------EFQTEI 531 (828)
Q Consensus 477 ~~l~~at~~---f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~ 531 (828)
..|....++ |.+.+.||+|++|.||+|...+|+.||||.++.... .... ....|.
T Consensus 85 LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~ 164 (397)
T 4gyi_A 85 LALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEF 164 (397)
T ss_dssp HHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHH
Confidence 344544444 788899999999999999998999999997653210 0011 123567
Q ss_pred HHHHcCCCCce--EEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEee
Q 003350 532 EMLSQFRHRHL--VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609 (828)
Q Consensus 532 ~~l~~l~H~ni--v~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 609 (828)
..|.++.+.++ ...+++. ..+|||||+++++|.+... ......++.|++.+|.|||+ .+||||
T Consensus 165 ~nL~rL~~~gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~---~gIVHr 229 (397)
T 4gyi_A 165 AFMKALYEEGFPVPEPIAQS----RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAK---HGLIHG 229 (397)
T ss_dssp HHHHHHHHTTCSCCCEEEEE----TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred HHHHHHHhcCCCCCeeeecc----CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHH---CCCcCC
Confidence 77777755443 2233322 2379999999988876542 12446788999999999999 899999
Q ss_pred eeecCcEEeCCCC----------cEEEEeeCCCCC
Q 003350 610 DVKSANILLDENF----------MAKVADFGLSKT 634 (828)
Q Consensus 610 DIkp~NILld~~~----------~~kl~DFGla~~ 634 (828)
||||.|||+++++ .+.|+||+-+..
T Consensus 230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999999998776 389999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=5.6e-11 Score=124.51 Aligned_cols=147 Identities=13% Similarity=0.078 Sum_probs=114.3
Q ss_pred HHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEE
Q 003350 479 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 479 l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 557 (828)
+......|.....++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3455567877777888888999999765 6789999876421122345788999999884 6778889999988889999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhc------------------------------------
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG------------------------------------ 601 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------ 601 (828)
||||++|.+|.+.+. +......++.+++++|+.||+.
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999887631 2234558889999999999981
Q ss_pred --------------------CCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 602 --------------------YAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 602 --------------------~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11458999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=120.84 Aligned_cols=129 Identities=19% Similarity=0.109 Sum_probs=97.9
Q ss_pred eeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc--eEEEEEEEccCCcEEEEEEeccCCccccc
Q 003350 493 GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLIGYCDEKNEMILIYEYMENGTLKGH 570 (828)
Q Consensus 493 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~ey~~~gsL~~~ 570 (828)
+.|..+.||+....+|+.+++|...... ...+..|+++++.+.+.+ +.+++++....+..++||||+++.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 3455699999987778889999876542 245778999999886545 455888888878899999999998884
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 003350 571 LYGSGLPSLSWKQRLEICIGSARGLHYLHTGY------------------------------------------------ 602 (828)
Q Consensus 571 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 602 (828)
... . ....++.++++.|..||+..
T Consensus 104 ~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 1 23367788888888888621
Q ss_pred -------CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 603 -------AKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 603 -------~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
...++|+|++|.|||++++..++|+|||.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=6.6e-09 Score=114.06 Aligned_cols=142 Identities=15% Similarity=0.209 Sum_probs=107.8
Q ss_pred ccceEeeeCcEEEEEEEecCCcEEEEEEcC--CCC-cccHHHHHHHHHHHHcCC--CCceEEEEEEEccC---CcEEEEE
Q 003350 488 ESWVIGIGGFGKVYKGELNDGTKVAVKRGN--PRS-QQGLAEFQTEIEMLSQFR--HRHLVSLIGYCDEK---NEMILIY 559 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 559 (828)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34678899999999998764 578888765 322 122356788999999986 45678899988766 4589999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY------------------------------------- 602 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 602 (828)
||+++..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998875422 234788899999999999999999721
Q ss_pred ------------------CCCEEeeeeecCcEEeCCCCc--EEEEeeCCCCC
Q 003350 603 ------------------AKAVIHRDVKSANILLDENFM--AKVADFGLSKT 634 (828)
Q Consensus 603 ------------------~~~ivHrDIkp~NILld~~~~--~kl~DFGla~~ 634 (828)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.75 E-value=3.8e-09 Score=113.19 Aligned_cols=187 Identities=17% Similarity=0.190 Sum_probs=124.0
Q ss_pred cceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCc--eEEEEEEEccCC---cEEEEEEec
Q 003350 489 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRH--LVSLIGYCDEKN---EMILIYEYM 562 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~ey~ 562 (828)
.+.++.|....||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+++..+.... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3578999999999863 56888885432 34567889999998873 332 445555544333 347899999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG----------------------------------------- 601 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 601 (828)
++.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988875432 2467788888999999999999861
Q ss_pred --------------CCCCEEeeeeecCcEEeCC--CCcEEEEeeCCCCCCCCCCcc-ceec-----------cccccccc
Q 003350 602 --------------YAKAVIHRDVKSANILLDE--NFMAKVADFGLSKTGPEIDQT-HVST-----------AVKGSFGY 653 (828)
Q Consensus 602 --------------~~~~ivHrDIkp~NILld~--~~~~kl~DFGla~~~~~~~~~-~~~~-----------~~~gt~~Y 653 (828)
....++|+|+++.||++++ ...+.|+||+.+........- .... ......+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1245899999999999998 556889999988653221000 0000 00001112
Q ss_pred cC-hhhhccCCCCcccceeehhhHHHHHHhcCCCC
Q 003350 654 LD-PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI 687 (828)
Q Consensus 654 ~a-PE~~~~~~~s~ksDVySfGvvl~elltG~~p~ 687 (828)
.. |+..... ....+.|+++.++|++.+|++++
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 3332211 22368999999999999998665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=8.2e-06 Score=87.20 Aligned_cols=135 Identities=17% Similarity=0.155 Sum_probs=96.1
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCC---ceEEEEEEEc-cCCcEEEEEEeccCC
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR---HLVSLIGYCD-EKNEMILIYEYMENG 565 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~ey~~~g 565 (828)
+.++.|....||+. +..+++|+.. .......+.+|.++|+.+.+. .+.+.+.++. ..+..++|||++++.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56888888899987 5668888743 233456788999999999652 3566677663 456678999999998
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 003350 566 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG-------------------------------------------- 601 (828)
Q Consensus 566 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------- 601 (828)
+|.+... ..++..++..++.++++.|+.||+.
T Consensus 99 ~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 99 ILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp ECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred ECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 8876321 1244555666666666666666641
Q ss_pred -------------CCCCEEeeeeecCcEEeCC---CCc-EEEEeeCCCCC
Q 003350 602 -------------YAKAVIHRDVKSANILLDE---NFM-AKVADFGLSKT 634 (828)
Q Consensus 602 -------------~~~~ivHrDIkp~NILld~---~~~-~kl~DFGla~~ 634 (828)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999987 455 58999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=7.5e-06 Score=85.53 Aligned_cols=135 Identities=18% Similarity=0.148 Sum_probs=96.7
Q ss_pred eEeeeCcE-EEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEEeccCCcc
Q 003350 491 VIGIGGFG-KVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 491 ~LG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
.+..|..+ .||+.... ++..+++|+.... ...++.+|...|+.+. +--+.++++++...+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987665 4567889975433 3456788999998874 33467788889888999999999999887
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 003350 568 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG---------------------------------------------- 601 (828)
Q Consensus 568 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------- 601 (828)
.+.... .......++.++++.|.-||..
T Consensus 108 ~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 665421 1234455666677777777631
Q ss_pred ---------CCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 602 ---------YAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 602 ---------~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
....++|+|+++.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012389999999999999887778999988654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=5.2e-06 Score=90.62 Aligned_cols=145 Identities=8% Similarity=0.047 Sum_probs=90.4
Q ss_pred ceE-eeeCcEEEEEEEec-------CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCC---CceEEEEEEEccC---
Q 003350 490 WVI-GIGGFGKVYKGELN-------DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRH---RHLVSLIGYCDEK--- 552 (828)
Q Consensus 490 ~~L-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~--- 552 (828)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+.. ..+.++++++...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 77888999988764 25678888765432 1012456788888888742 3567788887655
Q ss_pred CcEEEEEEeccCCcccccccC----CCCCCCChhhHHHHHHHHHHHHH--------------------------------
Q 003350 553 NEMILIYEYMENGTLKGHLYG----SGLPSLSWKQRLEICIGSARGLH-------------------------------- 596 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~-------------------------------- 596 (828)
+..++|||++++..+.+.+.. .....++..++..++.++++.|+
T Consensus 106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV 185 (357)
T ss_dssp SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence 357899999998777653200 00001222222233333333333
Q ss_pred ----------------------HHHhc-------CCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 597 ----------------------YLHTG-------YAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 597 ----------------------yLH~~-------~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+|.+. ....++|+|+++.|||++++..+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 33221 136799999999999999655578999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=7.7e-05 Score=82.61 Aligned_cols=75 Identities=13% Similarity=0.119 Sum_probs=48.9
Q ss_pred cceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc-------ccHHHHHHHHHHHHcCCC--Cc-eEEEEEEEccCCcEEE
Q 003350 489 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-------QGLAEFQTEIEMLSQFRH--RH-LVSLIGYCDEKNEMIL 557 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l 557 (828)
.+.||.|..+.||++... +++.++||....... .....+..|.++|+.+.. +. +.+++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 357899999999999764 467899997543211 123456788888887732 33 44555543 345689
Q ss_pred EEEeccCC
Q 003350 558 IYEYMENG 565 (828)
Q Consensus 558 V~ey~~~g 565 (828)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00027 Score=76.08 Aligned_cols=140 Identities=19% Similarity=0.182 Sum_probs=80.0
Q ss_pred ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-----CCceEEEE-E--EEccCCcEEEEEEe
Q 003350 490 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-----HRHLVSLI-G--YCDEKNEMILIYEY 561 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lV~ey 561 (828)
+.|+.|..+.||+....+| .+++|+.... ..++..|.+++..+. .|.++... | +....+..+++++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3455567889999987654 5889987652 233444555555442 34443310 0 11235668899999
Q ss_pred ccCCcccc--------------cccC--CCC----------CCCChhhHH------------------------------
Q 003350 562 MENGTLKG--------------HLYG--SGL----------PSLSWKQRL------------------------------ 585 (828)
Q Consensus 562 ~~~gsL~~--------------~l~~--~~~----------~~l~~~~~~------------------------------ 585 (828)
+++..+.. .+|. ... ..-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99866531 1111 000 012343211
Q ss_pred -HHHHHHHHHHHHHHh----------cCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 586 -EICIGSARGLHYLHT----------GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 586 -~i~~~ia~gL~yLH~----------~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.+...+.+++++|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123345666653 1347899999999999998888999999997654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00029 Score=74.19 Aligned_cols=79 Identities=19% Similarity=0.157 Sum_probs=58.1
Q ss_pred CCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC---CceEEEEEEEccCCcEEEEEEe
Q 003350 485 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH---RHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~ey 561 (828)
.....+.+|.|..+.||+.++.||+.+.+|+...........|..|.+.|+.|.- --+.+++++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3445567999999999999999999999998765544444568889999988742 2344555543 23789999
Q ss_pred ccCCcc
Q 003350 562 MENGTL 567 (828)
Q Consensus 562 ~~~gsL 567 (828)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00059 Score=72.76 Aligned_cols=138 Identities=14% Similarity=0.121 Sum_probs=92.0
Q ss_pred ccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC---CCceEEEEEEEccCCcEEEEEEeccC
Q 003350 488 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
..+.|+.|....+|+.... +..+++|+.... ....|..|.+.|+.|. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3457899999999998764 667888976532 3567889999988883 35678888888878889999999998
Q ss_pred Ccccc-----------cccCCCC-C-------------------CCChhhHH---HHH--HH--------------HHHH
Q 003350 565 GTLKG-----------HLYGSGL-P-------------------SLSWKQRL---EIC--IG--------------SARG 594 (828)
Q Consensus 565 gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~--~~--------------ia~g 594 (828)
..+.. .||.... . .-+|.... ++. .+ +.+.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76532 1222111 0 12454322 111 11 1111
Q ss_pred -HHHHHh-cCCCCEEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 595 -LHYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 595 -L~yLH~-~~~~~ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 2347899999999999999887 8888873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00099 Score=74.24 Aligned_cols=79 Identities=16% Similarity=0.212 Sum_probs=47.7
Q ss_pred CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccc-cccccccChhhhccC---CCCcccceeehhhHHH
Q 003350 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV-KGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLF 678 (828)
Q Consensus 603 ~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~---~~s~ksDVySfGvvl~ 678 (828)
...++|+|+++.|||++.++ ++|+||+.+...... .. ..... .-...|.+|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 47899999999999999876 999999988753210 00 00000 001245666554311 1122345557777788
Q ss_pred HHHhcC
Q 003350 679 EVLCAR 684 (828)
Q Consensus 679 elltG~ 684 (828)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0013 Score=70.10 Aligned_cols=158 Identities=11% Similarity=0.126 Sum_probs=88.6
Q ss_pred cCHHHHHHHhcCCCcc-----ceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc--eEEEE
Q 003350 474 FPFVAVQEATNNFDES-----WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLI 546 (828)
Q Consensus 474 ~~~~~l~~at~~f~~~-----~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 546 (828)
++..++......|... +.|+.|....+|+....+| .+++|....... ..++..|++++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence 5556677766667652 3455677789999987655 678888765211 134556777776663222 22222
Q ss_pred EE------EccCCcEEEEEEeccCCccccc--------------ccC--CC--CCC------CChhhHHH----------
Q 003350 547 GY------CDEKNEMILIYEYMENGTLKGH--------------LYG--SG--LPS------LSWKQRLE---------- 586 (828)
Q Consensus 547 g~------~~~~~~~~lV~ey~~~gsL~~~--------------l~~--~~--~~~------l~~~~~~~---------- 586 (828)
.. ....+..+++++|+++..+... +|. .. ... ..|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 11 1123567899999998664321 111 00 000 12332111
Q ss_pred --HHHHHHHHHHHHHhc----CCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 587 --ICIGSARGLHYLHTG----YAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 587 --i~~~ia~gL~yLH~~----~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+...+.+.++.+++. ....++|+|+++.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455666532 235799999999999999876668999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0021 Score=71.75 Aligned_cols=73 Identities=19% Similarity=0.178 Sum_probs=49.9
Q ss_pred ceEeeeCcEEEEEEEecC--------CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCce-EEEEEEEccCCcEEEEEE
Q 003350 490 WVIGIGGFGKVYKGELND--------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e 560 (828)
+.|+.|....+|+....+ +..+++|+..... ....+..|..++..+...++ .++++.+.. .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 467788889999998753 4788999874321 12455679888888743333 566776653 28999
Q ss_pred eccCCccc
Q 003350 561 YMENGTLK 568 (828)
Q Consensus 561 y~~~gsL~ 568 (828)
|+++.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99865553
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0039 Score=66.91 Aligned_cols=141 Identities=13% Similarity=0.114 Sum_probs=72.7
Q ss_pred ceEeeeCcEE-EEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC--CceEEEEEEEccCCcEEEEEEeccCCc
Q 003350 490 WVIGIGGFGK-VYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKNEMILIYEYMENGT 566 (828)
Q Consensus 490 ~~LG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~ey~~~gs 566 (828)
+.|+.|.... +|+....++..+++|....... .++..|++++..+.. -.+.+++.++...+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3465554444 6676654466777776554321 223456666665532 23456676654443 78999987655
Q ss_pred cccccc---------------------CCC---CCCCChhhHH-------H-------------HHHHHHHHHHHHH---
Q 003350 567 LKGHLY---------------------GSG---LPSLSWKQRL-------E-------------ICIGSARGLHYLH--- 599 (828)
Q Consensus 567 L~~~l~---------------------~~~---~~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 599 (828)
+.+++. ... .+.++..... . ....+.+.++.|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543221 111 0111111000 0 0011112222331
Q ss_pred hcCCCCEEeeeeecCcEEeCCC----CcEEEEeeCCCCCC
Q 003350 600 TGYAKAVIHRDVKSANILLDEN----FMAKVADFGLSKTG 635 (828)
Q Consensus 600 ~~~~~~ivHrDIkp~NILld~~----~~~kl~DFGla~~~ 635 (828)
......++|||+.+.|||++.+ ..+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1224689999999999999875 68999999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.006 Score=68.56 Aligned_cols=74 Identities=14% Similarity=0.140 Sum_probs=48.2
Q ss_pred ceEeeeCcEEEEEEEecC-CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCce-EEEEEEEccCCcEEEEEEeccCCcc
Q 003350 490 WVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYEYMENGTL 567 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ey~~~gsL 567 (828)
+.|+.|-...+|+....+ +..+++|+......... .-.+|..++..|...++ .++++.+.. .+|+||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 467778889999998765 47888987654322211 11478888888865444 467777642 259999998665
Q ss_pred c
Q 003350 568 K 568 (828)
Q Consensus 568 ~ 568 (828)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0029 Score=66.97 Aligned_cols=137 Identities=14% Similarity=0.088 Sum_probs=73.9
Q ss_pred cceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCce-EEEEEEEccCCcEEEEEEec-cCCc
Q 003350 489 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYEYM-ENGT 566 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ey~-~~gs 566 (828)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+...++ .++++++.+ .-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 467988999999998 458888766532211 112467777776642222 455555433 346899999 6555
Q ss_pred ccc------------------cccCCCC---CCCC-hhhHHHHHH--------------HHHHHHH----HHHh-cCCCC
Q 003350 567 LKG------------------HLYGSGL---PSLS-WKQRLEICI--------------GSARGLH----YLHT-GYAKA 605 (828)
Q Consensus 567 L~~------------------~l~~~~~---~~l~-~~~~~~i~~--------------~ia~gL~----yLH~-~~~~~ 605 (828)
|.. .+|.... .... +.....+.. .+.+.+. .|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 532 0111110 0001 111111100 0111111 1111 22356
Q ss_pred EEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 606 VIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 606 ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5566789999988764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.49 E-value=0.011 Score=62.94 Aligned_cols=157 Identities=10% Similarity=0.130 Sum_probs=88.9
Q ss_pred cCHHHHHHHhcCCCc-----cceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc--eEEEE
Q 003350 474 FPFVAVQEATNNFDE-----SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLI 546 (828)
Q Consensus 474 ~~~~~l~~at~~f~~-----~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 546 (828)
.+..++..+...|.. .+.|+ |....||+....+|+.+++|....... ....+..|..++..+.... +.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence 344455554444432 23566 778899998777777899998764321 2456677888887774222 33343
Q ss_pred EE-----EccCCcEEEEEEeccCCcccc----c----------ccC----CC---CCCCChhhH----HHH---------
Q 003350 547 GY-----CDEKNEMILIYEYMENGTLKG----H----------LYG----SG---LPSLSWKQR----LEI--------- 587 (828)
Q Consensus 547 g~-----~~~~~~~~lV~ey~~~gsL~~----~----------l~~----~~---~~~l~~~~~----~~i--------- 587 (828)
.. ....+..+++++++++..+.. . +|. .. ....++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 112345678999998865431 0 111 00 112222211 000
Q ss_pred ------HHHHHHHHHHHHhc----CCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 588 ------CIGSARGLHYLHTG----YAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 588 ------~~~ia~gL~yLH~~----~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
...+.+.++.+... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 346789999999999999 4 899999987764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0084 Score=65.55 Aligned_cols=140 Identities=17% Similarity=0.158 Sum_probs=83.9
Q ss_pred ceEeeeCcEEEEEEEec--------CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcEEEEEE
Q 003350 490 WVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 560 (828)
+.|..|-...+|+.... +++.+++|+..... .......+|.++++.+. +.-..++++++..+ +|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 35666777789998764 24789999864322 23556678999988774 22235667776542 9999
Q ss_pred eccCCccccc-----------------ccCCC---CCCC--ChhhHHHHHHHHHH-------------------HHHHHH
Q 003350 561 YMENGTLKGH-----------------LYGSG---LPSL--SWKQRLEICIGSAR-------------------GLHYLH 599 (828)
Q Consensus 561 y~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~~ia~-------------------gL~yLH 599 (828)
|+++..|..- ||... .+.. -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998666421 11211 1112 24555555544322 233333
Q ss_pred h-----cCCCCEEeeeeecCcEEeCCC----CcEEEEeeCCCCC
Q 003350 600 T-----GYAKAVIHRDVKSANILLDEN----FMAKVADFGLSKT 634 (828)
Q Consensus 600 ~-----~~~~~ivHrDIkp~NILld~~----~~~kl~DFGla~~ 634 (828)
+ .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123578999999999999876 7899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0069 Score=66.02 Aligned_cols=73 Identities=16% Similarity=0.135 Sum_probs=43.3
Q ss_pred ceEeeeCcEEEEEEEecC---------CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc-eEEEEEEEccCCcEEEEE
Q 003350 490 WVIGIGGFGKVYKGELND---------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH-LVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 559 (828)
+.|+.|..-.+|+....+ +..+++|+....... ......|.++++.+...+ ..++++... -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 456777788899987654 267888876543221 112357888887774333 345665442 26899
Q ss_pred EeccCCcc
Q 003350 560 EYMENGTL 567 (828)
Q Consensus 560 ey~~~gsL 567 (828)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.05 E-value=0.048 Score=58.61 Aligned_cols=31 Identities=16% Similarity=0.287 Sum_probs=27.8
Q ss_pred CCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 604 KAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 604 ~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999999888899999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.95 E-value=0.026 Score=55.97 Aligned_cols=99 Identities=16% Similarity=0.130 Sum_probs=63.8
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcccee
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 644 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 644 (828)
-+|.+.|...+ .++++++++.++.|.+.+|.-+-... .. ..+=+.|..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 37788875543 57999999999999999987762210 11 1233457899999999988763 1110
Q ss_pred ccccccccccChhhhccCCCCcccceeehhhHHHHHHh
Q 003350 645 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 682 (828)
Q Consensus 645 ~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt 682 (828)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122466888763 455788899999999998774
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.72 E-value=0.24 Score=54.72 Aligned_cols=139 Identities=12% Similarity=0.124 Sum_probs=83.1
Q ss_pred ceEeeeCcEEEEEEEecC--------CcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCc-eEEEEEEEccCCcEEEEEE
Q 003350 490 WVIGIGGFGKVYKGELND--------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH-LVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e 560 (828)
+.|..|-...+|+....+ ++.+++|+........ -.-.+|.++++.+...+ ..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456667788899987763 5788999865543221 12246888887774222 345555443 278999
Q ss_pred eccCCccccc-----------------ccC--------C---CCCCCChhhHHHHHHHH-------------------HH
Q 003350 561 YMENGTLKGH-----------------LYG--------S---GLPSLSWKQRLEICIGS-------------------AR 593 (828)
Q Consensus 561 y~~~gsL~~~-----------------l~~--------~---~~~~l~~~~~~~i~~~i-------------------a~ 593 (828)
|+++..|..- ||. . ...+.-|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998765321 011 0 11122354444443322 22
Q ss_pred HHHHHHh---------------------cCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 594 GLHYLHT---------------------GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 594 gL~yLH~---------------------~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.+..|.+ .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 12346899999999999 8888999999988754
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.19 E-value=0.01 Score=42.37 Aligned_cols=31 Identities=13% Similarity=0.174 Sum_probs=16.6
Q ss_pred eeEEeehhHHHHHHHHHHhheeeEEeecccC
Q 003350 402 VGVIVGVTIGVSVAALLAGILFMLCRKRRQL 432 (828)
Q Consensus 402 ~~iiigivvgv~vl~ll~~i~~~~~rrrr~~ 432 (828)
..|+.|++.|+++++++++.+++++|||+++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 3444555555666555555555555555543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.17 E-value=0.011 Score=42.36 Aligned_cols=31 Identities=13% Similarity=0.167 Sum_probs=16.9
Q ss_pred eeEEeehhHHHHHHHHHHhheeeEEeecccC
Q 003350 402 VGVIVGVTIGVSVAALLAGILFMLCRKRRQL 432 (828)
Q Consensus 402 ~~iiigivvgv~vl~ll~~i~~~~~rrrr~~ 432 (828)
..|+.|++.|+++++++++++++++|||+++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3444555555666655555555555555543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.06 E-value=0.7 Score=50.61 Aligned_cols=30 Identities=33% Similarity=0.431 Sum_probs=25.3
Q ss_pred CEEeeeeecCcEEe------CCCCcEEEEeeCCCCC
Q 003350 605 AVIHRDVKSANILL------DENFMAKVADFGLSKT 634 (828)
Q Consensus 605 ~ivHrDIkp~NILl------d~~~~~kl~DFGla~~ 634 (828)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567899999988754
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.94 E-value=0.04 Score=39.29 Aligned_cols=30 Identities=20% Similarity=0.474 Sum_probs=15.3
Q ss_pred eeEEeehhHHHHHHHHHHhheeeEEeeccc
Q 003350 402 VGVIVGVTIGVSVAALLAGILFMLCRKRRQ 431 (828)
Q Consensus 402 ~~iiigivvgv~vl~ll~~i~~~~~rrrr~ 431 (828)
...|++.++|++++++++++++++.|||+.
T Consensus 11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 11 LTSIISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred ccchHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 444666777755444444444444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 828 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-75 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 3e-75
Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 19/270 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
IG G FG VYKG+ + V + + Q L F+ E+ +L + RH +++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 610
++ ++ ++ E +L HL+ + ++I +A+G+ YLH K++IHRD
Sbjct: 75 A-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA---KSIIHRD 129
Query: 611 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEK 667
+KS NI L E+ K+ DFGL+ +H + GS ++ PE R Q + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 668 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727
SDVY+FG+VL+E++ + P +N + + +G L + K+R +
Sbjct: 190 SDVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRGYLSPDLS-----KVRSNC 238
Query: 728 LRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
+ +CL +RP +L ++E
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 4e-65
Identities = 67/298 (22%), Positives = 132/298 (44%), Gaps = 28/298 (9%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 550
IG G FG+V++G+ G +VAVK + R ++ + EI RH +++ I +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 551 EKN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA--- 603
+ N ++ L+ +Y E+G+L +L + + +++ + +A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT---VEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 604 --KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--HVSTAVKGSFGYLDPEYF 659
A+ HRD+KS NIL+ +N +AD GL+ T G+ Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 660 RRQ------QLTEKSDVYSFGVVLFEVLCARPVIDPTL----PREMVNLAEWAMKWQNKG 709
+ +++D+Y+ G+V +E+ + P + ++ +++ K
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 710 QLDQIIDPTLAGKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766
+Q + P + + + ++LR + +C G R + + L L QE +
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS-QLSQQEGI 301
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-65
Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 32/283 (11%)
Query: 486 FDESW-----------VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEML 534
+++ W +G G FG+V+ G N TKVAVK + F E ++
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLM 62
Query: 535 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 594
Q +H+ LV L + + +I EYMENG+L L L+ + L++ A G
Sbjct: 63 KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ ++ + IHRD+++ANIL+ + K+ADFGL++ + ++ K +
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWT 177
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714
PE T KSDV+SFG++L E++ + P + V QN + ++
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------IQNLERGYRM 229
Query: 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
+ P P+ L + C + DRP+ + LE
Sbjct: 230 VRPDNC----PEELYQL---MRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-63
Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 21/278 (7%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+ IG G FG V+ G + KVA+K +F E E++ + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
L G C E+ + L++E+ME+G L + + + L +C+ G+ YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLS-DYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
VIHRD+ + N L+ EN + KV+DFG+++ + DQ ST K + PE F +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 664 LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723
+ KSDV+SFGV+++EV +P E + +E ++ P LA
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGK-----IPYENRSNSEVVEDISTG---FRLYKPRLA--- 227
Query: 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761
+ + C + DRP+ +L L +
Sbjct: 228 -STHVYQI---MNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-63
Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 21/274 (7%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+ +G G FG V G+ VA+K S EF E +++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
L G C ++ + +I EYM NG L +L +Q LE+C + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
K +HRD+ + N L+++ + KV+DFGLS+ + D+ S K + PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 664 LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723
+ KSD+++FGV+++E+ +P E +E A +L P LA
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHIAQGLRLY---RPHLA--- 226
Query: 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
+ + C + +RP+ +L N+
Sbjct: 227 -SEKVYTI---MYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 4e-63
Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 21/279 (7%)
Query: 484 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+ +G G +G+VY+G VAVK + + + EF E ++ + +H +L
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
V L+G C + +I E+M G L +L +S L + + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 662
K IHRD+ + N L+ EN + KVADFGLS+ D K + PE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191
Query: 663 QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722
+ + KSDV++FGV+L+E+ P + Q+ ++++ +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYELLEKDYRME 236
Query: 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761
K E C DRPS ++ E Q
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-62
Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 27/269 (10%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC- 549
IG G FG V G+ G KVAVK ++ F E +++Q RH +LV L+G
Sbjct: 14 TIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+EK + ++ EYM G+L +L G L L+ + + YL +HR
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
D+ + N+L+ E+ +AKV+DFGL+K T K + PE R ++ + KSD
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSD 182
Query: 670 VYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLR 729
V+SFG++L+E+ +P + L + + + ++D P ++
Sbjct: 183 VWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMDAPDG-------CPPAVY 230
Query: 730 KFGETAEKCLADFGVDRPSMGDVLWNLEY 758
+ + C RPS + LE+
Sbjct: 231 EV---MKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-62
Identities = 60/294 (20%), Positives = 120/294 (40%), Gaps = 11/294 (3%)
Query: 482 ATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRH 539
++F++ +G G G V+K G +A K + + + + E+++L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
++V G E+ + E+M+ G+L L +G + + ++ I +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR 121
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
++HRDVK +NIL++ K+ DFG+S + ++ + G+ Y+ PE
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 175
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719
+ + +SD++S G+ L E+ R I P +E+ + ++ + P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDE 773
R E P + +++LE + +P E
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE-FQDFVNKCLIKNPAE 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-61
Identities = 83/302 (27%), Positives = 139/302 (46%), Gaps = 29/302 (9%)
Query: 485 NFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRH 539
+F+E VIG G FG VY G L D AVK N + G +++F TE ++ F H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 540 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598
+++SL+G C + +++ YM++G L+ + + + + K + + A+G+ +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDP 656
+ K +HRD+ + N +LDE F KVADFGL++ E D H T K ++
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716
E + Q+ T KSDV+SFGV+L+E++ P VN + + +L Q
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGRRLLQ--- 255
Query: 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENST 776
+ PD L + KC RPS +++ + + +
Sbjct: 256 ----PEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYV 308
Query: 777 NL 778
N+
Sbjct: 309 NV 310
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (527), Expect = 2e-61
Identities = 77/307 (25%), Positives = 121/307 (39%), Gaps = 47/307 (15%)
Query: 484 NNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQ 536
NN + IG G FG+V++ T VAVK S A+FQ E ++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 537 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG----------------------S 574
F + ++V L+G C M L++EYM G L L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 575 GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634
G P LS ++L I A G+ YL + +HRD+ + N L+ EN + K+ADFGLS+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 694
D ++ PE + T +SDV+++GVVL+E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 248
Query: 695 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754
E + + G + + P L C + DRPS +
Sbjct: 249 -----EEVIYYVRDGNILACPENC------PLELYNL---MRLCWSKLPADRPSFCSIHR 294
Query: 755 NLEYALQ 761
L+ +
Sbjct: 295 ILQRMCE 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-61
Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 21/274 (7%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+ +G G FG+V+ G N T+VA+K P F E +++ + RH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
L + + ++ EYM G+L L G L Q +++ A G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 663
+HRD+++ANIL+ EN + KVADFGL++ + ++ K + PE +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 664 LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 723
T KSDV+SFG++L E+ V P + ++ ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQVERGYRMPC 235
Query: 724 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
P+ + +C +RP+ + LE
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 1e-60
Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 36/305 (11%)
Query: 474 FPFVAVQEATNNFDESW---------VIGIGGFGKVYKGELNDGTK----VAVKRGNPR- 519
F F EA F + VIG G FG+V G L K VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 520 SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSL 579
+++ +F +E ++ QF H +++ L G + +++I E+MENG+L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125
Query: 580 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639
+ Q + + G A G+ YL +HRD+ + NIL++ N + KV+DFGLS+ +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 640 QTHVSTAV---KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV 696
T+ K + PE + ++ T SDV+S+G+V++EV+ P +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERPYWDM 237
Query: 697 NLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 756
+ + +L +D P +L + C RP G ++ L
Sbjct: 238 TNQDVINAIEQDYRLPPPMD-------CPSALHQL---MLDCWQKDRNHRPKFGQIVNTL 287
Query: 757 EYALQ 761
+ ++
Sbjct: 288 DKMIR 292
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-59
Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 26/290 (8%)
Query: 484 NNFDESWVIGIGGFGKVYKGELNDGT-----KVAVKRGNP-RSQQGLAEFQTEIEMLSQF 537
+ VIG G FG+VYKG L + VA+K +++ +F E ++ QF
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 538 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 597
H +++ L G + M++I EYMENG S Q + + G A G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDP 656
L +HRD+ + NIL++ N + KV+DFGLS+ + + T+ ++ K + P
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 657 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716
E ++ T SDV+SFG+V++EV+ L ++ + I+
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAIN 227
Query: 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 766
D + +C RP D++ L+ ++ +++
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-59
Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 25/271 (9%)
Query: 492 IGIGGFGKVYKGEL---NDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIG 547
+G G FG V +G VA+K +++ E E +++ Q + ++V LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
C + ++L+ E G L L G + E+ + G+ YL K +
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFV 131
Query: 608 HRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 666
HRD+ + N+LL AK++DFGLSK G + +A K + PE ++ +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 667 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 726
+SDV+S+GV ++E L P + + E + +++ P P
Sbjct: 192 RSDVWSYGVTMWEALSYG-----QKPYKKMKGPEVMAFIEQGKRME--CPPEC-----PP 239
Query: 727 SLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
L C DRP V +
Sbjct: 240 ELYAL---MSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 9e-59
Identities = 64/269 (23%), Positives = 112/269 (41%), Gaps = 26/269 (9%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
+G G FGKVYK + A K + +S++ L ++ EI++L+ H ++V L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+N + ++ E+ G + + P L+ Q +C + L+YLH +IHR
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF-----RRQQL 664
D+K+ NIL + K+ADFG+S Q + G+ ++ PE + +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 665 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724
K+DV+S G+ L E+ P P +N +K
Sbjct: 193 DYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLKIAKSEPPTLAQPSRW----- 241
Query: 725 PDSLRKFGETAEKCLADFGVDRPSMGDVL 753
+ + F +KCL R + +L
Sbjct: 242 SSNFKDF---LKKCLEKNVDARWTTSQLL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-58
Identities = 83/324 (25%), Positives = 139/324 (42%), Gaps = 44/324 (13%)
Query: 473 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDG---TKVAVKRGNPR-SQQGLAEFQ 528
+P + N+ VIG G FG+V K + A+KR S+ +F
Sbjct: 3 IYPVLDW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 529 TEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-------------- 573
E+E+L + H ++++L+G C+ + + L EY +G L L
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 574 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633
S +LS +Q L ARG+ YL K IHRD+ + NIL+ EN++AK+ADFGLS+
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR 693
+ T + ++ E T SDV+S+GV+L+E++ P
Sbjct: 176 GQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPY 227
Query: 694 EMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
+ AE K +L++ ++ D + +C + +RPS +L
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNC-------DDEVYDL---MRQCWREKPYERPSFAQIL 277
Query: 754 WNLEYALQLQEAVVHGDPDENSTN 777
+L L+ ++ V+ E T
Sbjct: 278 VSLNRMLEERKTYVNTTLYEKFTY 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-58
Identities = 62/295 (21%), Positives = 112/295 (37%), Gaps = 41/295 (13%)
Query: 491 VIGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQF-RHRHL 542
+G G FGKV + + VAVK P + +E+++LS H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP----------------SLSWKQRLE 586
V+L+G C ++I EY G L L +L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 587 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 646
A+G+ +L + K IHRD+ + NILL + K+ DFGL++ V
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 647 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706
+ ++ PE T +SDV+S+G+ L+E+ P +P +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------------ 254
Query: 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761
+ ++I + + + + C + RP+ ++ +E +
Sbjct: 255 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 6e-58
Identities = 63/273 (23%), Positives = 105/273 (38%), Gaps = 27/273 (9%)
Query: 491 VIGIGGFGKVYKGELND---GTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFRHRHLVSL 545
+G G FG V KG VAVK + E E ++ Q + ++V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
IG C E +L+ E E G L +L + + K +E+ + G+ YL
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SN 127
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
+HRD+ + N+LL AK++DFGLSK + + T K + PE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 665 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 724
+ KSDV+SFGV+++E + + ++ +++
Sbjct: 188 SSKSDVWSFGVLMWEAFSYG---------------QKPYRGMKGSEVTAMLEKGERMGCP 232
Query: 725 PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 757
R+ + C +RP V L
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 7e-58
Identities = 67/322 (20%), Positives = 119/322 (36%), Gaps = 57/322 (17%)
Query: 476 FVAVQEATNNFDESW-----------VIGIGGFGKVYKGELND------GTKVAVKRGNP 518
+ V +D W V+G G FGKV +VAVK
Sbjct: 18 YFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 77
Query: 519 RSQQG-LAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--- 573
++ +E++M++Q H ++V+L+G C + LI+EY G L +L
Sbjct: 78 KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKRE 137
Query: 574 ------------------SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSAN 615
L L+++ L A+G+ +L K+ +HRD+ + N
Sbjct: 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN 194
Query: 616 ILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 675
+L+ + K+ DFGL++ V + ++ PE T KSDV+S+G+
Sbjct: 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 254
Query: 676 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETA 735
+L+E+ P +P + ++I + +
Sbjct: 255 LLWEIFSLGVNPYPGIPVD--------------ANFYKLIQNGFKMDQPFYATEEIYIIM 300
Query: 736 EKCLADFGVDRPSMGDVLWNLE 757
+ C A RPS ++ L
Sbjct: 301 QSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-57
Identities = 69/276 (25%), Positives = 112/276 (40%), Gaps = 32/276 (11%)
Query: 486 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHL 542
FD IG G F VYKG + +VA R ++ F+ E EML +H ++
Sbjct: 13 FDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 543 VSLIGYC----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598
V K ++L+ E M +GTLK +L + K C +GL +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFL 128
Query: 599 HTGYAKAVIHRDVKSANILL-DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 657
HT +IHRD+K NI + K+ D GL+ + + + AV G+ ++ PE
Sbjct: 129 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPE 183
Query: 658 YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717
+ ++ E DVY+FG+ + E+ + P A + G D
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEY------PYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
+++ E C+ +R S+ D+L
Sbjct: 237 VA-----IPEVKEI---IEGCIRQNKDERYSIKDLL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (498), Expect = 4e-57
Identities = 64/275 (23%), Positives = 105/275 (38%), Gaps = 33/275 (12%)
Query: 486 FDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQG---LAEFQTEIEMLSQFRHRH 541
F + IG G FG VY + + VA+K+ + +Q + E+ L + RH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+ G ++ L+ EY L + + G+ +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH-- 132
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR- 660
+ +IHRDVK+ NILL E + K+ DFG + + + G+ ++ PE
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEVILA 185
Query: 661 --RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718
Q K DV+S G+ E+ +P + + + Q P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNESPA 233
Query: 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
L + R F + CL DRP+ +L
Sbjct: 234 LQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 5e-57
Identities = 68/330 (20%), Positives = 124/330 (37%), Gaps = 32/330 (9%)
Query: 486 FDESWVIGIGGFGKVYKGELND-----GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRH 539
F + V+G G FG VYKG VA+K S + E E +++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
H+ L+G C LI + M G L ++ + L C+ A+G++YL
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ ++HRD+ + N+L+ K+ DFGL+K ++ + + K ++ E
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719
+ T +SDV+S+GV ++E++ +P ++ I++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------------EISSILEKGE 230
Query: 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLI 779
P KC RP +++ + + + DE
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL-- 288
Query: 780 GELSPQIHNFSQVDTSVNAAAQSDVSAVDD 809
SP NF + ++ DV D+
Sbjct: 289 --PSPTDSNFYR--ALMDEEDMDDVVDADE 314
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-56
Identities = 63/282 (22%), Positives = 105/282 (37%), Gaps = 28/282 (9%)
Query: 475 PFVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNP-RSQQGLAEFQTEIE 532
PFV ++D +G G +G+V VAVK + R+ + EI
Sbjct: 2 PFV------EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 55
Query: 533 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 592
+ H ++V G+ E N L EY G L + +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLM 113
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 652
G+ YLH + HRD+K N+LLDE K++DFGL+ ++ + + G+
Sbjct: 114 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 653 YLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711
Y+ PE +R++ E DV+S G+VL +L D + + + W+ K
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEYSDWKEKKTY 225
Query: 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
+ K L + R ++ D+
Sbjct: 226 LNPWKKI------DSAPLAL---LHKILVENPSARITIPDIK 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-56
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 27/278 (9%)
Query: 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRH 541
+++ + IG G +G+ K +DG + K + S + +E+ +L + +H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 542 LVSLIGYCDEKNE--MILIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHY 597
+V ++ + ++ EY E G L + L + L + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 598 LH--TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 655
H + V+HRD+K AN+ LD K+ DFGL++ T + A G+ Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMS 182
Query: 656 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715
PE R EKSD++S G +L+E+ P P + E A K + G+ +I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP------PFTAFSQKELAGKIRE-GKFRRIP 235
Query: 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
D L + + L RPS+ ++L
Sbjct: 236 YRY------SDELNEI---ITRMLNLKDYHRPSVEEIL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-56
Identities = 73/280 (26%), Positives = 117/280 (41%), Gaps = 26/280 (9%)
Query: 491 VIGIGGFGKVYKGEL----NDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSL 545
IG G FG V++G N VA+K + + E F E + QF H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 546 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 605
IG E N + +I E G L+ SL + + L YL + K
Sbjct: 74 IGVITE-NPVWIIMELCTLGELR-SFLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 606 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
+HRD+ + N+L+ N K+ DFGLS+ + + ++ K ++ PE ++ T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFT 187
Query: 666 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725
SDV+ FGV ++E+L P + V + + +N +L + P P
Sbjct: 188 SASDVWMFGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGERLP--MPPNC-----P 235
Query: 726 DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 765
+L KC A RP ++ L L+ ++A
Sbjct: 236 PTLYSL---MTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 6e-56
Identities = 67/274 (24%), Positives = 105/274 (38%), Gaps = 30/274 (10%)
Query: 484 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRH 539
+F+ +G G FG VY +A+K + + + E+E+ S RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
+++ L GY + + LI EY GT+ L ++ A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH 123
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ K VIHRD+K N+LL K+ADFG S P T + G+ YL PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMI 176
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719
+ EK D++S GV+ +E L +P + +E + + +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-----RVEFTFPDFVTEGA 231
Query: 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
I + L RP + +VL
Sbjct: 232 RDLIS------------RLLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 23/264 (8%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
IG G G VY ++ G +VA+++ N + Q EI ++ + ++ ++V+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+E+ ++ EY+ G+L + + + Q +C + L +LH + VIHR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 610 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 669
D+KS NILL + K+ DFG + + + G+ ++ PE R+ K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 670 VYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLR 729
++S G++ E++ P P N G + L R
Sbjct: 199 IWSLGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPELQNPEKL-----SAIFR 247
Query: 730 KFGETAEKCLADFGVDRPSMGDVL 753
F +CL R S ++L
Sbjct: 248 DF---LNRCLDMDVEKRGSAKELL 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 74/296 (25%), Positives = 131/296 (44%), Gaps = 42/296 (14%)
Query: 491 VIGIGGFGKVYKGEL--------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHR 540
+G G FG+V E N TKVAVK +++ L++ +E+EM+ +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLE 586
++++L+G C + + +I EY G L+ +L P LS K +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 587 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 646
ARG+ YL +K IHRD+ + N+L+ E+ + K+ADFGL++ ID +T
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 647 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706
+ ++ PE + T +SDV+SFGV+L+E+ P +P E
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------------ 244
Query: 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762
+L +++ + + C RP+ ++ +L+ + L
Sbjct: 245 ---ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 33/293 (11%)
Query: 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQ 536
S +G G FG VY+G T+VA+K N S + EF E ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 537 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG--------LPSLSWKQRLEIC 588
F H+V L+G + ++I E M G LK +L L S + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 589 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 648
A G+ YL+ A +HRD+ + N ++ E+F K+ DFG+++ E D
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 649 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708
++ PE + T SDV+SFGVVL+E+ P + ++ +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVLRFVMEG 251
Query: 709 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761
G LD+ + PD L + C RPS +++ +++ ++
Sbjct: 252 GLLDKPDN-------CPDMLFEL---MRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-53
Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 30/281 (10%)
Query: 491 VIGIGGFGKVYKGELN----DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLV 543
+G G FG V +GE + VAVK P + + +F E+ + HR+L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
L G M ++ E G+L L + A G+ YL +
Sbjct: 75 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---S 129
Query: 604 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDPEYFRRQ 662
K IHRD+ + N+LL + K+ DFGL + P+ D +V K F + PE + +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 663 QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722
+ SD + FGV L+E+ P +N ++ K +G+ +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYG-----QEPWIGLNGSQILHKIDKEGERLPRPEDC---- 240
Query: 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763
P + +C A DRP+ + ++ L+ Q
Sbjct: 241 --PQDIYNV---MVQCWAHKPEDRPTFVAL---RDFLLEAQ 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-52
Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 9/205 (4%)
Query: 485 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHR 540
+F ++G G F V EL + A+K R + + E +++S+ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 600
V L + ++ Y +NG L ++ G S L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH- 125
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
K +IHRD+K NILL+E+ ++ DFG +K + + + G+ Y+ PE
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARP 685
+ + SD+++ G ++++++ P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (466), Expect = 3e-52
Identities = 58/273 (21%), Positives = 106/273 (38%), Gaps = 23/273 (8%)
Query: 484 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 542
+++D +G G FG V++ E G A K + + EI+ +S RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 543 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
V+L ++ NEM++IYE+M G L + +S + +E +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHE-- 142
Query: 603 AKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
+H D+K NI+ + K+ DFGL+ +D G+ + PE
Sbjct: 143 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 198
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720
+ + +D++S GV+ + +L E + + +D +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-----SCDWNMDDSAFSGI- 252
Query: 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
+ + F K L R ++ L
Sbjct: 253 ----SEDGKDF---IRKLLLADPNTRMTIHQAL 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-51
Identities = 62/294 (21%), Positives = 116/294 (39%), Gaps = 40/294 (13%)
Query: 491 VIGIGGFGKVYKG------ELNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRH-L 542
+G G FG+V + + VAVK + +E+++L H +
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 543 VSLIGYCDEKNEMILI-YEYMENGTLKGHLYGSGLPS--------------LSWKQRLEI 587
V+L+G C + +++ E+ + G L +L L+ + +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 588 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 647
A+G+ +L + + IHRD+ + NILL E + K+ DFGL++ +
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 648 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 707
+ ++ PE + T +SDV+SFGV+L+E+ P V + E +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCRRLK 251
Query: 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761
+G + D T + + C RP+ +++ +L LQ
Sbjct: 252 EGTRMRAPDYT------TPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-49
Identities = 55/335 (16%), Positives = 128/335 (38%), Gaps = 37/335 (11%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
+G G FG V++ E + K + + EI +L+ RHR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
+ E+++I+E++ + + S L+ ++ + L +LH + + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 610 DVKSANILLD--ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
D++ NI+ + K+ +FG ++ ++ + + Y PE + ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 668 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727
+D++S G +++ +L ++++ + D+ +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIE-----NIMNAEYTFDEEAFKEI-----SIE 233
Query: 728 LRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIH 787
F ++ L R + + LQ + + ST +I L + +
Sbjct: 234 AMDF---VDRLLVKERKSRMTASEA---------LQHPWLKQKIERVSTKVIRTLKHRRY 281
Query: 788 NFS----QVDTSVNAAAQSDVSAVDDISGVSMSRV 818
+ ++ V+AA S A+ GVS+++V
Sbjct: 282 YHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKV 316
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (443), Expect = 6e-49
Identities = 54/266 (20%), Positives = 105/266 (39%), Gaps = 23/266 (8%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
+G G FG V++ E G K N + EI +++Q H L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 609
++K EM+LI E++ G L + +S + + + GL ++H +++H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 610 DVKSANILLD--ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
D+K NI+ + + K+ DFGL+ +++ + + + PE R+ +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 668 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 727
+D+++ GV+ + +L E QN + D D +
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLET---------LQNVKRCDWEFDEDAFSSV-SPE 258
Query: 728 LRKFGETAEKCLADFGVDRPSMGDVL 753
+ F + L R ++ D L
Sbjct: 259 AKDF---IKNLLQKEPRKRLTVHDAL 281
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (432), Expect = 2e-48
Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 28/277 (10%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVSLI 546
++G GG +V+ L VAVK R F+ E + + H +V++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 547 GYCDEKNE----MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 602
+ + ++ EY++ TL+ ++ G ++ K+ +E+ + + L++ H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--- 128
Query: 603 AKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRR 661
+IHRDVK ANI++ KV DFG+++ + + AV G+ YL PE R
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 662 QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721
+ +SDVYS G VL+EVL P P + A + + I P+
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEP------PFTGDSPVSVAYQHVRED----PIPPSARH 238
Query: 722 KIRPDSLRKFGETAEKCLADFGVDRP-SMGDVLWNLE 757
+ L K LA +R + ++ +L
Sbjct: 239 EGLSADLDAV---VLKALAKNPENRYQTAAEMRADLV 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 4e-46
Identities = 58/268 (21%), Positives = 108/268 (40%), Gaps = 26/268 (9%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGY 548
V+G G F +V E VA+K ++ +G + EI +L + +H ++V+L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
+ + LI + + G L + G + + + + YLH ++H
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLG---IVH 130
Query: 609 RDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 665
RD+K N+L DE+ ++DFGLSK D V + G+ GY+ PE ++ +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 666 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 725
+ D +S GV+ + +LC P ++ + + + + D +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKL-----FEQILKAEYEFDSPYWDDI-----S 237
Query: 726 DSLRKFGETAEKCLADFGVDRPSMGDVL 753
DS + F + R + L
Sbjct: 238 DSAKDF---IRHLMEKDPEKRFTCEQAL 262
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (422), Expect = 5e-46
Identities = 73/357 (20%), Positives = 132/357 (36%), Gaps = 36/357 (10%)
Query: 484 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNP---RSQQGLAEFQTE---IEMLSQ 536
N+F +IG GGFG+VY D G A+K + + +QG E + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 537 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 596
+V + +++ I + M G L HL G+ S GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLE 121
Query: 597 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 656
++H + V++RD+K ANILLDE+ +++D GL+ + G+ GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 174
Query: 657 EYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715
E ++ +D +S G +LF++L ++ + M +L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTLTMAVELPDSF 232
Query: 716 DPTLAGKIR------PDS-LRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH 768
P L + + L G A++ P + W + + + ++
Sbjct: 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES-----PFFRSLDWQMVFLQKYPPPLI- 286
Query: 769 GDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKS 825
P N I +F + DT SD + R ++ ++
Sbjct: 287 --PPRGEVNAADAF--DIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAET 339
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (410), Expect = 2e-45
Identities = 57/286 (19%), Positives = 106/286 (37%), Gaps = 38/286 (13%)
Query: 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRS---------QQGLAEFQTEIEML 534
N++ ++G G V + + AVK + Q+ E+++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 535 SQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 593
+ H +++ L + L+++ M+ G L +L +LS K+ +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLE 121
Query: 594 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 653
+ LH ++HRD+K NILLD++ K+ DFG S ++D V G+ Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSY 175
Query: 654 LDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 707
L PE ++ D++S GV+++ +L P M+ M
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-----MIMSG 230
Query: 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
Q D+++ + L R + + L
Sbjct: 231 NYQFGSPEWDDY-----SDTVKDL---VSRFLVVQPQKRYTAEEAL 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-44
Identities = 65/294 (22%), Positives = 115/294 (39%), Gaps = 29/294 (9%)
Query: 482 ATNNFDESWVIGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQGLAEFQTEIE-----ML 534
A ++ IG G +GKV+K N G VA+KR ++ + T E L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 535 SQFRHRHLVSLIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 589
F H ++V L C D + ++ L++E+++ +L P + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMF 123
Query: 590 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 649
RGL +LH+ V+HRD+K NIL+ + K+ADFGL++ T+V
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVV 177
Query: 650 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM------ 703
+ Y PE + D++S G + E+ +P+ + + + +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETA----EKCLADFGVDRPSMGDVL 753
W L + + + + + E KCL R S L
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (401), Expect = 1e-43
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 14/218 (6%)
Query: 484 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 539
+F +G G FG+V+ ++G A+K + + E MLS H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
++ + G + ++ +I +Y+E G L L S + + L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLH 121
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ K +I+RD+K NILLD+N K+ DFG +K P++ T G+ Y+ PE
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 173
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 697
+ + D +SFG++++E+L + +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-43
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 12/219 (5%)
Query: 484 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLS-QFR 538
+F ++G G FGKV+ E A+K + + E +LS +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 539 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 598
H L + K + + EY+ G L H+ + GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFL 119
Query: 599 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
H+ K +++RD+K NILLD++ K+ADFG+ K D G+ Y+ PE
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 697
Q+ D +SFGV+L+E+L + E+ +
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-42
Identities = 52/272 (19%), Positives = 110/272 (40%), Gaps = 29/272 (10%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ-FRHRHLVSLIGY 548
V+G+G GKV + K A+K + + E+E+ + + H+V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 549 CD----EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
+ + ++++ E ++ G L + G + + ++ EI + YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 605 AVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
+ HRDVK N+L N + K+ DFG +K E + T + Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 662 QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721
++ + D++S GV+++ +LC P P + + + + ++ Q P
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP------PFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
+ ++ L R ++ + +
Sbjct: 242 SEVSEEVKML---IRNLLKTEPTQRMTITEFM 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 2e-42
Identities = 48/281 (17%), Positives = 92/281 (32%), Gaps = 26/281 (9%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 549
IG G FG +Y G + G +VA+K +++ + E ++ + + I +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 550 -DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
E + +++ E + + S S K L + + Y+H +K IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 609 RDVKSANIL---LDENFMAKVADFGLSK-----TGPEIDQTHVSTAVKGSFGYLDPEYFR 660
RDVK N L + + + DFGL+K + + + G+ Y
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 661 RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720
+ + + D+ S G VL E + + ++ +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY-- 244
Query: 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761
P + C + D+P +
Sbjct: 245 ----PSEFATY---LNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 59/281 (20%), Positives = 112/281 (39%), Gaps = 25/281 (8%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAE-----FQTEIEMLSQFRHRHLVS 544
+G G F VYK N VA+K+ + + EI++L + H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 545 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 604
L+ K+ + L++++ME + L+ + + +GL YLH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 605 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 664
++HRD+K N+LLDEN + K+ADFGL+K+ ++ + T + Y PE ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARM 177
Query: 665 -TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM------KWQNKGQL-DQIID 716
D+++ G +L E+L P + + + + +W + L D +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 717 PTLAGKIRPDSLRKFGETA----EKCLADFGVDRPSMGDVL 753
+ G G+ + R + L
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 5e-42
Identities = 53/277 (19%), Positives = 102/277 (36%), Gaps = 20/277 (7%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 548
IG G +G VYK + N G A+K R + + EI +L + +H ++V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
K ++L++E+++ K G L + G+ Y H + V+H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 609 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 668
RD+K N+L++ K+ADFGL++ + + + ++ +
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 669 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 728
D++S G + E++ P+ + + + N + +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 729 RKFGETAEKCLADFGVD------------RPSMGDVL 753
E+ K L + G+D R + L
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 20/284 (7%)
Query: 485 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRH 541
NF + IG G +G VYK G VA+K R + ++ + EI +L + H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+V L+ +N++ L++E++ K + S L + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
+ V+HRD+K N+L++ K+ADFGL++ + V +
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGC 177
Query: 662 QQLTEKSDVYSFGVVLFEVLCARPVIDPT--------LPREMVNLAEWAMKWQNKGQLDQ 713
+ + D++S G + E++ R + + R + E +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 714 IIDPTLAGKIRPDSLRKFGETA----EKCLADFGVDRPSMGDVL 753
P A + + E + L R S L
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-41
Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 22/292 (7%)
Query: 481 EATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFR 538
+ + IG G +G V + + +VA+K+ +P Q + EI++L +FR
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 539 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHY 597
H +++ + + Y+ + LY LS RGL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 598 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDP 656
+H+ V+HRD+K +N+LL+ K+ DFGL++ P+ D T T + Y P
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 657 EYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715
E + T+ D++S G +L E+L RP+ + +N + ++ L+ II
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 716 --------------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
+ ++ P++ K + +K L R + L
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 58/274 (21%), Positives = 110/274 (40%), Gaps = 32/274 (11%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQFRHRHLV 543
+G G F V K E + G + A K + R + + E+ +L + +H +++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 544 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 603
+L + K ++ILI E + G L L SL+ ++ E G++YLH+
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS--- 131
Query: 604 KAVIHRDVKSANILLDENFMA----KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ H D+K NI+L + + K+ DFGL+ +ID + + G+ ++ PE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIV 188
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719
+ L ++D++S GV+ + +L +E A + +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSAVNYEFEDEYFSNT 243
Query: 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
+ F + L R ++ D L
Sbjct: 244 -----SALAKDF---IRRLLVKDPKKRMTIQDSL 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (372), Expect = 4e-40
Identities = 44/283 (15%), Positives = 86/283 (30%), Gaps = 28/283 (9%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR-HLVSLIGY 548
IG G FG +++G L + +VA+K RS + + E + ++ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 549 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 608
E +L+ + + G L S K + +H K++++
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 609 RDVKSANILLDENFM-----AKVADFGLSK-----TGPEIDQTHVSTAVKGSFGYLDPEY 658
RD+K N L+ V DFG+ K + + G+ Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 659 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718
++ + + D+ + G V L K++ G+ Q
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN------KQKYERIGEKKQSTPLR 238
Query: 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761
P+ K+ P + L+
Sbjct: 239 ELCAGFPEEFYKY---MHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-40
Identities = 62/316 (19%), Positives = 113/316 (35%), Gaps = 36/316 (11%)
Query: 459 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGN 517
S TT A G P ++ ++ VIG G FG VY+ +L + G VA+K+
Sbjct: 1 SKVTTVVATPGQGPDRPQ------EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 54
Query: 518 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE------MILIYEYMENGTLKGHL 571
+ E++++ + H ++V L + E + L+ +Y+ +
Sbjct: 55 QDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 572 -YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADF 629
Y +L R L Y+H + + HRD+K N+LLD + + K+ DF
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 630 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDP 689
G +K + + + + F T DV+S G VL E+L +P+
Sbjct: 168 GSAK--QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 690 TLPREMVNLAEWAM------------KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEK 737
+ + + + + QI RP + + +
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 738 CLADFGVDRPSMGDVL 753
L R + +
Sbjct: 286 LLEYTPTARLTPLEAC 301
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-40
Identities = 50/239 (20%), Positives = 89/239 (37%), Gaps = 32/239 (13%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQFRHRH-- 541
++G GGFG VY G ++D VA+K + E+ +L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 542 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
++ L+ + + + +LI E E L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128
Query: 602 YAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 660
V+HRD+K NIL+D N K+ DFG + + V T G+ Y PE+ R
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPPEWIR 182
Query: 661 RQQL-TEKSDVYSFGVVLFEVLCARP-------------VIDPTLPREMVNLAEWAMKW 705
+ + V+S G++L++++C + E +L W +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 241
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 11/219 (5%)
Query: 484 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRH 539
N+FD ++G G FGKV G A+K + ++ +A TE +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
L +L + + + EY G L HL + ++ L YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ + V++RD+K N++LD++ K+ DFGL K G T G+ YL PE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVL 177
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 698
D + GVV++E++C R + L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 60/299 (20%), Positives = 121/299 (40%), Gaps = 34/299 (11%)
Query: 484 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFRHR 540
+ +++ IG G FG+V+K G KVA+K+ +++ EI++L +H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 541 HLVSLIGYCDE--------KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 592
++V+LI C K + L++++ E+ +LS +R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGS 650
L+ L+ + ++HRD+K+AN+L+ + + K+ADFGL++ + + Q + T +
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 651 FGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 709
Y PE ++ D++ G ++ E+ P++ + + L
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 710 QLDQIIDPTLAGKIR---------PDSLRKFGETAE------KCLADFGVDRPSMGDVL 753
+ + L K+ D L+ + K L R D L
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 2e-37
Identities = 55/287 (19%), Positives = 102/287 (35%), Gaps = 23/287 (8%)
Query: 484 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRH 539
+ FD +G G FG+V + G A+K + + + E +L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
LV L + + + ++ EY+ G + HL G S YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH 158
Query: 600 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 659
+ +I+RD+K N+L+D+ +V DFG +K T + G+ L PE
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEII 210
Query: 660 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719
+ + D ++ GV+++E+ P P ++ + K + + L
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE-KIVSGKVRFPSHFSSDLKDLL 269
Query: 720 AGKIRPDSLRKFG---ETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763
++ D ++FG W Y +++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNH-----KWFATTDWIAIYQRKVE 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-37
Identities = 56/279 (20%), Positives = 109/279 (39%), Gaps = 22/279 (7%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
IG G +G V+K + VA+K R + + + EI +L + +H+++V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 548 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 607
++ L++E+ + K +G + +GL + H+ + V+
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 608 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 667
HRD+K N+L++ N K+A+FGL++ I S V + F + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 668 SDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAM------KWQNKGQLDQIIDPTLA 720
D++S G + E+ A RP+ + + + +W + +L +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 721 GKIRP--DSLRKFGETA----EKCLADFGVDRPSMGDVL 753
+ + K T + L V R S + L
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 58/287 (20%), Positives = 106/287 (36%), Gaps = 36/287 (12%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
+G G +G V + G KVA+K +S+ E+ +L RH +++ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 548 YCDEKN------EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+ L+ +M GT G L L + + +GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH-- 138
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
A +IHRD+K N+ ++E+ K+ DFGL++ ++ V +
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNW 193
Query: 662 QQLTEKSDVYSFGVVLFEVLCARP---------------VIDPTLPREMVNLAEWAMKWQ 706
+ T+ D++S G ++ E++ + + T P E V +
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253
Query: 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
L ++ A I ++ EK L R + G+ L
Sbjct: 254 YMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 9e-32
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 17/213 (7%)
Query: 484 NNFDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNP----RSQQGLAEFQTEIEMLS 535
NF+ V+G G +GKV+ + G A+K + + +TE ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 536 QFRHR-HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 594
R LV+L + ++ LI +Y+ G L HL + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138
Query: 595 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
+ L + +I+RD+K NILLD N + DFGLSK + + G+ Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYM 197
Query: 655 DPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARP 685
P+ R + D +S GV+++E+L
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (308), Expect = 3e-31
Identities = 40/212 (18%), Positives = 88/212 (41%), Gaps = 20/212 (9%)
Query: 484 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRH 541
+++ +G G + +V++ + + KV VK P ++ + + EI++L R +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 542 LVSLIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 599
+++L + L++E++ N K +L+ + L Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCH 146
Query: 600 TGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 658
+ ++HRDVK N+++D E+ ++ D+GL++ S + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVRVASRYFKGPEL 200
Query: 659 FRRQQL-TEKSDVYSFGVVLFEVLCARPVIDP 689
Q+ D++S G +L ++ +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-31
Identities = 59/301 (19%), Positives = 110/301 (36%), Gaps = 53/301 (17%)
Query: 491 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 547
IG G G V + VA+K ++Q E+ ++ H++++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 548 YC------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 601
+E ++ L+ E M+ + ++ + G+ +LH+
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSA 138
Query: 602 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 661
+IHRD+K +NI++ + K+ DFGL++T + + T + Y PE
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILG 192
Query: 662 QQLTEKSDVYSFGVVLFEVLCARP----------------VIDPTLPREMVNLAEWAMKW 705
E D++S G ++ E++ + + P M L +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 706 -QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVD------------RPSMGDV 752
+N+ + + P K+ PDSL K A D R S+ D
Sbjct: 253 VENRPKYAGLTFP----KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 753 L 753
L
Sbjct: 309 L 309
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-30
Identities = 52/296 (17%), Positives = 101/296 (34%), Gaps = 34/296 (11%)
Query: 481 EATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQF 537
E + +G G +G V G +VAVK +S E+ +L
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 538 RHRHLVSLIGYCDEKN-----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 592
+H +++ L+ + + ++ L + L +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT---DDHVQFLIYQIL 131
Query: 593 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 652
RGL Y+H + +IHRD+K +N+ ++E+ K+ DFGL++ + +V+T +
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WY 184
Query: 653 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV---------------IDPTLPREMVN 697
+ D++S G ++ E+L R + + T E++
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 698 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 753
L Q+ A + + + EK L R + L
Sbjct: 245 KISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 1e-26
Identities = 51/299 (17%), Positives = 103/299 (34%), Gaps = 31/299 (10%)
Query: 491 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH---------- 539
+G G F V+ + + + T VA+K + + EI++L +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 540 -RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLY---GSGLPSLSWKQRLEICIGSARGL 595
H++ L+ + + K + + + L + +I GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 596 HYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 654
Y+H +IH D+K N+L++ + + ++ G T + Y
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 655 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714
PE +D++S ++FE++ + +P ++ + QI
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY---------TKDDDHIAQI 247
Query: 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDE 773
I+ L G++ P L + G+ G+ R W LE L + + E
Sbjct: 248 IE--LLGEL-PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 4e-19
Identities = 32/198 (16%), Positives = 60/198 (30%), Gaps = 36/198 (18%)
Query: 491 VIGIGGFGKVYKGELNDGTKVAVK----------RGNPRSQQGLAEFQTEIEMLSQFRHR 540
++G G V+ + VK + + G F ++ R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 541 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 600
L L G + +Y + N L + L + + E+ + +
Sbjct: 67 ALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 601 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP---- 656
+ ++H D+ N+L+ E + DF S V +G L+
Sbjct: 121 --HRGIVHGDLSQYNVLVSE-EGIWIIDFPQS----------VEVGEEGWREILERDVRN 167
Query: 657 --EYFRRQQLTEKSDVYS 672
YF R + D+ S
Sbjct: 168 IITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 828 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.66 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.38 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 94.36 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=426.59 Aligned_cols=272 Identities=26% Similarity=0.429 Sum_probs=209.7
Q ss_pred cCHHHHHHHhcCC---------CccceEeeeCcEEEEEEEecC-C---cEEEEEEcCCC-CcccHHHHHHHHHHHHcCCC
Q 003350 474 FPFVAVQEATNNF---------DESWVIGIGGFGKVYKGELND-G---TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRH 539 (828)
Q Consensus 474 ~~~~~l~~at~~f---------~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H 539 (828)
++++++..++.+| ...++||+|+||+||+|+++. + ..||||++... .....++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 3445555555444 455799999999999998752 2 36899987654 44556789999999999999
Q ss_pred CceEEEEEEEccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC
Q 003350 540 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619 (828)
Q Consensus 540 ~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld 619 (828)
||||+++|+|.+.+..++|||||++|+|.+++.... ..++|.+++.|+.|||+||+|||+ ++|+||||||+||||+
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVN 162 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEEC
Confidence 999999999999999999999999999999887543 469999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeeCCCCCCCCCCccc---eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhh
Q 003350 620 ENFMAKVADFGLSKTGPEIDQTH---VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREM 695 (828)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~ 695 (828)
.++++||+|||+++......... ......||+.|+|||++.++.++.++|||||||+||||+| |++||......+.
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~ 242 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999998754322211 1223468999999999999999999999999999999998 8999976654432
Q ss_pred hhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhh
Q 003350 696 VNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 765 (828)
Q Consensus 696 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~ 765 (828)
... . ..+ .....+.+++..+.+++.+||+.+|.+||+|.||++.|+++++....
T Consensus 243 ~~~------i-~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~s 296 (299)
T d1jpaa_ 243 INA------I-EQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296 (299)
T ss_dssp HHH------H-HTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred HHH------H-HcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhh
Confidence 211 1 111 11122345567789999999999999999999999999998875443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=419.69 Aligned_cols=256 Identities=28% Similarity=0.413 Sum_probs=203.4
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||+|++.+++.||||++.... ...++|.+|++++++++||||++++|+|...+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 3577778999999999999999888899999987644 345789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+++.... ..++|..++.|+.|+|+||+|||+ .+|+||||||+|||+|+++.+||+|||+++...... ...
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 158 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence 999999987654 468999999999999999999999 999999999999999999999999999998754422 222
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhc-CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....||+.|+|||++.+..++.|+|||||||++|||+|+ ++|+......+.... ... +. . ..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~------i~~-~~--~-------~~ 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED------IST-GF--R-------LY 222 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH------HHH-TC--C-------CC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH------HHh-cC--C-------CC
Confidence 3446799999999999999999999999999999999995 566654433222211 111 10 0 11
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.+..++.++.+++.+||+.+|.+||||+||++.|+++++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 123345678899999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=420.24 Aligned_cols=260 Identities=29% Similarity=0.519 Sum_probs=207.1
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...+.||+|+||.||+|++++ .||||+++.. +....++|.+|+++|++++|||||+++|++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 567788999999999999998753 5999998654 44567889999999999999999999999865 568999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|+|.+++.... ..++|.+++.|+.|||+||+|||+ ++||||||||+||||+.++.+||+|||+|+........
T Consensus 85 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999997544 469999999999999999999999 89999999999999999999999999999876543333
Q ss_pred ceeccccccccccChhhhcc---CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 642 HVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
.......||+.|+|||++.+ ..++.++|||||||+||||+||+.||....+.+... .....+. ..|.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~----~~p~ 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGRGY----LSPD 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHHTS----CCCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCC----CCCc
Confidence 44456789999999999964 358999999999999999999999997654333211 1111111 1111
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
+ ...+.+++..+.+++.+||+.+|.+||||.||++.|+.+.+
T Consensus 231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 12234456778999999999999999999999999987764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=418.26 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=211.0
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||+|++++++.||||++.... ...++|.+|+++|++++|||||+++|+|.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4677788999999999999999888999999987654 346789999999999999999999998865 56789999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+++......+++|.++++|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+|+.... .....
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~-~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTA 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS-SCEEC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC-Ccccc
Confidence 9999998876554569999999999999999999999 9999999999999999999999999999987654 22233
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCC-CCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP-VIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....||+.|+|||++.++.++.++|||||||++|||+||.. |+......+.. .. ...+ ..+ .
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~---~~----i~~~-----~~~----~ 230 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QN----LERG-----YRM----V 230 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HH----HHTT-----CCC----C
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHhc-----CCC----C
Confidence 455679999999999999999999999999999999999654 44443332221 11 1111 011 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.+...+..+.+++.+||+.+|.+||||.||++.|+....
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 223445678899999999999999999999999987653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-49 Score=420.99 Aligned_cols=257 Identities=27% Similarity=0.387 Sum_probs=215.0
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+|++. +++.||||++.... ...++|.+|+++|++++|||||+++|+|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356777889999999999999876 58899999987554 3467899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|+|.+++.......++|..++.|+.|+|+||+|||+ ++|+||||||+||||++++.+||+|||+|+.... +..
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS-SSS
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC-CCc
Confidence 999999999987666789999999999999999999999 8999999999999999999999999999997654 233
Q ss_pred ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCC-CChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDP-TLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
.......||+.|+|||++.+..++.|+|||||||++|||++|..|+.. ....+.. + ....+ ..
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~---~----~i~~~---------~~ 234 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---E----LLEKD---------YR 234 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H----HHHTT---------CC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH---H----HHhcC---------CC
Confidence 334556789999999999999999999999999999999997666543 3222211 1 11111 11
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
...+...+.++.+++.+||+.+|.+||||.||++.|+.+.
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1233445667899999999999999999999999887654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=409.85 Aligned_cols=262 Identities=29% Similarity=0.435 Sum_probs=205.6
Q ss_pred cCCCccceEeeeCcEEEEEEEecCC-----cEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDG-----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
..|...++||+|+||.||+|.++.. ..||||++... ......+|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3567778999999999999987632 47999998654 33445679999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
||||+.+|+|.+++.... ..++|.++++++.|+|+||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998876543 469999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCc-cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCC-CCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 638 IDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI-DPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 638 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
... ........||+.|+|||++.++.++.++|||||||++|||+||..|+ ......+.. .. ...+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~---~~----i~~~------ 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---KA----INDG------ 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HH----HHTT------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH---HH----Hhcc------
Confidence 222 22234457899999999999999999999999999999999965554 333322211 11 1111
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhhh
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 765 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~~ 765 (828)
.....+.+++..+.+++.+||+.+|.+||+|.||++.|+.+++..+.
T Consensus 230 ---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~ 276 (283)
T d1mqba_ 230 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276 (283)
T ss_dssp ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ---CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence 11123344567789999999999999999999999999988875443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=404.44 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=214.0
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888899999999999999998888999999876543 45789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|.+++.... ..+++..+++++.|+|+||+|||+ .+|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 157 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence 999999976544 468999999999999999999999 999999999999999999999999999998765422 223
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....||+.|+|||.+.+..++.|+|||||||++|||+| |+.||......+....+ ..+. . ..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-------~~~~--~-------~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------AQGL--R-------LY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------HTTC--C-------CC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-------HhCC--C-------CC
Confidence 345679999999999999999999999999999999998 89999866544432211 1111 0 11
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
.+...+..+.+++.+||+.+|.+|||++|+++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 223345678899999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=408.42 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=204.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|+..+.||+|+||+||+|+.. +|+.||||++.... .+..+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888899999999999999875 68999999876543 23456789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+++|+|.+++... ..+++.++..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+|+........
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999654 369999999999999999999999 99999999999999999999999999999876543334
Q ss_pred ceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
...+...||+.|+|||++.+..+ +.++|||||||++|||+||++||........ .... ...... .
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~----~~~~~~---------~ 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD----WKEKKT---------Y 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHH----HHTTCT---------T
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHH----HhcCCC---------C
Confidence 44556789999999999988876 5789999999999999999999975433221 1111 111110 0
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..........+.+++.+||+.+|.+|||+.|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111233456788999999999999999999853
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=406.55 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=210.1
Q ss_pred cCCCccc-eEeeeCcEEEEEEEec---CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESW-VIGIGGFGKVYKGELN---DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...+ .||+|+||.||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455555 4999999999999764 35579999987653 4456789999999999999999999999865 568999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++...+ ..+++.++++++.|+|+||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999886543 469999999999999999999999 99999999999999999999999999999876543
Q ss_pred Ccc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 639 DQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 639 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
... .......||+.|+|||++..+.++.++|||||||++|||+| |+.||......+.... ...+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-------i~~~~~----- 230 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGKR----- 230 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------HHTTCC-----
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCCC-----
Confidence 222 22334578999999999999999999999999999999998 8999986544332211 112111
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
...++.++.++.+++.+||+.+|.+||+|.+|++.|+....
T Consensus 231 ----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 231 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12234556778899999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=404.26 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=202.3
Q ss_pred ceEeeeCcEEEEEEEecC---CcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEeccC
Q 003350 490 WVIGIGGFGKVYKGELND---GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 564 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~~ 564 (828)
++||+|+||.||+|.+++ ++.||||++... +....++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999997643 468999998654 23345789999999999999999999999965 567899999999
Q ss_pred CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc-ce
Q 003350 565 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-HV 643 (828)
Q Consensus 565 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~-~~ 643 (828)
|+|.+++.... .++|.++++|+.|||+||+|||+ .+|+||||||+||||+.++.+||+|||+++........ ..
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999987543 69999999999999999999999 89999999999999999999999999999875442222 22
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....||+.|+|||.+.+..++.++|||||||++|||+| |++||......+.... ...+. ...
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-------i~~~~---------~~~ 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGE---------RMG 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC---------CCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-------HHcCC---------CCC
Confidence 334679999999999999999999999999999999998 8999986554332211 11111 112
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
.+..++.++.+++.+||+.+|.+||+|++|++.|+...
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 23445667889999999999999999999998887754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=402.86 Aligned_cols=245 Identities=27% Similarity=0.390 Sum_probs=207.3
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999875 5889999987542 2234677899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++.... .+++.++..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999996543 69999999999999999999999 99999999999999999999999999999875431
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......||+.|+|||++.+..++.++|||||||+||||++|+.||......+.... .. ... .
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~-~~~------~-- 221 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR------IS-RVE------F-- 221 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HH-TTC------C--
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH------HH-cCC------C--
Confidence 23456799999999999999999999999999999999999999986554332211 11 111 1
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.++...+.++.+++.+||+.+|.+|||+.|+++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122334567889999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=405.31 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=208.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
++|...+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46888899999999999999864 68999999987665556778999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++++||+|||+|+..... ..
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS 171 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccc--cc
Confidence 999999987653 59999999999999999999999 99999999999999999999999999999875432 22
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
......||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .....+. +.+ .
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~------~~~--~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT------PEL--Q 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS------CCC--S
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCC------CCC--C
Confidence 2345679999999999999999999999999999999999999997654433211 1111111 011 1
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+......+.+++.+||+.+|.+|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22344567889999999999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=415.88 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=208.6
Q ss_pred cCCCccceEeeeCcEEEEEEEecC------CcEEEEEEcCCC-CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (828)
++|...++||+|+||+||+|+... ...||||.+... .......|.+|+.+|.++ +|||||+++++|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568888999999999999998642 236999987654 334456789999999998 899999999999999999
Q ss_pred EEEEEeccCCcccccccCCC---------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecC
Q 003350 556 ILIYEYMENGTLKGHLYGSG---------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 614 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~ 614 (828)
++|||||++|+|.++|.... ...++|.+++.|+.|+++||+|||+ ++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 99999999999999996542 1358999999999999999999999 99999999999
Q ss_pred cEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChh
Q 003350 615 NILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPR 693 (828)
Q Consensus 615 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~ 693 (828)
|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||+||||+| |++||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987554333334456678999999999999999999999999999999997 89999764432
Q ss_pred hhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHH
Q 003350 694 EMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY 758 (828)
Q Consensus 694 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~ 758 (828)
+. +.. ....+ .....+..++..+.+++.+||+.+|.+||||+||++.|..
T Consensus 274 ~~--~~~----~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 AN--FYK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HH--HHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--HHH----HHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 22 111 11111 1112233456678999999999999999999999999853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=405.33 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=204.6
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEecc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 563 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~~ 563 (828)
++|...+.||+|+||.||+|++++++.||||++.... ...++|.+|+.+|++++|||||+++|+|.+ ++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4688889999999999999999888899999987553 346789999999999999999999999954 56899999999
Q ss_pred CCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccce
Q 003350 564 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 643 (828)
Q Consensus 564 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~~ 643 (828)
+|+|..++.......++|.+++.|+.|||.||+|||+ .+|+||||||+|||||.++++||+|||+++..... ....
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC-Ccee
Confidence 9999999876555579999999999999999999999 89999999999999999999999999999875432 2223
Q ss_pred eccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCC-CCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003350 644 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI-DPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 722 (828)
Q Consensus 644 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 722 (828)
.....||+.|+|||++..+.++.++|||||||++|||+||..|+ ......+... ++ ..+ ....
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~---~i----~~~---------~~~~ 234 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---QV----ERG---------YRMP 234 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HH----HTT---------CCCC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH---HH----Hhc---------CCCC
Confidence 34567999999999999999999999999999999999975554 4333322211 11 111 1112
Q ss_pred CChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 723 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 723 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
.+..++.++.+++.+||+.+|++||+|.+|+++|+...
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 33455667899999999999999999999988877633
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=403.21 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=195.1
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEcc--CCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 558 (828)
++|+..+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+++|++++||||+++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888899999999999999865 68999999986653 3446778999999999999999999999854 4568999
Q ss_pred EEeccCCcccccccCC--CCCCCChhhHHHHHHHHHHHHHHHHhcC--CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 559 YEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGY--AKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
|||+++|+|.+++... ....+++.+++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2357999999999999999999999832 23599999999999999999999999999987
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
... .........||+.|+|||++.+..++.++|||||||++|||+||++||......+... . ...+...
T Consensus 164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~------~-i~~~~~~-- 232 (269)
T d2java1 164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------K-IREGKFR-- 232 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------H-HHHTCCC--
T ss_pred ccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH------H-HHcCCCC--
Confidence 543 2223445789999999999999999999999999999999999999998655433211 1 1111111
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.++...+.++.+++.+||+.+|.+|||+.|+++
T Consensus 233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 122334567889999999999999999999964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=404.28 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=208.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
+.|+..+.||+|+||.||+|+.. +++.||||++........+.|.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35777889999999999999875 68899999988776677788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.+++.... ..+++.++..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+|+.... ...
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ 165 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC--Ccc
Confidence 9999999876533 369999999999999999999999 9999999999999999999999999999976422 112
Q ss_pred eeccccccccccChhhhc-----cCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 643 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
......||+.|+|||++. ...++.++|||||||++|||+||+.||....+.+... ..... .. +
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~------~i~~~-~~-----~ 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL------KIAKS-EP-----P 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHHS-CC-----C
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH------HHHcC-CC-----C
Confidence 234567999999999984 4568999999999999999999999998665443221 11111 11 1
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+ ..+...+..+.+++.+||+.+|.+|||+.|+++
T Consensus 234 ~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 112344567889999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-47 Score=409.31 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=214.4
Q ss_pred HHhcCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCCc-ccHHHHHHHHHHHHcCCCCceEEEEEEEccCC
Q 003350 481 EATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN 553 (828)
Q Consensus 481 ~at~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 553 (828)
...++|+..+.||+|+||.||+|+.+ +++.||||++..... +..++|.+|+++|++++||||++++++|...+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 34678999999999999999999864 357899999876543 34677999999999999999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCC----------------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeee
Q 003350 554 EMILIYEYMENGTLKGHLYGSG----------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 611 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDI 611 (828)
..++||||+++|+|.++++... ...++|.+++.|+.|+|.||+|||+ ++||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEE
Confidence 9999999999999999985321 2358999999999999999999999 99999999
Q ss_pred ecCcEEeCCCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcC-CCCCCC
Q 003350 612 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVIDPT 690 (828)
Q Consensus 612 kp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~-~p~~~~ 690 (828)
||+|||||.++++||+|||+++...........+...||+.|+|||.+.+..++.|+|||||||++|||++|. +||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999998654333333445677899999999999999999999999999999999995 677765
Q ss_pred ChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 691 LPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 691 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
.+.+.... ..++... ..+...+.++.+++.+||+.+|.+||||.||+++|+++.
T Consensus 247 ~~~e~~~~-------v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEEVIYY-------VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHHHHHH-------HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHHHHHH-------HHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 54443221 1122111 123345567899999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=397.14 Aligned_cols=251 Identities=29% Similarity=0.430 Sum_probs=201.5
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEcc-CCcEEEEEEec
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNEMILIYEYM 562 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~ey~ 562 (828)
++|...+.||+|+||.||+|+++ |+.||||+++... ..++|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 35666789999999999999986 7899999986543 45789999999999999999999999854 56789999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
++|+|.++|.......++|..+++|+.|||.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC-----
Confidence 99999999976544568999999999999999999999 9999999999999999999999999999986433
Q ss_pred eeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003350 643 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 721 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 721 (828)
......+|..|+|||++.++.++.++|||||||++|||+| |++|+......+. ..++ ..+ ...
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i----~~~---------~~~ 219 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKG---------YKM 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TTT---------CCC
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----HcC---------CCC
Confidence 1234568899999999999999999999999999999998 6888875543332 2221 111 111
Q ss_pred CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 722 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 722 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
.++...+.++.+++.+||+.+|.+||||.|++++|+++..
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2334445678899999999999999999999999988653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=402.42 Aligned_cols=250 Identities=21% Similarity=0.303 Sum_probs=205.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888899999999999999875 6899999987642 2334577999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999886543 69999999999999999999999 999999999999999999999999999998765433
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
.........||+.|+|||++.+..++.++|||||||++|||+||+.||....+.+... ... .+. .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i~-~~~------~-- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------KII-KLE------Y-- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-TTC------C--
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH------HHH-cCC------C--
Confidence 3334456789999999999999999999999999999999999999998654433211 111 111 1
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
.++.....++.+++.+||+.+|.+|||++|++..
T Consensus 228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1223345568899999999999999999998653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=395.68 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=203.2
Q ss_pred cCCCccceEeeeCcEEEEEEEecC----CcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...+.||+|+||.||+|++.. +..||||.+.... ....+.|.+|+++|++++||||++++|+|. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 567888999999999999998642 3578999887543 344677999999999999999999999996 4678999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++.... ..+++.+++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~- 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED- 160 (273)
T ss_dssp EECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC-
Confidence 99999999999876543 469999999999999999999999 9999999999999999999999999999987543
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 717 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 717 (828)
......+...||+.|+|||++.+..++.++|||||||++|||+| |++||......+....+ ..+..
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-------~~~~~------ 227 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGER------ 227 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTCC------
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCCC------
Confidence 22223445678999999999999999999999999999999998 89999876554432111 11110
Q ss_pred cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 718 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 718 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
...+...+..+.+++.+||+.+|.+|||+.||++.|+.+++..+
T Consensus 228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 12234456778999999999999999999999999999876643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=403.35 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=208.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCc----EEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 557 (828)
.+|+..++||+|+||+||+|.+. +|+ +||+|++... +.+..++|.+|+++|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888899999999999999864 343 6899988654 445678899999999999999999999999764 5678
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 637 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~ 637 (828)
++||+.+|+|.+++.... ..+++..+++++.|||+||+|||+ ++|+||||||+||||+.++++||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 899999999999886653 469999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 638 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 638 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
...........||+.|+|||++.++.++.++|||||||+||||+| |++||+.....+...... .+.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~~------ 230 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE------ 230 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HTC------
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC------
Confidence 344434455679999999999999999999999999999999998 789987665444322211 111
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhhh
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 764 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~~ 764 (828)
....++.++..+.+++.+||+.+|.+|||+.||++.|+.+.+..+
T Consensus 231 ---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~ 275 (317)
T d1xkka_ 231 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275 (317)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred ---CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChH
Confidence 112234456778999999999999999999999999988765543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=395.04 Aligned_cols=244 Identities=27% Similarity=0.402 Sum_probs=195.4
Q ss_pred CccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc----CCcEEEEE
Q 003350 487 DESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE----KNEMILIY 559 (828)
Q Consensus 487 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 559 (828)
...+.||+|+||+||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34468999999999999875 5889999987643 34456779999999999999999999999854 45689999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCC--EEeeeeecCcEEeC-CCCcEEEEeeCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA--VIHRDVKSANILLD-ENFMAKVADFGLSKTGP 636 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDIkp~NILld-~~~~~kl~DFGla~~~~ 636 (828)
||+++|+|.+++.... .+++.+++.++.||++||+|||+ ++ |+||||||+||||+ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999996543 69999999999999999999998 66 99999999999996 57899999999998643
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
. .......||+.|+|||++.+ .++.++|||||||++|||++|+.||........ +. ... ..+.. .
T Consensus 167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~---~~i-~~~~~----~ 231 (270)
T d1t4ha_ 167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RRV-TSGVK----P 231 (270)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HHH-TTTCC----C
T ss_pred C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HH---HHH-HcCCC----C
Confidence 2 22345689999999999865 699999999999999999999999975432221 11 111 11110 1
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.+. .....++.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASFD----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGG----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccC----ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111 223445788999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=408.47 Aligned_cols=265 Identities=22% Similarity=0.336 Sum_probs=205.4
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
.++|+..++||+|+||+||+|+.. +|+.||+|++... .....+++.+|+++|++++|||||+++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 567888999999999999999865 6899999988654 33445788999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+. .+|+||||||+||||++++++||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 999999999997543 699999999999999999999971 3899999999999999999999999999986421
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHH---------------HHH
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA---------------MKW 705 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~---------------~~~ 705 (828)
...+...||+.|+|||++.+..++.++||||+||++|||++|+.||......+........ ...
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2234568999999999999999999999999999999999999999765432211100000 000
Q ss_pred hhc--------CCcccccCcccc---CCCC-hhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 706 QNK--------GQLDQIIDPTLA---GKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 706 ~~~--------~~~~~~~d~~l~---~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
... ....+..+.... ...+ .....++.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 000000000000 0000 1224568899999999999999999999873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-45 Score=403.46 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=210.6
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457889999999999999999875 6899999999877766678899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC--CCCcEEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD--ENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld--~~~~~kl~DFGla~~~~~~~ 639 (828)
|++|+|.+++.... ..+++.++..|+.||+.||+|||+ .+||||||||+|||++ .++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-- 178 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 178 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc--
Confidence 99999999986543 369999999999999999999999 9999999999999995 467899999999987543
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ....... ..++.
T Consensus 179 -~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~~~~---~~~~~- 247 (350)
T d1koaa2 179 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR------NVKSCDW---NMDDS- 247 (350)
T ss_dssp -TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHTCC---CSCCG-
T ss_pred -ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC---CCCcc-
Confidence 223445689999999999999999999999999999999999999998655433221 1111100 00111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.....+..+.+++.+||+.+|.+|||+.|+++
T Consensus 248 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 248 ---AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ---GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11233556889999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-46 Score=399.53 Aligned_cols=245 Identities=25% Similarity=0.359 Sum_probs=202.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---ccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34788899999999999999864 688999998865432 33567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
|||++|+|..++... .++++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999997766443 369999999999999999999999 9999999999999999999999999999986432
Q ss_pred ccceeccccccccccChhhhcc---CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ....... .
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~~~~------~ 231 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE------S 231 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC------C
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhCC------C
Confidence 234579999999999864 46899999999999999999999999765433221 1111111 1
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+.+ .....+..+.+++.+||+.+|.+|||+.|+++
T Consensus 232 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111 11233556889999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-46 Score=398.73 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=192.6
Q ss_pred HhcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 482 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 482 at~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
..+.|...++||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3466888899999999999999875 58899999876543 233456889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC---CCCcEEEEeeCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGP 636 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kl~DFGla~~~~ 636 (828)
|||++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999654 369999999999999999999999 9999999999999994 57899999999998653
Q ss_pred CCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 716 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 716 (828)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..... .
T Consensus 162 ~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i~~~-~------ 225 (307)
T d1a06a_ 162 P---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------QILKA-E------ 225 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHTT-C------
T ss_pred C---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHH------HHhcc-C------
Confidence 3 223345679999999999999999999999999999999999999997654433211 11111 1
Q ss_pred ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.........+.+..+.+++.+||+.+|.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111222344567889999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=398.95 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=202.4
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEcc-CCc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE-KNE 554 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~~ 554 (828)
++|...++||+|+||.||+|+.. +++.||||++.... ....+++.+|..++.++ +|+||+.+++++.+ ...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 57888899999999999999753 24689999987543 34466788888888877 78999999999865 456
Q ss_pred EEEEEEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC
Q 003350 555 MILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 620 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~ 620 (828)
.++|||||++|+|.+++.... ...++|.+++.++.|||+||+|||+ ++|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 899999999999999986432 2358999999999999999999999 99999999999999999
Q ss_pred CCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhc-CCCCCCCChhhhhhHH
Q 003350 621 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLA 699 (828)
Q Consensus 621 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG-~~p~~~~~~~~~~~l~ 699 (828)
++++||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+|| ++||......+.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---- 245 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 245 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH----
Confidence 999999999999876544444444567899999999999999999999999999999999997 467765432221
Q ss_pred HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 700 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 700 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
......++.. + ..+...+.++.+++.+||+.+|.+|||+.||+++|+.++|.
T Consensus 246 --~~~~~~~~~~-----~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 --FCRRLKEGTR-----M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp --HHHHHHHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHhcCCC-----C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111122111 1 12234456788999999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-45 Score=400.66 Aligned_cols=252 Identities=19% Similarity=0.271 Sum_probs=210.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 356888899999999999999864 6899999998876666667889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC--CCCcEEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD--ENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld--~~~~~kl~DFGla~~~~~~~ 639 (828)
|++|+|.+++.... .++++.+++.|+.||+.||+|||+ .+|+||||||+||||+ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 108 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred CCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCC--
Confidence 99999998875543 469999999999999999999999 9999999999999998 678999999999987643
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .... +. ...
T Consensus 182 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~-~~------~~~ 247 (352)
T d1koba_ 182 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------NVKR-CD------WEF 247 (352)
T ss_dssp -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHH-CC------CCC
T ss_pred -CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh-CC------CCC
Confidence 223445679999999999999999999999999999999999999998655433211 1111 11 111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
........+..+.+++.+||+.+|.+|||+.|+++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122334566889999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=394.00 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=210.5
Q ss_pred cCCCccceEeeeCcEEEEEEEecC--------CcEEEEEEcCCCCc-ccHHHHHHHHHHHHcC-CCCceEEEEEEEccCC
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND--------GTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN 553 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 553 (828)
++|...+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 467777899999999999997532 34799999876543 4467889999999888 8999999999999999
Q ss_pred cEEEEEEeccCCcccccccCCC--------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC
Q 003350 554 EMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld 619 (828)
..++||||+++|+|.+++.... ...+++.++++++.|+|.||+|||+ .+||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999996543 2468999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhH
Q 003350 620 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 698 (828)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l 698 (828)
.++.+||+|||+++...............||+.|+|||.+.++.++.|+|||||||++|||+| |++||......+...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~- 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH-
Confidence 999999999999987654444444556779999999999999999999999999999999998 688887654433211
Q ss_pred HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 699 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
....+. .+ ..+...+.++.+++.+||+.+|.+|||+.||++.|++++.+
T Consensus 249 ------~i~~~~-----~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 249 ------LLKEGH-----RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ------HHHTTC-----CC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHcCC-----CC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 111111 11 12233456788999999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=396.54 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=214.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCCC-cccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 555 (828)
++|...++||+|+||.||+|++. +++.||||+++... .....+|.+|+.+++++ +|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 56777889999999999999752 45789999987654 34456799999999999 699999999999999999
Q ss_pred EEEEEeccCCcccccccCCC----------------CCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC
Q 003350 556 ILIYEYMENGTLKGHLYGSG----------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 619 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld 619 (828)
++|||||++|+|.++++... ...+++.++++++.|||+||+|||+ ++++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 99999999999999986432 2369999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhH
Q 003350 620 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 698 (828)
Q Consensus 620 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l 698 (828)
.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |++|+......+..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~-- 257 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-- 257 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 999999999999998765444445566789999999999999999999999999999999999 55656544332221
Q ss_pred HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 699 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 699 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
.. ....+ .....+...+..+.+++.+||+.+|.+||||.||+++|+++++.
T Consensus 258 ~~----~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YK----MIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HH----HHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11 11111 11122234456789999999999999999999999999987643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=393.37 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=204.2
Q ss_pred cceEeeeCcEEEEEEEecCC----cEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc-CCcEEEEEEec
Q 003350 489 SWVIGIGGFGKVYKGELNDG----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNEMILIYEYM 562 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~ey~ 562 (828)
.++||+|+||+||+|++.++ ..||||+++.. +....++|.+|+++|++++||||++++|+|.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999987532 36899998753 45556889999999999999999999999865 56899999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc--
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ-- 640 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~-- 640 (828)
++|+|.+++.... ..+++..+++++.|+|+||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999887544 468899999999999999999999 9999999999999999999999999999987544222
Q ss_pred cceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 720 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 720 (828)
........||..|+|||.+..+.++.++||||||+++|||+||+.|+...... ..+..+. ..+. ..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i----~~g~--~~------ 253 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL----LQGR--RL------ 253 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTC--CC------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCC--CC------
Confidence 12233467899999999999999999999999999999999988777543211 1111111 1111 00
Q ss_pred CCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHH
Q 003350 721 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 761 (828)
Q Consensus 721 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~ 761 (828)
..+..++..+.+++.+||+.+|.+||+|.||++.|+.+++
T Consensus 254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1123345678899999999999999999999999988764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=390.76 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=199.4
Q ss_pred cCCCccceEeeeCcEEEEEEEecC--C--cEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND--G--TKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
++|+..+.||+|+||.||+|+++. + ..||||++... ..+..++|.+|+++|++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 457778899999999999997642 2 37899987654 33446789999999999999999999999966 4678
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||+++|+|.+++.... ..+++..++.++.|+|+||+|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998876543 369999999999999999999999 999999999999999999999999999999765
Q ss_pred CCCcc-ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHh-cCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 637 EIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 637 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
..... .......||..|+|||++.+..++.++|||||||++|||+| |++||......+.. . ...+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~---~i~~~~~---- 232 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---H---KIDKEGE---- 232 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H---HHHTSCC----
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---H---HHHhCCC----
Confidence 43222 22334568889999999999999999999999999999998 89999765444322 1 1112111
Q ss_pred cCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHH
Q 003350 715 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA 759 (828)
Q Consensus 715 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~ 759 (828)
....+...+..+.+++.+||+.+|.+||||.||++.|+++
T Consensus 233 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 -----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112234456788999999999999999999999988875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=390.28 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=206.5
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC------CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR------SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 555 (828)
.++|...+.||+|+||.||+|+.. +|+.||||++... .....+.|.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467888999999999999999875 6899999987532 123467899999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC----cEEEEeeCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF----MAKVADFGL 631 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~----~~kl~DFGl 631 (828)
++|||||++|+|.+++...+ .+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999996543 69999999999999999999999 9999999999999998776 599999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
++.... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .... ...
T Consensus 164 a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i~~-~~~ 233 (293)
T d1jksa_ 164 AHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NVSA-VNY 233 (293)
T ss_dssp CEECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHT-TCC
T ss_pred hhhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH------HHHh-cCC
Confidence 987543 222345679999999999999999999999999999999999999998655433221 1111 100
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
-..+.. ....+..+.+++.+||+.+|.+|||+.|+++
T Consensus 234 --~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 --EFEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111 1223456789999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=395.63 Aligned_cols=257 Identities=30% Similarity=0.455 Sum_probs=206.9
Q ss_pred cCCCccceEeeeCcEEEEEEEecC-Cc--EEEEEEcCCC-CcccHHHHHHHHHHHHcC-CCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELND-GT--KVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...++||+|+||.||+|++++ +. .||||++... .....++|.+|+++|+++ +||||++++|+|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567788999999999999998763 43 5788887543 344567899999999999 799999999999999999999
Q ss_pred EEeccCCcccccccCC--------------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcE
Q 003350 559 YEYMENGTLKGHLYGS--------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 624 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~ 624 (828)
|||+++|+|.++|+.. ....++|.++++++.|||+||+|||+ .+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999653 23579999999999999999999999 999999999999999999999
Q ss_pred EEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcC-CCCCCCChhhhhhHHHHHH
Q 003350 625 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAM 703 (828)
Q Consensus 625 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~-~p~~~~~~~~~~~l~~~~~ 703 (828)
||+|||+++.... ........||..|+|||.+.++.++.++|||||||++|||++|. +||......+.. .
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~------~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E 237 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------H
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH------H
Confidence 9999999986432 11223456899999999999999999999999999999999975 567654433321 1
Q ss_pred HHhhcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHh
Q 003350 704 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 762 (828)
Q Consensus 704 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~ 762 (828)
. ..++. . ...+...+.++.+++.+||+.+|++||+|.||++.|+++++.
T Consensus 238 ~-i~~~~-----~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 K-LPQGY-----R----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp H-GGGTC-----C----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H-HHhcC-----C----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1 11111 1 122334566789999999999999999999999999988753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=393.42 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=211.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec------CCcEEEEEEcCCC-CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
++|...+.||+|+||.||+|.++ +++.||||+++.. ..+....|.+|++++++++||||++++|+|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56777889999999999999764 2578999998754 3344567899999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCC--------CCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEe
Q 003350 557 LIYEYMENGTLKGHLYGS--------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 628 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~D 628 (828)
+||||+++|+|.+++... ....++|..+++++.|+|+||+|||+ ++|+||||||+|||+|+++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 999999999999988632 23468999999999999999999999 8999999999999999999999999
Q ss_pred eCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcC-CCCCCCChhhhhhHHHHHHHHhh
Q 003350 629 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQN 707 (828)
Q Consensus 629 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 707 (828)
||+++...............||+.|+|||.+.+..++.++|||||||++|||+||+ +|+......+.. ....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------~~i~- 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RFVM- 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------HHHH-
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------HHHH-
Confidence 99998754433333345567899999999999999999999999999999999985 677654433322 1111
Q ss_pred cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHH
Q 003350 708 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL 760 (828)
Q Consensus 708 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~ 760 (828)
++.. ...+..++..+.+++.+||+.+|.+||||.||+++|++.+
T Consensus 250 ~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred hCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1111 1122344567899999999999999999999999887653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-44 Score=381.91 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=202.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHHHHHHHHHcCCCCceEEEEEEEccCC----c
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----E 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 554 (828)
.++|...+.||+|+||.||+|+.. +|+.||||.+.... ....+.|.+|+++|++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 356888899999999999999864 68999999986543 334567999999999999999999999986543 3
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++||||+++|+|.+++...+ .+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++..+|+|||.++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999886543 69999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCC-CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 635 GPEI-DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 635 ~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
.... ..........||+.|+|||++.+..++.++|||||||++|||+||++||....+.+.. ......+..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~-- 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI-- 232 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC--
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCC--
Confidence 4332 2222344567999999999999999999999999999999999999999865443321 111222111
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCC-ChHHHHHHHHHH
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-SMGDVLWNLEYA 759 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~eVl~~L~~~ 759 (828)
.+ .....+.+.++.+++.+||+.+|.+|| +++++++.|.++
T Consensus 233 --~~---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 --PP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp --CG---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --CC---chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 01 111223456788999999999999999 899998888765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=390.28 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=207.1
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56888999999999999999874 6899999987643 2334678899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
|||++|+|.+++...+ .+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999987654 68999999999999999999999 999999999999999999999999999998754322
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......+||+.|+|||++.+..++.++||||+||++|||++|++||......+.... .. .+. .
T Consensus 160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------i~-~~~------~-- 222 (337)
T d1o6la_ 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------IL-MEE------I-- 222 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-HCC------C--
T ss_pred --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH------Hh-cCC------C--
Confidence 224457899999999999999999999999999999999999999987654432211 11 111 1
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCC-----hHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eVl~ 754 (828)
.++...+.++.+++.+||+.+|.+||+ +.|+++
T Consensus 223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 122334556788999999999999995 677764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-44 Score=387.59 Aligned_cols=244 Identities=25% Similarity=0.344 Sum_probs=205.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888899999999999999875 6899999987642 2334678999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 9999999999886554 68899999999999999999999 9999999999999999999999999999987543
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......||+.|+|||++.+..++.++|||||||++|||+||+.||......+... ..... .
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~-~--------- 217 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILNA-E--------- 217 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHC-C---------
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH------HHHcC-C---------
Confidence 2345689999999999999999999999999999999999999998665433221 11111 1
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
..+++..+..+.+++.+||+.+|.+|| +++|+++
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 012233455688999999999999996 8888864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=392.75 Aligned_cols=269 Identities=24% Similarity=0.352 Sum_probs=201.5
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHH--HHHHHHcCCCCceEEEEEEEccCC----cEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGYCDEKN----EMIL 557 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~~l 557 (828)
+.|...+.||+|+||.||+|+++ |+.||||++.... .+++.. |+..+.+++||||++++++|...+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 34566789999999999999875 8899999986432 334444 455556789999999999996543 6899
Q ss_pred EEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhc-----CCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 558 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG-----YAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
|||||++|+|.++|+.. +++|.++++++.|+|.||+|||+. ..++|+||||||+||||+.++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999754 599999999999999999999973 2369999999999999999999999999999
Q ss_pred CCCCCCCcc--ceeccccccccccChhhhccC------CCCcccceeehhhHHHHHHhcCCCCCCCChhhh----h----
Q 003350 633 KTGPEIDQT--HVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM----V---- 696 (828)
Q Consensus 633 ~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~----~---- 696 (828)
+........ .......||+.|+|||++.+. .++.|+|||||||+||||+||..|+......+. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 865432221 123456799999999998754 267899999999999999999988743221110 0
Q ss_pred hHHHHHHHHhhcCCcccccCccccCCC-ChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 697 NLAEWAMKWQNKGQLDQIIDPTLAGKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 697 ~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
............ +.++|.+.... ..+.+..+.+++.+||+.+|.+||||.||++.|+++.+..
T Consensus 236 ~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 236 PSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 001111111111 11222222211 2345677999999999999999999999999999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.3e-44 Score=375.97 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=205.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc---------ccHHHHHHHHHHHHcCC-CCceEEEEEEEccC
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---------QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEK 552 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 552 (828)
++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999864 689999998765431 12346889999999997 99999999999999
Q ss_pred CcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCC
Q 003350 553 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 632 (828)
Q Consensus 553 ~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla 632 (828)
+..++|||||++|+|.+++...+ .+++.+++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999996544 69999999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhcc------CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 706 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 706 (828)
+.... ....+...||..|+|||++.+ ..++.++||||+||++|||++|+.||....+.+.... ..
T Consensus 158 ~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~------i~ 228 (277)
T d1phka_ 158 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM------IM 228 (277)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH
T ss_pred eEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH------HH
Confidence 87543 222345689999999999863 3578899999999999999999999987654332211 11
Q ss_pred hcCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 707 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 707 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+.. ..........+.++.+++.+||+.+|.+||++.||++
T Consensus 229 -~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 -SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -hCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 1111112345567889999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-43 Score=386.64 Aligned_cols=244 Identities=21% Similarity=0.308 Sum_probs=205.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 559 (828)
++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|++++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47888899999999999999875 6899999987532 2234577899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~ 639 (828)
||+.+|+|.+++...+ .+++.++..++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 9999999999986554 69999999999999999999999 9999999999999999999999999999987543
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
......||+.|+|||++.+..++.++|||||||++|||+||++||....+..... .... +. +
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~-~~------~-- 255 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------KIVS-GK------V-- 255 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH-CC------C--
T ss_pred ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH------HHhc-CC------C--
Confidence 1235679999999999999999999999999999999999999997654433211 1111 11 1
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCC-----ChHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW 754 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~eVl~ 754 (828)
..+.....++.+++.+||+.+|.+|+ ++.|+++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11233455688999999999999994 8888874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=375.99 Aligned_cols=259 Identities=22% Similarity=0.246 Sum_probs=196.2
Q ss_pred cceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCccc-----HHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEec
Q 003350 489 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG-----LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 562 (828)
Q Consensus 489 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey~ 562 (828)
.++||+|+||+||+|+.. +|+.||||++....... .+.+.+|+++|++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 368999999999999875 58999999986543221 246889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCccc
Q 003350 563 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 642 (828)
Q Consensus 563 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~~ 642 (828)
.++++....... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 83 ~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R 155 (299)
T ss_dssp SEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred cchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence 988877665433 469999999999999999999999 999999999999999999999999999998754322 2
Q ss_pred eeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc---Ccc
Q 003350 643 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII---DPT 718 (828)
Q Consensus 643 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---d~~ 718 (828)
......||+.|+|||++... .++.++|||||||++|||+||++||....+.+......-.............. ...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 23446799999999998754 67999999999999999999999998765544322211110000000000000 000
Q ss_pred -cc--CCC-----ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 719 -LA--GKI-----RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 719 -l~--~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. ... .......+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 000 1123456889999999999999999999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-43 Score=387.31 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=198.8
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC---cccHHHHH---HHHHHHHcCCCCceEEEEEEEccCCcEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQ---TEIEMLSQFRHRHLVSLIGYCDEKNEMI 556 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~ 556 (828)
++|...++||+|+||.||+|+.. +|+.||||++.... ......+. .|+++++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888999999999999999875 68999999875321 12223333 4477788889999999999999999999
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
+||||+++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999996543 68899999999999999999999 999999999999999999999999999998654
Q ss_pred CCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003350 637 EIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 715 (828)
Q Consensus 637 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 715 (828)
.. ......||+.|+|||++.. ..++.++|||||||+||||+||+.||......+...+.. .....
T Consensus 159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~~------ 224 (364)
T d1omwa3 159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTM------ 224 (364)
T ss_dssp SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSSC------
T ss_pred CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcccC------
Confidence 31 2345679999999999975 568999999999999999999999997654333221111 00000
Q ss_pred CccccCCCChhHHHHHHHHHHhhhhhCCCCCCC-----hHHHHH
Q 003350 716 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW 754 (828)
Q Consensus 716 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eVl~ 754 (828)
. ...+...+.++.+++.+||+.+|.+||+ ++|+++
T Consensus 225 ~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 1122334566889999999999999999 467764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=382.46 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=204.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC---CcccHHHHHHHHHHHH-cCCCCceEEEEEEEccCCcEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLS-QFRHRHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 558 (828)
++|...+.||+|+||+||+|+.. +++.||||++... .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888899999999999999875 6899999998643 2234566777777765 68999999999999999999999
Q ss_pred EEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCC
Q 003350 559 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 559 ~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~ 638 (828)
|||+++|+|.+++.... .+++.+++.++.||+.||+|||+ .+|+||||||+|||+++++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999996543 68899999999999999999999 99999999999999999999999999999865432
Q ss_pred CccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 718 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 718 (828)
....+...||+.|+|||++.+..++.++|||||||++|||+||+.||....+.+....+ ..+ .+.
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~------~~~ 221 (320)
T d1xjda_ 157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------RMD------NPF 221 (320)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHC------CCC
T ss_pred --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-------HcC------CCC
Confidence 22334568999999999999999999999999999999999999999876554432211 111 111
Q ss_pred ccCCCChhHHHHHHHHHHhhhhhCCCCCCChH-HHHH
Q 003350 719 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMG-DVLW 754 (828)
Q Consensus 719 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-eVl~ 754 (828)
++...+.++.+++.+||+.+|.+||++. |+++
T Consensus 222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2223455688999999999999999995 6753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=379.32 Aligned_cols=252 Identities=16% Similarity=0.245 Sum_probs=207.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
.++|...+.||+|+||+||+|... +++.||||.+...... ...+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467888899999999999999875 6889999998765433 45688999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC--CCcEEEEeeCCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE--NFMAKVADFGLSKTGPEID 639 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~--~~~~kl~DFGla~~~~~~~ 639 (828)
|++|+|.+++...+ ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 99999999996543 369999999999999999999999 99999999999999984 45899999999987543
Q ss_pred ccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003350 640 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 719 (828)
Q Consensus 640 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 719 (828)
........||+.|+|||.+.+..++.++||||+||++|||++|+.||......+... ..... .. .++...
T Consensus 157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~------~i~~~-~~--~~~~~~ 226 (321)
T d1tkia_ 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------NIMNA-EY--TFDEEA 226 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHT-CC--CCCHHH
T ss_pred -CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC-CC--CCChhh
Confidence 222345678999999999999999999999999999999999999998765433211 11111 00 011111
Q ss_pred cCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 720 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 720 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
. ...+.++.+++.+||+.+|.+|||+.|++++
T Consensus 227 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1234567899999999999999999999863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=382.69 Aligned_cols=253 Identities=20% Similarity=0.309 Sum_probs=198.9
Q ss_pred hcCCCcc-ceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCCcccHHHHHHHHHHHHc-CCCCceEEEEEEEcc----CCcE
Q 003350 483 TNNFDES-WVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ-FRHRHLVSLIGYCDE----KNEM 555 (828)
Q Consensus 483 t~~f~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~ 555 (828)
.++|... ++||+|+||.||+|+. .+++.||||++... ..+.+|++++.+ .+||||+++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3567765 5699999999999986 46899999998542 457789998765 489999999998854 4678
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC---CCcEEEEeeCCC
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVADFGLS 632 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~---~~~~kl~DFGla 632 (828)
++|||||++|+|.+++...+...+++.++..|+.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 999999999999999987655679999999999999999999999 99999999999999985 567999999999
Q ss_pred CCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 633 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 633 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
+..... .......||+.|+|||++.+..++.++|||||||+||||+||++||......+... ........+.
T Consensus 162 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~-- 233 (335)
T d2ozaa1 162 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQ-- 233 (335)
T ss_dssp EECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS--
T ss_pred eeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCC--
Confidence 875432 22345679999999999999999999999999999999999999996543222111 0000000000
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 755 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~ 755 (828)
..+........+.++.+++.+||+.+|.+|||+.|+++.
T Consensus 234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 001111112345678999999999999999999999763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-42 Score=368.98 Aligned_cols=264 Identities=20% Similarity=0.232 Sum_probs=202.6
Q ss_pred cCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...++||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788889999999999999999889999999986653 23357899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCcc
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 641 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~~ 641 (828)
+.++.+..+.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 9887776665433 479999999999999999999999 899999999999999999999999999997643311
Q ss_pred ceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC---ccccc--
Q 003350 642 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ---LDQII-- 715 (828)
Q Consensus 642 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~-- 715 (828)
.......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....+.+................ ..+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 123345689999999998754 568999999999999999999999986654433221111110000000 00000
Q ss_pred -------CccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 716 -------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 716 -------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.+.............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001112233567889999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=370.82 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=200.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|+++|++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47888899999999999999864 68999999986543 2335788999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
|+.+ ++.+++.......+++.++..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC--
Confidence 9975 44445544444579999999999999999999999 99999999999999999999999999999765432
Q ss_pred cceeccccccccccChhhhccCC-CCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhh--cCCccccc-C
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN--KGQLDQII-D 716 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~-d 716 (828)
........||+.|+|||.+.... ++.++|||||||++|||++|+.||......+..... ...... +....... .
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCTTTSTTGGGS
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH--HHhcCCCchhhccccccc
Confidence 22234567999999999987655 589999999999999999999999866543322111 111000 00000000 0
Q ss_pred ccccCC-----------CChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 717 PTLAGK-----------IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 717 ~~l~~~-----------~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+..... ........+.+++.+||+.+|.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000 01123466889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=369.24 Aligned_cols=240 Identities=24% Similarity=0.357 Sum_probs=194.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCc------ccHHHHHHHHHHHHcCC--CCceEEEEEEEccCC
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ------QGLAEFQTEIEMLSQFR--HRHLVSLIGYCDEKN 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~ 553 (828)
.++|...++||+|+||.||+|+.. +|+.||||++..... ....++.+|+.+|++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357888899999999999999865 689999998754211 11234678999999986 899999999999999
Q ss_pred cEEEEEEeccC-CcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-CCcEEEEeeCC
Q 003350 554 EMILIYEYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGL 631 (828)
Q Consensus 554 ~~~lV~ey~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-~~~~kl~DFGl 631 (828)
..++||||+.+ +++.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 5777777543 369999999999999999999999 99999999999999985 47999999999
Q ss_pred CCCCCCCCccceeccccccccccChhhhccCCC-CcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003350 632 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ 710 (828)
Q Consensus 632 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (828)
|+.... ...+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... + ... +.
T Consensus 158 a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----------i~~-~~ 220 (273)
T d1xwsa_ 158 GALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----------IIR-GQ 220 (273)
T ss_dssp CEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----------HHH-CC
T ss_pred ceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----------Hhh-cc
Confidence 986432 22345689999999999988765 577999999999999999999996421 1 001 11
Q ss_pred cccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 711 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 711 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. .++...+.++.+++.+||+.+|.+|||+.|+++
T Consensus 221 ------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------c----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 112233456889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-42 Score=366.59 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=198.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-C-CcEEEEEEcCCC--CcccHHHHHHHHHHHHcC---CCCceEEEEEEEc-----
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-D-GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQF---RHRHLVSLIGYCD----- 550 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~----- 550 (828)
.++|+..+.||+|+||+||+|+.. + ++.||||++... .......+.+|+++|+.+ +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999863 3 667999987532 122223456777776655 8999999999984
Q ss_pred cCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeC
Q 003350 551 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 630 (828)
Q Consensus 551 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFG 630 (828)
.....++++||++++.+...... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 34578999999998777644433 33568999999999999999999999 999999999999999999999999999
Q ss_pred CCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003350 631 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ 710 (828)
Q Consensus 631 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 710 (828)
+++.... ........||+.|+|||++.+..++.++||||+||++|||++|++||....+.+................
T Consensus 162 ~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 162 LARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp SCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9986432 2334567899999999999999999999999999999999999999987655443322211111000000
Q ss_pred c------cc-ccC---ccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 711 L------DQ-IID---PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 711 ~------~~-~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
. .. ... ..............+.+++.+||+.+|.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00 000 00001112234456788999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-40 Score=355.79 Aligned_cols=264 Identities=19% Similarity=0.216 Sum_probs=199.6
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEE-EEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS-LIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~ey 561 (828)
++|...+.||+|+||.||+|+.. +|+.||||.+...... +++..|++++++++|+|++. +.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46888899999999999999864 6899999987654332 45789999999998776554 45555778889999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeC---CCCcEEEEeeCCCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEI 638 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld---~~~~~kl~DFGla~~~~~~ 638 (828)
+. ++|.+.+.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 95 56666554333 469999999999999999999999 9999999999999985 4567999999999875432
Q ss_pred Ccc-----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003350 639 DQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 713 (828)
Q Consensus 639 ~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 713 (828)
... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......+................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---
Confidence 211 123456799999999999999999999999999999999999999976544333222111111000000
Q ss_pred ccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 714 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 714 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
.+.+. ...+.++.+++.+|++.+|.+||++.++.+.|+.+.+..
T Consensus 237 --~~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 --IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp --HHHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --hhHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 01111 233466889999999999999999999999888876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=358.84 Aligned_cols=267 Identities=22% Similarity=0.289 Sum_probs=197.9
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEcc--------
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-------- 551 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 551 (828)
.++|+..+.||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367888899999999999999874 7899999987543 33445778999999999999999999998844
Q ss_pred CCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCC
Q 003350 552 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 631 (828)
Q Consensus 552 ~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGl 631 (828)
.+..++||||++++.+...... ...++..++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 4568999999998777655433 3468899999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCCCCcc--ceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhc
Q 003350 632 SKTGPEIDQT--HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 708 (828)
Q Consensus 632 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 708 (828)
++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....+.+..........-...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9765432211 122345799999999998765 6899999999999999999999999876554443332222111111
Q ss_pred CCcccccCccccC--------CCC-hh------HHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 GQLDQIIDPTLAG--------KIR-PD------SLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 ~~~~~~~d~~l~~--------~~~-~~------~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
............. ... .+ ....+.+++.+||+.+|++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1111110000000 000 01 1234678999999999999999999973
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-40 Score=352.87 Aligned_cols=264 Identities=17% Similarity=0.170 Sum_probs=208.5
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC-CceEEEEEEEccCCcEEEEEEe
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLIGYCDEKNEMILIYEY 561 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ey 561 (828)
++|...++||+|+||.||+|+.. +|+.||||.+..... ..++.+|++.++.++| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57888899999999999999865 689999998755432 2356789999999965 8999999999999999999999
Q ss_pred ccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCC-----CCcEEEEeeCCCCCCC
Q 003350 562 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-----NFMAKVADFGLSKTGP 636 (828)
Q Consensus 562 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~-----~~~~kl~DFGla~~~~ 636 (828)
+ +++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+...
T Consensus 83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 579998886544 469999999999999999999999 99999999999999974 5789999999998654
Q ss_pred CCCcc-----ceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003350 637 EIDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 711 (828)
Q Consensus 637 ~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 711 (828)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 32111 1234567999999999999999999999999999999999999999765433322222211111111111
Q ss_pred ccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHHHHHHHHHhh
Q 003350 712 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 763 (828)
Q Consensus 712 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~~L~~~~~~~ 763 (828)
+.+. ...+.++.+++..|++.+|++||+++.+.+.|+++++..
T Consensus 238 -----~~l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 238 -----RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -----HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HHhc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 1111 223456888999999999999999999999888877544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=362.58 Aligned_cols=260 Identities=22% Similarity=0.242 Sum_probs=194.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceEEEEEEEccC------CcEEE
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------NEMIL 557 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 557 (828)
+|...++||+|+||+||+|+.. +|+.||||++...... +.+|+++|++++||||+++++++... ..+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4677789999999999999875 5899999998665332 34799999999999999999998432 34789
Q ss_pred EEEeccCCcccccccC-CCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-cEEEEeeCCCCCC
Q 003350 558 IYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTG 635 (828)
Q Consensus 558 V~ey~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kl~DFGla~~~ 635 (828)
|||||+++.+...... .....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987644443321 233579999999999999999999999 9999999999999999775 8999999999875
Q ss_pred CCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHH---------HHHH
Q 003350 636 PEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW---------AMKW 705 (828)
Q Consensus 636 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~ 705 (828)
... .......||..|+|||.+.+ ..++.++||||+||++|||++|++||......+....... ....
T Consensus 174 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 432 22344679999999998865 5789999999999999999999999976654433221111 0000
Q ss_pred hh---cCCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 706 QN---KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 706 ~~---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. ......................++.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00011110011111122334566889999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=363.01 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=197.1
Q ss_pred hcCCCccceEeeeCcEEEEEEEe-cCCcEEEEEEcCCCC-cccHHHHHHHHHHHHcCCCCceEEEEEEEccCC----cEE
Q 003350 483 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMI 556 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 556 (828)
+.+|...++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 34688889999999999999976 478999999987543 344668899999999999999999999986543 335
Q ss_pred EEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCC
Q 003350 557 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 636 (828)
Q Consensus 557 lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~ 636 (828)
++++|+.+|+|.+++... .+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 556677799999998643 59999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCc-cceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003350 637 EIDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 714 (828)
Q Consensus 637 ~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 714 (828)
.... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||......+....................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3211 112345679999999999854 56789999999999999999999999876544332222111100000000000
Q ss_pred ----------cCccccC----CCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 715 ----------IDPTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 715 ----------~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..+.... ...+....++.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 001122346889999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=360.53 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=193.7
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCC------
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN------ 553 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 553 (828)
.++|...+.||+|+||+||+|... +|+.||||++... +....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 457888899999999999999865 6899999998754 3344567899999999999999999999996554
Q ss_pred cEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 554 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 554 ~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
..++||||+ +.+|...... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence 579999999 4577766643 359999999999999999999999 999999999999999999999999999998
Q ss_pred CCCCCCccceeccccccccccChhhhcc-CCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHH-----hh
Q 003350 634 TGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-----QN 707 (828)
Q Consensus 634 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----~~ 707 (828)
.... ..+...||+.|+|||++.+ ..++.++||||+||++|||++|++||......+........... ..
T Consensus 170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 7533 2345679999999999876 45789999999999999999999999876543322211111000 00
Q ss_pred cC----------CcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 708 KG----------QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 708 ~~----------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
.. .+.+.....+. .........+.+++.+||+.+|.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000001111 111223456788999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=344.79 Aligned_cols=264 Identities=20% Similarity=0.245 Sum_probs=203.3
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEccCCcEEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e 560 (828)
++|+..+.||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+|+.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47888899999999999999874 6889999987543 33446789999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCCCCCCCc
Q 003350 561 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 640 (828)
Q Consensus 561 y~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~~~~~~~ 640 (828)
++.+++|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 99999998877554 468899999999999999999999 999999999999999999999999999998754322
Q ss_pred cceeccccccccccChhhhccCC-CCcccceeehhhHHHHHHhcCCCCCCCCh-hhhhhHHHHHHHHhhcCC---ccccc
Q 003350 641 THVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQNKGQ---LDQII 715 (828)
Q Consensus 641 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVySfGvvl~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~---~~~~~ 715 (828)
.......++..|+|||.+.... ++.++|||||||++|||++|+.||..... .+.............+.. ..+..
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2233456788899999987654 68999999999999999999988654332 222111111100000000 00000
Q ss_pred Cc---------cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 716 DP---------TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 716 d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
+. .-...........+.+++.+||+.+|.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011122334566889999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-38 Score=346.46 Aligned_cols=257 Identities=17% Similarity=0.215 Sum_probs=197.0
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEEc--cCCcEEEEE
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCD--EKNEMILIY 559 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--~~~~~~lV~ 559 (828)
++|...++||+|+||+||+|+.. +++.||||+++... .+++.+|+++|++++ ||||+++++++. .....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57888999999999999999874 68999999987543 467889999999995 999999999986 345699999
Q ss_pred EeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC-cEEEEeeCCCCCCCCC
Q 003350 560 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEI 638 (828)
Q Consensus 560 ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~-~~kl~DFGla~~~~~~ 638 (828)
||+++++|.... +.+++.++..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999998764 358999999999999999999999 9999999999999998654 6999999999875432
Q ss_pred CccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhh--hH---------HHHHHHHh
Q 003350 639 DQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV--NL---------AEWAMKWQ 706 (828)
Q Consensus 639 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~--~l---------~~~~~~~~ 706 (828)
.......||+.|+|||.+.+. .++.++||||+||+++||++|+.||......... .. ..|.....
T Consensus 184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 223456789999999998765 5799999999999999999999999755432211 00 01111100
Q ss_pred hcC--CcccccCc--------cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 707 NKG--QLDQIIDP--------TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 707 ~~~--~~~~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
... ........ ............++.+++.+||+.+|.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000000 0011111233466889999999999999999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=353.41 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=200.9
Q ss_pred cCCCccceEeeeCcEEEEEEEec----CCcEEEEEEcCCCC----cccHHHHHHHHHHHHcCCC-CceEEEEEEEccCCc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRH-RHLVSLIGYCDEKNE 554 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 554 (828)
++|+..+.||+|+||+||+|+.. +|+.||||.+.... ....+.+.+|+++|++++| |||+++++++.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56888999999999999999752 47899999876432 2334668899999999966 899999999999999
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.++|+||+.+|+|.+++.... .+.......++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999986554 56788999999999999999999 9999999999999999999999999999986
Q ss_pred CCCCCccceeccccccccccChhhhccC--CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD 712 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 712 (828)
... ..........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+...... ......
T Consensus 179 ~~~-~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~~---- 251 (322)
T d1vzoa_ 179 FVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS---- 251 (322)
T ss_dssp CCG-GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC----
T ss_pred hcc-cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcccC----
Confidence 543 222233456799999999999754 47889999999999999999999997654333221111 111000
Q ss_pred cccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCC-----hHHHHH
Q 003350 713 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW 754 (828)
Q Consensus 713 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~eVl~ 754 (828)
...++.....++.+++.+||+.+|.+||+ ++|+++
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01123345677889999999999999995 677753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=346.38 Aligned_cols=260 Identities=20% Similarity=0.231 Sum_probs=190.7
Q ss_pred cCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCC--CcccHHHHHHHHHHHHcCCCCceEEEEEEEc------cCCc
Q 003350 484 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD------EKNE 554 (828)
Q Consensus 484 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~------~~~~ 554 (828)
++|+..++||+|+||+||+|... +|+.||||++... .....+.+.+|+.+|++++||||+++++++. ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888899999999999999875 6899999998654 3344567899999999999999999999985 3468
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
+++||||+.++.+. .+. ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 89999999765554 432 358999999999999999999999 9999999999999999999999999999886
Q ss_pred CCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHH--------------
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE-------------- 700 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~-------------- 700 (828)
... ....+...||+.|+|||++.+..++.++||||+||+++||++|+.||.............
T Consensus 169 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 543 223455679999999999999999999999999999999999999997654332211110
Q ss_pred --HHHHHhhcC-Cc-----ccccCccccCCC---ChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 701 --WAMKWQNKG-QL-----DQIIDPTLAGKI---RPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 701 --~~~~~~~~~-~~-----~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
......... .. ............ .......+.+++.+||+.+|++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000 00 001111111111 1234567889999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-39 Score=350.85 Aligned_cols=260 Identities=20% Similarity=0.267 Sum_probs=195.8
Q ss_pred hcCCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCC--cccHHHHHHHHHHHHcCCCCceEEEEEEEcc-----CCc
Q 003350 483 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-----KNE 554 (828)
Q Consensus 483 t~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 554 (828)
.++|...++||+|+||+||+|+.. +|+.||||++.... ....+++.+|+++|++++|||++++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457888899999999999999864 69999999987543 3345678899999999999999999999853 334
Q ss_pred EEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 555 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 555 ~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.+++++|+.+|+|.+++... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence 57778888899999998543 59999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCCccceeccccccccccChhhhccC-CCCcccceeehhhHHHHHHhcCCCCCCCChhhhhhHHHHHHHHh-----hc
Q 003350 635 GPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ-----NK 708 (828)
Q Consensus 635 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----~~ 708 (828)
... ......||..|+|||.+.+. .++.++|||||||++|||++|++||................... ..
T Consensus 171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 432 23456789999999987665 56899999999999999999999998665443322221110000 00
Q ss_pred ----------CCcccccCccccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHHHH
Q 003350 709 ----------GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 754 (828)
Q Consensus 709 ----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eVl~ 754 (828)
..........+.. ........+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000000000 00123456788999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-33 Score=310.92 Aligned_cols=261 Identities=19% Similarity=0.207 Sum_probs=189.3
Q ss_pred CCCccceEeeeCcEEEEEEEec-CCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-----------CCceEEEEEEEcc-
Q 003350 485 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-----------HRHLVSLIGYCDE- 551 (828)
Q Consensus 485 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~- 551 (828)
+|...++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4788899999999999999874 68999999987543 23467789999998875 5789999988754
Q ss_pred -CCcEEEEEEeccCCcc-cccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCC------c
Q 003350 552 -KNEMILIYEYMENGTL-KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF------M 623 (828)
Q Consensus 552 -~~~~~lV~ey~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~------~ 623 (828)
....+++++++..+.. ...........+++..+..++.|+++||+|||+ ..+|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 3456677777655433 233333444678999999999999999999996 36899999999999998665 4
Q ss_pred EEEEeeCCCCCCCCCCccceeccccccccccChhhhccCCCCcccceeehhhHHHHHHhcCCCCCCCChhhh----hhHH
Q 003350 624 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM----VNLA 699 (828)
Q Consensus 624 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVySfGvvl~elltG~~p~~~~~~~~~----~~l~ 699 (828)
+|++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||........ ..+.
T Consensus 171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 99999999875432 22456799999999999999999999999999999999999999975432211 1111
Q ss_pred HHHHHHh-----------------hcCCcccccCc----------cccCCCChhHHHHHHHHHHhhhhhCCCCCCChHHH
Q 003350 700 EWAMKWQ-----------------NKGQLDQIIDP----------TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV 752 (828)
Q Consensus 700 ~~~~~~~-----------------~~~~~~~~~d~----------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~eV 752 (828)
.....+. ........+.. .............+.+++.+||+.||.+|||+.|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1111100 00000000000 00112345667889999999999999999999998
Q ss_pred H
Q 003350 753 L 753 (828)
Q Consensus 753 l 753 (828)
+
T Consensus 326 L 326 (362)
T d1q8ya_ 326 V 326 (362)
T ss_dssp H
T ss_pred h
Confidence 6
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=8.1e-22 Score=195.20 Aligned_cols=162 Identities=15% Similarity=0.143 Sum_probs=121.3
Q ss_pred ccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCc------------------ccHHHHHHHHHHHHcCCCCceEEEEEEE
Q 003350 488 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ------------------QGLAEFQTEIEMLSQFRHRHLVSLIGYC 549 (828)
Q Consensus 488 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~~ 549 (828)
..++||+|+||.||+|+..+|+.||||.++.... .....+..|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4679999999999999988899999997653210 0123345788999999999999888764
Q ss_pred ccCCcEEEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcCCCCEEeeeeecCcEEeCCCCcEEEEee
Q 003350 550 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 629 (828)
Q Consensus 550 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDIkp~NILld~~~~~kl~DF 629 (828)
. .+++|||+++..+.+ ++.....+++.|++++|+|||+ .+|+||||||+|||++++ .++|+||
T Consensus 84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence 3 379999998765543 4456677899999999999999 999999999999999965 5899999
Q ss_pred CCCCCCCCCCccceeccccccccccCh------hhhccCCCCcccceeehhhHH
Q 003350 630 GLSKTGPEIDQTHVSTAVKGSFGYLDP------EYFRRQQLTEKSDVYSFGVVL 677 (828)
Q Consensus 630 Gla~~~~~~~~~~~~~~~~gt~~Y~aP------E~~~~~~~s~ksDVySfGvvl 677 (828)
|+|......... .|... |.+ .+.|..++|+||..--+
T Consensus 147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999764321111 12111 222 35678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.24 E-value=1.3e-06 Score=88.27 Aligned_cols=150 Identities=13% Similarity=0.071 Sum_probs=100.6
Q ss_pred HHHHHHhcCCCccceEeeeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCC-CCceEEEEEEEccCCcE
Q 003350 477 VAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEM 555 (828)
Q Consensus 477 ~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 555 (828)
.+++.....|...+..+-+....||+...+ ++.+.+|+...........+.+|..++..+. +--+.+++.++...+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 356666667765444333445689988654 5567888876554434445678888887763 43456778888888889
Q ss_pred EEEEEeccCCcccccccCCCCCCCChhhHHHHHHHHHHHHHHHHhcC---------------------------------
Q 003350 556 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY--------------------------------- 602 (828)
Q Consensus 556 ~lV~ey~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 602 (828)
++||+++++.++.+.... .....+++.++++.|+.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999999887654311 1223345555666666666310
Q ss_pred -----------------------CCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 603 -----------------------AKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 603 -----------------------~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
...++|+|+.|.|||++++..+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877677999987653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.66 E-value=8.5e-05 Score=74.06 Aligned_cols=130 Identities=19% Similarity=0.151 Sum_probs=85.3
Q ss_pred EeeeC-cEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCC--CceEEEEEEEccCCcEEEEEEeccCCccc
Q 003350 492 IGIGG-FGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKNEMILIYEYMENGTLK 568 (828)
Q Consensus 492 LG~G~-fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~ey~~~gsL~ 568 (828)
+..|. .+.||+...+++..+++|........ .+..|.+.|+.+.. -.+.++++++.+.+..++||+++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 44444 36799998887888899986655432 45677777776643 33566788888888999999999987664
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHHHHHH-------------------------------------------------
Q 003350 569 GHLYGSGLPSLSWKQRLEICIGSARGLHYLH------------------------------------------------- 599 (828)
Q Consensus 569 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH------------------------------------------------- 599 (828)
+.. +. ...++.++++.|+-||
T Consensus 95 ~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 95 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 421 00 1111222233333333
Q ss_pred --hc----CCCCEEeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 600 --TG----YAKAVIHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 600 --~~----~~~~ivHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
.. ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 123489999999999999887778999987653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.84 E-value=0.00083 Score=71.50 Aligned_cols=76 Identities=14% Similarity=0.134 Sum_probs=47.5
Q ss_pred ceEeeeCcEEEEEEEecC-CcEEEEEEcCCC------C-cccHHHHHHHHHHHHcCC-C--CceEEEEEEEccCCcEEEE
Q 003350 490 WVIGIGGFGKVYKGELND-GTKVAVKRGNPR------S-QQGLAEFQTEIEMLSQFR-H--RHLVSLIGYCDEKNEMILI 558 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV 558 (828)
+.||.|..-.||+....+ ++.++||.-.+. + .........|.+.|+.+. + ..+.+++.+.. ...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEEE
Confidence 468999999999998764 678899964321 1 112334456887777662 2 34566666543 455789
Q ss_pred EEeccCCcc
Q 003350 559 YEYMENGTL 567 (828)
Q Consensus 559 ~ey~~~gsL 567 (828)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.13 E-value=0.0041 Score=64.03 Aligned_cols=134 Identities=11% Similarity=0.197 Sum_probs=78.5
Q ss_pred EEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCce--EEEEE-----EEccCCcEEEEEEeccCCccccc
Q 003350 498 GKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL--VSLIG-----YCDEKNEMILIYEYMENGTLKGH 570 (828)
Q Consensus 498 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~ey~~~gsL~~~ 570 (828)
=.||+.+.++|+.+++|...+.. ...+++..|...+..|...++ +..+. .....+..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 37999999999999999876542 235677888888887743222 11111 11335567889999987544210
Q ss_pred --------------cc----CC---CCCCCChh-------------------hHHHHHHHHHHHHHHHHh----cCCCCE
Q 003350 571 --------------LY----GS---GLPSLSWK-------------------QRLEICIGSARGLHYLHT----GYAKAV 606 (828)
Q Consensus 571 --------------l~----~~---~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~----~~~~~i 606 (828)
+| .. ....+++. .+-.+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 00 01112211 111222222333333332 234679
Q ss_pred EeeeeecCcEEeCCCCcEEEEeeCCCCC
Q 003350 607 IHRDVKSANILLDENFMAKVADFGLSKT 634 (828)
Q Consensus 607 vHrDIkp~NILld~~~~~kl~DFGla~~ 634 (828)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999854 45899998765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.60 E-value=0.009 Score=60.90 Aligned_cols=157 Identities=11% Similarity=0.034 Sum_probs=83.1
Q ss_pred cCHHHHHHHhcCCCccceEe-----eeCcEEEEEEEecCCcEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCceE--EEE
Q 003350 474 FPFVAVQEATNNFDESWVIG-----IGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV--SLI 546 (828)
Q Consensus 474 ~~~~~l~~at~~f~~~~~LG-----~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~ 546 (828)
.+..+++....+|...++.. .|---+.|+.+.++|+ +++|+...... .++...|++++..|.+.++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 46678888888998765543 3444678998877664 88888755322 23444566666666322211 111
Q ss_pred EE------EccCCcEEEEEEeccCCcccccc--------------c----CCC----CCC-----------------CCh
Q 003350 547 GY------CDEKNEMILIYEYMENGTLKGHL--------------Y----GSG----LPS-----------------LSW 581 (828)
Q Consensus 547 g~------~~~~~~~~lV~ey~~~gsL~~~l--------------~----~~~----~~~-----------------l~~ 581 (828)
.. .........++.++.+......- + ... ... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 00 11234456667766654332110 0 000 000 000
Q ss_pred hhHHHHHHHHHHHHHHHHh-cCCCCEEeeeeecCcEEeCCCCcEEEEeeCCCC
Q 003350 582 KQRLEICIGSARGLHYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFGLSK 633 (828)
Q Consensus 582 ~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDIkp~NILld~~~~~kl~DFGla~ 633 (828)
......+..+...+.-.+. ..+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222222222222221 345689999999999999998777899999865
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.38 E-value=0.018 Score=60.64 Aligned_cols=73 Identities=19% Similarity=0.183 Sum_probs=48.5
Q ss_pred ceEeeeCcEEEEEEEecCC--------cEEEEEEcCCCCcccHHHHHHHHHHHHcCCCCce-EEEEEEEccCCcEEEEEE
Q 003350 490 WVIGIGGFGKVYKGELNDG--------TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYE 560 (828)
Q Consensus 490 ~~LG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e 560 (828)
+.|+.|-.=.+|+....++ +.|.++.... .. ......+|.++++.+.-.++ .++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677777889999976542 4566666542 22 23345688888888843344 467777754 58999
Q ss_pred eccCCccc
Q 003350 561 YMENGTLK 568 (828)
Q Consensus 561 y~~~gsL~ 568 (828)
|+++..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=94.36 E-value=0.21 Score=44.14 Aligned_cols=77 Identities=16% Similarity=0.230 Sum_probs=58.2
Q ss_pred eEEeecCCceEEEEEEeeccCCCCcCCccceEEEEeCcEEEEeecCCCCcEEEEEEEecCCCcEEEEEecCC-CCcceee
Q 003350 96 YTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSN-NSFAFIN 174 (828)
Q Consensus 96 ~~~~~~~~~~ylvR~~f~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~E~~~~~~~~~~~vc~~~~~-~~~pfi~ 174 (828)
|.+.| ++|.|-|.+.| |+- -..++.+.+-..+..+.. ...-+.+.+.+.++.|++-|.... ...|=||
T Consensus 67 f~v~v-PnG~Y~Vtv~~--Gd~-------~~~~~~~eg~~~~~~~~g-~~~~~~~~V~VtDG~L~l~ft~~~~G~~~~in 135 (146)
T d2o14a1 67 FNVDL-PNGLYEVKVTL--GNT-------ARASVAAEGVFQVINMTG-DGAEDTFQIPVTDGQLNLLVTEGKAGTAFTLS 135 (146)
T ss_dssp EEEEC-CSEEEEEEEEE--SSC-------SEEEEEETTEEEEEEEES-TTCEEEEEEEECSSEEEEEEEESSTTSCCEEE
T ss_pred EEEEC-CCCeEEEEEEE--ecC-------CCccEEEeeEEeccccCC-ccEEEEEEEEEECCeEEEEEecCCCCCccEEE
Confidence 44444 69999999999 761 344677777666665533 345568899999999999998665 4589999
Q ss_pred eeeeEEeCC
Q 003350 175 ALEVVSVPD 183 (828)
Q Consensus 175 ~iE~~~~~~ 183 (828)
+|||.+.++
T Consensus 136 ~l~I~~~~d 144 (146)
T d2o14a1 136 ALKIKKLSD 144 (146)
T ss_dssp EEEEEEEES
T ss_pred EEEEEeccc
Confidence 999998765
|